data_1kgl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kgl _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.6 t0 . . . . . 0 CA--C 1.565 1.529 0 CA-C-O 121.397 0.618 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.76 -0.45 23.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -58.25 104.94 0.24 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 121.293 1.86 . . . . 0.0 114.767 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.39 -179.03 36.17 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-O 123.117 1.398 . . . . 0.0 115.938 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 134' ' ' HIS . 35.9 t80 -113.38 116.19 29.28 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 113.651 -1.274 . . . . 0.0 109.399 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -117.19 113.36 22.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -167.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -90.37 140.19 29.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.104 -0.997 . . . . 0.0 113.337 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.6 ttm -67.2 122.03 16.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.17 -45.72 13.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 166.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.7 m -152.71 159.6 43.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.418 -1.426 . . . . 0.0 113.871 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -134.43 113.13 11.53 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.594 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -122.01 123.68 42.2 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.331 0.653 . . . . 0.0 110.492 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.276 37.7 t30 68.06 30.47 5.89 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -79.25 -40.57 30.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.159 -1.588 . . . . 0.0 115.179 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.645 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 49.9 mt-10 -55.03 -42.2 72.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.11 -42.08 89.71 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -55.94 -48.06 76.41 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.75 -39.88 80.09 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -54.9 -44.05 73.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.69 -23.76 60.08 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.3 3.65 38.67 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.288 17.5 t0 61.27 48.33 6.26 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -169.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.29 147.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.001 0.905 . . . . 0.0 110.329 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -63.06 152.76 36.13 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.3 t -60.63 -43.75 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.84 -52.71 61.91 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -62.82 -36.96 84.91 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -54.04 -50.27 67.07 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 163.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.645 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 74.0 mmtt -66.58 -44.92 80.95 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.07 -57.5 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.204 0.911 . . . . 0.0 111.928 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.23 70.98 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -71.15 -35.08 71.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.68 -32.55 73.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.5 mt -73.92 128.15 34.75 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 119.373 0.988 . . . . 0.0 112.331 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -102.64 94.36 5.05 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.942 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.64 161.14 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.294 1.996 . . . . 0.0 115.683 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -104.16 124.41 49.05 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.629 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -88.24 109.34 19.85 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.234 -0.916 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.67 112.18 23.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.91 163.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.97 128.8 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.29 112.72 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.44 1.096 . . . . 0.0 110.52 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -127.34 76.03 1.63 Allowed 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.483 -0.76 . . . . 0.0 110.143 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -102.32 1.21 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.436 -0.79 . . . . 0.0 114.214 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.83 -26.35 20.57 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 162.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -70.56 134.31 47.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.333 1.879 . . . . 0.0 112.768 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 ttm -145.5 130.73 18.51 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.43 0.633 . . . . 0.0 112.074 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.15 108.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.16 110.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -100.98 106.31 17.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.65 -0.656 . . . . 0.0 109.822 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.1 m -88.97 99.45 12.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.49 125.86 41.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.107 0.563 . . . . 0.0 111.525 -163.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -147.31 155.39 41.98 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.097 0.951 . . . . 0.0 111.739 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -62.83 -32.86 74.15 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -75.46 -54.02 7.73 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -152.12 134.01 14.88 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.839 0.745 . . . . 0.0 110.383 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -92.77 122.42 35.14 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.13 0.572 . . . . 0.0 109.821 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -109.55 106.61 16.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.305 0.642 . . . . 0.0 110.499 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.1 mp -105.08 124.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.2 mtp -108.42 110.28 21.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.768 0.827 . . . . 0.0 109.498 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -107.52 118.17 36.01 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.338 0.655 . . . . 0.0 109.775 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.34 155.2 33.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -96.38 129.27 43.76 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.809 0.814 . . . . 0.0 110.713 159.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.96 128.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 C-N-CA 123.995 0.918 . . . . 0.0 109.686 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.13 -47.41 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 115.779 1.071 . . . . 0.0 115.779 -156.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -83.92 135.85 34.32 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.35 105.87 16.32 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.709 0.403 . . . . 0.0 110.36 169.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -113.49 157.14 22.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.864 0.84 . . . . 0.0 113.06 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.21 101.58 5.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 112.349 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -102.41 104.69 15.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.496 -0.752 . . . . 0.0 110.332 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -81.8 113.98 20.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.34 66.3 5.79 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.553 1.168 . . . . 0.0 112.101 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -75.71 117.64 17.68 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.387 1.075 . . . . 0.0 111.25 -168.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.56 -52.62 0.62 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -162.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.02 -68.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 124.733 1.213 . . . . 0.0 110.178 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -130.89 -6.09 3.99 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.285 17.3 t0 51.57 45.31 28.26 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -166.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -108.38 139.11 43.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 110.582 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -81.6 116.12 21.2 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 112.01 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.5 m -108.5 142.0 39.55 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.683 0.793 . . . . 0.0 111.293 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.01 94.73 7.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.132 168.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -99.82 123.55 44.19 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.576 -0.702 . . . . 0.0 110.621 -164.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 m -112.59 122.01 46.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.65 132.72 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -126.76 146.78 50.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.921 0.888 . . . . 0.0 111.685 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.3 m95 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 111.961 175.52 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.888 0.851 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.0 111.23 22.6 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -115.47 123.79 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.125 0.57 . . . . 0.0 110.614 -162.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.72 136.69 54.95 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.43 128.23 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.401 0.68 . . . . 0.0 109.543 165.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -104.34 101.68 11.38 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.549 0.74 . . . . 0.0 109.169 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -85.48 115.57 23.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.863 -1.148 . . . . 0.0 111.596 -170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.57 -120.37 0.63 Allowed Glycine 0 N--CA 1.485 1.915 0 O-C-N 121.905 -0.497 . . . . 0.0 113.516 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.4 -21.52 33.0 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -108.85 144.78 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.654 1.57 . . . . 0.0 113.033 -166.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.55 115.6 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.34 0.59 . . . . 0.0 112.179 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.46 45.47 78.11 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -85.05 124.35 31.63 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.388 0.613 . . . . 0.0 111.329 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.19 -169.14 41.3 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.248 0.916 . . . . 0.0 114.817 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -157.77 153.25 26.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.983 0.897 . . . . 0.0 113.211 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -129.26 125.33 36.62 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.263 3.3 pt20 -126.58 138.64 53.48 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -148.59 159.73 43.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.454 -0.779 . . . . 0.0 113.0 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.8 mt -98.4 125.33 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.32 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -111.53 97.09 6.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 161.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.84 -109.74 2.89 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.46 -0.775 . . . . 0.0 114.15 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -100.46 15.41 28.0 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -113.0 121.22 43.99 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.912 1.687 . . . . 0.0 111.842 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.97 117.02 20.44 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.218 1.007 . . . . 0.0 110.138 167.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -105.68 117.66 34.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.2 tp -113.96 126.83 55.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.027 0.931 . . . . 0.0 110.801 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -106.61 123.53 48.25 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.345 0.658 . . . . 0.0 109.489 164.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -113.21 128.13 56.38 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -115.07 137.0 52.51 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.84 119.98 7.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.548 0.739 . . . . 0.0 110.208 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 55.2 46.92 22.81 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.02 -33.0 0.91 Allowed Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.361 2.504 . . . . 0.0 119.361 -164.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.51 119.93 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.828 1.251 . . . . 0.0 111.209 -166.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.0 m -102.85 115.96 31.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.126 0.571 . . . . 0.0 111.022 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 t -88.8 131.27 35.15 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.056 0.542 . . . . 0.0 111.427 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -113.1 119.66 38.61 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.027 0.531 . . . . 0.0 110.294 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -124.95 133.73 52.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.43 0.692 . . . . 0.0 111.0 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.25 130.39 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.58 128.1 38.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.399 0.68 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -98.94 133.76 42.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.343 -1.473 . . . . 0.0 112.39 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -69.26 122.52 19.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.55 -38.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 7' ' ' TYR . 14.6 t60 . . . . . 0 N--CA 1.488 1.436 0 CA-C-N 119.927 1.239 . . . . 0.0 107.962 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.287 6.0 t70 . . . . . 0 CA--C 1.563 1.468 0 CA-C-O 121.524 0.678 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -81.32 13.92 2.69 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -63.38 116.76 5.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.36 173.18 26.44 Favored Glycine 0 N--CA 1.488 2.157 0 CA-C-O 122.697 1.165 . . . . 0.0 115.859 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -101.87 116.83 33.55 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.189 0.995 . . . . 0.0 109.497 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -117.82 110.8 18.23 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -93.34 139.88 30.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.111 -0.993 . . . . 0.0 112.851 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.4 ttp -69.46 125.71 27.54 Favored 'General case' 0 CA--C 1.571 1.772 0 O-C-N 120.419 -1.426 . . . . 0.0 114.68 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.84 -50.92 6.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.5 p -136.36 155.17 50.42 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -143.55 117.65 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.032 0.933 . . . . 0.0 108.947 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.05 -71.38 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -166.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -121.97 41.88 3.27 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.956 0.884 . . . . 0.0 112.108 -171.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -73.57 -39.94 64.29 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -57.22 -43.84 83.22 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.78 -39.05 84.1 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -56.54 -45.93 80.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 167.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 mt -71.38 -37.48 71.6 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -55.09 -46.0 75.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 161.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.0 -20.81 41.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.06 5.68 50.63 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.286 23.8 t70 61.03 50.13 5.25 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.52 1.509 . . . . 0.0 114.87 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -93.38 150.38 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.892 0.854 . . . . 0.0 109.891 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -63.81 152.42 39.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.79 -44.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.28 64.13 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.37 -38.52 89.9 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -53.99 -53.1 57.63 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -62.15 -43.72 98.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.4 mt -64.1 -53.81 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.898 0.879 . . . . 0.0 111.919 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.65 85.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -61.91 -36.67 82.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.58 -20.68 53.62 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.23 156.88 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -96.15 103.17 12.72 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.182 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.49 146.9 19.63 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.696 2.264 . . . . 0.0 112.947 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -134.28 107.7 7.8 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -83.77 107.45 16.19 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.516 -0.74 . . . . 0.0 111.094 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -94.31 106.43 18.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.63 129.24 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.2 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -99.71 109.84 22.28 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.082 0.553 . . . . 0.0 110.209 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -100.39 81.14 2.32 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.439 0.696 . . . . 0.0 109.304 167.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.63 -102.97 1.03 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 115.02 0.768 . . . . 0.0 115.02 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -86.32 -26.83 24.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 164.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -75.2 119.27 19.1 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.417 1.462 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 ttm -122.29 123.44 41.44 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.586 0.707 . . . . 0.0 110.538 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.9 mt -110.69 95.59 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.7 mt -93.1 104.25 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -100.82 99.29 9.78 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -87.09 100.49 12.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.311 -0.868 . . . . 0.0 109.364 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.3 mt -104.49 112.54 25.64 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.674 0.75 . . . . 0.0 110.531 -164.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -131.99 155.08 48.61 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.976 0.893 . . . . 0.0 111.309 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -65.58 -19.23 65.83 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -83.97 -50.76 7.72 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 119.057 0.844 . . . . 0.0 113.065 168.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -153.2 148.22 26.64 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.882 0.848 . . . . 0.0 110.505 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.52 130.44 50.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.885 . . . . 0.0 110.125 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.74 104.59 11.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.79 -0.569 . . . . 0.0 110.765 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.48 128.23 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.603 0.761 . . . . 0.0 109.122 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -113.41 108.1 16.75 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.722 0.809 . . . . 0.0 109.513 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.27 98.13 7.28 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.641 0.776 . . . . 0.0 110.446 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -144.8 155.92 43.76 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -93.11 131.34 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.863 -1.148 . . . . 0.0 111.007 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.1 t -68.37 126.64 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.65 -0.656 . . . . 0.0 110.689 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.14 -30.61 8.14 Favored Glycine 0 CA--C 1.552 2.384 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -91.86 144.8 25.11 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.168 1.484 . . . . 0.0 112.746 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.625 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 23.6 tt0 -90.6 128.08 36.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 111.507 168.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.01 149.27 51.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.655 0.782 . . . . 0.0 112.36 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -74.15 101.08 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.035 -1.04 . . . . 0.0 111.913 172.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -94.03 116.01 28.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.546 0.738 . . . . 0.0 110.206 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -80.94 127.43 32.56 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.586 0.707 . . . . 0.0 109.72 163.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mt -99.37 60.98 1.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.135 0.969 . . . . 0.0 111.128 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 119.15 23.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.318 1.047 . . . . 0.0 111.712 -166.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.65 -42.4 1.92 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -162.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.21 -69.57 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.107 0.963 . . . . 0.0 110.125 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -141.3 -1.02 1.37 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 166.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 28.2 m-20 63.93 65.26 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 120.22 1.373 . . . . 0.0 113.575 -173.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.9 mmt-85 -122.2 142.34 50.53 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.612 0.765 . . . . 0.0 110.643 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.38 111.12 22.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.529 165.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m -117.7 145.02 44.72 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.45 0.7 . . . . 0.0 112.098 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.0 mtp -83.4 98.99 9.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -98.86 122.56 42.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.076 0.55 . . . . 0.0 110.182 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.0 m -102.68 131.87 49.19 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.91 122.59 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.1 m -131.01 158.05 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.78 0.832 . . . . 0.0 112.007 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.9 m95 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.69 -1.256 . . . . 0.0 112.214 175.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.664 0.745 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.95 103.34 16.01 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.24 0.616 . . . . 0.0 109.511 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -110.74 131.79 54.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.572 0.749 . . . . 0.0 111.269 -167.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.2 t -130.93 141.86 50.31 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.43 128.1 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.913 0.885 . . . . 0.0 109.302 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -106.22 95.99 6.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.711 0.804 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.625 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 95.1 mttt -85.76 120.46 27.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 112.128 -170.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.49 -115.55 0.47 Allowed Glycine 0 N--CA 1.486 1.989 0 O-C-N 121.25 -0.906 . . . . 0.0 113.531 171.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.7 -13.5 57.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -114.71 146.4 40.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.294 1.406 . . . . 0.0 112.359 -170.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -90.24 103.27 15.97 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.462 -162.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.42 50.44 21.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -170.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -89.76 137.21 32.53 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.945 0.879 . . . . 0.0 111.933 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.42 -161.17 27.67 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 121.936 0.742 . . . . 0.0 114.257 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -157.42 157.93 34.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.866 . . . . 0.0 112.638 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -132.77 124.74 28.66 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.286 1.3 pt20 -129.43 141.82 50.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.48 161.2 43.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 0.0 112.53 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -103.83 123.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.934 . . . . 0.0 109.15 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.33 85.19 2.21 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 162.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.05 -111.77 4.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.96 -5.95 58.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 165.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.66 127.28 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 120.396 1.453 . . . . 0.0 111.92 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.1 tp -88.41 117.86 27.63 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.847 0.859 . . . . 0.0 109.724 166.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -100.77 121.52 41.82 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.756 0.823 . . . . 0.0 109.277 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -117.53 130.69 56.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.993 0.917 . . . . 0.0 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.77 118.93 34.97 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.733 0.813 . . . . 0.0 109.554 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.4 mtm -110.63 132.04 54.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.497 -0.752 . . . . 0.0 111.265 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -124.35 133.73 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.86 . . . . 0.0 112.169 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.57 126.88 8.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.272 0.629 . . . . 0.0 110.966 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 57.3 36.51 27.38 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.04 -19.94 2.65 Favored Glycine 0 CA--C 1.558 2.753 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 -162.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.79 119.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 119.568 1.684 . . . . 0.0 109.562 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -101.59 121.84 42.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.446 0.641 . . . . 0.0 110.743 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.1 t -97.6 124.82 42.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -102.31 127.29 49.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.957 -0.465 . . . . 0.0 111.666 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -127.16 142.82 51.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.941 0.896 . . . . 0.0 111.274 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.54 132.52 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.4 132.13 48.51 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.516 0.726 . . . . 0.0 111.235 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -97.2 127.98 43.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.702 -1.249 . . . . 0.0 112.18 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -67.19 122.94 18.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.1 -39.71 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.103 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.257 0.551 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -81.27 4.49 20.29 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -57.83 108.57 0.59 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.725 1.602 . . . . 0.0 115.144 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.89 179.12 33.5 Favored Glycine 0 N--CA 1.486 2.01 0 CA-C-O 122.756 1.198 . . . . 0.0 115.753 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -110.48 118.84 37.34 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.704 1.201 . . . . 0.0 109.151 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -119.15 118.86 32.5 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -88.76 144.89 25.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.943 -1.098 . . . . 0.0 112.905 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.418 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 7.3 ttp -71.83 124.68 25.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.498 -1.376 . . . . 0.0 113.495 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.07 -48.4 7.77 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.9 m -157.27 160.08 38.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.4 . . . . 0.0 112.993 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -142.69 124.5 15.1 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.342 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -126.41 125.08 41.59 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.062 0.945 . . . . 0.0 109.877 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.1 t30 66.1 37.17 5.3 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -79.04 -43.45 24.2 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.27 -34.76 77.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -70.37 -41.43 73.1 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -53.34 -47.31 69.47 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 120.458 1.481 . . . . 0.0 114.842 166.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.89 -38.35 70.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.83 -45.38 78.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.085 -1.635 . . . . 0.0 115.061 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -18.75 43.31 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 166.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.34 -4.54 59.05 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 25.8 t70 67.38 52.97 0.78 Allowed 'General case' 0 CA--C 1.572 1.805 0 CA-C-N 120.154 1.343 . . . . 0.0 113.996 -166.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -102.86 146.43 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.977 0.894 . . . . 0.0 109.685 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.76 152.38 44.45 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -60.28 -44.12 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.88 65.88 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 116.004 1.854 . . . . 0.0 116.004 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.82 -41.7 96.22 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -52.33 -53.21 47.45 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 166.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -63.23 -43.91 96.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.88 -53.65 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.631 0.772 . . . . 0.0 111.869 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.68 81.77 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -68.6 -30.91 69.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.31 -29.52 62.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 166.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.15 131.55 42.94 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.041 1.291 . . . . 0.0 112.723 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -105.63 89.51 3.48 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.482 173.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.4 Cg_endo -72.6 165.38 32.88 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.371 2.047 . . . . 0.0 115.601 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -111.6 120.24 41.42 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -89.92 110.58 21.53 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.438 -0.789 . . . . 0.0 111.004 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -98.53 110.13 22.78 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.713 -0.617 . . . . 0.0 109.802 169.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.44 125.83 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.43 107.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 165.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -102.42 102.09 12.38 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.643 0.777 . . . . 0.0 109.998 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -92.75 79.32 4.75 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 109.963 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.55 -101.79 0.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 114.508 0.563 . . . . 0.0 114.508 -173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.34 -26.62 24.76 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -79.1 106.27 11.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.772 1.624 . . . . 0.0 111.635 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -112.45 124.03 51.6 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.968 0.907 . . . . 0.0 110.722 -172.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.95 96.84 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.93 108.36 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -102.6 98.94 8.92 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.226 0.61 . . . . 0.0 109.38 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -84.14 101.41 11.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.14 127.5 43.16 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.074 0.55 . . . . 0.0 111.692 -166.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 t -150.79 153.48 35.53 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.981 0.896 . . . . 0.0 111.646 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.6 -31.83 72.73 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -73.02 -51.26 18.88 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -155.55 138.36 15.29 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.032 0.833 . . . . 0.0 110.792 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -99.18 116.92 32.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -107.5 107.71 18.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.854 -0.529 . . . . 0.0 111.035 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.51 127.24 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.1 105.55 15.61 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.596 0.758 . . . . 0.0 109.421 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.02 113.48 26.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.611 0.764 . . . . 0.0 109.753 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.83 157.23 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -168.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -97.35 132.15 43.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 111.473 165.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -69.78 122.09 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 123.38 0.672 . . . . 0.0 110.154 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.93 -37.96 3.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 -158.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.87 136.75 32.87 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 118.25 1.025 . . . . 0.0 113.547 -165.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -87.6 117.38 26.37 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.878 0.471 . . . . 0.0 110.93 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -134.24 145.77 49.46 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.378 0.671 . . . . 0.0 112.287 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.04 101.88 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.463 -1.398 . . . . 0.0 112.958 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.4 112.19 24.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.242 0.617 . . . . 0.0 110.444 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.81 114.99 19.15 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.581 0.705 . . . . 0.0 110.775 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.93 55.26 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 112.857 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 t -74.07 133.57 42.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.55 -54.18 1.48 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.707 -0.62 . . . . 0.0 114.116 -158.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.2 mt -71.27 -63.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.667 0.787 . . . . 0.0 111.221 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -139.21 -3.99 1.53 Allowed 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 166.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.416 4.4 p30 50.14 64.1 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.789 1.632 . . . . 0.0 115.088 -159.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -124.6 130.4 52.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.359 0.664 . . . . 0.0 109.747 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -90.81 112.91 24.92 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.854 -0.529 . . . . 0.0 110.246 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.8 m -123.54 132.44 53.9 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.361 0.665 . . . . 0.0 111.264 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtp -70.04 99.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.423 1.106 . . . . 0.0 110.395 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -108.19 122.35 46.74 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.844 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.6 m -107.68 120.51 42.44 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.9 t -109.62 124.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.7 m -138.44 155.28 48.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 112.473 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 70.6 m95 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.842 -1.162 . . . . 0.0 112.385 177.129 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.561 0.695 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.34 114.61 26.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.707 -0.62 . . . . 0.0 109.809 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.586 0.755 . . . . 0.0 111.26 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.6 t -128.0 138.37 52.57 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p -117.37 131.17 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.916 0.887 . . . . 0.0 109.654 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.18 97.8 7.2 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.0 0.92 . . . . 0.0 109.17 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -91.67 119.68 31.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.481 -0.762 . . . . 0.0 112.025 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.11 -107.15 0.28 Allowed Glycine 0 N--CA 1.487 2.036 0 O-C-N 121.211 -0.931 . . . . 0.0 113.48 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.6 -12.05 59.95 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -126.44 145.08 50.62 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.093 1.315 . . . . 0.0 112.053 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.13 110.57 18.13 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.779 0.832 . . . . 0.0 111.418 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.39 46.13 73.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -85.01 139.97 31.38 Favored 'General case' 0 CA--C 1.569 1.682 0 CA-C-N 118.001 0.901 . . . . 0.0 111.668 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.15 -164.49 33.87 Favored Glycine 0 N--CA 1.484 1.854 0 O-C-N 121.391 -0.818 . . . . 0.0 114.736 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.65 157.08 32.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -128.78 130.11 46.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -131.85 144.14 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.712 0.768 . . . . 0.0 112.882 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.4 p90 -153.52 163.63 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.452 0.701 . . . . 0.0 112.723 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.9 129.62 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.396 -0.815 . . . . 0.0 108.888 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.64 98.27 6.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 162.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.84 -115.06 4.58 Favored Glycine 0 N--CA 1.49 2.27 0 O-C-N 121.559 -0.713 . . . . 0.0 114.353 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -95.73 12.96 28.08 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 163.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -112.55 132.83 54.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.554 1.524 . . . . 0.0 112.553 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.65 120.24 31.55 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.254 1.022 . . . . 0.0 108.961 170.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -109.74 124.14 50.74 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 108.895 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.8 tp -130.81 132.51 45.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.644 0.777 . . . . 0.0 110.251 -167.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.17 120.11 34.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.735 -0.603 . . . . 0.0 110.02 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.1 mtm -112.1 132.21 54.98 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.622 0.769 . . . . 0.0 111.322 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -124.2 137.25 54.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 112.287 -167.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.61 124.59 8.62 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.096 0.559 . . . . 0.0 110.882 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 54.75 43.58 29.85 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.72 -28.56 1.3 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 119.587 2.595 . . . . 0.0 119.587 -164.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.89 120.91 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 118.909 1.354 . . . . 0.0 110.564 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 m -101.9 125.39 48.57 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 121.375 0.607 . . . . 0.0 111.032 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.1 t -92.82 133.57 35.93 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.352 0.661 . . . . 0.0 111.291 163.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -102.14 126.68 49.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.272 0.629 . . . . 0.0 110.536 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -128.6 138.98 52.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.058 0.943 . . . . 0.0 111.131 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.12 127.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -126.92 152.57 46.94 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.501 1.12 . . . . 0.0 110.65 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -124.45 135.91 53.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.214 -1.554 . . . . 0.0 112.714 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -70.23 125.4 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.18 -37.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 120.209 1.368 . . . . 0.0 108.346 169.119 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 CA--C 1.565 1.541 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -74.85 0.96 13.82 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 170.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -57.88 112.92 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 121.333 1.879 . . . . 0.0 114.57 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.0 32.32 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-O 123.108 1.393 . . . . 0.0 116.081 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -112.4 113.57 25.83 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.75 -1.225 . . . . 0.0 108.862 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -115.42 115.54 26.72 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -166.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -89.91 143.44 26.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 113.258 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.456 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 12.8 ttp -75.54 127.33 32.86 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 113.77 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -93.1 -45.88 7.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -157.2 158.22 35.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.4 -1.438 . . . . 0.0 113.1 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -137.18 132.26 33.68 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.762 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.33 120.44 19.91 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.351 0.661 . . . . 0.0 109.956 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.278 45.0 t30 65.36 32.14 9.94 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 117.506 2.409 . . . . 0.0 117.506 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -78.12 -37.25 46.6 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -56.31 -41.97 76.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.77 -39.33 84.11 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -58.63 -47.88 82.9 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 167.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.29 -40.39 90.0 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -54.66 -46.0 73.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 162.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.86 -13.74 27.17 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.81 -50.09 5.53 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.43 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.94 5.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.938 1.695 . . . . 0.0 115.126 163.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.69 147.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 118.626 -2.546 . . . . 0.0 113.118 -146.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -67.1 154.42 41.26 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.96 -47.11 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.83 64.08 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.33 -36.88 85.39 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -54.58 -50.23 68.49 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -60.43 -44.3 95.93 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.6 -56.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 123.895 0.878 . . . . 0.0 111.821 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.99 77.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -69.07 -32.29 71.65 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.04 -27.47 60.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.79 141.6 49.69 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.216 1.371 . . . . 0.0 113.706 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -100.68 92.93 2.53 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.467 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 72.4 Cg_endo -71.8 155.33 58.38 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 122.629 2.219 . . . . 0.0 114.946 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.96 117.77 35.07 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.114 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.06 108.02 18.69 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.609 -0.682 . . . . 0.0 110.382 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -93.35 109.64 21.19 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.196 168.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mt -107.25 128.42 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.55 108.31 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -102.48 112.62 25.42 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.993 0.917 . . . . 0.0 110.483 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -105.48 75.97 1.18 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.597 -0.689 . . . . 0.0 109.669 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.48 -99.3 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.636 ' HD2' ' NZ ' ' A' ' 68' ' ' LYS . 29.1 p-10 -78.24 -37.93 44.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 164.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -77.02 116.07 17.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 120.333 1.424 . . . . 0.0 112.31 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.9 ttm -126.59 124.81 40.79 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.655 0.782 . . . . 0.0 110.866 -170.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.7 99.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.19 110.9 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -106.93 97.27 7.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.6 m -83.49 102.82 12.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.11 116.85 32.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.587 0.708 . . . . 0.0 111.094 -166.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -135.66 150.76 49.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.53 0.732 . . . . 0.0 110.099 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -63.42 -27.05 69.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.03 -41.48 64.17 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 164.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -158.19 129.89 6.75 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.847 1.203 . . . . 0.0 112.931 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -105.03 120.65 42.01 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.641 0.777 . . . . 0.0 109.765 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -121.85 109.98 15.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.758 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.84 125.75 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -103.55 107.32 18.12 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.49 0.716 . . . . 0.0 109.348 166.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -107.66 112.13 24.69 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.473 0.709 . . . . 0.0 109.583 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -154.51 164.27 38.93 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.32 134.23 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.969 167.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.23 134.92 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 O-C-N 121.149 -0.97 . . . . 0.0 110.55 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.22 46.18 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -163.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.636 ' NZ ' ' HD2' ' A' ' 47' ' ' ASP . 10.7 mptt -108.36 145.0 35.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.926 1.363 . . . . 0.0 110.236 -162.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -90.72 128.9 36.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -139.21 158.99 43.19 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.143 0.973 . . . . 0.0 112.882 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.37 92.17 3.34 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 111.763 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -88.43 100.2 12.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.06 101.04 13.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 122.955 0.502 . . . . 0.0 110.552 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 mp -83.41 52.11 2.15 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.9 m -70.68 124.38 24.14 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.357 1.063 . . . . 0.0 110.302 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.28 -16.3 49.42 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 -162.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.21 -82.01 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.792 1.796 . . . . 0.0 106.948 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -122.3 17.55 10.64 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 52.88 46.97 25.7 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -129.27 140.56 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.64 0.733 . . . . 0.0 112.466 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -87.72 109.25 19.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.622 0.769 . . . . 0.0 111.149 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.4 m -101.37 140.31 35.84 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.438 0.695 . . . . 0.0 111.603 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.8 80.41 7.27 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.459 1.123 . . . . 0.0 110.193 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.7 m -85.51 128.08 34.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.173 -0.954 . . . . 0.0 110.672 -166.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -116.5 118.51 32.86 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.4 HG22 ' SG ' ' A' ' 95' ' ' CYS . 27.1 t -112.66 125.05 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.8 m -135.78 156.78 48.28 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.961 0.886 . . . . 0.0 112.928 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.4 m95 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.356 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttp . . . . . 0 CA--C 1.557 1.228 0 CA-C-O 121.945 0.878 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.2 tp -85.85 106.02 16.76 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -94.67 129.99 41.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.955 0.902 . . . . 0.0 111.459 -172.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.4 ' SG ' HG22 ' A' ' 86' ' ' VAL . 40.8 t -125.06 127.35 46.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.651 0.78 . . . . 0.0 112.068 -176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.59 119.64 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -95.41 97.1 9.57 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -81.38 115.87 20.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 111.692 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.37 -126.13 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 O-C-N 122.11 -0.369 . . . . 0.0 113.292 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.36 -31.69 37.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.59 144.79 26.91 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.041 1.292 . . . . 0.0 113.084 -164.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -81.63 106.31 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.351 0.661 . . . . 0.0 112.081 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.92 53.6 14.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -89.96 124.7 34.96 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.303 0.641 . . . . 0.0 110.857 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.9 -166.95 38.02 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -160.17 157.28 28.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.255 1.026 . . . . 0.0 113.004 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -128.94 129.83 45.96 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.0 139.42 52.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -148.61 166.33 28.62 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 52.1 mt -106.44 122.91 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.501 -0.749 . . . . 0.0 109.349 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -110.87 86.87 2.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.534 -0.729 . . . . 0.0 109.907 164.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.24 -109.69 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.527 -0.733 . . . . 0.0 113.557 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.92 43.69 1.4 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 156.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.25 124.67 43.51 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.624 0.77 . . . . 0.0 109.634 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.71 113.37 25.44 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 121.737 0.78 . . . . 0.0 108.975 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.92 124.04 48.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.4 tp -125.02 125.97 44.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.725 0.81 . . . . 0.0 110.716 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -108.46 123.29 48.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.41 135.76 52.71 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.695 -0.628 . . . . 0.0 111.582 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -123.76 133.77 53.78 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 112.735 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.78 5.88 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.794 0.838 . . . . 0.0 110.214 173.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 56.29 41.49 29.09 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.91 -12.05 2.3 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 120.11 2.804 . . . . 0.0 120.11 -163.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.11 123.53 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 119.692 1.746 . . . . 0.0 109.69 -166.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 m -99.6 118.01 35.21 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.662 0.385 . . . . 0.0 110.341 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -99.51 122.78 43.08 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.144 0.578 . . . . 0.0 110.856 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -101.77 129.46 47.96 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.683 0.754 . . . . 0.0 111.441 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -137.85 131.71 31.48 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.989 0.916 . . . . 0.0 110.276 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.88 132.47 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 109.017 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -132.42 149.75 52.28 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.842 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -124.14 128.27 49.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.431 -1.418 . . . . 0.0 111.127 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -71.49 120.16 16.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.465 -0.772 . . . . 0.0 112.838 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.3 -38.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 CA--C 1.566 1.568 0 CA-C-N 119.702 1.137 . . . . 0.0 108.219 169.591 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 CA--C 1.565 1.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -80.64 6.32 13.04 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -59.34 112.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 121.422 1.919 . . . . 0.0 114.799 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.6 178.82 33.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -109.67 109.73 20.55 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.595 1.158 . . . . 0.0 109.043 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -112.48 110.04 19.99 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -168.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -86.57 137.72 32.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.103 -0.998 . . . . 0.0 113.193 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ttp -74.1 122.39 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.02 1.282 . . . . 0.0 114.043 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 mt -82.16 -53.76 5.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.424 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -130.91 154.72 47.8 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -172.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -136.94 109.45 7.42 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.761 0.824 . . . . 0.0 108.839 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -93.07 -64.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -124.91 44.94 2.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.68 0.752 . . . . 0.0 111.916 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -72.5 -38.56 68.09 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.8 -41.74 96.23 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -71.16 -40.01 71.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -53.17 -47.27 68.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.24 -37.76 71.98 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -55.84 -44.16 77.73 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 163.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.47 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.95 1.06 53.94 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.289 4.2 t70 64.2 49.83 2.54 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -168.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.59 145.89 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.94 0.876 . . . . 0.0 109.903 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -61.93 153.97 27.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.01 -47.5 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.5 62.68 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.0 tp -66.33 -25.67 66.93 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -64.95 -47.23 78.37 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.767 1.621 . . . . 0.0 113.86 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -50.98 67.32 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -53.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 124.097 0.959 . . . . 0.0 112.212 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.2 -35.88 78.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -69.08 -32.61 72.19 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.63 -28.65 62.88 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.22 135.04 48.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.061 1.3 . . . . 0.0 112.826 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.57 89.59 2.28 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.648 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.29 151.96 60.81 Favored 'Trans proline' 0 CA--C 1.561 1.858 0 CA-C-N 123.056 2.127 . . . . 0.0 115.371 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.66 115.49 30.34 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -84.26 107.54 16.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.456 -0.778 . . . . 0.0 110.495 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -94.54 110.25 22.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -105.71 126.25 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.7 t -112.02 108.95 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -106.13 111.34 23.92 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 121.931 0.872 . . . . 0.0 110.702 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -99.78 76.24 1.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.659 1.184 . . . . 0.0 109.459 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.96 -106.46 1.93 Allowed Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.067 -1.021 . . . . 0.0 114.682 -175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.85 -22.12 24.63 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 162.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -70.09 120.99 16.62 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 120.132 1.333 . . . . 0.0 111.712 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -136.54 122.73 20.44 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 121.498 0.666 . . . . 0.0 111.043 -163.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.4 mt -116.21 99.98 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -95.66 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -99.68 98.86 9.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -84.1 95.67 8.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 109.019 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -93.26 124.52 37.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.057 0.543 . . . . 0.0 111.149 -166.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 t -146.34 154.16 41.34 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.107 0.956 . . . . 0.0 111.83 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -61.86 -30.82 71.11 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -77.82 -52.38 9.0 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -153.67 138.43 17.04 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.175 0.898 . . . . 0.0 110.877 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -93.08 117.79 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.736 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -106.21 104.22 13.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.521 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.29 125.47 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.2 mtp -103.98 110.13 22.16 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.309 165.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.56 111.1 20.83 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.238 1.015 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.34 168.82 26.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -164.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -106.8 135.21 48.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.975 -1.078 . . . . 0.0 110.238 161.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.0 125.55 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 O-C-N 121.42 -0.8 . . . . 0.0 108.94 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.58 -35.08 4.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -155.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 138.48 34.1 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 118.383 1.092 . . . . 0.0 113.165 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -87.62 114.77 24.53 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 122.024 -0.423 . . . . 0.0 110.336 167.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.95 148.6 50.51 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.497 0.719 . . . . 0.0 112.567 -173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.77 99.7 4.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 112.083 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.54 109.01 20.3 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.485 -0.759 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -79.38 106.07 11.15 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.215 0.531 . . . . 0.0 110.284 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.93 49.59 1.76 Allowed 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -79.95 130.39 35.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 113.275 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.89 -50.51 0.96 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.4 -0.813 . . . . 0.0 114.744 -154.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.8 mt -78.43 -65.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 124.398 1.079 . . . . 0.0 110.838 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.55 ' N ' ' HD2' ' A' ' 78' ' ' ASP . 14.5 p-10 -147.06 7.66 0.92 Allowed 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.274 2.3 m-20 57.46 30.55 18.83 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -104.57 141.1 37.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 111.298 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.86 98.28 11.28 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.155 0.582 . . . . 0.0 109.591 173.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.24 146.01 28.61 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.428 0.632 . . . . 0.0 112.104 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -79.26 95.66 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.914 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.8 m -93.99 126.72 39.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.058 0.543 . . . . 0.0 110.149 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -116.63 130.4 56.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.438 HG23 ' SG ' ' A' ' 95' ' ' CYS . 22.4 t -116.69 130.3 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -125.58 139.82 53.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.076 0.951 . . . . 0.0 111.087 -175.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.5 m95 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 112.611 177.09 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.391 0.615 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -98.51 114.71 27.22 Favored 'General case' 0 CA--C 1.561 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.171 169.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -117.15 129.24 55.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.147 0.579 . . . . 0.0 111.064 -163.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.438 ' SG ' HG23 ' A' ' 86' ' ' VAL . 53.5 t -130.37 145.56 51.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -121.74 135.34 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 124.175 0.99 . . . . 0.0 110.42 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.0 95.55 5.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.834 0.853 . . . . 0.0 109.734 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.25 124.37 33.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.642 -1.286 . . . . 0.0 112.843 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 -112.3 0.27 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 121.661 -0.649 . . . . 0.0 112.283 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -83.2 -10.05 58.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -113.16 143.97 43.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.549 1.522 . . . . 0.0 113.186 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -80.55 124.15 28.71 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.31 42.37 99.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 118.494 2.158 . . . . 0.0 118.494 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -91.36 134.08 34.91 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.843 0.83 . . . . 0.0 111.595 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.66 -163.83 32.49 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 121.882 0.712 . . . . 0.0 114.298 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -156.88 153.53 28.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -129.52 126.04 37.69 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.44 137.95 54.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -148.58 163.2 37.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 112.913 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.29 125.04 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.97 96.58 6.03 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.4 -109.0 2.67 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.374 -0.829 . . . . 0.0 113.882 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -109.75 25.71 11.48 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 158.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -108.81 123.63 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.917 1.235 . . . . 0.0 110.974 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -82.21 115.52 21.33 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.069 0.947 . . . . 0.0 109.151 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -102.16 115.45 30.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.4 123.15 49.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.809 0.843 . . . . 0.0 111.163 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.11 124.25 47.38 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 165.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.3 mtm -116.35 128.99 56.01 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.104 0.865 . . . . 0.0 110.904 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -116.18 136.78 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.55 120.42 8.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.594 0.757 . . . . 0.0 110.022 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 59.07 39.91 22.7 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.94 -34.87 1.25 Allowed Glycine 0 CA--C 1.558 2.749 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -161.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.08 118.36 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.008 1.323 . . . . 0.0 111.238 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.4 m -107.39 119.71 40.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.588 -168.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.8 t -94.36 126.13 39.42 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.531 0.732 . . . . 0.0 111.984 170.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -100.18 127.93 46.35 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.338 0.59 . . . . 0.0 111.751 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -127.64 137.12 52.44 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.899 0.88 . . . . 0.0 110.964 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.23 131.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.51 127.27 43.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.523 0.729 . . . . 0.0 110.319 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.79 123.38 41.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.762 -1.211 . . . . 0.0 111.559 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.55 115.85 8.41 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.237 0.926 . . . . 0.0 112.469 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.7 -36.96 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.588 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 171.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.548 0.213 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -76.56 -1.8 29.26 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -55.44 113.72 1.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 121.189 1.813 . . . . 0.0 114.7 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.69 -179.85 29.66 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-O 122.72 1.178 . . . . 0.0 115.53 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -113.2 118.91 36.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.311 1.044 . . . . 0.0 109.188 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -121.39 114.76 21.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -165.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -88.76 140.89 28.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.255 -0.903 . . . . 0.0 113.254 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.472 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 4.8 ttm -70.34 120.55 16.18 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.46 -45.24 16.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -153.58 159.09 42.07 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.236 1.38 . . . . 0.0 113.549 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -134.07 101.94 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.955 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.617 ' HE2' ' NZ ' ' A' ' 127' ' ' LYS . 18.5 tt0 -111.0 123.55 50.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.197 0.599 . . . . 0.0 111.001 -171.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 29.6 t30 66.31 36.26 5.44 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -79.14 -39.16 34.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.54 -40.59 79.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -66.18 -41.53 90.13 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -55.99 -48.11 76.47 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.88 -40.62 75.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -55.31 -45.87 76.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.69 -20.99 24.53 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 164.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.8 mt -96.17 13.19 28.19 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.304 22.8 t70 60.74 56.48 2.96 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-N 120.709 1.595 . . . . 0.0 113.464 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -106.62 146.82 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 122.093 0.949 . . . . 0.0 110.165 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -64.04 153.01 38.71 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -61.25 -44.03 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.98 -52.12 64.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.81 -38.72 91.84 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -53.2 -53.03 56.68 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -62.46 -46.49 88.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.58 -57.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 123.729 0.812 . . . . 0.0 111.774 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.13 72.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -69.91 -36.83 75.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 165.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.1 mt -73.01 -24.52 60.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.78 143.22 49.61 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.152 1.342 . . . . 0.0 113.805 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -102.82 90.27 2.23 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.757 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 59.6 Cg_endo -69.31 155.74 66.53 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 123.054 2.127 . . . . 0.0 114.987 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.3 118.83 34.37 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.474 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 30.2 mttp -86.03 115.4 23.61 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.525 -0.735 . . . . 0.0 110.849 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -102.2 106.44 17.27 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mp -101.18 131.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.313 -0.867 . . . . 0.0 109.237 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.63 109.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.47 106.62 17.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.883 0.873 . . . . 0.0 110.082 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -99.37 80.4 2.41 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 123.57 0.748 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.89 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.513 -0.742 . . . . 0.0 114.189 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -93.07 -20.14 20.83 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 163.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -74.16 105.89 5.57 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.667 2.03 . . . . 0.0 111.211 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.5 ttm -116.73 124.85 50.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.59 0.756 . . . . 0.0 110.557 -170.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.03 98.39 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.2 mt -94.32 110.83 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.29 96.09 6.12 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.474 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 51.1 m -85.78 99.11 11.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 108.79 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.18 115.93 28.46 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.832 -0.542 . . . . 0.0 111.343 -164.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 t -134.3 151.82 51.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.766 0.793 . . . . 0.0 110.521 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -64.05 -29.33 70.48 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.73 -51.31 28.16 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 167.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.88 134.93 13.92 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.38 0.991 . . . . 0.0 111.213 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.44 118.76 30.83 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 123.781 0.832 . . . . 0.0 109.555 170.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -102.81 116.84 33.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 110.4 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.27 117.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.9 mtp -105.6 105.31 15.28 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -108.36 108.82 19.95 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.575 0.75 . . . . 0.0 109.555 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.85 155.93 33.8 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -90.48 126.74 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.7 165.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.89 121.77 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 168.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.54 -35.13 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 -156.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.44 140.99 32.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.491 1.145 . . . . 0.0 113.3 -165.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -86.3 108.37 18.38 Favored 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 122.818 0.447 . . . . 0.0 110.387 166.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -119.92 143.4 48.0 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.673 0.789 . . . . 0.0 112.504 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.35 97.7 2.55 Favored 'General case' 0 CA--C 1.567 1.609 0 O-C-N 120.935 -1.103 . . . . 0.0 112.609 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -93.51 113.47 25.61 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.452 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.28 105.07 12.18 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.734 0.414 . . . . 0.0 110.752 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.55 52.32 2.31 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -83.58 132.43 34.91 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.089 0.947 . . . . 0.0 111.647 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.58 -62.17 0.38 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.273 -151.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mt -72.11 -70.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.559 1.144 . . . . 0.0 110.202 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -136.08 9.79 3.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 169.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 58.84 45.19 15.73 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -135.17 143.77 46.66 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.725 0.774 . . . . 0.0 111.282 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -88.0 126.24 34.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.624 -0.672 . . . . 0.0 111.341 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -122.66 140.64 52.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.156 0.582 . . . . 0.0 111.142 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.11 97.18 5.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 168.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.406 HG23 ' SG ' ' A' ' 95' ' ' CYS . 75.6 m -95.55 123.25 39.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.42 0.688 . . . . 0.0 110.218 -171.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 m -107.43 126.8 52.96 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 168.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.19 135.86 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -149.95 152.43 34.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.443 -1.411 . . . . 0.0 112.729 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.5 m95 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 120.861 -1.149 . . . . 0.0 112.653 178.278 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.426 0.632 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.73 105.09 16.71 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -109.76 136.1 49.63 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.606 0.762 . . . . 0.0 111.377 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.406 ' SG ' HG23 ' A' ' 84' ' ' THR . 44.3 t -134.93 138.17 43.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -169.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.36 133.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 123.715 0.806 . . . . 0.0 110.242 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -112.56 98.52 7.3 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.626 0.771 . . . . 0.0 109.575 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.31 117.02 27.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.424 -0.798 . . . . 0.0 111.749 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.27 -131.12 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 O-C-N 121.233 -0.917 . . . . 0.0 113.619 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.05 -34.81 69.05 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -96.34 140.0 31.64 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.226 1.012 . . . . 0.0 112.315 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.45 122.56 26.58 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -165.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.06 52.27 53.83 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -93.41 138.87 31.31 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.723 0.773 . . . . 0.0 111.707 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.96 -168.54 35.72 Favored Glycine 0 N--CA 1.485 1.911 0 CA-C-O 121.918 0.732 . . . . 0.0 114.722 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -156.49 153.64 29.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.6 m -128.52 123.12 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -123.57 131.75 53.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.699 0.8 . . . . 0.0 111.397 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -148.89 175.43 11.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.239 -0.913 . . . . 0.0 112.76 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.78 135.8 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.916 -1.115 . . . . 0.0 109.262 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.57 93.12 3.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 165.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.74 -120.04 5.26 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.873 -0.517 . . . . 0.0 113.351 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.43 41.27 1.25 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 161.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -131.1 118.67 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.348 0.659 . . . . 0.0 109.399 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.31 122.31 26.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.891 0.876 . . . . 0.0 110.437 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -112.91 119.79 39.17 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.2 tp -124.61 124.86 43.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.643 0.777 . . . . 0.0 110.53 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.95 121.31 42.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 165.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.7 mtm -110.62 127.46 55.26 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.905 0.775 . . . . 0.0 110.318 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -119.2 145.41 46.06 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.98 122.53 2.59 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.067 0.547 . . . . 0.0 110.75 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.299 7.1 mt-10 50.88 50.82 18.28 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.88 -28.77 2.78 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 120.162 2.825 . . . . 0.0 120.162 -169.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -76.05 156.0 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.817 1.309 . . . . 0.0 112.075 -171.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -123.54 127.51 48.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.0 110.688 168.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.5 t -94.24 136.86 34.07 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.999 0.52 . . . . 0.0 111.199 156.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.617 ' NZ ' ' HE2' ' A' ' 14' ' ' GLU . 35.0 mtmm -114.64 123.94 50.58 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.072 0.549 . . . . 0.0 110.272 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -121.12 135.13 55.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.72 -0.612 . . . . 0.0 111.17 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.12 129.3 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -133.27 136.78 45.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.525 -0.734 . . . . 0.0 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -103.62 133.24 48.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.308 -1.495 . . . . 0.0 112.676 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -69.14 122.89 19.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.6 m -117.53 -37.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 119.761 1.164 . . . . 0.0 107.93 170.413 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.258 46.7 t0 . . . . . 0 CA--C 1.569 1.687 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.97 6.07 14.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.32 108.85 0.99 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.481 1.492 . . . . 0.0 114.652 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.87 -179.64 33.44 Favored Glycine 0 N--CA 1.485 1.958 0 CA-C-O 122.807 1.226 . . . . 0.0 115.58 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -107.5 118.22 36.15 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.45 1.1 . . . . 0.0 109.274 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -117.12 111.75 19.93 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -168.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -85.3 139.03 31.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 112.765 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.445 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 30.6 ttm -65.92 124.99 24.0 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 120.092 1.315 . . . . 0.0 114.355 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -86.08 -43.99 12.63 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -153.0 156.9 39.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.366 -1.459 . . . . 0.0 113.408 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -131.35 109.23 10.2 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.922 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.06 121.09 38.11 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.272 0.629 . . . . 0.0 110.499 -168.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 30.3 t30 68.01 31.83 5.34 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -78.43 -38.46 41.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.93 -41.45 74.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.0 -37.85 78.94 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -55.1 -47.38 75.04 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 120.26 1.391 . . . . 0.0 114.658 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.96 -40.59 71.87 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -54.68 -42.86 71.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 165.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 -29.15 60.78 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.4 -0.71 53.75 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 17.2 t0 66.71 48.12 1.45 Allowed 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 144.47 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.985 172.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -64.53 155.0 34.34 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 171.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.94 -43.84 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.67 50.27 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.33 -37.42 85.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -56.78 -51.7 67.89 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 165.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -62.94 -46.74 86.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.45 -56.9 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.042 0.837 . . . . 0.0 111.719 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.39 -27.98 67.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -75.19 -33.67 61.45 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.63 -34.16 76.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 166.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.36 130.28 40.95 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.176 0.988 . . . . 0.0 112.278 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.39 100.01 9.63 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.838 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 38.1 Cg_endo -66.8 154.89 72.98 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 CA-C-N 123.466 2.274 . . . . 0.0 114.967 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -108.24 119.63 40.03 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -89.46 113.85 25.27 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.358 -0.839 . . . . 0.0 110.863 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.78 106.97 19.3 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.807 -0.558 . . . . 0.0 109.545 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -102.24 130.6 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.58 108.79 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 167.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -94.59 102.63 14.56 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.393 0.677 . . . . 0.0 110.064 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 74.05 3.02 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 121.492 0.663 . . . . 0.0 110.4 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 -103.48 0.98 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.592 -0.692 . . . . 0.0 114.591 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.62 -32.49 23.69 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 165.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -80.17 104.2 10.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.623 1.556 . . . . 0.0 110.998 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp -114.33 132.14 56.29 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 122.295 1.045 . . . . 0.0 111.47 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.31 99.73 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.78 110.26 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -103.6 101.61 11.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.726 -0.608 . . . . 0.0 109.476 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -86.13 102.76 14.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.48 130.24 49.23 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.931 0.492 . . . . 0.0 111.494 -166.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.6 t -149.17 155.15 40.22 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.117 0.96 . . . . 0.0 111.675 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.2 p -62.02 -32.56 73.07 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.81 -50.55 13.19 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -151.82 136.85 17.33 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 119.388 0.994 . . . . 0.0 112.273 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -94.08 136.82 33.96 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 121.738 -0.601 . . . . 0.0 110.98 166.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -128.26 113.44 15.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 110.807 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.98 129.57 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 123.478 0.711 . . . . 0.0 109.467 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtp -108.59 108.04 18.77 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.639 0.776 . . . . 0.0 110.005 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.03 118.12 35.18 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.137 0.975 . . . . 0.0 111.825 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.2 149.55 22.97 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -165.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -94.46 127.23 40.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 0.0 111.095 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.87 130.62 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 123.332 0.653 . . . . 0.0 111.209 -174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.14 -36.19 4.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -162.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.18 140.46 29.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.579 1.189 . . . . 0.0 112.813 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -87.14 114.82 24.08 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.804 -0.56 . . . . 0.0 110.877 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -121.71 139.23 53.83 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 111.92 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.45 90.58 2.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.11 . . . . 0.0 113.431 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -92.15 113.24 25.45 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.406 -0.808 . . . . 0.0 110.72 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.54 127.77 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.35 1.072 . . . . 0.0 111.209 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.15 49.38 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.616 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.3 t -71.76 137.19 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.418 1.087 . . . . 0.0 113.314 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.66 -57.0 0.98 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 120.862 -0.685 . . . . 0.0 114.083 -154.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -79.56 -67.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.649 1.18 . . . . 0.0 110.169 -171.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.84 25.35 0.84 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 160.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.301 0.9 OUTLIER 61.41 8.01 2.0 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -82.3 139.58 34.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.806 -1.184 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -92.87 108.57 20.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.3 m -112.77 124.0 51.59 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.654 0.74 . . . . 0.0 110.751 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtp -72.55 92.56 1.5 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.585 1.184 . . . . 0.0 111.043 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -100.98 123.98 46.0 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.268 -157.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.6 m -104.66 119.49 39.11 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.0 t -104.93 127.76 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.8 m -129.44 155.32 45.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 112.422 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 74.4 m95 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.0 111.71 172.199 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.667 0.746 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -92.87 98.08 11.15 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.169 0.588 . . . . 0.0 109.585 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -102.02 131.05 48.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.511 0.724 . . . . 0.0 110.963 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 51.9 t -128.81 142.17 51.06 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.93 126.12 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.768 0.827 . . . . 0.0 109.445 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.69 96.47 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.139 0.976 . . . . 0.0 109.069 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -96.27 116.32 28.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.177 -0.952 . . . . 0.0 111.985 -166.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.97 -105.93 0.19 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.297 -0.877 . . . . 0.0 112.792 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -79.09 -30.43 43.88 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.53 141.3 40.62 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.864 1.211 . . . . 0.0 113.018 -162.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.43 111.93 16.18 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.78 46.03 92.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 117.727 1.851 . . . . 0.0 117.727 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -83.44 137.98 33.67 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 118.282 1.041 . . . . 0.0 111.064 172.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.98 -163.49 34.48 Favored Glycine 0 N--CA 1.483 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 114.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.275 63.4 p-90 -158.06 169.06 25.41 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.547 1.165 . . . . 0.0 113.69 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.7 m -146.87 119.55 8.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.054 -1.654 . . . . 0.0 109.032 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -116.25 135.04 54.25 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -147.8 171.9 14.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.556 -0.715 . . . . 0.0 112.776 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.91 128.53 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.345 -0.847 . . . . 0.0 109.37 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.14 87.51 2.73 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.936 0.874 . . . . 0.0 110.281 166.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.12 -116.49 4.27 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.724 -0.61 . . . . 0.0 113.246 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -94.17 24.61 4.25 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 160.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.51 125.64 50.3 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.725 1.148 . . . . 0.0 111.349 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.03 120.31 25.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.36 0.664 . . . . 0.0 109.852 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.78 118.76 37.02 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.1 tp -125.94 122.21 35.34 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.593 0.757 . . . . 0.0 110.448 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.99 126.7 47.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.201 0.6 . . . . 0.0 109.535 167.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.1 mtp -122.68 123.87 42.12 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.983 0.913 . . . . 0.0 110.448 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -121.98 135.17 54.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 111.814 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.32 124.38 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.186 0.594 . . . . 0.0 110.737 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 56.29 41.36 29.26 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.07 -20.48 1.52 Allowed Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.702 2.641 . . . . 0.0 119.702 -164.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 51.0 t -80.43 118.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.723 1.761 . . . . 0.0 109.82 -169.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.5 m -99.53 124.33 44.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.797 0.808 . . . . 0.0 111.264 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.4 t -99.08 130.28 45.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.28 1.032 . . . . 0.0 110.894 168.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -105.31 117.86 35.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 110.568 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -117.47 125.33 50.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.554 0.742 . . . . 0.0 109.771 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.81 129.83 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.9 149.63 52.23 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 123.435 0.694 . . . . 0.0 111.453 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -115.54 132.53 56.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.106 -1.621 . . . . 0.0 112.252 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -69.3 124.8 24.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.38 -40.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 . . . . . 0 CA--C 1.562 1.435 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.663 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 t0 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.159 0.504 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -83.39 0.83 44.29 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -58.87 106.29 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 121.27 1.85 . . . . 0.0 114.791 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.89 176.87 32.45 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-O 122.825 1.236 . . . . 0.0 115.83 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -105.45 120.54 41.88 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.439 1.096 . . . . 0.0 109.9 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -119.53 113.23 20.42 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -92.07 140.32 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.741 -1.224 . . . . 0.0 113.197 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.7 ttp -73.52 123.58 24.21 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.654 1.57 . . . . 0.0 114.388 -171.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.01 -52.69 6.11 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.158 0.983 . . . . 0.0 113.465 169.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -136.96 154.47 50.42 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -138.72 106.88 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.213 0.605 . . . . 0.0 109.819 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.99 121.92 41.88 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.622 0.769 . . . . 0.0 110.186 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 27.7 t30 63.44 32.98 14.06 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -79.39 -46.61 17.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.491 -1.381 . . . . 0.0 114.411 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -58.45 -39.13 79.04 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.73 -40.81 84.15 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -56.66 -49.15 75.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 164.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.9 -37.81 88.89 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -52.29 -47.37 65.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 162.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.24 -18.52 61.42 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.18 4.16 52.95 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.263 5.8 t70 66.24 46.63 2.0 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -171.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.07 142.57 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.748 0.785 . . . . 0.0 109.46 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -64.43 154.61 35.17 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.44 -46.05 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.82 -50.23 69.09 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 tp -64.2 -35.49 80.98 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -57.13 -42.1 80.3 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 163.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.56 -43.86 75.71 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -64.04 -56.56 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 123.927 0.891 . . . . 0.0 111.821 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.95 77.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -71.26 -30.16 65.96 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.76 -30.74 64.38 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 167.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.98 140.27 50.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.666 1.121 . . . . 0.0 113.569 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -94.05 100.45 4.87 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.443 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' C ' ' HD2' ' A' ' 39' ' ' ASP . 72.4 Cg_endo -69.75 157.27 60.97 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 123.248 2.196 . . . . 0.0 114.152 167.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.448 ' HD2' ' C ' ' A' ' 38' ' ' PRO . 44.2 m-20 -128.11 118.12 22.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.315 -1.491 . . . . 0.0 108.793 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -86.07 109.26 18.71 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.714 -0.616 . . . . 0.0 111.005 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.68 107.44 19.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 168.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.1 mt -104.08 127.35 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.5 t -112.36 107.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -102.39 97.42 7.67 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.912 0.885 . . . . 0.0 109.888 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.46 78.44 4.99 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.379 -0.825 . . . . 0.0 110.129 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 -103.7 1.1 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.881 -0.512 . . . . 0.0 114.374 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.5 -26.21 32.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 164.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -81.22 105.78 12.69 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.374 1.443 . . . . 0.0 111.552 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -109.86 122.13 46.81 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.155 0.978 . . . . 0.0 111.203 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -114.48 97.29 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.3 mt -91.54 109.44 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -102.72 99.01 8.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -86.05 98.04 10.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 108.756 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -95.93 115.44 27.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.7 -0.625 . . . . 0.0 110.203 -165.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 t -133.41 152.61 51.93 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.735 0.778 . . . . 0.0 110.72 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.9 p -63.1 -29.38 70.76 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -75.94 -49.52 17.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -154.61 135.06 13.37 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 119.414 1.006 . . . . 0.0 111.604 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -85.99 117.32 24.76 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.432 0.693 . . . . 0.0 110.222 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -106.14 103.95 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.363 -0.835 . . . . 0.0 110.374 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.72 124.17 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -102.93 107.4 18.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.646 0.778 . . . . 0.0 109.375 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -108.09 110.29 21.93 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.721 0.808 . . . . 0.0 109.83 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.36 160.27 41.61 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -101.94 138.22 39.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 110.969 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.33 133.56 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.31 -25.33 27.4 Favored Glycine 0 CA--C 1.552 2.387 0 N-CA-C 117.73 1.852 . . . . 0.0 117.73 -164.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -101.98 134.26 45.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.178 1.489 . . . . 0.0 111.04 -158.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -83.06 103.15 12.28 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.999 0.52 . . . . 0.0 111.231 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.96 138.73 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.442 0.697 . . . . 0.0 112.286 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.98 96.49 1.04 Allowed 'General case' 0 CA--C 1.57 1.719 0 O-C-N 120.955 -1.091 . . . . 0.0 112.953 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -89.88 113.12 24.67 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.25 108.69 15.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.872 -0.518 . . . . 0.0 109.644 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mp -85.2 56.22 3.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.161 0.981 . . . . 0.0 113.474 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.0 t -78.32 129.16 34.69 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.508 1.147 . . . . 0.0 112.846 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.31 -42.2 2.01 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.3 -88.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -113.49 7.59 17.54 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 57.11 44.63 22.18 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -137.17 142.98 42.17 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.53 131.27 34.99 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.273 0.629 . . . . 0.0 112.5 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.2 125.92 27.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.102 0.561 . . . . 0.0 111.343 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 mmt -68.38 100.97 1.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.672 1.225 . . . . 0.0 110.555 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 m -100.46 122.22 42.84 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.755 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.661 ' HG1' ' NZ ' ' A' ' 98' ' ' LYS . 86.2 m -110.93 118.58 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 t -109.91 121.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.4 m -127.83 147.4 50.44 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.843 0.857 . . . . 0.0 112.359 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.8 m95 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 120.985 -1.072 . . . . 0.0 112.234 174.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.604 0.716 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -87.68 113.32 23.25 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 121.387 -0.82 . . . . 0.0 109.955 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -100.41 137.62 38.58 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.958 0.903 . . . . 0.0 111.735 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.4 t -131.64 136.87 48.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.364 0.666 . . . . 0.0 112.636 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.3 123.69 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.413 0.685 . . . . 0.0 109.776 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -99.8 98.38 9.19 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.513 1.125 . . . . 0.0 109.472 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.661 ' NZ ' ' HG1' ' A' ' 85' ' ' THR . 32.3 mtmm -89.74 115.21 26.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 111.445 -171.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.35 -112.59 0.27 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 121.767 -0.583 . . . . 0.0 112.457 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.18 -31.21 23.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -96.99 142.55 28.81 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.387 1.089 . . . . 0.0 113.797 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.53 106.77 11.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.044 -172.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.34 66.33 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -172.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -82.14 133.31 35.26 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.194 0.598 . . . . 0.0 110.823 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.43 -159.48 31.2 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -160.38 160.13 31.92 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.315 1.055 . . . . 0.0 112.92 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.3 m -133.04 128.45 36.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.113 -0.992 . . . . 0.0 108.396 170.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.77 138.48 53.37 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.7 163.85 37.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.3 mt -102.63 126.73 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.328 -0.857 . . . . 0.0 109.878 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.71 90.21 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.805 0.812 . . . . 0.0 110.175 164.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.14 -116.02 4.18 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 121.639 -0.663 . . . . 0.0 113.445 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -90.84 18.91 5.99 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 161.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -118.45 122.33 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.451 1.478 . . . . 0.0 111.113 -166.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.3 tp -82.85 111.89 19.16 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -98.04 119.39 36.59 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.63 117.8 26.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.601 0.76 . . . . 0.0 110.234 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.93 131.65 39.16 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.088 0.555 . . . . 0.0 109.781 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.0 mtp -127.07 121.44 31.54 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.444 0.698 . . . . 0.0 109.571 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -117.25 137.76 52.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 112.87 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.32 115.12 5.28 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 0.0 111.009 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.26 3.1 mt-10 58.14 44.65 18.77 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.24 -28.99 0.98 Allowed Glycine 0 CA--C 1.559 2.789 0 N-CA-C 119.172 2.429 . . . . 0.0 119.172 -162.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.5 t -71.69 115.26 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.752 1.221 . . . . 0.0 110.198 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.8 m -106.1 117.52 34.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.261 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 t -89.91 134.82 34.0 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.314 0.646 . . . . 0.0 111.448 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -109.68 118.61 37.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.756 -0.59 . . . . 0.0 110.809 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -116.66 137.06 52.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.65 0.78 . . . . 0.0 110.183 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.03 130.01 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -126.61 131.15 51.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.654 -0.654 . . . . 0.0 110.994 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -94.72 130.33 41.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.731 -1.231 . . . . 0.0 112.217 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -64.91 123.86 20.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.69 -36.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 120.228 1.377 . . . . 0.0 108.04 171.564 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 CA--C 1.561 1.387 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -76.47 -0.9 24.66 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -58.96 114.34 2.52 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 122.029 2.195 . . . . 0.0 114.407 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.03 177.7 28.58 Favored Glycine 0 N--CA 1.486 2.002 0 CA-C-O 122.925 1.292 . . . . 0.0 115.811 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -110.75 111.16 22.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.478 1.111 . . . . 0.0 108.904 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -114.16 111.82 22.19 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -166.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.56 142.43 27.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 112.815 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.404 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 38.5 ttp -72.18 121.61 19.62 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.834 1.197 . . . . 0.0 113.53 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.8 mt -81.88 -44.43 16.86 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 169.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.2 m -154.11 160.65 42.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.458 -1.401 . . . . 0.0 113.343 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.65 120.47 17.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.137 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.94 120.74 31.17 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 110.185 -170.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 32.6 t30 65.86 36.57 5.99 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -81.62 -42.34 20.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.14 -34.82 74.07 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.47 -44.78 70.48 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.018 1.736 . . . . 0.0 114.651 165.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -55.05 -45.45 75.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.73 -37.45 73.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.23 -43.73 87.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.2 -1.562 . . . . 0.0 114.848 163.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.27 24.84 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 163.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.0 mt -96.7 9.41 41.73 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 22.9 t70 62.61 59.93 1.4 Allowed 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 120.438 1.472 . . . . 0.0 113.145 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.98 139.08 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.616 0.722 . . . . 0.0 110.106 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.56 150.84 47.74 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.58 -47.01 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -49.98 70.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.23 -42.53 99.4 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 171.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -56.83 -48.57 77.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 121.304 1.866 . . . . 0.0 115.741 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.32 -43.32 99.06 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.56 -54.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 118.842 0.746 . . . . 0.0 111.691 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.52 78.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -66.77 -33.84 76.5 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 167.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.1 -25.08 58.23 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -70.68 147.74 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.365 1.439 . . . . 0.0 114.517 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -100.24 95.83 4.5 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.091 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 57.1 Cg_endo -69.61 141.49 46.0 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.479 2.119 . . . . 0.0 113.786 170.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.39 114.53 23.67 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.432 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 38.7 mttp -87.02 109.42 19.38 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.726 -0.609 . . . . 0.0 110.924 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.52 105.31 17.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 167.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mt -104.26 129.69 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.9 t -112.37 106.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -101.54 103.5 14.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.247 0.619 . . . . 0.0 109.781 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.65 72.0 5.85 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.39 -94.3 0.47 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.83 -25.11 17.5 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 166.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -83.63 116.42 22.61 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.416 1.462 . . . . 0.0 111.077 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.3 ttm -126.51 124.5 40.19 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.558 0.694 . . . . 0.0 110.945 -165.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.76 101.67 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.73 111.32 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -104.86 96.17 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.432 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 61.7 m -82.8 99.17 9.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 0.0 108.871 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.21 121.27 37.8 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.322 0.582 . . . . 0.0 110.401 -168.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -139.52 153.45 47.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.632 0.729 . . . . 0.0 110.67 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -63.6 -28.9 70.24 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.29 -52.55 10.58 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 170.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -156.04 136.75 13.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 119.461 1.028 . . . . 0.0 111.277 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.8 121.0 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.572 0.749 . . . . 0.0 110.111 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -109.72 116.74 32.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 110.366 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mm -110.64 119.66 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.2 mtp -107.33 104.17 13.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.825 -0.547 . . . . 0.0 110.082 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -110.14 115.75 30.29 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.074 0.95 . . . . 0.0 111.615 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -158.39 153.34 25.17 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -93.04 134.09 35.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.09 -1.007 . . . . 0.0 110.455 161.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.11 124.69 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.385 -0.822 . . . . 0.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.14 -38.32 3.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -155.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.94 133.76 35.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 117.959 0.88 . . . . 0.0 113.279 -161.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.46 102.58 12.18 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 121.953 -0.467 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -116.29 144.34 44.36 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.623 0.769 . . . . 0.0 112.173 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.59 92.21 3.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.597 -1.314 . . . . 0.0 113.197 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.17 118.9 24.42 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.388 -0.82 . . . . 0.0 110.767 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -76.8 127.81 33.45 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.759 -0.588 . . . . 0.0 110.518 161.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.3 55.29 0.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.553 0.692 . . . . 0.0 112.571 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.8 t -82.87 131.01 35.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 112.521 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -49.8 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.297 -0.877 . . . . 0.0 114.642 -155.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -78.34 -72.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.443 1.097 . . . . 0.0 109.902 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.45 ' N ' ' HD2' ' A' ' 78' ' ' ASP . 12.6 p-10 -135.34 -2.54 2.48 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.288 1.7 m-20 58.71 45.0 16.44 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -116.07 139.99 49.73 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.779 0.831 . . . . 0.0 110.993 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -83.54 124.24 30.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.108 0.48 . . . . 0.0 110.464 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 83.7 m -124.42 122.24 37.12 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.262 0.625 . . . . 0.0 110.851 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.73 99.05 2.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.292 1.044 . . . . 0.0 109.996 173.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.9 m -111.56 121.04 44.09 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.87 -158.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -104.76 120.66 41.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.74 128.04 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.9 m -132.75 145.72 51.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.595 0.758 . . . . 0.0 111.631 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m95 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.343 173.287 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.664 0.745 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.9 tp -89.44 105.76 18.0 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.815 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.26 147.82 24.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.058 0.943 . . . . 0.0 111.964 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.8 t -141.57 135.83 30.46 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.89 126.54 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.541 0.736 . . . . 0.0 109.046 163.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -102.53 108.13 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.518 0.727 . . . . 0.0 109.527 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -86.39 101.96 13.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.801 -1.187 . . . . 0.0 110.453 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.28 92.81 0.09 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.311 79.9 mt-10 70.11 -46.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -106.74 151.47 25.09 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.506 1.146 . . . . 0.0 113.191 -153.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -86.72 107.64 18.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.586 -0.697 . . . . 0.0 111.89 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.64 55.61 8.31 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -95.57 129.1 42.87 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 122.967 0.507 . . . . 0.0 111.719 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.22 -147.78 13.4 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -160.98 161.44 31.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.959 0.885 . . . . 0.0 112.958 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.2 m -134.97 123.38 23.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -123.29 131.96 53.85 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.508 0.723 . . . . 0.0 111.287 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.97 169.24 20.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.877 -1.139 . . . . 0.0 113.209 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -113.48 128.01 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -113.28 90.03 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.87 -113.13 4.06 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.46 -0.775 . . . . 0.0 114.819 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -88.25 4.4 45.97 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.46 131.65 54.06 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 120.037 1.289 . . . . 0.0 112.365 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.43 122.0 35.4 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -111.52 123.05 49.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.9 tp -123.4 121.14 35.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.351 0.661 . . . . 0.0 111.07 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.46 129.71 42.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.404 0.681 . . . . 0.0 110.235 163.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.6 mtm -119.69 130.85 55.23 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.736 0.698 . . . . 0.0 110.722 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -125.47 133.31 52.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 112.609 -164.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.28 131.88 7.69 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 55.02 38.78 31.08 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.36 3.72 Favored Glycine 0 CA--C 1.559 2.786 0 N-CA-C 120.182 2.833 . . . . 0.0 120.182 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.66 121.8 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 119.87 1.835 . . . . 0.0 108.6 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.2 m -98.59 124.37 43.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 121.671 0.748 . . . . 0.0 110.691 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.2 t -92.74 143.79 25.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.686 . . . . 0.0 111.345 160.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.8 122.87 44.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.937 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -115.34 130.8 57.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.73 132.11 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -128.97 159.29 36.34 Favored 'General case' 0 CA--C 1.574 1.887 0 C-N-CA 124.437 1.095 . . . . 0.0 111.206 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -130.94 132.11 44.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.534 -1.354 . . . . 0.0 111.846 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.51 116.17 10.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.18 -33.96 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t60 . . . . . 0 CA--C 1.562 1.414 0 CA-C-N 119.951 1.25 . . . . 0.0 107.993 170.017 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 t0 . . . . . 0 CA--C 1.564 1.506 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.8 -4.0 44.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -54.84 108.86 0.44 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 121.285 1.857 . . . . 0.0 115.136 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.56 -175.99 35.55 Favored Glycine 0 CA--C 1.546 2.017 0 CA-C-O 122.829 1.238 . . . . 0.0 115.828 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -117.51 118.06 31.14 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.311 1.045 . . . . 0.0 109.356 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -121.54 117.13 26.02 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.69 -0.631 . . . . 0.0 109.582 -164.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -84.99 147.07 26.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 0.0 113.537 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 31.9 ttm -70.61 128.93 37.78 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 120.372 1.442 . . . . 0.0 113.459 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.38 -45.71 9.76 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -157.3 156.13 31.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.255 1.843 . . . . 0.0 114.458 173.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -104.75 123.29 47.39 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.761 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.97 -66.74 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -126.44 39.16 3.99 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.206 0.602 . . . . 0.0 112.114 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -70.58 -36.84 73.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.77 -47.32 70.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.56 -37.72 77.12 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -52.94 -48.11 67.56 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 120.838 1.654 . . . . 0.0 114.049 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.0 -35.83 69.57 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -54.0 -46.03 71.64 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.605 1.548 . . . . 0.0 114.899 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.63 -23.4 58.92 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.75 -9.54 59.3 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 166.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.329 16.9 t70 71.93 48.71 0.27 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.489 1.516 . . . . 0.0 114.763 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.5 t -89.94 149.79 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 122.289 1.042 . . . . 0.0 110.561 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -62.95 149.09 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -60.64 -40.8 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.18 -55.31 34.71 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.64 -41.99 91.76 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -53.22 -51.96 60.46 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 168.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -65.61 -41.76 92.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.76 -58.13 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.332 0.969 . . . . 0.0 111.519 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.08 74.23 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.09 -28.82 63.56 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 166.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.85 -23.6 39.0 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 mt -69.93 149.51 47.71 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.673 1.578 . . . . 0.0 114.681 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -101.84 91.04 2.14 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.212 171.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 92.7 Cg_endo -75.18 152.35 39.85 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.532 2.154 . . . . 0.0 114.224 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -109.4 117.74 34.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.351 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -84.84 111.94 20.09 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.328 -0.857 . . . . 0.0 110.746 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 107.95 19.75 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.759 -0.588 . . . . 0.0 109.632 165.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -102.92 127.35 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.46 106.32 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 170.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.48 105.58 17.57 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.157 0.583 . . . . 0.0 110.159 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -95.3 79.9 3.51 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.53 0.681 . . . . 0.0 109.751 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.93 -105.06 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.21 -26.67 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 165.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -82.11 107.06 14.51 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.515 1.507 . . . . 0.0 111.49 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.4 ttm -108.44 124.64 50.72 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.999 0.92 . . . . 0.0 111.04 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.48 102.22 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.68 107.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -100.13 101.49 12.55 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -85.1 101.18 12.23 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 mt -99.03 121.33 40.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.899 0.48 . . . . 0.0 111.506 -164.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.8 t -144.41 150.61 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.908 0.861 . . . . 0.0 111.304 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.9 p -63.21 -31.19 72.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -71.04 -52.47 19.34 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -155.39 135.94 13.36 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.94 0.791 . . . . 0.0 110.857 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -88.53 127.77 35.55 Favored 'General case' 0 CA--C 1.568 1.636 0 O-C-N 121.876 -0.515 . . . . 0.0 110.582 167.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -110.14 123.42 49.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.585 -0.697 . . . . 0.0 110.857 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.69 121.09 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -112.46 104.51 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -108.78 110.43 21.81 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.63 0.772 . . . . 0.0 108.926 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -153.67 154.84 34.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -167.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -100.13 125.86 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.728 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.49 125.87 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.639 -0.663 . . . . 0.0 110.811 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.52 -38.86 3.12 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 116.723 1.449 . . . . 0.0 116.723 -161.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -85.47 146.97 26.69 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 118.405 1.102 . . . . 0.0 113.919 -172.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -93.58 112.97 24.97 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.979 0.512 . . . . 0.0 110.003 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -120.82 148.52 43.9 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.985 0.914 . . . . 0.0 112.473 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.551 ' HE2' ' NZ ' ' A' ' 81' ' ' LYS . 25.6 mt-10 -70.46 103.04 2.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.662 -1.274 . . . . 0.0 111.757 169.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -89.99 113.99 25.76 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.17 0.588 . . . . 0.0 109.892 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.94 122.49 24.24 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 121.082 0.468 . . . . 0.0 110.237 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -105.15 44.18 1.05 Allowed 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -81.0 132.67 35.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.952 -1.093 . . . . 0.0 111.366 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.33 -57.65 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.811 -151.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.8 mt -74.42 -63.41 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.76 17.56 1.27 Allowed 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 159.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.05 42.2 31.12 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -111.24 145.1 39.33 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.662 0.785 . . . . 0.0 111.342 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.551 ' NZ ' ' HE2' ' A' ' 71' ' ' GLU . 43.9 mtmt -90.38 117.6 29.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.04 . . . . 0.0 110.013 164.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.0 m -111.07 144.1 40.72 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.11 90.3 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.55 168.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.0 m -90.69 129.93 36.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 -172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 m -116.63 125.37 51.68 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.407 HG22 ' SG ' ' A' ' 95' ' ' CYS . 40.6 t -115.39 128.76 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.6 m -132.63 148.92 52.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.196 -0.94 . . . . 0.0 112.377 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.824 -1.172 . . . . 0.0 113.344 177.592 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 121.93 0.872 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.6 111.65 23.05 Favored 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -114.83 128.43 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.507 0.723 . . . . 0.0 110.532 -161.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.407 ' SG ' HG22 ' A' ' 86' ' ' VAL . 54.1 t -130.67 142.86 50.44 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.2 129.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.493 164.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -103.93 95.9 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -88.72 115.91 26.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.941 -1.099 . . . . 0.0 112.015 -167.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.18 -126.64 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 O-C-N 121.248 -0.907 . . . . 0.0 114.164 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.63 -32.1 65.64 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -103.99 138.65 40.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.823 1.192 . . . . 0.0 111.784 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.41 142.6 30.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.55 45.93 94.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 117.551 1.78 . . . . 0.0 117.551 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -99.95 130.92 46.17 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 121.698 0.761 . . . . 0.0 111.032 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.68 -166.4 34.75 Favored Glycine 0 N--CA 1.482 1.748 0 CA-C-O 121.806 0.67 . . . . 0.0 114.415 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -157.96 156.45 31.25 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.0 m -133.37 124.66 27.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.54 128.78 48.5 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.646 0.778 . . . . 0.0 111.336 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -146.32 169.26 19.18 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.113 -0.992 . . . . 0.0 113.191 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.2 mt -109.1 124.44 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.34 86.78 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.388 163.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.87 -110.54 3.25 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 121.231 -0.918 . . . . 0.0 115.045 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.66 -6.03 59.34 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 162.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.0 137.26 39.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.697 1.589 . . . . 0.0 112.826 -172.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.06 120.17 36.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.612 0.765 . . . . 0.0 109.04 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -110.11 117.58 34.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.2 tp -121.0 117.08 26.36 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.471 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.99 129.7 40.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.955 0.502 . . . . 0.0 109.867 166.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.8 mtp -124.45 123.43 40.14 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.742 0.817 . . . . 0.0 110.089 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -114.29 140.23 48.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.615 -0.678 . . . . 0.0 112.461 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.11 120.13 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.585 0.754 . . . . 0.0 109.506 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 58.56 41.34 22.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.75 -32.76 1.44 Allowed Glycine 0 CA--C 1.558 2.731 0 N-CA-C 118.852 2.301 . . . . 0.0 118.852 -163.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.28 116.19 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 124.757 1.223 . . . . 0.0 110.78 -168.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -106.37 115.31 29.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.099 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.0 t -97.49 127.21 43.26 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.784 0.834 . . . . 0.0 112.082 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -93.53 116.38 28.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -103.36 119.12 38.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 132.86 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -131.09 160.56 34.33 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 124.116 0.966 . . . . 0.0 111.703 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.12 129.7 40.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 110.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -68.47 124.87 24.75 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.56 -40.19 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.563 1.47 0 CA-C-N 119.781 1.173 . . . . 0.0 108.258 169.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.261 52.3 t0 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -78.54 5.26 11.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 117.975 2.583 . . . . 0.0 117.975 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -61.42 107.66 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.806 1.639 . . . . 0.0 114.481 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.17 178.79 32.53 Favored Glycine 0 N--CA 1.484 1.89 0 CA-C-O 122.621 1.123 . . . . 0.0 114.888 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -107.76 118.76 37.58 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.33 1.052 . . . . 0.0 109.27 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -118.81 112.48 19.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -168.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -89.53 139.55 30.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 112.831 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.443 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.2 ttp -69.31 121.52 17.05 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 119.889 1.222 . . . . 0.0 114.042 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.93 -44.41 18.29 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -152.95 159.13 42.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.398 -1.439 . . . . 0.0 113.724 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -140.39 118.76 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.692 -174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.96 118.3 19.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.745 -0.597 . . . . 0.0 110.439 -167.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.283 23.1 t30 66.6 33.76 6.33 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -80.25 -42.34 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 24.5 mt-10 -56.78 -42.85 80.16 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.28 -39.87 89.71 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -54.79 -47.58 73.81 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.64 -40.44 73.07 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -57.88 -41.9 83.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 165.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.43 58.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 164.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 mt -86.75 -49.67 7.29 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.22 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 125.835 1.654 . . . . 0.0 114.986 165.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.01 148.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 119.306 -2.121 . . . . 0.0 112.886 -136.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.66 153.21 40.2 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -60.0 -41.81 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.49 -54.73 42.3 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 172.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.16 -38.17 85.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -57.18 -51.22 70.21 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.585 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 71.3 mmtt -65.38 -41.71 93.44 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 174.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.17 -58.21 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 119.446 1.021 . . . . 0.0 111.373 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.64 76.48 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -68.45 -36.22 78.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.83 -28.75 63.78 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.0 mt -72.5 135.24 45.63 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.541 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 101.99 7.97 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.565 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 34.1 Cg_endo -65.76 142.99 72.26 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 CA-C-N 123.315 2.22 . . . . 0.0 113.94 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.54 113.39 25.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.466 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 34.4 mttp -88.57 110.78 21.18 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.767 -0.583 . . . . 0.0 111.287 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -97.84 106.91 19.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.61 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.18 109.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 164.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -102.22 109.88 21.68 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.537 0.735 . . . . 0.0 109.99 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -100.19 74.97 1.79 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.05 -104.02 0.89 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.12 -31.3 39.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.06 127.58 33.55 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.893 1.678 . . . . 0.0 111.701 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.11 123.67 22.24 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-O 121.348 0.594 . . . . 0.0 111.274 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.4 mt -109.61 105.8 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.16 115.71 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -107.39 96.16 6.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.466 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 86.7 m -86.75 95.52 9.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 mt -95.15 130.74 41.76 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -162.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -149.52 152.72 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.926 0.87 . . . . 0.0 110.97 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.6 p -62.33 -31.65 72.3 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -75.27 -52.46 10.81 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -151.0 129.27 11.97 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 119.042 0.837 . . . . 0.0 110.498 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.3 123.16 33.84 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.307 0.643 . . . . 0.0 109.568 167.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -103.56 110.85 23.05 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 119.087 0.858 . . . . 0.0 109.658 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.9 mm -104.1 116.9 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.1 mtp -103.81 133.91 48.0 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.37 109.43 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.97 160.44 41.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -167.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -103.37 131.09 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.836 0.827 . . . . 0.0 110.519 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.89 131.63 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 CA-C-O 121.966 0.889 . . . . 0.0 110.166 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.9 22.76 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 -161.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -101.33 143.22 31.64 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.241 1.521 . . . . 0.0 111.608 -166.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.39 108.8 20.14 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.003 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.13 146.97 44.69 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.54 108.02 4.72 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.96 0.886 . . . . 0.0 112.524 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.41 106.78 15.36 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.663 0.785 . . . . 0.0 109.939 -168.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.54 119.44 24.71 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.817 0.818 . . . . 0.0 110.707 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.04 52.49 1.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 m -73.66 128.22 34.91 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.468 1.107 . . . . 0.0 112.46 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.52 -60.98 0.41 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.987 -0.446 . . . . 0.0 113.648 -157.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.61 -61.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 124.245 1.018 . . . . 0.0 110.95 -174.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -143.63 3.57 1.29 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 165.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 7.8 t70 44.62 55.28 5.95 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -163.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -110.89 138.18 47.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.661 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -97.88 104.45 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.2 m -109.27 145.62 35.62 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.363 0.601 . . . . 0.0 111.862 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.8 mmm -85.17 91.72 8.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.147 169.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.9 m -96.6 122.66 39.76 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.653 -166.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 m -100.21 117.14 33.82 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -105.76 128.92 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -141.6 153.9 45.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.965 -1.085 . . . . 0.0 112.585 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.4 m95 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.979 -1.076 . . . . 0.0 111.868 175.756 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.74 106.69 18.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.097 -1.002 . . . . 0.0 110.098 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -95.37 150.42 20.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.967 0.907 . . . . 0.0 112.395 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -146.44 135.17 22.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.013 0.525 . . . . 0.0 112.315 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.93 126.6 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.65 0.78 . . . . 0.0 109.173 167.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -103.3 92.28 4.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -86.18 134.25 33.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.855 . . . . 0.0 112.961 -167.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 141.23 -90.68 0.18 Allowed Glycine 0 N--CA 1.486 2.031 0 O-C-N 121.441 -0.787 . . . . 0.0 113.713 167.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.29 -12.4 59.07 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -169.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -129.21 148.98 51.19 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.672 1.578 . . . . 0.0 112.757 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -82.11 114.18 20.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.787 0.835 . . . . 0.0 111.258 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.54 43.04 99.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 118.11 2.004 . . . . 0.0 118.11 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -86.17 135.93 33.39 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.304 1.052 . . . . 0.0 111.635 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -170.79 38.6 Favored Glycine 0 N--CA 1.482 1.721 0 CA-C-O 122.12 0.845 . . . . 0.0 114.262 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 61.7 p-90 -153.56 165.06 37.07 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.406 1.098 . . . . 0.0 113.183 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 m -138.47 125.77 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.43 129.0 42.46 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.725 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -151.62 165.49 34.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.002 -1.061 . . . . 0.0 113.242 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -107.41 131.0 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -0.936 . . . . 0.0 109.298 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -119.2 95.45 4.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 162.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.77 -117.4 4.72 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.677 -0.64 . . . . 0.0 114.151 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -94.59 15.9 16.85 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.994 1.849 . . . . 0.0 115.994 162.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -113.74 125.21 53.86 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.583 1.083 . . . . 0.0 111.055 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.3 120.64 26.1 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.375 1.07 . . . . 0.0 109.712 166.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -107.11 119.14 38.57 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.579 0.751 . . . . 0.0 108.979 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 tp -115.66 128.55 56.0 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.756 0.822 . . . . 0.0 110.013 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.88 123.8 50.66 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.638 0.775 . . . . 0.0 110.042 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.7 mtm -115.41 137.17 52.34 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.857 0.863 . . . . 0.0 111.483 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -127.11 135.05 50.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.539 -0.726 . . . . 0.0 111.578 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.77 125.4 6.38 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.118 0.567 . . . . 0.0 111.438 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 54.56 42.6 31.2 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.38 -6.95 6.92 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 120.377 2.911 . . . . 0.0 120.377 -165.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.21 126.15 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.281 2.04 . . . . 0.0 109.93 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -108.47 128.99 55.27 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.934 0.894 . . . . 0.0 111.085 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.4 t -125.12 126.5 45.41 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 0.0 112.75 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.95 135.54 35.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.552 -0.718 . . . . 0.0 112.127 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -129.04 134.5 48.15 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.351 0.661 . . . . 0.0 110.656 162.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.6 t -116.68 130.32 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.84 132.73 43.95 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.905 0.775 . . . . 0.0 111.252 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -103.61 133.75 48.1 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.227 -1.545 . . . . 0.0 112.631 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.96 120.88 16.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.0 -38.57 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 . . . . . 0 CA--C 1.563 1.464 0 CA-C-N 119.933 1.242 . . . . 0.0 108.318 169.274 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 CA--C 1.565 1.557 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -78.8 2.1 21.01 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -57.82 105.68 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 121.348 1.886 . . . . 0.0 115.114 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.53 179.83 35.55 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.432 ' H ' ' C ' ' A' ' 134' ' ' HIS . 34.1 t80 -109.64 113.0 25.41 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.592 1.157 . . . . 0.0 109.218 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -115.15 111.61 21.28 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -168.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.31 141.35 28.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.6 ttp -71.76 121.69 19.36 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.615 -1.303 . . . . 0.0 113.987 -173.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.2 mt -83.13 -45.09 14.36 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -153.52 160.45 42.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.505 -1.372 . . . . 0.0 113.333 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.34 117.98 10.4 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.002 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.76 121.0 35.26 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.749 0.82 . . . . 0.0 109.834 -172.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.285 31.1 t30 68.36 34.2 3.87 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -78.68 -40.53 33.66 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -56.4 -35.86 68.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 168.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.76 -41.92 67.83 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.946 1.703 . . . . 0.0 114.675 166.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.25 -51.12 65.54 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 120.079 1.308 . . . . 0.0 113.802 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.04 -38.18 82.21 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -59.92 -39.21 84.69 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -34.3 62.77 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 165.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.96 -9.79 58.86 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.318 15.9 t0 67.95 49.8 0.87 Allowed 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 125.592 1.557 . . . . 0.0 114.581 -161.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.5 t -93.51 137.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.93 0.872 . . . . 0.0 109.758 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -61.82 150.52 36.96 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 176.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -52.51 -44.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.51 68.96 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 172.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -36.29 80.79 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -61.97 -51.21 69.01 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.307 1.867 . . . . 0.0 115.447 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -60.22 -44.58 95.05 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.08 -55.96 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.724 0.693 . . . . 0.0 111.391 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.41 77.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -70.67 -32.05 69.18 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.61 -24.12 53.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -72.22 154.28 41.1 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -99.0 95.96 3.68 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.364 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.72 143.65 30.32 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.507 2.138 . . . . 0.0 113.477 166.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.14 117.22 32.67 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -85.92 107.18 17.6 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.371 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.22 108.7 20.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 170.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -106.6 127.84 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -116.15 109.15 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -106.79 105.48 15.53 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 123.881 0.873 . . . . 0.0 110.578 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.78 75.68 6.47 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 110.054 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.39 -100.36 0.47 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 115.231 0.853 . . . . 0.0 115.231 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.54 -29.04 28.19 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.17 110.49 17.42 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.353 1.433 . . . . 0.0 111.016 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -126.98 130.67 50.51 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.439 1.114 . . . . 0.0 111.949 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.86 101.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.2 mt -93.12 110.59 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -103.1 100.13 10.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -83.25 97.9 9.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.84 112.38 25.47 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.667 0.746 . . . . 0.0 110.627 -165.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 t -127.98 149.87 50.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.486 0.66 . . . . 0.0 109.789 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -61.33 -28.26 69.09 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -76.11 -42.47 46.99 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 166.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -156.47 131.39 9.06 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 120.214 1.37 . . . . 0.0 112.864 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -109.29 122.2 46.83 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.532 0.733 . . . . 0.0 110.297 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.42 108.88 15.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.325 -0.86 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.09 127.59 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-O 121.65 0.738 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -108.64 105.81 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.814 0.846 . . . . 0.0 109.505 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -104.99 116.65 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.429 0.692 . . . . 0.0 109.775 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -153.66 155.79 36.69 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.28 128.45 46.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.442 -0.786 . . . . 0.0 110.522 165.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.7 t -68.27 121.93 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 123.453 0.701 . . . . 0.0 110.255 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.36 -35.17 4.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -162.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.1 140.31 29.58 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.732 1.266 . . . . 0.0 112.06 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.13 107.12 18.99 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 122.041 -0.412 . . . . 0.0 111.079 171.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -112.46 133.77 54.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.577 0.751 . . . . 0.0 112.026 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.97 94.2 2.32 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 112.18 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -96.63 130.28 43.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.641 -0.662 . . . . 0.0 111.616 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.51 124.29 28.82 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.403 HD22 HE22 ' A' ' 97' ' ' GLN . 0.9 OUTLIER -78.19 67.73 4.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.115 1.436 . . . . 0.0 111.665 171.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -75.52 126.14 30.43 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.483 -166.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.22 64.75 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -170.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.75 -75.26 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.35 7.48 4.22 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.5 t0 43.84 59.98 2.9 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -115.2 141.51 47.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.59 -0.694 . . . . 0.0 111.375 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.47 115.52 28.1 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.335 0.654 . . . . 0.0 110.607 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.8 m -120.42 135.24 55.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.284 0.633 . . . . 0.0 111.751 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.0 mmm -76.63 99.77 5.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.787 . . . . 0.0 110.463 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.4 m -101.49 118.74 37.58 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.696 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.6 m -97.6 124.17 41.78 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.46 132.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.9 m -151.07 153.58 35.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.321 -1.487 . . . . 0.0 113.234 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.336 . . . . 0.0 113.27 -179.327 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.236 0.541 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.8 tp -89.4 107.36 19.03 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.586 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -90.1 141.35 28.77 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.898 0.879 . . . . 0.0 111.563 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -133.14 125.52 29.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.516 0.726 . . . . 0.0 110.923 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -113.19 121.63 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 123.225 0.61 . . . . 0.0 109.731 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.403 HE22 HD22 ' A' ' 74' ' ' LEU . 13.4 mt-30 -103.65 102.11 11.97 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.392 0.677 . . . . 0.0 111.024 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.34 125.0 39.66 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.68 -118.01 0.62 Allowed Glycine 0 N--CA 1.49 2.241 0 O-C-N 121.102 -0.999 . . . . 0.0 112.976 170.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.55 -36.12 81.89 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' A' ' 122' ' ' GLU . 7.8 mmtt -89.55 130.86 35.8 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -163.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.4 117.82 22.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.566 . . . . 0.0 111.889 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.11 46.94 93.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 117.737 1.855 . . . . 0.0 117.737 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -93.01 136.92 32.83 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.19 0.995 . . . . 0.0 111.762 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 -171.12 43.03 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 122.842 1.245 . . . . 0.0 114.244 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -154.08 152.78 30.86 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.101 0.953 . . . . 0.0 112.47 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 79.3 m -125.59 125.14 42.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.64 139.24 53.32 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -151.78 164.14 37.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 113.072 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.51 140.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 122.847 1.308 . . . . 0.0 110.689 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -137.16 84.05 2.03 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.08 -111.16 3.4 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.846 -0.533 . . . . 0.0 113.816 -171.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -93.03 6.96 46.07 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -106.62 127.59 53.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.96 1.709 . . . . 0.0 112.741 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.7 tp -85.61 119.16 25.64 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.119 0.968 . . . . 0.0 109.381 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.52 122.57 46.28 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.9 126.32 48.4 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.599 0.76 . . . . 0.0 111.473 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -106.0 123.1 47.45 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.394 0.678 . . . . 0.0 109.639 164.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 63.7 mtm -110.09 129.75 55.64 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 118.948 0.795 . . . . 0.0 110.64 172.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -125.68 144.55 50.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.41 127.7 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.606 0.763 . . . . 0.0 110.978 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' CG ' ' HZ1' ' A' ' 101' ' ' LYS . 40.3 mm-40 51.1 49.7 20.61 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -168.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.7 -32.54 1.43 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.67 157.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 125.14 1.376 . . . . 0.0 112.866 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.6 m -129.94 121.95 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.712 -1.243 . . . . 0.0 110.218 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.5 t -97.14 131.68 43.66 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.3 0.64 . . . . 0.0 110.508 161.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -113.8 120.01 39.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.859 -0.526 . . . . 0.0 110.511 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -120.18 139.24 52.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.565 0.746 . . . . 0.0 111.48 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.05 129.79 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.16 142.3 51.22 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.924 0.89 . . . . 0.0 110.663 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -112.59 133.38 54.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.377 -1.452 . . . . 0.0 111.94 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -67.92 122.64 18.61 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.4 m -117.27 -34.49 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.432 ' C ' ' H ' ' A' ' 7' ' ' TYR . 12.8 t60 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 CA--C 1.565 1.546 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -81.27 2.51 27.71 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -59.56 116.12 3.78 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.219 1.827 . . . . 0.0 114.59 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.94 177.95 31.52 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-O 123.246 1.47 . . . . 0.0 115.758 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -110.44 112.37 24.25 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 113.727 -1.236 . . . . 0.0 108.677 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -112.47 122.68 48.4 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -167.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -91.87 143.94 25.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.802 -1.186 . . . . 0.0 113.092 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.403 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.5 ttm -73.49 122.41 22.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.721 -1.237 . . . . 0.0 112.988 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.31 -44.74 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -154.0 158.31 40.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.459 -1.4 . . . . 0.0 112.645 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -135.8 100.62 4.51 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.08 -64.42 1.15 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -154.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -120.54 43.55 2.71 Favored 'General case' 0 CA--C 1.571 1.773 0 C-N-CA 123.717 0.807 . . . . 0.0 111.273 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -73.62 -39.85 64.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.64 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 18.8 tt0 -53.54 -46.05 70.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 168.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.44 -39.82 85.43 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -55.73 -45.98 77.87 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 165.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.97 -41.42 86.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -53.83 -44.71 70.47 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.89 52.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 166.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.68 -5.71 56.8 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 164.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 7.5 t70 69.6 62.78 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 120.38 1.445 . . . . 0.0 112.996 -164.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 83.5 t -104.03 148.23 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.19 0.995 . . . . 0.0 110.034 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -62.25 151.88 35.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.77 -42.91 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.95 -54.37 45.52 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.63 -38.5 84.98 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -53.53 -52.13 60.65 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.64 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 73.8 mmtt -65.29 -45.28 85.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.17 -56.49 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.538 0.735 . . . . 0.0 111.819 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -27.01 66.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.11 -43.22 83.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 162.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.67 -28.14 65.62 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 mt -68.46 135.59 51.91 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 120.034 1.288 . . . . 0.0 112.893 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -113.06 84.57 7.16 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.19 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 70.7 Cg_endo -71.95 168.6 23.46 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 122.624 2.216 . . . . 0.0 116.054 -176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.77 121.86 45.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.145 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -89.88 110.23 21.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.613 -0.679 . . . . 0.0 110.009 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.3 108.78 20.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 167.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -106.19 123.96 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.53 107.94 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -103.04 119.02 38.1 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.928 0.891 . . . . 0.0 109.36 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.7 -60.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 112.546 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.81 101.49 0.15 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.455 1.0 OUTLIER 60.46 -45.16 0.1 Allowed 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -150.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -70.34 126.66 30.28 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-N 119.874 1.215 . . . . 0.0 112.361 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 ttp -143.39 131.89 22.3 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.105 0.955 . . . . 0.0 111.674 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.9 mt -115.4 109.78 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -97.44 115.72 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -111.54 96.01 5.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.702 -0.624 . . . . 0.0 109.347 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.3 m -87.13 103.06 15.04 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.9 mt -101.04 114.86 29.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -130.28 149.29 52.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.7 0.8 . . . . 0.0 110.209 168.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -65.77 -16.36 63.72 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 167.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -76.56 -53.31 8.24 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.459 1.027 . . . . 0.0 112.739 163.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -155.0 135.16 13.1 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 121.784 0.802 . . . . 0.0 111.023 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.19 121.42 34.53 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.765 0.826 . . . . 0.0 110.084 173.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -112.34 104.94 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.833 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.82 125.28 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 121.818 0.818 . . . . 0.0 109.106 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.9 mtp -103.67 109.99 21.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.64 0.776 . . . . 0.0 109.015 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -108.31 110.6 22.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.554 0.742 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.69 42.25 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -166.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.24 129.9 55.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 168.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.07 123.51 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 123.519 0.728 . . . . 0.0 110.287 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.31 -32.32 7.66 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 117.333 1.693 . . . . 0.0 117.333 -164.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -87.87 145.15 26.2 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.991 1.395 . . . . 0.0 112.578 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.97 120.09 32.3 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.79 -0.569 . . . . 0.0 111.068 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -126.55 151.32 48.05 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.917 0.887 . . . . 0.0 112.263 -171.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.64 97.73 3.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.655 -1.278 . . . . 0.0 112.253 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -84.57 105.23 15.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.37 101.96 9.31 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.157 0.503 . . . . 0.0 110.362 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.48 52.44 2.37 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -83.08 130.73 35.15 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.034 0.934 . . . . 0.0 111.382 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.6 -51.62 0.73 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 -151.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.13 -73.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -164.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.88 28.91 2.11 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 159.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.28 16.7 m-20 55.83 31.26 17.32 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.154 2.649 . . . . 0.0 118.154 174.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.405 ' HE ' ' NZ ' ' A' ' 101' ' ' LYS . 39.3 mtt85 -108.01 141.18 40.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 113.147 -176.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -90.92 109.73 20.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.226 0.611 . . . . 0.0 110.667 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.1 m -107.14 128.46 54.42 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.045 0.538 . . . . 0.0 111.343 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 95.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.267 1.032 . . . . 0.0 110.483 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.9 m -105.47 125.92 51.54 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.607 -0.683 . . . . 0.0 109.941 -161.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 m -116.62 115.94 26.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.53 121.65 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -138.25 150.41 46.66 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.144 0.883 . . . . 0.0 111.874 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 85.5 m95 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 120.427 -1.421 . . . . 0.0 112.593 175.23 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.105 0.479 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.23 104.34 15.69 Favored 'General case' 0 CA--C 1.564 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -110.45 131.59 54.92 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.689 0.757 . . . . 0.0 111.152 -167.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 52.9 t -125.66 138.07 53.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.6 0.76 . . . . 0.0 112.88 -171.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -113.58 126.93 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 123.673 0.789 . . . . 0.0 109.178 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -102.49 95.37 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.485 0.714 . . . . 0.0 109.144 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.78 123.38 29.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.918 -1.114 . . . . 0.0 112.276 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.45 -90.66 0.11 Allowed Glycine 0 N--CA 1.484 1.886 0 O-C-N 121.598 -0.689 . . . . 0.0 114.49 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -88.74 -12.81 41.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -161.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' NZ ' ' HE ' ' A' ' 80' ' ' ARG . 23.3 mmtm -131.58 149.56 52.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.44 1.473 . . . . 0.0 111.612 -178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.39 115.01 21.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.459 1.104 . . . . 0.0 111.601 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.36 53.39 6.8 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -105.55 128.19 53.45 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.908 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.0 40.77 Favored Glycine 0 N--CA 1.486 1.997 0 O-C-N 121.601 -0.687 . . . . 0.0 114.395 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.255 40.1 p-90 -155.44 157.39 36.92 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.4 m -131.63 124.03 29.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.405 -0.81 . . . . 0.0 109.003 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.94 133.97 53.6 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.759 0.824 . . . . 0.0 111.722 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -149.78 171.52 16.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 0.0 112.746 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.23 126.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.45 90.71 3.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.438 163.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.98 -110.66 3.17 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.326 -0.858 . . . . 0.0 114.91 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.84 5.25 44.58 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 163.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -110.37 126.71 54.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.596 1.544 . . . . 0.0 112.432 -170.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.299 0.64 . . . . 0.0 109.791 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -113.55 120.14 39.94 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.0 tp -121.53 123.95 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.094 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -99.8 121.88 41.94 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.501 0.721 . . . . 0.0 110.025 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 50.1 mtm -115.44 132.97 56.46 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.536 1.062 . . . . 0.0 111.854 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.65 134.66 55.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 112.911 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.43 124.68 12.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 0.0 109.97 172.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 53.79 40.28 31.32 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 -8.35 9.54 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 120.263 2.865 . . . . 0.0 120.263 -164.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.58 117.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 120.399 2.1 . . . . 0.0 109.298 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.9 m -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.341 0.656 . . . . 0.0 111.234 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.6 t -97.22 129.79 44.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 111.753 166.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -98.18 125.41 43.2 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.696 0.68 . . . . 0.0 110.644 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -113.36 123.71 50.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.312 0.645 . . . . 0.0 109.323 169.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.81 133.65 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -135.4 156.61 48.63 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.522 1.129 . . . . 0.0 111.259 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.83 126.71 42.16 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.561 -1.337 . . . . 0.0 110.449 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -69.29 122.16 18.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.133 -0.979 . . . . 0.0 113.087 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.99 -38.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.5 t60 . . . . . 0 N--CA 1.487 1.404 0 CA-C-N 119.851 1.205 . . . . 0.0 108.112 170.071 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 t0 . . . . . 0 CA--C 1.564 1.502 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -82.53 4.49 24.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -60.6 114.28 2.9 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 121.419 1.918 . . . . 0.0 114.443 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.27 178.06 30.97 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-O 122.79 1.217 . . . . 0.0 115.738 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -108.88 115.26 29.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.399 1.079 . . . . 0.0 109.184 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -116.8 112.93 21.82 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.426 0.691 . . . . 0.0 109.189 -167.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -85.33 142.7 29.14 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.185 -0.947 . . . . 0.0 112.61 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.3 ttp -73.64 121.61 20.99 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-N 120.459 1.481 . . . . 0.0 113.042 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt -81.7 -44.12 17.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -154.5 160.22 41.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.413 -1.43 . . . . 0.0 113.322 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -136.0 118.86 16.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.808 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -124.26 122.68 38.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.597 0.759 . . . . 0.0 110.145 -170.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.2 t30 65.91 38.23 5.11 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.67 -40.89 16.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.77 -37.54 68.69 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.48 -41.12 69.75 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 120.922 1.692 . . . . 0.0 114.9 167.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -54.93 -46.67 74.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.55 -37.44 68.26 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -57.91 -41.38 82.51 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 164.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.15 -18.05 32.53 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 165.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -95.42 9.92 38.25 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 165.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.271 20.1 t70 57.99 50.16 10.66 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.5 t -98.72 141.01 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.836 0.827 . . . . 0.0 110.024 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.8 149.86 45.95 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.74 -45.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -50.58 70.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.36 -43.6 98.59 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -58.21 -47.88 82.08 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -60.04 -43.58 95.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.51 -56.98 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 118.717 0.69 . . . . 0.0 111.374 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.54 81.6 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -67.51 -32.59 73.5 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.34 -24.24 46.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 170.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.0 mt -68.92 147.05 52.23 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.513 1.506 . . . . 0.0 114.302 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.95 90.89 4.8 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.262 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.2 147.01 47.13 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.617 2.211 . . . . 0.0 114.415 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.99 117.84 29.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -88.44 110.75 21.08 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.654 -0.654 . . . . 0.0 111.084 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -96.08 107.7 20.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.514 -0.742 . . . . 0.0 109.355 167.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -105.84 127.33 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.18 110.08 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -106.78 110.86 23.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.312 0.645 . . . . 0.0 110.603 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -101.99 81.27 2.09 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.664 0.785 . . . . 0.0 109.52 168.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.91 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 121.559 -0.713 . . . . 0.0 114.341 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.76 -20.02 22.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 163.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -77.91 112.62 14.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.019 1.736 . . . . 0.0 111.923 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.3 ttm -123.27 125.01 44.27 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.677 0.751 . . . . 0.0 111.037 -165.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.1 mm -111.39 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -92.69 108.02 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.67 94.62 6.19 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.7 m -85.41 98.6 10.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.133 -0.979 . . . . 0.0 108.887 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.5 mt -97.18 115.13 27.01 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.848 -0.533 . . . . 0.0 110.7 -165.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 t -132.86 152.71 51.8 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.756 0.788 . . . . 0.0 110.476 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.6 p -64.34 -28.59 69.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -73.79 -48.19 33.34 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -154.89 135.57 13.54 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.498 1.044 . . . . 0.0 111.831 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.23 116.18 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.552 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -105.8 108.38 19.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 110.316 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mm -106.64 119.2 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.48 112.32 24.15 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.589 0.756 . . . . 0.0 109.641 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -112.27 112.36 23.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.599 0.76 . . . . 0.0 109.272 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -155.99 145.58 21.02 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -91.53 124.76 35.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.806 165.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.37 124.34 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.64 -0.663 . . . . 0.0 109.516 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.93 -39.27 2.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -157.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -95.6 152.83 18.09 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.561 1.181 . . . . 0.0 112.752 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -93.12 125.89 37.94 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.405 168.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.74 144.23 48.96 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.496 0.718 . . . . 0.0 112.32 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.27 100.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.493 -1.38 . . . . 0.0 112.978 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.94 104.91 16.72 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 121.829 -0.545 . . . . 0.0 109.707 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -74.0 99.18 3.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.793 0.437 . . . . 0.0 111.359 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.54 52.08 2.0 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -88.07 127.44 35.4 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.337 1.055 . . . . 0.0 111.411 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.97 -44.83 1.4 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 -148.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -93.66 -74.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.471 1.108 . . . . 0.0 108.647 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -122.46 -6.02 8.73 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 168.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 21.6 m-20 63.53 49.03 3.21 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 mtm-85 -141.94 143.26 33.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.116 -0.99 . . . . 0.0 111.475 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.86 94.97 6.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 -173.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -83.24 136.72 34.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.593 -0.692 . . . . 0.0 112.794 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.9 mtp -82.91 91.72 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.588 1.185 . . . . 0.0 110.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.429 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 40.4 m -102.75 122.13 43.84 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.414 -0.803 . . . . 0.0 110.898 -156.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -103.49 122.42 44.88 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.407 HG21 ' SG ' ' A' ' 95' ' ' CYS . 22.9 t -109.29 127.11 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -124.31 152.95 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.763 0.825 . . . . 0.0 111.924 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 120.933 -1.104 . . . . 0.0 113.193 178.143 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 122.162 0.982 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 tp -88.79 109.32 20.07 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -111.76 126.97 55.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 -162.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.429 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 44.8 t -127.62 135.41 50.23 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -168.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -112.83 122.28 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.607 0.763 . . . . 0.0 109.367 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -98.25 93.58 6.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.612 0.765 . . . . 0.0 109.111 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -85.77 122.51 29.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.8 -1.188 . . . . 0.0 112.309 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.8 -111.23 0.36 Allowed Glycine 0 N--CA 1.484 1.896 0 O-C-N 121.623 -0.673 . . . . 0.0 113.405 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.39 -3.61 56.53 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -121.06 143.42 49.08 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.196 1.362 . . . . 0.0 113.067 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -81.48 97.63 7.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -170.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.93 49.81 6.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.57 138.05 31.88 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.735 0.779 . . . . 0.0 112.436 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 -166.3 35.24 Favored Glycine 0 N--CA 1.486 1.974 0 CA-C-O 121.934 0.741 . . . . 0.0 114.807 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -159.09 153.35 23.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.8 m -130.23 125.98 36.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -126.3 129.15 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.765 0.826 . . . . 0.0 110.849 -172.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -145.72 167.56 22.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.978 -1.076 . . . . 0.0 113.449 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.8 mt -110.34 126.46 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.95 89.37 3.04 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 164.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.79 -112.05 3.57 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.299 -0.876 . . . . 0.0 114.679 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -89.99 2.96 54.55 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 161.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -102.63 134.43 46.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.557 1.526 . . . . 0.0 112.518 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -97.19 122.8 40.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.082 0.953 . . . . 0.0 109.19 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -114.52 122.38 46.39 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.464 0.706 . . . . 0.0 109.279 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp -123.95 122.15 37.18 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.456 0.702 . . . . 0.0 110.832 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.1 128.56 44.68 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.217 0.607 . . . . 0.0 109.865 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.4 mtm -117.95 130.43 56.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 118.894 0.77 . . . . 0.0 110.597 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -113.92 138.19 50.66 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.575 0.75 . . . . 0.0 112.818 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.87 116.51 4.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 110.2 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.305 6.0 mt-10 54.07 50.18 17.18 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.11 -14.48 3.84 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 120.577 2.991 . . . . 0.0 120.577 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.77 124.51 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.447 2.123 . . . . 0.0 110.017 -166.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -93.54 123.2 36.69 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.134 0.574 . . . . 0.0 110.697 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.67 135.92 37.91 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.066 0.547 . . . . 0.0 111.061 159.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -113.43 118.83 35.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.807 -0.558 . . . . 0.0 110.58 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -114.75 133.75 55.66 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.465 0.65 . . . . 0.0 110.903 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.36 131.0 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -127.66 160.42 31.68 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 124.475 1.11 . . . . 0.0 111.196 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -133.22 133.28 42.51 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.488 -1.383 . . . . 0.0 112.263 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -70.25 123.63 22.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.71 -37.56 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 . . . . . 0 CA--C 1.567 1.61 0 CA-C-N 119.739 1.154 . . . . 0.0 108.344 171.233 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.7 t0 . . . . . 0 CA--C 1.566 1.564 0 CA-C-O 121.24 0.543 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -81.83 -2.46 51.05 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 173.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -58.01 108.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 121.092 1.769 . . . . 0.0 114.499 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.71 33.94 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-O 122.609 1.116 . . . . 0.0 114.98 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -118.74 118.33 31.31 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.17 0.988 . . . . 0.0 109.441 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.19 114.72 20.66 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -164.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.04 141.15 29.15 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.978 -1.076 . . . . 0.0 113.769 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.1 ttp -76.24 119.21 19.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.26 -44.5 17.65 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -154.26 158.52 40.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.535 -1.353 . . . . 0.0 113.372 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -130.68 100.03 5.16 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.093 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -103.02 115.19 30.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.53 -0.731 . . . . 0.0 110.145 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 42.2 t30 58.56 31.31 20.91 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.14 -34.15 76.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 167.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 -49.54 77.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -37.11 80.11 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -57.73 -45.79 85.32 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.01 -40.33 78.74 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -55.48 -45.33 76.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.96 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 166.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.24 2.25 54.53 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.275 26.9 t0 64.49 56.61 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 120.259 1.39 . . . . 0.0 113.296 -169.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -103.1 139.45 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -66.77 157.17 33.53 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.9 t -60.7 -45.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -47.55 83.81 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.47 -44.77 92.94 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -52.09 -56.3 15.33 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -57.04 -33.07 66.84 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.18 -59.28 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 CA-C-N 118.757 0.708 . . . . 0.0 111.192 164.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.79 91.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -60.53 -36.7 79.03 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 170.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.58 -20.01 37.37 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.37 138.2 51.16 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 120.292 1.406 . . . . 0.0 113.091 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -111.23 85.4 5.44 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.22 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.8 158.83 54.52 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.608 2.205 . . . . 0.0 116.18 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.13 116.87 33.33 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.291 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -86.44 111.74 20.83 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.376 -0.828 . . . . 0.0 110.483 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.32 110.67 23.18 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.3 129.05 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.73 109.54 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -101.4 102.51 13.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.821 0.849 . . . . 0.0 110.126 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.8 71.93 5.72 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.72 0.808 . . . . 0.0 110.249 167.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.53 0.45 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -80.48 -33.38 36.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.74 114.83 19.9 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 120.186 1.357 . . . . 0.0 111.493 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.3 ttm -125.37 123.33 39.12 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.514 0.673 . . . . 0.0 110.984 -167.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.59 100.95 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.54 112.58 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -104.95 102.19 11.72 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 m -86.16 99.19 11.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.2 mt -99.6 116.05 30.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.088 0.555 . . . . 0.0 110.317 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -131.11 154.66 48.07 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.946 0.879 . . . . 0.0 110.741 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.3 p -62.97 -31.61 72.76 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -79.0 -45.06 21.0 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -158.01 132.69 8.4 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.973 1.261 . . . . 0.0 112.555 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -96.56 121.11 38.03 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.435 0.694 . . . . 0.0 110.388 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -110.67 104.63 13.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.375 -0.828 . . . . 0.0 110.631 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.54 125.54 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 122.087 0.946 . . . . 0.0 108.586 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.9 mtp -112.57 128.18 56.29 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.515 1.126 . . . . 0.0 108.603 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.04 95.15 3.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.686 . . . . 0.0 109.244 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -129.85 151.18 50.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -97.05 119.31 35.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.584 -0.698 . . . . 0.0 109.831 166.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.37 118.1 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 C-N-CA 123.458 0.703 . . . . 0.0 110.119 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.89 -43.45 1.49 Allowed Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -158.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.64 147.3 25.33 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.65 134.99 35.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.766 -0.584 . . . . 0.0 111.578 165.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -144.11 156.54 44.39 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.833 0.825 . . . . 0.0 112.903 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.98 98.16 3.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.46 0.704 . . . . 0.0 111.88 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -100.33 101.47 12.47 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.574 -0.704 . . . . 0.0 111.262 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -81.35 109.63 16.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.807 -0.558 . . . . 0.0 110.544 167.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.33 57.36 3.6 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-O 121.988 0.899 . . . . 0.0 112.854 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.0 t -76.31 140.48 41.52 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.15 0.98 . . . . 0.0 113.126 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.55 -46.43 1.96 Allowed Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -159.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mt -78.66 -74.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.513 1.125 . . . . 0.0 110.044 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -134.36 -3.47 2.71 Favored 'General case' 0 CA--C 1.574 1.886 0 C-N-CA 125.482 1.513 . . . . 0.0 114.457 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 1.6 m-20 54.1 57.18 6.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.68 134.58 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.19 0.519 . . . . 0.0 111.096 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -85.65 125.51 33.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.646 0.778 . . . . 0.0 111.61 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.92 148.7 48.21 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.493 0.717 . . . . 0.0 112.121 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.04 97.77 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.597 168.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.2 m -100.64 122.18 42.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 122.04 -0.412 . . . . 0.0 111.337 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -111.77 122.82 48.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.43 131.61 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.4 m -133.22 148.6 52.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 111.788 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 62.8 m95 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 111.121 172.089 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.58 0.705 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.52 108.64 21.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.537 -0.727 . . . . 0.0 110.218 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -112.46 132.39 55.08 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.463 0.705 . . . . 0.0 111.256 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -126.19 136.1 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.95 130.02 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -120.88 95.65 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.674 . . . . 0.0 110.405 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -77.91 120.83 23.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 112.925 -173.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.64 -115.71 0.35 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.989 -0.444 . . . . 0.0 112.255 172.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -78.53 -25.72 45.61 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -108.44 148.66 29.85 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.307 1.412 . . . . 0.0 112.957 -157.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.32 110.1 17.17 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.175 0.99 . . . . 0.0 111.85 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.49 51.52 9.59 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -92.76 116.59 29.16 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 117.316 0.558 . . . . 0.0 111.836 -171.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.55 -168.65 39.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -154.03 157.99 39.89 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.943 0.877 . . . . 0.0 112.958 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.5 m -132.93 127.49 34.41 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.036 -1.04 . . . . 0.0 108.682 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -127.58 131.44 49.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.778 . . . . 0.0 111.088 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.48 174.15 12.8 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.96 132.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.963 . . . . 0.0 109.436 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.09 92.17 3.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.743 0.817 . . . . 0.0 109.048 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.19 -114.85 4.44 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.346 -0.847 . . . . 0.0 114.746 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -88.7 4.98 45.38 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 163.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -106.56 129.92 54.41 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.101 1.319 . . . . 0.0 111.93 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.07 122.18 30.55 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.251 1.02 . . . . 0.0 109.733 166.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -113.44 124.33 52.17 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.733 0.813 . . . . 0.0 109.578 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.7 tp -127.83 119.5 25.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.253 0.621 . . . . 0.0 110.629 -173.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -90.26 135.23 33.8 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.892 0.477 . . . . 0.0 110.316 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.0 mtp -130.22 124.13 31.8 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.6 0.76 . . . . 0.0 109.856 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -122.88 132.32 54.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -0.753 . . . . 0.0 111.872 -164.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.03 131.66 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.233 0.613 . . . . 0.0 111.451 174.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 56.24 39.34 30.26 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.03 0.95 16.83 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 120.193 2.837 . . . . 0.0 120.193 -163.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.59 118.98 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 120.065 1.933 . . . . 0.0 108.942 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.4 m -95.04 116.88 29.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.658 0.742 . . . . 0.0 110.337 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.6 t -91.71 141.62 28.49 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.496 0.718 . . . . 0.0 111.116 161.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -115.58 123.28 48.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.399 -0.813 . . . . 0.0 110.952 166.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.43 129.14 56.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.187 0.595 . . . . 0.0 109.928 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.82 128.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -127.84 147.1 50.43 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.699 0.799 . . . . 0.0 111.002 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -116.37 135.81 53.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.378 -1.451 . . . . 0.0 112.29 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -70.06 122.95 20.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.29 -37.56 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 CA--C 1.567 1.603 0 CA-C-N 120.069 1.304 . . . . 0.0 108.595 170.467 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 121.783 0.801 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -75.17 3.18 9.16 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.716 2.488 . . . . 0.0 117.716 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -54.91 111.12 0.76 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.287 1.858 . . . . 0.0 114.959 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.44 175.86 28.85 Favored Glycine 0 N--CA 1.488 2.132 0 CA-C-O 122.217 0.898 . . . . 0.0 115.167 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -109.6 116.39 31.67 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.389 1.075 . . . . 0.0 109.515 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -118.33 112.73 20.42 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.688 -0.632 . . . . 0.0 109.412 -166.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.53 141.77 28.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.064 -1.023 . . . . 0.0 113.558 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttp -70.87 124.34 24.1 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -172.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.3 mt -85.67 -53.59 5.06 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.8 p -138.62 150.88 46.74 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 119.435 1.016 . . . . 0.0 113.477 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -129.13 113.78 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.867 0.867 . . . . 0.0 109.229 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -115.98 117.3 29.75 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 0.0 109.76 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.6 t30 63.74 36.45 10.61 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -74.57 -39.78 62.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.604 -1.31 . . . . 0.0 114.439 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.46 -41.84 97.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 174.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.13 -39.43 78.89 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.17 -49.42 71.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 165.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.75 -40.88 88.47 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -55.03 -46.39 75.27 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 164.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.32 -18.36 49.16 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 166.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.6 mt -91.03 3.53 54.5 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.279 40.3 m-20 66.12 52.17 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.116 1.366 . . . . 0.0 114.406 -171.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.95 144.57 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 122.123 0.964 . . . . 0.0 110.139 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -63.86 154.32 34.03 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.73 -44.42 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.74 -50.85 67.37 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.32 -40.12 95.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -55.05 -40.5 70.37 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -69.75 -48.45 59.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.916 -1.115 . . . . 0.0 113.761 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.63 -57.86 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.012 0.925 . . . . 0.0 112.136 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -30.35 71.42 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -69.09 -36.54 77.68 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.97 -23.63 59.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.53 152.42 41.88 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 120.404 1.456 . . . . 0.0 114.644 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -101.35 90.26 1.65 Allowed Pre-proline 0 CA--C 1.574 1.892 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.314 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.7 146.48 54.46 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 122.848 2.053 . . . . 0.0 114.808 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.23 113.16 24.93 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -89.67 107.39 19.06 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.375 -0.828 . . . . 0.0 110.538 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.71 107.22 19.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.717 -0.615 . . . . 0.0 109.908 172.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.65 131.42 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.3 t -113.21 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -93.65 104.86 16.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.221 0.609 . . . . 0.0 109.954 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.31 75.55 2.95 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 121.527 0.679 . . . . 0.0 109.931 167.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.23 -104.43 1.04 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -81.65 -32.0 32.06 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -81.24 107.39 13.99 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.935 1.243 . . . . 0.0 110.952 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.3 ttp -116.16 124.0 49.24 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.962 0.887 . . . . 0.0 111.047 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.41 101.57 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.9 mt -98.18 105.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -97.48 99.43 10.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -88.08 97.14 10.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.21 -0.931 . . . . 0.0 109.135 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.8 mt -100.39 121.73 42.0 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.261 0.624 . . . . 0.0 110.976 -164.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -139.49 157.24 46.18 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.122 0.963 . . . . 0.0 111.356 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.9 p -65.09 -30.81 71.79 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -74.98 -48.89 21.95 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 165.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -153.75 138.83 17.33 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 119.651 1.114 . . . . 0.0 113.431 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -94.03 128.16 40.23 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.724 0.81 . . . . 0.0 109.982 168.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -118.95 103.93 10.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.016 -1.052 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.29 128.25 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.9 mtp -115.41 104.86 12.19 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.636 0.775 . . . . 0.0 110.256 173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -111.12 113.64 26.31 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.031 0.933 . . . . 0.0 111.583 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.64 149.36 27.48 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -169.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -92.32 129.26 38.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 111.075 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.75 129.45 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 123.218 0.607 . . . . 0.0 111.048 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.64 -31.92 7.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -161.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -84.83 133.42 34.33 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.96 1.38 . . . . 0.0 112.993 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -86.55 98.39 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.786 0.435 . . . . 0.0 110.223 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -105.41 147.24 28.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.52 106.38 3.97 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.916 0.865 . . . . 0.0 112.131 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.73 103.03 10.8 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.616 0.766 . . . . 0.0 109.748 -166.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.81 116.68 20.11 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 121.84 0.829 . . . . 0.0 110.58 172.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.73 45.49 1.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.1 t -76.58 137.64 39.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.086 0.954 . . . . 0.0 112.593 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.83 -59.41 0.54 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.601 -152.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.03 -75.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 123.748 0.819 . . . . 0.0 109.595 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -140.33 21.14 2.4 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 174.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.268 11.9 t70 50.18 48.99 21.31 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 176.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HE ' ' NZ ' ' A' ' 101' ' ' LYS . 44.9 mtt85 -127.71 142.47 51.32 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.981 0.896 . . . . 0.0 112.378 -174.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -97.35 101.86 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.797 0.839 . . . . 0.0 110.652 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.3 m -102.11 147.67 26.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.518 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.97 95.22 10.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 109.009 167.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 124.19 47.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 111.243 -166.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -107.55 123.74 48.89 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -108.8 128.87 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t -123.57 149.66 45.01 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.98 0.912 . . . . 0.0 111.833 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 7.1 m95 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 120.89 -1.131 . . . . 0.0 112.228 170.543 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.649 0.737 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.66 110.18 21.08 Favored 'General case' 0 CA--C 1.564 1.51 0 O-C-N 121.518 -0.739 . . . . 0.0 109.123 172.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.7 122.4 45.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.099 0.56 . . . . 0.0 110.433 -161.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 52.5 t -122.07 138.88 54.28 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.05 123.85 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.601 0.76 . . . . 0.0 109.25 168.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -102.35 93.85 5.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -91.45 117.45 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 111.824 -166.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.8 -90.21 0.1 OUTLIER Glycine 0 N--CA 1.481 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 113.262 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -91.51 -16.98 26.4 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -164.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' NZ ' ' HE ' ' A' ' 80' ' ' ARG . 25.2 mmtm -125.33 148.35 48.76 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.22 1.373 . . . . 0.0 112.093 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.45 112.35 17.7 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 123.762 0.825 . . . . 0.0 112.231 -172.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.56 90.15 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -86.47 135.6 33.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.776 0.798 . . . . 0.0 111.431 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.9 -170.93 40.76 Favored Glycine 0 N--CA 1.482 1.757 0 CA-C-O 121.994 0.774 . . . . 0.0 114.602 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -156.42 150.42 25.11 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.2 m -124.87 125.99 44.85 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.48 129.16 48.12 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.513 0.725 . . . . 0.0 111.02 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.81 170.86 16.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.146 -0.971 . . . . 0.0 113.16 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.15 127.6 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.293 -0.88 . . . . 0.0 109.054 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.39 91.6 3.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 161.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.86 -111.7 3.54 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.172 -0.955 . . . . 0.0 115.03 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -94.06 8.82 40.11 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 162.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -107.84 123.8 49.13 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.399 1.454 . . . . 0.0 111.489 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.1 tp -81.32 118.73 22.88 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.64 1.176 . . . . 0.0 109.732 167.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.13 117.28 33.64 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.5 tp -115.18 128.89 56.47 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.79 0.836 . . . . 0.0 110.205 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -114.96 120.51 40.15 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.061 0.545 . . . . 0.0 109.962 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -110.18 133.58 53.08 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.764 0.825 . . . . 0.0 110.66 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -116.21 141.61 47.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.59 118.07 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.664 0.786 . . . . 0.0 110.615 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 55.2 44.15 28.15 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.33 3.05 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 120.477 2.951 . . . . 0.0 120.477 -164.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.98 122.81 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 120.256 2.028 . . . . 0.0 110.21 -167.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.8 m -94.73 125.73 39.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.334 0.654 . . . . 0.0 111.488 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 14.4 t -97.78 127.45 43.74 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.076 0.55 . . . . 0.0 110.762 158.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -107.58 129.31 55.0 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.385 0.612 . . . . 0.0 111.403 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -127.76 137.9 52.58 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.667 0.787 . . . . 0.0 111.031 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.74 131.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -131.21 130.37 42.86 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.453 0.701 . . . . 0.0 110.823 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -101.33 131.31 47.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.166 -1.584 . . . . 0.0 112.475 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.35 121.71 15.46 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.37 -38.23 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.8 t60 . . . . . 0 N--CA 1.488 1.435 0 CA-C-N 120.056 1.298 . . . . 0.0 107.796 169.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 121.879 0.847 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -71.76 1.85 6.27 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -54.62 108.36 0.38 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.45 177.94 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 CA-C-O 122.652 1.14 . . . . 0.0 115.157 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -111.01 116.61 31.47 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.426 1.09 . . . . 0.0 109.16 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -118.27 112.36 19.98 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.197 0.599 . . . . 0.0 109.539 -166.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -83.44 140.57 32.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.928 . . . . 0.0 113.41 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.7 ttm -69.7 125.1 25.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.235 1.38 . . . . 0.0 113.732 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.18 -57.75 2.9 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.657 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.0 m -127.89 149.95 50.08 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.29 1.043 . . . . 0.0 112.485 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.67 89.66 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.37 120.61 40.78 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.382 0.673 . . . . 0.0 110.62 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 33.6 t30 67.55 35.75 4.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -79.04 -41.02 29.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.327 -1.483 . . . . 0.0 114.84 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.617 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 2.9 mt-10 -50.51 -44.69 56.19 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 165.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.05 -36.36 69.58 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.877 1.671 . . . . 0.0 115.148 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -56.49 -49.01 75.92 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 164.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.21 -33.78 72.1 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -61.07 -41.35 96.45 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 164.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -18.22 56.7 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 165.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.65 -4.9 59.24 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 162.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 63.8 46.81 3.81 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 120.528 1.513 . . . . 0.0 114.707 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -93.01 140.95 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.812 0.815 . . . . 0.0 109.693 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.0 149.32 37.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.2 -45.0 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.75 62.92 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.85 -36.47 83.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -59.37 -49.94 75.88 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.588 1.995 . . . . 0.0 115.667 167.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.617 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 72.5 mmtt -61.78 -42.42 98.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 174.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.65 -56.84 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.83 0.741 . . . . 0.0 111.308 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.51 87.54 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.93 -33.49 75.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.59 -30.31 65.68 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 167.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.71 137.64 47.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.972 1.26 . . . . 0.0 113.536 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -108.26 85.88 3.0 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.17 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.4 Cg_endo -68.6 154.16 72.09 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.601 2.2 . . . . 0.0 114.926 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' N ' ' HD2' ' A' ' 39' ' ' ASP . 1.3 m-20 -104.71 118.23 36.06 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -85.89 112.3 21.03 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.748 -0.595 . . . . 0.0 110.531 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.85 109.67 22.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.714 -0.616 . . . . 0.0 109.637 167.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.44 126.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.01 108.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.14 113.78 27.54 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.179 0.992 . . . . 0.0 110.532 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -106.57 80.53 1.48 Allowed 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 123.845 0.858 . . . . 0.0 109.446 168.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.0 2.68 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 121.316 -0.865 . . . . 0.0 114.47 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.1 -25.63 22.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 164.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -74.43 118.03 16.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.909 1.686 . . . . 0.0 111.323 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.9 ttp -138.2 131.86 30.96 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.098 0.952 . . . . 0.0 111.902 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.53 103.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -93.04 112.12 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.18 98.79 8.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.7 m -86.07 98.91 11.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.694 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.5 mt -102.34 115.18 30.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.498 0.666 . . . . 0.0 110.884 -165.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.0 t -128.98 146.78 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.475 0.71 . . . . 0.0 109.922 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 t -64.05 -15.36 59.31 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.23 -48.69 13.74 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -159.77 132.76 6.8 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.393 0.997 . . . . 0.0 111.041 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.78 124.4 46.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.564 -0.71 . . . . 0.0 110.413 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -112.44 117.1 31.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mm -113.53 119.12 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -171.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 83.0 mtp -105.7 109.1 20.94 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.292 0.637 . . . . 0.0 109.33 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -109.8 108.94 19.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -153.58 160.06 42.34 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -99.34 129.23 45.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 111.322 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.41 124.56 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.17 5.57 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -163.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -96.64 144.86 26.29 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.743 1.271 . . . . 0.0 112.876 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.26 113.0 21.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 0.0 110.673 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -121.42 149.48 42.95 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.664 0.786 . . . . 0.0 112.671 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.48 97.23 2.53 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 112.974 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.15 103.3 16.0 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.414 -0.804 . . . . 0.0 110.373 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -85.22 104.09 14.77 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.007 0.432 . . . . 0.0 110.48 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mp -83.96 53.32 2.54 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.863 0.839 . . . . 0.0 112.848 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -86.99 138.54 31.42 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.77 -31.93 6.19 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -153.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mt -92.81 -71.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.525 1.13 . . . . 0.0 108.324 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -126.58 -17.3 5.09 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.279 11.1 t70 62.35 73.09 0.48 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 120.246 1.385 . . . . 0.0 112.57 -158.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -133.42 131.76 40.35 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.15 0.58 . . . . 0.0 110.224 172.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -102.66 102.05 12.22 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.768 0.827 . . . . 0.0 109.771 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.53 124.52 51.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.044 0.538 . . . . 0.0 111.576 -172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.69 99.2 2.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.001 0.905 . . . . 0.0 109.667 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -113.2 120.39 41.08 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.06 -158.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.8 m -98.28 121.16 39.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -106.66 128.23 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -145.79 156.8 43.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.646 -1.284 . . . . 0.0 112.899 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.5 m95 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 120.976 -1.078 . . . . 0.0 112.352 -179.406 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.436 0.636 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.1 tp -89.79 106.39 18.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.709 -0.619 . . . . 0.0 110.03 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -112.76 130.95 55.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.6 0.714 . . . . 0.0 111.089 -168.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.6 t -126.93 134.16 50.48 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.706 0.802 . . . . 0.0 113.058 -170.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.92 121.05 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.441 0.696 . . . . 0.0 109.704 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -100.35 97.07 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.526 0.73 . . . . 0.0 109.883 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.02 114.64 27.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 111.362 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.29 -112.16 0.36 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 120.919 -1.113 . . . . 0.0 114.027 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -80.09 -11.37 59.77 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -123.0 148.46 45.48 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 119.537 1.062 . . . . 0.0 111.869 -170.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.57 133.86 37.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.69 43.68 59.87 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 119.588 2.595 . . . . 0.0 119.588 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -94.89 135.05 36.86 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 117.79 0.795 . . . . 0.0 111.783 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.96 -167.56 36.18 Favored Glycine 0 N--CA 1.481 1.65 0 CA-C-O 122.126 0.848 . . . . 0.0 114.706 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -156.0 153.27 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -126.7 124.74 40.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -123.64 135.68 54.06 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.536 0.734 . . . . 0.0 111.74 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -150.15 169.14 21.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.68 128.2 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.63 93.83 4.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 162.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.99 -114.6 4.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 121.221 -0.925 . . . . 0.0 114.986 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -96.03 23.56 6.33 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 163.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.4 128.63 53.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.936 1.243 . . . . 0.0 111.118 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.83 126.39 35.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.227 1.011 . . . . 0.0 109.812 168.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.68 122.77 43.31 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.09 120.26 28.49 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.574 0.749 . . . . 0.0 110.267 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -100.03 125.5 46.1 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.114 0.566 . . . . 0.0 109.727 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 11.5 mtp -119.66 120.78 37.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.435 0.694 . . . . 0.0 110.308 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -109.09 135.89 49.5 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.46 117.71 10.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.605 0.762 . . . . 0.0 109.05 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.292 11.5 mt-10 54.63 47.84 21.7 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.15 -31.02 1.83 Allowed Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.799 2.68 . . . . 0.0 119.799 -166.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 50.9 t -79.68 122.23 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 119.239 1.519 . . . . 0.0 111.296 -164.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.2 m -94.36 126.98 39.96 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.363 0.665 . . . . 0.0 111.483 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.8 t -100.18 129.8 46.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.405 0.682 . . . . 0.0 110.83 162.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -103.63 110.57 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.194 0.598 . . . . 0.0 110.562 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -108.88 120.67 43.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.514 0.725 . . . . 0.0 109.511 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.82 130.42 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -133.27 150.11 51.93 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.441 0.696 . . . . 0.0 111.3 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -115.49 133.79 55.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.345 -1.472 . . . . 0.0 112.153 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -69.74 123.02 20.34 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.65 -37.45 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.565 1.529 0 CA-C-N 120.051 1.296 . . . . 0.0 108.264 169.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 CA--C 1.562 1.429 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -75.96 -2.06 28.61 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 169.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -60.71 109.18 0.97 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.009 1.731 . . . . 0.0 113.956 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.42 179.67 34.4 Favored Glycine 0 N--CA 1.486 1.967 0 CA-C-O 122.907 1.282 . . . . 0.0 115.801 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -109.51 109.53 20.36 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.422 1.089 . . . . 0.0 109.118 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -110.88 111.79 23.18 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 137.62 32.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 0.0 112.728 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 ttp -68.5 118.67 11.85 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -172.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.6 mt -79.58 -45.05 19.92 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -153.68 160.26 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.618 -1.301 . . . . 0.0 113.13 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -141.64 117.61 10.55 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.014 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.67 122.97 39.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.469 0.708 . . . . 0.0 110.213 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.8 t30 66.72 36.85 4.48 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -80.3 -42.43 23.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.607 -1.308 . . . . 0.0 114.505 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.34 -39.96 80.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.74 -42.09 78.08 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 121.039 1.745 . . . . 0.0 114.809 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -55.88 -46.9 78.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 168.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -68.45 -37.23 80.02 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -57.72 -44.36 85.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.315 -1.491 . . . . 0.0 114.903 162.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -16.9 47.72 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 118.205 2.669 . . . . 0.0 118.205 166.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.82 2.19 56.89 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 38.7 t70 64.92 58.57 0.93 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.232 1.413 . . . . 0.0 114.022 -170.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -111.12 140.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-O 121.48 0.657 . . . . 0.0 109.84 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -65.54 150.45 48.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.15 -45.38 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.65 72.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.18 -41.59 97.07 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -56.99 -47.85 79.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.99 -56.04 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.915 0.78 . . . . 0.0 111.741 171.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.56 77.07 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -68.71 -33.68 74.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 167.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.72 -26.2 60.58 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.23 146.84 48.76 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.128 1.331 . . . . 0.0 114.147 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -104.44 89.87 2.92 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 118.211 -0.899 . . . . 0.0 109.899 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.29 150.4 47.07 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 122.404 2.069 . . . . 0.0 114.731 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -114.75 117.08 29.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -85.3 107.28 17.24 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.591 -0.693 . . . . 0.0 110.866 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.69 108.29 19.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.516 -0.74 . . . . 0.0 109.219 167.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.77 136.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.58 110.98 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -95.37 108.16 20.34 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.337 0.655 . . . . 0.0 109.929 170.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.31 76.14 1.68 Allowed 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 121.558 0.694 . . . . 0.0 109.661 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 -103.79 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.34 -0.85 . . . . 0.0 114.766 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.97 -22.6 21.86 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 162.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -75.67 114.2 13.99 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 120.642 1.564 . . . . 0.0 111.557 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 tpp -120.0 132.49 55.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.843 0.457 . . . . 0.0 111.468 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.99 101.39 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.0 mt -96.8 110.37 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -105.07 97.58 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.8 m -83.02 99.48 9.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.7 mt -98.87 116.42 31.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.824 -0.547 . . . . 0.0 110.69 -166.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.5 t -137.86 152.55 49.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.602 0.761 . . . . 0.0 110.637 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -74.44 -49.31 22.9 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -153.53 135.75 14.87 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.569 1.077 . . . . 0.0 111.657 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -89.79 120.36 30.97 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -113.5 106.02 14.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.645 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.24 127.39 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.479 0.712 . . . . 0.0 109.317 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.9 mtp -109.15 110.69 21.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.838 0.855 . . . . 0.0 109.352 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -112.99 117.34 31.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.451 0.7 . . . . 0.0 109.84 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -156.95 155.92 32.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -96.27 125.23 40.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 111.148 165.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.53 124.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.547 0.739 . . . . 0.0 109.532 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.05 -41.78 2.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -157.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -92.97 142.39 27.35 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.878 0.871 . . . . 0.0 113.169 -170.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -87.66 124.13 33.22 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.862 -0.524 . . . . 0.0 110.976 166.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -132.76 152.42 51.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.826 0.85 . . . . 0.0 111.554 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.75 105.28 5.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.425 -1.422 . . . . 0.0 112.317 169.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -92.24 114.06 26.5 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.416 ' HD2' ' NZ ' ' A' ' 81' ' ' LYS . 6.7 t0 -77.39 121.3 23.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 159.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.86 63.32 7.36 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.197 0.998 . . . . 0.0 111.653 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -79.45 118.77 21.63 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.723 0.809 . . . . 0.0 111.166 -168.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.24 -48.43 0.94 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 -159.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -80.37 -85.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -171.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.08 8.26 13.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 55.94 46.27 22.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.41 140.99 52.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.784 . . . . 0.0 111.268 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' NZ ' ' HD2' ' A' ' 73' ' ' ASP . 66.4 mttm -86.95 111.33 20.73 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.266 173.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.83 135.41 45.43 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.291 0.637 . . . . 0.0 111.285 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mmt -77.58 99.46 5.75 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.225 1.012 . . . . 0.0 109.614 165.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.6 m -104.28 122.55 45.64 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.657 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.6 m -103.78 126.57 51.0 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 166.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.6 t -111.34 128.75 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -134.14 149.93 51.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.063 0.945 . . . . 0.0 111.925 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.0 m95 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.647 -1.283 . . . . 0.0 114.294 -179.062 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.533 0.683 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -89.26 109.68 20.54 Favored 'General case' 0 CA--C 1.562 1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.201 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -95.31 140.35 30.33 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.219 1.008 . . . . 0.0 111.595 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 51.8 t -137.73 133.88 34.66 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.12 128.83 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.636 0.774 . . . . 0.0 109.526 168.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -107.12 103.47 12.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.812 0.845 . . . . 0.0 110.102 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -86.71 113.07 22.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 111.48 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.11 -129.79 1.21 Allowed Glycine 0 N--CA 1.487 2.058 0 O-C-N 121.652 -0.655 . . . . 0.0 113.789 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.0 -22.18 45.9 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -170.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -105.66 142.08 36.0 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.481 1.491 . . . . 0.0 111.593 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -86.82 141.71 28.62 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.2 50.71 60.72 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -170.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -109.38 125.08 52.01 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.544 0.738 . . . . 0.0 110.344 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.61 35.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.4 159.35 37.3 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.377 1.085 . . . . 0.0 113.348 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.5 m -133.33 125.13 28.54 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -121.12 136.1 55.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.906 -0.496 . . . . 0.0 111.677 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -146.65 156.37 43.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.912 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.35 126.69 47.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -111.64 94.22 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 158.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.83 -110.44 3.16 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.163 -0.961 . . . . 0.0 115.236 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -95.74 7.61 45.81 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 164.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -110.96 127.15 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.23 1.377 . . . . 0.0 111.834 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 tp -85.29 115.87 23.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.168 0.987 . . . . 0.0 109.39 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.19 120.02 39.62 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 tp -117.32 120.75 39.17 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.835 0.854 . . . . 0.0 110.425 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -97.09 123.5 40.86 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 162.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.7 mtm -112.88 126.65 55.68 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.519 0.6 . . . . 0.0 109.763 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -121.82 137.19 54.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.542 -0.724 . . . . 0.0 112.364 -167.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.4 126.8 5.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.12 0.568 . . . . 0.0 110.922 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 57.25 40.93 27.53 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.28 -13.34 2.79 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 120.261 2.864 . . . . 0.0 120.261 -163.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.75 122.08 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 119.701 1.75 . . . . 0.0 109.174 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -102.9 126.47 50.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 122.949 0.5 . . . . 0.0 111.074 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.6 t -95.77 131.57 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.269 0.628 . . . . 0.0 111.131 162.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -112.69 112.35 23.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.062 0.545 . . . . 0.0 110.092 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -115.32 144.81 43.19 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.44 0.696 . . . . 0.0 111.847 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.0 t -123.62 127.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.61 131.63 46.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.59 0.756 . . . . 0.0 110.43 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -104.32 131.66 51.42 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.546 -1.346 . . . . 0.0 112.031 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -68.99 113.52 6.45 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.71 -31.17 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 170.871 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 . . . . . 0 CA--C 1.567 1.634 0 CA-C-O 121.232 0.539 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.9 3.25 42.7 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -59.73 120.54 9.72 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.076 1.762 . . . . 0.0 114.793 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 174.12 28.2 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 122.847 1.248 . . . . 0.0 115.446 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -107.71 111.52 23.76 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.108 0.963 . . . . 0.0 108.573 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -114.28 111.85 22.17 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -90.66 139.8 30.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.057 -1.027 . . . . 0.0 113.189 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.433 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 36.7 ttp -72.94 125.6 27.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.441 -1.412 . . . . 0.0 114.17 -171.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.06 -50.3 7.14 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 169.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.3 p -136.79 149.28 47.69 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 119.369 0.986 . . . . 0.0 113.459 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -128.21 103.73 7.35 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.42 -60.8 1.87 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.24 43.31 3.15 Favored 'General case' 0 CA--C 1.572 1.826 0 C-N-CA 123.868 0.867 . . . . 0.0 110.575 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -76.65 -45.66 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.79 -47.95 70.3 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 166.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.59 -37.22 86.82 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.38 -43.75 83.88 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 120.85 1.659 . . . . 0.0 115.149 162.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.83 -38.14 85.85 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 172.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -55.93 -43.23 77.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 162.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.22 62.28 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.56 12.48 29.43 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 164.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.264 28.0 t70 56.92 47.9 16.88 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 120.602 1.546 . . . . 0.0 115.036 -174.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -93.35 155.57 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.448 -0.783 . . . . 0.0 110.722 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 151.13 47.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.45 -43.87 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.73 62.75 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 33.8 tp -61.35 -39.34 90.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -54.1 -39.01 65.99 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -71.57 -50.56 29.84 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.68 -54.56 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 123.906 0.883 . . . . 0.0 112.468 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.71 75.61 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.91 -39.89 91.0 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 165.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.78 -24.01 62.51 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.04 148.04 51.54 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.45 1.477 . . . . 0.0 113.72 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -107.67 86.54 2.95 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.03 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 53.5 Cg_endo -72.69 154.82 54.51 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 115.934 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -118.81 111.42 18.42 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -83.53 107.19 15.84 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.59 -0.694 . . . . 0.0 110.708 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.54 107.95 19.91 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.84 125.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -110.89 105.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.0 105.96 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.269 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.2 77.85 5.22 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.68 0.792 . . . . 0.0 109.922 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.29 -97.12 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 O-C-N 121.416 -0.803 . . . . 0.0 114.793 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.47 -17.51 20.49 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 164.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.99 114.11 21.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.789 1.631 . . . . 0.0 111.264 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.7 ttm -121.04 124.13 44.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.568 0.747 . . . . 0.0 111.225 -167.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.6 mt -114.08 96.79 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.6 mt -90.17 112.29 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -106.48 97.79 7.55 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 m -82.77 94.44 7.63 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.0 109.338 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -90.81 131.75 36.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.121 0.568 . . . . 0.0 111.687 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -150.88 155.9 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.097 0.951 . . . . 0.0 111.909 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.8 p -61.13 -32.57 72.26 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -78.1 -55.11 5.54 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -155.57 139.95 16.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.959 0.799 . . . . 0.0 110.238 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -88.82 125.11 34.76 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.051 0.54 . . . . 0.0 110.826 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -104.21 118.03 35.65 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.109 0.868 . . . . 0.0 110.584 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.11 120.7 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.8 mtp -108.84 111.54 23.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.258 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.09 108.44 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.408 0.683 . . . . 0.0 109.272 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -152.48 155.02 36.67 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -167.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.35 134.73 40.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.817 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.44 123.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.78 5.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -154.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -95.18 135.39 36.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.389 1.095 . . . . 0.0 112.772 -161.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -85.66 107.08 17.39 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 122.033 -0.417 . . . . 0.0 110.15 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -116.85 157.83 24.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.81 0.844 . . . . 0.0 112.33 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.63 104.46 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.672 -1.268 . . . . 0.0 112.167 169.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -90.75 107.09 18.95 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 121.39 -0.818 . . . . 0.0 108.959 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.47 ' HD2' ' NZ ' ' A' ' 81' ' ' LYS . 9.5 t0 -82.7 120.29 25.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 164.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mp -90.9 49.97 1.73 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -74.17 132.96 42.7 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.218 1.007 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 -50.17 1.03 Allowed Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.571 -0.705 . . . . 0.0 114.576 -158.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 mt -79.35 -66.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 125.002 1.321 . . . . 0.0 111.067 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -143.99 -6.54 0.76 Allowed 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.877 1.671 . . . . 0.0 114.175 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.287 3.3 t70 52.03 45.56 28.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -127.01 141.08 51.88 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.574 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.47 ' NZ ' ' HD2' ' A' ' 73' ' ' ASP . 66.2 mttm -84.23 127.36 33.9 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.707 0.765 . . . . 0.0 112.564 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.6 m -113.51 141.29 47.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.578 0.751 . . . . 0.0 111.076 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.29 98.35 4.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 159.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.423 HG23 ' SG ' ' A' ' 95' ' ' CYS . 89.9 m -99.66 121.53 41.36 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.0 m -109.33 120.42 42.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 t -110.64 124.99 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.0 m -134.63 158.52 43.83 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 112.565 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 79.2 m95 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 112.093 177.384 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.66 100.71 13.51 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.734 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -108.24 140.34 41.62 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.677 0.791 . . . . 0.0 111.482 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' A' ' 84' ' ' THR . 50.2 t -134.19 141.44 47.05 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -170.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -114.17 128.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.783 0.833 . . . . 0.0 109.84 166.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -101.88 103.86 14.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.499 0.72 . . . . 0.0 109.264 173.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -89.14 99.75 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.187 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.16 94.4 0.09 OUTLIER Glycine 0 N--CA 1.488 2.114 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 -169.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.296 40.0 mt-10 73.19 -51.07 0.71 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 161.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -99.27 144.77 28.01 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.622 0.769 . . . . 0.0 111.306 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.77 162.48 21.7 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.69 51.97 48.93 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -121.19 122.27 39.6 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.533 0.682 . . . . 0.0 111.926 -159.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.93 -162.83 34.44 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 121.447 -0.783 . . . . 0.0 114.064 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.268 67.3 p-90 -156.79 168.32 27.8 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 123.215 1.484 . . . . 0.0 113.115 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -146.86 130.57 16.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.975 -1.703 . . . . 0.0 108.599 168.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -127.53 142.48 51.37 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.282 1.039 . . . . 0.0 112.255 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -146.59 167.48 23.63 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.9 mt -114.62 126.7 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.284 -0.885 . . . . 0.0 109.176 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.35 89.85 3.24 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 163.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.67 -110.47 3.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -99.32 17.12 20.88 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HE2' ' NZ ' ' A' ' 131' ' ' LYS . 85.4 mt-10 -110.55 126.21 54.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.496 1.044 . . . . 0.0 111.593 174.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.4 tp -86.43 122.39 30.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.801 0.84 . . . . 0.0 109.683 166.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -111.15 119.49 39.15 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.0 tp -118.17 128.63 54.9 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.717 0.807 . . . . 0.0 110.54 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -108.53 119.34 39.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.619 0.767 . . . . 0.0 109.547 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.2 mtm -112.92 129.87 56.32 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.487 0.715 . . . . 0.0 111.312 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -123.61 132.78 53.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 111.901 -167.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.27 129.79 14.91 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.779 0.831 . . . . 0.0 109.305 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 55.57 36.08 26.45 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.07 -3.83 27.43 Favored Glycine 0 CA--C 1.557 2.684 0 N-CA-C 119.878 2.711 . . . . 0.0 119.878 -164.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.92 113.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 120.071 1.935 . . . . 0.0 109.091 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.0 m -93.37 119.39 32.44 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -173.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.8 t -90.81 125.96 35.87 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.385 0.674 . . . . 0.0 112.067 164.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -98.4 122.84 42.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.791 0.436 . . . . 0.0 110.33 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -117.82 139.85 50.51 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.315 0.646 . . . . 0.0 110.664 168.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.0 130.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -128.82 136.42 50.46 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 123.299 0.64 . . . . 0.0 111.411 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.574 ' NZ ' ' HE2' ' A' ' 114' ' ' GLU . 3.2 tpmt? -96.09 127.32 42.0 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.649 1.179 . . . . 0.0 111.501 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -68.55 119.82 13.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.185 0.902 . . . . 0.0 112.777 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.22 -38.5 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 CA--C 1.561 1.389 0 CA-C-N 119.78 1.173 . . . . 0.0 107.909 169.542 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.343 15.3 t70 . . . . . 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 112.66 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.41 15.62 1.22 Allowed 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -59.19 117.32 4.61 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.48 176.08 30.12 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-O 122.6 1.111 . . . . 0.0 115.865 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -106.94 113.86 27.6 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.442 1.097 . . . . 0.0 109.034 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -117.56 112.99 21.32 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -92.67 140.64 29.32 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.843 -1.161 . . . . 0.0 113.397 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.403 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 34.5 ttp -70.4 117.37 11.85 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-N 119.726 1.148 . . . . 0.0 114.0 -173.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.14 -46.88 21.98 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 167.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.2 m -153.75 160.49 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.811 1.291 . . . . 0.0 112.704 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -150.33 112.75 4.68 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.773 -174.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HE2' ' NZ ' ' A' ' 127' ' ' LYS . 33.1 tt0 -94.3 -69.74 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -117.19 42.22 2.59 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -73.44 -36.01 65.86 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -59.85 -39.56 85.6 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.79 -40.28 83.95 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 167.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.35 -47.81 82.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.25 -39.37 75.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -54.4 -43.43 71.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 162.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.85 51.7 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 165.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.16 2.2 47.74 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.297 20.2 t70 63.64 49.34 3.04 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -167.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.83 146.41 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.162 0.982 . . . . 0.0 110.13 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -65.89 153.63 41.47 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.3 t -59.72 -44.74 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.45 -49.55 74.26 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.76 -43.25 98.23 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -52.46 -50.84 61.84 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 165.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.98 -45.14 93.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.27 -54.43 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 118.945 0.793 . . . . 0.0 111.6 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.51 -29.92 65.35 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.29 -26.8 56.26 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.6 144.37 57.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.367 1.439 . . . . 0.0 113.563 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -107.73 84.62 2.05 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.847 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 71.2 Cg_endo -74.02 156.5 47.46 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.579 2.186 . . . . 0.0 115.171 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.42 118.83 33.78 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.513 ' HZ3' HD21 ' A' ' 117' ' ' LEU . 60.3 mttt -84.81 108.14 17.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.36 -0.837 . . . . 0.0 110.661 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -96.22 107.66 20.03 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.1 128.13 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.51 107.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -100.04 118.7 36.98 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.356 0.663 . . . . 0.0 110.708 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.41 81.83 1.58 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 -104.19 1.16 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -82.3 -27.36 32.35 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -79.12 116.13 19.21 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.196 1.362 . . . . 0.0 111.943 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -124.28 127.13 47.2 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 121.506 0.67 . . . . 0.0 110.971 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.05 99.26 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.3 mt -91.24 107.03 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -100.95 99.91 10.45 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -88.0 99.41 12.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.08 129.07 48.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.066 0.546 . . . . 0.0 111.848 -162.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -148.18 145.92 28.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.58 0.705 . . . . 0.0 110.379 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.5 p -60.78 -26.03 66.96 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -73.31 -50.63 21.1 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 165.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -159.74 133.44 7.21 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.624 1.102 . . . . 0.0 111.268 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -97.91 139.73 33.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.64 . . . . 0.0 111.395 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -123.77 119.99 31.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -0.779 . . . . 0.0 110.251 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -113.35 122.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.3 mtp -109.48 106.17 15.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.717 -0.614 . . . . 0.0 109.793 175.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -107.76 112.28 24.87 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.516 0.726 . . . . 0.0 109.738 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.24 155.84 31.51 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -95.67 130.84 42.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 111.054 164.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 t -69.14 123.53 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 109.933 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.14 -34.41 4.84 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 -161.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -94.56 147.55 23.16 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.815 1.307 . . . . 0.0 113.065 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.59 124.69 35.94 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.787 -0.57 . . . . 0.0 110.865 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -133.53 151.95 51.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.568 0.747 . . . . 0.0 112.568 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.4 110.39 7.65 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.436 1.113 . . . . 0.0 112.324 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -94.04 100.12 12.3 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.224 1.01 . . . . 0.0 109.554 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.26 104.58 8.94 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.447 0.641 . . . . 0.0 110.003 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mt -90.45 45.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -81.86 131.5 35.26 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.198 0.999 . . . . 0.0 110.546 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.2 -34.99 4.48 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.924 1.529 . . . . 0.0 116.924 -159.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 mt -86.36 -67.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 124.439 1.096 . . . . 0.0 109.553 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -136.59 -7.35 1.94 Allowed 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.257 26.8 t0 57.4 64.69 1.53 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 120.304 1.411 . . . . 0.0 114.666 -166.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -136.82 144.12 43.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.6 -0.688 . . . . 0.0 111.057 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -97.6 112.02 24.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 111.066 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -110.31 146.55 35.53 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.41 0.684 . . . . 0.0 111.701 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.8 mmt -82.09 97.6 8.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.161 -1.587 . . . . 0.0 110.229 171.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.436 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 36.1 m -91.91 126.29 36.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 111.634 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 m -107.39 125.96 51.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 162.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.82 127.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -129.29 159.08 37.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.029 0.931 . . . . 0.0 111.829 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.0 m95 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 120.603 -1.311 . . . . 0.0 112.278 173.427 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.55 0.691 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.6 tp -88.58 107.56 18.97 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 123.286 0.634 . . . . 0.0 109.761 173.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -114.08 132.4 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.583 0.753 . . . . 0.0 111.527 -167.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.436 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 40.6 t -131.65 138.42 48.75 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.38 124.77 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.444 167.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -101.06 97.26 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 0.0 109.544 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -85.2 115.82 23.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 112.01 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.59 0.3 Allowed Glycine 0 N--CA 1.483 1.833 0 O-C-N 121.396 -0.815 . . . . 0.0 113.663 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -87.67 -7.89 56.85 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -166.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -126.38 143.7 51.08 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.458 1.481 . . . . 0.0 112.081 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -85.67 113.63 22.02 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.424 0.63 . . . . 0.0 112.523 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.93 56.68 6.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -101.54 130.68 47.88 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.413 0.625 . . . . 0.0 111.243 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.15 -170.21 40.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -155.62 153.45 30.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.2 m -127.83 121.05 29.13 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -119.65 123.42 43.79 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.599 0.759 . . . . 0.0 110.67 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -142.86 153.29 43.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 113.194 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -100.64 126.12 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.0 109.227 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.57 92.83 3.99 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.99 -115.13 4.82 Favored Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.637 -0.664 . . . . 0.0 114.473 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 p30 -94.58 8.05 43.57 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 164.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.18 126.71 53.55 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.598 1.545 . . . . 0.0 111.141 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.41 113.57 25.51 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.32 1.048 . . . . 0.0 109.226 169.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -99.46 125.48 45.21 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 109.531 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.513 HD21 ' HZ3' ' A' ' 40' ' ' LYS . 31.6 tp -122.47 120.5 34.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.696 0.798 . . . . 0.0 110.267 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.05 130.33 47.05 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.936 165.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -125.02 129.26 49.94 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.68 1.127 . . . . 0.0 111.111 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.21 144.36 45.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.483 -0.76 . . . . 0.0 112.715 -171.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.73 127.89 4.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.539 0.736 . . . . 0.0 110.162 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 52.57 50.28 18.55 Favored 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.89 -20.29 1.88 Allowed Glycine 0 CA--C 1.557 2.671 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.7 t -67.84 172.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 CA-C-N 120.146 1.973 . . . . 0.0 112.993 -169.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.5 m -144.28 115.3 7.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 119.31 -2.119 . . . . 0.0 109.83 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -93.84 121.92 35.79 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.752 0.821 . . . . 0.0 111.381 166.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.479 ' NZ ' ' HE2' ' A' ' 14' ' ' GLU . 28.4 mtmt -98.11 123.99 42.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.822 0.449 . . . . 0.0 111.433 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -122.0 139.19 53.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.937 0.895 . . . . 0.0 110.499 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 36.2 t -120.26 126.77 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -127.58 122.33 32.93 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.56 0.744 . . . . 0.0 110.575 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -98.19 135.24 40.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.471 -1.393 . . . . 0.0 112.872 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -69.11 121.79 17.44 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.33 -35.78 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 120.057 1.299 . . . . 0.0 108.232 169.885 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.571 1.783 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.77 114.07 3.41 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.701 2.268 . . . . 0.0 114.709 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 m -69.35 143.85 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -172.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -78.97 95.85 5.58 Favored 'General case' 0 CA--C 1.565 1.529 0 O-C-N 121.616 -0.677 . . . . 0.0 112.408 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.76 -0.45 23.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -58.25 104.94 0.24 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 121.293 1.86 . . . . 0.0 114.767 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.39 -179.03 36.17 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-O 123.117 1.398 . . . . 0.0 115.938 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 134' ' ' HIS . 35.9 t80 -113.38 116.19 29.28 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 113.651 -1.274 . . . . 0.0 109.399 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -117.19 113.36 22.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -167.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -90.37 140.19 29.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.104 -0.997 . . . . 0.0 113.337 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.6 ttm -67.2 122.03 16.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.17 -45.72 13.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 166.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.7 m -152.71 159.6 43.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.418 -1.426 . . . . 0.0 113.871 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -134.43 113.13 11.53 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.594 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -122.01 123.68 42.2 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.331 0.653 . . . . 0.0 110.492 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.276 37.7 t30 68.06 30.47 5.89 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -79.25 -40.57 30.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.159 -1.588 . . . . 0.0 115.179 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.645 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 49.9 mt-10 -55.03 -42.2 72.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.11 -42.08 89.71 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -55.94 -48.06 76.41 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.75 -39.88 80.09 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -54.9 -44.05 73.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.69 -23.76 60.08 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.3 3.65 38.67 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.288 17.5 t0 61.27 48.33 6.26 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -169.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.29 147.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.001 0.905 . . . . 0.0 110.329 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -63.06 152.76 36.13 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.3 t -60.63 -43.75 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.84 -52.71 61.91 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -62.82 -36.96 84.91 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -54.04 -50.27 67.07 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 163.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.645 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 74.0 mmtt -66.58 -44.92 80.95 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.07 -57.5 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.204 0.911 . . . . 0.0 111.928 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.23 70.98 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -71.15 -35.08 71.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.68 -32.55 73.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.5 mt -73.92 128.15 34.75 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 119.373 0.988 . . . . 0.0 112.331 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -102.64 94.36 5.05 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.942 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.64 161.14 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.294 1.996 . . . . 0.0 115.683 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -104.16 124.41 49.05 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.629 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -88.24 109.34 19.85 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.234 -0.916 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.67 112.18 23.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.91 163.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.97 128.8 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.29 112.72 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.44 1.096 . . . . 0.0 110.52 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -127.34 76.03 1.63 Allowed 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.483 -0.76 . . . . 0.0 110.143 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -102.32 1.21 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.436 -0.79 . . . . 0.0 114.214 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.83 -26.35 20.57 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 162.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -70.56 134.31 47.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.333 1.879 . . . . 0.0 112.768 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 ttm -145.5 130.73 18.51 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.43 0.633 . . . . 0.0 112.074 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.15 108.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.16 110.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -100.98 106.31 17.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.65 -0.656 . . . . 0.0 109.822 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.1 m -88.97 99.45 12.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.49 125.86 41.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.107 0.563 . . . . 0.0 111.525 -163.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -147.31 155.39 41.98 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.097 0.951 . . . . 0.0 111.739 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -62.83 -32.86 74.15 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -75.46 -54.02 7.73 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -152.12 134.01 14.88 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.839 0.745 . . . . 0.0 110.383 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -92.77 122.42 35.14 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.13 0.572 . . . . 0.0 109.821 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -109.55 106.61 16.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.305 0.642 . . . . 0.0 110.499 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.1 mp -105.08 124.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.2 mtp -108.42 110.28 21.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.768 0.827 . . . . 0.0 109.498 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -107.52 118.17 36.01 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.338 0.655 . . . . 0.0 109.775 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.34 155.2 33.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -96.38 129.27 43.76 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.809 0.814 . . . . 0.0 110.713 159.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.96 128.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 C-N-CA 123.995 0.918 . . . . 0.0 109.686 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.13 -47.41 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 115.779 1.071 . . . . 0.0 115.779 -156.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -83.92 135.85 34.32 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.35 105.87 16.32 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.709 0.403 . . . . 0.0 110.36 169.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -113.49 157.14 22.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.864 0.84 . . . . 0.0 113.06 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.21 101.58 5.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 112.349 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -102.41 104.69 15.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.496 -0.752 . . . . 0.0 110.332 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -81.8 113.98 20.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.34 66.3 5.79 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.553 1.168 . . . . 0.0 112.101 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -75.71 117.64 17.68 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.387 1.075 . . . . 0.0 111.25 -168.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.56 -52.62 0.62 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -162.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.02 -68.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 124.733 1.213 . . . . 0.0 110.178 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -130.89 -6.09 3.99 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.285 17.3 t0 51.57 45.31 28.26 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -166.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -108.38 139.11 43.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 110.582 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -81.6 116.12 21.2 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 112.01 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.5 m -108.5 142.0 39.55 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.683 0.793 . . . . 0.0 111.293 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.01 94.73 7.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.132 168.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -99.82 123.55 44.19 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.576 -0.702 . . . . 0.0 110.621 -164.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 m -112.59 122.01 46.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.65 132.72 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -126.76 146.78 50.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.921 0.888 . . . . 0.0 111.685 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -87.43 116.9 25.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 111.961 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -105.06 62.88 0.7 Allowed 'General case' 0 CA--C 1.575 1.913 0 O-C-N 121.811 -0.556 . . . . 0.0 110.307 161.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.76 -95.12 0.12 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.096 1.599 . . . . 0.0 117.096 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.524 ' N ' ' HD2' ' A' ' 91' ' ' ASP . 1.6 m-20 -75.49 -32.85 60.7 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 167.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -94.88 121.69 36.74 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 119.302 0.956 . . . . 0.0 111.192 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.0 111.23 22.6 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -115.47 123.79 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.125 0.57 . . . . 0.0 110.614 -162.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.72 136.69 54.95 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.43 128.23 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.401 0.68 . . . . 0.0 109.543 165.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -104.34 101.68 11.38 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.549 0.74 . . . . 0.0 109.169 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -85.48 115.57 23.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.863 -1.148 . . . . 0.0 111.596 -170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.57 -120.37 0.63 Allowed Glycine 0 N--CA 1.485 1.915 0 O-C-N 121.905 -0.497 . . . . 0.0 113.516 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.4 -21.52 33.0 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -108.85 144.78 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.654 1.57 . . . . 0.0 113.033 -166.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.55 115.6 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.34 0.59 . . . . 0.0 112.179 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.46 45.47 78.11 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -85.05 124.35 31.63 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.388 0.613 . . . . 0.0 111.329 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.19 -169.14 41.3 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.248 0.916 . . . . 0.0 114.817 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -157.77 153.25 26.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.983 0.897 . . . . 0.0 113.211 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -129.26 125.33 36.62 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.263 3.3 pt20 -126.58 138.64 53.48 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -148.59 159.73 43.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.454 -0.779 . . . . 0.0 113.0 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.8 mt -98.4 125.33 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.32 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -111.53 97.09 6.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 161.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.84 -109.74 2.89 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.46 -0.775 . . . . 0.0 114.15 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -100.46 15.41 28.0 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -113.0 121.22 43.99 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.912 1.687 . . . . 0.0 111.842 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.97 117.02 20.44 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.218 1.007 . . . . 0.0 110.138 167.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -105.68 117.66 34.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.2 tp -113.96 126.83 55.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.027 0.931 . . . . 0.0 110.801 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -106.61 123.53 48.25 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.345 0.658 . . . . 0.0 109.489 164.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -113.21 128.13 56.38 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -115.07 137.0 52.51 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.84 119.98 7.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.548 0.739 . . . . 0.0 110.208 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 55.2 46.92 22.81 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.02 -33.0 0.91 Allowed Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.361 2.504 . . . . 0.0 119.361 -164.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.51 119.93 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.828 1.251 . . . . 0.0 111.209 -166.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.0 m -102.85 115.96 31.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.126 0.571 . . . . 0.0 111.022 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 t -88.8 131.27 35.15 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.056 0.542 . . . . 0.0 111.427 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -113.1 119.66 38.61 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.027 0.531 . . . . 0.0 110.294 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -124.95 133.73 52.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.43 0.692 . . . . 0.0 111.0 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.25 130.39 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.58 128.1 38.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.399 0.68 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -98.94 133.76 42.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.343 -1.473 . . . . 0.0 112.39 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -69.26 122.52 19.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.55 -38.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 7' ' ' TYR . 14.6 t60 . . . . . 0 N--CA 1.488 1.436 0 CA-C-N 119.927 1.239 . . . . 0.0 107.962 168.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' MET . . . . . 0.445 ' N ' ' HD2' ' A' ' 3' ' ' ASP 0.293 48.4 ttp . . . . . 0 CA--C 1.573 1.845 0 CA-C-O 115.583 -2.151 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.48 -78.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 125.39 2.961 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 -30.84 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 123.563 0.745 . . . . 0.0 112.932 166.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.445 ' HD2' ' N ' ' A' ' 0' ' ' MET 0.287 6.0 t70 70.31 86.44 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.757 1.623 . . . . 0.0 112.587 -172.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -81.32 13.92 2.69 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -63.38 116.76 5.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.36 173.18 26.44 Favored Glycine 0 N--CA 1.488 2.157 0 CA-C-O 122.697 1.165 . . . . 0.0 115.859 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -101.87 116.83 33.55 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.189 0.995 . . . . 0.0 109.497 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -117.82 110.8 18.23 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -93.34 139.88 30.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.111 -0.993 . . . . 0.0 112.851 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.4 ttp -69.46 125.71 27.54 Favored 'General case' 0 CA--C 1.571 1.772 0 O-C-N 120.419 -1.426 . . . . 0.0 114.68 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.84 -50.92 6.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.5 p -136.36 155.17 50.42 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -143.55 117.65 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.032 0.933 . . . . 0.0 108.947 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.05 -71.38 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -166.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -121.97 41.88 3.27 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.956 0.884 . . . . 0.0 112.108 -171.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -73.57 -39.94 64.29 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -57.22 -43.84 83.22 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.78 -39.05 84.1 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -56.54 -45.93 80.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 167.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 mt -71.38 -37.48 71.6 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -55.09 -46.0 75.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 161.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.0 -20.81 41.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.06 5.68 50.63 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.286 23.8 t70 61.03 50.13 5.25 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.52 1.509 . . . . 0.0 114.87 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -93.38 150.38 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.892 0.854 . . . . 0.0 109.891 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -63.81 152.42 39.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.79 -44.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.28 64.13 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.37 -38.52 89.9 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -53.99 -53.1 57.63 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -62.15 -43.72 98.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.4 mt -64.1 -53.81 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.898 0.879 . . . . 0.0 111.919 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.65 85.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -61.91 -36.67 82.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.58 -20.68 53.62 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.23 156.88 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -96.15 103.17 12.72 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.182 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.49 146.9 19.63 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.696 2.264 . . . . 0.0 112.947 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -134.28 107.7 7.8 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -83.77 107.45 16.19 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.516 -0.74 . . . . 0.0 111.094 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -94.31 106.43 18.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.63 129.24 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.2 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -99.71 109.84 22.28 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.082 0.553 . . . . 0.0 110.209 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -100.39 81.14 2.32 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.439 0.696 . . . . 0.0 109.304 167.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.63 -102.97 1.03 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 115.02 0.768 . . . . 0.0 115.02 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -86.32 -26.83 24.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 164.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -75.2 119.27 19.1 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.417 1.462 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 ttm -122.29 123.44 41.44 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.586 0.707 . . . . 0.0 110.538 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.9 mt -110.69 95.59 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.7 mt -93.1 104.25 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -100.82 99.29 9.78 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -87.09 100.49 12.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.311 -0.868 . . . . 0.0 109.364 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.3 mt -104.49 112.54 25.64 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.674 0.75 . . . . 0.0 110.531 -164.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -131.99 155.08 48.61 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.976 0.893 . . . . 0.0 111.309 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -65.58 -19.23 65.83 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -83.97 -50.76 7.72 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 119.057 0.844 . . . . 0.0 113.065 168.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -153.2 148.22 26.64 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.882 0.848 . . . . 0.0 110.505 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.52 130.44 50.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.885 . . . . 0.0 110.125 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.74 104.59 11.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.79 -0.569 . . . . 0.0 110.765 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.48 128.23 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.603 0.761 . . . . 0.0 109.122 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -113.41 108.1 16.75 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.722 0.809 . . . . 0.0 109.513 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.27 98.13 7.28 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.641 0.776 . . . . 0.0 110.446 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -144.8 155.92 43.76 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -93.11 131.34 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.863 -1.148 . . . . 0.0 111.007 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.1 t -68.37 126.64 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.65 -0.656 . . . . 0.0 110.689 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.14 -30.61 8.14 Favored Glycine 0 CA--C 1.552 2.384 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -91.86 144.8 25.11 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.168 1.484 . . . . 0.0 112.746 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.625 ' HE2' ' NZ ' ' A' ' 98' ' ' LYS . 23.6 tt0 -90.6 128.08 36.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 111.507 168.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.01 149.27 51.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.655 0.782 . . . . 0.0 112.36 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -74.15 101.08 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.035 -1.04 . . . . 0.0 111.913 172.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -94.03 116.01 28.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.546 0.738 . . . . 0.0 110.206 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -80.94 127.43 32.56 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.586 0.707 . . . . 0.0 109.72 163.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mt -99.37 60.98 1.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.135 0.969 . . . . 0.0 111.128 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 119.15 23.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.318 1.047 . . . . 0.0 111.712 -166.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.65 -42.4 1.92 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -162.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.21 -69.57 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.107 0.963 . . . . 0.0 110.125 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -141.3 -1.02 1.37 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 166.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 28.2 m-20 63.93 65.26 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 120.22 1.373 . . . . 0.0 113.575 -173.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.9 mmt-85 -122.2 142.34 50.53 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.612 0.765 . . . . 0.0 110.643 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.38 111.12 22.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.529 165.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m -117.7 145.02 44.72 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.45 0.7 . . . . 0.0 112.098 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.0 mtp -83.4 98.99 9.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -98.86 122.56 42.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.076 0.55 . . . . 0.0 110.182 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.0 m -102.68 131.87 49.19 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.91 122.59 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.1 m -131.01 158.05 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.78 0.832 . . . . 0.0 112.007 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -85.8 121.42 28.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.69 -1.256 . . . . 0.0 112.214 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -94.66 73.61 3.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.533 0.682 . . . . 0.0 109.264 157.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.85 -100.35 0.32 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -169.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.44 -29.43 28.07 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -83.55 131.26 35.0 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.85 1.205 . . . . 0.0 111.823 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.95 103.34 16.01 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.24 0.616 . . . . 0.0 109.511 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -110.74 131.79 54.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.572 0.749 . . . . 0.0 111.269 -167.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.2 t -130.93 141.86 50.31 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.43 128.1 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.913 0.885 . . . . 0.0 109.302 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -106.22 95.99 6.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.711 0.804 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.625 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 95.1 mttt -85.76 120.46 27.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 112.128 -170.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.49 -115.55 0.47 Allowed Glycine 0 N--CA 1.486 1.989 0 O-C-N 121.25 -0.906 . . . . 0.0 113.531 171.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.7 -13.5 57.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -114.71 146.4 40.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.294 1.406 . . . . 0.0 112.359 -170.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -90.24 103.27 15.97 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.462 -162.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.42 50.44 21.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -170.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -89.76 137.21 32.53 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.945 0.879 . . . . 0.0 111.933 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.42 -161.17 27.67 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 121.936 0.742 . . . . 0.0 114.257 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -157.42 157.93 34.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.866 . . . . 0.0 112.638 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -132.77 124.74 28.66 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.286 1.3 pt20 -129.43 141.82 50.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.48 161.2 43.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 0.0 112.53 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -103.83 123.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.934 . . . . 0.0 109.15 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.33 85.19 2.21 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 162.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.05 -111.77 4.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.96 -5.95 58.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 165.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.66 127.28 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 120.396 1.453 . . . . 0.0 111.92 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.1 tp -88.41 117.86 27.63 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.847 0.859 . . . . 0.0 109.724 166.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -100.77 121.52 41.82 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.756 0.823 . . . . 0.0 109.277 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -117.53 130.69 56.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.993 0.917 . . . . 0.0 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.77 118.93 34.97 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.733 0.813 . . . . 0.0 109.554 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.4 mtm -110.63 132.04 54.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.497 -0.752 . . . . 0.0 111.265 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -124.35 133.73 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.86 . . . . 0.0 112.169 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.57 126.88 8.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.272 0.629 . . . . 0.0 110.966 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 57.3 36.51 27.38 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.04 -19.94 2.65 Favored Glycine 0 CA--C 1.558 2.753 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 -162.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.79 119.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 119.568 1.684 . . . . 0.0 109.562 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -101.59 121.84 42.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.446 0.641 . . . . 0.0 110.743 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.1 t -97.6 124.82 42.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -102.31 127.29 49.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.957 -0.465 . . . . 0.0 111.666 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -127.16 142.82 51.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.941 0.896 . . . . 0.0 111.274 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.54 132.52 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.4 132.13 48.51 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.516 0.726 . . . . 0.0 111.235 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -97.2 127.98 43.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.702 -1.249 . . . . 0.0 112.18 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -67.19 122.94 18.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.1 -39.71 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.103 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.573 1.847 0 CA-C-O 117.861 -1.066 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.96 120.66 7.54 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.657 2.238 . . . . 0.0 114.77 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.61 148.5 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.766 0.793 . . . . 0.0 113.063 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.51 106.2 18.34 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 111.136 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -81.27 4.49 20.29 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -57.83 108.57 0.59 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.725 1.602 . . . . 0.0 115.144 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.89 179.12 33.5 Favored Glycine 0 N--CA 1.486 2.01 0 CA-C-O 122.756 1.198 . . . . 0.0 115.753 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -110.48 118.84 37.34 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.704 1.201 . . . . 0.0 109.151 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -119.15 118.86 32.5 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -88.76 144.89 25.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.943 -1.098 . . . . 0.0 112.905 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.418 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 7.3 ttp -71.83 124.68 25.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.498 -1.376 . . . . 0.0 113.495 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.07 -48.4 7.77 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.9 m -157.27 160.08 38.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.4 . . . . 0.0 112.993 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -142.69 124.5 15.1 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.342 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -126.41 125.08 41.59 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.062 0.945 . . . . 0.0 109.877 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.1 t30 66.1 37.17 5.3 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -79.04 -43.45 24.2 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.27 -34.76 77.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -70.37 -41.43 73.1 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -53.34 -47.31 69.47 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 120.458 1.481 . . . . 0.0 114.842 166.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.89 -38.35 70.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.83 -45.38 78.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.085 -1.635 . . . . 0.0 115.061 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -18.75 43.31 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 166.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.34 -4.54 59.05 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 25.8 t70 67.38 52.97 0.78 Allowed 'General case' 0 CA--C 1.572 1.805 0 CA-C-N 120.154 1.343 . . . . 0.0 113.996 -166.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -102.86 146.43 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.977 0.894 . . . . 0.0 109.685 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.76 152.38 44.45 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -60.28 -44.12 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.88 65.88 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 116.004 1.854 . . . . 0.0 116.004 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.82 -41.7 96.22 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -52.33 -53.21 47.45 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 166.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -63.23 -43.91 96.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.88 -53.65 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.631 0.772 . . . . 0.0 111.869 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.68 81.77 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -68.6 -30.91 69.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.31 -29.52 62.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 166.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.15 131.55 42.94 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.041 1.291 . . . . 0.0 112.723 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -105.63 89.51 3.48 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.482 173.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.4 Cg_endo -72.6 165.38 32.88 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.371 2.047 . . . . 0.0 115.601 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -111.6 120.24 41.42 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -89.92 110.58 21.53 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.438 -0.789 . . . . 0.0 111.004 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -98.53 110.13 22.78 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.713 -0.617 . . . . 0.0 109.802 169.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.44 125.83 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.43 107.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 165.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -102.42 102.09 12.38 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.643 0.777 . . . . 0.0 109.998 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -92.75 79.32 4.75 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 109.963 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.55 -101.79 0.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 114.508 0.563 . . . . 0.0 114.508 -173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.34 -26.62 24.76 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -79.1 106.27 11.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.772 1.624 . . . . 0.0 111.635 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -112.45 124.03 51.6 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.968 0.907 . . . . 0.0 110.722 -172.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.95 96.84 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.93 108.36 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -102.6 98.94 8.92 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.226 0.61 . . . . 0.0 109.38 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -84.14 101.41 11.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.14 127.5 43.16 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.074 0.55 . . . . 0.0 111.692 -166.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 t -150.79 153.48 35.53 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.981 0.896 . . . . 0.0 111.646 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.6 -31.83 72.73 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -73.02 -51.26 18.88 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -155.55 138.36 15.29 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.032 0.833 . . . . 0.0 110.792 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -99.18 116.92 32.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -107.5 107.71 18.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.854 -0.529 . . . . 0.0 111.035 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.51 127.24 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.1 105.55 15.61 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.596 0.758 . . . . 0.0 109.421 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.02 113.48 26.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.611 0.764 . . . . 0.0 109.753 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.83 157.23 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -168.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -97.35 132.15 43.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 111.473 165.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -69.78 122.09 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 123.38 0.672 . . . . 0.0 110.154 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.93 -37.96 3.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 -158.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.87 136.75 32.87 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 118.25 1.025 . . . . 0.0 113.547 -165.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -87.6 117.38 26.37 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.878 0.471 . . . . 0.0 110.93 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -134.24 145.77 49.46 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.378 0.671 . . . . 0.0 112.287 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.04 101.88 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.463 -1.398 . . . . 0.0 112.958 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.4 112.19 24.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.242 0.617 . . . . 0.0 110.444 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.81 114.99 19.15 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.581 0.705 . . . . 0.0 110.775 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.93 55.26 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 112.857 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 t -74.07 133.57 42.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.55 -54.18 1.48 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.707 -0.62 . . . . 0.0 114.116 -158.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.2 mt -71.27 -63.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.667 0.787 . . . . 0.0 111.221 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -139.21 -3.99 1.53 Allowed 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 166.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.416 4.4 p30 50.14 64.1 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.789 1.632 . . . . 0.0 115.088 -159.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -124.6 130.4 52.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.359 0.664 . . . . 0.0 109.747 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -90.81 112.91 24.92 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.854 -0.529 . . . . 0.0 110.246 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.8 m -123.54 132.44 53.9 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.361 0.665 . . . . 0.0 111.264 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtp -70.04 99.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.423 1.106 . . . . 0.0 110.395 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -108.19 122.35 46.74 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.844 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.6 m -107.68 120.51 42.44 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.9 t -109.62 124.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.7 m -138.44 155.28 48.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 112.473 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -84.21 119.9 25.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.842 -1.162 . . . . 0.0 112.385 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.42 70.93 5.13 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 109.539 160.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.71 -108.96 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 -169.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -77.17 -22.37 52.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -97.47 135.7 38.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.234 1.379 . . . . 0.0 111.314 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.34 114.61 26.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.707 -0.62 . . . . 0.0 109.809 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.586 0.755 . . . . 0.0 111.26 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.6 t -128.0 138.37 52.57 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p -117.37 131.17 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.916 0.887 . . . . 0.0 109.654 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.18 97.8 7.2 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.0 0.92 . . . . 0.0 109.17 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -91.67 119.68 31.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.481 -0.762 . . . . 0.0 112.025 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.11 -107.15 0.28 Allowed Glycine 0 N--CA 1.487 2.036 0 O-C-N 121.211 -0.931 . . . . 0.0 113.48 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.6 -12.05 59.95 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -126.44 145.08 50.62 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.093 1.315 . . . . 0.0 112.053 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.13 110.57 18.13 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.779 0.832 . . . . 0.0 111.418 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.39 46.13 73.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -85.01 139.97 31.38 Favored 'General case' 0 CA--C 1.569 1.682 0 CA-C-N 118.001 0.901 . . . . 0.0 111.668 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.15 -164.49 33.87 Favored Glycine 0 N--CA 1.484 1.854 0 O-C-N 121.391 -0.818 . . . . 0.0 114.736 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.65 157.08 32.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -128.78 130.11 46.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -131.85 144.14 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.712 0.768 . . . . 0.0 112.882 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.4 p90 -153.52 163.63 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.452 0.701 . . . . 0.0 112.723 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.9 129.62 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.396 -0.815 . . . . 0.0 108.888 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.64 98.27 6.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 162.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.84 -115.06 4.58 Favored Glycine 0 N--CA 1.49 2.27 0 O-C-N 121.559 -0.713 . . . . 0.0 114.353 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -95.73 12.96 28.08 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 163.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -112.55 132.83 54.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.554 1.524 . . . . 0.0 112.553 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.65 120.24 31.55 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.254 1.022 . . . . 0.0 108.961 170.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -109.74 124.14 50.74 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 108.895 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.8 tp -130.81 132.51 45.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.644 0.777 . . . . 0.0 110.251 -167.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.17 120.11 34.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.735 -0.603 . . . . 0.0 110.02 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.1 mtm -112.1 132.21 54.98 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.622 0.769 . . . . 0.0 111.322 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -124.2 137.25 54.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 112.287 -167.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.61 124.59 8.62 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.096 0.559 . . . . 0.0 110.882 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 54.75 43.58 29.85 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.72 -28.56 1.3 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 119.587 2.595 . . . . 0.0 119.587 -164.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.89 120.91 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 118.909 1.354 . . . . 0.0 110.564 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 m -101.9 125.39 48.57 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 121.375 0.607 . . . . 0.0 111.032 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.1 t -92.82 133.57 35.93 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.352 0.661 . . . . 0.0 111.291 163.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -102.14 126.68 49.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.272 0.629 . . . . 0.0 110.536 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -128.6 138.98 52.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.058 0.943 . . . . 0.0 111.131 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.12 127.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -126.92 152.57 46.94 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.501 1.12 . . . . 0.0 110.65 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -124.45 135.91 53.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.214 -1.554 . . . . 0.0 112.714 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -70.23 125.4 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.18 -37.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 120.209 1.368 . . . . 0.0 108.346 169.119 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 CA--C 1.575 1.907 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.93 -173.65 1.92 Allowed 'Trans proline' 0 CA--C 1.568 2.209 0 C-N-CA 122.549 2.166 . . . . 0.0 115.293 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.46 126.71 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.765 -1.209 . . . . 0.0 111.613 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.14 102.14 8.31 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -74.85 0.96 13.82 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 170.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -57.88 112.92 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 121.333 1.879 . . . . 0.0 114.57 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.0 32.32 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-O 123.108 1.393 . . . . 0.0 116.081 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -112.4 113.57 25.83 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.75 -1.225 . . . . 0.0 108.862 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -115.42 115.54 26.72 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -166.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -89.91 143.44 26.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 113.258 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.456 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 12.8 ttp -75.54 127.33 32.86 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 113.77 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -93.1 -45.88 7.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -157.2 158.22 35.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.4 -1.438 . . . . 0.0 113.1 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -137.18 132.26 33.68 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.762 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.33 120.44 19.91 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.351 0.661 . . . . 0.0 109.956 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.278 45.0 t30 65.36 32.14 9.94 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 117.506 2.409 . . . . 0.0 117.506 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -78.12 -37.25 46.6 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -56.31 -41.97 76.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.77 -39.33 84.11 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -58.63 -47.88 82.9 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 167.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.29 -40.39 90.0 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -54.66 -46.0 73.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 162.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.86 -13.74 27.17 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.81 -50.09 5.53 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.43 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.94 5.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.938 1.695 . . . . 0.0 115.126 163.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.69 147.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 118.626 -2.546 . . . . 0.0 113.118 -146.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -67.1 154.42 41.26 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.96 -47.11 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.83 64.08 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.33 -36.88 85.39 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -54.58 -50.23 68.49 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -60.43 -44.3 95.93 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.6 -56.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 123.895 0.878 . . . . 0.0 111.821 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.99 77.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -69.07 -32.29 71.65 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.04 -27.47 60.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.79 141.6 49.69 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.216 1.371 . . . . 0.0 113.706 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -100.68 92.93 2.53 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.467 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 72.4 Cg_endo -71.8 155.33 58.38 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 122.629 2.219 . . . . 0.0 114.946 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.96 117.77 35.07 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.114 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.06 108.02 18.69 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.609 -0.682 . . . . 0.0 110.382 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -93.35 109.64 21.19 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.196 168.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mt -107.25 128.42 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.55 108.31 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -102.48 112.62 25.42 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.993 0.917 . . . . 0.0 110.483 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -105.48 75.97 1.18 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.597 -0.689 . . . . 0.0 109.669 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.48 -99.3 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.636 ' HD2' ' NZ ' ' A' ' 68' ' ' LYS . 29.1 p-10 -78.24 -37.93 44.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 164.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -77.02 116.07 17.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 120.333 1.424 . . . . 0.0 112.31 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.9 ttm -126.59 124.81 40.79 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.655 0.782 . . . . 0.0 110.866 -170.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.7 99.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.19 110.9 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -106.93 97.27 7.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.6 m -83.49 102.82 12.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.11 116.85 32.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.587 0.708 . . . . 0.0 111.094 -166.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -135.66 150.76 49.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.53 0.732 . . . . 0.0 110.099 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -63.42 -27.05 69.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.03 -41.48 64.17 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 164.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -158.19 129.89 6.75 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.847 1.203 . . . . 0.0 112.931 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -105.03 120.65 42.01 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.641 0.777 . . . . 0.0 109.765 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -121.85 109.98 15.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.758 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.84 125.75 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -103.55 107.32 18.12 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.49 0.716 . . . . 0.0 109.348 166.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -107.66 112.13 24.69 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.473 0.709 . . . . 0.0 109.583 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -154.51 164.27 38.93 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.32 134.23 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.969 167.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.23 134.92 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 O-C-N 121.149 -0.97 . . . . 0.0 110.55 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.22 46.18 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -163.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.636 ' NZ ' ' HD2' ' A' ' 47' ' ' ASP . 10.7 mptt -108.36 145.0 35.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.926 1.363 . . . . 0.0 110.236 -162.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -90.72 128.9 36.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -139.21 158.99 43.19 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.143 0.973 . . . . 0.0 112.882 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.37 92.17 3.34 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 111.763 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -88.43 100.2 12.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.06 101.04 13.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 122.955 0.502 . . . . 0.0 110.552 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 mp -83.41 52.11 2.15 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.9 m -70.68 124.38 24.14 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.357 1.063 . . . . 0.0 110.302 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.28 -16.3 49.42 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 -162.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.21 -82.01 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.792 1.796 . . . . 0.0 106.948 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -122.3 17.55 10.64 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 52.88 46.97 25.7 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -129.27 140.56 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.64 0.733 . . . . 0.0 112.466 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -87.72 109.25 19.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.622 0.769 . . . . 0.0 111.149 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.4 m -101.37 140.31 35.84 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.438 0.695 . . . . 0.0 111.603 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.8 80.41 7.27 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.459 1.123 . . . . 0.0 110.193 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.7 m -85.51 128.08 34.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.173 -0.954 . . . . 0.0 110.672 -166.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -116.5 118.51 32.86 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.4 HG22 ' SG ' ' A' ' 95' ' ' CYS . 27.1 t -112.66 125.05 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.8 m -135.78 156.78 48.28 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.961 0.886 . . . . 0.0 112.928 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -88.11 122.9 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.69 66.25 0.66 Allowed 'General case' 0 CA--C 1.576 1.981 0 C-N-CA 123.59 0.756 . . . . 0.0 110.289 160.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.69 -96.39 0.25 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -79.35 -36.93 38.63 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -85.25 116.44 23.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.945 0.878 . . . . 0.0 112.287 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.2 tp -85.85 106.02 16.76 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -94.67 129.99 41.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.955 0.902 . . . . 0.0 111.459 -172.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.4 ' SG ' HG22 ' A' ' 86' ' ' VAL . 40.8 t -125.06 127.35 46.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.651 0.78 . . . . 0.0 112.068 -176.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.59 119.64 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -95.41 97.1 9.57 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -81.38 115.87 20.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 111.692 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.37 -126.13 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 O-C-N 122.11 -0.369 . . . . 0.0 113.292 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.36 -31.69 37.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.59 144.79 26.91 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.041 1.292 . . . . 0.0 113.084 -164.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -81.63 106.31 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.351 0.661 . . . . 0.0 112.081 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.92 53.6 14.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -89.96 124.7 34.96 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.303 0.641 . . . . 0.0 110.857 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.9 -166.95 38.02 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -160.17 157.28 28.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.255 1.026 . . . . 0.0 113.004 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -128.94 129.83 45.96 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.0 139.42 52.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -148.61 166.33 28.62 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 52.1 mt -106.44 122.91 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.501 -0.749 . . . . 0.0 109.349 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -110.87 86.87 2.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.534 -0.729 . . . . 0.0 109.907 164.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.24 -109.69 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.527 -0.733 . . . . 0.0 113.557 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.92 43.69 1.4 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 156.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.25 124.67 43.51 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.624 0.77 . . . . 0.0 109.634 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.71 113.37 25.44 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 121.737 0.78 . . . . 0.0 108.975 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.92 124.04 48.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.4 tp -125.02 125.97 44.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.725 0.81 . . . . 0.0 110.716 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -108.46 123.29 48.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.41 135.76 52.71 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.695 -0.628 . . . . 0.0 111.582 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -123.76 133.77 53.78 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 112.735 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.78 5.88 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.794 0.838 . . . . 0.0 110.214 173.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 56.29 41.49 29.09 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.91 -12.05 2.3 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 120.11 2.804 . . . . 0.0 120.11 -163.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.11 123.53 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 119.692 1.746 . . . . 0.0 109.69 -166.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 m -99.6 118.01 35.21 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.662 0.385 . . . . 0.0 110.341 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -99.51 122.78 43.08 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.144 0.578 . . . . 0.0 110.856 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -101.77 129.46 47.96 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.683 0.754 . . . . 0.0 111.441 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -137.85 131.71 31.48 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.989 0.916 . . . . 0.0 110.276 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.88 132.47 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 109.017 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -132.42 149.75 52.28 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.842 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -124.14 128.27 49.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.431 -1.418 . . . . 0.0 111.127 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -71.49 120.16 16.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.465 -0.772 . . . . 0.0 112.838 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.3 -38.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 CA--C 1.566 1.568 0 CA-C-N 119.702 1.137 . . . . 0.0 108.219 169.591 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.7 mtm . . . . . 0 CA--C 1.574 1.901 0 CA-C-O 116.107 -1.902 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.09 133.57 13.67 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 124.994 2.819 . . . . 0.0 114.149 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -74.86 148.69 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.12 106.24 17.11 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 112.614 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -80.64 6.32 13.04 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -59.34 112.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 121.422 1.919 . . . . 0.0 114.799 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.6 178.82 33.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -109.67 109.73 20.55 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.595 1.158 . . . . 0.0 109.043 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -112.48 110.04 19.99 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -168.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -86.57 137.72 32.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.103 -0.998 . . . . 0.0 113.193 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ttp -74.1 122.39 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.02 1.282 . . . . 0.0 114.043 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 mt -82.16 -53.76 5.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.424 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -130.91 154.72 47.8 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -172.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -136.94 109.45 7.42 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.761 0.824 . . . . 0.0 108.839 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -93.07 -64.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -124.91 44.94 2.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.68 0.752 . . . . 0.0 111.916 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -72.5 -38.56 68.09 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.8 -41.74 96.23 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -71.16 -40.01 71.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -53.17 -47.27 68.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.24 -37.76 71.98 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -55.84 -44.16 77.73 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 163.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.47 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.95 1.06 53.94 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.289 4.2 t70 64.2 49.83 2.54 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -168.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.59 145.89 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.94 0.876 . . . . 0.0 109.903 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -61.93 153.97 27.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.01 -47.5 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.5 62.68 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.0 tp -66.33 -25.67 66.93 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -64.95 -47.23 78.37 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.767 1.621 . . . . 0.0 113.86 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -50.98 67.32 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -53.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 124.097 0.959 . . . . 0.0 112.212 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.2 -35.88 78.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -69.08 -32.61 72.19 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.63 -28.65 62.88 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.22 135.04 48.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.061 1.3 . . . . 0.0 112.826 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.57 89.59 2.28 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.648 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.29 151.96 60.81 Favored 'Trans proline' 0 CA--C 1.561 1.858 0 CA-C-N 123.056 2.127 . . . . 0.0 115.371 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.66 115.49 30.34 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -84.26 107.54 16.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.456 -0.778 . . . . 0.0 110.495 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -94.54 110.25 22.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -105.71 126.25 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.7 t -112.02 108.95 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -106.13 111.34 23.92 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 121.931 0.872 . . . . 0.0 110.702 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -99.78 76.24 1.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.659 1.184 . . . . 0.0 109.459 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.96 -106.46 1.93 Allowed Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.067 -1.021 . . . . 0.0 114.682 -175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.85 -22.12 24.63 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 162.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -70.09 120.99 16.62 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 120.132 1.333 . . . . 0.0 111.712 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -136.54 122.73 20.44 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 121.498 0.666 . . . . 0.0 111.043 -163.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.4 mt -116.21 99.98 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -95.66 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -99.68 98.86 9.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -84.1 95.67 8.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 109.019 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -93.26 124.52 37.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.057 0.543 . . . . 0.0 111.149 -166.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 t -146.34 154.16 41.34 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.107 0.956 . . . . 0.0 111.83 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -61.86 -30.82 71.11 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -77.82 -52.38 9.0 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -153.67 138.43 17.04 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.175 0.898 . . . . 0.0 110.877 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -93.08 117.79 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.736 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -106.21 104.22 13.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.521 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.29 125.47 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.2 mtp -103.98 110.13 22.16 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.309 165.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.56 111.1 20.83 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.238 1.015 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.34 168.82 26.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -164.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -106.8 135.21 48.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.975 -1.078 . . . . 0.0 110.238 161.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.0 125.55 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 O-C-N 121.42 -0.8 . . . . 0.0 108.94 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.58 -35.08 4.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -155.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 138.48 34.1 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 118.383 1.092 . . . . 0.0 113.165 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -87.62 114.77 24.53 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 122.024 -0.423 . . . . 0.0 110.336 167.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.95 148.6 50.51 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.497 0.719 . . . . 0.0 112.567 -173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.77 99.7 4.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 112.083 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.54 109.01 20.3 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.485 -0.759 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -79.38 106.07 11.15 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.215 0.531 . . . . 0.0 110.284 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.93 49.59 1.76 Allowed 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -79.95 130.39 35.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 113.275 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.89 -50.51 0.96 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.4 -0.813 . . . . 0.0 114.744 -154.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.8 mt -78.43 -65.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 124.398 1.079 . . . . 0.0 110.838 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.55 ' N ' ' HD2' ' A' ' 78' ' ' ASP . 14.5 p-10 -147.06 7.66 0.92 Allowed 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.274 2.3 m-20 57.46 30.55 18.83 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -104.57 141.1 37.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 111.298 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.86 98.28 11.28 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.155 0.582 . . . . 0.0 109.591 173.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.24 146.01 28.61 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.428 0.632 . . . . 0.0 112.104 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -79.26 95.66 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.914 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.8 m -93.99 126.72 39.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.058 0.543 . . . . 0.0 110.149 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -116.63 130.4 56.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.438 HG23 ' SG ' ' A' ' 95' ' ' CYS . 22.4 t -116.69 130.3 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -125.58 139.82 53.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.076 0.951 . . . . 0.0 111.087 -175.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -84.53 120.97 26.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 112.611 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -111.59 61.16 0.62 Allowed 'General case' 0 CA--C 1.575 1.932 0 C-N-CA 123.871 0.869 . . . . 0.0 110.549 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.27 -93.28 0.19 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.14 -34.96 32.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -91.69 128.31 37.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.533 1.061 . . . . 0.0 111.252 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -98.51 114.71 27.22 Favored 'General case' 0 CA--C 1.561 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.171 169.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -117.15 129.24 55.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.147 0.579 . . . . 0.0 111.064 -163.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.438 ' SG ' HG23 ' A' ' 86' ' ' VAL . 53.5 t -130.37 145.56 51.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -121.74 135.34 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 124.175 0.99 . . . . 0.0 110.42 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.0 95.55 5.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.834 0.853 . . . . 0.0 109.734 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.25 124.37 33.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.642 -1.286 . . . . 0.0 112.843 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 -112.3 0.27 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 121.661 -0.649 . . . . 0.0 112.283 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -83.2 -10.05 58.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -113.16 143.97 43.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.549 1.522 . . . . 0.0 113.186 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -80.55 124.15 28.71 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.31 42.37 99.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 118.494 2.158 . . . . 0.0 118.494 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -91.36 134.08 34.91 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.843 0.83 . . . . 0.0 111.595 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.66 -163.83 32.49 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 121.882 0.712 . . . . 0.0 114.298 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -156.88 153.53 28.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -129.52 126.04 37.69 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.44 137.95 54.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -148.58 163.2 37.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 112.913 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.29 125.04 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.97 96.58 6.03 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.4 -109.0 2.67 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.374 -0.829 . . . . 0.0 113.882 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -109.75 25.71 11.48 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 158.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -108.81 123.63 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.917 1.235 . . . . 0.0 110.974 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -82.21 115.52 21.33 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.069 0.947 . . . . 0.0 109.151 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -102.16 115.45 30.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.4 123.15 49.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.809 0.843 . . . . 0.0 111.163 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.11 124.25 47.38 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 165.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.3 mtm -116.35 128.99 56.01 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.104 0.865 . . . . 0.0 110.904 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -116.18 136.78 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.55 120.42 8.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.594 0.757 . . . . 0.0 110.022 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 59.07 39.91 22.7 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.94 -34.87 1.25 Allowed Glycine 0 CA--C 1.558 2.749 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -161.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.08 118.36 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.008 1.323 . . . . 0.0 111.238 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.4 m -107.39 119.71 40.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.588 -168.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.8 t -94.36 126.13 39.42 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.531 0.732 . . . . 0.0 111.984 170.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -100.18 127.93 46.35 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.338 0.59 . . . . 0.0 111.751 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -127.64 137.12 52.44 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.899 0.88 . . . . 0.0 110.964 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.23 131.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.51 127.27 43.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.523 0.729 . . . . 0.0 110.319 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.79 123.38 41.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.762 -1.211 . . . . 0.0 111.559 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.55 115.85 8.41 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.237 0.926 . . . . 0.0 112.469 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.7 -36.96 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.588 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 171.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.571 1.788 0 CA-C-O 118.79 -0.624 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.11 120.7 7.79 Favored 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 122.741 2.294 . . . . 0.0 115.013 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -75.72 143.93 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.757 0.789 . . . . 0.0 112.945 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.2 103.26 12.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.003 . . . . 0.0 111.567 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -76.56 -1.8 29.26 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -55.44 113.72 1.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 121.189 1.813 . . . . 0.0 114.7 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.69 -179.85 29.66 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-O 122.72 1.178 . . . . 0.0 115.53 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -113.2 118.91 36.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.311 1.044 . . . . 0.0 109.188 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -121.39 114.76 21.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -165.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -88.76 140.89 28.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.255 -0.903 . . . . 0.0 113.254 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.472 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 4.8 ttm -70.34 120.55 16.18 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.46 -45.24 16.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -153.58 159.09 42.07 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.236 1.38 . . . . 0.0 113.549 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -134.07 101.94 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.955 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.617 ' HE2' ' NZ ' ' A' ' 127' ' ' LYS . 18.5 tt0 -111.0 123.55 50.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.197 0.599 . . . . 0.0 111.001 -171.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 29.6 t30 66.31 36.26 5.44 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -79.14 -39.16 34.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.54 -40.59 79.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -66.18 -41.53 90.13 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -55.99 -48.11 76.47 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.88 -40.62 75.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -55.31 -45.87 76.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.69 -20.99 24.53 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 164.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.8 mt -96.17 13.19 28.19 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.304 22.8 t70 60.74 56.48 2.96 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-N 120.709 1.595 . . . . 0.0 113.464 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -106.62 146.82 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 122.093 0.949 . . . . 0.0 110.165 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -64.04 153.01 38.71 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -61.25 -44.03 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.98 -52.12 64.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.81 -38.72 91.84 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -53.2 -53.03 56.68 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -62.46 -46.49 88.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.58 -57.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 123.729 0.812 . . . . 0.0 111.774 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.13 72.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -69.91 -36.83 75.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 165.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.1 mt -73.01 -24.52 60.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.78 143.22 49.61 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.152 1.342 . . . . 0.0 113.805 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -102.82 90.27 2.23 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.757 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 59.6 Cg_endo -69.31 155.74 66.53 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 123.054 2.127 . . . . 0.0 114.987 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.3 118.83 34.37 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.474 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 30.2 mttp -86.03 115.4 23.61 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.525 -0.735 . . . . 0.0 110.849 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -102.2 106.44 17.27 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mp -101.18 131.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.313 -0.867 . . . . 0.0 109.237 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.63 109.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.47 106.62 17.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.883 0.873 . . . . 0.0 110.082 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -99.37 80.4 2.41 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 123.57 0.748 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.89 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.513 -0.742 . . . . 0.0 114.189 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -93.07 -20.14 20.83 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 163.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -74.16 105.89 5.57 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.667 2.03 . . . . 0.0 111.211 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.5 ttm -116.73 124.85 50.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.59 0.756 . . . . 0.0 110.557 -170.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.03 98.39 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.2 mt -94.32 110.83 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.29 96.09 6.12 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.474 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 51.1 m -85.78 99.11 11.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 108.79 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.18 115.93 28.46 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.832 -0.542 . . . . 0.0 111.343 -164.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 t -134.3 151.82 51.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.766 0.793 . . . . 0.0 110.521 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -64.05 -29.33 70.48 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.73 -51.31 28.16 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 167.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.88 134.93 13.92 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.38 0.991 . . . . 0.0 111.213 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.44 118.76 30.83 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 123.781 0.832 . . . . 0.0 109.555 170.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -102.81 116.84 33.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 110.4 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.27 117.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.9 mtp -105.6 105.31 15.28 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -108.36 108.82 19.95 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.575 0.75 . . . . 0.0 109.555 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.85 155.93 33.8 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -90.48 126.74 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.7 165.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.89 121.77 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 168.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.54 -35.13 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 -156.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.44 140.99 32.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.491 1.145 . . . . 0.0 113.3 -165.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -86.3 108.37 18.38 Favored 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 122.818 0.447 . . . . 0.0 110.387 166.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -119.92 143.4 48.0 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.673 0.789 . . . . 0.0 112.504 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.35 97.7 2.55 Favored 'General case' 0 CA--C 1.567 1.609 0 O-C-N 120.935 -1.103 . . . . 0.0 112.609 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -93.51 113.47 25.61 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.452 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.28 105.07 12.18 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.734 0.414 . . . . 0.0 110.752 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.55 52.32 2.31 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -83.58 132.43 34.91 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.089 0.947 . . . . 0.0 111.647 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.58 -62.17 0.38 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.273 -151.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mt -72.11 -70.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.559 1.144 . . . . 0.0 110.202 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -136.08 9.79 3.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 169.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 58.84 45.19 15.73 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -135.17 143.77 46.66 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.725 0.774 . . . . 0.0 111.282 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -88.0 126.24 34.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.624 -0.672 . . . . 0.0 111.341 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -122.66 140.64 52.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.156 0.582 . . . . 0.0 111.142 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.11 97.18 5.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 168.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.406 HG23 ' SG ' ' A' ' 95' ' ' CYS . 75.6 m -95.55 123.25 39.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.42 0.688 . . . . 0.0 110.218 -171.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 m -107.43 126.8 52.96 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 168.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.19 135.86 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -149.95 152.43 34.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.443 -1.411 . . . . 0.0 112.729 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -80.71 118.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.861 -1.149 . . . . 0.0 112.653 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.11 71.11 6.3 Favored 'General case' 0 CA--C 1.571 1.764 0 O-C-N 121.51 -0.744 . . . . 0.0 109.565 159.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.02 -109.67 2.94 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.76 -23.05 58.48 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -93.34 127.15 38.83 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.86 1.209 . . . . 0.0 111.367 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.73 105.09 16.71 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -109.76 136.1 49.63 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.606 0.762 . . . . 0.0 111.377 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.406 ' SG ' HG23 ' A' ' 84' ' ' THR . 44.3 t -134.93 138.17 43.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -169.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.36 133.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 123.715 0.806 . . . . 0.0 110.242 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -112.56 98.52 7.3 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.626 0.771 . . . . 0.0 109.575 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.31 117.02 27.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.424 -0.798 . . . . 0.0 111.749 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.27 -131.12 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 O-C-N 121.233 -0.917 . . . . 0.0 113.619 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.05 -34.81 69.05 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -96.34 140.0 31.64 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.226 1.012 . . . . 0.0 112.315 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.45 122.56 26.58 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -165.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.06 52.27 53.83 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -93.41 138.87 31.31 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.723 0.773 . . . . 0.0 111.707 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.96 -168.54 35.72 Favored Glycine 0 N--CA 1.485 1.911 0 CA-C-O 121.918 0.732 . . . . 0.0 114.722 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -156.49 153.64 29.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.6 m -128.52 123.12 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -123.57 131.75 53.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.699 0.8 . . . . 0.0 111.397 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -148.89 175.43 11.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.239 -0.913 . . . . 0.0 112.76 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.78 135.8 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.916 -1.115 . . . . 0.0 109.262 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.57 93.12 3.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 165.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.74 -120.04 5.26 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.873 -0.517 . . . . 0.0 113.351 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.43 41.27 1.25 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 161.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -131.1 118.67 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.348 0.659 . . . . 0.0 109.399 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.31 122.31 26.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.891 0.876 . . . . 0.0 110.437 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -112.91 119.79 39.17 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.2 tp -124.61 124.86 43.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.643 0.777 . . . . 0.0 110.53 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.95 121.31 42.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 165.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.7 mtm -110.62 127.46 55.26 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.905 0.775 . . . . 0.0 110.318 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -119.2 145.41 46.06 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.98 122.53 2.59 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.067 0.547 . . . . 0.0 110.75 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.299 7.1 mt-10 50.88 50.82 18.28 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.88 -28.77 2.78 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 120.162 2.825 . . . . 0.0 120.162 -169.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -76.05 156.0 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.817 1.309 . . . . 0.0 112.075 -171.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -123.54 127.51 48.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.0 110.688 168.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.5 t -94.24 136.86 34.07 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.999 0.52 . . . . 0.0 111.199 156.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.617 ' NZ ' ' HE2' ' A' ' 14' ' ' GLU . 35.0 mtmm -114.64 123.94 50.58 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.072 0.549 . . . . 0.0 110.272 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -121.12 135.13 55.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.72 -0.612 . . . . 0.0 111.17 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.12 129.3 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -133.27 136.78 45.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.525 -0.734 . . . . 0.0 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -103.62 133.24 48.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.308 -1.495 . . . . 0.0 112.676 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -69.14 122.89 19.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.6 m -117.53 -37.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 119.761 1.164 . . . . 0.0 107.93 170.413 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 16.1 ttt . . . . . 0 CA--C 1.577 1.992 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 -121.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 122.613 2.209 . . . . 0.0 114.56 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.42 -20.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.258 46.7 t0 65.44 83.06 0.17 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 125.082 1.353 . . . . 0.0 113.749 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.97 6.07 14.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.32 108.85 0.99 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.481 1.492 . . . . 0.0 114.652 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.87 -179.64 33.44 Favored Glycine 0 N--CA 1.485 1.958 0 CA-C-O 122.807 1.226 . . . . 0.0 115.58 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -107.5 118.22 36.15 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.45 1.1 . . . . 0.0 109.274 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -117.12 111.75 19.93 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -168.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -85.3 139.03 31.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 112.765 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.445 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 30.6 ttm -65.92 124.99 24.0 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 120.092 1.315 . . . . 0.0 114.355 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -86.08 -43.99 12.63 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -153.0 156.9 39.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.366 -1.459 . . . . 0.0 113.408 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -131.35 109.23 10.2 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.922 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.06 121.09 38.11 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.272 0.629 . . . . 0.0 110.499 -168.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 30.3 t30 68.01 31.83 5.34 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -78.43 -38.46 41.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.93 -41.45 74.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.0 -37.85 78.94 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -55.1 -47.38 75.04 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 120.26 1.391 . . . . 0.0 114.658 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.96 -40.59 71.87 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -54.68 -42.86 71.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 165.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 -29.15 60.78 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.4 -0.71 53.75 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 17.2 t0 66.71 48.12 1.45 Allowed 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 144.47 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.985 172.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -64.53 155.0 34.34 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 171.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.94 -43.84 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.67 50.27 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.33 -37.42 85.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -56.78 -51.7 67.89 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 165.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -62.94 -46.74 86.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.45 -56.9 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.042 0.837 . . . . 0.0 111.719 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.39 -27.98 67.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -75.19 -33.67 61.45 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.63 -34.16 76.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 166.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.36 130.28 40.95 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.176 0.988 . . . . 0.0 112.278 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.39 100.01 9.63 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.838 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 38.1 Cg_endo -66.8 154.89 72.98 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 CA-C-N 123.466 2.274 . . . . 0.0 114.967 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -108.24 119.63 40.03 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -89.46 113.85 25.27 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.358 -0.839 . . . . 0.0 110.863 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.78 106.97 19.3 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.807 -0.558 . . . . 0.0 109.545 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -102.24 130.6 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.58 108.79 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 167.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -94.59 102.63 14.56 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.393 0.677 . . . . 0.0 110.064 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 74.05 3.02 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 121.492 0.663 . . . . 0.0 110.4 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 -103.48 0.98 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.592 -0.692 . . . . 0.0 114.591 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.62 -32.49 23.69 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 165.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -80.17 104.2 10.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.623 1.556 . . . . 0.0 110.998 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp -114.33 132.14 56.29 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 122.295 1.045 . . . . 0.0 111.47 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.31 99.73 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.78 110.26 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -103.6 101.61 11.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.726 -0.608 . . . . 0.0 109.476 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -86.13 102.76 14.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.48 130.24 49.23 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.931 0.492 . . . . 0.0 111.494 -166.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.6 t -149.17 155.15 40.22 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.117 0.96 . . . . 0.0 111.675 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.2 p -62.02 -32.56 73.07 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.81 -50.55 13.19 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -151.82 136.85 17.33 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 119.388 0.994 . . . . 0.0 112.273 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -94.08 136.82 33.96 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 121.738 -0.601 . . . . 0.0 110.98 166.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -128.26 113.44 15.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 110.807 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.98 129.57 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 123.478 0.711 . . . . 0.0 109.467 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtp -108.59 108.04 18.77 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.639 0.776 . . . . 0.0 110.005 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.03 118.12 35.18 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.137 0.975 . . . . 0.0 111.825 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.2 149.55 22.97 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -165.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -94.46 127.23 40.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 0.0 111.095 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.87 130.62 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 123.332 0.653 . . . . 0.0 111.209 -174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.14 -36.19 4.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -162.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.18 140.46 29.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.579 1.189 . . . . 0.0 112.813 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -87.14 114.82 24.08 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.804 -0.56 . . . . 0.0 110.877 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -121.71 139.23 53.83 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 111.92 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.45 90.58 2.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.11 . . . . 0.0 113.431 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -92.15 113.24 25.45 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.406 -0.808 . . . . 0.0 110.72 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.54 127.77 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.35 1.072 . . . . 0.0 111.209 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.15 49.38 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.616 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.3 t -71.76 137.19 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.418 1.087 . . . . 0.0 113.314 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.66 -57.0 0.98 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 120.862 -0.685 . . . . 0.0 114.083 -154.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -79.56 -67.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.649 1.18 . . . . 0.0 110.169 -171.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.84 25.35 0.84 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 160.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.301 0.9 OUTLIER 61.41 8.01 2.0 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -82.3 139.58 34.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.806 -1.184 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -92.87 108.57 20.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.3 m -112.77 124.0 51.59 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.654 0.74 . . . . 0.0 110.751 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtp -72.55 92.56 1.5 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.585 1.184 . . . . 0.0 111.043 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -100.98 123.98 46.0 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.268 -157.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.6 m -104.66 119.49 39.11 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.0 t -104.93 127.76 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.8 m -129.44 155.32 45.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 112.422 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -90.85 118.52 30.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.0 111.71 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.06 75.68 1.68 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 166.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 -106.04 1.45 Allowed Glycine 0 N--CA 1.488 2.109 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.183 -167.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.9 -19.51 25.74 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -83.89 133.45 34.72 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 121.085 1.766 . . . . 0.0 111.948 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -92.87 98.08 11.15 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.169 0.588 . . . . 0.0 109.585 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -102.02 131.05 48.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.511 0.724 . . . . 0.0 110.963 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 51.9 t -128.81 142.17 51.06 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.93 126.12 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.768 0.827 . . . . 0.0 109.445 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.69 96.47 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.139 0.976 . . . . 0.0 109.069 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -96.27 116.32 28.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.177 -0.952 . . . . 0.0 111.985 -166.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.97 -105.93 0.19 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.297 -0.877 . . . . 0.0 112.792 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -79.09 -30.43 43.88 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.53 141.3 40.62 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.864 1.211 . . . . 0.0 113.018 -162.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.43 111.93 16.18 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.78 46.03 92.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 117.727 1.851 . . . . 0.0 117.727 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -83.44 137.98 33.67 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 118.282 1.041 . . . . 0.0 111.064 172.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.98 -163.49 34.48 Favored Glycine 0 N--CA 1.483 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 114.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.275 63.4 p-90 -158.06 169.06 25.41 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.547 1.165 . . . . 0.0 113.69 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.7 m -146.87 119.55 8.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.054 -1.654 . . . . 0.0 109.032 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -116.25 135.04 54.25 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -147.8 171.9 14.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.556 -0.715 . . . . 0.0 112.776 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.91 128.53 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.345 -0.847 . . . . 0.0 109.37 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.14 87.51 2.73 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.936 0.874 . . . . 0.0 110.281 166.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.12 -116.49 4.27 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.724 -0.61 . . . . 0.0 113.246 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -94.17 24.61 4.25 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 160.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.51 125.64 50.3 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.725 1.148 . . . . 0.0 111.349 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.03 120.31 25.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.36 0.664 . . . . 0.0 109.852 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.78 118.76 37.02 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.1 tp -125.94 122.21 35.34 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.593 0.757 . . . . 0.0 110.448 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.99 126.7 47.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.201 0.6 . . . . 0.0 109.535 167.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.1 mtp -122.68 123.87 42.12 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.983 0.913 . . . . 0.0 110.448 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -121.98 135.17 54.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 111.814 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.32 124.38 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.186 0.594 . . . . 0.0 110.737 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 56.29 41.36 29.26 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.07 -20.48 1.52 Allowed Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.702 2.641 . . . . 0.0 119.702 -164.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 51.0 t -80.43 118.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.723 1.761 . . . . 0.0 109.82 -169.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.5 m -99.53 124.33 44.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.797 0.808 . . . . 0.0 111.264 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 10.4 t -99.08 130.28 45.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.28 1.032 . . . . 0.0 110.894 168.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -105.31 117.86 35.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 110.568 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -117.47 125.33 50.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.554 0.742 . . . . 0.0 109.771 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.81 129.83 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.9 149.63 52.23 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 123.435 0.694 . . . . 0.0 111.453 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -115.54 132.53 56.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.106 -1.621 . . . . 0.0 112.252 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -69.3 124.8 24.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.38 -40.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 . . . . . 0 CA--C 1.562 1.435 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.663 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 57.1 mtt . . . . . 0 CA--C 1.574 1.878 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.33 130.55 14.13 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.725 2.283 . . . . 0.0 114.508 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.63 149.62 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.142 0.973 . . . . 0.0 113.429 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -87.52 106.22 17.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.37 -0.831 . . . . 0.0 111.833 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -83.39 0.83 44.29 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -58.87 106.29 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 121.27 1.85 . . . . 0.0 114.791 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.89 176.87 32.45 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-O 122.825 1.236 . . . . 0.0 115.83 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -105.45 120.54 41.88 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.439 1.096 . . . . 0.0 109.9 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -119.53 113.23 20.42 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -92.07 140.32 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.741 -1.224 . . . . 0.0 113.197 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.7 ttp -73.52 123.58 24.21 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.654 1.57 . . . . 0.0 114.388 -171.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.01 -52.69 6.11 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.158 0.983 . . . . 0.0 113.465 169.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -136.96 154.47 50.42 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -138.72 106.88 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.213 0.605 . . . . 0.0 109.819 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.99 121.92 41.88 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.622 0.769 . . . . 0.0 110.186 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 27.7 t30 63.44 32.98 14.06 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -79.39 -46.61 17.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.491 -1.381 . . . . 0.0 114.411 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -58.45 -39.13 79.04 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.73 -40.81 84.15 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -56.66 -49.15 75.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 164.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.9 -37.81 88.89 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -52.29 -47.37 65.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 162.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.24 -18.52 61.42 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.18 4.16 52.95 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.263 5.8 t70 66.24 46.63 2.0 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -171.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.07 142.57 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.748 0.785 . . . . 0.0 109.46 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -64.43 154.61 35.17 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.44 -46.05 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.82 -50.23 69.09 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 tp -64.2 -35.49 80.98 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -57.13 -42.1 80.3 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 163.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.56 -43.86 75.71 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -64.04 -56.56 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 123.927 0.891 . . . . 0.0 111.821 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.95 77.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -71.26 -30.16 65.96 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.76 -30.74 64.38 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 167.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.98 140.27 50.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.666 1.121 . . . . 0.0 113.569 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -94.05 100.45 4.87 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.443 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' C ' ' HD2' ' A' ' 39' ' ' ASP . 72.4 Cg_endo -69.75 157.27 60.97 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 123.248 2.196 . . . . 0.0 114.152 167.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.448 ' HD2' ' C ' ' A' ' 38' ' ' PRO . 44.2 m-20 -128.11 118.12 22.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.315 -1.491 . . . . 0.0 108.793 174.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -86.07 109.26 18.71 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.714 -0.616 . . . . 0.0 111.005 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.68 107.44 19.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 168.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.1 mt -104.08 127.35 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.5 t -112.36 107.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -102.39 97.42 7.67 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.912 0.885 . . . . 0.0 109.888 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.46 78.44 4.99 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.379 -0.825 . . . . 0.0 110.129 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 -103.7 1.1 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.881 -0.512 . . . . 0.0 114.374 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.5 -26.21 32.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 164.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -81.22 105.78 12.69 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.374 1.443 . . . . 0.0 111.552 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -109.86 122.13 46.81 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.155 0.978 . . . . 0.0 111.203 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -114.48 97.29 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.3 mt -91.54 109.44 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -102.72 99.01 8.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -86.05 98.04 10.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 108.756 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -95.93 115.44 27.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.7 -0.625 . . . . 0.0 110.203 -165.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 t -133.41 152.61 51.93 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.735 0.778 . . . . 0.0 110.72 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.9 p -63.1 -29.38 70.76 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -75.94 -49.52 17.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -154.61 135.06 13.37 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 119.414 1.006 . . . . 0.0 111.604 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -85.99 117.32 24.76 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.432 0.693 . . . . 0.0 110.222 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -106.14 103.95 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.363 -0.835 . . . . 0.0 110.374 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.72 124.17 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -102.93 107.4 18.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.646 0.778 . . . . 0.0 109.375 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -108.09 110.29 21.93 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.721 0.808 . . . . 0.0 109.83 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.36 160.27 41.61 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -101.94 138.22 39.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 110.969 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.33 133.56 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.31 -25.33 27.4 Favored Glycine 0 CA--C 1.552 2.387 0 N-CA-C 117.73 1.852 . . . . 0.0 117.73 -164.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -101.98 134.26 45.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.178 1.489 . . . . 0.0 111.04 -158.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -83.06 103.15 12.28 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.999 0.52 . . . . 0.0 111.231 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.96 138.73 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.442 0.697 . . . . 0.0 112.286 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.98 96.49 1.04 Allowed 'General case' 0 CA--C 1.57 1.719 0 O-C-N 120.955 -1.091 . . . . 0.0 112.953 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -89.88 113.12 24.67 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.25 108.69 15.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.872 -0.518 . . . . 0.0 109.644 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mp -85.2 56.22 3.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.161 0.981 . . . . 0.0 113.474 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.0 t -78.32 129.16 34.69 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.508 1.147 . . . . 0.0 112.846 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.31 -42.2 2.01 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.3 -88.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -113.49 7.59 17.54 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 57.11 44.63 22.18 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -137.17 142.98 42.17 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.53 131.27 34.99 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.273 0.629 . . . . 0.0 112.5 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.2 125.92 27.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.102 0.561 . . . . 0.0 111.343 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 mmt -68.38 100.97 1.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.672 1.225 . . . . 0.0 110.555 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 m -100.46 122.22 42.84 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.755 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.661 ' HG1' ' NZ ' ' A' ' 98' ' ' LYS . 86.2 m -110.93 118.58 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 t -109.91 121.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.4 m -127.83 147.4 50.44 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.843 0.857 . . . . 0.0 112.359 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -82.44 115.08 21.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.985 -1.072 . . . . 0.0 112.234 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -103.71 72.03 1.1 Allowed 'General case' 0 CA--C 1.568 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 109.74 166.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.37 -110.69 3.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.91 -26.05 59.36 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -101.29 126.54 48.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 119.901 1.228 . . . . 0.0 111.057 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -87.68 113.32 23.25 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 121.387 -0.82 . . . . 0.0 109.955 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -100.41 137.62 38.58 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.958 0.903 . . . . 0.0 111.735 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.4 t -131.64 136.87 48.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.364 0.666 . . . . 0.0 112.636 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.3 123.69 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.413 0.685 . . . . 0.0 109.776 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -99.8 98.38 9.19 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.513 1.125 . . . . 0.0 109.472 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.661 ' NZ ' ' HG1' ' A' ' 85' ' ' THR . 32.3 mtmm -89.74 115.21 26.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 111.445 -171.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.35 -112.59 0.27 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 121.767 -0.583 . . . . 0.0 112.457 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.18 -31.21 23.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -96.99 142.55 28.81 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.387 1.089 . . . . 0.0 113.797 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.53 106.77 11.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.044 -172.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.34 66.33 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -172.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -82.14 133.31 35.26 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.194 0.598 . . . . 0.0 110.823 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.43 -159.48 31.2 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -160.38 160.13 31.92 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.315 1.055 . . . . 0.0 112.92 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.3 m -133.04 128.45 36.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.113 -0.992 . . . . 0.0 108.396 170.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.77 138.48 53.37 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.7 163.85 37.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.3 mt -102.63 126.73 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.328 -0.857 . . . . 0.0 109.878 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.71 90.21 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.805 0.812 . . . . 0.0 110.175 164.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.14 -116.02 4.18 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 121.639 -0.663 . . . . 0.0 113.445 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -90.84 18.91 5.99 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 161.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -118.45 122.33 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.451 1.478 . . . . 0.0 111.113 -166.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.3 tp -82.85 111.89 19.16 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -98.04 119.39 36.59 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.63 117.8 26.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.601 0.76 . . . . 0.0 110.234 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.93 131.65 39.16 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.088 0.555 . . . . 0.0 109.781 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.0 mtp -127.07 121.44 31.54 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.444 0.698 . . . . 0.0 109.571 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -117.25 137.76 52.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 112.87 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.32 115.12 5.28 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 0.0 111.009 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.26 3.1 mt-10 58.14 44.65 18.77 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.24 -28.99 0.98 Allowed Glycine 0 CA--C 1.559 2.789 0 N-CA-C 119.172 2.429 . . . . 0.0 119.172 -162.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.5 t -71.69 115.26 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.752 1.221 . . . . 0.0 110.198 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.8 m -106.1 117.52 34.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.261 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 t -89.91 134.82 34.0 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.314 0.646 . . . . 0.0 111.448 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -109.68 118.61 37.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.756 -0.59 . . . . 0.0 110.809 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -116.66 137.06 52.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.65 0.78 . . . . 0.0 110.183 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.03 130.01 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -126.61 131.15 51.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.654 -0.654 . . . . 0.0 110.994 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -94.72 130.33 41.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.731 -1.231 . . . . 0.0 112.217 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -64.91 123.86 20.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.69 -36.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 120.228 1.377 . . . . 0.0 108.04 171.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 CA--C 1.576 1.942 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.41 174.64 8.91 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 C-N-CA 122.599 2.199 . . . . 0.0 115.141 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.23 127.11 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.4 102.4 12.01 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -159.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -76.47 -0.9 24.66 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -58.96 114.34 2.52 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 122.029 2.195 . . . . 0.0 114.407 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.03 177.7 28.58 Favored Glycine 0 N--CA 1.486 2.002 0 CA-C-O 122.925 1.292 . . . . 0.0 115.811 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -110.75 111.16 22.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.478 1.111 . . . . 0.0 108.904 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -114.16 111.82 22.19 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -166.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.56 142.43 27.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 112.815 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.404 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 38.5 ttp -72.18 121.61 19.62 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.834 1.197 . . . . 0.0 113.53 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.8 mt -81.88 -44.43 16.86 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 169.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.2 m -154.11 160.65 42.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.458 -1.401 . . . . 0.0 113.343 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.65 120.47 17.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.137 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.94 120.74 31.17 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 110.185 -170.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 32.6 t30 65.86 36.57 5.99 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -81.62 -42.34 20.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.14 -34.82 74.07 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.47 -44.78 70.48 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.018 1.736 . . . . 0.0 114.651 165.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -55.05 -45.45 75.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.73 -37.45 73.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.23 -43.73 87.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.2 -1.562 . . . . 0.0 114.848 163.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.27 24.84 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 163.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.0 mt -96.7 9.41 41.73 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 22.9 t70 62.61 59.93 1.4 Allowed 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 120.438 1.472 . . . . 0.0 113.145 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.98 139.08 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.616 0.722 . . . . 0.0 110.106 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.56 150.84 47.74 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.58 -47.01 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -49.98 70.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.23 -42.53 99.4 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 171.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -56.83 -48.57 77.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 121.304 1.866 . . . . 0.0 115.741 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.32 -43.32 99.06 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.56 -54.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 118.842 0.746 . . . . 0.0 111.691 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.52 78.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -66.77 -33.84 76.5 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 167.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.1 -25.08 58.23 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -70.68 147.74 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.365 1.439 . . . . 0.0 114.517 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -100.24 95.83 4.5 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.091 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 57.1 Cg_endo -69.61 141.49 46.0 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.479 2.119 . . . . 0.0 113.786 170.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.39 114.53 23.67 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 38.7 mttp -87.02 109.42 19.38 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.726 -0.609 . . . . 0.0 110.924 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.52 105.31 17.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 167.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mt -104.26 129.69 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.9 t -112.37 106.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -101.54 103.5 14.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.247 0.619 . . . . 0.0 109.781 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.65 72.0 5.85 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.39 -94.3 0.47 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.83 -25.11 17.5 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 166.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -83.63 116.42 22.61 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.416 1.462 . . . . 0.0 111.077 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.3 ttm -126.51 124.5 40.19 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.558 0.694 . . . . 0.0 110.945 -165.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.76 101.67 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.73 111.32 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -104.86 96.17 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.432 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 61.7 m -82.8 99.17 9.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 0.0 108.871 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.21 121.27 37.8 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.322 0.582 . . . . 0.0 110.401 -168.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -139.52 153.45 47.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.632 0.729 . . . . 0.0 110.67 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -63.6 -28.9 70.24 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.29 -52.55 10.58 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 170.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -156.04 136.75 13.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 119.461 1.028 . . . . 0.0 111.277 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.8 121.0 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.572 0.749 . . . . 0.0 110.111 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -109.72 116.74 32.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 110.366 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mm -110.64 119.66 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.2 mtp -107.33 104.17 13.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.825 -0.547 . . . . 0.0 110.082 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -110.14 115.75 30.29 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.074 0.95 . . . . 0.0 111.615 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -158.39 153.34 25.17 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -93.04 134.09 35.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.09 -1.007 . . . . 0.0 110.455 161.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.11 124.69 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.385 -0.822 . . . . 0.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.14 -38.32 3.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -155.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.94 133.76 35.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 117.959 0.88 . . . . 0.0 113.279 -161.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.46 102.58 12.18 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 121.953 -0.467 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -116.29 144.34 44.36 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.623 0.769 . . . . 0.0 112.173 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.59 92.21 3.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.597 -1.314 . . . . 0.0 113.197 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.17 118.9 24.42 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.388 -0.82 . . . . 0.0 110.767 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -76.8 127.81 33.45 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.759 -0.588 . . . . 0.0 110.518 161.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.3 55.29 0.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.553 0.692 . . . . 0.0 112.571 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.8 t -82.87 131.01 35.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 112.521 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -49.8 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.297 -0.877 . . . . 0.0 114.642 -155.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -78.34 -72.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.443 1.097 . . . . 0.0 109.902 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.45 ' N ' ' HD2' ' A' ' 78' ' ' ASP . 12.6 p-10 -135.34 -2.54 2.48 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.288 1.7 m-20 58.71 45.0 16.44 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -116.07 139.99 49.73 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.779 0.831 . . . . 0.0 110.993 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -83.54 124.24 30.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.108 0.48 . . . . 0.0 110.464 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 83.7 m -124.42 122.24 37.12 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.262 0.625 . . . . 0.0 110.851 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.73 99.05 2.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.292 1.044 . . . . 0.0 109.996 173.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.9 m -111.56 121.04 44.09 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.87 -158.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -104.76 120.66 41.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.74 128.04 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.9 m -132.75 145.72 51.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.595 0.758 . . . . 0.0 111.631 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -80.4 118.23 21.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.343 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.62 69.76 2.55 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.443 -0.786 . . . . 0.0 110.034 161.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.41 -96.94 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.3 -29.66 28.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -96.29 131.89 42.33 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 120.204 1.365 . . . . 0.0 111.466 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.9 tp -89.44 105.76 18.0 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.815 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.26 147.82 24.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.058 0.943 . . . . 0.0 111.964 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.8 t -141.57 135.83 30.46 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.89 126.54 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.541 0.736 . . . . 0.0 109.046 163.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -102.53 108.13 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.518 0.727 . . . . 0.0 109.527 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -86.39 101.96 13.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.801 -1.187 . . . . 0.0 110.453 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.28 92.81 0.09 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.311 79.9 mt-10 70.11 -46.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -106.74 151.47 25.09 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.506 1.146 . . . . 0.0 113.191 -153.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -86.72 107.64 18.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.586 -0.697 . . . . 0.0 111.89 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.64 55.61 8.31 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -95.57 129.1 42.87 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 122.967 0.507 . . . . 0.0 111.719 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.22 -147.78 13.4 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -160.98 161.44 31.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.959 0.885 . . . . 0.0 112.958 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.2 m -134.97 123.38 23.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -123.29 131.96 53.85 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.508 0.723 . . . . 0.0 111.287 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.97 169.24 20.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.877 -1.139 . . . . 0.0 113.209 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -113.48 128.01 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -113.28 90.03 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.87 -113.13 4.06 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.46 -0.775 . . . . 0.0 114.819 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -88.25 4.4 45.97 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.46 131.65 54.06 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 120.037 1.289 . . . . 0.0 112.365 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.43 122.0 35.4 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -111.52 123.05 49.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.9 tp -123.4 121.14 35.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.351 0.661 . . . . 0.0 111.07 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.46 129.71 42.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.404 0.681 . . . . 0.0 110.235 163.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.6 mtm -119.69 130.85 55.23 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.736 0.698 . . . . 0.0 110.722 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -125.47 133.31 52.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 112.609 -164.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.28 131.88 7.69 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 55.02 38.78 31.08 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.36 3.72 Favored Glycine 0 CA--C 1.559 2.786 0 N-CA-C 120.182 2.833 . . . . 0.0 120.182 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.66 121.8 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 119.87 1.835 . . . . 0.0 108.6 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.2 m -98.59 124.37 43.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 121.671 0.748 . . . . 0.0 110.691 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 11.2 t -92.74 143.79 25.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.686 . . . . 0.0 111.345 160.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.8 122.87 44.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.937 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -115.34 130.8 57.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.73 132.11 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -128.97 159.29 36.34 Favored 'General case' 0 CA--C 1.574 1.887 0 C-N-CA 124.437 1.095 . . . . 0.0 111.206 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -130.94 132.11 44.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.534 -1.354 . . . . 0.0 111.846 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.51 116.17 10.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.18 -33.96 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t60 . . . . . 0 CA--C 1.562 1.414 0 CA-C-N 119.951 1.25 . . . . 0.0 107.993 170.017 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 CA--C 1.571 1.764 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.6 119.58 6.01 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 C-N-CA 122.649 2.232 . . . . 0.0 114.714 -175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.77 142.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.239 1.019 . . . . 0.0 113.426 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -80.96 100.43 8.92 Favored 'General case' 0 CA--C 1.564 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 112.855 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.8 -4.0 44.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -54.84 108.86 0.44 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 121.285 1.857 . . . . 0.0 115.136 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.56 -175.99 35.55 Favored Glycine 0 CA--C 1.546 2.017 0 CA-C-O 122.829 1.238 . . . . 0.0 115.828 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -117.51 118.06 31.14 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.311 1.045 . . . . 0.0 109.356 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -121.54 117.13 26.02 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.69 -0.631 . . . . 0.0 109.582 -164.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -84.99 147.07 26.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 0.0 113.537 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 31.9 ttm -70.61 128.93 37.78 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 120.372 1.442 . . . . 0.0 113.459 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.38 -45.71 9.76 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -157.3 156.13 31.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.255 1.843 . . . . 0.0 114.458 173.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -104.75 123.29 47.39 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.761 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.97 -66.74 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -126.44 39.16 3.99 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.206 0.602 . . . . 0.0 112.114 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -70.58 -36.84 73.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.77 -47.32 70.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.56 -37.72 77.12 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -52.94 -48.11 67.56 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 120.838 1.654 . . . . 0.0 114.049 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.0 -35.83 69.57 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -54.0 -46.03 71.64 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.605 1.548 . . . . 0.0 114.899 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.63 -23.4 58.92 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.75 -9.54 59.3 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 166.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.329 16.9 t70 71.93 48.71 0.27 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.489 1.516 . . . . 0.0 114.763 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.5 t -89.94 149.79 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 122.289 1.042 . . . . 0.0 110.561 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -62.95 149.09 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -60.64 -40.8 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.18 -55.31 34.71 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.64 -41.99 91.76 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -53.22 -51.96 60.46 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 168.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -65.61 -41.76 92.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.76 -58.13 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.332 0.969 . . . . 0.0 111.519 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.08 74.23 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.09 -28.82 63.56 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 166.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.85 -23.6 39.0 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 mt -69.93 149.51 47.71 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.673 1.578 . . . . 0.0 114.681 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -101.84 91.04 2.14 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.212 171.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 92.7 Cg_endo -75.18 152.35 39.85 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.532 2.154 . . . . 0.0 114.224 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -109.4 117.74 34.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.351 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -84.84 111.94 20.09 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.328 -0.857 . . . . 0.0 110.746 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 107.95 19.75 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.759 -0.588 . . . . 0.0 109.632 165.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -102.92 127.35 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.46 106.32 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 170.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.48 105.58 17.57 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.157 0.583 . . . . 0.0 110.159 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -95.3 79.9 3.51 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.53 0.681 . . . . 0.0 109.751 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.93 -105.06 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.21 -26.67 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 165.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -82.11 107.06 14.51 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.515 1.507 . . . . 0.0 111.49 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.4 ttm -108.44 124.64 50.72 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.999 0.92 . . . . 0.0 111.04 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.48 102.22 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.68 107.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -100.13 101.49 12.55 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -85.1 101.18 12.23 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 mt -99.03 121.33 40.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.899 0.48 . . . . 0.0 111.506 -164.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.8 t -144.41 150.61 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.908 0.861 . . . . 0.0 111.304 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.9 p -63.21 -31.19 72.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -71.04 -52.47 19.34 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -155.39 135.94 13.36 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.94 0.791 . . . . 0.0 110.857 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -88.53 127.77 35.55 Favored 'General case' 0 CA--C 1.568 1.636 0 O-C-N 121.876 -0.515 . . . . 0.0 110.582 167.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -110.14 123.42 49.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.585 -0.697 . . . . 0.0 110.857 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.69 121.09 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -112.46 104.51 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -108.78 110.43 21.81 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.63 0.772 . . . . 0.0 108.926 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -153.67 154.84 34.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -167.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -100.13 125.86 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.728 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.49 125.87 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.639 -0.663 . . . . 0.0 110.811 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.52 -38.86 3.12 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 116.723 1.449 . . . . 0.0 116.723 -161.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -85.47 146.97 26.69 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 118.405 1.102 . . . . 0.0 113.919 -172.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -93.58 112.97 24.97 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.979 0.512 . . . . 0.0 110.003 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -120.82 148.52 43.9 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.985 0.914 . . . . 0.0 112.473 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.551 ' HE2' ' NZ ' ' A' ' 81' ' ' LYS . 25.6 mt-10 -70.46 103.04 2.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.662 -1.274 . . . . 0.0 111.757 169.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -89.99 113.99 25.76 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.17 0.588 . . . . 0.0 109.892 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.94 122.49 24.24 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 121.082 0.468 . . . . 0.0 110.237 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -105.15 44.18 1.05 Allowed 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -81.0 132.67 35.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.952 -1.093 . . . . 0.0 111.366 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.33 -57.65 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.811 -151.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.8 mt -74.42 -63.41 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.76 17.56 1.27 Allowed 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 159.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.05 42.2 31.12 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -111.24 145.1 39.33 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.662 0.785 . . . . 0.0 111.342 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.551 ' NZ ' ' HE2' ' A' ' 71' ' ' GLU . 43.9 mtmt -90.38 117.6 29.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.04 . . . . 0.0 110.013 164.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.0 m -111.07 144.1 40.72 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.11 90.3 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.55 168.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.0 m -90.69 129.93 36.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 -172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 m -116.63 125.37 51.68 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.407 HG22 ' SG ' ' A' ' 95' ' ' CYS . 40.6 t -115.39 128.76 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.6 m -132.63 148.92 52.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.196 -0.94 . . . . 0.0 112.377 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.33 123.11 29.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.824 -1.172 . . . . 0.0 113.344 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -111.79 73.39 0.82 Allowed 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 123.654 0.782 . . . . 0.0 109.666 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.01 -110.02 3.08 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -69.7 -24.11 63.53 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -99.13 120.62 39.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.206 0.912 . . . . 0.0 111.191 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.6 111.65 23.05 Favored 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -114.83 128.43 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.507 0.723 . . . . 0.0 110.532 -161.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.407 ' SG ' HG22 ' A' ' 86' ' ' VAL . 54.1 t -130.67 142.86 50.44 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.2 129.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.493 164.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -103.93 95.9 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -88.72 115.91 26.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.941 -1.099 . . . . 0.0 112.015 -167.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.18 -126.64 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 O-C-N 121.248 -0.907 . . . . 0.0 114.164 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.63 -32.1 65.64 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -103.99 138.65 40.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.823 1.192 . . . . 0.0 111.784 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.41 142.6 30.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.55 45.93 94.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 117.551 1.78 . . . . 0.0 117.551 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -99.95 130.92 46.17 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 121.698 0.761 . . . . 0.0 111.032 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.68 -166.4 34.75 Favored Glycine 0 N--CA 1.482 1.748 0 CA-C-O 121.806 0.67 . . . . 0.0 114.415 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -157.96 156.45 31.25 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.0 m -133.37 124.66 27.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.54 128.78 48.5 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.646 0.778 . . . . 0.0 111.336 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -146.32 169.26 19.18 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.113 -0.992 . . . . 0.0 113.191 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.2 mt -109.1 124.44 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.34 86.78 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.388 163.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.87 -110.54 3.25 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 121.231 -0.918 . . . . 0.0 115.045 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.66 -6.03 59.34 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 162.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.0 137.26 39.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.697 1.589 . . . . 0.0 112.826 -172.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.06 120.17 36.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.612 0.765 . . . . 0.0 109.04 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -110.11 117.58 34.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.2 tp -121.0 117.08 26.36 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.471 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.99 129.7 40.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.955 0.502 . . . . 0.0 109.867 166.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.8 mtp -124.45 123.43 40.14 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.742 0.817 . . . . 0.0 110.089 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -114.29 140.23 48.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.615 -0.678 . . . . 0.0 112.461 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.11 120.13 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.585 0.754 . . . . 0.0 109.506 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 58.56 41.34 22.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.75 -32.76 1.44 Allowed Glycine 0 CA--C 1.558 2.731 0 N-CA-C 118.852 2.301 . . . . 0.0 118.852 -163.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.28 116.19 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 124.757 1.223 . . . . 0.0 110.78 -168.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -106.37 115.31 29.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.099 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.0 t -97.49 127.21 43.26 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.784 0.834 . . . . 0.0 112.082 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -93.53 116.38 28.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -103.36 119.12 38.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 132.86 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -131.09 160.56 34.33 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 124.116 0.966 . . . . 0.0 111.703 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.12 129.7 40.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 110.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -68.47 124.87 24.75 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.56 -40.19 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.563 1.47 0 CA-C-N 119.781 1.173 . . . . 0.0 108.258 169.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.575 1.923 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.47 -173.99 2.08 Favored 'Trans proline' 0 CA--C 1.57 2.298 0 C-N-CA 122.352 2.035 . . . . 0.0 115.623 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -60.4 -17.18 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 119.567 3.173 . . . . 0.0 119.567 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.261 52.3 t0 67.99 86.28 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.236 1.38 . . . . 0.0 113.802 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -78.54 5.26 11.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 117.975 2.583 . . . . 0.0 117.975 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -61.42 107.66 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.806 1.639 . . . . 0.0 114.481 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.17 178.79 32.53 Favored Glycine 0 N--CA 1.484 1.89 0 CA-C-O 122.621 1.123 . . . . 0.0 114.888 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -107.76 118.76 37.58 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.33 1.052 . . . . 0.0 109.27 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -118.81 112.48 19.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -168.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -89.53 139.55 30.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 112.831 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.443 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.2 ttp -69.31 121.52 17.05 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 119.889 1.222 . . . . 0.0 114.042 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.93 -44.41 18.29 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -152.95 159.13 42.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.398 -1.439 . . . . 0.0 113.724 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -140.39 118.76 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.692 -174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.96 118.3 19.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.745 -0.597 . . . . 0.0 110.439 -167.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.283 23.1 t30 66.6 33.76 6.33 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -80.25 -42.34 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 24.5 mt-10 -56.78 -42.85 80.16 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.28 -39.87 89.71 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -54.79 -47.58 73.81 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.64 -40.44 73.07 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -57.88 -41.9 83.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 165.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.43 58.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 164.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 mt -86.75 -49.67 7.29 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.22 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 125.835 1.654 . . . . 0.0 114.986 165.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.01 148.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 119.306 -2.121 . . . . 0.0 112.886 -136.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.66 153.21 40.2 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -60.0 -41.81 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.49 -54.73 42.3 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 172.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.16 -38.17 85.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -57.18 -51.22 70.21 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.585 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 71.3 mmtt -65.38 -41.71 93.44 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 174.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.17 -58.21 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 119.446 1.021 . . . . 0.0 111.373 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.64 76.48 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -68.45 -36.22 78.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.83 -28.75 63.78 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.0 mt -72.5 135.24 45.63 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.541 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 101.99 7.97 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.565 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 34.1 Cg_endo -65.76 142.99 72.26 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 CA-C-N 123.315 2.22 . . . . 0.0 113.94 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.54 113.39 25.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.466 ' NZ ' ' HG1' ' A' ' 53' ' ' THR . 34.4 mttp -88.57 110.78 21.18 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.767 -0.583 . . . . 0.0 111.287 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -97.84 106.91 19.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.61 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.18 109.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 164.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -102.22 109.88 21.68 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.537 0.735 . . . . 0.0 109.99 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -100.19 74.97 1.79 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.05 -104.02 0.89 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.12 -31.3 39.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.06 127.58 33.55 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.893 1.678 . . . . 0.0 111.701 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.11 123.67 22.24 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-O 121.348 0.594 . . . . 0.0 111.274 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.4 mt -109.61 105.8 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.16 115.71 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -107.39 96.16 6.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.466 ' HG1' ' NZ ' ' A' ' 40' ' ' LYS . 86.7 m -86.75 95.52 9.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 mt -95.15 130.74 41.76 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -162.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -149.52 152.72 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.926 0.87 . . . . 0.0 110.97 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.6 p -62.33 -31.65 72.3 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -75.27 -52.46 10.81 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -151.0 129.27 11.97 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 119.042 0.837 . . . . 0.0 110.498 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.3 123.16 33.84 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.307 0.643 . . . . 0.0 109.568 167.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -103.56 110.85 23.05 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 119.087 0.858 . . . . 0.0 109.658 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.9 mm -104.1 116.9 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.1 mtp -103.81 133.91 48.0 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.37 109.43 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.97 160.44 41.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -167.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -103.37 131.09 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.836 0.827 . . . . 0.0 110.519 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.89 131.63 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 CA-C-O 121.966 0.889 . . . . 0.0 110.166 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.9 22.76 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 -161.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -101.33 143.22 31.64 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.241 1.521 . . . . 0.0 111.608 -166.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.39 108.8 20.14 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.003 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.13 146.97 44.69 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.54 108.02 4.72 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.96 0.886 . . . . 0.0 112.524 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.41 106.78 15.36 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.663 0.785 . . . . 0.0 109.939 -168.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.54 119.44 24.71 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.817 0.818 . . . . 0.0 110.707 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.04 52.49 1.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 m -73.66 128.22 34.91 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.468 1.107 . . . . 0.0 112.46 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.52 -60.98 0.41 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.987 -0.446 . . . . 0.0 113.648 -157.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.61 -61.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 124.245 1.018 . . . . 0.0 110.95 -174.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -143.63 3.57 1.29 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 165.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 7.8 t70 44.62 55.28 5.95 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -163.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -110.89 138.18 47.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.661 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -97.88 104.45 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.2 m -109.27 145.62 35.62 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.363 0.601 . . . . 0.0 111.862 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.8 mmm -85.17 91.72 8.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.147 169.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.9 m -96.6 122.66 39.76 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.653 -166.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 m -100.21 117.14 33.82 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -105.76 128.92 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -141.6 153.9 45.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.965 -1.085 . . . . 0.0 112.585 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -81.27 114.32 19.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.979 -1.076 . . . . 0.0 111.868 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -85.42 70.24 10.78 Favored 'General case' 0 CA--C 1.572 1.806 0 CA-C-O 121.597 0.713 . . . . 0.0 110.121 162.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.33 -98.84 0.21 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -169.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.47 -26.03 26.54 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -94.11 138.99 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.667 1.576 . . . . 0.0 111.513 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.74 106.69 18.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.097 -1.002 . . . . 0.0 110.098 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -95.37 150.42 20.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.967 0.907 . . . . 0.0 112.395 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -146.44 135.17 22.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.013 0.525 . . . . 0.0 112.315 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.93 126.6 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.65 0.78 . . . . 0.0 109.173 167.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -103.3 92.28 4.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -86.18 134.25 33.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.855 . . . . 0.0 112.961 -167.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 141.23 -90.68 0.18 Allowed Glycine 0 N--CA 1.486 2.031 0 O-C-N 121.441 -0.787 . . . . 0.0 113.713 167.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.29 -12.4 59.07 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -169.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -129.21 148.98 51.19 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.672 1.578 . . . . 0.0 112.757 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -82.11 114.18 20.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.787 0.835 . . . . 0.0 111.258 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.54 43.04 99.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 118.11 2.004 . . . . 0.0 118.11 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -86.17 135.93 33.39 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.304 1.052 . . . . 0.0 111.635 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -170.79 38.6 Favored Glycine 0 N--CA 1.482 1.721 0 CA-C-O 122.12 0.845 . . . . 0.0 114.262 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 61.7 p-90 -153.56 165.06 37.07 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.406 1.098 . . . . 0.0 113.183 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 m -138.47 125.77 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.43 129.0 42.46 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.725 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -151.62 165.49 34.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.002 -1.061 . . . . 0.0 113.242 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -107.41 131.0 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -0.936 . . . . 0.0 109.298 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -119.2 95.45 4.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 162.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.77 -117.4 4.72 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.677 -0.64 . . . . 0.0 114.151 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -94.59 15.9 16.85 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.994 1.849 . . . . 0.0 115.994 162.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -113.74 125.21 53.86 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.583 1.083 . . . . 0.0 111.055 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.3 120.64 26.1 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.375 1.07 . . . . 0.0 109.712 166.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -107.11 119.14 38.57 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.579 0.751 . . . . 0.0 108.979 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 tp -115.66 128.55 56.0 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.756 0.822 . . . . 0.0 110.013 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.88 123.8 50.66 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.638 0.775 . . . . 0.0 110.042 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.7 mtm -115.41 137.17 52.34 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.857 0.863 . . . . 0.0 111.483 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -127.11 135.05 50.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.539 -0.726 . . . . 0.0 111.578 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.77 125.4 6.38 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.118 0.567 . . . . 0.0 111.438 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 54.56 42.6 31.2 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.38 -6.95 6.92 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 120.377 2.911 . . . . 0.0 120.377 -165.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.21 126.15 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.281 2.04 . . . . 0.0 109.93 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -108.47 128.99 55.27 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.934 0.894 . . . . 0.0 111.085 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.4 t -125.12 126.5 45.41 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 0.0 112.75 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.95 135.54 35.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.552 -0.718 . . . . 0.0 112.127 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -129.04 134.5 48.15 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.351 0.661 . . . . 0.0 110.656 162.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.6 t -116.68 130.32 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.84 132.73 43.95 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.905 0.775 . . . . 0.0 111.252 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -103.61 133.75 48.1 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.227 -1.545 . . . . 0.0 112.631 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.96 120.88 16.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.0 -38.57 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 . . . . . 0 CA--C 1.563 1.464 0 CA-C-N 119.933 1.242 . . . . 0.0 108.318 169.274 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 78.2 mtp . . . . . 0 CA--C 1.572 1.802 0 CA-C-O 115.91 -1.995 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.27 92.74 0.74 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.482 2.994 . . . . 0.0 114.683 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.0 147.9 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -80.9 105.76 12.38 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.452 -0.78 . . . . 0.0 112.554 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -78.8 2.1 21.01 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -57.82 105.68 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 121.348 1.886 . . . . 0.0 115.114 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.53 179.83 35.55 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.432 ' H ' ' C ' ' A' ' 134' ' ' HIS . 34.1 t80 -109.64 113.0 25.41 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.592 1.157 . . . . 0.0 109.218 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -115.15 111.61 21.28 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -168.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.31 141.35 28.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.6 ttp -71.76 121.69 19.36 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.615 -1.303 . . . . 0.0 113.987 -173.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.2 mt -83.13 -45.09 14.36 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -153.52 160.45 42.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.505 -1.372 . . . . 0.0 113.333 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.34 117.98 10.4 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.002 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.76 121.0 35.26 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.749 0.82 . . . . 0.0 109.834 -172.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.285 31.1 t30 68.36 34.2 3.87 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -78.68 -40.53 33.66 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -56.4 -35.86 68.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 168.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.76 -41.92 67.83 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.946 1.703 . . . . 0.0 114.675 166.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.25 -51.12 65.54 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 120.079 1.308 . . . . 0.0 113.802 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.04 -38.18 82.21 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -59.92 -39.21 84.69 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -34.3 62.77 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 165.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.96 -9.79 58.86 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.318 15.9 t0 67.95 49.8 0.87 Allowed 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 125.592 1.557 . . . . 0.0 114.581 -161.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.5 t -93.51 137.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.93 0.872 . . . . 0.0 109.758 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -61.82 150.52 36.96 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 176.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -52.51 -44.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.51 68.96 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 172.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -36.29 80.79 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -61.97 -51.21 69.01 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.307 1.867 . . . . 0.0 115.447 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -60.22 -44.58 95.05 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.08 -55.96 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.724 0.693 . . . . 0.0 111.391 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.41 77.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -70.67 -32.05 69.18 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.61 -24.12 53.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -72.22 154.28 41.1 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -99.0 95.96 3.68 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.364 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.72 143.65 30.32 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.507 2.138 . . . . 0.0 113.477 166.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.14 117.22 32.67 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -85.92 107.18 17.6 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.371 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.22 108.7 20.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 170.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -106.6 127.84 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -116.15 109.15 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -106.79 105.48 15.53 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 123.881 0.873 . . . . 0.0 110.578 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.78 75.68 6.47 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 110.054 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.39 -100.36 0.47 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 115.231 0.853 . . . . 0.0 115.231 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.54 -29.04 28.19 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.17 110.49 17.42 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.353 1.433 . . . . 0.0 111.016 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -126.98 130.67 50.51 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.439 1.114 . . . . 0.0 111.949 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.86 101.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.2 mt -93.12 110.59 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -103.1 100.13 10.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -83.25 97.9 9.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.84 112.38 25.47 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.667 0.746 . . . . 0.0 110.627 -165.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 t -127.98 149.87 50.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.486 0.66 . . . . 0.0 109.789 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -61.33 -28.26 69.09 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -76.11 -42.47 46.99 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 166.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -156.47 131.39 9.06 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 120.214 1.37 . . . . 0.0 112.864 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -109.29 122.2 46.83 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.532 0.733 . . . . 0.0 110.297 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.42 108.88 15.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.325 -0.86 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.09 127.59 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-O 121.65 0.738 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -108.64 105.81 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.814 0.846 . . . . 0.0 109.505 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -104.99 116.65 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.429 0.692 . . . . 0.0 109.775 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -153.66 155.79 36.69 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.28 128.45 46.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.442 -0.786 . . . . 0.0 110.522 165.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.7 t -68.27 121.93 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 123.453 0.701 . . . . 0.0 110.255 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.36 -35.17 4.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -162.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.1 140.31 29.58 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.732 1.266 . . . . 0.0 112.06 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.13 107.12 18.99 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 122.041 -0.412 . . . . 0.0 111.079 171.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -112.46 133.77 54.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.577 0.751 . . . . 0.0 112.026 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.97 94.2 2.32 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 112.18 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -96.63 130.28 43.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.641 -0.662 . . . . 0.0 111.616 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.51 124.29 28.82 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.403 HD22 HE22 ' A' ' 97' ' ' GLN . 0.9 OUTLIER -78.19 67.73 4.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.115 1.436 . . . . 0.0 111.665 171.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -75.52 126.14 30.43 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.483 -166.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.22 64.75 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -170.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.75 -75.26 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.35 7.48 4.22 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.5 t0 43.84 59.98 2.9 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -115.2 141.51 47.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.59 -0.694 . . . . 0.0 111.375 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.47 115.52 28.1 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.335 0.654 . . . . 0.0 110.607 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.8 m -120.42 135.24 55.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.284 0.633 . . . . 0.0 111.751 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.0 mmm -76.63 99.77 5.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.787 . . . . 0.0 110.463 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.4 m -101.49 118.74 37.58 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.696 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.6 m -97.6 124.17 41.78 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.46 132.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.9 m -151.07 153.58 35.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.321 -1.487 . . . . 0.0 113.234 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -84.97 117.58 24.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.336 . . . . 0.0 113.27 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -99.12 78.97 2.29 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 123.427 0.691 . . . . 0.0 109.258 164.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -121.69 21.61 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.36 -8.33 56.88 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 168.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -98.23 128.76 44.85 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.067 1.303 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.8 tp -89.4 107.36 19.03 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.586 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -90.1 141.35 28.77 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.898 0.879 . . . . 0.0 111.563 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -133.14 125.52 29.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.516 0.726 . . . . 0.0 110.923 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -113.19 121.63 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 123.225 0.61 . . . . 0.0 109.731 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.403 HE22 HD22 ' A' ' 74' ' ' LEU . 13.4 mt-30 -103.65 102.11 11.97 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.392 0.677 . . . . 0.0 111.024 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.34 125.0 39.66 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.68 -118.01 0.62 Allowed Glycine 0 N--CA 1.49 2.241 0 O-C-N 121.102 -0.999 . . . . 0.0 112.976 170.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.55 -36.12 81.89 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' A' ' 122' ' ' GLU . 7.8 mmtt -89.55 130.86 35.8 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -163.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.4 117.82 22.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.566 . . . . 0.0 111.889 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.11 46.94 93.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 117.737 1.855 . . . . 0.0 117.737 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -93.01 136.92 32.83 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.19 0.995 . . . . 0.0 111.762 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 -171.12 43.03 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 122.842 1.245 . . . . 0.0 114.244 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -154.08 152.78 30.86 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.101 0.953 . . . . 0.0 112.47 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 79.3 m -125.59 125.14 42.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.64 139.24 53.32 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -151.78 164.14 37.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 113.072 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.51 140.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 122.847 1.308 . . . . 0.0 110.689 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -137.16 84.05 2.03 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.08 -111.16 3.4 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.846 -0.533 . . . . 0.0 113.816 -171.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -93.03 6.96 46.07 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -106.62 127.59 53.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.96 1.709 . . . . 0.0 112.741 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.7 tp -85.61 119.16 25.64 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.119 0.968 . . . . 0.0 109.381 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.52 122.57 46.28 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.9 126.32 48.4 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.599 0.76 . . . . 0.0 111.473 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -106.0 123.1 47.45 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.394 0.678 . . . . 0.0 109.639 164.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 63.7 mtm -110.09 129.75 55.64 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 118.948 0.795 . . . . 0.0 110.64 172.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -125.68 144.55 50.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.41 127.7 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.606 0.763 . . . . 0.0 110.978 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' CG ' ' HZ1' ' A' ' 101' ' ' LYS . 40.3 mm-40 51.1 49.7 20.61 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -168.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.7 -32.54 1.43 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.67 157.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 125.14 1.376 . . . . 0.0 112.866 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.6 m -129.94 121.95 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.712 -1.243 . . . . 0.0 110.218 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.5 t -97.14 131.68 43.66 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.3 0.64 . . . . 0.0 110.508 161.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -113.8 120.01 39.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.859 -0.526 . . . . 0.0 110.511 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -120.18 139.24 52.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.565 0.746 . . . . 0.0 111.48 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.05 129.79 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.16 142.3 51.22 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.924 0.89 . . . . 0.0 110.663 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -112.59 133.38 54.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.377 -1.452 . . . . 0.0 111.94 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -67.92 122.64 18.61 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.4 m -117.27 -34.49 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.432 ' C ' ' H ' ' A' ' 7' ' ' TYR . 12.8 t60 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 169.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 CA--C 1.571 1.752 0 CA-C-O 115.994 -1.955 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.28 115.76 3.5 Favored 'Trans proline' 0 C--N 1.374 1.917 0 CA-C-N 124.946 2.802 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.96 139.94 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 CA-C-O 122.003 0.906 . . . . 0.0 110.314 -174.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.72 104.04 8.02 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.328 -0.857 . . . . 0.0 113.282 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -81.27 2.51 27.71 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -59.56 116.12 3.78 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.219 1.827 . . . . 0.0 114.59 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.94 177.95 31.52 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-O 123.246 1.47 . . . . 0.0 115.758 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -110.44 112.37 24.25 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 113.727 -1.236 . . . . 0.0 108.677 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -112.47 122.68 48.4 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -167.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -91.87 143.94 25.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.802 -1.186 . . . . 0.0 113.092 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.403 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.5 ttm -73.49 122.41 22.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.721 -1.237 . . . . 0.0 112.988 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.31 -44.74 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -154.0 158.31 40.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.459 -1.4 . . . . 0.0 112.645 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -135.8 100.62 4.51 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.08 -64.42 1.15 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -154.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -120.54 43.55 2.71 Favored 'General case' 0 CA--C 1.571 1.773 0 C-N-CA 123.717 0.807 . . . . 0.0 111.273 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -73.62 -39.85 64.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.64 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 18.8 tt0 -53.54 -46.05 70.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 168.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.44 -39.82 85.43 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -55.73 -45.98 77.87 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 165.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.97 -41.42 86.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -53.83 -44.71 70.47 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.89 52.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 166.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.68 -5.71 56.8 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 164.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 7.5 t70 69.6 62.78 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 120.38 1.445 . . . . 0.0 112.996 -164.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 83.5 t -104.03 148.23 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.19 0.995 . . . . 0.0 110.034 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -62.25 151.88 35.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.77 -42.91 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.95 -54.37 45.52 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.63 -38.5 84.98 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -53.53 -52.13 60.65 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.64 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 73.8 mmtt -65.29 -45.28 85.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.17 -56.49 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.538 0.735 . . . . 0.0 111.819 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -27.01 66.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.11 -43.22 83.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 162.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.67 -28.14 65.62 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 mt -68.46 135.59 51.91 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 120.034 1.288 . . . . 0.0 112.893 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -113.06 84.57 7.16 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.19 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 70.7 Cg_endo -71.95 168.6 23.46 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 122.624 2.216 . . . . 0.0 116.054 -176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.77 121.86 45.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.145 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -89.88 110.23 21.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.613 -0.679 . . . . 0.0 110.009 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.3 108.78 20.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 167.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -106.19 123.96 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.53 107.94 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -103.04 119.02 38.1 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.928 0.891 . . . . 0.0 109.36 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.7 -60.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 112.546 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.81 101.49 0.15 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.455 1.0 OUTLIER 60.46 -45.16 0.1 Allowed 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -150.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -70.34 126.66 30.28 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-N 119.874 1.215 . . . . 0.0 112.361 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 ttp -143.39 131.89 22.3 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.105 0.955 . . . . 0.0 111.674 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.9 mt -115.4 109.78 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -97.44 115.72 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -111.54 96.01 5.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.702 -0.624 . . . . 0.0 109.347 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.3 m -87.13 103.06 15.04 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.9 mt -101.04 114.86 29.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -130.28 149.29 52.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.7 0.8 . . . . 0.0 110.209 168.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -65.77 -16.36 63.72 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 167.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -76.56 -53.31 8.24 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.459 1.027 . . . . 0.0 112.739 163.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -155.0 135.16 13.1 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 121.784 0.802 . . . . 0.0 111.023 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.19 121.42 34.53 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.765 0.826 . . . . 0.0 110.084 173.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -112.34 104.94 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.833 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.82 125.28 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 121.818 0.818 . . . . 0.0 109.106 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.9 mtp -103.67 109.99 21.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.64 0.776 . . . . 0.0 109.015 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -108.31 110.6 22.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.554 0.742 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.69 42.25 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -166.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.24 129.9 55.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 168.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.07 123.51 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 123.519 0.728 . . . . 0.0 110.287 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.31 -32.32 7.66 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 117.333 1.693 . . . . 0.0 117.333 -164.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -87.87 145.15 26.2 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.991 1.395 . . . . 0.0 112.578 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.97 120.09 32.3 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.79 -0.569 . . . . 0.0 111.068 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -126.55 151.32 48.05 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.917 0.887 . . . . 0.0 112.263 -171.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.64 97.73 3.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.655 -1.278 . . . . 0.0 112.253 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -84.57 105.23 15.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.37 101.96 9.31 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.157 0.503 . . . . 0.0 110.362 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.48 52.44 2.37 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -83.08 130.73 35.15 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.034 0.934 . . . . 0.0 111.382 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.6 -51.62 0.73 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 -151.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.13 -73.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -164.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.88 28.91 2.11 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 159.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.28 16.7 m-20 55.83 31.26 17.32 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.154 2.649 . . . . 0.0 118.154 174.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.405 ' HE ' ' NZ ' ' A' ' 101' ' ' LYS . 39.3 mtt85 -108.01 141.18 40.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 113.147 -176.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -90.92 109.73 20.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.226 0.611 . . . . 0.0 110.667 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.1 m -107.14 128.46 54.42 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.045 0.538 . . . . 0.0 111.343 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 95.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.267 1.032 . . . . 0.0 110.483 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.9 m -105.47 125.92 51.54 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.607 -0.683 . . . . 0.0 109.941 -161.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 m -116.62 115.94 26.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.53 121.65 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -138.25 150.41 46.66 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.144 0.883 . . . . 0.0 111.874 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -78.94 115.82 18.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.427 -1.421 . . . . 0.0 112.593 175.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.56 83.01 4.42 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 162.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.86 -107.29 1.8 Allowed Glycine 0 CA--C 1.547 2.083 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.534 ' N ' ' HD2' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -95.35 -0.26 52.87 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 171.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -103.18 127.36 50.5 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.06 1.754 . . . . 0.0 110.385 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.23 104.34 15.69 Favored 'General case' 0 CA--C 1.564 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -110.45 131.59 54.92 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.689 0.757 . . . . 0.0 111.152 -167.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 52.9 t -125.66 138.07 53.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.6 0.76 . . . . 0.0 112.88 -171.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -113.58 126.93 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 123.673 0.789 . . . . 0.0 109.178 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -102.49 95.37 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.485 0.714 . . . . 0.0 109.144 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.78 123.38 29.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.918 -1.114 . . . . 0.0 112.276 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.45 -90.66 0.11 Allowed Glycine 0 N--CA 1.484 1.886 0 O-C-N 121.598 -0.689 . . . . 0.0 114.49 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -88.74 -12.81 41.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -161.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' NZ ' ' HE ' ' A' ' 80' ' ' ARG . 23.3 mmtm -131.58 149.56 52.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.44 1.473 . . . . 0.0 111.612 -178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.39 115.01 21.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.459 1.104 . . . . 0.0 111.601 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.36 53.39 6.8 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -105.55 128.19 53.45 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.908 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.0 40.77 Favored Glycine 0 N--CA 1.486 1.997 0 O-C-N 121.601 -0.687 . . . . 0.0 114.395 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.255 40.1 p-90 -155.44 157.39 36.92 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.4 m -131.63 124.03 29.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.405 -0.81 . . . . 0.0 109.003 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.94 133.97 53.6 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.759 0.824 . . . . 0.0 111.722 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -149.78 171.52 16.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 0.0 112.746 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.23 126.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.45 90.71 3.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.438 163.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.98 -110.66 3.17 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.326 -0.858 . . . . 0.0 114.91 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.84 5.25 44.58 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 163.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -110.37 126.71 54.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.596 1.544 . . . . 0.0 112.432 -170.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.299 0.64 . . . . 0.0 109.791 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -113.55 120.14 39.94 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.0 tp -121.53 123.95 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.094 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -99.8 121.88 41.94 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.501 0.721 . . . . 0.0 110.025 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 50.1 mtm -115.44 132.97 56.46 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.536 1.062 . . . . 0.0 111.854 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.65 134.66 55.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 112.911 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.43 124.68 12.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 0.0 109.97 172.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 53.79 40.28 31.32 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 -8.35 9.54 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 120.263 2.865 . . . . 0.0 120.263 -164.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.58 117.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 120.399 2.1 . . . . 0.0 109.298 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.9 m -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.341 0.656 . . . . 0.0 111.234 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.6 t -97.22 129.79 44.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 111.753 166.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -98.18 125.41 43.2 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.696 0.68 . . . . 0.0 110.644 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -113.36 123.71 50.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.312 0.645 . . . . 0.0 109.323 169.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.81 133.65 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -135.4 156.61 48.63 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.522 1.129 . . . . 0.0 111.259 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.83 126.71 42.16 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.561 -1.337 . . . . 0.0 110.449 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -69.29 122.16 18.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.133 -0.979 . . . . 0.0 113.087 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.99 -38.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.5 t60 . . . . . 0 N--CA 1.487 1.404 0 CA-C-N 119.851 1.205 . . . . 0.0 108.112 170.071 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 CA--C 1.57 1.73 0 CA-C-O 117.602 -1.189 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.63 120.97 7.02 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.637 2.225 . . . . 0.0 114.773 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.4 m -72.81 151.72 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -87.59 104.77 16.81 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.53 -0.731 . . . . 0.0 112.046 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -82.53 4.49 24.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -60.6 114.28 2.9 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 121.419 1.918 . . . . 0.0 114.443 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.27 178.06 30.97 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-O 122.79 1.217 . . . . 0.0 115.738 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -108.88 115.26 29.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.399 1.079 . . . . 0.0 109.184 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -116.8 112.93 21.82 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.426 0.691 . . . . 0.0 109.189 -167.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -85.33 142.7 29.14 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.185 -0.947 . . . . 0.0 112.61 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.3 ttp -73.64 121.61 20.99 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-N 120.459 1.481 . . . . 0.0 113.042 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt -81.7 -44.12 17.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -154.5 160.22 41.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.413 -1.43 . . . . 0.0 113.322 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -136.0 118.86 16.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.808 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -124.26 122.68 38.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.597 0.759 . . . . 0.0 110.145 -170.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.2 t30 65.91 38.23 5.11 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.67 -40.89 16.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.77 -37.54 68.69 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.48 -41.12 69.75 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 120.922 1.692 . . . . 0.0 114.9 167.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -54.93 -46.67 74.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.55 -37.44 68.26 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -57.91 -41.38 82.51 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 164.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.15 -18.05 32.53 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 165.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -95.42 9.92 38.25 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 165.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.271 20.1 t70 57.99 50.16 10.66 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.5 t -98.72 141.01 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.836 0.827 . . . . 0.0 110.024 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.8 149.86 45.95 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.74 -45.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -50.58 70.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.36 -43.6 98.59 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -58.21 -47.88 82.08 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -60.04 -43.58 95.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.51 -56.98 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 118.717 0.69 . . . . 0.0 111.374 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.54 81.6 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -67.51 -32.59 73.5 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.34 -24.24 46.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 170.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.0 mt -68.92 147.05 52.23 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.513 1.506 . . . . 0.0 114.302 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.95 90.89 4.8 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.262 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.2 147.01 47.13 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.617 2.211 . . . . 0.0 114.415 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.99 117.84 29.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -88.44 110.75 21.08 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.654 -0.654 . . . . 0.0 111.084 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -96.08 107.7 20.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.514 -0.742 . . . . 0.0 109.355 167.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -105.84 127.33 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.18 110.08 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -106.78 110.86 23.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.312 0.645 . . . . 0.0 110.603 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -101.99 81.27 2.09 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.664 0.785 . . . . 0.0 109.52 168.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.91 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 121.559 -0.713 . . . . 0.0 114.341 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.76 -20.02 22.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 163.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -77.91 112.62 14.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.019 1.736 . . . . 0.0 111.923 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.3 ttm -123.27 125.01 44.27 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.677 0.751 . . . . 0.0 111.037 -165.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.1 mm -111.39 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -92.69 108.02 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.67 94.62 6.19 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.7 m -85.41 98.6 10.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.133 -0.979 . . . . 0.0 108.887 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.5 mt -97.18 115.13 27.01 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.848 -0.533 . . . . 0.0 110.7 -165.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 t -132.86 152.71 51.8 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.756 0.788 . . . . 0.0 110.476 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.6 p -64.34 -28.59 69.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -73.79 -48.19 33.34 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -154.89 135.57 13.54 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.498 1.044 . . . . 0.0 111.831 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.23 116.18 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.552 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -105.8 108.38 19.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 110.316 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mm -106.64 119.2 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.48 112.32 24.15 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.589 0.756 . . . . 0.0 109.641 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -112.27 112.36 23.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.599 0.76 . . . . 0.0 109.272 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -155.99 145.58 21.02 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -91.53 124.76 35.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.806 165.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.37 124.34 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.64 -0.663 . . . . 0.0 109.516 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.93 -39.27 2.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -157.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -95.6 152.83 18.09 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.561 1.181 . . . . 0.0 112.752 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -93.12 125.89 37.94 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.405 168.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.74 144.23 48.96 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.496 0.718 . . . . 0.0 112.32 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.27 100.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.493 -1.38 . . . . 0.0 112.978 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.94 104.91 16.72 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 121.829 -0.545 . . . . 0.0 109.707 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -74.0 99.18 3.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.793 0.437 . . . . 0.0 111.359 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.54 52.08 2.0 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -88.07 127.44 35.4 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.337 1.055 . . . . 0.0 111.411 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.97 -44.83 1.4 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 -148.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -93.66 -74.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.471 1.108 . . . . 0.0 108.647 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -122.46 -6.02 8.73 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 168.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 21.6 m-20 63.53 49.03 3.21 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 mtm-85 -141.94 143.26 33.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.116 -0.99 . . . . 0.0 111.475 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.86 94.97 6.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 -173.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -83.24 136.72 34.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.593 -0.692 . . . . 0.0 112.794 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.9 mtp -82.91 91.72 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.588 1.185 . . . . 0.0 110.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.429 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 40.4 m -102.75 122.13 43.84 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.414 -0.803 . . . . 0.0 110.898 -156.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -103.49 122.42 44.88 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.407 HG21 ' SG ' ' A' ' 95' ' ' CYS . 22.9 t -109.29 127.11 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -124.31 152.95 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.763 0.825 . . . . 0.0 111.924 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -88.98 120.94 30.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.933 -1.104 . . . . 0.0 113.193 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -112.18 67.35 0.65 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 123.536 0.734 . . . . 0.0 110.412 164.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -102.76 0.68 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.38 -31.37 65.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -94.83 117.14 29.65 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.162 0.982 . . . . 0.0 110.845 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 tp -88.79 109.32 20.07 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -111.76 126.97 55.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 -162.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.429 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 44.8 t -127.62 135.41 50.23 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -168.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -112.83 122.28 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.607 0.763 . . . . 0.0 109.367 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -98.25 93.58 6.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.612 0.765 . . . . 0.0 109.111 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -85.77 122.51 29.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.8 -1.188 . . . . 0.0 112.309 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.8 -111.23 0.36 Allowed Glycine 0 N--CA 1.484 1.896 0 O-C-N 121.623 -0.673 . . . . 0.0 113.405 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.39 -3.61 56.53 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -121.06 143.42 49.08 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.196 1.362 . . . . 0.0 113.067 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -81.48 97.63 7.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -170.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.93 49.81 6.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.57 138.05 31.88 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.735 0.779 . . . . 0.0 112.436 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 -166.3 35.24 Favored Glycine 0 N--CA 1.486 1.974 0 CA-C-O 121.934 0.741 . . . . 0.0 114.807 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -159.09 153.35 23.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.8 m -130.23 125.98 36.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -126.3 129.15 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.765 0.826 . . . . 0.0 110.849 -172.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -145.72 167.56 22.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.978 -1.076 . . . . 0.0 113.449 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.8 mt -110.34 126.46 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.95 89.37 3.04 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 164.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.79 -112.05 3.57 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.299 -0.876 . . . . 0.0 114.679 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -89.99 2.96 54.55 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 161.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -102.63 134.43 46.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.557 1.526 . . . . 0.0 112.518 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -97.19 122.8 40.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.082 0.953 . . . . 0.0 109.19 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -114.52 122.38 46.39 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.464 0.706 . . . . 0.0 109.279 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp -123.95 122.15 37.18 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.456 0.702 . . . . 0.0 110.832 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.1 128.56 44.68 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.217 0.607 . . . . 0.0 109.865 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.4 mtm -117.95 130.43 56.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 118.894 0.77 . . . . 0.0 110.597 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -113.92 138.19 50.66 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.575 0.75 . . . . 0.0 112.818 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.87 116.51 4.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 110.2 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.305 6.0 mt-10 54.07 50.18 17.18 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.11 -14.48 3.84 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 120.577 2.991 . . . . 0.0 120.577 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.77 124.51 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.447 2.123 . . . . 0.0 110.017 -166.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -93.54 123.2 36.69 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.134 0.574 . . . . 0.0 110.697 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.67 135.92 37.91 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.066 0.547 . . . . 0.0 111.061 159.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -113.43 118.83 35.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.807 -0.558 . . . . 0.0 110.58 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -114.75 133.75 55.66 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.465 0.65 . . . . 0.0 110.903 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.36 131.0 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -127.66 160.42 31.68 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 124.475 1.11 . . . . 0.0 111.196 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -133.22 133.28 42.51 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.488 -1.383 . . . . 0.0 112.263 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -70.25 123.63 22.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.71 -37.56 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 . . . . . 0 CA--C 1.567 1.61 0 CA-C-N 119.739 1.154 . . . . 0.0 108.344 171.233 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . 0.289 55.6 ttm . . . . . 0 CA--C 1.571 1.767 0 CA-C-O 115.602 -2.142 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.63 164.63 35.08 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 CA-C-N 125.22 2.9 . . . . 0.0 114.946 167.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.14 136.09 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.973 -1.079 . . . . 0.0 112.429 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -82.99 102.82 11.99 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 121.24 0.543 . . . . 0.0 112.072 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -81.83 -2.46 51.05 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 173.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -58.01 108.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 121.092 1.769 . . . . 0.0 114.499 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.71 33.94 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-O 122.609 1.116 . . . . 0.0 114.98 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -118.74 118.33 31.31 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.17 0.988 . . . . 0.0 109.441 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.19 114.72 20.66 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -164.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.04 141.15 29.15 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.978 -1.076 . . . . 0.0 113.769 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.1 ttp -76.24 119.21 19.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.26 -44.5 17.65 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -154.26 158.52 40.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.535 -1.353 . . . . 0.0 113.372 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -130.68 100.03 5.16 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.093 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -103.02 115.19 30.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.53 -0.731 . . . . 0.0 110.145 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 42.2 t30 58.56 31.31 20.91 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.14 -34.15 76.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 167.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 -49.54 77.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -37.11 80.11 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -57.73 -45.79 85.32 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.01 -40.33 78.74 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -55.48 -45.33 76.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.96 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 166.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.24 2.25 54.53 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.275 26.9 t0 64.49 56.61 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 120.259 1.39 . . . . 0.0 113.296 -169.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -103.1 139.45 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -66.77 157.17 33.53 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.9 t -60.7 -45.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -47.55 83.81 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.47 -44.77 92.94 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -52.09 -56.3 15.33 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -57.04 -33.07 66.84 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.18 -59.28 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 CA-C-N 118.757 0.708 . . . . 0.0 111.192 164.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.79 91.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -60.53 -36.7 79.03 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 170.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.58 -20.01 37.37 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.37 138.2 51.16 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 120.292 1.406 . . . . 0.0 113.091 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -111.23 85.4 5.44 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.22 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.8 158.83 54.52 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.608 2.205 . . . . 0.0 116.18 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.13 116.87 33.33 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.291 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -86.44 111.74 20.83 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.376 -0.828 . . . . 0.0 110.483 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.32 110.67 23.18 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.3 129.05 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.73 109.54 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -101.4 102.51 13.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.821 0.849 . . . . 0.0 110.126 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.8 71.93 5.72 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.72 0.808 . . . . 0.0 110.249 167.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.53 0.45 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -80.48 -33.38 36.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.74 114.83 19.9 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 120.186 1.357 . . . . 0.0 111.493 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.3 ttm -125.37 123.33 39.12 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.514 0.673 . . . . 0.0 110.984 -167.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.59 100.95 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.54 112.58 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -104.95 102.19 11.72 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 m -86.16 99.19 11.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.2 mt -99.6 116.05 30.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.088 0.555 . . . . 0.0 110.317 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -131.11 154.66 48.07 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.946 0.879 . . . . 0.0 110.741 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.3 p -62.97 -31.61 72.76 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -79.0 -45.06 21.0 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -158.01 132.69 8.4 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.973 1.261 . . . . 0.0 112.555 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -96.56 121.11 38.03 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.435 0.694 . . . . 0.0 110.388 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -110.67 104.63 13.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.375 -0.828 . . . . 0.0 110.631 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.54 125.54 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 122.087 0.946 . . . . 0.0 108.586 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.9 mtp -112.57 128.18 56.29 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.515 1.126 . . . . 0.0 108.603 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.04 95.15 3.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.686 . . . . 0.0 109.244 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -129.85 151.18 50.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -97.05 119.31 35.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.584 -0.698 . . . . 0.0 109.831 166.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.37 118.1 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 C-N-CA 123.458 0.703 . . . . 0.0 110.119 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.89 -43.45 1.49 Allowed Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -158.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.64 147.3 25.33 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.65 134.99 35.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.766 -0.584 . . . . 0.0 111.578 165.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -144.11 156.54 44.39 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.833 0.825 . . . . 0.0 112.903 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.98 98.16 3.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.46 0.704 . . . . 0.0 111.88 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -100.33 101.47 12.47 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.574 -0.704 . . . . 0.0 111.262 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -81.35 109.63 16.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.807 -0.558 . . . . 0.0 110.544 167.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.33 57.36 3.6 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-O 121.988 0.899 . . . . 0.0 112.854 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.0 t -76.31 140.48 41.52 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.15 0.98 . . . . 0.0 113.126 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.55 -46.43 1.96 Allowed Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -159.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mt -78.66 -74.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.513 1.125 . . . . 0.0 110.044 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -134.36 -3.47 2.71 Favored 'General case' 0 CA--C 1.574 1.886 0 C-N-CA 125.482 1.513 . . . . 0.0 114.457 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 1.6 m-20 54.1 57.18 6.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.68 134.58 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.19 0.519 . . . . 0.0 111.096 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -85.65 125.51 33.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.646 0.778 . . . . 0.0 111.61 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.92 148.7 48.21 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.493 0.717 . . . . 0.0 112.121 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.04 97.77 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.597 168.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.2 m -100.64 122.18 42.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 122.04 -0.412 . . . . 0.0 111.337 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -111.77 122.82 48.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.43 131.61 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.4 m -133.22 148.6 52.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 111.788 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -82.95 115.13 21.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 111.121 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.82 71.75 10.83 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 109.957 163.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.0 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -165.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.88 -16.71 14.39 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -87.59 139.37 30.61 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.905 1.684 . . . . 0.0 111.472 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.52 108.64 21.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.537 -0.727 . . . . 0.0 110.218 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -112.46 132.39 55.08 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.463 0.705 . . . . 0.0 111.256 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -126.19 136.1 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.95 130.02 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -120.88 95.65 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.674 . . . . 0.0 110.405 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -77.91 120.83 23.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 112.925 -173.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.64 -115.71 0.35 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.989 -0.444 . . . . 0.0 112.255 172.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -78.53 -25.72 45.61 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -108.44 148.66 29.85 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.307 1.412 . . . . 0.0 112.957 -157.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.32 110.1 17.17 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.175 0.99 . . . . 0.0 111.85 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.49 51.52 9.59 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -92.76 116.59 29.16 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 117.316 0.558 . . . . 0.0 111.836 -171.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.55 -168.65 39.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -154.03 157.99 39.89 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.943 0.877 . . . . 0.0 112.958 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.5 m -132.93 127.49 34.41 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.036 -1.04 . . . . 0.0 108.682 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -127.58 131.44 49.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.778 . . . . 0.0 111.088 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.48 174.15 12.8 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.96 132.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.963 . . . . 0.0 109.436 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.09 92.17 3.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.743 0.817 . . . . 0.0 109.048 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.19 -114.85 4.44 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.346 -0.847 . . . . 0.0 114.746 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -88.7 4.98 45.38 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 163.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -106.56 129.92 54.41 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.101 1.319 . . . . 0.0 111.93 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.07 122.18 30.55 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.251 1.02 . . . . 0.0 109.733 166.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -113.44 124.33 52.17 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.733 0.813 . . . . 0.0 109.578 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.7 tp -127.83 119.5 25.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.253 0.621 . . . . 0.0 110.629 -173.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -90.26 135.23 33.8 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.892 0.477 . . . . 0.0 110.316 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.0 mtp -130.22 124.13 31.8 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.6 0.76 . . . . 0.0 109.856 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -122.88 132.32 54.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -0.753 . . . . 0.0 111.872 -164.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.03 131.66 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.233 0.613 . . . . 0.0 111.451 174.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 56.24 39.34 30.26 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.03 0.95 16.83 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 120.193 2.837 . . . . 0.0 120.193 -163.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.59 118.98 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 120.065 1.933 . . . . 0.0 108.942 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.4 m -95.04 116.88 29.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.658 0.742 . . . . 0.0 110.337 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.6 t -91.71 141.62 28.49 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.496 0.718 . . . . 0.0 111.116 161.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -115.58 123.28 48.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.399 -0.813 . . . . 0.0 110.952 166.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.43 129.14 56.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.187 0.595 . . . . 0.0 109.928 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.82 128.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -127.84 147.1 50.43 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.699 0.799 . . . . 0.0 111.002 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -116.37 135.81 53.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.378 -1.451 . . . . 0.0 112.29 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -70.06 122.95 20.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.29 -37.56 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 CA--C 1.567 1.603 0 CA-C-N 120.069 1.304 . . . . 0.0 108.595 170.467 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.572 1.822 0 CA-C-O 115.984 -1.96 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.5 172.25 16.08 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 CA-C-N 125.16 2.878 . . . . 0.0 115.533 173.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.13 125.43 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.074 . . . . 0.0 112.002 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.04 106.8 17.46 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.783 0.801 . . . . 0.0 112.185 -170.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -75.17 3.18 9.16 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.716 2.488 . . . . 0.0 117.716 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -54.91 111.12 0.76 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.287 1.858 . . . . 0.0 114.959 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.44 175.86 28.85 Favored Glycine 0 N--CA 1.488 2.132 0 CA-C-O 122.217 0.898 . . . . 0.0 115.167 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -109.6 116.39 31.67 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.389 1.075 . . . . 0.0 109.515 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -118.33 112.73 20.42 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.688 -0.632 . . . . 0.0 109.412 -166.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.53 141.77 28.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.064 -1.023 . . . . 0.0 113.558 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttp -70.87 124.34 24.1 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -172.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.3 mt -85.67 -53.59 5.06 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.8 p -138.62 150.88 46.74 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 119.435 1.016 . . . . 0.0 113.477 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -129.13 113.78 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.867 0.867 . . . . 0.0 109.229 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -115.98 117.3 29.75 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 0.0 109.76 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.6 t30 63.74 36.45 10.61 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -74.57 -39.78 62.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.604 -1.31 . . . . 0.0 114.439 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.46 -41.84 97.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 174.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.13 -39.43 78.89 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.17 -49.42 71.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 165.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.75 -40.88 88.47 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -55.03 -46.39 75.27 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 164.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.32 -18.36 49.16 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 166.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.6 mt -91.03 3.53 54.5 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.279 40.3 m-20 66.12 52.17 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.116 1.366 . . . . 0.0 114.406 -171.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.95 144.57 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 122.123 0.964 . . . . 0.0 110.139 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -63.86 154.32 34.03 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.73 -44.42 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.74 -50.85 67.37 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.32 -40.12 95.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -55.05 -40.5 70.37 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -69.75 -48.45 59.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.916 -1.115 . . . . 0.0 113.761 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.63 -57.86 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.012 0.925 . . . . 0.0 112.136 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -30.35 71.42 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -69.09 -36.54 77.68 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.97 -23.63 59.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.53 152.42 41.88 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 120.404 1.456 . . . . 0.0 114.644 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -101.35 90.26 1.65 Allowed Pre-proline 0 CA--C 1.574 1.892 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.314 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.7 146.48 54.46 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 122.848 2.053 . . . . 0.0 114.808 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.23 113.16 24.93 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -89.67 107.39 19.06 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.375 -0.828 . . . . 0.0 110.538 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.71 107.22 19.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.717 -0.615 . . . . 0.0 109.908 172.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.65 131.42 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.3 t -113.21 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -93.65 104.86 16.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.221 0.609 . . . . 0.0 109.954 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.31 75.55 2.95 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 121.527 0.679 . . . . 0.0 109.931 167.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.23 -104.43 1.04 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -81.65 -32.0 32.06 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -81.24 107.39 13.99 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.935 1.243 . . . . 0.0 110.952 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.3 ttp -116.16 124.0 49.24 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.962 0.887 . . . . 0.0 111.047 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.41 101.57 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.9 mt -98.18 105.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -97.48 99.43 10.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -88.08 97.14 10.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.21 -0.931 . . . . 0.0 109.135 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.8 mt -100.39 121.73 42.0 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.261 0.624 . . . . 0.0 110.976 -164.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -139.49 157.24 46.18 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.122 0.963 . . . . 0.0 111.356 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.9 p -65.09 -30.81 71.79 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -74.98 -48.89 21.95 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 165.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -153.75 138.83 17.33 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 119.651 1.114 . . . . 0.0 113.431 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -94.03 128.16 40.23 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.724 0.81 . . . . 0.0 109.982 168.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -118.95 103.93 10.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.016 -1.052 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.29 128.25 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.9 mtp -115.41 104.86 12.19 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.636 0.775 . . . . 0.0 110.256 173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -111.12 113.64 26.31 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.031 0.933 . . . . 0.0 111.583 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.64 149.36 27.48 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -169.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -92.32 129.26 38.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 111.075 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.75 129.45 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 123.218 0.607 . . . . 0.0 111.048 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.64 -31.92 7.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -161.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -84.83 133.42 34.33 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.96 1.38 . . . . 0.0 112.993 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -86.55 98.39 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.786 0.435 . . . . 0.0 110.223 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -105.41 147.24 28.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.52 106.38 3.97 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.916 0.865 . . . . 0.0 112.131 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.73 103.03 10.8 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.616 0.766 . . . . 0.0 109.748 -166.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.81 116.68 20.11 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 121.84 0.829 . . . . 0.0 110.58 172.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.73 45.49 1.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.1 t -76.58 137.64 39.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.086 0.954 . . . . 0.0 112.593 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.83 -59.41 0.54 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.601 -152.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.03 -75.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 123.748 0.819 . . . . 0.0 109.595 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -140.33 21.14 2.4 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 174.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.268 11.9 t70 50.18 48.99 21.31 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 176.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HE ' ' NZ ' ' A' ' 101' ' ' LYS . 44.9 mtt85 -127.71 142.47 51.32 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.981 0.896 . . . . 0.0 112.378 -174.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -97.35 101.86 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.797 0.839 . . . . 0.0 110.652 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.3 m -102.11 147.67 26.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.518 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.97 95.22 10.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 109.009 167.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 124.19 47.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 111.243 -166.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -107.55 123.74 48.89 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -108.8 128.87 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t -123.57 149.66 45.01 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.98 0.912 . . . . 0.0 111.833 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -90.44 115.81 27.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.89 -1.131 . . . . 0.0 112.228 170.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -98.43 66.19 1.7 Allowed 'General case' 0 CA--C 1.574 1.892 0 O-C-N 121.687 -0.633 . . . . 0.0 110.26 157.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.14 0.02 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.553 ' N ' ' HD2' ' A' ' 91' ' ' ASP . 1.1 m-20 -86.76 -27.41 23.64 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 167.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -100.28 122.89 43.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.223 1.374 . . . . 0.0 111.076 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.66 110.18 21.08 Favored 'General case' 0 CA--C 1.564 1.51 0 O-C-N 121.518 -0.739 . . . . 0.0 109.123 172.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.7 122.4 45.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.099 0.56 . . . . 0.0 110.433 -161.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 52.5 t -122.07 138.88 54.28 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.05 123.85 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.601 0.76 . . . . 0.0 109.25 168.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -102.35 93.85 5.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -91.45 117.45 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 111.824 -166.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.8 -90.21 0.1 OUTLIER Glycine 0 N--CA 1.481 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 113.262 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -91.51 -16.98 26.4 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -164.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' NZ ' ' HE ' ' A' ' 80' ' ' ARG . 25.2 mmtm -125.33 148.35 48.76 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.22 1.373 . . . . 0.0 112.093 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.45 112.35 17.7 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 123.762 0.825 . . . . 0.0 112.231 -172.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.56 90.15 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -86.47 135.6 33.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.776 0.798 . . . . 0.0 111.431 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.9 -170.93 40.76 Favored Glycine 0 N--CA 1.482 1.757 0 CA-C-O 121.994 0.774 . . . . 0.0 114.602 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -156.42 150.42 25.11 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.2 m -124.87 125.99 44.85 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.48 129.16 48.12 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.513 0.725 . . . . 0.0 111.02 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.81 170.86 16.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.146 -0.971 . . . . 0.0 113.16 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.15 127.6 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.293 -0.88 . . . . 0.0 109.054 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.39 91.6 3.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 161.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.86 -111.7 3.54 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.172 -0.955 . . . . 0.0 115.03 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -94.06 8.82 40.11 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 162.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -107.84 123.8 49.13 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.399 1.454 . . . . 0.0 111.489 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.1 tp -81.32 118.73 22.88 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.64 1.176 . . . . 0.0 109.732 167.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.13 117.28 33.64 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.5 tp -115.18 128.89 56.47 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.79 0.836 . . . . 0.0 110.205 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -114.96 120.51 40.15 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.061 0.545 . . . . 0.0 109.962 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -110.18 133.58 53.08 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.764 0.825 . . . . 0.0 110.66 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -116.21 141.61 47.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.59 118.07 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.664 0.786 . . . . 0.0 110.615 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 55.2 44.15 28.15 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.33 3.05 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 120.477 2.951 . . . . 0.0 120.477 -164.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.98 122.81 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 120.256 2.028 . . . . 0.0 110.21 -167.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.8 m -94.73 125.73 39.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.334 0.654 . . . . 0.0 111.488 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 14.4 t -97.78 127.45 43.74 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.076 0.55 . . . . 0.0 110.762 158.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -107.58 129.31 55.0 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.385 0.612 . . . . 0.0 111.403 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -127.76 137.9 52.58 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.667 0.787 . . . . 0.0 111.031 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.74 131.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -131.21 130.37 42.86 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.453 0.701 . . . . 0.0 110.823 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -101.33 131.31 47.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.166 -1.584 . . . . 0.0 112.475 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.35 121.71 15.46 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.37 -38.23 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.8 t60 . . . . . 0 N--CA 1.488 1.435 0 CA-C-N 120.056 1.298 . . . . 0.0 107.796 169.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -72.48 140.24 32.83 Favored 'Trans proline' 0 CA--C 1.561 1.871 0 C-N-CA 122.622 2.215 . . . . 0.0 115.815 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.42 131.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.271 0.558 . . . . 0.0 111.237 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -83.24 100.89 10.89 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 120.651 -1.281 . . . . 0.0 112.422 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -71.76 1.85 6.27 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -54.62 108.36 0.38 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.45 177.94 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 CA-C-O 122.652 1.14 . . . . 0.0 115.157 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -111.01 116.61 31.47 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.426 1.09 . . . . 0.0 109.16 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -118.27 112.36 19.98 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.197 0.599 . . . . 0.0 109.539 -166.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -83.44 140.57 32.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.928 . . . . 0.0 113.41 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.464 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.7 ttm -69.7 125.1 25.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.235 1.38 . . . . 0.0 113.732 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.18 -57.75 2.9 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.657 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.0 m -127.89 149.95 50.08 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.29 1.043 . . . . 0.0 112.485 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.67 89.66 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.37 120.61 40.78 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.382 0.673 . . . . 0.0 110.62 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 33.6 t30 67.55 35.75 4.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -79.04 -41.02 29.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.327 -1.483 . . . . 0.0 114.84 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.617 ' HE2' ' NZ ' ' A' ' 31' ' ' LYS . 2.9 mt-10 -50.51 -44.69 56.19 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 165.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.05 -36.36 69.58 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.877 1.671 . . . . 0.0 115.148 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -56.49 -49.01 75.92 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 164.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.21 -33.78 72.1 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -61.07 -41.35 96.45 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 164.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -18.22 56.7 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 165.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.65 -4.9 59.24 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 162.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 63.8 46.81 3.81 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 120.528 1.513 . . . . 0.0 114.707 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -93.01 140.95 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.812 0.815 . . . . 0.0 109.693 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.0 149.32 37.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.2 -45.0 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.75 62.92 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.85 -36.47 83.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -59.37 -49.94 75.88 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.588 1.995 . . . . 0.0 115.667 167.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.617 ' NZ ' ' HE2' ' A' ' 17' ' ' GLU . 72.5 mmtt -61.78 -42.42 98.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 174.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.65 -56.84 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.83 0.741 . . . . 0.0 111.308 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.51 87.54 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.93 -33.49 75.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.59 -30.31 65.68 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 167.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.71 137.64 47.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.972 1.26 . . . . 0.0 113.536 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -108.26 85.88 3.0 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.17 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.4 Cg_endo -68.6 154.16 72.09 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.601 2.2 . . . . 0.0 114.926 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' N ' ' HD2' ' A' ' 39' ' ' ASP . 1.3 m-20 -104.71 118.23 36.06 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -85.89 112.3 21.03 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.748 -0.595 . . . . 0.0 110.531 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.85 109.67 22.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.714 -0.616 . . . . 0.0 109.637 167.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.44 126.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.01 108.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.14 113.78 27.54 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.179 0.992 . . . . 0.0 110.532 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -106.57 80.53 1.48 Allowed 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 123.845 0.858 . . . . 0.0 109.446 168.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.0 2.68 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 121.316 -0.865 . . . . 0.0 114.47 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.1 -25.63 22.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 164.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -74.43 118.03 16.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.909 1.686 . . . . 0.0 111.323 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.9 ttp -138.2 131.86 30.96 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.098 0.952 . . . . 0.0 111.902 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.53 103.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -93.04 112.12 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.18 98.79 8.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.7 m -86.07 98.91 11.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.694 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.5 mt -102.34 115.18 30.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.498 0.666 . . . . 0.0 110.884 -165.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.0 t -128.98 146.78 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.475 0.71 . . . . 0.0 109.922 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 t -64.05 -15.36 59.31 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.23 -48.69 13.74 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -159.77 132.76 6.8 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.393 0.997 . . . . 0.0 111.041 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.78 124.4 46.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.564 -0.71 . . . . 0.0 110.413 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -112.44 117.1 31.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mm -113.53 119.12 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -171.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 83.0 mtp -105.7 109.1 20.94 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.292 0.637 . . . . 0.0 109.33 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -109.8 108.94 19.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -153.58 160.06 42.34 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -99.34 129.23 45.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 111.322 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.41 124.56 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.17 5.57 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -163.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -96.64 144.86 26.29 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.743 1.271 . . . . 0.0 112.876 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.26 113.0 21.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 0.0 110.673 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -121.42 149.48 42.95 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.664 0.786 . . . . 0.0 112.671 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.48 97.23 2.53 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 112.974 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.15 103.3 16.0 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.414 -0.804 . . . . 0.0 110.373 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -85.22 104.09 14.77 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.007 0.432 . . . . 0.0 110.48 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mp -83.96 53.32 2.54 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.863 0.839 . . . . 0.0 112.848 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -86.99 138.54 31.42 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.77 -31.93 6.19 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -153.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mt -92.81 -71.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.525 1.13 . . . . 0.0 108.324 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -126.58 -17.3 5.09 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.279 11.1 t70 62.35 73.09 0.48 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 120.246 1.385 . . . . 0.0 112.57 -158.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -133.42 131.76 40.35 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.15 0.58 . . . . 0.0 110.224 172.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -102.66 102.05 12.22 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.768 0.827 . . . . 0.0 109.771 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.53 124.52 51.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.044 0.538 . . . . 0.0 111.576 -172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.69 99.2 2.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.001 0.905 . . . . 0.0 109.667 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -113.2 120.39 41.08 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.06 -158.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.8 m -98.28 121.16 39.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -106.66 128.23 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -145.79 156.8 43.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.646 -1.284 . . . . 0.0 112.899 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -85.23 118.28 24.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.976 -1.078 . . . . 0.0 112.352 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -91.88 77.82 5.43 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 161.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -107.28 1.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -73.34 -30.44 63.34 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 169.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -90.25 132.58 35.44 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 120.527 1.512 . . . . 0.0 111.97 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.1 tp -89.79 106.39 18.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.709 -0.619 . . . . 0.0 110.03 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -112.76 130.95 55.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.6 0.714 . . . . 0.0 111.089 -168.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.6 t -126.93 134.16 50.48 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.706 0.802 . . . . 0.0 113.058 -170.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.92 121.05 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.441 0.696 . . . . 0.0 109.704 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -100.35 97.07 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.526 0.73 . . . . 0.0 109.883 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.02 114.64 27.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 111.362 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.29 -112.16 0.36 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 120.919 -1.113 . . . . 0.0 114.027 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -80.09 -11.37 59.77 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -123.0 148.46 45.48 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 119.537 1.062 . . . . 0.0 111.869 -170.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.57 133.86 37.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.69 43.68 59.87 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 119.588 2.595 . . . . 0.0 119.588 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -94.89 135.05 36.86 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 117.79 0.795 . . . . 0.0 111.783 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.96 -167.56 36.18 Favored Glycine 0 N--CA 1.481 1.65 0 CA-C-O 122.126 0.848 . . . . 0.0 114.706 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -156.0 153.27 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -126.7 124.74 40.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -123.64 135.68 54.06 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.536 0.734 . . . . 0.0 111.74 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -150.15 169.14 21.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.68 128.2 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.63 93.83 4.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 162.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.99 -114.6 4.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 121.221 -0.925 . . . . 0.0 114.986 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -96.03 23.56 6.33 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 163.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.4 128.63 53.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.936 1.243 . . . . 0.0 111.118 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.83 126.39 35.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.227 1.011 . . . . 0.0 109.812 168.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.68 122.77 43.31 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.09 120.26 28.49 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.574 0.749 . . . . 0.0 110.267 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -100.03 125.5 46.1 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.114 0.566 . . . . 0.0 109.727 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 11.5 mtp -119.66 120.78 37.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.435 0.694 . . . . 0.0 110.308 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -109.09 135.89 49.5 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.46 117.71 10.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.605 0.762 . . . . 0.0 109.05 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.292 11.5 mt-10 54.63 47.84 21.7 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.15 -31.02 1.83 Allowed Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.799 2.68 . . . . 0.0 119.799 -166.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 50.9 t -79.68 122.23 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 119.239 1.519 . . . . 0.0 111.296 -164.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.2 m -94.36 126.98 39.96 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.363 0.665 . . . . 0.0 111.483 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.8 t -100.18 129.8 46.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.405 0.682 . . . . 0.0 110.83 162.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -103.63 110.57 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.194 0.598 . . . . 0.0 110.562 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -108.88 120.67 43.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.514 0.725 . . . . 0.0 109.511 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.82 130.42 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -133.27 150.11 51.93 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.441 0.696 . . . . 0.0 111.3 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -115.49 133.79 55.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.345 -1.472 . . . . 0.0 112.153 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -69.74 123.02 20.34 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.65 -37.45 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.565 1.529 0 CA-C-N 120.051 1.296 . . . . 0.0 108.264 169.53 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 CA--C 1.573 1.838 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.92 165.38 32.48 Favored 'Trans proline' 0 CA--C 1.568 2.21 0 C-N-CA 122.529 2.153 . . . . 0.0 115.132 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.8 m -54.45 138.84 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -160.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.45 93.26 4.72 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -75.96 -2.06 28.61 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 169.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -60.71 109.18 0.97 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.009 1.731 . . . . 0.0 113.956 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.42 179.67 34.4 Favored Glycine 0 N--CA 1.486 1.967 0 CA-C-O 122.907 1.282 . . . . 0.0 115.801 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -109.51 109.53 20.36 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.422 1.089 . . . . 0.0 109.118 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -110.88 111.79 23.18 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 137.62 32.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 0.0 112.728 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 ttp -68.5 118.67 11.85 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -172.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.6 mt -79.58 -45.05 19.92 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -153.68 160.26 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.618 -1.301 . . . . 0.0 113.13 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -141.64 117.61 10.55 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.014 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.67 122.97 39.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.469 0.708 . . . . 0.0 110.213 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.8 t30 66.72 36.85 4.48 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -80.3 -42.43 23.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.607 -1.308 . . . . 0.0 114.505 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.34 -39.96 80.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.74 -42.09 78.08 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 121.039 1.745 . . . . 0.0 114.809 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -55.88 -46.9 78.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 168.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -68.45 -37.23 80.02 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -57.72 -44.36 85.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.315 -1.491 . . . . 0.0 114.903 162.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -16.9 47.72 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 118.205 2.669 . . . . 0.0 118.205 166.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.82 2.19 56.89 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 38.7 t70 64.92 58.57 0.93 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.232 1.413 . . . . 0.0 114.022 -170.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -111.12 140.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-O 121.48 0.657 . . . . 0.0 109.84 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -65.54 150.45 48.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.15 -45.38 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.65 72.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.18 -41.59 97.07 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -56.99 -47.85 79.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.99 -56.04 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.915 0.78 . . . . 0.0 111.741 171.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.56 77.07 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -68.71 -33.68 74.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 167.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.72 -26.2 60.58 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.23 146.84 48.76 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.128 1.331 . . . . 0.0 114.147 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -104.44 89.87 2.92 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 118.211 -0.899 . . . . 0.0 109.899 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.29 150.4 47.07 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 122.404 2.069 . . . . 0.0 114.731 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -114.75 117.08 29.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -85.3 107.28 17.24 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.591 -0.693 . . . . 0.0 110.866 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.69 108.29 19.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.516 -0.74 . . . . 0.0 109.219 167.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.77 136.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.58 110.98 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -95.37 108.16 20.34 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.337 0.655 . . . . 0.0 109.929 170.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.31 76.14 1.68 Allowed 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 121.558 0.694 . . . . 0.0 109.661 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 -103.79 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.34 -0.85 . . . . 0.0 114.766 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.97 -22.6 21.86 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 162.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -75.67 114.2 13.99 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 120.642 1.564 . . . . 0.0 111.557 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 tpp -120.0 132.49 55.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.843 0.457 . . . . 0.0 111.468 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.99 101.39 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.0 mt -96.8 110.37 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -105.07 97.58 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.8 m -83.02 99.48 9.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.7 mt -98.87 116.42 31.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.824 -0.547 . . . . 0.0 110.69 -166.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.5 t -137.86 152.55 49.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.602 0.761 . . . . 0.0 110.637 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -74.44 -49.31 22.9 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -153.53 135.75 14.87 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.569 1.077 . . . . 0.0 111.657 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -89.79 120.36 30.97 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -113.5 106.02 14.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.645 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.24 127.39 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.479 0.712 . . . . 0.0 109.317 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.9 mtp -109.15 110.69 21.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.838 0.855 . . . . 0.0 109.352 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -112.99 117.34 31.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.451 0.7 . . . . 0.0 109.84 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -156.95 155.92 32.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -96.27 125.23 40.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 111.148 165.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.53 124.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.547 0.739 . . . . 0.0 109.532 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.05 -41.78 2.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -157.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -92.97 142.39 27.35 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.878 0.871 . . . . 0.0 113.169 -170.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -87.66 124.13 33.22 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.862 -0.524 . . . . 0.0 110.976 166.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -132.76 152.42 51.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.826 0.85 . . . . 0.0 111.554 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.75 105.28 5.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.425 -1.422 . . . . 0.0 112.317 169.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -92.24 114.06 26.5 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.416 ' HD2' ' NZ ' ' A' ' 81' ' ' LYS . 6.7 t0 -77.39 121.3 23.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 159.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.86 63.32 7.36 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.197 0.998 . . . . 0.0 111.653 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -79.45 118.77 21.63 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.723 0.809 . . . . 0.0 111.166 -168.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.24 -48.43 0.94 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 -159.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -80.37 -85.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -171.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.08 8.26 13.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 55.94 46.27 22.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.41 140.99 52.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.784 . . . . 0.0 111.268 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' NZ ' ' HD2' ' A' ' 73' ' ' ASP . 66.4 mttm -86.95 111.33 20.73 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.266 173.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.83 135.41 45.43 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.291 0.637 . . . . 0.0 111.285 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mmt -77.58 99.46 5.75 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.225 1.012 . . . . 0.0 109.614 165.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.6 m -104.28 122.55 45.64 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.657 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.6 m -103.78 126.57 51.0 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 166.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.6 t -111.34 128.75 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -134.14 149.93 51.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.063 0.945 . . . . 0.0 111.925 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -85.11 128.9 34.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.647 -1.283 . . . . 0.0 114.294 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -122.09 68.98 0.94 Allowed 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 123.964 0.905 . . . . 0.0 109.953 164.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.18 -103.48 1.01 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.25 -30.18 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -90.35 116.45 28.32 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 119.255 0.934 . . . . 0.0 110.907 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -89.26 109.68 20.54 Favored 'General case' 0 CA--C 1.562 1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.201 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -95.31 140.35 30.33 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.219 1.008 . . . . 0.0 111.595 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 51.8 t -137.73 133.88 34.66 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.12 128.83 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.636 0.774 . . . . 0.0 109.526 168.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -107.12 103.47 12.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.812 0.845 . . . . 0.0 110.102 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -86.71 113.07 22.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 111.48 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.11 -129.79 1.21 Allowed Glycine 0 N--CA 1.487 2.058 0 O-C-N 121.652 -0.655 . . . . 0.0 113.789 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.0 -22.18 45.9 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -170.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -105.66 142.08 36.0 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.481 1.491 . . . . 0.0 111.593 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -86.82 141.71 28.62 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.2 50.71 60.72 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -170.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -109.38 125.08 52.01 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.544 0.738 . . . . 0.0 110.344 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.61 35.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.4 159.35 37.3 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.377 1.085 . . . . 0.0 113.348 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.5 m -133.33 125.13 28.54 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -121.12 136.1 55.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.906 -0.496 . . . . 0.0 111.677 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -146.65 156.37 43.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.912 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.35 126.69 47.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -111.64 94.22 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 158.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.83 -110.44 3.16 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.163 -0.961 . . . . 0.0 115.236 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -95.74 7.61 45.81 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 164.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -110.96 127.15 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.23 1.377 . . . . 0.0 111.834 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 tp -85.29 115.87 23.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.168 0.987 . . . . 0.0 109.39 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.19 120.02 39.62 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 tp -117.32 120.75 39.17 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.835 0.854 . . . . 0.0 110.425 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -97.09 123.5 40.86 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 162.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.7 mtm -112.88 126.65 55.68 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.519 0.6 . . . . 0.0 109.763 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -121.82 137.19 54.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.542 -0.724 . . . . 0.0 112.364 -167.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.4 126.8 5.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.12 0.568 . . . . 0.0 110.922 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 57.25 40.93 27.53 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.28 -13.34 2.79 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 120.261 2.864 . . . . 0.0 120.261 -163.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.75 122.08 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 119.701 1.75 . . . . 0.0 109.174 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -102.9 126.47 50.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 122.949 0.5 . . . . 0.0 111.074 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.6 t -95.77 131.57 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.269 0.628 . . . . 0.0 111.131 162.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -112.69 112.35 23.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.062 0.545 . . . . 0.0 110.092 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -115.32 144.81 43.19 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.44 0.696 . . . . 0.0 111.847 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.0 t -123.62 127.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.61 131.63 46.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.59 0.756 . . . . 0.0 110.43 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -104.32 131.66 51.42 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.546 -1.346 . . . . 0.0 112.031 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -68.99 113.52 6.45 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.71 -31.17 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 170.871 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 51.8 mtm . . . . . 0 CA--C 1.569 1.688 0 CA-C-O 115.597 -2.144 . . . . 0.0 112.616 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.29 113.66 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 125.397 2.963 . . . . 0.0 115.33 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.59 144.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.062 0.934 . . . . 0.0 111.877 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -76.92 106.95 8.92 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.492 -0.755 . . . . 0.0 111.793 170.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.9 3.25 42.7 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -59.73 120.54 9.72 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.076 1.762 . . . . 0.0 114.793 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 174.12 28.2 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 122.847 1.248 . . . . 0.0 115.446 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -107.71 111.52 23.76 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.108 0.963 . . . . 0.0 108.573 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -114.28 111.85 22.17 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -90.66 139.8 30.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.057 -1.027 . . . . 0.0 113.189 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.433 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 36.7 ttp -72.94 125.6 27.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.441 -1.412 . . . . 0.0 114.17 -171.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.06 -50.3 7.14 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 169.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.3 p -136.79 149.28 47.69 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 119.369 0.986 . . . . 0.0 113.459 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -128.21 103.73 7.35 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.42 -60.8 1.87 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.24 43.31 3.15 Favored 'General case' 0 CA--C 1.572 1.826 0 C-N-CA 123.868 0.867 . . . . 0.0 110.575 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -76.65 -45.66 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.79 -47.95 70.3 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 166.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.59 -37.22 86.82 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.38 -43.75 83.88 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 120.85 1.659 . . . . 0.0 115.149 162.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.83 -38.14 85.85 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 172.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -55.93 -43.23 77.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 162.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.22 62.28 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.56 12.48 29.43 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 164.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.264 28.0 t70 56.92 47.9 16.88 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 120.602 1.546 . . . . 0.0 115.036 -174.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -93.35 155.57 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.448 -0.783 . . . . 0.0 110.722 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 151.13 47.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.45 -43.87 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.73 62.75 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 33.8 tp -61.35 -39.34 90.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -54.1 -39.01 65.99 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -71.57 -50.56 29.84 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.68 -54.56 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 123.906 0.883 . . . . 0.0 112.468 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.71 75.61 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.91 -39.89 91.0 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 165.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.78 -24.01 62.51 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.04 148.04 51.54 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.45 1.477 . . . . 0.0 113.72 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -107.67 86.54 2.95 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.03 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 53.5 Cg_endo -72.69 154.82 54.51 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 115.934 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -118.81 111.42 18.42 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -83.53 107.19 15.84 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.59 -0.694 . . . . 0.0 110.708 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.54 107.95 19.91 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.84 125.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -110.89 105.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.0 105.96 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.269 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.2 77.85 5.22 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.68 0.792 . . . . 0.0 109.922 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.29 -97.12 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 O-C-N 121.416 -0.803 . . . . 0.0 114.793 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.47 -17.51 20.49 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 164.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.99 114.11 21.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.789 1.631 . . . . 0.0 111.264 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.7 ttm -121.04 124.13 44.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.568 0.747 . . . . 0.0 111.225 -167.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.6 mt -114.08 96.79 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.6 mt -90.17 112.29 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -106.48 97.79 7.55 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 m -82.77 94.44 7.63 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.0 109.338 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -90.81 131.75 36.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.121 0.568 . . . . 0.0 111.687 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -150.88 155.9 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.097 0.951 . . . . 0.0 111.909 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.8 p -61.13 -32.57 72.26 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -78.1 -55.11 5.54 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -155.57 139.95 16.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.959 0.799 . . . . 0.0 110.238 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -88.82 125.11 34.76 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.051 0.54 . . . . 0.0 110.826 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -104.21 118.03 35.65 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.109 0.868 . . . . 0.0 110.584 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.11 120.7 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.8 mtp -108.84 111.54 23.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.258 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.09 108.44 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.408 0.683 . . . . 0.0 109.272 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -152.48 155.02 36.67 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -167.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.35 134.73 40.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.817 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.44 123.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.78 5.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -154.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -95.18 135.39 36.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.389 1.095 . . . . 0.0 112.772 -161.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -85.66 107.08 17.39 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 122.033 -0.417 . . . . 0.0 110.15 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -116.85 157.83 24.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.81 0.844 . . . . 0.0 112.33 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.63 104.46 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.672 -1.268 . . . . 0.0 112.167 169.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -90.75 107.09 18.95 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 121.39 -0.818 . . . . 0.0 108.959 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.47 ' HD2' ' NZ ' ' A' ' 81' ' ' LYS . 9.5 t0 -82.7 120.29 25.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 164.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mp -90.9 49.97 1.73 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -74.17 132.96 42.7 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.218 1.007 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 -50.17 1.03 Allowed Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.571 -0.705 . . . . 0.0 114.576 -158.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 mt -79.35 -66.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 125.002 1.321 . . . . 0.0 111.067 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -143.99 -6.54 0.76 Allowed 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.877 1.671 . . . . 0.0 114.175 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.287 3.3 t70 52.03 45.56 28.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -127.01 141.08 51.88 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.574 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.47 ' NZ ' ' HD2' ' A' ' 73' ' ' ASP . 66.2 mttm -84.23 127.36 33.9 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.707 0.765 . . . . 0.0 112.564 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.6 m -113.51 141.29 47.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.578 0.751 . . . . 0.0 111.076 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.29 98.35 4.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 159.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.423 HG23 ' SG ' ' A' ' 95' ' ' CYS . 89.9 m -99.66 121.53 41.36 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.0 m -109.33 120.42 42.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 t -110.64 124.99 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.0 m -134.63 158.52 43.83 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 112.565 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -88.06 113.67 23.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 112.093 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.35 77.15 3.4 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.933 0.873 . . . . 0.0 109.256 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.07 -105.67 1.27 Allowed Glycine 0 CA--C 1.547 2.048 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.959 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -86.36 -26.35 24.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -83.18 134.24 34.99 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.611 1.55 . . . . 0.0 112.268 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.66 100.71 13.51 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.734 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -108.24 140.34 41.62 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.677 0.791 . . . . 0.0 111.482 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.423 ' SG ' HG23 ' A' ' 84' ' ' THR . 50.2 t -134.19 141.44 47.05 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -170.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -114.17 128.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.783 0.833 . . . . 0.0 109.84 166.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -101.88 103.86 14.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.499 0.72 . . . . 0.0 109.264 173.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -89.14 99.75 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.187 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.16 94.4 0.09 OUTLIER Glycine 0 N--CA 1.488 2.114 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 -169.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.296 40.0 mt-10 73.19 -51.07 0.71 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 161.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -99.27 144.77 28.01 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.622 0.769 . . . . 0.0 111.306 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.77 162.48 21.7 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.69 51.97 48.93 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -121.19 122.27 39.6 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.533 0.682 . . . . 0.0 111.926 -159.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.93 -162.83 34.44 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 121.447 -0.783 . . . . 0.0 114.064 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.268 67.3 p-90 -156.79 168.32 27.8 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 123.215 1.484 . . . . 0.0 113.115 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -146.86 130.57 16.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.975 -1.703 . . . . 0.0 108.599 168.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -127.53 142.48 51.37 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.282 1.039 . . . . 0.0 112.255 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -146.59 167.48 23.63 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.9 mt -114.62 126.7 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.284 -0.885 . . . . 0.0 109.176 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.35 89.85 3.24 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 163.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.67 -110.47 3.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -99.32 17.12 20.88 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HE2' ' NZ ' ' A' ' 131' ' ' LYS . 85.4 mt-10 -110.55 126.21 54.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.496 1.044 . . . . 0.0 111.593 174.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.4 tp -86.43 122.39 30.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.801 0.84 . . . . 0.0 109.683 166.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -111.15 119.49 39.15 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.0 tp -118.17 128.63 54.9 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.717 0.807 . . . . 0.0 110.54 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -108.53 119.34 39.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.619 0.767 . . . . 0.0 109.547 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.2 mtm -112.92 129.87 56.32 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.487 0.715 . . . . 0.0 111.312 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -123.61 132.78 53.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 111.901 -167.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.27 129.79 14.91 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.779 0.831 . . . . 0.0 109.305 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 55.57 36.08 26.45 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.07 -3.83 27.43 Favored Glycine 0 CA--C 1.557 2.684 0 N-CA-C 119.878 2.711 . . . . 0.0 119.878 -164.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.92 113.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 120.071 1.935 . . . . 0.0 109.091 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.0 m -93.37 119.39 32.44 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -173.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.8 t -90.81 125.96 35.87 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.385 0.674 . . . . 0.0 112.067 164.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -98.4 122.84 42.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.791 0.436 . . . . 0.0 110.33 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -117.82 139.85 50.51 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.315 0.646 . . . . 0.0 110.664 168.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.0 130.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -128.82 136.42 50.46 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 123.299 0.64 . . . . 0.0 111.411 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.574 ' NZ ' ' HE2' ' A' ' 114' ' ' GLU . 3.2 tpmt? -96.09 127.32 42.0 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.649 1.179 . . . . 0.0 111.501 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -68.55 119.82 13.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.185 0.902 . . . . 0.0 112.777 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.22 -38.5 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 CA--C 1.561 1.389 0 CA-C-N 119.78 1.173 . . . . 0.0 107.909 169.542 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.572 1.802 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.53 -82.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 125.077 2.849 . . . . 0.0 113.114 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.15 -27.69 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 121.395 -0.816 . . . . 0.0 112.37 157.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.343 15.3 t70 68.46 90.06 0.1 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.366 1.466 . . . . 0.0 112.66 -167.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.41 15.62 1.22 Allowed 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -59.19 117.32 4.61 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.48 176.08 30.12 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-O 122.6 1.111 . . . . 0.0 115.865 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -106.94 113.86 27.6 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.442 1.097 . . . . 0.0 109.034 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -117.56 112.99 21.32 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -92.67 140.64 29.32 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.843 -1.161 . . . . 0.0 113.397 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.403 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 34.5 ttp -70.4 117.37 11.85 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-N 119.726 1.148 . . . . 0.0 114.0 -173.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.14 -46.88 21.98 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 167.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.2 m -153.75 160.49 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.811 1.291 . . . . 0.0 112.704 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -150.33 112.75 4.68 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.773 -174.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HE2' ' NZ ' ' A' ' 127' ' ' LYS . 33.1 tt0 -94.3 -69.74 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -117.19 42.22 2.59 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -73.44 -36.01 65.86 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -59.85 -39.56 85.6 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.79 -40.28 83.95 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 167.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.35 -47.81 82.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.25 -39.37 75.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -54.4 -43.43 71.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 162.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.85 51.7 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 165.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.16 2.2 47.74 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.297 20.2 t70 63.64 49.34 3.04 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -167.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.83 146.41 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.162 0.982 . . . . 0.0 110.13 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -65.89 153.63 41.47 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.3 t -59.72 -44.74 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.45 -49.55 74.26 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.76 -43.25 98.23 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -52.46 -50.84 61.84 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 165.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.98 -45.14 93.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.27 -54.43 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 118.945 0.793 . . . . 0.0 111.6 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.51 -29.92 65.35 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.29 -26.8 56.26 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.6 144.37 57.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.367 1.439 . . . . 0.0 113.563 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -107.73 84.62 2.05 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.847 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 71.2 Cg_endo -74.02 156.5 47.46 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.579 2.186 . . . . 0.0 115.171 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.42 118.83 33.78 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' NZ ' ' HO1' ' A' ' 175' ' ' RTL . 60.3 mttt -84.81 108.14 17.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.36 -0.837 . . . . 0.0 110.661 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -96.22 107.66 20.03 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.1 128.13 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.51 107.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -100.04 118.7 36.98 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.356 0.663 . . . . 0.0 110.708 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.41 81.83 1.58 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 -104.19 1.16 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -82.3 -27.36 32.35 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -79.12 116.13 19.21 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.196 1.362 . . . . 0.0 111.943 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -124.28 127.13 47.2 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 121.506 0.67 . . . . 0.0 110.971 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.05 99.26 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.3 mt -91.24 107.03 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -100.95 99.91 10.45 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -88.0 99.41 12.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.08 129.07 48.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.066 0.546 . . . . 0.0 111.848 -162.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -148.18 145.92 28.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.58 0.705 . . . . 0.0 110.379 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.5 p -60.78 -26.03 66.96 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -73.31 -50.63 21.1 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 165.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -159.74 133.44 7.21 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.624 1.102 . . . . 0.0 111.268 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -97.91 139.73 33.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.64 . . . . 0.0 111.395 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -123.77 119.99 31.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -0.779 . . . . 0.0 110.251 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -113.35 122.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.3 mtp -109.48 106.17 15.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.717 -0.614 . . . . 0.0 109.793 175.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -107.76 112.28 24.87 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.516 0.726 . . . . 0.0 109.738 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.24 155.84 31.51 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -95.67 130.84 42.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 111.054 164.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 t -69.14 123.53 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 109.933 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.14 -34.41 4.84 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 -161.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -94.56 147.55 23.16 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.815 1.307 . . . . 0.0 113.065 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.59 124.69 35.94 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.787 -0.57 . . . . 0.0 110.865 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -133.53 151.95 51.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.568 0.747 . . . . 0.0 112.568 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.4 110.39 7.65 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.436 1.113 . . . . 0.0 112.324 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -94.04 100.12 12.3 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.224 1.01 . . . . 0.0 109.554 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.26 104.58 8.94 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.447 0.641 . . . . 0.0 110.003 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mt -90.45 45.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -81.86 131.5 35.26 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.198 0.999 . . . . 0.0 110.546 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.2 -34.99 4.48 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.924 1.529 . . . . 0.0 116.924 -159.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 mt -86.36 -67.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 124.439 1.096 . . . . 0.0 109.553 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -136.59 -7.35 1.94 Allowed 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.257 26.8 t0 57.4 64.69 1.53 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 120.304 1.411 . . . . 0.0 114.666 -166.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -136.82 144.12 43.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.6 -0.688 . . . . 0.0 111.057 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -97.6 112.02 24.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 111.066 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -110.31 146.55 35.53 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.41 0.684 . . . . 0.0 111.701 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.8 mmt -82.09 97.6 8.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.161 -1.587 . . . . 0.0 110.229 171.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.436 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 36.1 m -91.91 126.29 36.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 111.634 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 m -107.39 125.96 51.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 162.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.82 127.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -129.29 159.08 37.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.029 0.931 . . . . 0.0 111.829 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -88.74 126.15 35.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.603 -1.311 . . . . 0.0 112.278 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -102.05 74.19 1.43 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 158.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.44 -98.72 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 -173.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.31 -35.33 61.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -87.63 129.89 34.97 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.111 0.869 . . . . 0.0 111.776 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.6 tp -88.58 107.56 18.97 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 123.286 0.634 . . . . 0.0 109.761 173.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -114.08 132.4 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.583 0.753 . . . . 0.0 111.527 -167.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.436 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 40.6 t -131.65 138.42 48.75 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.38 124.77 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.444 167.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -101.06 97.26 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 0.0 109.544 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -85.2 115.82 23.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 112.01 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.59 0.3 Allowed Glycine 0 N--CA 1.483 1.833 0 O-C-N 121.396 -0.815 . . . . 0.0 113.663 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -87.67 -7.89 56.85 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -166.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -126.38 143.7 51.08 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.458 1.481 . . . . 0.0 112.081 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -85.67 113.63 22.02 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.424 0.63 . . . . 0.0 112.523 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.93 56.68 6.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -101.54 130.68 47.88 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.413 0.625 . . . . 0.0 111.243 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.15 -170.21 40.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -155.62 153.45 30.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.2 m -127.83 121.05 29.13 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -119.65 123.42 43.79 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.599 0.759 . . . . 0.0 110.67 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -142.86 153.29 43.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 113.194 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -100.64 126.12 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.0 109.227 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.57 92.83 3.99 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.99 -115.13 4.82 Favored Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.637 -0.664 . . . . 0.0 114.473 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 p30 -94.58 8.05 43.57 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 164.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.18 126.71 53.55 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.598 1.545 . . . . 0.0 111.141 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.41 113.57 25.51 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.32 1.048 . . . . 0.0 109.226 169.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -99.46 125.48 45.21 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 109.531 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.513 HD21 ' HZ3' ' A' ' 40' ' ' LYS . 31.6 tp -122.47 120.5 34.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.696 0.798 . . . . 0.0 110.267 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.05 130.33 47.05 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.936 165.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -125.02 129.26 49.94 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.68 1.127 . . . . 0.0 111.111 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.21 144.36 45.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.483 -0.76 . . . . 0.0 112.715 -171.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.73 127.89 4.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.539 0.736 . . . . 0.0 110.162 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 52.57 50.28 18.55 Favored 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.89 -20.29 1.88 Allowed Glycine 0 CA--C 1.557 2.671 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.7 t -67.84 172.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 CA-C-N 120.146 1.973 . . . . 0.0 112.993 -169.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.5 m -144.28 115.3 7.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 119.31 -2.119 . . . . 0.0 109.83 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -93.84 121.92 35.79 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.752 0.821 . . . . 0.0 111.381 166.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.479 ' NZ ' ' HE2' ' A' ' 14' ' ' GLU . 28.4 mtmt -98.11 123.99 42.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.822 0.449 . . . . 0.0 111.433 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -122.0 139.19 53.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.937 0.895 . . . . 0.0 110.499 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 36.2 t -120.26 126.77 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -127.58 122.33 32.93 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.56 0.744 . . . . 0.0 110.575 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -98.19 135.24 40.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.471 -1.393 . . . . 0.0 112.872 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -69.11 121.79 17.44 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.33 -35.78 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 120.057 1.299 . . . . 0.0 108.232 169.885 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' RTL . . . . . 0.67 ' HO1' ' NZ ' ' A' ' 40' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.6 t0 . . . . . 0 CA--C 1.565 1.529 0 CA-C-O 121.397 0.618 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.76 -0.45 23.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -58.25 104.94 0.24 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 121.293 1.86 . . . . 0.0 114.767 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.39 -179.03 36.17 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-O 123.117 1.398 . . . . 0.0 115.938 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -113.38 116.19 29.28 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 113.651 -1.274 . . . . 0.0 109.399 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -117.19 113.36 22.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -167.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -90.37 140.19 29.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.104 -0.997 . . . . 0.0 113.337 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.6 ttm -67.2 122.03 16.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.17 -45.72 13.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 166.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.7 m -152.71 159.6 43.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.418 -1.426 . . . . 0.0 113.871 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -134.43 113.13 11.53 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.594 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -122.01 123.68 42.2 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.331 0.653 . . . . 0.0 110.492 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.276 37.7 t30 68.06 30.47 5.89 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -79.25 -40.57 30.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.159 -1.588 . . . . 0.0 115.179 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -55.03 -42.2 72.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.11 -42.08 89.71 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -55.94 -48.06 76.41 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.75 -39.88 80.09 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -54.9 -44.05 73.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.69 -23.76 60.08 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.3 3.65 38.67 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.288 17.5 t0 61.27 48.33 6.26 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -169.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.29 147.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.001 0.905 . . . . 0.0 110.329 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -63.06 152.76 36.13 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.3 t -60.63 -43.75 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.84 -52.71 61.91 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -62.82 -36.96 84.91 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -54.04 -50.27 67.07 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 163.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -66.58 -44.92 80.95 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.07 -57.5 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.204 0.911 . . . . 0.0 111.928 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.23 70.98 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -71.15 -35.08 71.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.68 -32.55 73.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.5 mt -73.92 128.15 34.75 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 119.373 0.988 . . . . 0.0 112.331 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -102.64 94.36 5.05 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.942 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.64 161.14 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.294 1.996 . . . . 0.0 115.683 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -104.16 124.41 49.05 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.629 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -88.24 109.34 19.85 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.234 -0.916 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.67 112.18 23.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.91 163.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.97 128.8 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.29 112.72 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.44 1.096 . . . . 0.0 110.52 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -127.34 76.03 1.63 Allowed 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.483 -0.76 . . . . 0.0 110.143 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -102.32 1.21 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.436 -0.79 . . . . 0.0 114.214 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.83 -26.35 20.57 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 162.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -70.56 134.31 47.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.333 1.879 . . . . 0.0 112.768 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 ttm -145.5 130.73 18.51 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.43 0.633 . . . . 0.0 112.074 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.15 108.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.16 110.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -100.98 106.31 17.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.65 -0.656 . . . . 0.0 109.822 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.1 m -88.97 99.45 12.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.49 125.86 41.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.107 0.563 . . . . 0.0 111.525 -163.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -147.31 155.39 41.98 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.097 0.951 . . . . 0.0 111.739 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -62.83 -32.86 74.15 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -75.46 -54.02 7.73 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -152.12 134.01 14.88 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.839 0.745 . . . . 0.0 110.383 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -92.77 122.42 35.14 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.13 0.572 . . . . 0.0 109.821 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -109.55 106.61 16.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.305 0.642 . . . . 0.0 110.499 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.1 mp -105.08 124.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.2 mtp -108.42 110.28 21.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.768 0.827 . . . . 0.0 109.498 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -107.52 118.17 36.01 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.338 0.655 . . . . 0.0 109.775 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.34 155.2 33.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -96.38 129.27 43.76 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.809 0.814 . . . . 0.0 110.713 159.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.96 128.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 C-N-CA 123.995 0.918 . . . . 0.0 109.686 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.13 -47.41 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 115.779 1.071 . . . . 0.0 115.779 -156.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -83.92 135.85 34.32 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.35 105.87 16.32 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.709 0.403 . . . . 0.0 110.36 169.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -113.49 157.14 22.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.864 0.84 . . . . 0.0 113.06 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.21 101.58 5.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 112.349 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -102.41 104.69 15.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.496 -0.752 . . . . 0.0 110.332 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -81.8 113.98 20.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.34 66.3 5.79 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.553 1.168 . . . . 0.0 112.101 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -75.71 117.64 17.68 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.387 1.075 . . . . 0.0 111.25 -168.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.56 -52.62 0.62 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -162.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.02 -68.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 124.733 1.213 . . . . 0.0 110.178 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -130.89 -6.09 3.99 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.285 17.3 t0 51.57 45.31 28.26 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -166.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -108.38 139.11 43.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 110.582 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -81.6 116.12 21.2 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 112.01 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.5 m -108.5 142.0 39.55 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.683 0.793 . . . . 0.0 111.293 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.01 94.73 7.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.132 168.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -99.82 123.55 44.19 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.576 -0.702 . . . . 0.0 110.621 -164.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 m -112.59 122.01 46.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.65 132.72 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -126.76 146.78 50.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.921 0.888 . . . . 0.0 111.685 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.3 m95 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 111.961 175.52 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.888 0.851 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.0 111.23 22.6 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -115.47 123.79 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.125 0.57 . . . . 0.0 110.614 -162.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.72 136.69 54.95 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.43 128.23 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.401 0.68 . . . . 0.0 109.543 165.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -104.34 101.68 11.38 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.549 0.74 . . . . 0.0 109.169 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -85.48 115.57 23.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.863 -1.148 . . . . 0.0 111.596 -170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.57 -120.37 0.63 Allowed Glycine 0 N--CA 1.485 1.915 0 O-C-N 121.905 -0.497 . . . . 0.0 113.516 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.4 -21.52 33.0 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -108.85 144.78 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.654 1.57 . . . . 0.0 113.033 -166.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.55 115.6 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.34 0.59 . . . . 0.0 112.179 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.46 45.47 78.11 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -85.05 124.35 31.63 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.388 0.613 . . . . 0.0 111.329 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.19 -169.14 41.3 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.248 0.916 . . . . 0.0 114.817 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -157.77 153.25 26.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.983 0.897 . . . . 0.0 113.211 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -129.26 125.33 36.62 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.263 3.3 pt20 -126.58 138.64 53.48 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -148.59 159.73 43.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.454 -0.779 . . . . 0.0 113.0 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.8 mt -98.4 125.33 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.32 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -111.53 97.09 6.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 161.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.84 -109.74 2.89 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.46 -0.775 . . . . 0.0 114.15 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -100.46 15.41 28.0 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -113.0 121.22 43.99 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.912 1.687 . . . . 0.0 111.842 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.97 117.02 20.44 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.218 1.007 . . . . 0.0 110.138 167.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -105.68 117.66 34.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.2 tp -113.96 126.83 55.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.027 0.931 . . . . 0.0 110.801 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -106.61 123.53 48.25 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.345 0.658 . . . . 0.0 109.489 164.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -113.21 128.13 56.38 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -115.07 137.0 52.51 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.84 119.98 7.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.548 0.739 . . . . 0.0 110.208 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 55.2 46.92 22.81 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.02 -33.0 0.91 Allowed Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.361 2.504 . . . . 0.0 119.361 -164.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.51 119.93 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.828 1.251 . . . . 0.0 111.209 -166.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.0 m -102.85 115.96 31.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.126 0.571 . . . . 0.0 111.022 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 t -88.8 131.27 35.15 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.056 0.542 . . . . 0.0 111.427 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -113.1 119.66 38.61 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.027 0.531 . . . . 0.0 110.294 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -124.95 133.73 52.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.43 0.692 . . . . 0.0 111.0 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.25 130.39 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.58 128.1 38.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.399 0.68 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -98.94 133.76 42.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.343 -1.473 . . . . 0.0 112.39 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -69.26 122.52 19.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.55 -38.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 N--CA 1.488 1.436 0 CA-C-N 119.927 1.239 . . . . 0.0 107.962 168.516 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.287 6.0 t70 . . . . . 0 CA--C 1.563 1.468 0 CA-C-O 121.524 0.678 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -81.32 13.92 2.69 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -63.38 116.76 5.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.36 173.18 26.44 Favored Glycine 0 N--CA 1.488 2.157 0 CA-C-O 122.697 1.165 . . . . 0.0 115.859 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -101.87 116.83 33.55 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.189 0.995 . . . . 0.0 109.497 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -117.82 110.8 18.23 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -93.34 139.88 30.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.111 -0.993 . . . . 0.0 112.851 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.4 ttp -69.46 125.71 27.54 Favored 'General case' 0 CA--C 1.571 1.772 0 O-C-N 120.419 -1.426 . . . . 0.0 114.68 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.84 -50.92 6.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.5 p -136.36 155.17 50.42 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -143.55 117.65 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.032 0.933 . . . . 0.0 108.947 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.05 -71.38 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -166.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -121.97 41.88 3.27 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.956 0.884 . . . . 0.0 112.108 -171.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.455 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 8.1 t80 -73.57 -39.94 64.29 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -57.22 -43.84 83.22 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.78 -39.05 84.1 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -56.54 -45.93 80.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 167.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 mt -71.38 -37.48 71.6 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -55.09 -46.0 75.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 161.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.0 -20.81 41.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.06 5.68 50.63 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.286 23.8 t70 61.03 50.13 5.25 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.52 1.509 . . . . 0.0 114.87 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -93.38 150.38 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.892 0.854 . . . . 0.0 109.891 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -63.81 152.42 39.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.79 -44.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.28 64.13 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.37 -38.52 89.9 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -53.99 -53.1 57.63 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -62.15 -43.72 98.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.4 mt -64.1 -53.81 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.898 0.879 . . . . 0.0 111.919 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.65 85.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -61.91 -36.67 82.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.58 -20.68 53.62 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.23 156.88 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -96.15 103.17 12.72 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.182 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.49 146.9 19.63 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.696 2.264 . . . . 0.0 112.947 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -134.28 107.7 7.8 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -83.77 107.45 16.19 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.516 -0.74 . . . . 0.0 111.094 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -94.31 106.43 18.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.63 129.24 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.2 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -99.71 109.84 22.28 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.082 0.553 . . . . 0.0 110.209 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -100.39 81.14 2.32 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.439 0.696 . . . . 0.0 109.304 167.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.63 -102.97 1.03 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 115.02 0.768 . . . . 0.0 115.02 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -86.32 -26.83 24.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 164.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -75.2 119.27 19.1 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.417 1.462 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 ttm -122.29 123.44 41.44 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.586 0.707 . . . . 0.0 110.538 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.9 mt -110.69 95.59 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.7 mt -93.1 104.25 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -100.82 99.29 9.78 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -87.09 100.49 12.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.311 -0.868 . . . . 0.0 109.364 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.3 mt -104.49 112.54 25.64 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.674 0.75 . . . . 0.0 110.531 -164.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -131.99 155.08 48.61 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.976 0.893 . . . . 0.0 111.309 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -65.58 -19.23 65.83 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -83.97 -50.76 7.72 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 119.057 0.844 . . . . 0.0 113.065 168.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -153.2 148.22 26.64 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.882 0.848 . . . . 0.0 110.505 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.52 130.44 50.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.885 . . . . 0.0 110.125 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.74 104.59 11.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.79 -0.569 . . . . 0.0 110.765 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.48 128.23 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.603 0.761 . . . . 0.0 109.122 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -113.41 108.1 16.75 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.722 0.809 . . . . 0.0 109.513 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.27 98.13 7.28 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.641 0.776 . . . . 0.0 110.446 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -144.8 155.92 43.76 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -93.11 131.34 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.863 -1.148 . . . . 0.0 111.007 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.1 t -68.37 126.64 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.65 -0.656 . . . . 0.0 110.689 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.14 -30.61 8.14 Favored Glycine 0 CA--C 1.552 2.384 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -91.86 144.8 25.11 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.168 1.484 . . . . 0.0 112.746 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.6 128.08 36.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 111.507 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.01 149.27 51.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.655 0.782 . . . . 0.0 112.36 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -74.15 101.08 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.035 -1.04 . . . . 0.0 111.913 172.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -94.03 116.01 28.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.546 0.738 . . . . 0.0 110.206 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -80.94 127.43 32.56 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.586 0.707 . . . . 0.0 109.72 163.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mt -99.37 60.98 1.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.135 0.969 . . . . 0.0 111.128 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 119.15 23.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.318 1.047 . . . . 0.0 111.712 -166.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.65 -42.4 1.92 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -162.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.21 -69.57 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.107 0.963 . . . . 0.0 110.125 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -141.3 -1.02 1.37 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 166.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 28.2 m-20 63.93 65.26 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 120.22 1.373 . . . . 0.0 113.575 -173.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HE ' ' HZ2' ' A' ' 101' ' ' LYS . 82.9 mmt-85 -122.2 142.34 50.53 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.612 0.765 . . . . 0.0 110.643 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.38 111.12 22.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.529 165.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m -117.7 145.02 44.72 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.45 0.7 . . . . 0.0 112.098 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.0 mtp -83.4 98.99 9.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -98.86 122.56 42.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.076 0.55 . . . . 0.0 110.182 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.0 m -102.68 131.87 49.19 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 95' ' ' CYS . 38.2 t -117.91 122.59 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.1 m -131.01 158.05 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.78 0.832 . . . . 0.0 112.007 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.9 m95 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.69 -1.256 . . . . 0.0 112.214 175.953 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.664 0.745 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.95 103.34 16.01 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.24 0.616 . . . . 0.0 109.511 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -110.74 131.79 54.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.572 0.749 . . . . 0.0 111.269 -167.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 86' ' ' VAL . 50.2 t -130.93 141.86 50.31 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.43 128.1 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.913 0.885 . . . . 0.0 109.302 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -106.22 95.99 6.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.711 0.804 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.76 120.46 27.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 112.128 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.49 -115.55 0.47 Allowed Glycine 0 N--CA 1.486 1.989 0 O-C-N 121.25 -0.906 . . . . 0.0 113.531 171.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.7 -13.5 57.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.428 ' HZ2' ' HE ' ' A' ' 80' ' ' ARG . 21.1 mmtp -114.71 146.4 40.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.294 1.406 . . . . 0.0 112.359 -170.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -90.24 103.27 15.97 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.462 -162.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.42 50.44 21.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -170.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -89.76 137.21 32.53 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.945 0.879 . . . . 0.0 111.933 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.42 -161.17 27.67 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 121.936 0.742 . . . . 0.0 114.257 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -157.42 157.93 34.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.866 . . . . 0.0 112.638 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -132.77 124.74 28.66 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.286 1.3 pt20 -129.43 141.82 50.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.48 161.2 43.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 0.0 112.53 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -103.83 123.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.934 . . . . 0.0 109.15 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.33 85.19 2.21 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 162.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.05 -111.77 4.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.96 -5.95 58.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 165.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.66 127.28 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 120.396 1.453 . . . . 0.0 111.92 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.1 tp -88.41 117.86 27.63 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.847 0.859 . . . . 0.0 109.724 166.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -100.77 121.52 41.82 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.756 0.823 . . . . 0.0 109.277 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -117.53 130.69 56.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.993 0.917 . . . . 0.0 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.77 118.93 34.97 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.733 0.813 . . . . 0.0 109.554 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.4 mtm -110.63 132.04 54.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.497 -0.752 . . . . 0.0 111.265 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -124.35 133.73 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.86 . . . . 0.0 112.169 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.57 126.88 8.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.272 0.629 . . . . 0.0 110.966 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 57.3 36.51 27.38 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.04 -19.94 2.65 Favored Glycine 0 CA--C 1.558 2.753 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 -162.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.79 119.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 119.568 1.684 . . . . 0.0 109.562 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -101.59 121.84 42.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.446 0.641 . . . . 0.0 110.743 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.455 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 7.1 t -97.6 124.82 42.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 169.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -102.31 127.29 49.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.957 -0.465 . . . . 0.0 111.666 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -127.16 142.82 51.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.941 0.896 . . . . 0.0 111.274 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.54 132.52 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.4 132.13 48.51 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.516 0.726 . . . . 0.0 111.235 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -97.2 127.98 43.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.702 -1.249 . . . . 0.0 112.18 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -67.19 122.94 18.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.1 -39.71 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.103 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.257 0.551 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -81.27 4.49 20.29 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -57.83 108.57 0.59 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.725 1.602 . . . . 0.0 115.144 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.89 179.12 33.5 Favored Glycine 0 N--CA 1.486 2.01 0 CA-C-O 122.756 1.198 . . . . 0.0 115.753 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -110.48 118.84 37.34 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.704 1.201 . . . . 0.0 109.151 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -119.15 118.86 32.5 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -88.76 144.89 25.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.943 -1.098 . . . . 0.0 112.905 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.415 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 7.3 ttp -71.83 124.68 25.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.498 -1.376 . . . . 0.0 113.495 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.07 -48.4 7.77 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.9 m -157.27 160.08 38.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.4 . . . . 0.0 112.993 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -142.69 124.5 15.1 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.342 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -126.41 125.08 41.59 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.062 0.945 . . . . 0.0 109.877 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.1 t30 66.1 37.17 5.3 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.557 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 5.7 t80 -79.04 -43.45 24.2 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.27 -34.76 77.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -70.37 -41.43 73.1 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -53.34 -47.31 69.47 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 120.458 1.481 . . . . 0.0 114.842 166.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.89 -38.35 70.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.83 -45.38 78.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.085 -1.635 . . . . 0.0 115.061 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -18.75 43.31 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 166.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.34 -4.54 59.05 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 25.8 t70 67.38 52.97 0.78 Allowed 'General case' 0 CA--C 1.572 1.805 0 CA-C-N 120.154 1.343 . . . . 0.0 113.996 -166.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -102.86 146.43 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.977 0.894 . . . . 0.0 109.685 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.76 152.38 44.45 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -60.28 -44.12 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.88 65.88 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 116.004 1.854 . . . . 0.0 116.004 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.82 -41.7 96.22 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -52.33 -53.21 47.45 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 166.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -63.23 -43.91 96.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.88 -53.65 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.631 0.772 . . . . 0.0 111.869 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.68 81.77 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -68.6 -30.91 69.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.31 -29.52 62.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 166.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.15 131.55 42.94 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.041 1.291 . . . . 0.0 112.723 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -105.63 89.51 3.48 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.482 173.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.4 Cg_endo -72.6 165.38 32.88 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.371 2.047 . . . . 0.0 115.601 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -111.6 120.24 41.42 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -89.92 110.58 21.53 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.438 -0.789 . . . . 0.0 111.004 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -98.53 110.13 22.78 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.713 -0.617 . . . . 0.0 109.802 169.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.44 125.83 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.43 107.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 165.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -102.42 102.09 12.38 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.643 0.777 . . . . 0.0 109.998 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -92.75 79.32 4.75 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 109.963 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.55 -101.79 0.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 114.508 0.563 . . . . 0.0 114.508 -173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.34 -26.62 24.76 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -79.1 106.27 11.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.772 1.624 . . . . 0.0 111.635 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -112.45 124.03 51.6 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.968 0.907 . . . . 0.0 110.722 -172.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.95 96.84 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.93 108.36 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -102.6 98.94 8.92 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.226 0.61 . . . . 0.0 109.38 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -84.14 101.41 11.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.14 127.5 43.16 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.074 0.55 . . . . 0.0 111.692 -166.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 t -150.79 153.48 35.53 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.981 0.896 . . . . 0.0 111.646 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.6 -31.83 72.73 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -73.02 -51.26 18.88 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -155.55 138.36 15.29 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.032 0.833 . . . . 0.0 110.792 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -99.18 116.92 32.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -107.5 107.71 18.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.854 -0.529 . . . . 0.0 111.035 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.51 127.24 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.1 105.55 15.61 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.596 0.758 . . . . 0.0 109.421 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.02 113.48 26.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.611 0.764 . . . . 0.0 109.753 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.83 157.23 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -168.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -97.35 132.15 43.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 111.473 165.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -69.78 122.09 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 123.38 0.672 . . . . 0.0 110.154 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.93 -37.96 3.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 -158.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.87 136.75 32.87 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 118.25 1.025 . . . . 0.0 113.547 -165.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -87.6 117.38 26.37 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.878 0.471 . . . . 0.0 110.93 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -134.24 145.77 49.46 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.378 0.671 . . . . 0.0 112.287 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.04 101.88 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.463 -1.398 . . . . 0.0 112.958 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.4 112.19 24.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.242 0.617 . . . . 0.0 110.444 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.81 114.99 19.15 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.581 0.705 . . . . 0.0 110.775 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.93 55.26 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 112.857 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 t -74.07 133.57 42.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.55 -54.18 1.48 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.707 -0.62 . . . . 0.0 114.116 -158.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.2 mt -71.27 -63.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.667 0.787 . . . . 0.0 111.221 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -139.21 -3.99 1.53 Allowed 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 166.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.416 4.4 p30 50.14 64.1 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.789 1.632 . . . . 0.0 115.088 -159.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -124.6 130.4 52.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.359 0.664 . . . . 0.0 109.747 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -90.81 112.91 24.92 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.854 -0.529 . . . . 0.0 110.246 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.8 m -123.54 132.44 53.9 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.361 0.665 . . . . 0.0 111.264 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtp -70.04 99.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.423 1.106 . . . . 0.0 110.395 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -108.19 122.35 46.74 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.844 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.6 m -107.68 120.51 42.44 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.9 t -109.62 124.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.7 m -138.44 155.28 48.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 112.473 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 70.6 m95 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.842 -1.162 . . . . 0.0 112.385 177.129 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.561 0.695 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.34 114.61 26.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.707 -0.62 . . . . 0.0 109.809 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.586 0.755 . . . . 0.0 111.26 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.6 t -128.0 138.37 52.57 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p -117.37 131.17 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.916 0.887 . . . . 0.0 109.654 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.18 97.8 7.2 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.0 0.92 . . . . 0.0 109.17 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -91.67 119.68 31.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.481 -0.762 . . . . 0.0 112.025 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.11 -107.15 0.28 Allowed Glycine 0 N--CA 1.487 2.036 0 O-C-N 121.211 -0.931 . . . . 0.0 113.48 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.6 -12.05 59.95 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -126.44 145.08 50.62 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.093 1.315 . . . . 0.0 112.053 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.13 110.57 18.13 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.779 0.832 . . . . 0.0 111.418 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.39 46.13 73.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -85.01 139.97 31.38 Favored 'General case' 0 CA--C 1.569 1.682 0 CA-C-N 118.001 0.901 . . . . 0.0 111.668 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.15 -164.49 33.87 Favored Glycine 0 N--CA 1.484 1.854 0 O-C-N 121.391 -0.818 . . . . 0.0 114.736 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.65 157.08 32.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -128.78 130.11 46.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -131.85 144.14 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.712 0.768 . . . . 0.0 112.882 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.4 p90 -153.52 163.63 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.452 0.701 . . . . 0.0 112.723 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.9 129.62 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.396 -0.815 . . . . 0.0 108.888 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.64 98.27 6.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 162.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.84 -115.06 4.58 Favored Glycine 0 N--CA 1.49 2.27 0 O-C-N 121.559 -0.713 . . . . 0.0 114.353 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -95.73 12.96 28.08 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 163.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -112.55 132.83 54.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.554 1.524 . . . . 0.0 112.553 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.65 120.24 31.55 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.254 1.022 . . . . 0.0 108.961 170.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -109.74 124.14 50.74 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 108.895 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.8 tp -130.81 132.51 45.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.644 0.777 . . . . 0.0 110.251 -167.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.17 120.11 34.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.735 -0.603 . . . . 0.0 110.02 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.1 mtm -112.1 132.21 54.98 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.622 0.769 . . . . 0.0 111.322 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -124.2 137.25 54.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 112.287 -167.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.61 124.59 8.62 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.096 0.559 . . . . 0.0 110.882 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 54.75 43.58 29.85 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.72 -28.56 1.3 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 119.587 2.595 . . . . 0.0 119.587 -164.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.89 120.91 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 118.909 1.354 . . . . 0.0 110.564 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 m -101.9 125.39 48.57 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 121.375 0.607 . . . . 0.0 111.032 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.557 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 13.1 t -92.82 133.57 35.93 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.352 0.661 . . . . 0.0 111.291 163.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -102.14 126.68 49.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.272 0.629 . . . . 0.0 110.536 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 138.98 52.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.058 0.943 . . . . 0.0 111.131 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.12 127.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -126.92 152.57 46.94 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.501 1.12 . . . . 0.0 110.65 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -124.45 135.91 53.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.214 -1.554 . . . . 0.0 112.714 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -70.23 125.4 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.18 -37.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 120.209 1.368 . . . . 0.0 108.346 169.119 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 CA--C 1.565 1.541 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -74.85 0.96 13.82 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 170.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -57.88 112.92 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 121.333 1.879 . . . . 0.0 114.57 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.0 32.32 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-O 123.108 1.393 . . . . 0.0 116.081 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -112.4 113.57 25.83 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.75 -1.225 . . . . 0.0 108.862 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -115.42 115.54 26.72 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -166.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -89.91 143.44 26.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 113.258 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.44 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 12.8 ttp -75.54 127.33 32.86 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 113.77 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -93.1 -45.88 7.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -157.2 158.22 35.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.4 -1.438 . . . . 0.0 113.1 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -137.18 132.26 33.68 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.762 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.33 120.44 19.91 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.351 0.661 . . . . 0.0 109.956 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.278 45.0 t30 65.36 32.14 9.94 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 117.506 2.409 . . . . 0.0 117.506 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -78.12 -37.25 46.6 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -56.31 -41.97 76.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.77 -39.33 84.11 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -58.63 -47.88 82.9 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 167.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.29 -40.39 90.0 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -54.66 -46.0 73.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 162.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.86 -13.74 27.17 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.81 -50.09 5.53 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.43 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.94 5.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.938 1.695 . . . . 0.0 115.126 163.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.69 147.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 118.626 -2.546 . . . . 0.0 113.118 -146.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -67.1 154.42 41.26 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.96 -47.11 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.83 64.08 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.33 -36.88 85.39 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -54.58 -50.23 68.49 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -60.43 -44.3 95.93 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.6 -56.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 123.895 0.878 . . . . 0.0 111.821 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.99 77.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -69.07 -32.29 71.65 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.04 -27.47 60.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.79 141.6 49.69 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.216 1.371 . . . . 0.0 113.706 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -100.68 92.93 2.53 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.467 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 72.4 Cg_endo -71.8 155.33 58.38 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 122.629 2.219 . . . . 0.0 114.946 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.96 117.77 35.07 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.114 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.06 108.02 18.69 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.609 -0.682 . . . . 0.0 110.382 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -93.35 109.64 21.19 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.196 168.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mt -107.25 128.42 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.55 108.31 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -102.48 112.62 25.42 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.993 0.917 . . . . 0.0 110.483 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -105.48 75.97 1.18 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.597 -0.689 . . . . 0.0 109.669 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.48 -99.3 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -78.24 -37.93 44.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -77.02 116.07 17.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 120.333 1.424 . . . . 0.0 112.31 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.9 ttm -126.59 124.81 40.79 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.655 0.782 . . . . 0.0 110.866 -170.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.7 99.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.19 110.9 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -106.93 97.27 7.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.6 m -83.49 102.82 12.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.11 116.85 32.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.587 0.708 . . . . 0.0 111.094 -166.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -135.66 150.76 49.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.53 0.732 . . . . 0.0 110.099 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -63.42 -27.05 69.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.03 -41.48 64.17 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 164.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -158.19 129.89 6.75 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.847 1.203 . . . . 0.0 112.931 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -105.03 120.65 42.01 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.641 0.777 . . . . 0.0 109.765 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -121.85 109.98 15.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.758 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.84 125.75 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -103.55 107.32 18.12 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.49 0.716 . . . . 0.0 109.348 166.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -107.66 112.13 24.69 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.473 0.709 . . . . 0.0 109.583 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -154.51 164.27 38.93 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.32 134.23 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.969 167.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.23 134.92 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 O-C-N 121.149 -0.97 . . . . 0.0 110.55 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.22 46.18 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -163.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.36 145.0 35.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.926 1.363 . . . . 0.0 110.236 -162.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -90.72 128.9 36.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -139.21 158.99 43.19 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.143 0.973 . . . . 0.0 112.882 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.37 92.17 3.34 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 111.763 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -88.43 100.2 12.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.06 101.04 13.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 122.955 0.502 . . . . 0.0 110.552 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 mp -83.41 52.11 2.15 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.9 m -70.68 124.38 24.14 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.357 1.063 . . . . 0.0 110.302 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.28 -16.3 49.42 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 -162.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.21 -82.01 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.792 1.796 . . . . 0.0 106.948 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -122.3 17.55 10.64 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 52.88 46.97 25.7 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -129.27 140.56 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.64 0.733 . . . . 0.0 112.466 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -87.72 109.25 19.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.622 0.769 . . . . 0.0 111.149 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.4 m -101.37 140.31 35.84 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.438 0.695 . . . . 0.0 111.603 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.8 80.41 7.27 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.459 1.123 . . . . 0.0 110.193 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.7 m -85.51 128.08 34.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.173 -0.954 . . . . 0.0 110.672 -166.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -116.5 118.51 32.86 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 t -112.66 125.05 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.8 m -135.78 156.78 48.28 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.961 0.886 . . . . 0.0 112.928 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.4 m95 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.356 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttp . . . . . 0 CA--C 1.557 1.228 0 CA-C-O 121.945 0.878 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.2 tp -85.85 106.02 16.76 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -94.67 129.99 41.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.955 0.902 . . . . 0.0 111.459 -172.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -125.06 127.35 46.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.651 0.78 . . . . 0.0 112.068 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.59 119.64 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -95.41 97.1 9.57 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -81.38 115.87 20.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 111.692 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.37 -126.13 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 O-C-N 122.11 -0.369 . . . . 0.0 113.292 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.36 -31.69 37.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.59 144.79 26.91 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.041 1.292 . . . . 0.0 113.084 -164.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -81.63 106.31 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.351 0.661 . . . . 0.0 112.081 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.92 53.6 14.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -89.96 124.7 34.96 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.303 0.641 . . . . 0.0 110.857 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.9 -166.95 38.02 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -160.17 157.28 28.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.255 1.026 . . . . 0.0 113.004 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -128.94 129.83 45.96 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.0 139.42 52.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -148.61 166.33 28.62 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 52.1 mt -106.44 122.91 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.501 -0.749 . . . . 0.0 109.349 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -110.87 86.87 2.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.534 -0.729 . . . . 0.0 109.907 164.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.24 -109.69 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.527 -0.733 . . . . 0.0 113.557 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.92 43.69 1.4 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 156.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.25 124.67 43.51 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.624 0.77 . . . . 0.0 109.634 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.71 113.37 25.44 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 121.737 0.78 . . . . 0.0 108.975 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.92 124.04 48.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.4 tp -125.02 125.97 44.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.725 0.81 . . . . 0.0 110.716 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -108.46 123.29 48.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.41 135.76 52.71 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.695 -0.628 . . . . 0.0 111.582 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -123.76 133.77 53.78 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 112.735 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.78 5.88 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.794 0.838 . . . . 0.0 110.214 173.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 56.29 41.49 29.09 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.91 -12.05 2.3 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 120.11 2.804 . . . . 0.0 120.11 -163.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.11 123.53 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 119.692 1.746 . . . . 0.0 109.69 -166.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 m -99.6 118.01 35.21 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.662 0.385 . . . . 0.0 110.341 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -99.51 122.78 43.08 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.144 0.578 . . . . 0.0 110.856 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -101.77 129.46 47.96 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.683 0.754 . . . . 0.0 111.441 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -137.85 131.71 31.48 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.989 0.916 . . . . 0.0 110.276 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.88 132.47 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 109.017 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -132.42 149.75 52.28 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.842 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -124.14 128.27 49.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.431 -1.418 . . . . 0.0 111.127 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -71.49 120.16 16.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.465 -0.772 . . . . 0.0 112.838 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.3 -38.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 CA--C 1.566 1.568 0 CA-C-N 119.702 1.137 . . . . 0.0 108.219 169.591 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 CA--C 1.565 1.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -80.64 6.32 13.04 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -59.34 112.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 121.422 1.919 . . . . 0.0 114.799 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.6 178.82 33.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -109.67 109.73 20.55 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.595 1.158 . . . . 0.0 109.043 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -112.48 110.04 19.99 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -168.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -86.57 137.72 32.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.103 -0.998 . . . . 0.0 113.193 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ttp -74.1 122.39 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.02 1.282 . . . . 0.0 114.043 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 mt -82.16 -53.76 5.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.424 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -130.91 154.72 47.8 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -172.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -136.94 109.45 7.42 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.761 0.824 . . . . 0.0 108.839 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -93.07 -64.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -124.91 44.94 2.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.68 0.752 . . . . 0.0 111.916 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 4.3 t80 -72.5 -38.56 68.09 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.8 -41.74 96.23 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -71.16 -40.01 71.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -53.17 -47.27 68.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.24 -37.76 71.98 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -55.84 -44.16 77.73 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 163.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.47 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.95 1.06 53.94 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.289 4.2 t70 64.2 49.83 2.54 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -168.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.59 145.89 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.94 0.876 . . . . 0.0 109.903 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -61.93 153.97 27.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.01 -47.5 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.5 62.68 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.0 tp -66.33 -25.67 66.93 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -64.95 -47.23 78.37 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.767 1.621 . . . . 0.0 113.86 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -50.98 67.32 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -53.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 124.097 0.959 . . . . 0.0 112.212 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.2 -35.88 78.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -69.08 -32.61 72.19 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.63 -28.65 62.88 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.22 135.04 48.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.061 1.3 . . . . 0.0 112.826 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.57 89.59 2.28 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.648 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.29 151.96 60.81 Favored 'Trans proline' 0 CA--C 1.561 1.858 0 CA-C-N 123.056 2.127 . . . . 0.0 115.371 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.66 115.49 30.34 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -84.26 107.54 16.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.456 -0.778 . . . . 0.0 110.495 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -94.54 110.25 22.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -105.71 126.25 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.7 t -112.02 108.95 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -106.13 111.34 23.92 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 121.931 0.872 . . . . 0.0 110.702 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -99.78 76.24 1.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.659 1.184 . . . . 0.0 109.459 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.96 -106.46 1.93 Allowed Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.067 -1.021 . . . . 0.0 114.682 -175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.85 -22.12 24.63 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 162.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -70.09 120.99 16.62 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 120.132 1.333 . . . . 0.0 111.712 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -136.54 122.73 20.44 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 121.498 0.666 . . . . 0.0 111.043 -163.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.4 mt -116.21 99.98 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -95.66 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -99.68 98.86 9.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -84.1 95.67 8.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 109.019 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -93.26 124.52 37.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.057 0.543 . . . . 0.0 111.149 -166.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 t -146.34 154.16 41.34 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.107 0.956 . . . . 0.0 111.83 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -61.86 -30.82 71.11 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -77.82 -52.38 9.0 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -153.67 138.43 17.04 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.175 0.898 . . . . 0.0 110.877 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -93.08 117.79 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.736 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -106.21 104.22 13.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.521 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.29 125.47 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.2 mtp -103.98 110.13 22.16 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.309 165.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.56 111.1 20.83 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.238 1.015 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.34 168.82 26.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -164.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -106.8 135.21 48.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.975 -1.078 . . . . 0.0 110.238 161.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.0 125.55 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 O-C-N 121.42 -0.8 . . . . 0.0 108.94 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.58 -35.08 4.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -155.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 138.48 34.1 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 118.383 1.092 . . . . 0.0 113.165 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -87.62 114.77 24.53 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 122.024 -0.423 . . . . 0.0 110.336 167.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.95 148.6 50.51 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.497 0.719 . . . . 0.0 112.567 -173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.77 99.7 4.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 112.083 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.54 109.01 20.3 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.485 -0.759 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -79.38 106.07 11.15 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.215 0.531 . . . . 0.0 110.284 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.93 49.59 1.76 Allowed 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -79.95 130.39 35.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 113.275 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.89 -50.51 0.96 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.4 -0.813 . . . . 0.0 114.744 -154.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.8 mt -78.43 -65.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 124.398 1.079 . . . . 0.0 110.838 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -147.06 7.66 0.92 Allowed 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.274 2.3 m-20 57.46 30.55 18.83 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -104.57 141.1 37.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 111.298 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.86 98.28 11.28 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.155 0.582 . . . . 0.0 109.591 173.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.24 146.01 28.61 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.428 0.632 . . . . 0.0 112.104 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -79.26 95.66 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.914 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.8 m -93.99 126.72 39.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.058 0.543 . . . . 0.0 110.149 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -116.63 130.4 56.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.4 t -116.69 130.3 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -125.58 139.82 53.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.076 0.951 . . . . 0.0 111.087 -175.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.5 m95 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 112.611 177.09 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.391 0.615 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -98.51 114.71 27.22 Favored 'General case' 0 CA--C 1.561 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.171 169.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -117.15 129.24 55.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.147 0.579 . . . . 0.0 111.064 -163.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.43 ' SG ' HG22 ' A' ' 86' ' ' VAL . 53.5 t -130.37 145.56 51.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -121.74 135.34 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 124.175 0.99 . . . . 0.0 110.42 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.0 95.55 5.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.834 0.853 . . . . 0.0 109.734 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.25 124.37 33.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.642 -1.286 . . . . 0.0 112.843 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 -112.3 0.27 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 121.661 -0.649 . . . . 0.0 112.283 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -83.2 -10.05 58.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -113.16 143.97 43.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.549 1.522 . . . . 0.0 113.186 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -80.55 124.15 28.71 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.31 42.37 99.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 118.494 2.158 . . . . 0.0 118.494 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -91.36 134.08 34.91 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.843 0.83 . . . . 0.0 111.595 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.66 -163.83 32.49 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 121.882 0.712 . . . . 0.0 114.298 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -156.88 153.53 28.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -129.52 126.04 37.69 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.44 137.95 54.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -148.58 163.2 37.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 112.913 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.29 125.04 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.97 96.58 6.03 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.4 -109.0 2.67 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.374 -0.829 . . . . 0.0 113.882 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -109.75 25.71 11.48 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 158.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -108.81 123.63 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.917 1.235 . . . . 0.0 110.974 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -82.21 115.52 21.33 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.069 0.947 . . . . 0.0 109.151 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -102.16 115.45 30.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.4 123.15 49.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.809 0.843 . . . . 0.0 111.163 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.11 124.25 47.38 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 165.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.3 mtm -116.35 128.99 56.01 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.104 0.865 . . . . 0.0 110.904 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -116.18 136.78 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.55 120.42 8.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.594 0.757 . . . . 0.0 110.022 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 59.07 39.91 22.7 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.94 -34.87 1.25 Allowed Glycine 0 CA--C 1.558 2.749 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -161.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.08 118.36 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.008 1.323 . . . . 0.0 111.238 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.4 m -107.39 119.71 40.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.588 -168.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.461 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 11.8 t -94.36 126.13 39.42 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.531 0.732 . . . . 0.0 111.984 170.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -100.18 127.93 46.35 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.338 0.59 . . . . 0.0 111.751 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -127.64 137.12 52.44 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.899 0.88 . . . . 0.0 110.964 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.23 131.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.51 127.27 43.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.523 0.729 . . . . 0.0 110.319 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.79 123.38 41.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.762 -1.211 . . . . 0.0 111.559 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.55 115.85 8.41 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.237 0.926 . . . . 0.0 112.469 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.7 -36.96 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.588 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 171.98 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.548 0.213 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -76.56 -1.8 29.26 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -55.44 113.72 1.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 121.189 1.813 . . . . 0.0 114.7 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.69 -179.85 29.66 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-O 122.72 1.178 . . . . 0.0 115.53 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -113.2 118.91 36.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.311 1.044 . . . . 0.0 109.188 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -121.39 114.76 21.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -165.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -88.76 140.89 28.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.255 -0.903 . . . . 0.0 113.254 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.461 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 4.8 ttm -70.34 120.55 16.18 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.46 -45.24 16.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -153.58 159.09 42.07 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.236 1.38 . . . . 0.0 113.549 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -134.07 101.94 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.955 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.0 123.55 50.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.197 0.599 . . . . 0.0 111.001 -171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 29.6 t30 66.31 36.26 5.44 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 5.1 t80 -79.14 -39.16 34.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.54 -40.59 79.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -66.18 -41.53 90.13 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -55.99 -48.11 76.47 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.88 -40.62 75.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -55.31 -45.87 76.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.69 -20.99 24.53 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 164.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.8 mt -96.17 13.19 28.19 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.304 22.8 t70 60.74 56.48 2.96 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-N 120.709 1.595 . . . . 0.0 113.464 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -106.62 146.82 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 122.093 0.949 . . . . 0.0 110.165 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -64.04 153.01 38.71 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -61.25 -44.03 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.98 -52.12 64.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.81 -38.72 91.84 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -53.2 -53.03 56.68 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -62.46 -46.49 88.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.58 -57.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 123.729 0.812 . . . . 0.0 111.774 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.13 72.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -69.91 -36.83 75.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 165.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.1 mt -73.01 -24.52 60.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.78 143.22 49.61 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.152 1.342 . . . . 0.0 113.805 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -102.82 90.27 2.23 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.757 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 59.6 Cg_endo -69.31 155.74 66.53 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 123.054 2.127 . . . . 0.0 114.987 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.3 118.83 34.37 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -86.03 115.4 23.61 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.525 -0.735 . . . . 0.0 110.849 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -102.2 106.44 17.27 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mp -101.18 131.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.313 -0.867 . . . . 0.0 109.237 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.63 109.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.47 106.62 17.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.883 0.873 . . . . 0.0 110.082 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -99.37 80.4 2.41 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 123.57 0.748 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.89 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.513 -0.742 . . . . 0.0 114.189 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -93.07 -20.14 20.83 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 163.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -74.16 105.89 5.57 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.667 2.03 . . . . 0.0 111.211 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.5 ttm -116.73 124.85 50.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.59 0.756 . . . . 0.0 110.557 -170.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.03 98.39 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.2 mt -94.32 110.83 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.29 96.09 6.12 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.1 m -85.78 99.11 11.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 108.79 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.18 115.93 28.46 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.832 -0.542 . . . . 0.0 111.343 -164.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 t -134.3 151.82 51.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.766 0.793 . . . . 0.0 110.521 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -64.05 -29.33 70.48 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.73 -51.31 28.16 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 167.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.88 134.93 13.92 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.38 0.991 . . . . 0.0 111.213 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.44 118.76 30.83 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 123.781 0.832 . . . . 0.0 109.555 170.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -102.81 116.84 33.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 110.4 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.27 117.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.9 mtp -105.6 105.31 15.28 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -108.36 108.82 19.95 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.575 0.75 . . . . 0.0 109.555 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.85 155.93 33.8 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -90.48 126.74 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.7 165.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.89 121.77 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 168.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.54 -35.13 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 -156.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.44 140.99 32.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.491 1.145 . . . . 0.0 113.3 -165.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -86.3 108.37 18.38 Favored 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 122.818 0.447 . . . . 0.0 110.387 166.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -119.92 143.4 48.0 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.673 0.789 . . . . 0.0 112.504 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.35 97.7 2.55 Favored 'General case' 0 CA--C 1.567 1.609 0 O-C-N 120.935 -1.103 . . . . 0.0 112.609 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -93.51 113.47 25.61 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.452 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.28 105.07 12.18 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.734 0.414 . . . . 0.0 110.752 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.55 52.32 2.31 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -83.58 132.43 34.91 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.089 0.947 . . . . 0.0 111.647 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.58 -62.17 0.38 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.273 -151.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mt -72.11 -70.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.559 1.144 . . . . 0.0 110.202 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -136.08 9.79 3.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 169.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 58.84 45.19 15.73 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -135.17 143.77 46.66 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.725 0.774 . . . . 0.0 111.282 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -88.0 126.24 34.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.624 -0.672 . . . . 0.0 111.341 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -122.66 140.64 52.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.156 0.582 . . . . 0.0 111.142 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.11 97.18 5.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 168.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.6 m -95.55 123.25 39.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.42 0.688 . . . . 0.0 110.218 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 m -107.43 126.8 52.96 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 168.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.19 135.86 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -149.95 152.43 34.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.443 -1.411 . . . . 0.0 112.729 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.5 m95 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 120.861 -1.149 . . . . 0.0 112.653 178.278 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.426 0.632 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.73 105.09 16.71 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -109.76 136.1 49.63 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.606 0.762 . . . . 0.0 111.377 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -134.93 138.17 43.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.36 133.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 123.715 0.806 . . . . 0.0 110.242 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -112.56 98.52 7.3 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.626 0.771 . . . . 0.0 109.575 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.31 117.02 27.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.424 -0.798 . . . . 0.0 111.749 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.27 -131.12 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 O-C-N 121.233 -0.917 . . . . 0.0 113.619 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.05 -34.81 69.05 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -96.34 140.0 31.64 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.226 1.012 . . . . 0.0 112.315 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.45 122.56 26.58 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -165.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.06 52.27 53.83 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -93.41 138.87 31.31 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.723 0.773 . . . . 0.0 111.707 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.96 -168.54 35.72 Favored Glycine 0 N--CA 1.485 1.911 0 CA-C-O 121.918 0.732 . . . . 0.0 114.722 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -156.49 153.64 29.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.6 m -128.52 123.12 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -123.57 131.75 53.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.699 0.8 . . . . 0.0 111.397 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -148.89 175.43 11.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.239 -0.913 . . . . 0.0 112.76 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.78 135.8 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.916 -1.115 . . . . 0.0 109.262 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.57 93.12 3.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 165.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.74 -120.04 5.26 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.873 -0.517 . . . . 0.0 113.351 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.43 41.27 1.25 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 161.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -131.1 118.67 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.348 0.659 . . . . 0.0 109.399 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.31 122.31 26.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.891 0.876 . . . . 0.0 110.437 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -112.91 119.79 39.17 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.2 tp -124.61 124.86 43.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.643 0.777 . . . . 0.0 110.53 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.95 121.31 42.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 165.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.7 mtm -110.62 127.46 55.26 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.905 0.775 . . . . 0.0 110.318 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -119.2 145.41 46.06 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.98 122.53 2.59 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.067 0.547 . . . . 0.0 110.75 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.299 7.1 mt-10 50.88 50.82 18.28 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.88 -28.77 2.78 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 120.162 2.825 . . . . 0.0 120.162 -169.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -76.05 156.0 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.817 1.309 . . . . 0.0 112.075 -171.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -123.54 127.51 48.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.0 110.688 168.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 17.5 t -94.24 136.86 34.07 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.999 0.52 . . . . 0.0 111.199 156.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -114.64 123.94 50.58 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.072 0.549 . . . . 0.0 110.272 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -121.12 135.13 55.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.72 -0.612 . . . . 0.0 111.17 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.12 129.3 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -133.27 136.78 45.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.525 -0.734 . . . . 0.0 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -103.62 133.24 48.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.308 -1.495 . . . . 0.0 112.676 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -69.14 122.89 19.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.6 m -117.53 -37.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 119.761 1.164 . . . . 0.0 107.93 170.413 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.258 46.7 t0 . . . . . 0 CA--C 1.569 1.687 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.97 6.07 14.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.32 108.85 0.99 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.481 1.492 . . . . 0.0 114.652 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.87 -179.64 33.44 Favored Glycine 0 N--CA 1.485 1.958 0 CA-C-O 122.807 1.226 . . . . 0.0 115.58 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -107.5 118.22 36.15 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.45 1.1 . . . . 0.0 109.274 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -117.12 111.75 19.93 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -168.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -85.3 139.03 31.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 112.765 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 30.6 ttm -65.92 124.99 24.0 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 120.092 1.315 . . . . 0.0 114.355 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -86.08 -43.99 12.63 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -153.0 156.9 39.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.366 -1.459 . . . . 0.0 113.408 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -131.35 109.23 10.2 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.922 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.06 121.09 38.11 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.272 0.629 . . . . 0.0 110.499 -168.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 30.3 t30 68.01 31.83 5.34 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 9.1 t80 -78.43 -38.46 41.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.93 -41.45 74.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.0 -37.85 78.94 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -55.1 -47.38 75.04 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 120.26 1.391 . . . . 0.0 114.658 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.96 -40.59 71.87 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -54.68 -42.86 71.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 165.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 -29.15 60.78 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.4 -0.71 53.75 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 17.2 t0 66.71 48.12 1.45 Allowed 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 144.47 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.985 172.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -64.53 155.0 34.34 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 171.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.94 -43.84 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.67 50.27 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.33 -37.42 85.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -56.78 -51.7 67.89 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 165.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -62.94 -46.74 86.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.45 -56.9 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.042 0.837 . . . . 0.0 111.719 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.39 -27.98 67.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -75.19 -33.67 61.45 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.63 -34.16 76.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 166.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.36 130.28 40.95 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.176 0.988 . . . . 0.0 112.278 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.39 100.01 9.63 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.838 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 38.1 Cg_endo -66.8 154.89 72.98 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 CA-C-N 123.466 2.274 . . . . 0.0 114.967 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -108.24 119.63 40.03 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -89.46 113.85 25.27 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.358 -0.839 . . . . 0.0 110.863 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.78 106.97 19.3 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.807 -0.558 . . . . 0.0 109.545 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -102.24 130.6 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.58 108.79 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 167.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -94.59 102.63 14.56 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.393 0.677 . . . . 0.0 110.064 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 74.05 3.02 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 121.492 0.663 . . . . 0.0 110.4 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 -103.48 0.98 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.592 -0.692 . . . . 0.0 114.591 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.62 -32.49 23.69 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 165.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -80.17 104.2 10.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.623 1.556 . . . . 0.0 110.998 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp -114.33 132.14 56.29 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 122.295 1.045 . . . . 0.0 111.47 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.31 99.73 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.78 110.26 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -103.6 101.61 11.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.726 -0.608 . . . . 0.0 109.476 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -86.13 102.76 14.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.48 130.24 49.23 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.931 0.492 . . . . 0.0 111.494 -166.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.6 t -149.17 155.15 40.22 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.117 0.96 . . . . 0.0 111.675 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.2 p -62.02 -32.56 73.07 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.81 -50.55 13.19 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -151.82 136.85 17.33 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 119.388 0.994 . . . . 0.0 112.273 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -94.08 136.82 33.96 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 121.738 -0.601 . . . . 0.0 110.98 166.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -128.26 113.44 15.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 110.807 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.98 129.57 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 123.478 0.711 . . . . 0.0 109.467 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtp -108.59 108.04 18.77 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.639 0.776 . . . . 0.0 110.005 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.03 118.12 35.18 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.137 0.975 . . . . 0.0 111.825 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.2 149.55 22.97 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -165.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -94.46 127.23 40.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 0.0 111.095 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.87 130.62 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 123.332 0.653 . . . . 0.0 111.209 -174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.14 -36.19 4.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -162.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.18 140.46 29.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.579 1.189 . . . . 0.0 112.813 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -87.14 114.82 24.08 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.804 -0.56 . . . . 0.0 110.877 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -121.71 139.23 53.83 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 111.92 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.45 90.58 2.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.11 . . . . 0.0 113.431 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -92.15 113.24 25.45 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.406 -0.808 . . . . 0.0 110.72 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.54 127.77 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.35 1.072 . . . . 0.0 111.209 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.15 49.38 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.616 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.3 t -71.76 137.19 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.418 1.087 . . . . 0.0 113.314 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.66 -57.0 0.98 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 120.862 -0.685 . . . . 0.0 114.083 -154.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -79.56 -67.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.649 1.18 . . . . 0.0 110.169 -171.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.84 25.35 0.84 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 160.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.301 0.9 OUTLIER 61.41 8.01 2.0 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -82.3 139.58 34.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.806 -1.184 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -92.87 108.57 20.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.3 m -112.77 124.0 51.59 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.654 0.74 . . . . 0.0 110.751 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtp -72.55 92.56 1.5 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.585 1.184 . . . . 0.0 111.043 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -100.98 123.98 46.0 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.268 -157.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.6 m -104.66 119.49 39.11 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.41 HG22 ' SG ' ' A' ' 95' ' ' CYS . 30.0 t -104.93 127.76 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.8 m -129.44 155.32 45.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 112.422 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 74.4 m95 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.0 111.71 172.199 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.667 0.746 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -92.87 98.08 11.15 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.169 0.588 . . . . 0.0 109.585 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -102.02 131.05 48.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.511 0.724 . . . . 0.0 110.963 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 86' ' ' VAL . 51.9 t -128.81 142.17 51.06 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.93 126.12 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.768 0.827 . . . . 0.0 109.445 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.69 96.47 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.139 0.976 . . . . 0.0 109.069 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -96.27 116.32 28.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.177 -0.952 . . . . 0.0 111.985 -166.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.97 -105.93 0.19 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.297 -0.877 . . . . 0.0 112.792 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -79.09 -30.43 43.88 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.53 141.3 40.62 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.864 1.211 . . . . 0.0 113.018 -162.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.43 111.93 16.18 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.78 46.03 92.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 117.727 1.851 . . . . 0.0 117.727 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -83.44 137.98 33.67 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 118.282 1.041 . . . . 0.0 111.064 172.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.98 -163.49 34.48 Favored Glycine 0 N--CA 1.483 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 114.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.275 63.4 p-90 -158.06 169.06 25.41 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.547 1.165 . . . . 0.0 113.69 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.7 m -146.87 119.55 8.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.054 -1.654 . . . . 0.0 109.032 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -116.25 135.04 54.25 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -147.8 171.9 14.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.556 -0.715 . . . . 0.0 112.776 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.91 128.53 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.345 -0.847 . . . . 0.0 109.37 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.14 87.51 2.73 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.936 0.874 . . . . 0.0 110.281 166.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.12 -116.49 4.27 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.724 -0.61 . . . . 0.0 113.246 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -94.17 24.61 4.25 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 160.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.51 125.64 50.3 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.725 1.148 . . . . 0.0 111.349 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.03 120.31 25.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.36 0.664 . . . . 0.0 109.852 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.78 118.76 37.02 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.1 tp -125.94 122.21 35.34 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.593 0.757 . . . . 0.0 110.448 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.99 126.7 47.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.201 0.6 . . . . 0.0 109.535 167.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.1 mtp -122.68 123.87 42.12 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.983 0.913 . . . . 0.0 110.448 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -121.98 135.17 54.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 111.814 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.32 124.38 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.186 0.594 . . . . 0.0 110.737 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 56.29 41.36 29.26 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.07 -20.48 1.52 Allowed Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.702 2.641 . . . . 0.0 119.702 -164.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 51.0 t -80.43 118.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.723 1.761 . . . . 0.0 109.82 -169.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.5 m -99.53 124.33 44.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.797 0.808 . . . . 0.0 111.264 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.429 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 10.4 t -99.08 130.28 45.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.28 1.032 . . . . 0.0 110.894 168.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -105.31 117.86 35.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 110.568 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -117.47 125.33 50.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.554 0.742 . . . . 0.0 109.771 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.81 129.83 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.9 149.63 52.23 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 123.435 0.694 . . . . 0.0 111.453 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -115.54 132.53 56.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.106 -1.621 . . . . 0.0 112.252 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -69.3 124.8 24.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.38 -40.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 . . . . . 0 CA--C 1.562 1.435 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.663 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 t0 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.159 0.504 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -83.39 0.83 44.29 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -58.87 106.29 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 121.27 1.85 . . . . 0.0 114.791 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.89 176.87 32.45 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-O 122.825 1.236 . . . . 0.0 115.83 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -105.45 120.54 41.88 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.439 1.096 . . . . 0.0 109.9 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -119.53 113.23 20.42 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -92.07 140.32 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.741 -1.224 . . . . 0.0 113.197 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.7 ttp -73.52 123.58 24.21 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.654 1.57 . . . . 0.0 114.388 -171.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.01 -52.69 6.11 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.158 0.983 . . . . 0.0 113.465 169.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -136.96 154.47 50.42 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -138.72 106.88 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.213 0.605 . . . . 0.0 109.819 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.99 121.92 41.88 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.622 0.769 . . . . 0.0 110.186 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 27.7 t30 63.44 32.98 14.06 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -79.39 -46.61 17.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.491 -1.381 . . . . 0.0 114.411 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -58.45 -39.13 79.04 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.73 -40.81 84.15 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -56.66 -49.15 75.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 164.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.9 -37.81 88.89 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -52.29 -47.37 65.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 162.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.24 -18.52 61.42 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.18 4.16 52.95 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.263 5.8 t70 66.24 46.63 2.0 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -171.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.07 142.57 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.748 0.785 . . . . 0.0 109.46 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -64.43 154.61 35.17 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.44 -46.05 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.82 -50.23 69.09 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 tp -64.2 -35.49 80.98 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -57.13 -42.1 80.3 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 163.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.56 -43.86 75.71 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -64.04 -56.56 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 123.927 0.891 . . . . 0.0 111.821 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.95 77.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -71.26 -30.16 65.96 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.76 -30.74 64.38 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 167.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.98 140.27 50.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.666 1.121 . . . . 0.0 113.569 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -94.05 100.45 4.87 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.443 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.75 157.27 60.97 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 123.248 2.196 . . . . 0.0 114.152 167.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -128.11 118.12 22.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.315 -1.491 . . . . 0.0 108.793 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -86.07 109.26 18.71 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.714 -0.616 . . . . 0.0 111.005 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.68 107.44 19.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 168.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.1 mt -104.08 127.35 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.5 t -112.36 107.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -102.39 97.42 7.67 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.912 0.885 . . . . 0.0 109.888 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.46 78.44 4.99 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.379 -0.825 . . . . 0.0 110.129 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 -103.7 1.1 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.881 -0.512 . . . . 0.0 114.374 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.5 -26.21 32.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 164.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -81.22 105.78 12.69 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.374 1.443 . . . . 0.0 111.552 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -109.86 122.13 46.81 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.155 0.978 . . . . 0.0 111.203 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -114.48 97.29 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.3 mt -91.54 109.44 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -102.72 99.01 8.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -86.05 98.04 10.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 108.756 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -95.93 115.44 27.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.7 -0.625 . . . . 0.0 110.203 -165.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 t -133.41 152.61 51.93 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.735 0.778 . . . . 0.0 110.72 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.9 p -63.1 -29.38 70.76 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -75.94 -49.52 17.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -154.61 135.06 13.37 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 119.414 1.006 . . . . 0.0 111.604 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -85.99 117.32 24.76 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.432 0.693 . . . . 0.0 110.222 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -106.14 103.95 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.363 -0.835 . . . . 0.0 110.374 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.72 124.17 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -102.93 107.4 18.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.646 0.778 . . . . 0.0 109.375 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -108.09 110.29 21.93 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.721 0.808 . . . . 0.0 109.83 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.36 160.27 41.61 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -101.94 138.22 39.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 110.969 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.33 133.56 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.31 -25.33 27.4 Favored Glycine 0 CA--C 1.552 2.387 0 N-CA-C 117.73 1.852 . . . . 0.0 117.73 -164.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -101.98 134.26 45.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.178 1.489 . . . . 0.0 111.04 -158.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -83.06 103.15 12.28 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.999 0.52 . . . . 0.0 111.231 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.96 138.73 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.442 0.697 . . . . 0.0 112.286 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.98 96.49 1.04 Allowed 'General case' 0 CA--C 1.57 1.719 0 O-C-N 120.955 -1.091 . . . . 0.0 112.953 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -89.88 113.12 24.67 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.25 108.69 15.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.872 -0.518 . . . . 0.0 109.644 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mp -85.2 56.22 3.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.161 0.981 . . . . 0.0 113.474 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.0 t -78.32 129.16 34.69 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.508 1.147 . . . . 0.0 112.846 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.31 -42.2 2.01 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.3 -88.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -113.49 7.59 17.54 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 57.11 44.63 22.18 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -137.17 142.98 42.17 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.53 131.27 34.99 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.273 0.629 . . . . 0.0 112.5 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.2 125.92 27.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.102 0.561 . . . . 0.0 111.343 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 mmt -68.38 100.97 1.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.672 1.225 . . . . 0.0 110.555 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 m -100.46 122.22 42.84 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.755 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -110.93 118.58 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 t -109.91 121.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.4 m -127.83 147.4 50.44 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.843 0.857 . . . . 0.0 112.359 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.8 m95 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 120.985 -1.072 . . . . 0.0 112.234 174.987 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.604 0.716 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -87.68 113.32 23.25 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 121.387 -0.82 . . . . 0.0 109.955 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -100.41 137.62 38.58 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.958 0.903 . . . . 0.0 111.735 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.4 t -131.64 136.87 48.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.364 0.666 . . . . 0.0 112.636 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.3 123.69 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.413 0.685 . . . . 0.0 109.776 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -99.8 98.38 9.19 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.513 1.125 . . . . 0.0 109.472 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -89.74 115.21 26.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 111.445 -171.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.35 -112.59 0.27 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 121.767 -0.583 . . . . 0.0 112.457 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.18 -31.21 23.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -96.99 142.55 28.81 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.387 1.089 . . . . 0.0 113.797 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.53 106.77 11.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.044 -172.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.34 66.33 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -172.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -82.14 133.31 35.26 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.194 0.598 . . . . 0.0 110.823 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.43 -159.48 31.2 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -160.38 160.13 31.92 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.315 1.055 . . . . 0.0 112.92 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.3 m -133.04 128.45 36.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.113 -0.992 . . . . 0.0 108.396 170.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.77 138.48 53.37 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.7 163.85 37.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.3 mt -102.63 126.73 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.328 -0.857 . . . . 0.0 109.878 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.71 90.21 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.805 0.812 . . . . 0.0 110.175 164.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.14 -116.02 4.18 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 121.639 -0.663 . . . . 0.0 113.445 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -90.84 18.91 5.99 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 161.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -118.45 122.33 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.451 1.478 . . . . 0.0 111.113 -166.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.3 tp -82.85 111.89 19.16 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -98.04 119.39 36.59 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.63 117.8 26.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.601 0.76 . . . . 0.0 110.234 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.93 131.65 39.16 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.088 0.555 . . . . 0.0 109.781 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.0 mtp -127.07 121.44 31.54 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.444 0.698 . . . . 0.0 109.571 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -117.25 137.76 52.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 112.87 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.32 115.12 5.28 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 0.0 111.009 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.26 3.1 mt-10 58.14 44.65 18.77 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.24 -28.99 0.98 Allowed Glycine 0 CA--C 1.559 2.789 0 N-CA-C 119.172 2.429 . . . . 0.0 119.172 -162.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.5 t -71.69 115.26 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.752 1.221 . . . . 0.0 110.198 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.8 m -106.1 117.52 34.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.261 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 t -89.91 134.82 34.0 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.314 0.646 . . . . 0.0 111.448 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -109.68 118.61 37.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.756 -0.59 . . . . 0.0 110.809 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -116.66 137.06 52.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.65 0.78 . . . . 0.0 110.183 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.03 130.01 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -126.61 131.15 51.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.654 -0.654 . . . . 0.0 110.994 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -94.72 130.33 41.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.731 -1.231 . . . . 0.0 112.217 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -64.91 123.86 20.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.69 -36.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 120.228 1.377 . . . . 0.0 108.04 171.564 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 CA--C 1.561 1.387 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -76.47 -0.9 24.66 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -58.96 114.34 2.52 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 122.029 2.195 . . . . 0.0 114.407 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.03 177.7 28.58 Favored Glycine 0 N--CA 1.486 2.002 0 CA-C-O 122.925 1.292 . . . . 0.0 115.811 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -110.75 111.16 22.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.478 1.111 . . . . 0.0 108.904 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -114.16 111.82 22.19 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -166.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.56 142.43 27.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 112.815 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.5 ttp -72.18 121.61 19.62 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.834 1.197 . . . . 0.0 113.53 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.8 mt -81.88 -44.43 16.86 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 169.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.2 m -154.11 160.65 42.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.458 -1.401 . . . . 0.0 113.343 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.65 120.47 17.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.137 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.94 120.74 31.17 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 110.185 -170.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 32.6 t30 65.86 36.57 5.99 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.594 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 6.3 t80 -81.62 -42.34 20.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.14 -34.82 74.07 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.47 -44.78 70.48 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.018 1.736 . . . . 0.0 114.651 165.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -55.05 -45.45 75.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.73 -37.45 73.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.23 -43.73 87.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.2 -1.562 . . . . 0.0 114.848 163.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.27 24.84 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 163.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.0 mt -96.7 9.41 41.73 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 22.9 t70 62.61 59.93 1.4 Allowed 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 120.438 1.472 . . . . 0.0 113.145 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.98 139.08 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.616 0.722 . . . . 0.0 110.106 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.56 150.84 47.74 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.58 -47.01 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -49.98 70.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.23 -42.53 99.4 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 171.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -56.83 -48.57 77.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 121.304 1.866 . . . . 0.0 115.741 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.32 -43.32 99.06 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.56 -54.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 118.842 0.746 . . . . 0.0 111.691 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.52 78.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -66.77 -33.84 76.5 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 167.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.1 -25.08 58.23 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -70.68 147.74 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.365 1.439 . . . . 0.0 114.517 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -100.24 95.83 4.5 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.091 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.61 141.49 46.0 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.479 2.119 . . . . 0.0 113.786 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.39 114.53 23.67 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -87.02 109.42 19.38 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.726 -0.609 . . . . 0.0 110.924 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.52 105.31 17.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 167.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mt -104.26 129.69 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.9 t -112.37 106.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -101.54 103.5 14.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.247 0.619 . . . . 0.0 109.781 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.65 72.0 5.85 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.39 -94.3 0.47 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.83 -25.11 17.5 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 166.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -83.63 116.42 22.61 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.416 1.462 . . . . 0.0 111.077 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.3 ttm -126.51 124.5 40.19 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.558 0.694 . . . . 0.0 110.945 -165.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.76 101.67 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.73 111.32 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -104.86 96.17 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 m -82.8 99.17 9.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 0.0 108.871 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.21 121.27 37.8 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.322 0.582 . . . . 0.0 110.401 -168.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -139.52 153.45 47.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.632 0.729 . . . . 0.0 110.67 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -63.6 -28.9 70.24 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.29 -52.55 10.58 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 170.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -156.04 136.75 13.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 119.461 1.028 . . . . 0.0 111.277 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.8 121.0 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.572 0.749 . . . . 0.0 110.111 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -109.72 116.74 32.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 110.366 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mm -110.64 119.66 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.2 mtp -107.33 104.17 13.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.825 -0.547 . . . . 0.0 110.082 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -110.14 115.75 30.29 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.074 0.95 . . . . 0.0 111.615 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -158.39 153.34 25.17 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -93.04 134.09 35.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.09 -1.007 . . . . 0.0 110.455 161.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.11 124.69 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.385 -0.822 . . . . 0.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.14 -38.32 3.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -155.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.94 133.76 35.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 117.959 0.88 . . . . 0.0 113.279 -161.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.46 102.58 12.18 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 121.953 -0.467 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -116.29 144.34 44.36 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.623 0.769 . . . . 0.0 112.173 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.59 92.21 3.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.597 -1.314 . . . . 0.0 113.197 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.17 118.9 24.42 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.388 -0.82 . . . . 0.0 110.767 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -76.8 127.81 33.45 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.759 -0.588 . . . . 0.0 110.518 161.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.3 55.29 0.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.553 0.692 . . . . 0.0 112.571 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.8 t -82.87 131.01 35.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 112.521 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -49.8 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.297 -0.877 . . . . 0.0 114.642 -155.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -78.34 -72.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.443 1.097 . . . . 0.0 109.902 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -135.34 -2.54 2.48 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.288 1.7 m-20 58.71 45.0 16.44 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -116.07 139.99 49.73 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.779 0.831 . . . . 0.0 110.993 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -83.54 124.24 30.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.108 0.48 . . . . 0.0 110.464 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 83.7 m -124.42 122.24 37.12 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.262 0.625 . . . . 0.0 110.851 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.73 99.05 2.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.292 1.044 . . . . 0.0 109.996 173.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.9 m -111.56 121.04 44.09 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.87 -158.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -104.76 120.66 41.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.74 128.04 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.9 m -132.75 145.72 51.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.595 0.758 . . . . 0.0 111.631 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m95 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.343 173.287 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.664 0.745 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.9 tp -89.44 105.76 18.0 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.815 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.26 147.82 24.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.058 0.943 . . . . 0.0 111.964 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.8 t -141.57 135.83 30.46 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.89 126.54 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.541 0.736 . . . . 0.0 109.046 163.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -102.53 108.13 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.518 0.727 . . . . 0.0 109.527 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -86.39 101.96 13.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.801 -1.187 . . . . 0.0 110.453 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.28 92.81 0.09 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.311 79.9 mt-10 70.11 -46.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -106.74 151.47 25.09 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.506 1.146 . . . . 0.0 113.191 -153.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -86.72 107.64 18.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.586 -0.697 . . . . 0.0 111.89 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.64 55.61 8.31 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -95.57 129.1 42.87 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 122.967 0.507 . . . . 0.0 111.719 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.22 -147.78 13.4 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -160.98 161.44 31.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.959 0.885 . . . . 0.0 112.958 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.2 m -134.97 123.38 23.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -123.29 131.96 53.85 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.508 0.723 . . . . 0.0 111.287 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.97 169.24 20.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.877 -1.139 . . . . 0.0 113.209 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -113.48 128.01 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -113.28 90.03 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.87 -113.13 4.06 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.46 -0.775 . . . . 0.0 114.819 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -88.25 4.4 45.97 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.46 131.65 54.06 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 120.037 1.289 . . . . 0.0 112.365 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.43 122.0 35.4 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -111.52 123.05 49.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.9 tp -123.4 121.14 35.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.351 0.661 . . . . 0.0 111.07 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.46 129.71 42.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.404 0.681 . . . . 0.0 110.235 163.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.6 mtm -119.69 130.85 55.23 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.736 0.698 . . . . 0.0 110.722 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -125.47 133.31 52.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 112.609 -164.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.28 131.88 7.69 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 55.02 38.78 31.08 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.36 3.72 Favored Glycine 0 CA--C 1.559 2.786 0 N-CA-C 120.182 2.833 . . . . 0.0 120.182 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.66 121.8 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 119.87 1.835 . . . . 0.0 108.6 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.2 m -98.59 124.37 43.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 121.671 0.748 . . . . 0.0 110.691 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.594 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 11.2 t -92.74 143.79 25.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.686 . . . . 0.0 111.345 160.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.8 122.87 44.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.937 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -115.34 130.8 57.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.73 132.11 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -128.97 159.29 36.34 Favored 'General case' 0 CA--C 1.574 1.887 0 C-N-CA 124.437 1.095 . . . . 0.0 111.206 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -130.94 132.11 44.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.534 -1.354 . . . . 0.0 111.846 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.51 116.17 10.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.18 -33.96 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t60 . . . . . 0 CA--C 1.562 1.414 0 CA-C-N 119.951 1.25 . . . . 0.0 107.993 170.017 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 t0 . . . . . 0 CA--C 1.564 1.506 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.8 -4.0 44.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -54.84 108.86 0.44 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 121.285 1.857 . . . . 0.0 115.136 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.56 -175.99 35.55 Favored Glycine 0 CA--C 1.546 2.017 0 CA-C-O 122.829 1.238 . . . . 0.0 115.828 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -117.51 118.06 31.14 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.311 1.045 . . . . 0.0 109.356 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -121.54 117.13 26.02 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.69 -0.631 . . . . 0.0 109.582 -164.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -84.99 147.07 26.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 0.0 113.537 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 31.9 ttm -70.61 128.93 37.78 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 120.372 1.442 . . . . 0.0 113.459 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.38 -45.71 9.76 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -157.3 156.13 31.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.255 1.843 . . . . 0.0 114.458 173.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -104.75 123.29 47.39 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.761 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.97 -66.74 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -126.44 39.16 3.99 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.206 0.602 . . . . 0.0 112.114 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -70.58 -36.84 73.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.77 -47.32 70.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.56 -37.72 77.12 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -52.94 -48.11 67.56 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 120.838 1.654 . . . . 0.0 114.049 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.0 -35.83 69.57 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -54.0 -46.03 71.64 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.605 1.548 . . . . 0.0 114.899 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.63 -23.4 58.92 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.75 -9.54 59.3 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 166.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.329 16.9 t70 71.93 48.71 0.27 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.489 1.516 . . . . 0.0 114.763 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.5 t -89.94 149.79 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 122.289 1.042 . . . . 0.0 110.561 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -62.95 149.09 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -60.64 -40.8 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.18 -55.31 34.71 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.64 -41.99 91.76 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -53.22 -51.96 60.46 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 168.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -65.61 -41.76 92.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.76 -58.13 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.332 0.969 . . . . 0.0 111.519 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.08 74.23 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.09 -28.82 63.56 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 166.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.85 -23.6 39.0 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 mt -69.93 149.51 47.71 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.673 1.578 . . . . 0.0 114.681 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -101.84 91.04 2.14 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.212 171.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 92.7 Cg_endo -75.18 152.35 39.85 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.532 2.154 . . . . 0.0 114.224 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -109.4 117.74 34.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.351 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -84.84 111.94 20.09 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.328 -0.857 . . . . 0.0 110.746 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 107.95 19.75 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.759 -0.588 . . . . 0.0 109.632 165.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -102.92 127.35 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.46 106.32 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 170.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.48 105.58 17.57 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.157 0.583 . . . . 0.0 110.159 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -95.3 79.9 3.51 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.53 0.681 . . . . 0.0 109.751 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.93 -105.06 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.21 -26.67 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 165.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -82.11 107.06 14.51 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.515 1.507 . . . . 0.0 111.49 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.4 ttm -108.44 124.64 50.72 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.999 0.92 . . . . 0.0 111.04 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.48 102.22 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.68 107.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -100.13 101.49 12.55 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -85.1 101.18 12.23 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 mt -99.03 121.33 40.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.899 0.48 . . . . 0.0 111.506 -164.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.8 t -144.41 150.61 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.908 0.861 . . . . 0.0 111.304 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.9 p -63.21 -31.19 72.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -71.04 -52.47 19.34 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -155.39 135.94 13.36 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.94 0.791 . . . . 0.0 110.857 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -88.53 127.77 35.55 Favored 'General case' 0 CA--C 1.568 1.636 0 O-C-N 121.876 -0.515 . . . . 0.0 110.582 167.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -110.14 123.42 49.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.585 -0.697 . . . . 0.0 110.857 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.69 121.09 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -112.46 104.51 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -108.78 110.43 21.81 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.63 0.772 . . . . 0.0 108.926 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -153.67 154.84 34.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -167.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -100.13 125.86 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.728 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.49 125.87 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.639 -0.663 . . . . 0.0 110.811 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.52 -38.86 3.12 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 116.723 1.449 . . . . 0.0 116.723 -161.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -85.47 146.97 26.69 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 118.405 1.102 . . . . 0.0 113.919 -172.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -93.58 112.97 24.97 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.979 0.512 . . . . 0.0 110.003 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -120.82 148.52 43.9 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.985 0.914 . . . . 0.0 112.473 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -70.46 103.04 2.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.662 -1.274 . . . . 0.0 111.757 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -89.99 113.99 25.76 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.17 0.588 . . . . 0.0 109.892 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.94 122.49 24.24 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 121.082 0.468 . . . . 0.0 110.237 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -105.15 44.18 1.05 Allowed 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -81.0 132.67 35.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.952 -1.093 . . . . 0.0 111.366 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.33 -57.65 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.811 -151.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.8 mt -74.42 -63.41 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.76 17.56 1.27 Allowed 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 159.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.05 42.2 31.12 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -111.24 145.1 39.33 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.662 0.785 . . . . 0.0 111.342 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -90.38 117.6 29.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.04 . . . . 0.0 110.013 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.0 m -111.07 144.1 40.72 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.11 90.3 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.55 168.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.0 m -90.69 129.93 36.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 -172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 m -116.63 125.37 51.68 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.438 HG22 ' SG ' ' A' ' 95' ' ' CYS . 40.6 t -115.39 128.76 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.6 m -132.63 148.92 52.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.196 -0.94 . . . . 0.0 112.377 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.824 -1.172 . . . . 0.0 113.344 177.592 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 121.93 0.872 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.6 111.65 23.05 Favored 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -114.83 128.43 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.507 0.723 . . . . 0.0 110.532 -161.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 86' ' ' VAL . 54.1 t -130.67 142.86 50.44 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.2 129.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.493 164.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -103.93 95.9 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -88.72 115.91 26.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.941 -1.099 . . . . 0.0 112.015 -167.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.18 -126.64 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 O-C-N 121.248 -0.907 . . . . 0.0 114.164 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.63 -32.1 65.64 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -103.99 138.65 40.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.823 1.192 . . . . 0.0 111.784 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.41 142.6 30.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.55 45.93 94.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 117.551 1.78 . . . . 0.0 117.551 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -99.95 130.92 46.17 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 121.698 0.761 . . . . 0.0 111.032 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.68 -166.4 34.75 Favored Glycine 0 N--CA 1.482 1.748 0 CA-C-O 121.806 0.67 . . . . 0.0 114.415 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -157.96 156.45 31.25 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.0 m -133.37 124.66 27.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.54 128.78 48.5 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.646 0.778 . . . . 0.0 111.336 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -146.32 169.26 19.18 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.113 -0.992 . . . . 0.0 113.191 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.2 mt -109.1 124.44 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.34 86.78 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.388 163.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.87 -110.54 3.25 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 121.231 -0.918 . . . . 0.0 115.045 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.66 -6.03 59.34 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 162.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.0 137.26 39.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.697 1.589 . . . . 0.0 112.826 -172.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.06 120.17 36.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.612 0.765 . . . . 0.0 109.04 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -110.11 117.58 34.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.2 tp -121.0 117.08 26.36 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.471 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.99 129.7 40.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.955 0.502 . . . . 0.0 109.867 166.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.8 mtp -124.45 123.43 40.14 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.742 0.817 . . . . 0.0 110.089 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -114.29 140.23 48.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.615 -0.678 . . . . 0.0 112.461 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.11 120.13 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.585 0.754 . . . . 0.0 109.506 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 58.56 41.34 22.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.75 -32.76 1.44 Allowed Glycine 0 CA--C 1.558 2.731 0 N-CA-C 118.852 2.301 . . . . 0.0 118.852 -163.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.28 116.19 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 124.757 1.223 . . . . 0.0 110.78 -168.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -106.37 115.31 29.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.099 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.0 t -97.49 127.21 43.26 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.784 0.834 . . . . 0.0 112.082 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -93.53 116.38 28.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -103.36 119.12 38.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 132.86 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -131.09 160.56 34.33 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 124.116 0.966 . . . . 0.0 111.703 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.12 129.7 40.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 110.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -68.47 124.87 24.75 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.56 -40.19 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.563 1.47 0 CA-C-N 119.781 1.173 . . . . 0.0 108.258 169.983 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.261 52.3 t0 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -78.54 5.26 11.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 117.975 2.583 . . . . 0.0 117.975 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -61.42 107.66 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.806 1.639 . . . . 0.0 114.481 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.17 178.79 32.53 Favored Glycine 0 N--CA 1.484 1.89 0 CA-C-O 122.621 1.123 . . . . 0.0 114.888 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -107.76 118.76 37.58 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.33 1.052 . . . . 0.0 109.27 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -118.81 112.48 19.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -168.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -89.53 139.55 30.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 112.831 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.434 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.2 ttp -69.31 121.52 17.05 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 119.889 1.222 . . . . 0.0 114.042 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.93 -44.41 18.29 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -152.95 159.13 42.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.398 -1.439 . . . . 0.0 113.724 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -140.39 118.76 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.692 -174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.96 118.3 19.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.745 -0.597 . . . . 0.0 110.439 -167.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.283 23.1 t30 66.6 33.76 6.33 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -80.25 -42.34 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.78 -42.85 80.16 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.28 -39.87 89.71 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -54.79 -47.58 73.81 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.64 -40.44 73.07 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -57.88 -41.9 83.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 165.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.43 58.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 164.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 mt -86.75 -49.67 7.29 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.22 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 125.835 1.654 . . . . 0.0 114.986 165.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.01 148.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 119.306 -2.121 . . . . 0.0 112.886 -136.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.66 153.21 40.2 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -60.0 -41.81 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.49 -54.73 42.3 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 172.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.16 -38.17 85.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -57.18 -51.22 70.21 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.38 -41.71 93.44 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.17 -58.21 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 119.446 1.021 . . . . 0.0 111.373 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.64 76.48 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -68.45 -36.22 78.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.83 -28.75 63.78 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.0 mt -72.5 135.24 45.63 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.541 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 101.99 7.97 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.565 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 34.1 Cg_endo -65.76 142.99 72.26 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 CA-C-N 123.315 2.22 . . . . 0.0 113.94 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.54 113.39 25.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -88.57 110.78 21.18 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.767 -0.583 . . . . 0.0 111.287 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -97.84 106.91 19.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.61 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.18 109.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 164.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -102.22 109.88 21.68 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.537 0.735 . . . . 0.0 109.99 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -100.19 74.97 1.79 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.05 -104.02 0.89 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.12 -31.3 39.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.06 127.58 33.55 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.893 1.678 . . . . 0.0 111.701 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.11 123.67 22.24 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-O 121.348 0.594 . . . . 0.0 111.274 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.4 mt -109.61 105.8 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.16 115.71 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -107.39 96.16 6.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -86.75 95.52 9.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 mt -95.15 130.74 41.76 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -162.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -149.52 152.72 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.926 0.87 . . . . 0.0 110.97 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.6 p -62.33 -31.65 72.3 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -75.27 -52.46 10.81 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -151.0 129.27 11.97 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 119.042 0.837 . . . . 0.0 110.498 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.3 123.16 33.84 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.307 0.643 . . . . 0.0 109.568 167.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -103.56 110.85 23.05 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 119.087 0.858 . . . . 0.0 109.658 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.9 mm -104.1 116.9 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.1 mtp -103.81 133.91 48.0 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.37 109.43 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.97 160.44 41.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -167.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -103.37 131.09 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.836 0.827 . . . . 0.0 110.519 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.89 131.63 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 CA-C-O 121.966 0.889 . . . . 0.0 110.166 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.9 22.76 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 -161.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -101.33 143.22 31.64 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.241 1.521 . . . . 0.0 111.608 -166.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.39 108.8 20.14 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.003 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.13 146.97 44.69 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.54 108.02 4.72 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.96 0.886 . . . . 0.0 112.524 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.41 106.78 15.36 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.663 0.785 . . . . 0.0 109.939 -168.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.54 119.44 24.71 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.817 0.818 . . . . 0.0 110.707 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.04 52.49 1.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 m -73.66 128.22 34.91 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.468 1.107 . . . . 0.0 112.46 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.52 -60.98 0.41 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.987 -0.446 . . . . 0.0 113.648 -157.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.61 -61.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 124.245 1.018 . . . . 0.0 110.95 -174.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -143.63 3.57 1.29 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 165.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 7.8 t70 44.62 55.28 5.95 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -163.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.521 ' HE ' ' HZ1' ' A' ' 101' ' ' LYS . 76.2 mmt-85 -110.89 138.18 47.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.661 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -97.88 104.45 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.2 m -109.27 145.62 35.62 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.363 0.601 . . . . 0.0 111.862 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.8 mmm -85.17 91.72 8.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.147 169.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.9 m -96.6 122.66 39.76 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.653 -166.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 m -100.21 117.14 33.82 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -105.76 128.92 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -141.6 153.9 45.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.965 -1.085 . . . . 0.0 112.585 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.4 m95 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.979 -1.076 . . . . 0.0 111.868 175.756 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.74 106.69 18.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.097 -1.002 . . . . 0.0 110.098 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -95.37 150.42 20.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.967 0.907 . . . . 0.0 112.395 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -146.44 135.17 22.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.013 0.525 . . . . 0.0 112.315 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.93 126.6 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.65 0.78 . . . . 0.0 109.173 167.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -103.3 92.28 4.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -86.18 134.25 33.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.855 . . . . 0.0 112.961 -167.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 141.23 -90.68 0.18 Allowed Glycine 0 N--CA 1.486 2.031 0 O-C-N 121.441 -0.787 . . . . 0.0 113.713 167.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.29 -12.4 59.07 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -169.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HZ1' ' HE ' ' A' ' 80' ' ' ARG . 24.0 mmtm -129.21 148.98 51.19 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.672 1.578 . . . . 0.0 112.757 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -82.11 114.18 20.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.787 0.835 . . . . 0.0 111.258 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.54 43.04 99.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 118.11 2.004 . . . . 0.0 118.11 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -86.17 135.93 33.39 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.304 1.052 . . . . 0.0 111.635 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -170.79 38.6 Favored Glycine 0 N--CA 1.482 1.721 0 CA-C-O 122.12 0.845 . . . . 0.0 114.262 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 61.7 p-90 -153.56 165.06 37.07 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.406 1.098 . . . . 0.0 113.183 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 m -138.47 125.77 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.43 129.0 42.46 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.725 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -151.62 165.49 34.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.002 -1.061 . . . . 0.0 113.242 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -107.41 131.0 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -0.936 . . . . 0.0 109.298 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -119.2 95.45 4.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 162.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.77 -117.4 4.72 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.677 -0.64 . . . . 0.0 114.151 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -94.59 15.9 16.85 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.994 1.849 . . . . 0.0 115.994 162.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -113.74 125.21 53.86 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.583 1.083 . . . . 0.0 111.055 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.3 120.64 26.1 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.375 1.07 . . . . 0.0 109.712 166.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -107.11 119.14 38.57 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.579 0.751 . . . . 0.0 108.979 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 tp -115.66 128.55 56.0 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.756 0.822 . . . . 0.0 110.013 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.88 123.8 50.66 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.638 0.775 . . . . 0.0 110.042 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.7 mtm -115.41 137.17 52.34 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.857 0.863 . . . . 0.0 111.483 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -127.11 135.05 50.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.539 -0.726 . . . . 0.0 111.578 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.77 125.4 6.38 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.118 0.567 . . . . 0.0 111.438 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 54.56 42.6 31.2 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.38 -6.95 6.92 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 120.377 2.911 . . . . 0.0 120.377 -165.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.21 126.15 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.281 2.04 . . . . 0.0 109.93 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -108.47 128.99 55.27 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.934 0.894 . . . . 0.0 111.085 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.4 t -125.12 126.5 45.41 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 0.0 112.75 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.95 135.54 35.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.552 -0.718 . . . . 0.0 112.127 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -129.04 134.5 48.15 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.351 0.661 . . . . 0.0 110.656 162.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.6 t -116.68 130.32 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.84 132.73 43.95 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.905 0.775 . . . . 0.0 111.252 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -103.61 133.75 48.1 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.227 -1.545 . . . . 0.0 112.631 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.96 120.88 16.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.0 -38.57 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 . . . . . 0 CA--C 1.563 1.464 0 CA-C-N 119.933 1.242 . . . . 0.0 108.318 169.274 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 CA--C 1.565 1.557 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -78.8 2.1 21.01 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -57.82 105.68 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 121.348 1.886 . . . . 0.0 115.114 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.53 179.83 35.55 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -109.64 113.0 25.41 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.592 1.157 . . . . 0.0 109.218 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -115.15 111.61 21.28 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -168.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.31 141.35 28.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.6 ttp -71.76 121.69 19.36 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.615 -1.303 . . . . 0.0 113.987 -173.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.2 mt -83.13 -45.09 14.36 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -153.52 160.45 42.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.505 -1.372 . . . . 0.0 113.333 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.34 117.98 10.4 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.002 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.76 121.0 35.26 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.749 0.82 . . . . 0.0 109.834 -172.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.285 31.1 t30 68.36 34.2 3.87 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -78.68 -40.53 33.66 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -56.4 -35.86 68.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 168.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.76 -41.92 67.83 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.946 1.703 . . . . 0.0 114.675 166.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.25 -51.12 65.54 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 120.079 1.308 . . . . 0.0 113.802 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.04 -38.18 82.21 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -59.92 -39.21 84.69 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -34.3 62.77 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 165.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.96 -9.79 58.86 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.318 15.9 t0 67.95 49.8 0.87 Allowed 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 125.592 1.557 . . . . 0.0 114.581 -161.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.5 t -93.51 137.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.93 0.872 . . . . 0.0 109.758 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -61.82 150.52 36.96 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 176.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -52.51 -44.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.51 68.96 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 172.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -36.29 80.79 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -61.97 -51.21 69.01 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.307 1.867 . . . . 0.0 115.447 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -60.22 -44.58 95.05 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.08 -55.96 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.724 0.693 . . . . 0.0 111.391 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.41 77.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -70.67 -32.05 69.18 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.61 -24.12 53.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -72.22 154.28 41.1 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -99.0 95.96 3.68 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.364 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.72 143.65 30.32 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.507 2.138 . . . . 0.0 113.477 166.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.14 117.22 32.67 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -85.92 107.18 17.6 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.371 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.22 108.7 20.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 170.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -106.6 127.84 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -116.15 109.15 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -106.79 105.48 15.53 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 123.881 0.873 . . . . 0.0 110.578 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.78 75.68 6.47 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 110.054 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.39 -100.36 0.47 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 115.231 0.853 . . . . 0.0 115.231 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.54 -29.04 28.19 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.17 110.49 17.42 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.353 1.433 . . . . 0.0 111.016 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -126.98 130.67 50.51 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.439 1.114 . . . . 0.0 111.949 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.86 101.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.2 mt -93.12 110.59 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -103.1 100.13 10.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -83.25 97.9 9.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.84 112.38 25.47 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.667 0.746 . . . . 0.0 110.627 -165.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 t -127.98 149.87 50.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.486 0.66 . . . . 0.0 109.789 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -61.33 -28.26 69.09 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -76.11 -42.47 46.99 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 166.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -156.47 131.39 9.06 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 120.214 1.37 . . . . 0.0 112.864 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -109.29 122.2 46.83 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.532 0.733 . . . . 0.0 110.297 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.42 108.88 15.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.325 -0.86 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.09 127.59 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-O 121.65 0.738 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -108.64 105.81 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.814 0.846 . . . . 0.0 109.505 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -104.99 116.65 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.429 0.692 . . . . 0.0 109.775 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -153.66 155.79 36.69 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.28 128.45 46.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.442 -0.786 . . . . 0.0 110.522 165.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.7 t -68.27 121.93 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 123.453 0.701 . . . . 0.0 110.255 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.36 -35.17 4.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -162.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.1 140.31 29.58 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.732 1.266 . . . . 0.0 112.06 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.13 107.12 18.99 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 122.041 -0.412 . . . . 0.0 111.079 171.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -112.46 133.77 54.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.577 0.751 . . . . 0.0 112.026 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.97 94.2 2.32 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 112.18 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -96.63 130.28 43.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.641 -0.662 . . . . 0.0 111.616 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.51 124.29 28.82 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.19 67.73 4.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.115 1.436 . . . . 0.0 111.665 171.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -75.52 126.14 30.43 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.483 -166.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.22 64.75 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -170.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.75 -75.26 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.35 7.48 4.22 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.5 t0 43.84 59.98 2.9 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -115.2 141.51 47.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.59 -0.694 . . . . 0.0 111.375 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.47 115.52 28.1 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.335 0.654 . . . . 0.0 110.607 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.8 m -120.42 135.24 55.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.284 0.633 . . . . 0.0 111.751 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.0 mmm -76.63 99.77 5.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.787 . . . . 0.0 110.463 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.4 m -101.49 118.74 37.58 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.696 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.6 m -97.6 124.17 41.78 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.46 132.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.9 m -151.07 153.58 35.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.321 -1.487 . . . . 0.0 113.234 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.336 . . . . 0.0 113.27 -179.327 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.236 0.541 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.8 tp -89.4 107.36 19.03 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.586 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -90.1 141.35 28.77 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.898 0.879 . . . . 0.0 111.563 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -133.14 125.52 29.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.516 0.726 . . . . 0.0 110.923 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -113.19 121.63 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 123.225 0.61 . . . . 0.0 109.731 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -103.65 102.11 11.97 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.392 0.677 . . . . 0.0 111.024 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.34 125.0 39.66 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.68 -118.01 0.62 Allowed Glycine 0 N--CA 1.49 2.241 0 O-C-N 121.102 -0.999 . . . . 0.0 112.976 170.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.55 -36.12 81.89 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -89.55 130.86 35.8 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -163.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.4 117.82 22.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.566 . . . . 0.0 111.889 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.11 46.94 93.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 117.737 1.855 . . . . 0.0 117.737 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -93.01 136.92 32.83 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.19 0.995 . . . . 0.0 111.762 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 -171.12 43.03 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 122.842 1.245 . . . . 0.0 114.244 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -154.08 152.78 30.86 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.101 0.953 . . . . 0.0 112.47 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 79.3 m -125.59 125.14 42.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.64 139.24 53.32 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -151.78 164.14 37.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 113.072 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.51 140.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 122.847 1.308 . . . . 0.0 110.689 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -137.16 84.05 2.03 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.08 -111.16 3.4 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.846 -0.533 . . . . 0.0 113.816 -171.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -93.03 6.96 46.07 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -106.62 127.59 53.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.96 1.709 . . . . 0.0 112.741 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.7 tp -85.61 119.16 25.64 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.119 0.968 . . . . 0.0 109.381 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.52 122.57 46.28 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.9 126.32 48.4 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.599 0.76 . . . . 0.0 111.473 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -106.0 123.1 47.45 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.394 0.678 . . . . 0.0 109.639 164.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 63.7 mtm -110.09 129.75 55.64 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 118.948 0.795 . . . . 0.0 110.64 172.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -125.68 144.55 50.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.41 127.7 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.606 0.763 . . . . 0.0 110.978 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 51.1 49.7 20.61 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.7 -32.54 1.43 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.67 157.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 125.14 1.376 . . . . 0.0 112.866 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.6 m -129.94 121.95 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.712 -1.243 . . . . 0.0 110.218 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.5 t -97.14 131.68 43.66 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.3 0.64 . . . . 0.0 110.508 161.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -113.8 120.01 39.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.859 -0.526 . . . . 0.0 110.511 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -120.18 139.24 52.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.565 0.746 . . . . 0.0 111.48 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.05 129.79 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.16 142.3 51.22 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.924 0.89 . . . . 0.0 110.663 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -112.59 133.38 54.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.377 -1.452 . . . . 0.0 111.94 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -67.92 122.64 18.61 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.4 m -117.27 -34.49 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t60 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 169.118 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 CA--C 1.565 1.546 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -81.27 2.51 27.71 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -59.56 116.12 3.78 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.219 1.827 . . . . 0.0 114.59 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.94 177.95 31.52 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-O 123.246 1.47 . . . . 0.0 115.758 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -110.44 112.37 24.25 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 113.727 -1.236 . . . . 0.0 108.677 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -112.47 122.68 48.4 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -167.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -91.87 143.94 25.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.802 -1.186 . . . . 0.0 113.092 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.402 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.5 ttm -73.49 122.41 22.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.721 -1.237 . . . . 0.0 112.988 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.31 -44.74 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -154.0 158.31 40.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.459 -1.4 . . . . 0.0 112.645 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -135.8 100.62 4.51 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.08 -64.42 1.15 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -154.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -120.54 43.55 2.71 Favored 'General case' 0 CA--C 1.571 1.773 0 C-N-CA 123.717 0.807 . . . . 0.0 111.273 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 17.0 t80 -73.62 -39.85 64.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.54 -46.05 70.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.44 -39.82 85.43 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -55.73 -45.98 77.87 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 165.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.97 -41.42 86.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -53.83 -44.71 70.47 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.89 52.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 166.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.68 -5.71 56.8 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 164.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 7.5 t70 69.6 62.78 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 120.38 1.445 . . . . 0.0 112.996 -164.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 83.5 t -104.03 148.23 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.19 0.995 . . . . 0.0 110.034 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -62.25 151.88 35.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.77 -42.91 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.95 -54.37 45.52 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.63 -38.5 84.98 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -53.53 -52.13 60.65 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -65.29 -45.28 85.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.17 -56.49 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.538 0.735 . . . . 0.0 111.819 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -27.01 66.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.11 -43.22 83.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 162.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.67 -28.14 65.62 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 mt -68.46 135.59 51.91 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 120.034 1.288 . . . . 0.0 112.893 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -113.06 84.57 7.16 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.19 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 70.7 Cg_endo -71.95 168.6 23.46 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 122.624 2.216 . . . . 0.0 116.054 -176.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.77 121.86 45.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.145 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -89.88 110.23 21.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.613 -0.679 . . . . 0.0 110.009 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.3 108.78 20.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 167.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -106.19 123.96 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.53 107.94 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -103.04 119.02 38.1 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.928 0.891 . . . . 0.0 109.36 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.7 -60.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 112.546 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.81 101.49 0.15 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.455 1.0 OUTLIER 60.46 -45.16 0.1 Allowed 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -150.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -70.34 126.66 30.28 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-N 119.874 1.215 . . . . 0.0 112.361 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 ttp -143.39 131.89 22.3 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.105 0.955 . . . . 0.0 111.674 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.9 mt -115.4 109.78 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -97.44 115.72 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -111.54 96.01 5.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.702 -0.624 . . . . 0.0 109.347 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.3 m -87.13 103.06 15.04 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.9 mt -101.04 114.86 29.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -130.28 149.29 52.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.7 0.8 . . . . 0.0 110.209 168.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -65.77 -16.36 63.72 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 167.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -76.56 -53.31 8.24 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.459 1.027 . . . . 0.0 112.739 163.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -155.0 135.16 13.1 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 121.784 0.802 . . . . 0.0 111.023 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.19 121.42 34.53 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.765 0.826 . . . . 0.0 110.084 173.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -112.34 104.94 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.833 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.82 125.28 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 121.818 0.818 . . . . 0.0 109.106 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.9 mtp -103.67 109.99 21.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.64 0.776 . . . . 0.0 109.015 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -108.31 110.6 22.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.554 0.742 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.69 42.25 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -166.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.24 129.9 55.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 168.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.07 123.51 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 123.519 0.728 . . . . 0.0 110.287 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.31 -32.32 7.66 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 117.333 1.693 . . . . 0.0 117.333 -164.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -87.87 145.15 26.2 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.991 1.395 . . . . 0.0 112.578 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.97 120.09 32.3 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.79 -0.569 . . . . 0.0 111.068 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -126.55 151.32 48.05 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.917 0.887 . . . . 0.0 112.263 -171.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.64 97.73 3.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.655 -1.278 . . . . 0.0 112.253 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -84.57 105.23 15.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.37 101.96 9.31 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.157 0.503 . . . . 0.0 110.362 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.48 52.44 2.37 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -83.08 130.73 35.15 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.034 0.934 . . . . 0.0 111.382 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.6 -51.62 0.73 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 -151.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.13 -73.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -164.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.88 28.91 2.11 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 159.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.28 16.7 m-20 55.83 31.26 17.32 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.154 2.649 . . . . 0.0 118.154 174.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -108.01 141.18 40.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 113.147 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -90.92 109.73 20.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.226 0.611 . . . . 0.0 110.667 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.1 m -107.14 128.46 54.42 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.045 0.538 . . . . 0.0 111.343 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 95.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.267 1.032 . . . . 0.0 110.483 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.9 m -105.47 125.92 51.54 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.607 -0.683 . . . . 0.0 109.941 -161.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 m -116.62 115.94 26.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.415 HG22 ' SG ' ' A' ' 95' ' ' CYS . 60.8 t -107.53 121.65 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -138.25 150.41 46.66 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.144 0.883 . . . . 0.0 111.874 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 85.5 m95 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 120.427 -1.421 . . . . 0.0 112.593 175.23 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.105 0.479 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.23 104.34 15.69 Favored 'General case' 0 CA--C 1.564 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -110.45 131.59 54.92 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.689 0.757 . . . . 0.0 111.152 -167.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 86' ' ' VAL . 52.9 t -125.66 138.07 53.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.6 0.76 . . . . 0.0 112.88 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -113.58 126.93 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 123.673 0.789 . . . . 0.0 109.178 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -102.49 95.37 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.485 0.714 . . . . 0.0 109.144 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.78 123.38 29.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.918 -1.114 . . . . 0.0 112.276 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.45 -90.66 0.11 Allowed Glycine 0 N--CA 1.484 1.886 0 O-C-N 121.598 -0.689 . . . . 0.0 114.49 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -88.74 -12.81 41.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -161.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -131.58 149.56 52.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.44 1.473 . . . . 0.0 111.612 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.39 115.01 21.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.459 1.104 . . . . 0.0 111.601 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.36 53.39 6.8 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -105.55 128.19 53.45 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.908 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.0 40.77 Favored Glycine 0 N--CA 1.486 1.997 0 O-C-N 121.601 -0.687 . . . . 0.0 114.395 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.255 40.1 p-90 -155.44 157.39 36.92 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.4 m -131.63 124.03 29.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.405 -0.81 . . . . 0.0 109.003 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.94 133.97 53.6 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.759 0.824 . . . . 0.0 111.722 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -149.78 171.52 16.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 0.0 112.746 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.23 126.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.45 90.71 3.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.438 163.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.98 -110.66 3.17 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.326 -0.858 . . . . 0.0 114.91 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.84 5.25 44.58 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 163.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -110.37 126.71 54.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.596 1.544 . . . . 0.0 112.432 -170.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.299 0.64 . . . . 0.0 109.791 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -113.55 120.14 39.94 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.0 tp -121.53 123.95 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.094 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -99.8 121.88 41.94 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.501 0.721 . . . . 0.0 110.025 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 50.1 mtm -115.44 132.97 56.46 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.536 1.062 . . . . 0.0 111.854 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.65 134.66 55.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 112.911 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.43 124.68 12.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 0.0 109.97 172.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 53.79 40.28 31.32 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 -8.35 9.54 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 120.263 2.865 . . . . 0.0 120.263 -164.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.58 117.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 120.399 2.1 . . . . 0.0 109.298 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.9 m -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.341 0.656 . . . . 0.0 111.234 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.45 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 8.6 t -97.22 129.79 44.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 111.753 166.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -98.18 125.41 43.2 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.696 0.68 . . . . 0.0 110.644 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -113.36 123.71 50.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.312 0.645 . . . . 0.0 109.323 169.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.81 133.65 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -135.4 156.61 48.63 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.522 1.129 . . . . 0.0 111.259 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.83 126.71 42.16 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.561 -1.337 . . . . 0.0 110.449 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -69.29 122.16 18.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.133 -0.979 . . . . 0.0 113.087 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.99 -38.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.5 t60 . . . . . 0 N--CA 1.487 1.404 0 CA-C-N 119.851 1.205 . . . . 0.0 108.112 170.071 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 t0 . . . . . 0 CA--C 1.564 1.502 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -82.53 4.49 24.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -60.6 114.28 2.9 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 121.419 1.918 . . . . 0.0 114.443 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.27 178.06 30.97 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-O 122.79 1.217 . . . . 0.0 115.738 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -108.88 115.26 29.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.399 1.079 . . . . 0.0 109.184 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -116.8 112.93 21.82 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.426 0.691 . . . . 0.0 109.189 -167.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -85.33 142.7 29.14 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.185 -0.947 . . . . 0.0 112.61 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.3 ttp -73.64 121.61 20.99 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-N 120.459 1.481 . . . . 0.0 113.042 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt -81.7 -44.12 17.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -154.5 160.22 41.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.413 -1.43 . . . . 0.0 113.322 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -136.0 118.86 16.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.808 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -124.26 122.68 38.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.597 0.759 . . . . 0.0 110.145 -170.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.2 t30 65.91 38.23 5.11 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.67 -40.89 16.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.77 -37.54 68.69 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.48 -41.12 69.75 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 120.922 1.692 . . . . 0.0 114.9 167.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -54.93 -46.67 74.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.55 -37.44 68.26 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -57.91 -41.38 82.51 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 164.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.15 -18.05 32.53 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 165.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -95.42 9.92 38.25 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 165.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.271 20.1 t70 57.99 50.16 10.66 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.5 t -98.72 141.01 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.836 0.827 . . . . 0.0 110.024 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.8 149.86 45.95 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.74 -45.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -50.58 70.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.36 -43.6 98.59 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -58.21 -47.88 82.08 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -60.04 -43.58 95.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.51 -56.98 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 118.717 0.69 . . . . 0.0 111.374 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.54 81.6 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -67.51 -32.59 73.5 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.34 -24.24 46.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 170.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.0 mt -68.92 147.05 52.23 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.513 1.506 . . . . 0.0 114.302 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.95 90.89 4.8 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.262 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.2 147.01 47.13 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.617 2.211 . . . . 0.0 114.415 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.99 117.84 29.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -88.44 110.75 21.08 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.654 -0.654 . . . . 0.0 111.084 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -96.08 107.7 20.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.514 -0.742 . . . . 0.0 109.355 167.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -105.84 127.33 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.18 110.08 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -106.78 110.86 23.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.312 0.645 . . . . 0.0 110.603 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -101.99 81.27 2.09 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.664 0.785 . . . . 0.0 109.52 168.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.91 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 121.559 -0.713 . . . . 0.0 114.341 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.76 -20.02 22.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 163.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -77.91 112.62 14.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.019 1.736 . . . . 0.0 111.923 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.3 ttm -123.27 125.01 44.27 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.677 0.751 . . . . 0.0 111.037 -165.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.1 mm -111.39 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -92.69 108.02 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.67 94.62 6.19 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.7 m -85.41 98.6 10.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.133 -0.979 . . . . 0.0 108.887 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.5 mt -97.18 115.13 27.01 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.848 -0.533 . . . . 0.0 110.7 -165.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 t -132.86 152.71 51.8 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.756 0.788 . . . . 0.0 110.476 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.6 p -64.34 -28.59 69.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -73.79 -48.19 33.34 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -154.89 135.57 13.54 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.498 1.044 . . . . 0.0 111.831 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.23 116.18 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.552 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -105.8 108.38 19.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 110.316 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mm -106.64 119.2 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.48 112.32 24.15 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.589 0.756 . . . . 0.0 109.641 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -112.27 112.36 23.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.599 0.76 . . . . 0.0 109.272 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -155.99 145.58 21.02 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -91.53 124.76 35.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.806 165.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.37 124.34 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.64 -0.663 . . . . 0.0 109.516 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.93 -39.27 2.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -157.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -95.6 152.83 18.09 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.561 1.181 . . . . 0.0 112.752 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -93.12 125.89 37.94 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.405 168.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.74 144.23 48.96 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.496 0.718 . . . . 0.0 112.32 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.27 100.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.493 -1.38 . . . . 0.0 112.978 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.94 104.91 16.72 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 121.829 -0.545 . . . . 0.0 109.707 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -74.0 99.18 3.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.793 0.437 . . . . 0.0 111.359 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.54 52.08 2.0 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -88.07 127.44 35.4 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.337 1.055 . . . . 0.0 111.411 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.97 -44.83 1.4 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 -148.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -93.66 -74.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.471 1.108 . . . . 0.0 108.647 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -122.46 -6.02 8.73 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 168.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 21.6 m-20 63.53 49.03 3.21 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 mtm-85 -141.94 143.26 33.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.116 -0.99 . . . . 0.0 111.475 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.86 94.97 6.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 -173.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -83.24 136.72 34.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.593 -0.692 . . . . 0.0 112.794 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.9 mtp -82.91 91.72 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.588 1.185 . . . . 0.0 110.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.429 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 40.4 m -102.75 122.13 43.84 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.414 -0.803 . . . . 0.0 110.898 -156.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -103.49 122.42 44.88 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.9 t -109.29 127.11 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -124.31 152.95 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.763 0.825 . . . . 0.0 111.924 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 120.933 -1.104 . . . . 0.0 113.193 178.143 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 122.162 0.982 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 tp -88.79 109.32 20.07 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -111.76 126.97 55.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 -162.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.429 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 44.8 t -127.62 135.41 50.23 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -168.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -112.83 122.28 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.607 0.763 . . . . 0.0 109.367 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -98.25 93.58 6.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.612 0.765 . . . . 0.0 109.111 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -85.77 122.51 29.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.8 -1.188 . . . . 0.0 112.309 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.8 -111.23 0.36 Allowed Glycine 0 N--CA 1.484 1.896 0 O-C-N 121.623 -0.673 . . . . 0.0 113.405 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.39 -3.61 56.53 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -121.06 143.42 49.08 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.196 1.362 . . . . 0.0 113.067 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -81.48 97.63 7.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -170.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.93 49.81 6.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.57 138.05 31.88 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.735 0.779 . . . . 0.0 112.436 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 -166.3 35.24 Favored Glycine 0 N--CA 1.486 1.974 0 CA-C-O 121.934 0.741 . . . . 0.0 114.807 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -159.09 153.35 23.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.8 m -130.23 125.98 36.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -126.3 129.15 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.765 0.826 . . . . 0.0 110.849 -172.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -145.72 167.56 22.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.978 -1.076 . . . . 0.0 113.449 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.8 mt -110.34 126.46 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.95 89.37 3.04 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 164.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.79 -112.05 3.57 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.299 -0.876 . . . . 0.0 114.679 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -89.99 2.96 54.55 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 161.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -102.63 134.43 46.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.557 1.526 . . . . 0.0 112.518 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -97.19 122.8 40.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.082 0.953 . . . . 0.0 109.19 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -114.52 122.38 46.39 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.464 0.706 . . . . 0.0 109.279 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp -123.95 122.15 37.18 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.456 0.702 . . . . 0.0 110.832 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.1 128.56 44.68 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.217 0.607 . . . . 0.0 109.865 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.4 mtm -117.95 130.43 56.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 118.894 0.77 . . . . 0.0 110.597 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -113.92 138.19 50.66 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.575 0.75 . . . . 0.0 112.818 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.87 116.51 4.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 110.2 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.305 6.0 mt-10 54.07 50.18 17.18 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.11 -14.48 3.84 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 120.577 2.991 . . . . 0.0 120.577 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.77 124.51 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.447 2.123 . . . . 0.0 110.017 -166.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -93.54 123.2 36.69 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.134 0.574 . . . . 0.0 110.697 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.67 135.92 37.91 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.066 0.547 . . . . 0.0 111.061 159.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -113.43 118.83 35.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.807 -0.558 . . . . 0.0 110.58 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -114.75 133.75 55.66 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.465 0.65 . . . . 0.0 110.903 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.36 131.0 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -127.66 160.42 31.68 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 124.475 1.11 . . . . 0.0 111.196 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -133.22 133.28 42.51 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.488 -1.383 . . . . 0.0 112.263 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -70.25 123.63 22.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.71 -37.56 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 . . . . . 0 CA--C 1.567 1.61 0 CA-C-N 119.739 1.154 . . . . 0.0 108.344 171.233 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.7 t0 . . . . . 0 CA--C 1.566 1.564 0 CA-C-O 121.24 0.543 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -81.83 -2.46 51.05 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 173.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -58.01 108.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 121.092 1.769 . . . . 0.0 114.499 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.71 33.94 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-O 122.609 1.116 . . . . 0.0 114.98 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -118.74 118.33 31.31 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.17 0.988 . . . . 0.0 109.441 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.19 114.72 20.66 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -164.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.04 141.15 29.15 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.978 -1.076 . . . . 0.0 113.769 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.1 ttp -76.24 119.21 19.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.26 -44.5 17.65 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -154.26 158.52 40.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.535 -1.353 . . . . 0.0 113.372 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -130.68 100.03 5.16 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.093 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -103.02 115.19 30.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.53 -0.731 . . . . 0.0 110.145 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 42.2 t30 58.56 31.31 20.91 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.14 -34.15 76.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 167.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 -49.54 77.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -37.11 80.11 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -57.73 -45.79 85.32 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.01 -40.33 78.74 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -55.48 -45.33 76.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.96 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 166.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.24 2.25 54.53 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.275 26.9 t0 64.49 56.61 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 120.259 1.39 . . . . 0.0 113.296 -169.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -103.1 139.45 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -66.77 157.17 33.53 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.9 t -60.7 -45.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -47.55 83.81 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.47 -44.77 92.94 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -52.09 -56.3 15.33 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -57.04 -33.07 66.84 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.18 -59.28 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 CA-C-N 118.757 0.708 . . . . 0.0 111.192 164.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.79 91.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -60.53 -36.7 79.03 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 170.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.58 -20.01 37.37 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.37 138.2 51.16 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 120.292 1.406 . . . . 0.0 113.091 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -111.23 85.4 5.44 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.22 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.8 158.83 54.52 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.608 2.205 . . . . 0.0 116.18 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.13 116.87 33.33 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.291 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -86.44 111.74 20.83 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.376 -0.828 . . . . 0.0 110.483 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.32 110.67 23.18 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.3 129.05 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.73 109.54 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -101.4 102.51 13.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.821 0.849 . . . . 0.0 110.126 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.8 71.93 5.72 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.72 0.808 . . . . 0.0 110.249 167.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.53 0.45 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -80.48 -33.38 36.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.74 114.83 19.9 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 120.186 1.357 . . . . 0.0 111.493 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.3 ttm -125.37 123.33 39.12 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.514 0.673 . . . . 0.0 110.984 -167.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.59 100.95 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.54 112.58 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -104.95 102.19 11.72 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 m -86.16 99.19 11.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.2 mt -99.6 116.05 30.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.088 0.555 . . . . 0.0 110.317 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -131.11 154.66 48.07 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.946 0.879 . . . . 0.0 110.741 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.3 p -62.97 -31.61 72.76 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -79.0 -45.06 21.0 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -158.01 132.69 8.4 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.973 1.261 . . . . 0.0 112.555 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -96.56 121.11 38.03 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.435 0.694 . . . . 0.0 110.388 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -110.67 104.63 13.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.375 -0.828 . . . . 0.0 110.631 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.54 125.54 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 122.087 0.946 . . . . 0.0 108.586 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.9 mtp -112.57 128.18 56.29 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.515 1.126 . . . . 0.0 108.603 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.04 95.15 3.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.686 . . . . 0.0 109.244 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -129.85 151.18 50.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -97.05 119.31 35.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.584 -0.698 . . . . 0.0 109.831 166.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.37 118.1 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 C-N-CA 123.458 0.703 . . . . 0.0 110.119 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.89 -43.45 1.49 Allowed Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -158.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.64 147.3 25.33 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.65 134.99 35.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.766 -0.584 . . . . 0.0 111.578 165.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -144.11 156.54 44.39 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.833 0.825 . . . . 0.0 112.903 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.98 98.16 3.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.46 0.704 . . . . 0.0 111.88 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -100.33 101.47 12.47 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.574 -0.704 . . . . 0.0 111.262 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -81.35 109.63 16.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.807 -0.558 . . . . 0.0 110.544 167.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.33 57.36 3.6 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-O 121.988 0.899 . . . . 0.0 112.854 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.0 t -76.31 140.48 41.52 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.15 0.98 . . . . 0.0 113.126 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.55 -46.43 1.96 Allowed Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -159.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mt -78.66 -74.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.513 1.125 . . . . 0.0 110.044 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -134.36 -3.47 2.71 Favored 'General case' 0 CA--C 1.574 1.886 0 C-N-CA 125.482 1.513 . . . . 0.0 114.457 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 1.6 m-20 54.1 57.18 6.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.68 134.58 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.19 0.519 . . . . 0.0 111.096 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -85.65 125.51 33.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.646 0.778 . . . . 0.0 111.61 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.92 148.7 48.21 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.493 0.717 . . . . 0.0 112.121 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.04 97.77 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.597 168.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.2 m -100.64 122.18 42.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 122.04 -0.412 . . . . 0.0 111.337 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -111.77 122.82 48.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.43 131.61 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.4 m -133.22 148.6 52.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 111.788 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 62.8 m95 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 111.121 172.089 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.58 0.705 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.52 108.64 21.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.537 -0.727 . . . . 0.0 110.218 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -112.46 132.39 55.08 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.463 0.705 . . . . 0.0 111.256 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -126.19 136.1 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.95 130.02 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -120.88 95.65 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.674 . . . . 0.0 110.405 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -77.91 120.83 23.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 112.925 -173.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.64 -115.71 0.35 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.989 -0.444 . . . . 0.0 112.255 172.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -78.53 -25.72 45.61 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -108.44 148.66 29.85 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.307 1.412 . . . . 0.0 112.957 -157.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.32 110.1 17.17 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.175 0.99 . . . . 0.0 111.85 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.49 51.52 9.59 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -92.76 116.59 29.16 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 117.316 0.558 . . . . 0.0 111.836 -171.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.55 -168.65 39.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -154.03 157.99 39.89 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.943 0.877 . . . . 0.0 112.958 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.5 m -132.93 127.49 34.41 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.036 -1.04 . . . . 0.0 108.682 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -127.58 131.44 49.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.778 . . . . 0.0 111.088 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.48 174.15 12.8 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.96 132.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.963 . . . . 0.0 109.436 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.09 92.17 3.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.743 0.817 . . . . 0.0 109.048 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.19 -114.85 4.44 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.346 -0.847 . . . . 0.0 114.746 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -88.7 4.98 45.38 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 163.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -106.56 129.92 54.41 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.101 1.319 . . . . 0.0 111.93 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.07 122.18 30.55 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.251 1.02 . . . . 0.0 109.733 166.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -113.44 124.33 52.17 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.733 0.813 . . . . 0.0 109.578 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.7 tp -127.83 119.5 25.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.253 0.621 . . . . 0.0 110.629 -173.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -90.26 135.23 33.8 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.892 0.477 . . . . 0.0 110.316 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.0 mtp -130.22 124.13 31.8 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.6 0.76 . . . . 0.0 109.856 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -122.88 132.32 54.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -0.753 . . . . 0.0 111.872 -164.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.03 131.66 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.233 0.613 . . . . 0.0 111.451 174.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 56.24 39.34 30.26 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.03 0.95 16.83 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 120.193 2.837 . . . . 0.0 120.193 -163.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.59 118.98 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 120.065 1.933 . . . . 0.0 108.942 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.4 m -95.04 116.88 29.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.658 0.742 . . . . 0.0 110.337 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.6 t -91.71 141.62 28.49 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.496 0.718 . . . . 0.0 111.116 161.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -115.58 123.28 48.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.399 -0.813 . . . . 0.0 110.952 166.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.43 129.14 56.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.187 0.595 . . . . 0.0 109.928 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.82 128.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -127.84 147.1 50.43 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.699 0.799 . . . . 0.0 111.002 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -116.37 135.81 53.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.378 -1.451 . . . . 0.0 112.29 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -70.06 122.95 20.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.29 -37.56 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 CA--C 1.567 1.603 0 CA-C-N 120.069 1.304 . . . . 0.0 108.595 170.467 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 121.783 0.801 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -75.17 3.18 9.16 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.716 2.488 . . . . 0.0 117.716 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -54.91 111.12 0.76 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.287 1.858 . . . . 0.0 114.959 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.44 175.86 28.85 Favored Glycine 0 N--CA 1.488 2.132 0 CA-C-O 122.217 0.898 . . . . 0.0 115.167 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -109.6 116.39 31.67 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.389 1.075 . . . . 0.0 109.515 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -118.33 112.73 20.42 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.688 -0.632 . . . . 0.0 109.412 -166.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.53 141.77 28.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.064 -1.023 . . . . 0.0 113.558 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttp -70.87 124.34 24.1 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -172.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.3 mt -85.67 -53.59 5.06 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.8 p -138.62 150.88 46.74 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 119.435 1.016 . . . . 0.0 113.477 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -129.13 113.78 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.867 0.867 . . . . 0.0 109.229 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -115.98 117.3 29.75 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 0.0 109.76 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.6 t30 63.74 36.45 10.61 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.422 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 4.3 t80 -74.57 -39.78 62.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.604 -1.31 . . . . 0.0 114.439 175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.46 -41.84 97.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 174.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.13 -39.43 78.89 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.17 -49.42 71.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 165.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.75 -40.88 88.47 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -55.03 -46.39 75.27 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 164.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.32 -18.36 49.16 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 166.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.6 mt -91.03 3.53 54.5 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.279 40.3 m-20 66.12 52.17 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.116 1.366 . . . . 0.0 114.406 -171.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.95 144.57 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 122.123 0.964 . . . . 0.0 110.139 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -63.86 154.32 34.03 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.73 -44.42 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.74 -50.85 67.37 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.32 -40.12 95.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -55.05 -40.5 70.37 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -69.75 -48.45 59.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.916 -1.115 . . . . 0.0 113.761 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.63 -57.86 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.012 0.925 . . . . 0.0 112.136 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -30.35 71.42 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -69.09 -36.54 77.68 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.97 -23.63 59.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.53 152.42 41.88 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 120.404 1.456 . . . . 0.0 114.644 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -101.35 90.26 1.65 Allowed Pre-proline 0 CA--C 1.574 1.892 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.314 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.7 146.48 54.46 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 122.848 2.053 . . . . 0.0 114.808 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.23 113.16 24.93 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -89.67 107.39 19.06 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.375 -0.828 . . . . 0.0 110.538 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.71 107.22 19.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.717 -0.615 . . . . 0.0 109.908 172.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.65 131.42 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.3 t -113.21 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -93.65 104.86 16.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.221 0.609 . . . . 0.0 109.954 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.31 75.55 2.95 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 121.527 0.679 . . . . 0.0 109.931 167.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.23 -104.43 1.04 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -81.65 -32.0 32.06 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -81.24 107.39 13.99 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.935 1.243 . . . . 0.0 110.952 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.3 ttp -116.16 124.0 49.24 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.962 0.887 . . . . 0.0 111.047 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.41 101.57 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.9 mt -98.18 105.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -97.48 99.43 10.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -88.08 97.14 10.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.21 -0.931 . . . . 0.0 109.135 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.8 mt -100.39 121.73 42.0 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.261 0.624 . . . . 0.0 110.976 -164.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -139.49 157.24 46.18 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.122 0.963 . . . . 0.0 111.356 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.9 p -65.09 -30.81 71.79 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -74.98 -48.89 21.95 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 165.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -153.75 138.83 17.33 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 119.651 1.114 . . . . 0.0 113.431 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -94.03 128.16 40.23 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.724 0.81 . . . . 0.0 109.982 168.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -118.95 103.93 10.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.016 -1.052 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.29 128.25 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.9 mtp -115.41 104.86 12.19 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.636 0.775 . . . . 0.0 110.256 173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -111.12 113.64 26.31 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.031 0.933 . . . . 0.0 111.583 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.64 149.36 27.48 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -169.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -92.32 129.26 38.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 111.075 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.75 129.45 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 123.218 0.607 . . . . 0.0 111.048 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.64 -31.92 7.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -161.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -84.83 133.42 34.33 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.96 1.38 . . . . 0.0 112.993 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -86.55 98.39 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.786 0.435 . . . . 0.0 110.223 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -105.41 147.24 28.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.52 106.38 3.97 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.916 0.865 . . . . 0.0 112.131 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.73 103.03 10.8 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.616 0.766 . . . . 0.0 109.748 -166.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.81 116.68 20.11 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 121.84 0.829 . . . . 0.0 110.58 172.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.73 45.49 1.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.1 t -76.58 137.64 39.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.086 0.954 . . . . 0.0 112.593 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.83 -59.41 0.54 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.601 -152.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.03 -75.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 123.748 0.819 . . . . 0.0 109.595 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -140.33 21.14 2.4 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 174.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.268 11.9 t70 50.18 48.99 21.31 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 176.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -127.71 142.47 51.32 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.981 0.896 . . . . 0.0 112.378 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -97.35 101.86 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.797 0.839 . . . . 0.0 110.652 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.3 m -102.11 147.67 26.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.518 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.97 95.22 10.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 109.009 167.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 124.19 47.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 111.243 -166.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -107.55 123.74 48.89 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -108.8 128.87 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t -123.57 149.66 45.01 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.98 0.912 . . . . 0.0 111.833 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 7.1 m95 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 120.89 -1.131 . . . . 0.0 112.228 170.543 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.649 0.737 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.66 110.18 21.08 Favored 'General case' 0 CA--C 1.564 1.51 0 O-C-N 121.518 -0.739 . . . . 0.0 109.123 172.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.7 122.4 45.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.099 0.56 . . . . 0.0 110.433 -161.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 52.5 t -122.07 138.88 54.28 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.05 123.85 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.601 0.76 . . . . 0.0 109.25 168.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -102.35 93.85 5.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -91.45 117.45 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 111.824 -166.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.8 -90.21 0.1 OUTLIER Glycine 0 N--CA 1.481 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 113.262 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -91.51 -16.98 26.4 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -164.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -125.33 148.35 48.76 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.22 1.373 . . . . 0.0 112.093 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.45 112.35 17.7 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 123.762 0.825 . . . . 0.0 112.231 -172.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.56 90.15 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -86.47 135.6 33.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.776 0.798 . . . . 0.0 111.431 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.9 -170.93 40.76 Favored Glycine 0 N--CA 1.482 1.757 0 CA-C-O 121.994 0.774 . . . . 0.0 114.602 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -156.42 150.42 25.11 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.2 m -124.87 125.99 44.85 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.48 129.16 48.12 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.513 0.725 . . . . 0.0 111.02 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.81 170.86 16.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.146 -0.971 . . . . 0.0 113.16 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.15 127.6 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.293 -0.88 . . . . 0.0 109.054 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.39 91.6 3.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 161.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.86 -111.7 3.54 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.172 -0.955 . . . . 0.0 115.03 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -94.06 8.82 40.11 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 162.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -107.84 123.8 49.13 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.399 1.454 . . . . 0.0 111.489 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.1 tp -81.32 118.73 22.88 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.64 1.176 . . . . 0.0 109.732 167.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.13 117.28 33.64 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.5 tp -115.18 128.89 56.47 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.79 0.836 . . . . 0.0 110.205 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -114.96 120.51 40.15 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.061 0.545 . . . . 0.0 109.962 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -110.18 133.58 53.08 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.764 0.825 . . . . 0.0 110.66 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -116.21 141.61 47.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.59 118.07 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.664 0.786 . . . . 0.0 110.615 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 55.2 44.15 28.15 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.33 3.05 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 120.477 2.951 . . . . 0.0 120.477 -164.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.98 122.81 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 120.256 2.028 . . . . 0.0 110.21 -167.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.8 m -94.73 125.73 39.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.334 0.654 . . . . 0.0 111.488 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.422 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 14.4 t -97.78 127.45 43.74 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.076 0.55 . . . . 0.0 110.762 158.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -107.58 129.31 55.0 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.385 0.612 . . . . 0.0 111.403 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -127.76 137.9 52.58 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.667 0.787 . . . . 0.0 111.031 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.74 131.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -131.21 130.37 42.86 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.453 0.701 . . . . 0.0 110.823 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -101.33 131.31 47.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.166 -1.584 . . . . 0.0 112.475 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.35 121.71 15.46 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.37 -38.23 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.8 t60 . . . . . 0 N--CA 1.488 1.435 0 CA-C-N 120.056 1.298 . . . . 0.0 107.796 169.946 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 121.879 0.847 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -71.76 1.85 6.27 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -54.62 108.36 0.38 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.45 177.94 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 CA-C-O 122.652 1.14 . . . . 0.0 115.157 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -111.01 116.61 31.47 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.426 1.09 . . . . 0.0 109.16 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -118.27 112.36 19.98 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.197 0.599 . . . . 0.0 109.539 -166.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -83.44 140.57 32.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.928 . . . . 0.0 113.41 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.463 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.7 ttm -69.7 125.1 25.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.235 1.38 . . . . 0.0 113.732 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.18 -57.75 2.9 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.657 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.0 m -127.89 149.95 50.08 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.29 1.043 . . . . 0.0 112.485 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.67 89.66 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.37 120.61 40.78 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.382 0.673 . . . . 0.0 110.62 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 33.6 t30 67.55 35.75 4.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -79.04 -41.02 29.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.327 -1.483 . . . . 0.0 114.84 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -50.51 -44.69 56.19 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 165.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.05 -36.36 69.58 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.877 1.671 . . . . 0.0 115.148 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -56.49 -49.01 75.92 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 164.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.21 -33.78 72.1 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -61.07 -41.35 96.45 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 164.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -18.22 56.7 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 165.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.65 -4.9 59.24 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 162.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 63.8 46.81 3.81 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 120.528 1.513 . . . . 0.0 114.707 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -93.01 140.95 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.812 0.815 . . . . 0.0 109.693 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.0 149.32 37.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.2 -45.0 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.75 62.92 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.85 -36.47 83.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -59.37 -49.94 75.88 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.588 1.995 . . . . 0.0 115.667 167.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -61.78 -42.42 98.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.65 -56.84 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.83 0.741 . . . . 0.0 111.308 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.51 87.54 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.93 -33.49 75.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.59 -30.31 65.68 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 167.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.71 137.64 47.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.972 1.26 . . . . 0.0 113.536 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -108.26 85.88 3.0 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.17 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.4 Cg_endo -68.6 154.16 72.09 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.601 2.2 . . . . 0.0 114.926 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.71 118.23 36.06 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -85.89 112.3 21.03 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.748 -0.595 . . . . 0.0 110.531 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.85 109.67 22.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.714 -0.616 . . . . 0.0 109.637 167.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.44 126.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.01 108.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.14 113.78 27.54 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.179 0.992 . . . . 0.0 110.532 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -106.57 80.53 1.48 Allowed 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 123.845 0.858 . . . . 0.0 109.446 168.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.0 2.68 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 121.316 -0.865 . . . . 0.0 114.47 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.1 -25.63 22.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 164.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -74.43 118.03 16.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.909 1.686 . . . . 0.0 111.323 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.9 ttp -138.2 131.86 30.96 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.098 0.952 . . . . 0.0 111.902 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.53 103.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -93.04 112.12 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.18 98.79 8.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.7 m -86.07 98.91 11.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.694 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.5 mt -102.34 115.18 30.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.498 0.666 . . . . 0.0 110.884 -165.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.0 t -128.98 146.78 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.475 0.71 . . . . 0.0 109.922 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 t -64.05 -15.36 59.31 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.23 -48.69 13.74 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -159.77 132.76 6.8 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.393 0.997 . . . . 0.0 111.041 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.78 124.4 46.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.564 -0.71 . . . . 0.0 110.413 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -112.44 117.1 31.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mm -113.53 119.12 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -171.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 83.0 mtp -105.7 109.1 20.94 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.292 0.637 . . . . 0.0 109.33 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -109.8 108.94 19.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -153.58 160.06 42.34 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -99.34 129.23 45.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 111.322 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.41 124.56 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.17 5.57 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -163.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -96.64 144.86 26.29 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.743 1.271 . . . . 0.0 112.876 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.26 113.0 21.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 0.0 110.673 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -121.42 149.48 42.95 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.664 0.786 . . . . 0.0 112.671 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.48 97.23 2.53 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 112.974 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.15 103.3 16.0 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.414 -0.804 . . . . 0.0 110.373 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -85.22 104.09 14.77 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.007 0.432 . . . . 0.0 110.48 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mp -83.96 53.32 2.54 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.863 0.839 . . . . 0.0 112.848 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -86.99 138.54 31.42 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.77 -31.93 6.19 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -153.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mt -92.81 -71.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.525 1.13 . . . . 0.0 108.324 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -126.58 -17.3 5.09 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.279 11.1 t70 62.35 73.09 0.48 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 120.246 1.385 . . . . 0.0 112.57 -158.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -133.42 131.76 40.35 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.15 0.58 . . . . 0.0 110.224 172.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -102.66 102.05 12.22 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.768 0.827 . . . . 0.0 109.771 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.53 124.52 51.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.044 0.538 . . . . 0.0 111.576 -172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.69 99.2 2.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.001 0.905 . . . . 0.0 109.667 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -113.2 120.39 41.08 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.06 -158.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.8 m -98.28 121.16 39.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -106.66 128.23 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -145.79 156.8 43.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.646 -1.284 . . . . 0.0 112.899 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.5 m95 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 120.976 -1.078 . . . . 0.0 112.352 -179.406 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.436 0.636 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.1 tp -89.79 106.39 18.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.709 -0.619 . . . . 0.0 110.03 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -112.76 130.95 55.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.6 0.714 . . . . 0.0 111.089 -168.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.6 t -126.93 134.16 50.48 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.706 0.802 . . . . 0.0 113.058 -170.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.92 121.05 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.441 0.696 . . . . 0.0 109.704 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -100.35 97.07 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.526 0.73 . . . . 0.0 109.883 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.02 114.64 27.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 111.362 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.29 -112.16 0.36 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 120.919 -1.113 . . . . 0.0 114.027 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -80.09 -11.37 59.77 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -123.0 148.46 45.48 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 119.537 1.062 . . . . 0.0 111.869 -170.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.57 133.86 37.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.69 43.68 59.87 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 119.588 2.595 . . . . 0.0 119.588 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -94.89 135.05 36.86 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 117.79 0.795 . . . . 0.0 111.783 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.96 -167.56 36.18 Favored Glycine 0 N--CA 1.481 1.65 0 CA-C-O 122.126 0.848 . . . . 0.0 114.706 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -156.0 153.27 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -126.7 124.74 40.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -123.64 135.68 54.06 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.536 0.734 . . . . 0.0 111.74 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -150.15 169.14 21.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.68 128.2 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.63 93.83 4.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 162.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.99 -114.6 4.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 121.221 -0.925 . . . . 0.0 114.986 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -96.03 23.56 6.33 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 163.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.4 128.63 53.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.936 1.243 . . . . 0.0 111.118 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.83 126.39 35.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.227 1.011 . . . . 0.0 109.812 168.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.68 122.77 43.31 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.09 120.26 28.49 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.574 0.749 . . . . 0.0 110.267 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -100.03 125.5 46.1 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.114 0.566 . . . . 0.0 109.727 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 11.5 mtp -119.66 120.78 37.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.435 0.694 . . . . 0.0 110.308 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -109.09 135.89 49.5 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.46 117.71 10.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.605 0.762 . . . . 0.0 109.05 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.292 11.5 mt-10 54.63 47.84 21.7 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.15 -31.02 1.83 Allowed Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.799 2.68 . . . . 0.0 119.799 -166.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 50.9 t -79.68 122.23 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 119.239 1.519 . . . . 0.0 111.296 -164.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.2 m -94.36 126.98 39.96 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.363 0.665 . . . . 0.0 111.483 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.8 t -100.18 129.8 46.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.405 0.682 . . . . 0.0 110.83 162.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -103.63 110.57 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.194 0.598 . . . . 0.0 110.562 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -108.88 120.67 43.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.514 0.725 . . . . 0.0 109.511 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.82 130.42 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -133.27 150.11 51.93 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.441 0.696 . . . . 0.0 111.3 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -115.49 133.79 55.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.345 -1.472 . . . . 0.0 112.153 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -69.74 123.02 20.34 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.65 -37.45 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.565 1.529 0 CA-C-N 120.051 1.296 . . . . 0.0 108.264 169.53 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 CA--C 1.562 1.429 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -75.96 -2.06 28.61 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 169.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -60.71 109.18 0.97 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.009 1.731 . . . . 0.0 113.956 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.42 179.67 34.4 Favored Glycine 0 N--CA 1.486 1.967 0 CA-C-O 122.907 1.282 . . . . 0.0 115.801 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -109.51 109.53 20.36 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.422 1.089 . . . . 0.0 109.118 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -110.88 111.79 23.18 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 137.62 32.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 0.0 112.728 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 ttp -68.5 118.67 11.85 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -172.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.6 mt -79.58 -45.05 19.92 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -153.68 160.26 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.618 -1.301 . . . . 0.0 113.13 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -141.64 117.61 10.55 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.014 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.67 122.97 39.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.469 0.708 . . . . 0.0 110.213 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.8 t30 66.72 36.85 4.48 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -80.3 -42.43 23.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.607 -1.308 . . . . 0.0 114.505 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.34 -39.96 80.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.74 -42.09 78.08 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 121.039 1.745 . . . . 0.0 114.809 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -55.88 -46.9 78.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 168.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -68.45 -37.23 80.02 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -57.72 -44.36 85.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.315 -1.491 . . . . 0.0 114.903 162.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -16.9 47.72 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 118.205 2.669 . . . . 0.0 118.205 166.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.82 2.19 56.89 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 38.7 t70 64.92 58.57 0.93 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.232 1.413 . . . . 0.0 114.022 -170.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -111.12 140.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-O 121.48 0.657 . . . . 0.0 109.84 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -65.54 150.45 48.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.15 -45.38 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.65 72.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.18 -41.59 97.07 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -56.99 -47.85 79.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.99 -56.04 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.915 0.78 . . . . 0.0 111.741 171.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.56 77.07 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -68.71 -33.68 74.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 167.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.72 -26.2 60.58 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.23 146.84 48.76 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.128 1.331 . . . . 0.0 114.147 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -104.44 89.87 2.92 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 118.211 -0.899 . . . . 0.0 109.899 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.29 150.4 47.07 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 122.404 2.069 . . . . 0.0 114.731 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -114.75 117.08 29.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -85.3 107.28 17.24 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.591 -0.693 . . . . 0.0 110.866 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.69 108.29 19.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.516 -0.74 . . . . 0.0 109.219 167.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.77 136.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.58 110.98 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -95.37 108.16 20.34 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.337 0.655 . . . . 0.0 109.929 170.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.31 76.14 1.68 Allowed 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 121.558 0.694 . . . . 0.0 109.661 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 -103.79 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.34 -0.85 . . . . 0.0 114.766 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.97 -22.6 21.86 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 162.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -75.67 114.2 13.99 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 120.642 1.564 . . . . 0.0 111.557 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 tpp -120.0 132.49 55.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.843 0.457 . . . . 0.0 111.468 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.99 101.39 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.0 mt -96.8 110.37 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -105.07 97.58 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.8 m -83.02 99.48 9.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.7 mt -98.87 116.42 31.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.824 -0.547 . . . . 0.0 110.69 -166.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.5 t -137.86 152.55 49.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.602 0.761 . . . . 0.0 110.637 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -74.44 -49.31 22.9 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -153.53 135.75 14.87 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.569 1.077 . . . . 0.0 111.657 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -89.79 120.36 30.97 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -113.5 106.02 14.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.645 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.24 127.39 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.479 0.712 . . . . 0.0 109.317 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.9 mtp -109.15 110.69 21.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.838 0.855 . . . . 0.0 109.352 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -112.99 117.34 31.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.451 0.7 . . . . 0.0 109.84 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -156.95 155.92 32.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -96.27 125.23 40.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 111.148 165.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.53 124.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.547 0.739 . . . . 0.0 109.532 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.05 -41.78 2.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -157.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -92.97 142.39 27.35 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.878 0.871 . . . . 0.0 113.169 -170.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -87.66 124.13 33.22 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.862 -0.524 . . . . 0.0 110.976 166.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -132.76 152.42 51.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.826 0.85 . . . . 0.0 111.554 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.75 105.28 5.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.425 -1.422 . . . . 0.0 112.317 169.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -92.24 114.06 26.5 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -77.39 121.3 23.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 159.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.532 HD22 HH21 ' A' ' 104' ' ' ARG . 4.4 mp -87.86 63.32 7.36 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.197 0.998 . . . . 0.0 111.653 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -79.45 118.77 21.63 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.723 0.809 . . . . 0.0 111.166 -168.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.24 -48.43 0.94 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 -159.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -80.37 -85.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -171.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.08 8.26 13.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 55.94 46.27 22.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.41 140.99 52.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.784 . . . . 0.0 111.268 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.95 111.33 20.73 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.266 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.83 135.41 45.43 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.291 0.637 . . . . 0.0 111.285 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mmt -77.58 99.46 5.75 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.225 1.012 . . . . 0.0 109.614 165.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.6 m -104.28 122.55 45.64 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.657 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.6 m -103.78 126.57 51.0 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 166.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.6 t -111.34 128.75 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -134.14 149.93 51.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.063 0.945 . . . . 0.0 111.925 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.0 m95 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.647 -1.283 . . . . 0.0 114.294 -179.062 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.533 0.683 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -89.26 109.68 20.54 Favored 'General case' 0 CA--C 1.562 1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.201 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -95.31 140.35 30.33 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.219 1.008 . . . . 0.0 111.595 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 51.8 t -137.73 133.88 34.66 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.12 128.83 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.636 0.774 . . . . 0.0 109.526 168.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -107.12 103.47 12.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.812 0.845 . . . . 0.0 110.102 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -86.71 113.07 22.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 111.48 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.11 -129.79 1.21 Allowed Glycine 0 N--CA 1.487 2.058 0 O-C-N 121.652 -0.655 . . . . 0.0 113.789 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.0 -22.18 45.9 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -170.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -105.66 142.08 36.0 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.481 1.491 . . . . 0.0 111.593 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -86.82 141.71 28.62 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.2 50.71 60.72 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -170.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.532 HH21 HD22 ' A' ' 74' ' ' LEU . 18.5 ttt180 -109.38 125.08 52.01 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.544 0.738 . . . . 0.0 110.344 -170.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.61 35.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.4 159.35 37.3 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.377 1.085 . . . . 0.0 113.348 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.5 m -133.33 125.13 28.54 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -121.12 136.1 55.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.906 -0.496 . . . . 0.0 111.677 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -146.65 156.37 43.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.912 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.35 126.69 47.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -111.64 94.22 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 158.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.83 -110.44 3.16 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.163 -0.961 . . . . 0.0 115.236 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -95.74 7.61 45.81 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 164.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -110.96 127.15 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.23 1.377 . . . . 0.0 111.834 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 tp -85.29 115.87 23.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.168 0.987 . . . . 0.0 109.39 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.19 120.02 39.62 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 tp -117.32 120.75 39.17 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.835 0.854 . . . . 0.0 110.425 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -97.09 123.5 40.86 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 162.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.7 mtm -112.88 126.65 55.68 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.519 0.6 . . . . 0.0 109.763 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -121.82 137.19 54.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.542 -0.724 . . . . 0.0 112.364 -167.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.4 126.8 5.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.12 0.568 . . . . 0.0 110.922 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 57.25 40.93 27.53 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.28 -13.34 2.79 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 120.261 2.864 . . . . 0.0 120.261 -163.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.75 122.08 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 119.701 1.75 . . . . 0.0 109.174 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -102.9 126.47 50.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 122.949 0.5 . . . . 0.0 111.074 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.6 t -95.77 131.57 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.269 0.628 . . . . 0.0 111.131 162.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -112.69 112.35 23.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.062 0.545 . . . . 0.0 110.092 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -115.32 144.81 43.19 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.44 0.696 . . . . 0.0 111.847 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.0 t -123.62 127.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.61 131.63 46.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.59 0.756 . . . . 0.0 110.43 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -104.32 131.66 51.42 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.546 -1.346 . . . . 0.0 112.031 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -68.99 113.52 6.45 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.71 -31.17 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 170.871 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 . . . . . 0 CA--C 1.567 1.634 0 CA-C-O 121.232 0.539 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.9 3.25 42.7 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -59.73 120.54 9.72 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.076 1.762 . . . . 0.0 114.793 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 174.12 28.2 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 122.847 1.248 . . . . 0.0 115.446 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -107.71 111.52 23.76 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.108 0.963 . . . . 0.0 108.573 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -114.28 111.85 22.17 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -90.66 139.8 30.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.057 -1.027 . . . . 0.0 113.189 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 36.7 ttp -72.94 125.6 27.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.441 -1.412 . . . . 0.0 114.17 -171.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.06 -50.3 7.14 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 169.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.3 p -136.79 149.28 47.69 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 119.369 0.986 . . . . 0.0 113.459 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -128.21 103.73 7.35 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.42 -60.8 1.87 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.24 43.31 3.15 Favored 'General case' 0 CA--C 1.572 1.826 0 C-N-CA 123.868 0.867 . . . . 0.0 110.575 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -76.65 -45.66 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.79 -47.95 70.3 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 166.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.59 -37.22 86.82 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.38 -43.75 83.88 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 120.85 1.659 . . . . 0.0 115.149 162.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.83 -38.14 85.85 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 172.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -55.93 -43.23 77.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 162.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.22 62.28 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.56 12.48 29.43 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 164.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.264 28.0 t70 56.92 47.9 16.88 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 120.602 1.546 . . . . 0.0 115.036 -174.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -93.35 155.57 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.448 -0.783 . . . . 0.0 110.722 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 151.13 47.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.45 -43.87 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.73 62.75 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 33.8 tp -61.35 -39.34 90.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -54.1 -39.01 65.99 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -71.57 -50.56 29.84 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.68 -54.56 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 123.906 0.883 . . . . 0.0 112.468 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.71 75.61 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.91 -39.89 91.0 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 165.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.78 -24.01 62.51 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.04 148.04 51.54 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.45 1.477 . . . . 0.0 113.72 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -107.67 86.54 2.95 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.03 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 53.5 Cg_endo -72.69 154.82 54.51 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 115.934 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -118.81 111.42 18.42 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -83.53 107.19 15.84 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.59 -0.694 . . . . 0.0 110.708 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.54 107.95 19.91 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.84 125.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -110.89 105.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.0 105.96 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.269 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.2 77.85 5.22 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.68 0.792 . . . . 0.0 109.922 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.29 -97.12 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 O-C-N 121.416 -0.803 . . . . 0.0 114.793 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.47 -17.51 20.49 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 164.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.99 114.11 21.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.789 1.631 . . . . 0.0 111.264 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.7 ttm -121.04 124.13 44.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.568 0.747 . . . . 0.0 111.225 -167.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.6 mt -114.08 96.79 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.6 mt -90.17 112.29 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -106.48 97.79 7.55 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 m -82.77 94.44 7.63 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.0 109.338 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -90.81 131.75 36.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.121 0.568 . . . . 0.0 111.687 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -150.88 155.9 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.097 0.951 . . . . 0.0 111.909 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.8 p -61.13 -32.57 72.26 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -78.1 -55.11 5.54 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -155.57 139.95 16.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.959 0.799 . . . . 0.0 110.238 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -88.82 125.11 34.76 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.051 0.54 . . . . 0.0 110.826 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -104.21 118.03 35.65 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.109 0.868 . . . . 0.0 110.584 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.11 120.7 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.8 mtp -108.84 111.54 23.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.258 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.09 108.44 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.408 0.683 . . . . 0.0 109.272 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -152.48 155.02 36.67 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -167.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.35 134.73 40.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.817 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.44 123.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.78 5.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -154.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -95.18 135.39 36.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.389 1.095 . . . . 0.0 112.772 -161.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -85.66 107.08 17.39 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 122.033 -0.417 . . . . 0.0 110.15 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -116.85 157.83 24.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.81 0.844 . . . . 0.0 112.33 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.63 104.46 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.672 -1.268 . . . . 0.0 112.167 169.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -90.75 107.09 18.95 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 121.39 -0.818 . . . . 0.0 108.959 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -82.7 120.29 25.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 164.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.401 HD22 HH21 ' A' ' 104' ' ' ARG . 4.7 mp -90.9 49.97 1.73 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -74.17 132.96 42.7 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.218 1.007 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 -50.17 1.03 Allowed Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.571 -0.705 . . . . 0.0 114.576 -158.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 mt -79.35 -66.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 125.002 1.321 . . . . 0.0 111.067 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -143.99 -6.54 0.76 Allowed 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.877 1.671 . . . . 0.0 114.175 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.287 3.3 t70 52.03 45.56 28.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -127.01 141.08 51.88 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.574 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -84.23 127.36 33.9 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.707 0.765 . . . . 0.0 112.564 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.6 m -113.51 141.29 47.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.578 0.751 . . . . 0.0 111.076 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.29 98.35 4.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 159.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.41 HG23 ' SG ' ' A' ' 95' ' ' CYS . 89.9 m -99.66 121.53 41.36 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.0 m -109.33 120.42 42.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 t -110.64 124.99 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.0 m -134.63 158.52 43.83 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 112.565 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 79.2 m95 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 112.093 177.384 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.66 100.71 13.51 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.734 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -108.24 140.34 41.62 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.677 0.791 . . . . 0.0 111.482 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' A' ' 84' ' ' THR . 50.2 t -134.19 141.44 47.05 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -170.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -114.17 128.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.783 0.833 . . . . 0.0 109.84 166.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -101.88 103.86 14.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.499 0.72 . . . . 0.0 109.264 173.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -89.14 99.75 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.187 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.16 94.4 0.09 OUTLIER Glycine 0 N--CA 1.488 2.114 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 -169.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.296 40.0 mt-10 73.19 -51.07 0.71 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 161.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -99.27 144.77 28.01 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.622 0.769 . . . . 0.0 111.306 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.77 162.48 21.7 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.69 51.97 48.93 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.401 HH21 HD22 ' A' ' 74' ' ' LEU . 27.7 ttt180 -121.19 122.27 39.6 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.533 0.682 . . . . 0.0 111.926 -159.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.93 -162.83 34.44 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 121.447 -0.783 . . . . 0.0 114.064 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.268 67.3 p-90 -156.79 168.32 27.8 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 123.215 1.484 . . . . 0.0 113.115 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -146.86 130.57 16.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.975 -1.703 . . . . 0.0 108.599 168.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -127.53 142.48 51.37 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.282 1.039 . . . . 0.0 112.255 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -146.59 167.48 23.63 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.9 mt -114.62 126.7 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.284 -0.885 . . . . 0.0 109.176 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.35 89.85 3.24 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 163.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.67 -110.47 3.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -99.32 17.12 20.88 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -110.55 126.21 54.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.496 1.044 . . . . 0.0 111.593 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.4 tp -86.43 122.39 30.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.801 0.84 . . . . 0.0 109.683 166.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -111.15 119.49 39.15 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.0 tp -118.17 128.63 54.9 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.717 0.807 . . . . 0.0 110.54 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -108.53 119.34 39.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.619 0.767 . . . . 0.0 109.547 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.2 mtm -112.92 129.87 56.32 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.487 0.715 . . . . 0.0 111.312 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -123.61 132.78 53.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 111.901 -167.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.27 129.79 14.91 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.779 0.831 . . . . 0.0 109.305 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 55.57 36.08 26.45 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.07 -3.83 27.43 Favored Glycine 0 CA--C 1.557 2.684 0 N-CA-C 119.878 2.711 . . . . 0.0 119.878 -164.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.92 113.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 120.071 1.935 . . . . 0.0 109.091 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.0 m -93.37 119.39 32.44 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -173.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.8 t -90.81 125.96 35.87 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.385 0.674 . . . . 0.0 112.067 164.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -98.4 122.84 42.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.791 0.436 . . . . 0.0 110.33 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -117.82 139.85 50.51 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.315 0.646 . . . . 0.0 110.664 168.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.0 130.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -128.82 136.42 50.46 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 123.299 0.64 . . . . 0.0 111.411 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -96.09 127.32 42.0 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.649 1.179 . . . . 0.0 111.501 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -68.55 119.82 13.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.185 0.902 . . . . 0.0 112.777 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.22 -38.5 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 CA--C 1.561 1.389 0 CA-C-N 119.78 1.173 . . . . 0.0 107.909 169.542 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.343 15.3 t70 . . . . . 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 112.66 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.41 15.62 1.22 Allowed 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -59.19 117.32 4.61 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.48 176.08 30.12 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-O 122.6 1.111 . . . . 0.0 115.865 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -106.94 113.86 27.6 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.442 1.097 . . . . 0.0 109.034 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -117.56 112.99 21.32 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -92.67 140.64 29.32 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.843 -1.161 . . . . 0.0 113.397 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.5 ttp -70.4 117.37 11.85 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-N 119.726 1.148 . . . . 0.0 114.0 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.14 -46.88 21.98 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 167.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.2 m -153.75 160.49 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.811 1.291 . . . . 0.0 112.704 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -150.33 112.75 4.68 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.773 -174.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.3 -69.74 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -117.19 42.22 2.59 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -73.44 -36.01 65.86 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -59.85 -39.56 85.6 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.79 -40.28 83.95 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 167.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.35 -47.81 82.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.25 -39.37 75.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -54.4 -43.43 71.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 162.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.85 51.7 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 165.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.16 2.2 47.74 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.297 20.2 t70 63.64 49.34 3.04 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -167.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.83 146.41 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.162 0.982 . . . . 0.0 110.13 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -65.89 153.63 41.47 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.3 t -59.72 -44.74 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.45 -49.55 74.26 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.76 -43.25 98.23 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -52.46 -50.84 61.84 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 165.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.98 -45.14 93.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.27 -54.43 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 118.945 0.793 . . . . 0.0 111.6 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.51 -29.92 65.35 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.29 -26.8 56.26 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.6 144.37 57.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.367 1.439 . . . . 0.0 113.563 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -107.73 84.62 2.05 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.847 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.02 156.5 47.46 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.579 2.186 . . . . 0.0 115.171 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.42 118.83 33.78 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HZ1' HD22 ' A' ' 117' ' ' LEU . 60.3 mttt -84.81 108.14 17.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.36 -0.837 . . . . 0.0 110.661 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -96.22 107.66 20.03 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.1 128.13 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.51 107.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -100.04 118.7 36.98 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.356 0.663 . . . . 0.0 110.708 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.41 81.83 1.58 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 -104.19 1.16 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -82.3 -27.36 32.35 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -79.12 116.13 19.21 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.196 1.362 . . . . 0.0 111.943 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -124.28 127.13 47.2 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 121.506 0.67 . . . . 0.0 110.971 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.05 99.26 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.3 mt -91.24 107.03 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -100.95 99.91 10.45 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -88.0 99.41 12.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.08 129.07 48.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.066 0.546 . . . . 0.0 111.848 -162.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -148.18 145.92 28.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.58 0.705 . . . . 0.0 110.379 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.5 p -60.78 -26.03 66.96 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -73.31 -50.63 21.1 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 165.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -159.74 133.44 7.21 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.624 1.102 . . . . 0.0 111.268 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -97.91 139.73 33.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.64 . . . . 0.0 111.395 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -123.77 119.99 31.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -0.779 . . . . 0.0 110.251 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -113.35 122.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.3 mtp -109.48 106.17 15.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.717 -0.614 . . . . 0.0 109.793 175.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -107.76 112.28 24.87 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.516 0.726 . . . . 0.0 109.738 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.24 155.84 31.51 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -95.67 130.84 42.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 111.054 164.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 t -69.14 123.53 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 109.933 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.14 -34.41 4.84 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 -161.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -94.56 147.55 23.16 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.815 1.307 . . . . 0.0 113.065 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.59 124.69 35.94 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.787 -0.57 . . . . 0.0 110.865 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -133.53 151.95 51.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.568 0.747 . . . . 0.0 112.568 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.4 110.39 7.65 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.436 1.113 . . . . 0.0 112.324 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -94.04 100.12 12.3 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.224 1.01 . . . . 0.0 109.554 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.26 104.58 8.94 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.447 0.641 . . . . 0.0 110.003 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mt -90.45 45.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -81.86 131.5 35.26 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.198 0.999 . . . . 0.0 110.546 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.2 -34.99 4.48 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.924 1.529 . . . . 0.0 116.924 -159.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 mt -86.36 -67.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 124.439 1.096 . . . . 0.0 109.553 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -136.59 -7.35 1.94 Allowed 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.257 26.8 t0 57.4 64.69 1.53 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 120.304 1.411 . . . . 0.0 114.666 -166.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -136.82 144.12 43.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.6 -0.688 . . . . 0.0 111.057 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -97.6 112.02 24.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 111.066 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -110.31 146.55 35.53 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.41 0.684 . . . . 0.0 111.701 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.8 mmt -82.09 97.6 8.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.161 -1.587 . . . . 0.0 110.229 171.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.436 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 36.1 m -91.91 126.29 36.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 111.634 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 m -107.39 125.96 51.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 162.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.82 127.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -129.29 159.08 37.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.029 0.931 . . . . 0.0 111.829 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.0 m95 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 120.603 -1.311 . . . . 0.0 112.278 173.427 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.55 0.691 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.6 tp -88.58 107.56 18.97 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 123.286 0.634 . . . . 0.0 109.761 173.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -114.08 132.4 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.583 0.753 . . . . 0.0 111.527 -167.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.436 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 40.6 t -131.65 138.42 48.75 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.38 124.77 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.444 167.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -101.06 97.26 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 0.0 109.544 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -85.2 115.82 23.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 112.01 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.59 0.3 Allowed Glycine 0 N--CA 1.483 1.833 0 O-C-N 121.396 -0.815 . . . . 0.0 113.663 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -87.67 -7.89 56.85 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -166.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -126.38 143.7 51.08 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.458 1.481 . . . . 0.0 112.081 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -85.67 113.63 22.02 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.424 0.63 . . . . 0.0 112.523 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.93 56.68 6.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -101.54 130.68 47.88 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.413 0.625 . . . . 0.0 111.243 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.15 -170.21 40.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -155.62 153.45 30.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.2 m -127.83 121.05 29.13 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -119.65 123.42 43.79 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.599 0.759 . . . . 0.0 110.67 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -142.86 153.29 43.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 113.194 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -100.64 126.12 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.0 109.227 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.57 92.83 3.99 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.99 -115.13 4.82 Favored Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.637 -0.664 . . . . 0.0 114.473 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 p30 -94.58 8.05 43.57 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 164.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.18 126.71 53.55 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.598 1.545 . . . . 0.0 111.141 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.41 113.57 25.51 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.32 1.048 . . . . 0.0 109.226 169.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -99.46 125.48 45.21 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 109.531 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.433 HD22 ' HZ1' ' A' ' 40' ' ' LYS . 31.6 tp -122.47 120.5 34.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.696 0.798 . . . . 0.0 110.267 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.05 130.33 47.05 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.936 165.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -125.02 129.26 49.94 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.68 1.127 . . . . 0.0 111.111 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.21 144.36 45.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.483 -0.76 . . . . 0.0 112.715 -171.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.73 127.89 4.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.539 0.736 . . . . 0.0 110.162 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 52.57 50.28 18.55 Favored 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.89 -20.29 1.88 Allowed Glycine 0 CA--C 1.557 2.671 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.7 t -67.84 172.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 CA-C-N 120.146 1.973 . . . . 0.0 112.993 -169.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.5 m -144.28 115.3 7.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 119.31 -2.119 . . . . 0.0 109.83 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -93.84 121.92 35.79 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.752 0.821 . . . . 0.0 111.381 166.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -98.11 123.99 42.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.822 0.449 . . . . 0.0 111.433 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -122.0 139.19 53.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.937 0.895 . . . . 0.0 110.499 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 36.2 t -120.26 126.77 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -127.58 122.33 32.93 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.56 0.744 . . . . 0.0 110.575 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -98.19 135.24 40.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.471 -1.393 . . . . 0.0 112.872 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -69.11 121.79 17.44 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.33 -35.78 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 120.057 1.299 . . . . 0.0 108.232 169.885 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.571 1.783 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.77 114.07 3.41 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.701 2.268 . . . . 0.0 114.709 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 m -69.35 143.85 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -172.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -78.97 95.85 5.58 Favored 'General case' 0 CA--C 1.565 1.529 0 O-C-N 121.616 -0.677 . . . . 0.0 112.408 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.76 -0.45 23.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -58.25 104.94 0.24 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 121.293 1.86 . . . . 0.0 114.767 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.39 -179.03 36.17 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-O 123.117 1.398 . . . . 0.0 115.938 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -113.38 116.19 29.28 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 113.651 -1.274 . . . . 0.0 109.399 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -117.19 113.36 22.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -167.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -90.37 140.19 29.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.104 -0.997 . . . . 0.0 113.337 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.6 ttm -67.2 122.03 16.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.17 -45.72 13.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 166.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.7 m -152.71 159.6 43.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.418 -1.426 . . . . 0.0 113.871 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -134.43 113.13 11.53 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.594 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -122.01 123.68 42.2 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.331 0.653 . . . . 0.0 110.492 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.276 37.7 t30 68.06 30.47 5.89 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -79.25 -40.57 30.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.159 -1.588 . . . . 0.0 115.179 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -55.03 -42.2 72.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.11 -42.08 89.71 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -55.94 -48.06 76.41 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.75 -39.88 80.09 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -54.9 -44.05 73.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.69 -23.76 60.08 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.3 3.65 38.67 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.288 17.5 t0 61.27 48.33 6.26 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -169.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.29 147.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.001 0.905 . . . . 0.0 110.329 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -63.06 152.76 36.13 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.3 t -60.63 -43.75 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.84 -52.71 61.91 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -62.82 -36.96 84.91 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -54.04 -50.27 67.07 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 163.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -66.58 -44.92 80.95 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.07 -57.5 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.204 0.911 . . . . 0.0 111.928 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.23 70.98 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -71.15 -35.08 71.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.68 -32.55 73.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.5 mt -73.92 128.15 34.75 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 119.373 0.988 . . . . 0.0 112.331 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -102.64 94.36 5.05 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.942 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.64 161.14 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.294 1.996 . . . . 0.0 115.683 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -104.16 124.41 49.05 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.629 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -88.24 109.34 19.85 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.234 -0.916 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.67 112.18 23.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.91 163.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.97 128.8 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.29 112.72 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.44 1.096 . . . . 0.0 110.52 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -127.34 76.03 1.63 Allowed 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.483 -0.76 . . . . 0.0 110.143 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -102.32 1.21 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.436 -0.79 . . . . 0.0 114.214 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.83 -26.35 20.57 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 162.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -70.56 134.31 47.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.333 1.879 . . . . 0.0 112.768 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 ttm -145.5 130.73 18.51 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.43 0.633 . . . . 0.0 112.074 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.15 108.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.16 110.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -100.98 106.31 17.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.65 -0.656 . . . . 0.0 109.822 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.1 m -88.97 99.45 12.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.49 125.86 41.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.107 0.563 . . . . 0.0 111.525 -163.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -147.31 155.39 41.98 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.097 0.951 . . . . 0.0 111.739 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -62.83 -32.86 74.15 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -75.46 -54.02 7.73 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -152.12 134.01 14.88 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.839 0.745 . . . . 0.0 110.383 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -92.77 122.42 35.14 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.13 0.572 . . . . 0.0 109.821 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -109.55 106.61 16.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.305 0.642 . . . . 0.0 110.499 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.1 mp -105.08 124.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.2 mtp -108.42 110.28 21.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.768 0.827 . . . . 0.0 109.498 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -107.52 118.17 36.01 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.338 0.655 . . . . 0.0 109.775 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.34 155.2 33.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -96.38 129.27 43.76 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.809 0.814 . . . . 0.0 110.713 159.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.96 128.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 C-N-CA 123.995 0.918 . . . . 0.0 109.686 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.13 -47.41 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 115.779 1.071 . . . . 0.0 115.779 -156.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -83.92 135.85 34.32 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.35 105.87 16.32 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.709 0.403 . . . . 0.0 110.36 169.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -113.49 157.14 22.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.864 0.84 . . . . 0.0 113.06 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.21 101.58 5.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 112.349 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -102.41 104.69 15.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.496 -0.752 . . . . 0.0 110.332 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -81.8 113.98 20.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.34 66.3 5.79 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.553 1.168 . . . . 0.0 112.101 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -75.71 117.64 17.68 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.387 1.075 . . . . 0.0 111.25 -168.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.56 -52.62 0.62 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -162.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.02 -68.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 124.733 1.213 . . . . 0.0 110.178 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -130.89 -6.09 3.99 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.285 17.3 t0 51.57 45.31 28.26 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -166.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -108.38 139.11 43.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 110.582 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -81.6 116.12 21.2 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 112.01 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.5 m -108.5 142.0 39.55 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.683 0.793 . . . . 0.0 111.293 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.01 94.73 7.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.132 168.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -99.82 123.55 44.19 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.576 -0.702 . . . . 0.0 110.621 -164.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 m -112.59 122.01 46.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.65 132.72 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -126.76 146.78 50.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.921 0.888 . . . . 0.0 111.685 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -87.43 116.9 25.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 111.961 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -105.06 62.88 0.7 Allowed 'General case' 0 CA--C 1.575 1.913 0 O-C-N 121.811 -0.556 . . . . 0.0 110.307 161.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.76 -95.12 0.12 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.096 1.599 . . . . 0.0 117.096 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.49 -32.85 60.7 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 167.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -94.88 121.69 36.74 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 119.302 0.956 . . . . 0.0 111.192 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.0 111.23 22.6 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -115.47 123.79 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.125 0.57 . . . . 0.0 110.614 -162.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.72 136.69 54.95 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.43 128.23 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.401 0.68 . . . . 0.0 109.543 165.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -104.34 101.68 11.38 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.549 0.74 . . . . 0.0 109.169 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -85.48 115.57 23.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.863 -1.148 . . . . 0.0 111.596 -170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.57 -120.37 0.63 Allowed Glycine 0 N--CA 1.485 1.915 0 O-C-N 121.905 -0.497 . . . . 0.0 113.516 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.4 -21.52 33.0 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -108.85 144.78 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.654 1.57 . . . . 0.0 113.033 -166.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.55 115.6 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.34 0.59 . . . . 0.0 112.179 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.46 45.47 78.11 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -85.05 124.35 31.63 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.388 0.613 . . . . 0.0 111.329 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.19 -169.14 41.3 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.248 0.916 . . . . 0.0 114.817 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -157.77 153.25 26.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.983 0.897 . . . . 0.0 113.211 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -129.26 125.33 36.62 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.263 3.3 pt20 -126.58 138.64 53.48 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -148.59 159.73 43.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.454 -0.779 . . . . 0.0 113.0 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.8 mt -98.4 125.33 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.32 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -111.53 97.09 6.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 161.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.84 -109.74 2.89 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.46 -0.775 . . . . 0.0 114.15 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -100.46 15.41 28.0 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -113.0 121.22 43.99 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.912 1.687 . . . . 0.0 111.842 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.97 117.02 20.44 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.218 1.007 . . . . 0.0 110.138 167.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -105.68 117.66 34.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.2 tp -113.96 126.83 55.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.027 0.931 . . . . 0.0 110.801 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -106.61 123.53 48.25 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.345 0.658 . . . . 0.0 109.489 164.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -113.21 128.13 56.38 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -115.07 137.0 52.51 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.84 119.98 7.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.548 0.739 . . . . 0.0 110.208 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 55.2 46.92 22.81 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.02 -33.0 0.91 Allowed Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.361 2.504 . . . . 0.0 119.361 -164.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.51 119.93 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.828 1.251 . . . . 0.0 111.209 -166.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.0 m -102.85 115.96 31.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.126 0.571 . . . . 0.0 111.022 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 t -88.8 131.27 35.15 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.056 0.542 . . . . 0.0 111.427 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -113.1 119.66 38.61 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.027 0.531 . . . . 0.0 110.294 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -124.95 133.73 52.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.43 0.692 . . . . 0.0 111.0 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.25 130.39 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.58 128.1 38.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.399 0.68 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -98.94 133.76 42.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.343 -1.473 . . . . 0.0 112.39 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -69.26 122.52 19.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.55 -38.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 N--CA 1.488 1.436 0 CA-C-N 119.927 1.239 . . . . 0.0 107.962 168.516 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.42 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . 0.293 48.4 ttp . . . . . 0 CA--C 1.573 1.845 0 CA-C-O 115.583 -2.151 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.48 -78.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 125.39 2.961 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 -30.84 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 123.563 0.745 . . . . 0.0 112.932 166.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.287 6.0 t70 70.31 86.44 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.757 1.623 . . . . 0.0 112.587 -172.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -81.32 13.92 2.69 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -63.38 116.76 5.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.36 173.18 26.44 Favored Glycine 0 N--CA 1.488 2.157 0 CA-C-O 122.697 1.165 . . . . 0.0 115.859 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -101.87 116.83 33.55 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.189 0.995 . . . . 0.0 109.497 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -117.82 110.8 18.23 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -93.34 139.88 30.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.111 -0.993 . . . . 0.0 112.851 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.4 ttp -69.46 125.71 27.54 Favored 'General case' 0 CA--C 1.571 1.772 0 O-C-N 120.419 -1.426 . . . . 0.0 114.68 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.84 -50.92 6.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.5 p -136.36 155.17 50.42 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -143.55 117.65 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.032 0.933 . . . . 0.0 108.947 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.05 -71.38 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -166.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -121.97 41.88 3.27 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.956 0.884 . . . . 0.0 112.108 -171.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.455 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 8.1 t80 -73.57 -39.94 64.29 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -57.22 -43.84 83.22 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.78 -39.05 84.1 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -56.54 -45.93 80.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 167.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 mt -71.38 -37.48 71.6 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -55.09 -46.0 75.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 161.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.0 -20.81 41.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.06 5.68 50.63 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.286 23.8 t70 61.03 50.13 5.25 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.52 1.509 . . . . 0.0 114.87 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -93.38 150.38 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.892 0.854 . . . . 0.0 109.891 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -63.81 152.42 39.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.79 -44.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.28 64.13 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.37 -38.52 89.9 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -53.99 -53.1 57.63 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -62.15 -43.72 98.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.4 mt -64.1 -53.81 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.898 0.879 . . . . 0.0 111.919 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.65 85.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -61.91 -36.67 82.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.58 -20.68 53.62 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.23 156.88 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -96.15 103.17 12.72 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.182 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.49 146.9 19.63 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.696 2.264 . . . . 0.0 112.947 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -134.28 107.7 7.8 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -83.77 107.45 16.19 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.516 -0.74 . . . . 0.0 111.094 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -94.31 106.43 18.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.63 129.24 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.2 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -99.71 109.84 22.28 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.082 0.553 . . . . 0.0 110.209 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -100.39 81.14 2.32 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.439 0.696 . . . . 0.0 109.304 167.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.63 -102.97 1.03 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 115.02 0.768 . . . . 0.0 115.02 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -86.32 -26.83 24.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 164.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -75.2 119.27 19.1 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.417 1.462 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 ttm -122.29 123.44 41.44 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.586 0.707 . . . . 0.0 110.538 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.9 mt -110.69 95.59 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.7 mt -93.1 104.25 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -100.82 99.29 9.78 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -87.09 100.49 12.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.311 -0.868 . . . . 0.0 109.364 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.3 mt -104.49 112.54 25.64 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.674 0.75 . . . . 0.0 110.531 -164.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -131.99 155.08 48.61 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.976 0.893 . . . . 0.0 111.309 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -65.58 -19.23 65.83 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -83.97 -50.76 7.72 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 119.057 0.844 . . . . 0.0 113.065 168.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -153.2 148.22 26.64 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.882 0.848 . . . . 0.0 110.505 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.52 130.44 50.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.885 . . . . 0.0 110.125 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.74 104.59 11.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.79 -0.569 . . . . 0.0 110.765 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.48 128.23 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.603 0.761 . . . . 0.0 109.122 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -113.41 108.1 16.75 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.722 0.809 . . . . 0.0 109.513 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.27 98.13 7.28 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.641 0.776 . . . . 0.0 110.446 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -144.8 155.92 43.76 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -93.11 131.34 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.863 -1.148 . . . . 0.0 111.007 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.1 t -68.37 126.64 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.65 -0.656 . . . . 0.0 110.689 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.14 -30.61 8.14 Favored Glycine 0 CA--C 1.552 2.384 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -91.86 144.8 25.11 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.168 1.484 . . . . 0.0 112.746 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.6 128.08 36.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 111.507 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.01 149.27 51.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.655 0.782 . . . . 0.0 112.36 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -74.15 101.08 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.035 -1.04 . . . . 0.0 111.913 172.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -94.03 116.01 28.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.546 0.738 . . . . 0.0 110.206 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -80.94 127.43 32.56 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.586 0.707 . . . . 0.0 109.72 163.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mt -99.37 60.98 1.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.135 0.969 . . . . 0.0 111.128 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 119.15 23.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.318 1.047 . . . . 0.0 111.712 -166.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.65 -42.4 1.92 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -162.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.21 -69.57 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.107 0.963 . . . . 0.0 110.125 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -141.3 -1.02 1.37 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 166.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 28.2 m-20 63.93 65.26 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 120.22 1.373 . . . . 0.0 113.575 -173.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HE ' ' HZ2' ' A' ' 101' ' ' LYS . 82.9 mmt-85 -122.2 142.34 50.53 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.612 0.765 . . . . 0.0 110.643 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.38 111.12 22.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.529 165.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m -117.7 145.02 44.72 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.45 0.7 . . . . 0.0 112.098 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.0 mtp -83.4 98.99 9.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -98.86 122.56 42.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.076 0.55 . . . . 0.0 110.182 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.0 m -102.68 131.87 49.19 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 95' ' ' CYS . 38.2 t -117.91 122.59 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.1 m -131.01 158.05 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.78 0.832 . . . . 0.0 112.007 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -85.8 121.42 28.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.69 -1.256 . . . . 0.0 112.214 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -94.66 73.61 3.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.533 0.682 . . . . 0.0 109.264 157.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.85 -100.35 0.32 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -169.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.44 -29.43 28.07 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -83.55 131.26 35.0 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.85 1.205 . . . . 0.0 111.823 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.95 103.34 16.01 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.24 0.616 . . . . 0.0 109.511 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -110.74 131.79 54.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.572 0.749 . . . . 0.0 111.269 -167.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 86' ' ' VAL . 50.2 t -130.93 141.86 50.31 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.43 128.1 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.913 0.885 . . . . 0.0 109.302 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -106.22 95.99 6.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.711 0.804 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.76 120.46 27.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 112.128 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.49 -115.55 0.47 Allowed Glycine 0 N--CA 1.486 1.989 0 O-C-N 121.25 -0.906 . . . . 0.0 113.531 171.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.7 -13.5 57.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.428 ' HZ2' ' HE ' ' A' ' 80' ' ' ARG . 21.1 mmtp -114.71 146.4 40.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.294 1.406 . . . . 0.0 112.359 -170.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -90.24 103.27 15.97 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.462 -162.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.42 50.44 21.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -170.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -89.76 137.21 32.53 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.945 0.879 . . . . 0.0 111.933 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.42 -161.17 27.67 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 121.936 0.742 . . . . 0.0 114.257 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -157.42 157.93 34.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.866 . . . . 0.0 112.638 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -132.77 124.74 28.66 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.286 1.3 pt20 -129.43 141.82 50.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.48 161.2 43.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 0.0 112.53 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -103.83 123.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.934 . . . . 0.0 109.15 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.33 85.19 2.21 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 162.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.05 -111.77 4.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.96 -5.95 58.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 165.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.66 127.28 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 120.396 1.453 . . . . 0.0 111.92 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.1 tp -88.41 117.86 27.63 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.847 0.859 . . . . 0.0 109.724 166.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -100.77 121.52 41.82 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.756 0.823 . . . . 0.0 109.277 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -117.53 130.69 56.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.993 0.917 . . . . 0.0 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.77 118.93 34.97 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.733 0.813 . . . . 0.0 109.554 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.4 mtm -110.63 132.04 54.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.497 -0.752 . . . . 0.0 111.265 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -124.35 133.73 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.86 . . . . 0.0 112.169 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.57 126.88 8.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.272 0.629 . . . . 0.0 110.966 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 57.3 36.51 27.38 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.04 -19.94 2.65 Favored Glycine 0 CA--C 1.558 2.753 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 -162.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.79 119.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 119.568 1.684 . . . . 0.0 109.562 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -101.59 121.84 42.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.446 0.641 . . . . 0.0 110.743 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.455 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 7.1 t -97.6 124.82 42.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 169.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -102.31 127.29 49.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.957 -0.465 . . . . 0.0 111.666 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -127.16 142.82 51.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.941 0.896 . . . . 0.0 111.274 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.54 132.52 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.4 132.13 48.51 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.516 0.726 . . . . 0.0 111.235 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -97.2 127.98 43.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.702 -1.249 . . . . 0.0 112.18 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -67.19 122.94 18.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.1 -39.71 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.103 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.448 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.573 1.847 0 CA-C-O 117.861 -1.066 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.96 120.66 7.54 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.657 2.238 . . . . 0.0 114.77 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.61 148.5 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.766 0.793 . . . . 0.0 113.063 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.51 106.2 18.34 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 111.136 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -81.27 4.49 20.29 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -57.83 108.57 0.59 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.725 1.602 . . . . 0.0 115.144 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.89 179.12 33.5 Favored Glycine 0 N--CA 1.486 2.01 0 CA-C-O 122.756 1.198 . . . . 0.0 115.753 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -110.48 118.84 37.34 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.704 1.201 . . . . 0.0 109.151 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -119.15 118.86 32.5 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -88.76 144.89 25.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.943 -1.098 . . . . 0.0 112.905 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.415 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 7.3 ttp -71.83 124.68 25.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.498 -1.376 . . . . 0.0 113.495 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.07 -48.4 7.77 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.9 m -157.27 160.08 38.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.4 . . . . 0.0 112.993 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -142.69 124.5 15.1 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.342 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -126.41 125.08 41.59 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.062 0.945 . . . . 0.0 109.877 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.1 t30 66.1 37.17 5.3 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.557 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 5.7 t80 -79.04 -43.45 24.2 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.27 -34.76 77.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -70.37 -41.43 73.1 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -53.34 -47.31 69.47 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 120.458 1.481 . . . . 0.0 114.842 166.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.89 -38.35 70.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.83 -45.38 78.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.085 -1.635 . . . . 0.0 115.061 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -18.75 43.31 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 166.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.34 -4.54 59.05 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 25.8 t70 67.38 52.97 0.78 Allowed 'General case' 0 CA--C 1.572 1.805 0 CA-C-N 120.154 1.343 . . . . 0.0 113.996 -166.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -102.86 146.43 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.977 0.894 . . . . 0.0 109.685 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.76 152.38 44.45 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -60.28 -44.12 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.88 65.88 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 116.004 1.854 . . . . 0.0 116.004 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.82 -41.7 96.22 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -52.33 -53.21 47.45 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 166.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -63.23 -43.91 96.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.88 -53.65 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.631 0.772 . . . . 0.0 111.869 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.68 81.77 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -68.6 -30.91 69.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.31 -29.52 62.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 166.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.15 131.55 42.94 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.041 1.291 . . . . 0.0 112.723 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -105.63 89.51 3.48 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.482 173.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.4 Cg_endo -72.6 165.38 32.88 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.371 2.047 . . . . 0.0 115.601 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -111.6 120.24 41.42 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -89.92 110.58 21.53 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.438 -0.789 . . . . 0.0 111.004 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -98.53 110.13 22.78 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.713 -0.617 . . . . 0.0 109.802 169.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.44 125.83 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.43 107.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 165.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -102.42 102.09 12.38 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.643 0.777 . . . . 0.0 109.998 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -92.75 79.32 4.75 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 109.963 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.55 -101.79 0.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 114.508 0.563 . . . . 0.0 114.508 -173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.34 -26.62 24.76 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -79.1 106.27 11.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.772 1.624 . . . . 0.0 111.635 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -112.45 124.03 51.6 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.968 0.907 . . . . 0.0 110.722 -172.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.95 96.84 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.93 108.36 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -102.6 98.94 8.92 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.226 0.61 . . . . 0.0 109.38 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -84.14 101.41 11.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.14 127.5 43.16 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.074 0.55 . . . . 0.0 111.692 -166.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 t -150.79 153.48 35.53 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.981 0.896 . . . . 0.0 111.646 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.6 -31.83 72.73 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -73.02 -51.26 18.88 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -155.55 138.36 15.29 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.032 0.833 . . . . 0.0 110.792 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -99.18 116.92 32.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -107.5 107.71 18.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.854 -0.529 . . . . 0.0 111.035 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.51 127.24 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.1 105.55 15.61 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.596 0.758 . . . . 0.0 109.421 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.02 113.48 26.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.611 0.764 . . . . 0.0 109.753 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.83 157.23 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -168.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -97.35 132.15 43.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 111.473 165.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -69.78 122.09 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 123.38 0.672 . . . . 0.0 110.154 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.93 -37.96 3.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 -158.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.87 136.75 32.87 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 118.25 1.025 . . . . 0.0 113.547 -165.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -87.6 117.38 26.37 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.878 0.471 . . . . 0.0 110.93 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -134.24 145.77 49.46 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.378 0.671 . . . . 0.0 112.287 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.04 101.88 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.463 -1.398 . . . . 0.0 112.958 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.4 112.19 24.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.242 0.617 . . . . 0.0 110.444 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.81 114.99 19.15 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.581 0.705 . . . . 0.0 110.775 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.93 55.26 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 112.857 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 t -74.07 133.57 42.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.55 -54.18 1.48 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.707 -0.62 . . . . 0.0 114.116 -158.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.2 mt -71.27 -63.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.667 0.787 . . . . 0.0 111.221 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -139.21 -3.99 1.53 Allowed 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 166.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.416 4.4 p30 50.14 64.1 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.789 1.632 . . . . 0.0 115.088 -159.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -124.6 130.4 52.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.359 0.664 . . . . 0.0 109.747 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -90.81 112.91 24.92 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.854 -0.529 . . . . 0.0 110.246 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.8 m -123.54 132.44 53.9 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.361 0.665 . . . . 0.0 111.264 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtp -70.04 99.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.423 1.106 . . . . 0.0 110.395 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -108.19 122.35 46.74 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.844 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.6 m -107.68 120.51 42.44 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.9 t -109.62 124.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.7 m -138.44 155.28 48.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 112.473 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -84.21 119.9 25.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.842 -1.162 . . . . 0.0 112.385 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.42 70.93 5.13 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 109.539 160.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.71 -108.96 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 -169.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -77.17 -22.37 52.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -97.47 135.7 38.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.234 1.379 . . . . 0.0 111.314 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.34 114.61 26.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.707 -0.62 . . . . 0.0 109.809 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.586 0.755 . . . . 0.0 111.26 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.6 t -128.0 138.37 52.57 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p -117.37 131.17 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.916 0.887 . . . . 0.0 109.654 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.18 97.8 7.2 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.0 0.92 . . . . 0.0 109.17 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -91.67 119.68 31.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.481 -0.762 . . . . 0.0 112.025 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.11 -107.15 0.28 Allowed Glycine 0 N--CA 1.487 2.036 0 O-C-N 121.211 -0.931 . . . . 0.0 113.48 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.6 -12.05 59.95 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -126.44 145.08 50.62 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.093 1.315 . . . . 0.0 112.053 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.13 110.57 18.13 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.779 0.832 . . . . 0.0 111.418 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.39 46.13 73.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -85.01 139.97 31.38 Favored 'General case' 0 CA--C 1.569 1.682 0 CA-C-N 118.001 0.901 . . . . 0.0 111.668 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.15 -164.49 33.87 Favored Glycine 0 N--CA 1.484 1.854 0 O-C-N 121.391 -0.818 . . . . 0.0 114.736 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.65 157.08 32.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -128.78 130.11 46.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -131.85 144.14 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.712 0.768 . . . . 0.0 112.882 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.4 p90 -153.52 163.63 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.452 0.701 . . . . 0.0 112.723 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.9 129.62 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.396 -0.815 . . . . 0.0 108.888 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.64 98.27 6.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 162.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.84 -115.06 4.58 Favored Glycine 0 N--CA 1.49 2.27 0 O-C-N 121.559 -0.713 . . . . 0.0 114.353 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -95.73 12.96 28.08 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 163.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -112.55 132.83 54.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.554 1.524 . . . . 0.0 112.553 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.65 120.24 31.55 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.254 1.022 . . . . 0.0 108.961 170.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -109.74 124.14 50.74 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 108.895 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.8 tp -130.81 132.51 45.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.644 0.777 . . . . 0.0 110.251 -167.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.17 120.11 34.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.735 -0.603 . . . . 0.0 110.02 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.449 ' SD ' H202 ' A' ' 175' ' ' RTL . 64.1 mtm -112.1 132.21 54.98 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.622 0.769 . . . . 0.0 111.322 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -124.2 137.25 54.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 112.287 -167.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.61 124.59 8.62 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.096 0.559 . . . . 0.0 110.882 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 54.75 43.58 29.85 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.72 -28.56 1.3 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 119.587 2.595 . . . . 0.0 119.587 -164.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.89 120.91 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 118.909 1.354 . . . . 0.0 110.564 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 m -101.9 125.39 48.57 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 121.375 0.607 . . . . 0.0 111.032 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.557 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 13.1 t -92.82 133.57 35.93 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.352 0.661 . . . . 0.0 111.291 163.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -102.14 126.68 49.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.272 0.629 . . . . 0.0 110.536 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 138.98 52.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.058 0.943 . . . . 0.0 111.131 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.12 127.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -126.92 152.57 46.94 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.501 1.12 . . . . 0.0 110.65 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -124.45 135.91 53.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.214 -1.554 . . . . 0.0 112.714 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -70.23 125.4 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.18 -37.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 120.209 1.368 . . . . 0.0 108.346 169.119 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.449 H202 ' SD ' ' A' ' 119' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 CA--C 1.575 1.907 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.93 -173.65 1.92 Allowed 'Trans proline' 0 CA--C 1.568 2.209 0 C-N-CA 122.549 2.166 . . . . 0.0 115.293 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.46 126.71 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.765 -1.209 . . . . 0.0 111.613 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.14 102.14 8.31 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -74.85 0.96 13.82 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 170.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -57.88 112.92 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 121.333 1.879 . . . . 0.0 114.57 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.0 32.32 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-O 123.108 1.393 . . . . 0.0 116.081 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -112.4 113.57 25.83 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.75 -1.225 . . . . 0.0 108.862 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -115.42 115.54 26.72 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -166.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -89.91 143.44 26.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 113.258 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.44 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 12.8 ttp -75.54 127.33 32.86 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 113.77 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -93.1 -45.88 7.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -157.2 158.22 35.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.4 -1.438 . . . . 0.0 113.1 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -137.18 132.26 33.68 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.762 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.33 120.44 19.91 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.351 0.661 . . . . 0.0 109.956 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.278 45.0 t30 65.36 32.14 9.94 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 117.506 2.409 . . . . 0.0 117.506 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -78.12 -37.25 46.6 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -56.31 -41.97 76.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.77 -39.33 84.11 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -58.63 -47.88 82.9 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 167.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.29 -40.39 90.0 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -54.66 -46.0 73.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 162.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.86 -13.74 27.17 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.81 -50.09 5.53 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.43 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.94 5.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.938 1.695 . . . . 0.0 115.126 163.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.69 147.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 118.626 -2.546 . . . . 0.0 113.118 -146.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -67.1 154.42 41.26 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.96 -47.11 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.83 64.08 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.33 -36.88 85.39 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -54.58 -50.23 68.49 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -60.43 -44.3 95.93 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.6 -56.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 123.895 0.878 . . . . 0.0 111.821 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.99 77.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -69.07 -32.29 71.65 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.04 -27.47 60.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.79 141.6 49.69 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.216 1.371 . . . . 0.0 113.706 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -100.68 92.93 2.53 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.467 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 72.4 Cg_endo -71.8 155.33 58.38 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 122.629 2.219 . . . . 0.0 114.946 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.96 117.77 35.07 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.114 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.06 108.02 18.69 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.609 -0.682 . . . . 0.0 110.382 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -93.35 109.64 21.19 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.196 168.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mt -107.25 128.42 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.55 108.31 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -102.48 112.62 25.42 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.993 0.917 . . . . 0.0 110.483 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -105.48 75.97 1.18 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.597 -0.689 . . . . 0.0 109.669 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.48 -99.3 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -78.24 -37.93 44.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -77.02 116.07 17.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 120.333 1.424 . . . . 0.0 112.31 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.9 ttm -126.59 124.81 40.79 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.655 0.782 . . . . 0.0 110.866 -170.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.7 99.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.19 110.9 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -106.93 97.27 7.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.6 m -83.49 102.82 12.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.11 116.85 32.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.587 0.708 . . . . 0.0 111.094 -166.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -135.66 150.76 49.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.53 0.732 . . . . 0.0 110.099 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -63.42 -27.05 69.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.03 -41.48 64.17 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 164.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -158.19 129.89 6.75 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.847 1.203 . . . . 0.0 112.931 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -105.03 120.65 42.01 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.641 0.777 . . . . 0.0 109.765 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -121.85 109.98 15.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.758 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.84 125.75 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -103.55 107.32 18.12 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.49 0.716 . . . . 0.0 109.348 166.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -107.66 112.13 24.69 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.473 0.709 . . . . 0.0 109.583 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -154.51 164.27 38.93 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.32 134.23 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.969 167.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.23 134.92 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 O-C-N 121.149 -0.97 . . . . 0.0 110.55 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.22 46.18 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -163.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.36 145.0 35.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.926 1.363 . . . . 0.0 110.236 -162.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -90.72 128.9 36.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -139.21 158.99 43.19 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.143 0.973 . . . . 0.0 112.882 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.37 92.17 3.34 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 111.763 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -88.43 100.2 12.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.06 101.04 13.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 122.955 0.502 . . . . 0.0 110.552 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 mp -83.41 52.11 2.15 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.9 m -70.68 124.38 24.14 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.357 1.063 . . . . 0.0 110.302 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.28 -16.3 49.42 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 -162.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.21 -82.01 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.792 1.796 . . . . 0.0 106.948 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -122.3 17.55 10.64 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 52.88 46.97 25.7 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -129.27 140.56 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.64 0.733 . . . . 0.0 112.466 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -87.72 109.25 19.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.622 0.769 . . . . 0.0 111.149 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.4 m -101.37 140.31 35.84 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.438 0.695 . . . . 0.0 111.603 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.8 80.41 7.27 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.459 1.123 . . . . 0.0 110.193 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.7 m -85.51 128.08 34.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.173 -0.954 . . . . 0.0 110.672 -166.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -116.5 118.51 32.86 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 t -112.66 125.05 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.8 m -135.78 156.78 48.28 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.961 0.886 . . . . 0.0 112.928 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -88.11 122.9 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.69 66.25 0.66 Allowed 'General case' 0 CA--C 1.576 1.981 0 C-N-CA 123.59 0.756 . . . . 0.0 110.289 160.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.69 -96.39 0.25 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -79.35 -36.93 38.63 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -85.25 116.44 23.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.945 0.878 . . . . 0.0 112.287 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.2 tp -85.85 106.02 16.76 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -94.67 129.99 41.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.955 0.902 . . . . 0.0 111.459 -172.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -125.06 127.35 46.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.651 0.78 . . . . 0.0 112.068 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.59 119.64 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -95.41 97.1 9.57 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -81.38 115.87 20.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 111.692 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.37 -126.13 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 O-C-N 122.11 -0.369 . . . . 0.0 113.292 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.36 -31.69 37.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.59 144.79 26.91 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.041 1.292 . . . . 0.0 113.084 -164.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -81.63 106.31 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.351 0.661 . . . . 0.0 112.081 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.92 53.6 14.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -89.96 124.7 34.96 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.303 0.641 . . . . 0.0 110.857 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.9 -166.95 38.02 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -160.17 157.28 28.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.255 1.026 . . . . 0.0 113.004 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -128.94 129.83 45.96 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.0 139.42 52.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -148.61 166.33 28.62 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 52.1 mt -106.44 122.91 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.501 -0.749 . . . . 0.0 109.349 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -110.87 86.87 2.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.534 -0.729 . . . . 0.0 109.907 164.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.24 -109.69 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.527 -0.733 . . . . 0.0 113.557 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.92 43.69 1.4 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 156.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.25 124.67 43.51 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.624 0.77 . . . . 0.0 109.634 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.71 113.37 25.44 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 121.737 0.78 . . . . 0.0 108.975 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.92 124.04 48.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.4 tp -125.02 125.97 44.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.725 0.81 . . . . 0.0 110.716 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -108.46 123.29 48.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.509 ' SD ' H202 ' A' ' 175' ' ' RTL . 65.5 mtm -112.41 135.76 52.71 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.695 -0.628 . . . . 0.0 111.582 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -123.76 133.77 53.78 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 112.735 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.78 5.88 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.794 0.838 . . . . 0.0 110.214 173.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 56.29 41.49 29.09 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.91 -12.05 2.3 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 120.11 2.804 . . . . 0.0 120.11 -163.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.11 123.53 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 119.692 1.746 . . . . 0.0 109.69 -166.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 m -99.6 118.01 35.21 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.662 0.385 . . . . 0.0 110.341 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -99.51 122.78 43.08 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.144 0.578 . . . . 0.0 110.856 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -101.77 129.46 47.96 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.683 0.754 . . . . 0.0 111.441 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -137.85 131.71 31.48 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.989 0.916 . . . . 0.0 110.276 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.88 132.47 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 109.017 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -132.42 149.75 52.28 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.842 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -124.14 128.27 49.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.431 -1.418 . . . . 0.0 111.127 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -71.49 120.16 16.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.465 -0.772 . . . . 0.0 112.838 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.3 -38.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 CA--C 1.566 1.568 0 CA-C-N 119.702 1.137 . . . . 0.0 108.219 169.591 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.509 H202 ' SD ' ' A' ' 119' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.7 mtm . . . . . 0 CA--C 1.574 1.901 0 CA-C-O 116.107 -1.902 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.09 133.57 13.67 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 124.994 2.819 . . . . 0.0 114.149 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -74.86 148.69 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.12 106.24 17.11 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 112.614 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -80.64 6.32 13.04 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -59.34 112.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 121.422 1.919 . . . . 0.0 114.799 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.6 178.82 33.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -109.67 109.73 20.55 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.595 1.158 . . . . 0.0 109.043 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -112.48 110.04 19.99 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -168.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -86.57 137.72 32.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.103 -0.998 . . . . 0.0 113.193 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ttp -74.1 122.39 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.02 1.282 . . . . 0.0 114.043 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 mt -82.16 -53.76 5.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.424 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -130.91 154.72 47.8 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -172.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -136.94 109.45 7.42 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.761 0.824 . . . . 0.0 108.839 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -93.07 -64.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -124.91 44.94 2.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.68 0.752 . . . . 0.0 111.916 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 4.3 t80 -72.5 -38.56 68.09 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.8 -41.74 96.23 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -71.16 -40.01 71.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -53.17 -47.27 68.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.24 -37.76 71.98 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -55.84 -44.16 77.73 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 163.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.47 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.95 1.06 53.94 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.289 4.2 t70 64.2 49.83 2.54 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -168.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.59 145.89 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.94 0.876 . . . . 0.0 109.903 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -61.93 153.97 27.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.01 -47.5 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.5 62.68 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.0 tp -66.33 -25.67 66.93 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -64.95 -47.23 78.37 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.767 1.621 . . . . 0.0 113.86 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -50.98 67.32 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -53.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 124.097 0.959 . . . . 0.0 112.212 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.2 -35.88 78.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -69.08 -32.61 72.19 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.63 -28.65 62.88 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.22 135.04 48.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.061 1.3 . . . . 0.0 112.826 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.57 89.59 2.28 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.648 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.29 151.96 60.81 Favored 'Trans proline' 0 CA--C 1.561 1.858 0 CA-C-N 123.056 2.127 . . . . 0.0 115.371 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.66 115.49 30.34 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -84.26 107.54 16.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.456 -0.778 . . . . 0.0 110.495 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -94.54 110.25 22.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -105.71 126.25 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.7 t -112.02 108.95 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -106.13 111.34 23.92 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 121.931 0.872 . . . . 0.0 110.702 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -99.78 76.24 1.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.659 1.184 . . . . 0.0 109.459 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.96 -106.46 1.93 Allowed Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.067 -1.021 . . . . 0.0 114.682 -175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.85 -22.12 24.63 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 162.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -70.09 120.99 16.62 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 120.132 1.333 . . . . 0.0 111.712 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -136.54 122.73 20.44 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 121.498 0.666 . . . . 0.0 111.043 -163.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.4 mt -116.21 99.98 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -95.66 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -99.68 98.86 9.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -84.1 95.67 8.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 109.019 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -93.26 124.52 37.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.057 0.543 . . . . 0.0 111.149 -166.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 t -146.34 154.16 41.34 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.107 0.956 . . . . 0.0 111.83 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -61.86 -30.82 71.11 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -77.82 -52.38 9.0 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -153.67 138.43 17.04 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.175 0.898 . . . . 0.0 110.877 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -93.08 117.79 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.736 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -106.21 104.22 13.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.521 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.29 125.47 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.2 mtp -103.98 110.13 22.16 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.309 165.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.56 111.1 20.83 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.238 1.015 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.34 168.82 26.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -164.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -106.8 135.21 48.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.975 -1.078 . . . . 0.0 110.238 161.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.0 125.55 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 O-C-N 121.42 -0.8 . . . . 0.0 108.94 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.58 -35.08 4.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -155.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 138.48 34.1 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 118.383 1.092 . . . . 0.0 113.165 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -87.62 114.77 24.53 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 122.024 -0.423 . . . . 0.0 110.336 167.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.95 148.6 50.51 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.497 0.719 . . . . 0.0 112.567 -173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.77 99.7 4.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 112.083 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.54 109.01 20.3 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.485 -0.759 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -79.38 106.07 11.15 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.215 0.531 . . . . 0.0 110.284 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.93 49.59 1.76 Allowed 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -79.95 130.39 35.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 113.275 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.89 -50.51 0.96 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.4 -0.813 . . . . 0.0 114.744 -154.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.8 mt -78.43 -65.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 124.398 1.079 . . . . 0.0 110.838 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -147.06 7.66 0.92 Allowed 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.274 2.3 m-20 57.46 30.55 18.83 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -104.57 141.1 37.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 111.298 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.86 98.28 11.28 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.155 0.582 . . . . 0.0 109.591 173.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.24 146.01 28.61 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.428 0.632 . . . . 0.0 112.104 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -79.26 95.66 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.914 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.8 m -93.99 126.72 39.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.058 0.543 . . . . 0.0 110.149 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -116.63 130.4 56.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.4 t -116.69 130.3 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -125.58 139.82 53.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.076 0.951 . . . . 0.0 111.087 -175.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -84.53 120.97 26.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 112.611 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -111.59 61.16 0.62 Allowed 'General case' 0 CA--C 1.575 1.932 0 C-N-CA 123.871 0.869 . . . . 0.0 110.549 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.27 -93.28 0.19 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.14 -34.96 32.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -91.69 128.31 37.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.533 1.061 . . . . 0.0 111.252 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -98.51 114.71 27.22 Favored 'General case' 0 CA--C 1.561 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.171 169.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -117.15 129.24 55.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.147 0.579 . . . . 0.0 111.064 -163.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.43 ' SG ' HG22 ' A' ' 86' ' ' VAL . 53.5 t -130.37 145.56 51.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -121.74 135.34 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 124.175 0.99 . . . . 0.0 110.42 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.0 95.55 5.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.834 0.853 . . . . 0.0 109.734 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.25 124.37 33.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.642 -1.286 . . . . 0.0 112.843 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 -112.3 0.27 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 121.661 -0.649 . . . . 0.0 112.283 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -83.2 -10.05 58.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -113.16 143.97 43.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.549 1.522 . . . . 0.0 113.186 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -80.55 124.15 28.71 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.31 42.37 99.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 118.494 2.158 . . . . 0.0 118.494 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -91.36 134.08 34.91 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.843 0.83 . . . . 0.0 111.595 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.66 -163.83 32.49 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 121.882 0.712 . . . . 0.0 114.298 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -156.88 153.53 28.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -129.52 126.04 37.69 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.44 137.95 54.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -148.58 163.2 37.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 112.913 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.29 125.04 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.97 96.58 6.03 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.4 -109.0 2.67 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.374 -0.829 . . . . 0.0 113.882 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -109.75 25.71 11.48 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 158.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -108.81 123.63 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.917 1.235 . . . . 0.0 110.974 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -82.21 115.52 21.33 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.069 0.947 . . . . 0.0 109.151 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -102.16 115.45 30.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.4 123.15 49.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.809 0.843 . . . . 0.0 111.163 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.11 124.25 47.38 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 165.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.3 mtm -116.35 128.99 56.01 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.104 0.865 . . . . 0.0 110.904 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -116.18 136.78 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.55 120.42 8.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.594 0.757 . . . . 0.0 110.022 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 59.07 39.91 22.7 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.94 -34.87 1.25 Allowed Glycine 0 CA--C 1.558 2.749 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -161.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.08 118.36 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.008 1.323 . . . . 0.0 111.238 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.4 m -107.39 119.71 40.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.588 -168.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.461 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 11.8 t -94.36 126.13 39.42 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.531 0.732 . . . . 0.0 111.984 170.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -100.18 127.93 46.35 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.338 0.59 . . . . 0.0 111.751 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -127.64 137.12 52.44 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.899 0.88 . . . . 0.0 110.964 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.23 131.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.51 127.27 43.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.523 0.729 . . . . 0.0 110.319 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.79 123.38 41.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.762 -1.211 . . . . 0.0 111.559 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.55 115.85 8.41 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.237 0.926 . . . . 0.0 112.469 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.7 -36.96 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.588 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 171.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.445 H151 H201 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.571 1.788 0 CA-C-O 118.79 -0.624 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.11 120.7 7.79 Favored 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 122.741 2.294 . . . . 0.0 115.013 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -75.72 143.93 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.757 0.789 . . . . 0.0 112.945 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.2 103.26 12.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.003 . . . . 0.0 111.567 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -76.56 -1.8 29.26 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -55.44 113.72 1.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 121.189 1.813 . . . . 0.0 114.7 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.69 -179.85 29.66 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-O 122.72 1.178 . . . . 0.0 115.53 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -113.2 118.91 36.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.311 1.044 . . . . 0.0 109.188 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -121.39 114.76 21.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -165.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -88.76 140.89 28.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.255 -0.903 . . . . 0.0 113.254 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.461 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 4.8 ttm -70.34 120.55 16.18 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.46 -45.24 16.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -153.58 159.09 42.07 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.236 1.38 . . . . 0.0 113.549 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -134.07 101.94 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.955 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.0 123.55 50.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.197 0.599 . . . . 0.0 111.001 -171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 29.6 t30 66.31 36.26 5.44 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 5.1 t80 -79.14 -39.16 34.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.54 -40.59 79.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -66.18 -41.53 90.13 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -55.99 -48.11 76.47 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.88 -40.62 75.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -55.31 -45.87 76.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.69 -20.99 24.53 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 164.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.8 mt -96.17 13.19 28.19 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.304 22.8 t70 60.74 56.48 2.96 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-N 120.709 1.595 . . . . 0.0 113.464 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -106.62 146.82 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 122.093 0.949 . . . . 0.0 110.165 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -64.04 153.01 38.71 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -61.25 -44.03 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.98 -52.12 64.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.81 -38.72 91.84 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -53.2 -53.03 56.68 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -62.46 -46.49 88.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.58 -57.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 123.729 0.812 . . . . 0.0 111.774 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.13 72.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -69.91 -36.83 75.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 165.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.1 mt -73.01 -24.52 60.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.78 143.22 49.61 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.152 1.342 . . . . 0.0 113.805 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -102.82 90.27 2.23 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.757 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 59.6 Cg_endo -69.31 155.74 66.53 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 123.054 2.127 . . . . 0.0 114.987 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.3 118.83 34.37 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -86.03 115.4 23.61 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.525 -0.735 . . . . 0.0 110.849 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -102.2 106.44 17.27 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mp -101.18 131.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.313 -0.867 . . . . 0.0 109.237 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.63 109.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.47 106.62 17.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.883 0.873 . . . . 0.0 110.082 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -99.37 80.4 2.41 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 123.57 0.748 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.89 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.513 -0.742 . . . . 0.0 114.189 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -93.07 -20.14 20.83 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 163.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -74.16 105.89 5.57 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.667 2.03 . . . . 0.0 111.211 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.5 ttm -116.73 124.85 50.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.59 0.756 . . . . 0.0 110.557 -170.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.03 98.39 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.2 mt -94.32 110.83 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.29 96.09 6.12 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.1 m -85.78 99.11 11.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 108.79 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.18 115.93 28.46 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.832 -0.542 . . . . 0.0 111.343 -164.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 t -134.3 151.82 51.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.766 0.793 . . . . 0.0 110.521 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -64.05 -29.33 70.48 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.73 -51.31 28.16 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 167.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.88 134.93 13.92 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.38 0.991 . . . . 0.0 111.213 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.44 118.76 30.83 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 123.781 0.832 . . . . 0.0 109.555 170.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -102.81 116.84 33.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 110.4 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.27 117.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.9 mtp -105.6 105.31 15.28 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -108.36 108.82 19.95 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.575 0.75 . . . . 0.0 109.555 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.85 155.93 33.8 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -90.48 126.74 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.7 165.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.89 121.77 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 168.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.54 -35.13 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 -156.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.44 140.99 32.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.491 1.145 . . . . 0.0 113.3 -165.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -86.3 108.37 18.38 Favored 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 122.818 0.447 . . . . 0.0 110.387 166.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -119.92 143.4 48.0 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.673 0.789 . . . . 0.0 112.504 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.35 97.7 2.55 Favored 'General case' 0 CA--C 1.567 1.609 0 O-C-N 120.935 -1.103 . . . . 0.0 112.609 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -93.51 113.47 25.61 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.452 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.28 105.07 12.18 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.734 0.414 . . . . 0.0 110.752 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.55 52.32 2.31 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -83.58 132.43 34.91 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.089 0.947 . . . . 0.0 111.647 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.58 -62.17 0.38 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.273 -151.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mt -72.11 -70.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.559 1.144 . . . . 0.0 110.202 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -136.08 9.79 3.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 169.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 58.84 45.19 15.73 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -135.17 143.77 46.66 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.725 0.774 . . . . 0.0 111.282 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -88.0 126.24 34.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.624 -0.672 . . . . 0.0 111.341 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -122.66 140.64 52.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.156 0.582 . . . . 0.0 111.142 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.11 97.18 5.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 168.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.6 m -95.55 123.25 39.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.42 0.688 . . . . 0.0 110.218 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 m -107.43 126.8 52.96 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 168.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.19 135.86 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -149.95 152.43 34.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.443 -1.411 . . . . 0.0 112.729 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -80.71 118.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.861 -1.149 . . . . 0.0 112.653 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.11 71.11 6.3 Favored 'General case' 0 CA--C 1.571 1.764 0 O-C-N 121.51 -0.744 . . . . 0.0 109.565 159.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.02 -109.67 2.94 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.76 -23.05 58.48 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -93.34 127.15 38.83 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.86 1.209 . . . . 0.0 111.367 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.73 105.09 16.71 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -109.76 136.1 49.63 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.606 0.762 . . . . 0.0 111.377 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -134.93 138.17 43.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.36 133.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 123.715 0.806 . . . . 0.0 110.242 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -112.56 98.52 7.3 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.626 0.771 . . . . 0.0 109.575 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.31 117.02 27.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.424 -0.798 . . . . 0.0 111.749 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.27 -131.12 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 O-C-N 121.233 -0.917 . . . . 0.0 113.619 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.05 -34.81 69.05 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -96.34 140.0 31.64 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.226 1.012 . . . . 0.0 112.315 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.45 122.56 26.58 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -165.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.06 52.27 53.83 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -93.41 138.87 31.31 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.723 0.773 . . . . 0.0 111.707 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.96 -168.54 35.72 Favored Glycine 0 N--CA 1.485 1.911 0 CA-C-O 121.918 0.732 . . . . 0.0 114.722 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -156.49 153.64 29.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.6 m -128.52 123.12 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -123.57 131.75 53.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.699 0.8 . . . . 0.0 111.397 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -148.89 175.43 11.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.239 -0.913 . . . . 0.0 112.76 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.78 135.8 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.916 -1.115 . . . . 0.0 109.262 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.57 93.12 3.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 165.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.74 -120.04 5.26 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.873 -0.517 . . . . 0.0 113.351 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.43 41.27 1.25 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 161.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -131.1 118.67 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.348 0.659 . . . . 0.0 109.399 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.31 122.31 26.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.891 0.876 . . . . 0.0 110.437 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -112.91 119.79 39.17 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.2 tp -124.61 124.86 43.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.643 0.777 . . . . 0.0 110.53 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.95 121.31 42.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 165.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.7 mtm -110.62 127.46 55.26 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.905 0.775 . . . . 0.0 110.318 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -119.2 145.41 46.06 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.98 122.53 2.59 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.067 0.547 . . . . 0.0 110.75 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.299 7.1 mt-10 50.88 50.82 18.28 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.88 -28.77 2.78 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 120.162 2.825 . . . . 0.0 120.162 -169.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -76.05 156.0 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.817 1.309 . . . . 0.0 112.075 -171.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -123.54 127.51 48.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.0 110.688 168.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 17.5 t -94.24 136.86 34.07 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.999 0.52 . . . . 0.0 111.199 156.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -114.64 123.94 50.58 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.072 0.549 . . . . 0.0 110.272 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -121.12 135.13 55.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.72 -0.612 . . . . 0.0 111.17 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.12 129.3 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -133.27 136.78 45.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.525 -0.734 . . . . 0.0 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -103.62 133.24 48.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.308 -1.495 . . . . 0.0 112.676 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -69.14 122.89 19.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.6 m -117.53 -37.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 119.761 1.164 . . . . 0.0 107.93 170.413 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.433 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 16.1 ttt . . . . . 0 CA--C 1.577 1.992 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 -121.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 122.613 2.209 . . . . 0.0 114.56 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.42 -20.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.258 46.7 t0 65.44 83.06 0.17 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 125.082 1.353 . . . . 0.0 113.749 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.97 6.07 14.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.32 108.85 0.99 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.481 1.492 . . . . 0.0 114.652 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.87 -179.64 33.44 Favored Glycine 0 N--CA 1.485 1.958 0 CA-C-O 122.807 1.226 . . . . 0.0 115.58 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -107.5 118.22 36.15 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.45 1.1 . . . . 0.0 109.274 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -117.12 111.75 19.93 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -168.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -85.3 139.03 31.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 112.765 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 30.6 ttm -65.92 124.99 24.0 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 120.092 1.315 . . . . 0.0 114.355 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -86.08 -43.99 12.63 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -153.0 156.9 39.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.366 -1.459 . . . . 0.0 113.408 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -131.35 109.23 10.2 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.922 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.06 121.09 38.11 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.272 0.629 . . . . 0.0 110.499 -168.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 30.3 t30 68.01 31.83 5.34 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 9.1 t80 -78.43 -38.46 41.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.93 -41.45 74.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.0 -37.85 78.94 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -55.1 -47.38 75.04 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 120.26 1.391 . . . . 0.0 114.658 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.96 -40.59 71.87 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -54.68 -42.86 71.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 165.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 -29.15 60.78 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.4 -0.71 53.75 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 17.2 t0 66.71 48.12 1.45 Allowed 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 144.47 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.985 172.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -64.53 155.0 34.34 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 171.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.94 -43.84 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.67 50.27 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.33 -37.42 85.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -56.78 -51.7 67.89 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 165.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -62.94 -46.74 86.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.45 -56.9 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.042 0.837 . . . . 0.0 111.719 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.39 -27.98 67.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -75.19 -33.67 61.45 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.63 -34.16 76.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 166.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.36 130.28 40.95 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.176 0.988 . . . . 0.0 112.278 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.39 100.01 9.63 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.838 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 38.1 Cg_endo -66.8 154.89 72.98 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 CA-C-N 123.466 2.274 . . . . 0.0 114.967 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -108.24 119.63 40.03 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -89.46 113.85 25.27 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.358 -0.839 . . . . 0.0 110.863 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.78 106.97 19.3 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.807 -0.558 . . . . 0.0 109.545 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -102.24 130.6 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.58 108.79 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 167.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -94.59 102.63 14.56 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.393 0.677 . . . . 0.0 110.064 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 74.05 3.02 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 121.492 0.663 . . . . 0.0 110.4 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 -103.48 0.98 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.592 -0.692 . . . . 0.0 114.591 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.62 -32.49 23.69 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 165.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -80.17 104.2 10.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.623 1.556 . . . . 0.0 110.998 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp -114.33 132.14 56.29 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 122.295 1.045 . . . . 0.0 111.47 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.31 99.73 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.78 110.26 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -103.6 101.61 11.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.726 -0.608 . . . . 0.0 109.476 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -86.13 102.76 14.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.48 130.24 49.23 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.931 0.492 . . . . 0.0 111.494 -166.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.6 t -149.17 155.15 40.22 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.117 0.96 . . . . 0.0 111.675 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.2 p -62.02 -32.56 73.07 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.81 -50.55 13.19 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -151.82 136.85 17.33 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 119.388 0.994 . . . . 0.0 112.273 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -94.08 136.82 33.96 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 121.738 -0.601 . . . . 0.0 110.98 166.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -128.26 113.44 15.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 110.807 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.98 129.57 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 123.478 0.711 . . . . 0.0 109.467 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtp -108.59 108.04 18.77 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.639 0.776 . . . . 0.0 110.005 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.03 118.12 35.18 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.137 0.975 . . . . 0.0 111.825 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.2 149.55 22.97 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -165.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -94.46 127.23 40.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 0.0 111.095 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.87 130.62 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 123.332 0.653 . . . . 0.0 111.209 -174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.14 -36.19 4.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -162.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.18 140.46 29.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.579 1.189 . . . . 0.0 112.813 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -87.14 114.82 24.08 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.804 -0.56 . . . . 0.0 110.877 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -121.71 139.23 53.83 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 111.92 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.45 90.58 2.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.11 . . . . 0.0 113.431 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -92.15 113.24 25.45 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.406 -0.808 . . . . 0.0 110.72 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.54 127.77 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.35 1.072 . . . . 0.0 111.209 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.15 49.38 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.616 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.3 t -71.76 137.19 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.418 1.087 . . . . 0.0 113.314 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.66 -57.0 0.98 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 120.862 -0.685 . . . . 0.0 114.083 -154.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -79.56 -67.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.649 1.18 . . . . 0.0 110.169 -171.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.84 25.35 0.84 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 160.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.301 0.9 OUTLIER 61.41 8.01 2.0 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -82.3 139.58 34.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.806 -1.184 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -92.87 108.57 20.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.3 m -112.77 124.0 51.59 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.654 0.74 . . . . 0.0 110.751 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtp -72.55 92.56 1.5 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.585 1.184 . . . . 0.0 111.043 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -100.98 123.98 46.0 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.268 -157.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.6 m -104.66 119.49 39.11 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.41 HG22 ' SG ' ' A' ' 95' ' ' CYS . 30.0 t -104.93 127.76 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.8 m -129.44 155.32 45.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 112.422 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -90.85 118.52 30.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.0 111.71 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.06 75.68 1.68 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 166.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 -106.04 1.45 Allowed Glycine 0 N--CA 1.488 2.109 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.183 -167.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.9 -19.51 25.74 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -83.89 133.45 34.72 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 121.085 1.766 . . . . 0.0 111.948 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -92.87 98.08 11.15 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.169 0.588 . . . . 0.0 109.585 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -102.02 131.05 48.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.511 0.724 . . . . 0.0 110.963 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 86' ' ' VAL . 51.9 t -128.81 142.17 51.06 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.93 126.12 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.768 0.827 . . . . 0.0 109.445 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.69 96.47 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.139 0.976 . . . . 0.0 109.069 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -96.27 116.32 28.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.177 -0.952 . . . . 0.0 111.985 -166.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.97 -105.93 0.19 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.297 -0.877 . . . . 0.0 112.792 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -79.09 -30.43 43.88 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.53 141.3 40.62 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.864 1.211 . . . . 0.0 113.018 -162.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.43 111.93 16.18 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.78 46.03 92.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 117.727 1.851 . . . . 0.0 117.727 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -83.44 137.98 33.67 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 118.282 1.041 . . . . 0.0 111.064 172.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.98 -163.49 34.48 Favored Glycine 0 N--CA 1.483 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 114.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.275 63.4 p-90 -158.06 169.06 25.41 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.547 1.165 . . . . 0.0 113.69 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.7 m -146.87 119.55 8.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.054 -1.654 . . . . 0.0 109.032 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -116.25 135.04 54.25 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -147.8 171.9 14.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.556 -0.715 . . . . 0.0 112.776 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.91 128.53 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.345 -0.847 . . . . 0.0 109.37 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.14 87.51 2.73 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.936 0.874 . . . . 0.0 110.281 166.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.12 -116.49 4.27 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.724 -0.61 . . . . 0.0 113.246 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -94.17 24.61 4.25 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 160.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.51 125.64 50.3 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.725 1.148 . . . . 0.0 111.349 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.03 120.31 25.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.36 0.664 . . . . 0.0 109.852 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.78 118.76 37.02 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.1 tp -125.94 122.21 35.34 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.593 0.757 . . . . 0.0 110.448 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.99 126.7 47.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.201 0.6 . . . . 0.0 109.535 167.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.1 mtp -122.68 123.87 42.12 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.983 0.913 . . . . 0.0 110.448 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -121.98 135.17 54.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 111.814 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.32 124.38 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.186 0.594 . . . . 0.0 110.737 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 56.29 41.36 29.26 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.07 -20.48 1.52 Allowed Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.702 2.641 . . . . 0.0 119.702 -164.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 51.0 t -80.43 118.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.723 1.761 . . . . 0.0 109.82 -169.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.5 m -99.53 124.33 44.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.797 0.808 . . . . 0.0 111.264 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.429 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 10.4 t -99.08 130.28 45.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.28 1.032 . . . . 0.0 110.894 168.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -105.31 117.86 35.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 110.568 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -117.47 125.33 50.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.554 0.742 . . . . 0.0 109.771 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.81 129.83 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.9 149.63 52.23 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 123.435 0.694 . . . . 0.0 111.453 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -115.54 132.53 56.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.106 -1.621 . . . . 0.0 112.252 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -69.3 124.8 24.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.38 -40.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 . . . . . 0 CA--C 1.562 1.435 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.663 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.434 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 57.1 mtt . . . . . 0 CA--C 1.574 1.878 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.33 130.55 14.13 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.725 2.283 . . . . 0.0 114.508 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.63 149.62 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.142 0.973 . . . . 0.0 113.429 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -87.52 106.22 17.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.37 -0.831 . . . . 0.0 111.833 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -83.39 0.83 44.29 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -58.87 106.29 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 121.27 1.85 . . . . 0.0 114.791 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.89 176.87 32.45 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-O 122.825 1.236 . . . . 0.0 115.83 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -105.45 120.54 41.88 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.439 1.096 . . . . 0.0 109.9 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -119.53 113.23 20.42 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -92.07 140.32 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.741 -1.224 . . . . 0.0 113.197 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.7 ttp -73.52 123.58 24.21 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.654 1.57 . . . . 0.0 114.388 -171.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.01 -52.69 6.11 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.158 0.983 . . . . 0.0 113.465 169.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -136.96 154.47 50.42 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -138.72 106.88 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.213 0.605 . . . . 0.0 109.819 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.99 121.92 41.88 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.622 0.769 . . . . 0.0 110.186 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 27.7 t30 63.44 32.98 14.06 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -79.39 -46.61 17.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.491 -1.381 . . . . 0.0 114.411 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -58.45 -39.13 79.04 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.73 -40.81 84.15 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -56.66 -49.15 75.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 164.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.9 -37.81 88.89 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -52.29 -47.37 65.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 162.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.24 -18.52 61.42 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.18 4.16 52.95 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.263 5.8 t70 66.24 46.63 2.0 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -171.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.07 142.57 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.748 0.785 . . . . 0.0 109.46 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -64.43 154.61 35.17 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.44 -46.05 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.82 -50.23 69.09 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 tp -64.2 -35.49 80.98 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -57.13 -42.1 80.3 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 163.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.56 -43.86 75.71 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -64.04 -56.56 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 123.927 0.891 . . . . 0.0 111.821 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.95 77.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -71.26 -30.16 65.96 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.76 -30.74 64.38 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 167.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.98 140.27 50.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.666 1.121 . . . . 0.0 113.569 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -94.05 100.45 4.87 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.443 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.75 157.27 60.97 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 123.248 2.196 . . . . 0.0 114.152 167.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -128.11 118.12 22.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.315 -1.491 . . . . 0.0 108.793 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -86.07 109.26 18.71 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.714 -0.616 . . . . 0.0 111.005 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.68 107.44 19.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 168.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.1 mt -104.08 127.35 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.5 t -112.36 107.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -102.39 97.42 7.67 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.912 0.885 . . . . 0.0 109.888 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.46 78.44 4.99 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.379 -0.825 . . . . 0.0 110.129 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 -103.7 1.1 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.881 -0.512 . . . . 0.0 114.374 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.5 -26.21 32.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 164.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -81.22 105.78 12.69 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.374 1.443 . . . . 0.0 111.552 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -109.86 122.13 46.81 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.155 0.978 . . . . 0.0 111.203 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -114.48 97.29 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.3 mt -91.54 109.44 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -102.72 99.01 8.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -86.05 98.04 10.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 108.756 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -95.93 115.44 27.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.7 -0.625 . . . . 0.0 110.203 -165.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 t -133.41 152.61 51.93 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.735 0.778 . . . . 0.0 110.72 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.9 p -63.1 -29.38 70.76 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -75.94 -49.52 17.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -154.61 135.06 13.37 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 119.414 1.006 . . . . 0.0 111.604 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -85.99 117.32 24.76 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.432 0.693 . . . . 0.0 110.222 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -106.14 103.95 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.363 -0.835 . . . . 0.0 110.374 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.72 124.17 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -102.93 107.4 18.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.646 0.778 . . . . 0.0 109.375 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -108.09 110.29 21.93 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.721 0.808 . . . . 0.0 109.83 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.36 160.27 41.61 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -101.94 138.22 39.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 110.969 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.33 133.56 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.31 -25.33 27.4 Favored Glycine 0 CA--C 1.552 2.387 0 N-CA-C 117.73 1.852 . . . . 0.0 117.73 -164.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -101.98 134.26 45.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.178 1.489 . . . . 0.0 111.04 -158.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -83.06 103.15 12.28 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.999 0.52 . . . . 0.0 111.231 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.96 138.73 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.442 0.697 . . . . 0.0 112.286 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.98 96.49 1.04 Allowed 'General case' 0 CA--C 1.57 1.719 0 O-C-N 120.955 -1.091 . . . . 0.0 112.953 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -89.88 113.12 24.67 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.25 108.69 15.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.872 -0.518 . . . . 0.0 109.644 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mp -85.2 56.22 3.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.161 0.981 . . . . 0.0 113.474 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.0 t -78.32 129.16 34.69 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.508 1.147 . . . . 0.0 112.846 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.31 -42.2 2.01 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.3 -88.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -113.49 7.59 17.54 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 57.11 44.63 22.18 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -137.17 142.98 42.17 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.53 131.27 34.99 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.273 0.629 . . . . 0.0 112.5 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.2 125.92 27.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.102 0.561 . . . . 0.0 111.343 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 mmt -68.38 100.97 1.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.672 1.225 . . . . 0.0 110.555 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 m -100.46 122.22 42.84 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.755 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -110.93 118.58 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 t -109.91 121.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.4 m -127.83 147.4 50.44 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.843 0.857 . . . . 0.0 112.359 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -82.44 115.08 21.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.985 -1.072 . . . . 0.0 112.234 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -103.71 72.03 1.1 Allowed 'General case' 0 CA--C 1.568 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 109.74 166.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.37 -110.69 3.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.91 -26.05 59.36 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -101.29 126.54 48.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 119.901 1.228 . . . . 0.0 111.057 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -87.68 113.32 23.25 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 121.387 -0.82 . . . . 0.0 109.955 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -100.41 137.62 38.58 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.958 0.903 . . . . 0.0 111.735 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.4 t -131.64 136.87 48.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.364 0.666 . . . . 0.0 112.636 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.3 123.69 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.413 0.685 . . . . 0.0 109.776 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -99.8 98.38 9.19 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.513 1.125 . . . . 0.0 109.472 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -89.74 115.21 26.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 111.445 -171.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.35 -112.59 0.27 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 121.767 -0.583 . . . . 0.0 112.457 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.18 -31.21 23.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -96.99 142.55 28.81 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.387 1.089 . . . . 0.0 113.797 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.53 106.77 11.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.044 -172.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.34 66.33 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -172.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -82.14 133.31 35.26 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.194 0.598 . . . . 0.0 110.823 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.43 -159.48 31.2 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -160.38 160.13 31.92 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.315 1.055 . . . . 0.0 112.92 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.3 m -133.04 128.45 36.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.113 -0.992 . . . . 0.0 108.396 170.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.77 138.48 53.37 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.7 163.85 37.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.3 mt -102.63 126.73 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.328 -0.857 . . . . 0.0 109.878 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.71 90.21 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.805 0.812 . . . . 0.0 110.175 164.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.14 -116.02 4.18 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 121.639 -0.663 . . . . 0.0 113.445 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -90.84 18.91 5.99 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 161.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -118.45 122.33 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.451 1.478 . . . . 0.0 111.113 -166.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.3 tp -82.85 111.89 19.16 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -98.04 119.39 36.59 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.63 117.8 26.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.601 0.76 . . . . 0.0 110.234 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.93 131.65 39.16 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.088 0.555 . . . . 0.0 109.781 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.0 mtp -127.07 121.44 31.54 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.444 0.698 . . . . 0.0 109.571 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -117.25 137.76 52.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 112.87 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.32 115.12 5.28 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 0.0 111.009 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.26 3.1 mt-10 58.14 44.65 18.77 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.24 -28.99 0.98 Allowed Glycine 0 CA--C 1.559 2.789 0 N-CA-C 119.172 2.429 . . . . 0.0 119.172 -162.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.5 t -71.69 115.26 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.752 1.221 . . . . 0.0 110.198 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.8 m -106.1 117.52 34.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.261 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 t -89.91 134.82 34.0 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.314 0.646 . . . . 0.0 111.448 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -109.68 118.61 37.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.756 -0.59 . . . . 0.0 110.809 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -116.66 137.06 52.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.65 0.78 . . . . 0.0 110.183 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.03 130.01 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -126.61 131.15 51.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.654 -0.654 . . . . 0.0 110.994 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -94.72 130.33 41.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.731 -1.231 . . . . 0.0 112.217 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -64.91 123.86 20.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.69 -36.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 120.228 1.377 . . . . 0.0 108.04 171.564 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.542 ' H8 ' H161 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 CA--C 1.576 1.942 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.41 174.64 8.91 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 C-N-CA 122.599 2.199 . . . . 0.0 115.141 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.23 127.11 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.4 102.4 12.01 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -159.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -76.47 -0.9 24.66 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -58.96 114.34 2.52 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 122.029 2.195 . . . . 0.0 114.407 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.03 177.7 28.58 Favored Glycine 0 N--CA 1.486 2.002 0 CA-C-O 122.925 1.292 . . . . 0.0 115.811 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -110.75 111.16 22.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.478 1.111 . . . . 0.0 108.904 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -114.16 111.82 22.19 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -166.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.56 142.43 27.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 112.815 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.5 ttp -72.18 121.61 19.62 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.834 1.197 . . . . 0.0 113.53 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.8 mt -81.88 -44.43 16.86 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 169.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.2 m -154.11 160.65 42.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.458 -1.401 . . . . 0.0 113.343 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.65 120.47 17.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.137 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.94 120.74 31.17 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 110.185 -170.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 32.6 t30 65.86 36.57 5.99 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.594 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 6.3 t80 -81.62 -42.34 20.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.14 -34.82 74.07 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.47 -44.78 70.48 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.018 1.736 . . . . 0.0 114.651 165.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -55.05 -45.45 75.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.73 -37.45 73.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.23 -43.73 87.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.2 -1.562 . . . . 0.0 114.848 163.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.27 24.84 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 163.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.0 mt -96.7 9.41 41.73 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 22.9 t70 62.61 59.93 1.4 Allowed 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 120.438 1.472 . . . . 0.0 113.145 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.98 139.08 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.616 0.722 . . . . 0.0 110.106 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.56 150.84 47.74 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.58 -47.01 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -49.98 70.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.23 -42.53 99.4 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 171.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -56.83 -48.57 77.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 121.304 1.866 . . . . 0.0 115.741 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.32 -43.32 99.06 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.56 -54.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 118.842 0.746 . . . . 0.0 111.691 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.52 78.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -66.77 -33.84 76.5 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 167.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.1 -25.08 58.23 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -70.68 147.74 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.365 1.439 . . . . 0.0 114.517 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -100.24 95.83 4.5 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.091 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.61 141.49 46.0 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.479 2.119 . . . . 0.0 113.786 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.39 114.53 23.67 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -87.02 109.42 19.38 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.726 -0.609 . . . . 0.0 110.924 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.52 105.31 17.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 167.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mt -104.26 129.69 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.9 t -112.37 106.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -101.54 103.5 14.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.247 0.619 . . . . 0.0 109.781 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.65 72.0 5.85 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.39 -94.3 0.47 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.83 -25.11 17.5 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 166.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -83.63 116.42 22.61 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.416 1.462 . . . . 0.0 111.077 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.3 ttm -126.51 124.5 40.19 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.558 0.694 . . . . 0.0 110.945 -165.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.76 101.67 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.73 111.32 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -104.86 96.17 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 m -82.8 99.17 9.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 0.0 108.871 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.21 121.27 37.8 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.322 0.582 . . . . 0.0 110.401 -168.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -139.52 153.45 47.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.632 0.729 . . . . 0.0 110.67 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -63.6 -28.9 70.24 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.29 -52.55 10.58 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 170.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -156.04 136.75 13.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 119.461 1.028 . . . . 0.0 111.277 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.8 121.0 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.572 0.749 . . . . 0.0 110.111 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -109.72 116.74 32.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 110.366 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mm -110.64 119.66 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.2 mtp -107.33 104.17 13.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.825 -0.547 . . . . 0.0 110.082 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -110.14 115.75 30.29 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.074 0.95 . . . . 0.0 111.615 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -158.39 153.34 25.17 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -93.04 134.09 35.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.09 -1.007 . . . . 0.0 110.455 161.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.11 124.69 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.385 -0.822 . . . . 0.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.14 -38.32 3.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -155.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.94 133.76 35.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 117.959 0.88 . . . . 0.0 113.279 -161.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.46 102.58 12.18 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 121.953 -0.467 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -116.29 144.34 44.36 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.623 0.769 . . . . 0.0 112.173 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.59 92.21 3.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.597 -1.314 . . . . 0.0 113.197 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.17 118.9 24.42 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.388 -0.82 . . . . 0.0 110.767 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -76.8 127.81 33.45 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.759 -0.588 . . . . 0.0 110.518 161.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.3 55.29 0.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.553 0.692 . . . . 0.0 112.571 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.8 t -82.87 131.01 35.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 112.521 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -49.8 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.297 -0.877 . . . . 0.0 114.642 -155.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -78.34 -72.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.443 1.097 . . . . 0.0 109.902 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -135.34 -2.54 2.48 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.288 1.7 m-20 58.71 45.0 16.44 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -116.07 139.99 49.73 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.779 0.831 . . . . 0.0 110.993 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -83.54 124.24 30.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.108 0.48 . . . . 0.0 110.464 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 83.7 m -124.42 122.24 37.12 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.262 0.625 . . . . 0.0 110.851 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.73 99.05 2.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.292 1.044 . . . . 0.0 109.996 173.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.9 m -111.56 121.04 44.09 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.87 -158.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -104.76 120.66 41.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.74 128.04 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.9 m -132.75 145.72 51.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.595 0.758 . . . . 0.0 111.631 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -80.4 118.23 21.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.343 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.62 69.76 2.55 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.443 -0.786 . . . . 0.0 110.034 161.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.41 -96.94 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.3 -29.66 28.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -96.29 131.89 42.33 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 120.204 1.365 . . . . 0.0 111.466 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.9 tp -89.44 105.76 18.0 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.815 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.26 147.82 24.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.058 0.943 . . . . 0.0 111.964 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.8 t -141.57 135.83 30.46 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.89 126.54 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.541 0.736 . . . . 0.0 109.046 163.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -102.53 108.13 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.518 0.727 . . . . 0.0 109.527 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -86.39 101.96 13.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.801 -1.187 . . . . 0.0 110.453 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.28 92.81 0.09 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.311 79.9 mt-10 70.11 -46.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -106.74 151.47 25.09 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.506 1.146 . . . . 0.0 113.191 -153.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -86.72 107.64 18.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.586 -0.697 . . . . 0.0 111.89 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.64 55.61 8.31 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -95.57 129.1 42.87 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 122.967 0.507 . . . . 0.0 111.719 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.22 -147.78 13.4 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -160.98 161.44 31.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.959 0.885 . . . . 0.0 112.958 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.2 m -134.97 123.38 23.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -123.29 131.96 53.85 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.508 0.723 . . . . 0.0 111.287 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.97 169.24 20.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.877 -1.139 . . . . 0.0 113.209 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -113.48 128.01 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -113.28 90.03 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.87 -113.13 4.06 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.46 -0.775 . . . . 0.0 114.819 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -88.25 4.4 45.97 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.46 131.65 54.06 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 120.037 1.289 . . . . 0.0 112.365 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.43 122.0 35.4 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -111.52 123.05 49.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.9 tp -123.4 121.14 35.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.351 0.661 . . . . 0.0 111.07 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.46 129.71 42.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.404 0.681 . . . . 0.0 110.235 163.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.6 mtm -119.69 130.85 55.23 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.736 0.698 . . . . 0.0 110.722 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -125.47 133.31 52.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 112.609 -164.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.28 131.88 7.69 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 55.02 38.78 31.08 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.36 3.72 Favored Glycine 0 CA--C 1.559 2.786 0 N-CA-C 120.182 2.833 . . . . 0.0 120.182 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.66 121.8 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 119.87 1.835 . . . . 0.0 108.6 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.2 m -98.59 124.37 43.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 121.671 0.748 . . . . 0.0 110.691 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.594 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 11.2 t -92.74 143.79 25.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.686 . . . . 0.0 111.345 160.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.8 122.87 44.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.937 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -115.34 130.8 57.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.73 132.11 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -128.97 159.29 36.34 Favored 'General case' 0 CA--C 1.574 1.887 0 C-N-CA 124.437 1.095 . . . . 0.0 111.206 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -130.94 132.11 44.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.534 -1.354 . . . . 0.0 111.846 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.51 116.17 10.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.18 -33.96 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t60 . . . . . 0 CA--C 1.562 1.414 0 CA-C-N 119.951 1.25 . . . . 0.0 107.993 170.017 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.431 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 CA--C 1.571 1.764 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.6 119.58 6.01 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 C-N-CA 122.649 2.232 . . . . 0.0 114.714 -175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.77 142.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.239 1.019 . . . . 0.0 113.426 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -80.96 100.43 8.92 Favored 'General case' 0 CA--C 1.564 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 112.855 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.8 -4.0 44.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -54.84 108.86 0.44 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 121.285 1.857 . . . . 0.0 115.136 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.56 -175.99 35.55 Favored Glycine 0 CA--C 1.546 2.017 0 CA-C-O 122.829 1.238 . . . . 0.0 115.828 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -117.51 118.06 31.14 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.311 1.045 . . . . 0.0 109.356 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -121.54 117.13 26.02 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.69 -0.631 . . . . 0.0 109.582 -164.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -84.99 147.07 26.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 0.0 113.537 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 31.9 ttm -70.61 128.93 37.78 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 120.372 1.442 . . . . 0.0 113.459 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.38 -45.71 9.76 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -157.3 156.13 31.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.255 1.843 . . . . 0.0 114.458 173.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -104.75 123.29 47.39 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.761 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.97 -66.74 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -126.44 39.16 3.99 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.206 0.602 . . . . 0.0 112.114 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -70.58 -36.84 73.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.77 -47.32 70.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.56 -37.72 77.12 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -52.94 -48.11 67.56 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 120.838 1.654 . . . . 0.0 114.049 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.0 -35.83 69.57 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -54.0 -46.03 71.64 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.605 1.548 . . . . 0.0 114.899 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.63 -23.4 58.92 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.75 -9.54 59.3 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 166.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.329 16.9 t70 71.93 48.71 0.27 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.489 1.516 . . . . 0.0 114.763 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.5 t -89.94 149.79 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 122.289 1.042 . . . . 0.0 110.561 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -62.95 149.09 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -60.64 -40.8 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.18 -55.31 34.71 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.64 -41.99 91.76 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -53.22 -51.96 60.46 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 168.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -65.61 -41.76 92.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.76 -58.13 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.332 0.969 . . . . 0.0 111.519 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.08 74.23 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.09 -28.82 63.56 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 166.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.85 -23.6 39.0 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 mt -69.93 149.51 47.71 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.673 1.578 . . . . 0.0 114.681 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -101.84 91.04 2.14 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.212 171.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 92.7 Cg_endo -75.18 152.35 39.85 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.532 2.154 . . . . 0.0 114.224 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -109.4 117.74 34.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.351 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -84.84 111.94 20.09 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.328 -0.857 . . . . 0.0 110.746 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 107.95 19.75 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.759 -0.588 . . . . 0.0 109.632 165.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -102.92 127.35 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.46 106.32 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 170.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.48 105.58 17.57 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.157 0.583 . . . . 0.0 110.159 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -95.3 79.9 3.51 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.53 0.681 . . . . 0.0 109.751 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.93 -105.06 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.21 -26.67 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 165.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -82.11 107.06 14.51 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.515 1.507 . . . . 0.0 111.49 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.4 ttm -108.44 124.64 50.72 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.999 0.92 . . . . 0.0 111.04 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.48 102.22 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.68 107.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -100.13 101.49 12.55 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -85.1 101.18 12.23 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 mt -99.03 121.33 40.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.899 0.48 . . . . 0.0 111.506 -164.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.8 t -144.41 150.61 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.908 0.861 . . . . 0.0 111.304 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.9 p -63.21 -31.19 72.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -71.04 -52.47 19.34 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -155.39 135.94 13.36 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.94 0.791 . . . . 0.0 110.857 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -88.53 127.77 35.55 Favored 'General case' 0 CA--C 1.568 1.636 0 O-C-N 121.876 -0.515 . . . . 0.0 110.582 167.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -110.14 123.42 49.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.585 -0.697 . . . . 0.0 110.857 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.69 121.09 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -112.46 104.51 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -108.78 110.43 21.81 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.63 0.772 . . . . 0.0 108.926 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -153.67 154.84 34.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -167.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -100.13 125.86 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.728 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.49 125.87 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.639 -0.663 . . . . 0.0 110.811 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.52 -38.86 3.12 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 116.723 1.449 . . . . 0.0 116.723 -161.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -85.47 146.97 26.69 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 118.405 1.102 . . . . 0.0 113.919 -172.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -93.58 112.97 24.97 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.979 0.512 . . . . 0.0 110.003 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -120.82 148.52 43.9 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.985 0.914 . . . . 0.0 112.473 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -70.46 103.04 2.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.662 -1.274 . . . . 0.0 111.757 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -89.99 113.99 25.76 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.17 0.588 . . . . 0.0 109.892 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.94 122.49 24.24 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 121.082 0.468 . . . . 0.0 110.237 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -105.15 44.18 1.05 Allowed 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -81.0 132.67 35.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.952 -1.093 . . . . 0.0 111.366 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.33 -57.65 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.811 -151.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.8 mt -74.42 -63.41 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.76 17.56 1.27 Allowed 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 159.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.05 42.2 31.12 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -111.24 145.1 39.33 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.662 0.785 . . . . 0.0 111.342 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -90.38 117.6 29.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.04 . . . . 0.0 110.013 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.0 m -111.07 144.1 40.72 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.11 90.3 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.55 168.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.0 m -90.69 129.93 36.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 -172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 m -116.63 125.37 51.68 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.438 HG22 ' SG ' ' A' ' 95' ' ' CYS . 40.6 t -115.39 128.76 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.6 m -132.63 148.92 52.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.196 -0.94 . . . . 0.0 112.377 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.33 123.11 29.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.824 -1.172 . . . . 0.0 113.344 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -111.79 73.39 0.82 Allowed 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 123.654 0.782 . . . . 0.0 109.666 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.01 -110.02 3.08 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -69.7 -24.11 63.53 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -99.13 120.62 39.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.206 0.912 . . . . 0.0 111.191 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.6 111.65 23.05 Favored 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -114.83 128.43 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.507 0.723 . . . . 0.0 110.532 -161.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 86' ' ' VAL . 54.1 t -130.67 142.86 50.44 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.2 129.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.493 164.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -103.93 95.9 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -88.72 115.91 26.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.941 -1.099 . . . . 0.0 112.015 -167.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.18 -126.64 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 O-C-N 121.248 -0.907 . . . . 0.0 114.164 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.63 -32.1 65.64 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -103.99 138.65 40.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.823 1.192 . . . . 0.0 111.784 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.41 142.6 30.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.55 45.93 94.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 117.551 1.78 . . . . 0.0 117.551 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -99.95 130.92 46.17 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 121.698 0.761 . . . . 0.0 111.032 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.68 -166.4 34.75 Favored Glycine 0 N--CA 1.482 1.748 0 CA-C-O 121.806 0.67 . . . . 0.0 114.415 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -157.96 156.45 31.25 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.0 m -133.37 124.66 27.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.54 128.78 48.5 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.646 0.778 . . . . 0.0 111.336 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -146.32 169.26 19.18 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.113 -0.992 . . . . 0.0 113.191 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.2 mt -109.1 124.44 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.34 86.78 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.388 163.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.87 -110.54 3.25 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 121.231 -0.918 . . . . 0.0 115.045 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.66 -6.03 59.34 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 162.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.0 137.26 39.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.697 1.589 . . . . 0.0 112.826 -172.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.06 120.17 36.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.612 0.765 . . . . 0.0 109.04 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -110.11 117.58 34.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.2 tp -121.0 117.08 26.36 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.471 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.99 129.7 40.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.955 0.502 . . . . 0.0 109.867 166.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.8 mtp -124.45 123.43 40.14 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.742 0.817 . . . . 0.0 110.089 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -114.29 140.23 48.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.615 -0.678 . . . . 0.0 112.461 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.11 120.13 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.585 0.754 . . . . 0.0 109.506 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 58.56 41.34 22.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.75 -32.76 1.44 Allowed Glycine 0 CA--C 1.558 2.731 0 N-CA-C 118.852 2.301 . . . . 0.0 118.852 -163.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.28 116.19 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 124.757 1.223 . . . . 0.0 110.78 -168.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -106.37 115.31 29.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.099 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.0 t -97.49 127.21 43.26 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.784 0.834 . . . . 0.0 112.082 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -93.53 116.38 28.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -103.36 119.12 38.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 132.86 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -131.09 160.56 34.33 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 124.116 0.966 . . . . 0.0 111.703 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.12 129.7 40.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 110.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -68.47 124.87 24.75 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.56 -40.19 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.563 1.47 0 CA-C-N 119.781 1.173 . . . . 0.0 108.258 169.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.434 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.575 1.923 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.47 -173.99 2.08 Favored 'Trans proline' 0 CA--C 1.57 2.298 0 C-N-CA 122.352 2.035 . . . . 0.0 115.623 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -60.4 -17.18 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 119.567 3.173 . . . . 0.0 119.567 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.261 52.3 t0 67.99 86.28 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.236 1.38 . . . . 0.0 113.802 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -78.54 5.26 11.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 117.975 2.583 . . . . 0.0 117.975 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -61.42 107.66 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.806 1.639 . . . . 0.0 114.481 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.17 178.79 32.53 Favored Glycine 0 N--CA 1.484 1.89 0 CA-C-O 122.621 1.123 . . . . 0.0 114.888 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -107.76 118.76 37.58 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.33 1.052 . . . . 0.0 109.27 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -118.81 112.48 19.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -168.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -89.53 139.55 30.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 112.831 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.434 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.2 ttp -69.31 121.52 17.05 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 119.889 1.222 . . . . 0.0 114.042 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.93 -44.41 18.29 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -152.95 159.13 42.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.398 -1.439 . . . . 0.0 113.724 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -140.39 118.76 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.692 -174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.96 118.3 19.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.745 -0.597 . . . . 0.0 110.439 -167.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.283 23.1 t30 66.6 33.76 6.33 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -80.25 -42.34 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.78 -42.85 80.16 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.28 -39.87 89.71 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -54.79 -47.58 73.81 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.64 -40.44 73.07 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -57.88 -41.9 83.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 165.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.43 58.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 164.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 mt -86.75 -49.67 7.29 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.22 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 125.835 1.654 . . . . 0.0 114.986 165.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.01 148.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 119.306 -2.121 . . . . 0.0 112.886 -136.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.66 153.21 40.2 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -60.0 -41.81 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.49 -54.73 42.3 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 172.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.16 -38.17 85.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -57.18 -51.22 70.21 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.38 -41.71 93.44 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.17 -58.21 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 119.446 1.021 . . . . 0.0 111.373 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.64 76.48 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -68.45 -36.22 78.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.83 -28.75 63.78 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.0 mt -72.5 135.24 45.63 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.541 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 101.99 7.97 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.565 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 34.1 Cg_endo -65.76 142.99 72.26 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 CA-C-N 123.315 2.22 . . . . 0.0 113.94 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.54 113.39 25.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -88.57 110.78 21.18 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.767 -0.583 . . . . 0.0 111.287 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -97.84 106.91 19.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.61 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.18 109.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 164.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -102.22 109.88 21.68 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.537 0.735 . . . . 0.0 109.99 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -100.19 74.97 1.79 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.05 -104.02 0.89 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.12 -31.3 39.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.06 127.58 33.55 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.893 1.678 . . . . 0.0 111.701 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.11 123.67 22.24 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-O 121.348 0.594 . . . . 0.0 111.274 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.4 mt -109.61 105.8 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.16 115.71 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -107.39 96.16 6.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -86.75 95.52 9.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 mt -95.15 130.74 41.76 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -162.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -149.52 152.72 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.926 0.87 . . . . 0.0 110.97 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.6 p -62.33 -31.65 72.3 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -75.27 -52.46 10.81 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -151.0 129.27 11.97 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 119.042 0.837 . . . . 0.0 110.498 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.3 123.16 33.84 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.307 0.643 . . . . 0.0 109.568 167.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -103.56 110.85 23.05 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 119.087 0.858 . . . . 0.0 109.658 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.9 mm -104.1 116.9 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.1 mtp -103.81 133.91 48.0 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.37 109.43 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.97 160.44 41.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -167.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -103.37 131.09 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.836 0.827 . . . . 0.0 110.519 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.89 131.63 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 CA-C-O 121.966 0.889 . . . . 0.0 110.166 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.9 22.76 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 -161.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -101.33 143.22 31.64 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.241 1.521 . . . . 0.0 111.608 -166.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.39 108.8 20.14 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.003 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.13 146.97 44.69 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.54 108.02 4.72 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.96 0.886 . . . . 0.0 112.524 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.41 106.78 15.36 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.663 0.785 . . . . 0.0 109.939 -168.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.54 119.44 24.71 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.817 0.818 . . . . 0.0 110.707 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.04 52.49 1.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 m -73.66 128.22 34.91 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.468 1.107 . . . . 0.0 112.46 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.52 -60.98 0.41 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.987 -0.446 . . . . 0.0 113.648 -157.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.61 -61.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 124.245 1.018 . . . . 0.0 110.95 -174.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -143.63 3.57 1.29 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 165.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 7.8 t70 44.62 55.28 5.95 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -163.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.521 ' HE ' ' HZ1' ' A' ' 101' ' ' LYS . 76.2 mmt-85 -110.89 138.18 47.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.661 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -97.88 104.45 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.2 m -109.27 145.62 35.62 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.363 0.601 . . . . 0.0 111.862 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.8 mmm -85.17 91.72 8.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.147 169.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.9 m -96.6 122.66 39.76 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.653 -166.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 m -100.21 117.14 33.82 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -105.76 128.92 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -141.6 153.9 45.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.965 -1.085 . . . . 0.0 112.585 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -81.27 114.32 19.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.979 -1.076 . . . . 0.0 111.868 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -85.42 70.24 10.78 Favored 'General case' 0 CA--C 1.572 1.806 0 CA-C-O 121.597 0.713 . . . . 0.0 110.121 162.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.33 -98.84 0.21 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -169.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.47 -26.03 26.54 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -94.11 138.99 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.667 1.576 . . . . 0.0 111.513 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.74 106.69 18.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.097 -1.002 . . . . 0.0 110.098 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -95.37 150.42 20.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.967 0.907 . . . . 0.0 112.395 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -146.44 135.17 22.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.013 0.525 . . . . 0.0 112.315 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.93 126.6 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.65 0.78 . . . . 0.0 109.173 167.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -103.3 92.28 4.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -86.18 134.25 33.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.855 . . . . 0.0 112.961 -167.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 141.23 -90.68 0.18 Allowed Glycine 0 N--CA 1.486 2.031 0 O-C-N 121.441 -0.787 . . . . 0.0 113.713 167.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.29 -12.4 59.07 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -169.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HZ1' ' HE ' ' A' ' 80' ' ' ARG . 24.0 mmtm -129.21 148.98 51.19 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.672 1.578 . . . . 0.0 112.757 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -82.11 114.18 20.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.787 0.835 . . . . 0.0 111.258 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.54 43.04 99.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 118.11 2.004 . . . . 0.0 118.11 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -86.17 135.93 33.39 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.304 1.052 . . . . 0.0 111.635 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -170.79 38.6 Favored Glycine 0 N--CA 1.482 1.721 0 CA-C-O 122.12 0.845 . . . . 0.0 114.262 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 61.7 p-90 -153.56 165.06 37.07 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.406 1.098 . . . . 0.0 113.183 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 m -138.47 125.77 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.43 129.0 42.46 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.725 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -151.62 165.49 34.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.002 -1.061 . . . . 0.0 113.242 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -107.41 131.0 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -0.936 . . . . 0.0 109.298 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -119.2 95.45 4.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 162.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.77 -117.4 4.72 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.677 -0.64 . . . . 0.0 114.151 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -94.59 15.9 16.85 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.994 1.849 . . . . 0.0 115.994 162.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -113.74 125.21 53.86 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.583 1.083 . . . . 0.0 111.055 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.3 120.64 26.1 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.375 1.07 . . . . 0.0 109.712 166.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -107.11 119.14 38.57 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.579 0.751 . . . . 0.0 108.979 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 tp -115.66 128.55 56.0 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.756 0.822 . . . . 0.0 110.013 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.88 123.8 50.66 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.638 0.775 . . . . 0.0 110.042 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.7 mtm -115.41 137.17 52.34 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.857 0.863 . . . . 0.0 111.483 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -127.11 135.05 50.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.539 -0.726 . . . . 0.0 111.578 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.77 125.4 6.38 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.118 0.567 . . . . 0.0 111.438 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 54.56 42.6 31.2 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.38 -6.95 6.92 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 120.377 2.911 . . . . 0.0 120.377 -165.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.21 126.15 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.281 2.04 . . . . 0.0 109.93 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -108.47 128.99 55.27 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.934 0.894 . . . . 0.0 111.085 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.4 t -125.12 126.5 45.41 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 0.0 112.75 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.95 135.54 35.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.552 -0.718 . . . . 0.0 112.127 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -129.04 134.5 48.15 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.351 0.661 . . . . 0.0 110.656 162.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.6 t -116.68 130.32 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.84 132.73 43.95 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.905 0.775 . . . . 0.0 111.252 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -103.61 133.75 48.1 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.227 -1.545 . . . . 0.0 112.631 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.96 120.88 16.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.0 -38.57 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 . . . . . 0 CA--C 1.563 1.464 0 CA-C-N 119.933 1.242 . . . . 0.0 108.318 169.274 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.409 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 78.2 mtp . . . . . 0 CA--C 1.572 1.802 0 CA-C-O 115.91 -1.995 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.27 92.74 0.74 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.482 2.994 . . . . 0.0 114.683 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.0 147.9 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -80.9 105.76 12.38 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.452 -0.78 . . . . 0.0 112.554 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -78.8 2.1 21.01 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -57.82 105.68 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 121.348 1.886 . . . . 0.0 115.114 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.53 179.83 35.55 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -109.64 113.0 25.41 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.592 1.157 . . . . 0.0 109.218 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -115.15 111.61 21.28 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -168.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.31 141.35 28.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.6 ttp -71.76 121.69 19.36 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.615 -1.303 . . . . 0.0 113.987 -173.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.2 mt -83.13 -45.09 14.36 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -153.52 160.45 42.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.505 -1.372 . . . . 0.0 113.333 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.34 117.98 10.4 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.002 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.76 121.0 35.26 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.749 0.82 . . . . 0.0 109.834 -172.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.285 31.1 t30 68.36 34.2 3.87 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -78.68 -40.53 33.66 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -56.4 -35.86 68.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 168.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.76 -41.92 67.83 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.946 1.703 . . . . 0.0 114.675 166.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.25 -51.12 65.54 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 120.079 1.308 . . . . 0.0 113.802 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.04 -38.18 82.21 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -59.92 -39.21 84.69 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -34.3 62.77 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 165.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.96 -9.79 58.86 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.318 15.9 t0 67.95 49.8 0.87 Allowed 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 125.592 1.557 . . . . 0.0 114.581 -161.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.5 t -93.51 137.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.93 0.872 . . . . 0.0 109.758 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -61.82 150.52 36.96 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 176.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -52.51 -44.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.51 68.96 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 172.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -36.29 80.79 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -61.97 -51.21 69.01 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.307 1.867 . . . . 0.0 115.447 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -60.22 -44.58 95.05 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.08 -55.96 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.724 0.693 . . . . 0.0 111.391 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.41 77.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -70.67 -32.05 69.18 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.61 -24.12 53.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -72.22 154.28 41.1 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -99.0 95.96 3.68 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.364 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.72 143.65 30.32 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.507 2.138 . . . . 0.0 113.477 166.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.14 117.22 32.67 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -85.92 107.18 17.6 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.371 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.22 108.7 20.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 170.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -106.6 127.84 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -116.15 109.15 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -106.79 105.48 15.53 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 123.881 0.873 . . . . 0.0 110.578 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.78 75.68 6.47 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 110.054 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.39 -100.36 0.47 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 115.231 0.853 . . . . 0.0 115.231 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.54 -29.04 28.19 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.17 110.49 17.42 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.353 1.433 . . . . 0.0 111.016 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -126.98 130.67 50.51 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.439 1.114 . . . . 0.0 111.949 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.86 101.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.2 mt -93.12 110.59 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -103.1 100.13 10.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -83.25 97.9 9.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.84 112.38 25.47 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.667 0.746 . . . . 0.0 110.627 -165.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 t -127.98 149.87 50.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.486 0.66 . . . . 0.0 109.789 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -61.33 -28.26 69.09 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -76.11 -42.47 46.99 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 166.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -156.47 131.39 9.06 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 120.214 1.37 . . . . 0.0 112.864 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -109.29 122.2 46.83 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.532 0.733 . . . . 0.0 110.297 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.42 108.88 15.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.325 -0.86 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.09 127.59 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-O 121.65 0.738 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -108.64 105.81 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.814 0.846 . . . . 0.0 109.505 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -104.99 116.65 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.429 0.692 . . . . 0.0 109.775 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -153.66 155.79 36.69 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.28 128.45 46.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.442 -0.786 . . . . 0.0 110.522 165.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.7 t -68.27 121.93 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 123.453 0.701 . . . . 0.0 110.255 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.36 -35.17 4.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -162.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.1 140.31 29.58 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.732 1.266 . . . . 0.0 112.06 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.13 107.12 18.99 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 122.041 -0.412 . . . . 0.0 111.079 171.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -112.46 133.77 54.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.577 0.751 . . . . 0.0 112.026 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.97 94.2 2.32 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 112.18 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -96.63 130.28 43.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.641 -0.662 . . . . 0.0 111.616 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.51 124.29 28.82 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.19 67.73 4.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.115 1.436 . . . . 0.0 111.665 171.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -75.52 126.14 30.43 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.483 -166.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.22 64.75 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -170.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.75 -75.26 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.35 7.48 4.22 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.5 t0 43.84 59.98 2.9 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -115.2 141.51 47.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.59 -0.694 . . . . 0.0 111.375 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.47 115.52 28.1 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.335 0.654 . . . . 0.0 110.607 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.8 m -120.42 135.24 55.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.284 0.633 . . . . 0.0 111.751 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.0 mmm -76.63 99.77 5.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.787 . . . . 0.0 110.463 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.4 m -101.49 118.74 37.58 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.696 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.6 m -97.6 124.17 41.78 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.46 132.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.9 m -151.07 153.58 35.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.321 -1.487 . . . . 0.0 113.234 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -84.97 117.58 24.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.336 . . . . 0.0 113.27 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -99.12 78.97 2.29 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 123.427 0.691 . . . . 0.0 109.258 164.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -121.69 21.61 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.36 -8.33 56.88 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 168.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -98.23 128.76 44.85 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.067 1.303 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.8 tp -89.4 107.36 19.03 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.586 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -90.1 141.35 28.77 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.898 0.879 . . . . 0.0 111.563 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -133.14 125.52 29.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.516 0.726 . . . . 0.0 110.923 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -113.19 121.63 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 123.225 0.61 . . . . 0.0 109.731 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -103.65 102.11 11.97 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.392 0.677 . . . . 0.0 111.024 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.34 125.0 39.66 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.68 -118.01 0.62 Allowed Glycine 0 N--CA 1.49 2.241 0 O-C-N 121.102 -0.999 . . . . 0.0 112.976 170.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.55 -36.12 81.89 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -89.55 130.86 35.8 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -163.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.4 117.82 22.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.566 . . . . 0.0 111.889 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.11 46.94 93.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 117.737 1.855 . . . . 0.0 117.737 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -93.01 136.92 32.83 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.19 0.995 . . . . 0.0 111.762 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 -171.12 43.03 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 122.842 1.245 . . . . 0.0 114.244 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -154.08 152.78 30.86 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.101 0.953 . . . . 0.0 112.47 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 79.3 m -125.59 125.14 42.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.64 139.24 53.32 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -151.78 164.14 37.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 113.072 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.51 140.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 122.847 1.308 . . . . 0.0 110.689 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -137.16 84.05 2.03 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.08 -111.16 3.4 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.846 -0.533 . . . . 0.0 113.816 -171.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -93.03 6.96 46.07 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -106.62 127.59 53.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.96 1.709 . . . . 0.0 112.741 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.7 tp -85.61 119.16 25.64 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.119 0.968 . . . . 0.0 109.381 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.52 122.57 46.28 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.9 126.32 48.4 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.599 0.76 . . . . 0.0 111.473 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -106.0 123.1 47.45 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.394 0.678 . . . . 0.0 109.639 164.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 63.7 mtm -110.09 129.75 55.64 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 118.948 0.795 . . . . 0.0 110.64 172.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -125.68 144.55 50.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.41 127.7 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.606 0.763 . . . . 0.0 110.978 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 51.1 49.7 20.61 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.7 -32.54 1.43 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.67 157.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 125.14 1.376 . . . . 0.0 112.866 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.6 m -129.94 121.95 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.712 -1.243 . . . . 0.0 110.218 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.5 t -97.14 131.68 43.66 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.3 0.64 . . . . 0.0 110.508 161.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -113.8 120.01 39.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.859 -0.526 . . . . 0.0 110.511 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -120.18 139.24 52.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.565 0.746 . . . . 0.0 111.48 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.05 129.79 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.16 142.3 51.22 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.924 0.89 . . . . 0.0 110.663 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -112.59 133.38 54.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.377 -1.452 . . . . 0.0 111.94 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -67.92 122.64 18.61 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.4 m -117.27 -34.49 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t60 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 169.118 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.442 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 CA--C 1.571 1.752 0 CA-C-O 115.994 -1.955 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.28 115.76 3.5 Favored 'Trans proline' 0 C--N 1.374 1.917 0 CA-C-N 124.946 2.802 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.96 139.94 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 CA-C-O 122.003 0.906 . . . . 0.0 110.314 -174.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.72 104.04 8.02 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.328 -0.857 . . . . 0.0 113.282 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -81.27 2.51 27.71 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -59.56 116.12 3.78 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.219 1.827 . . . . 0.0 114.59 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.94 177.95 31.52 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-O 123.246 1.47 . . . . 0.0 115.758 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -110.44 112.37 24.25 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 113.727 -1.236 . . . . 0.0 108.677 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -112.47 122.68 48.4 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -167.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -91.87 143.94 25.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.802 -1.186 . . . . 0.0 113.092 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.402 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.5 ttm -73.49 122.41 22.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.721 -1.237 . . . . 0.0 112.988 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.31 -44.74 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -154.0 158.31 40.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.459 -1.4 . . . . 0.0 112.645 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -135.8 100.62 4.51 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.08 -64.42 1.15 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -154.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -120.54 43.55 2.71 Favored 'General case' 0 CA--C 1.571 1.773 0 C-N-CA 123.717 0.807 . . . . 0.0 111.273 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 17.0 t80 -73.62 -39.85 64.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.54 -46.05 70.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.44 -39.82 85.43 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -55.73 -45.98 77.87 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 165.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.97 -41.42 86.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -53.83 -44.71 70.47 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.89 52.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 166.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.68 -5.71 56.8 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 164.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 7.5 t70 69.6 62.78 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 120.38 1.445 . . . . 0.0 112.996 -164.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 83.5 t -104.03 148.23 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.19 0.995 . . . . 0.0 110.034 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -62.25 151.88 35.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.77 -42.91 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.95 -54.37 45.52 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.63 -38.5 84.98 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -53.53 -52.13 60.65 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -65.29 -45.28 85.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.17 -56.49 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.538 0.735 . . . . 0.0 111.819 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -27.01 66.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.11 -43.22 83.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 162.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.67 -28.14 65.62 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 mt -68.46 135.59 51.91 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 120.034 1.288 . . . . 0.0 112.893 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -113.06 84.57 7.16 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.19 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 70.7 Cg_endo -71.95 168.6 23.46 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 122.624 2.216 . . . . 0.0 116.054 -176.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.77 121.86 45.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.145 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -89.88 110.23 21.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.613 -0.679 . . . . 0.0 110.009 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.3 108.78 20.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 167.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -106.19 123.96 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.53 107.94 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -103.04 119.02 38.1 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.928 0.891 . . . . 0.0 109.36 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.7 -60.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 112.546 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.81 101.49 0.15 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.455 1.0 OUTLIER 60.46 -45.16 0.1 Allowed 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -150.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -70.34 126.66 30.28 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-N 119.874 1.215 . . . . 0.0 112.361 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 ttp -143.39 131.89 22.3 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.105 0.955 . . . . 0.0 111.674 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.9 mt -115.4 109.78 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -97.44 115.72 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -111.54 96.01 5.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.702 -0.624 . . . . 0.0 109.347 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.3 m -87.13 103.06 15.04 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.9 mt -101.04 114.86 29.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -130.28 149.29 52.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.7 0.8 . . . . 0.0 110.209 168.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -65.77 -16.36 63.72 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 167.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -76.56 -53.31 8.24 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.459 1.027 . . . . 0.0 112.739 163.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -155.0 135.16 13.1 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 121.784 0.802 . . . . 0.0 111.023 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.19 121.42 34.53 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.765 0.826 . . . . 0.0 110.084 173.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -112.34 104.94 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.833 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.82 125.28 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 121.818 0.818 . . . . 0.0 109.106 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.9 mtp -103.67 109.99 21.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.64 0.776 . . . . 0.0 109.015 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -108.31 110.6 22.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.554 0.742 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.69 42.25 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -166.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.24 129.9 55.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 168.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.07 123.51 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 123.519 0.728 . . . . 0.0 110.287 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.31 -32.32 7.66 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 117.333 1.693 . . . . 0.0 117.333 -164.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -87.87 145.15 26.2 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.991 1.395 . . . . 0.0 112.578 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.97 120.09 32.3 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.79 -0.569 . . . . 0.0 111.068 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -126.55 151.32 48.05 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.917 0.887 . . . . 0.0 112.263 -171.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.64 97.73 3.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.655 -1.278 . . . . 0.0 112.253 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -84.57 105.23 15.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.37 101.96 9.31 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.157 0.503 . . . . 0.0 110.362 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.48 52.44 2.37 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -83.08 130.73 35.15 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.034 0.934 . . . . 0.0 111.382 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.6 -51.62 0.73 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 -151.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.13 -73.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -164.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.88 28.91 2.11 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 159.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.28 16.7 m-20 55.83 31.26 17.32 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.154 2.649 . . . . 0.0 118.154 174.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -108.01 141.18 40.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 113.147 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -90.92 109.73 20.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.226 0.611 . . . . 0.0 110.667 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.1 m -107.14 128.46 54.42 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.045 0.538 . . . . 0.0 111.343 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 95.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.267 1.032 . . . . 0.0 110.483 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.9 m -105.47 125.92 51.54 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.607 -0.683 . . . . 0.0 109.941 -161.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 m -116.62 115.94 26.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.415 HG22 ' SG ' ' A' ' 95' ' ' CYS . 60.8 t -107.53 121.65 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -138.25 150.41 46.66 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.144 0.883 . . . . 0.0 111.874 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -78.94 115.82 18.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.427 -1.421 . . . . 0.0 112.593 175.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.56 83.01 4.42 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 162.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.86 -107.29 1.8 Allowed Glycine 0 CA--C 1.547 2.083 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.35 -0.26 52.87 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 171.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -103.18 127.36 50.5 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.06 1.754 . . . . 0.0 110.385 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.23 104.34 15.69 Favored 'General case' 0 CA--C 1.564 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -110.45 131.59 54.92 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.689 0.757 . . . . 0.0 111.152 -167.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 86' ' ' VAL . 52.9 t -125.66 138.07 53.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.6 0.76 . . . . 0.0 112.88 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -113.58 126.93 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 123.673 0.789 . . . . 0.0 109.178 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -102.49 95.37 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.485 0.714 . . . . 0.0 109.144 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.78 123.38 29.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.918 -1.114 . . . . 0.0 112.276 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.45 -90.66 0.11 Allowed Glycine 0 N--CA 1.484 1.886 0 O-C-N 121.598 -0.689 . . . . 0.0 114.49 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -88.74 -12.81 41.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -161.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -131.58 149.56 52.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.44 1.473 . . . . 0.0 111.612 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.39 115.01 21.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.459 1.104 . . . . 0.0 111.601 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.36 53.39 6.8 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -105.55 128.19 53.45 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.908 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.0 40.77 Favored Glycine 0 N--CA 1.486 1.997 0 O-C-N 121.601 -0.687 . . . . 0.0 114.395 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.255 40.1 p-90 -155.44 157.39 36.92 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.4 m -131.63 124.03 29.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.405 -0.81 . . . . 0.0 109.003 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.94 133.97 53.6 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.759 0.824 . . . . 0.0 111.722 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -149.78 171.52 16.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 0.0 112.746 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.23 126.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.45 90.71 3.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.438 163.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.98 -110.66 3.17 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.326 -0.858 . . . . 0.0 114.91 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.84 5.25 44.58 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 163.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -110.37 126.71 54.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.596 1.544 . . . . 0.0 112.432 -170.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.299 0.64 . . . . 0.0 109.791 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -113.55 120.14 39.94 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.0 tp -121.53 123.95 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.094 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -99.8 121.88 41.94 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.501 0.721 . . . . 0.0 110.025 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 50.1 mtm -115.44 132.97 56.46 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.536 1.062 . . . . 0.0 111.854 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.65 134.66 55.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 112.911 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.43 124.68 12.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 0.0 109.97 172.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 53.79 40.28 31.32 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 -8.35 9.54 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 120.263 2.865 . . . . 0.0 120.263 -164.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.58 117.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 120.399 2.1 . . . . 0.0 109.298 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.9 m -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.341 0.656 . . . . 0.0 111.234 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.45 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 8.6 t -97.22 129.79 44.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 111.753 166.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -98.18 125.41 43.2 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.696 0.68 . . . . 0.0 110.644 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -113.36 123.71 50.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.312 0.645 . . . . 0.0 109.323 169.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.81 133.65 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -135.4 156.61 48.63 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.522 1.129 . . . . 0.0 111.259 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.83 126.71 42.16 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.561 -1.337 . . . . 0.0 110.449 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -69.29 122.16 18.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.133 -0.979 . . . . 0.0 113.087 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.99 -38.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.5 t60 . . . . . 0 N--CA 1.487 1.404 0 CA-C-N 119.851 1.205 . . . . 0.0 108.112 170.071 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.459 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 CA--C 1.57 1.73 0 CA-C-O 117.602 -1.189 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.63 120.97 7.02 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.637 2.225 . . . . 0.0 114.773 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.4 m -72.81 151.72 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -87.59 104.77 16.81 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.53 -0.731 . . . . 0.0 112.046 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -82.53 4.49 24.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -60.6 114.28 2.9 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 121.419 1.918 . . . . 0.0 114.443 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.27 178.06 30.97 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-O 122.79 1.217 . . . . 0.0 115.738 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -108.88 115.26 29.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.399 1.079 . . . . 0.0 109.184 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -116.8 112.93 21.82 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.426 0.691 . . . . 0.0 109.189 -167.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -85.33 142.7 29.14 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.185 -0.947 . . . . 0.0 112.61 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.3 ttp -73.64 121.61 20.99 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-N 120.459 1.481 . . . . 0.0 113.042 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt -81.7 -44.12 17.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -154.5 160.22 41.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.413 -1.43 . . . . 0.0 113.322 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -136.0 118.86 16.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.808 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -124.26 122.68 38.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.597 0.759 . . . . 0.0 110.145 -170.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.2 t30 65.91 38.23 5.11 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.67 -40.89 16.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.77 -37.54 68.69 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.48 -41.12 69.75 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 120.922 1.692 . . . . 0.0 114.9 167.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -54.93 -46.67 74.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.55 -37.44 68.26 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -57.91 -41.38 82.51 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 164.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.15 -18.05 32.53 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 165.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -95.42 9.92 38.25 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 165.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.271 20.1 t70 57.99 50.16 10.66 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.5 t -98.72 141.01 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.836 0.827 . . . . 0.0 110.024 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.8 149.86 45.95 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.74 -45.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -50.58 70.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.36 -43.6 98.59 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -58.21 -47.88 82.08 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -60.04 -43.58 95.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.51 -56.98 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 118.717 0.69 . . . . 0.0 111.374 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.54 81.6 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -67.51 -32.59 73.5 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.34 -24.24 46.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 170.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.0 mt -68.92 147.05 52.23 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.513 1.506 . . . . 0.0 114.302 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.95 90.89 4.8 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.262 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.2 147.01 47.13 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.617 2.211 . . . . 0.0 114.415 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.99 117.84 29.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -88.44 110.75 21.08 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.654 -0.654 . . . . 0.0 111.084 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -96.08 107.7 20.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.514 -0.742 . . . . 0.0 109.355 167.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -105.84 127.33 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.18 110.08 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -106.78 110.86 23.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.312 0.645 . . . . 0.0 110.603 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -101.99 81.27 2.09 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.664 0.785 . . . . 0.0 109.52 168.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.91 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 121.559 -0.713 . . . . 0.0 114.341 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.76 -20.02 22.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 163.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -77.91 112.62 14.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.019 1.736 . . . . 0.0 111.923 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.3 ttm -123.27 125.01 44.27 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.677 0.751 . . . . 0.0 111.037 -165.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.1 mm -111.39 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -92.69 108.02 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.67 94.62 6.19 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.7 m -85.41 98.6 10.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.133 -0.979 . . . . 0.0 108.887 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.5 mt -97.18 115.13 27.01 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.848 -0.533 . . . . 0.0 110.7 -165.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 t -132.86 152.71 51.8 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.756 0.788 . . . . 0.0 110.476 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.6 p -64.34 -28.59 69.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -73.79 -48.19 33.34 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -154.89 135.57 13.54 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.498 1.044 . . . . 0.0 111.831 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.23 116.18 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.552 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -105.8 108.38 19.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 110.316 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mm -106.64 119.2 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.48 112.32 24.15 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.589 0.756 . . . . 0.0 109.641 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -112.27 112.36 23.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.599 0.76 . . . . 0.0 109.272 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -155.99 145.58 21.02 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -91.53 124.76 35.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.806 165.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.37 124.34 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.64 -0.663 . . . . 0.0 109.516 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.93 -39.27 2.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -157.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -95.6 152.83 18.09 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.561 1.181 . . . . 0.0 112.752 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -93.12 125.89 37.94 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.405 168.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.74 144.23 48.96 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.496 0.718 . . . . 0.0 112.32 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.27 100.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.493 -1.38 . . . . 0.0 112.978 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.94 104.91 16.72 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 121.829 -0.545 . . . . 0.0 109.707 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -74.0 99.18 3.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.793 0.437 . . . . 0.0 111.359 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.54 52.08 2.0 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -88.07 127.44 35.4 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.337 1.055 . . . . 0.0 111.411 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.97 -44.83 1.4 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 -148.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -93.66 -74.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.471 1.108 . . . . 0.0 108.647 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -122.46 -6.02 8.73 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 168.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 21.6 m-20 63.53 49.03 3.21 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 mtm-85 -141.94 143.26 33.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.116 -0.99 . . . . 0.0 111.475 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.86 94.97 6.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 -173.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -83.24 136.72 34.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.593 -0.692 . . . . 0.0 112.794 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.9 mtp -82.91 91.72 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.588 1.185 . . . . 0.0 110.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.429 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 40.4 m -102.75 122.13 43.84 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.414 -0.803 . . . . 0.0 110.898 -156.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -103.49 122.42 44.88 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.9 t -109.29 127.11 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -124.31 152.95 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.763 0.825 . . . . 0.0 111.924 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -88.98 120.94 30.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.933 -1.104 . . . . 0.0 113.193 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -112.18 67.35 0.65 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 123.536 0.734 . . . . 0.0 110.412 164.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -102.76 0.68 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.38 -31.37 65.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -94.83 117.14 29.65 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.162 0.982 . . . . 0.0 110.845 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 tp -88.79 109.32 20.07 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -111.76 126.97 55.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 -162.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.429 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 44.8 t -127.62 135.41 50.23 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -168.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -112.83 122.28 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.607 0.763 . . . . 0.0 109.367 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -98.25 93.58 6.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.612 0.765 . . . . 0.0 109.111 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -85.77 122.51 29.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.8 -1.188 . . . . 0.0 112.309 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.8 -111.23 0.36 Allowed Glycine 0 N--CA 1.484 1.896 0 O-C-N 121.623 -0.673 . . . . 0.0 113.405 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.39 -3.61 56.53 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -121.06 143.42 49.08 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.196 1.362 . . . . 0.0 113.067 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -81.48 97.63 7.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -170.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.93 49.81 6.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.57 138.05 31.88 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.735 0.779 . . . . 0.0 112.436 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 -166.3 35.24 Favored Glycine 0 N--CA 1.486 1.974 0 CA-C-O 121.934 0.741 . . . . 0.0 114.807 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -159.09 153.35 23.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.8 m -130.23 125.98 36.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -126.3 129.15 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.765 0.826 . . . . 0.0 110.849 -172.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -145.72 167.56 22.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.978 -1.076 . . . . 0.0 113.449 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.8 mt -110.34 126.46 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.95 89.37 3.04 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 164.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.79 -112.05 3.57 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.299 -0.876 . . . . 0.0 114.679 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -89.99 2.96 54.55 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 161.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -102.63 134.43 46.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.557 1.526 . . . . 0.0 112.518 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -97.19 122.8 40.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.082 0.953 . . . . 0.0 109.19 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -114.52 122.38 46.39 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.464 0.706 . . . . 0.0 109.279 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp -123.95 122.15 37.18 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.456 0.702 . . . . 0.0 110.832 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.1 128.56 44.68 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.217 0.607 . . . . 0.0 109.865 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.4 mtm -117.95 130.43 56.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 118.894 0.77 . . . . 0.0 110.597 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -113.92 138.19 50.66 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.575 0.75 . . . . 0.0 112.818 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.87 116.51 4.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 110.2 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.305 6.0 mt-10 54.07 50.18 17.18 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.11 -14.48 3.84 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 120.577 2.991 . . . . 0.0 120.577 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.77 124.51 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.447 2.123 . . . . 0.0 110.017 -166.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -93.54 123.2 36.69 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.134 0.574 . . . . 0.0 110.697 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.67 135.92 37.91 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.066 0.547 . . . . 0.0 111.061 159.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -113.43 118.83 35.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.807 -0.558 . . . . 0.0 110.58 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -114.75 133.75 55.66 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.465 0.65 . . . . 0.0 110.903 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.36 131.0 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -127.66 160.42 31.68 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 124.475 1.11 . . . . 0.0 111.196 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -133.22 133.28 42.51 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.488 -1.383 . . . . 0.0 112.263 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -70.25 123.63 22.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.71 -37.56 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 . . . . . 0 CA--C 1.567 1.61 0 CA-C-N 119.739 1.154 . . . . 0.0 108.344 171.233 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . 0.289 55.6 ttm . . . . . 0 CA--C 1.571 1.767 0 CA-C-O 115.602 -2.142 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.63 164.63 35.08 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 CA-C-N 125.22 2.9 . . . . 0.0 114.946 167.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.14 136.09 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.973 -1.079 . . . . 0.0 112.429 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -82.99 102.82 11.99 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 121.24 0.543 . . . . 0.0 112.072 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -81.83 -2.46 51.05 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 173.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -58.01 108.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 121.092 1.769 . . . . 0.0 114.499 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.71 33.94 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-O 122.609 1.116 . . . . 0.0 114.98 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -118.74 118.33 31.31 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.17 0.988 . . . . 0.0 109.441 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.19 114.72 20.66 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -164.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.04 141.15 29.15 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.978 -1.076 . . . . 0.0 113.769 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.1 ttp -76.24 119.21 19.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.26 -44.5 17.65 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -154.26 158.52 40.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.535 -1.353 . . . . 0.0 113.372 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -130.68 100.03 5.16 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.093 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -103.02 115.19 30.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.53 -0.731 . . . . 0.0 110.145 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 42.2 t30 58.56 31.31 20.91 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.14 -34.15 76.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 167.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 -49.54 77.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -37.11 80.11 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -57.73 -45.79 85.32 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.01 -40.33 78.74 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -55.48 -45.33 76.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.96 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 166.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.24 2.25 54.53 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.275 26.9 t0 64.49 56.61 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 120.259 1.39 . . . . 0.0 113.296 -169.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -103.1 139.45 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -66.77 157.17 33.53 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.9 t -60.7 -45.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -47.55 83.81 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.47 -44.77 92.94 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -52.09 -56.3 15.33 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -57.04 -33.07 66.84 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.18 -59.28 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 CA-C-N 118.757 0.708 . . . . 0.0 111.192 164.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.79 91.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -60.53 -36.7 79.03 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 170.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.58 -20.01 37.37 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.37 138.2 51.16 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 120.292 1.406 . . . . 0.0 113.091 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -111.23 85.4 5.44 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.22 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.8 158.83 54.52 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.608 2.205 . . . . 0.0 116.18 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.13 116.87 33.33 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.291 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -86.44 111.74 20.83 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.376 -0.828 . . . . 0.0 110.483 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.32 110.67 23.18 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.3 129.05 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.73 109.54 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -101.4 102.51 13.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.821 0.849 . . . . 0.0 110.126 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.8 71.93 5.72 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.72 0.808 . . . . 0.0 110.249 167.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.53 0.45 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -80.48 -33.38 36.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.74 114.83 19.9 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 120.186 1.357 . . . . 0.0 111.493 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.3 ttm -125.37 123.33 39.12 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.514 0.673 . . . . 0.0 110.984 -167.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.59 100.95 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.54 112.58 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -104.95 102.19 11.72 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 m -86.16 99.19 11.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.2 mt -99.6 116.05 30.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.088 0.555 . . . . 0.0 110.317 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -131.11 154.66 48.07 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.946 0.879 . . . . 0.0 110.741 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.3 p -62.97 -31.61 72.76 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -79.0 -45.06 21.0 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -158.01 132.69 8.4 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.973 1.261 . . . . 0.0 112.555 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -96.56 121.11 38.03 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.435 0.694 . . . . 0.0 110.388 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -110.67 104.63 13.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.375 -0.828 . . . . 0.0 110.631 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.54 125.54 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 122.087 0.946 . . . . 0.0 108.586 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.9 mtp -112.57 128.18 56.29 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.515 1.126 . . . . 0.0 108.603 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.04 95.15 3.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.686 . . . . 0.0 109.244 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -129.85 151.18 50.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -97.05 119.31 35.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.584 -0.698 . . . . 0.0 109.831 166.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.37 118.1 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 C-N-CA 123.458 0.703 . . . . 0.0 110.119 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.89 -43.45 1.49 Allowed Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -158.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.64 147.3 25.33 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.65 134.99 35.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.766 -0.584 . . . . 0.0 111.578 165.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -144.11 156.54 44.39 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.833 0.825 . . . . 0.0 112.903 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.98 98.16 3.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.46 0.704 . . . . 0.0 111.88 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -100.33 101.47 12.47 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.574 -0.704 . . . . 0.0 111.262 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -81.35 109.63 16.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.807 -0.558 . . . . 0.0 110.544 167.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.33 57.36 3.6 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-O 121.988 0.899 . . . . 0.0 112.854 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.0 t -76.31 140.48 41.52 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.15 0.98 . . . . 0.0 113.126 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.55 -46.43 1.96 Allowed Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -159.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HA ' H183 ' A' ' 175' ' ' RTL . 30.6 mt -78.66 -74.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.513 1.125 . . . . 0.0 110.044 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -134.36 -3.47 2.71 Favored 'General case' 0 CA--C 1.574 1.886 0 C-N-CA 125.482 1.513 . . . . 0.0 114.457 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 1.6 m-20 54.1 57.18 6.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.68 134.58 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.19 0.519 . . . . 0.0 111.096 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -85.65 125.51 33.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.646 0.778 . . . . 0.0 111.61 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.92 148.7 48.21 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.493 0.717 . . . . 0.0 112.121 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.04 97.77 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.597 168.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.2 m -100.64 122.18 42.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 122.04 -0.412 . . . . 0.0 111.337 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -111.77 122.82 48.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.43 131.61 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.4 m -133.22 148.6 52.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 111.788 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -82.95 115.13 21.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 111.121 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.82 71.75 10.83 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 109.957 163.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.0 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -165.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.88 -16.71 14.39 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -87.59 139.37 30.61 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.905 1.684 . . . . 0.0 111.472 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.52 108.64 21.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.537 -0.727 . . . . 0.0 110.218 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -112.46 132.39 55.08 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.463 0.705 . . . . 0.0 111.256 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -126.19 136.1 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.95 130.02 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -120.88 95.65 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.674 . . . . 0.0 110.405 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -77.91 120.83 23.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 112.925 -173.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.64 -115.71 0.35 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.989 -0.444 . . . . 0.0 112.255 172.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -78.53 -25.72 45.61 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -108.44 148.66 29.85 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.307 1.412 . . . . 0.0 112.957 -157.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.32 110.1 17.17 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.175 0.99 . . . . 0.0 111.85 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.49 51.52 9.59 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -92.76 116.59 29.16 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 117.316 0.558 . . . . 0.0 111.836 -171.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.55 -168.65 39.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -154.03 157.99 39.89 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.943 0.877 . . . . 0.0 112.958 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.5 m -132.93 127.49 34.41 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.036 -1.04 . . . . 0.0 108.682 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -127.58 131.44 49.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.778 . . . . 0.0 111.088 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.48 174.15 12.8 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.96 132.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.963 . . . . 0.0 109.436 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.09 92.17 3.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.743 0.817 . . . . 0.0 109.048 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.19 -114.85 4.44 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.346 -0.847 . . . . 0.0 114.746 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -88.7 4.98 45.38 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 163.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -106.56 129.92 54.41 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.101 1.319 . . . . 0.0 111.93 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.07 122.18 30.55 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.251 1.02 . . . . 0.0 109.733 166.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -113.44 124.33 52.17 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.733 0.813 . . . . 0.0 109.578 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.7 tp -127.83 119.5 25.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.253 0.621 . . . . 0.0 110.629 -173.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -90.26 135.23 33.8 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.892 0.477 . . . . 0.0 110.316 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.0 mtp -130.22 124.13 31.8 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.6 0.76 . . . . 0.0 109.856 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -122.88 132.32 54.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -0.753 . . . . 0.0 111.872 -164.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.03 131.66 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.233 0.613 . . . . 0.0 111.451 174.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 56.24 39.34 30.26 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.03 0.95 16.83 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 120.193 2.837 . . . . 0.0 120.193 -163.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.59 118.98 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 120.065 1.933 . . . . 0.0 108.942 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.4 m -95.04 116.88 29.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.658 0.742 . . . . 0.0 110.337 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.6 t -91.71 141.62 28.49 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.496 0.718 . . . . 0.0 111.116 161.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -115.58 123.28 48.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.399 -0.813 . . . . 0.0 110.952 166.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.43 129.14 56.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.187 0.595 . . . . 0.0 109.928 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.82 128.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -127.84 147.1 50.43 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.699 0.799 . . . . 0.0 111.002 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -116.37 135.81 53.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.378 -1.451 . . . . 0.0 112.29 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -70.06 122.95 20.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.29 -37.56 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 CA--C 1.567 1.603 0 CA-C-N 120.069 1.304 . . . . 0.0 108.595 170.467 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.472 H183 ' HA ' ' A' ' 77' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.572 1.822 0 CA-C-O 115.984 -1.96 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.5 172.25 16.08 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 CA-C-N 125.16 2.878 . . . . 0.0 115.533 173.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.13 125.43 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.074 . . . . 0.0 112.002 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.04 106.8 17.46 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.783 0.801 . . . . 0.0 112.185 -170.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -75.17 3.18 9.16 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.716 2.488 . . . . 0.0 117.716 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -54.91 111.12 0.76 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.287 1.858 . . . . 0.0 114.959 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.44 175.86 28.85 Favored Glycine 0 N--CA 1.488 2.132 0 CA-C-O 122.217 0.898 . . . . 0.0 115.167 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -109.6 116.39 31.67 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.389 1.075 . . . . 0.0 109.515 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -118.33 112.73 20.42 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.688 -0.632 . . . . 0.0 109.412 -166.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.53 141.77 28.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.064 -1.023 . . . . 0.0 113.558 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttp -70.87 124.34 24.1 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -172.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.3 mt -85.67 -53.59 5.06 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.8 p -138.62 150.88 46.74 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 119.435 1.016 . . . . 0.0 113.477 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -129.13 113.78 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.867 0.867 . . . . 0.0 109.229 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -115.98 117.3 29.75 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 0.0 109.76 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.6 t30 63.74 36.45 10.61 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.422 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 4.3 t80 -74.57 -39.78 62.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.604 -1.31 . . . . 0.0 114.439 175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.46 -41.84 97.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 174.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.13 -39.43 78.89 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.17 -49.42 71.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 165.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.75 -40.88 88.47 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -55.03 -46.39 75.27 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 164.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.32 -18.36 49.16 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 166.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.6 mt -91.03 3.53 54.5 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.279 40.3 m-20 66.12 52.17 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.116 1.366 . . . . 0.0 114.406 -171.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.95 144.57 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 122.123 0.964 . . . . 0.0 110.139 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -63.86 154.32 34.03 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.73 -44.42 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.74 -50.85 67.37 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.532 HD21 H182 ' A' ' 175' ' ' RTL . 4.9 tt -62.32 -40.12 95.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 170.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -55.05 -40.5 70.37 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -69.75 -48.45 59.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.916 -1.115 . . . . 0.0 113.761 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.63 -57.86 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.012 0.925 . . . . 0.0 112.136 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -30.35 71.42 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -69.09 -36.54 77.68 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.97 -23.63 59.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.53 152.42 41.88 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 120.404 1.456 . . . . 0.0 114.644 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -101.35 90.26 1.65 Allowed Pre-proline 0 CA--C 1.574 1.892 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.314 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.7 146.48 54.46 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 122.848 2.053 . . . . 0.0 114.808 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.23 113.16 24.93 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -89.67 107.39 19.06 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.375 -0.828 . . . . 0.0 110.538 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.71 107.22 19.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.717 -0.615 . . . . 0.0 109.908 172.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.65 131.42 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.3 t -113.21 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -93.65 104.86 16.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.221 0.609 . . . . 0.0 109.954 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.31 75.55 2.95 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 121.527 0.679 . . . . 0.0 109.931 167.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.23 -104.43 1.04 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -81.65 -32.0 32.06 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -81.24 107.39 13.99 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.935 1.243 . . . . 0.0 110.952 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.3 ttp -116.16 124.0 49.24 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.962 0.887 . . . . 0.0 111.047 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.41 101.57 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.9 mt -98.18 105.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -97.48 99.43 10.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -88.08 97.14 10.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.21 -0.931 . . . . 0.0 109.135 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.8 mt -100.39 121.73 42.0 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.261 0.624 . . . . 0.0 110.976 -164.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -139.49 157.24 46.18 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.122 0.963 . . . . 0.0 111.356 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.9 p -65.09 -30.81 71.79 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -74.98 -48.89 21.95 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 165.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -153.75 138.83 17.33 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 119.651 1.114 . . . . 0.0 113.431 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -94.03 128.16 40.23 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.724 0.81 . . . . 0.0 109.982 168.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -118.95 103.93 10.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.016 -1.052 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.29 128.25 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.9 mtp -115.41 104.86 12.19 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.636 0.775 . . . . 0.0 110.256 173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -111.12 113.64 26.31 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.031 0.933 . . . . 0.0 111.583 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.64 149.36 27.48 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -169.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -92.32 129.26 38.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 111.075 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.75 129.45 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 123.218 0.607 . . . . 0.0 111.048 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.64 -31.92 7.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -161.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -84.83 133.42 34.33 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.96 1.38 . . . . 0.0 112.993 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -86.55 98.39 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.786 0.435 . . . . 0.0 110.223 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -105.41 147.24 28.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.52 106.38 3.97 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.916 0.865 . . . . 0.0 112.131 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.73 103.03 10.8 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.616 0.766 . . . . 0.0 109.748 -166.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.81 116.68 20.11 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 121.84 0.829 . . . . 0.0 110.58 172.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.73 45.49 1.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.1 t -76.58 137.64 39.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.086 0.954 . . . . 0.0 112.593 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.83 -59.41 0.54 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.601 -152.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.03 -75.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 123.748 0.819 . . . . 0.0 109.595 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -140.33 21.14 2.4 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 174.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.268 11.9 t70 50.18 48.99 21.31 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 176.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -127.71 142.47 51.32 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.981 0.896 . . . . 0.0 112.378 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -97.35 101.86 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.797 0.839 . . . . 0.0 110.652 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.3 m -102.11 147.67 26.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.518 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.97 95.22 10.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 109.009 167.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 124.19 47.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 111.243 -166.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -107.55 123.74 48.89 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -108.8 128.87 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t -123.57 149.66 45.01 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.98 0.912 . . . . 0.0 111.833 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -90.44 115.81 27.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.89 -1.131 . . . . 0.0 112.228 170.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -98.43 66.19 1.7 Allowed 'General case' 0 CA--C 1.574 1.892 0 O-C-N 121.687 -0.633 . . . . 0.0 110.26 157.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.14 0.02 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.76 -27.41 23.64 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -100.28 122.89 43.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.223 1.374 . . . . 0.0 111.076 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.66 110.18 21.08 Favored 'General case' 0 CA--C 1.564 1.51 0 O-C-N 121.518 -0.739 . . . . 0.0 109.123 172.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.7 122.4 45.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.099 0.56 . . . . 0.0 110.433 -161.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 52.5 t -122.07 138.88 54.28 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.05 123.85 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.601 0.76 . . . . 0.0 109.25 168.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -102.35 93.85 5.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -91.45 117.45 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 111.824 -166.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.8 -90.21 0.1 OUTLIER Glycine 0 N--CA 1.481 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 113.262 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -91.51 -16.98 26.4 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -164.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -125.33 148.35 48.76 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.22 1.373 . . . . 0.0 112.093 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.45 112.35 17.7 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 123.762 0.825 . . . . 0.0 112.231 -172.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.56 90.15 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -86.47 135.6 33.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.776 0.798 . . . . 0.0 111.431 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.9 -170.93 40.76 Favored Glycine 0 N--CA 1.482 1.757 0 CA-C-O 121.994 0.774 . . . . 0.0 114.602 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -156.42 150.42 25.11 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.2 m -124.87 125.99 44.85 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.48 129.16 48.12 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.513 0.725 . . . . 0.0 111.02 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.81 170.86 16.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.146 -0.971 . . . . 0.0 113.16 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.15 127.6 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.293 -0.88 . . . . 0.0 109.054 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.39 91.6 3.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 161.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.86 -111.7 3.54 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.172 -0.955 . . . . 0.0 115.03 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -94.06 8.82 40.11 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 162.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -107.84 123.8 49.13 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.399 1.454 . . . . 0.0 111.489 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.1 tp -81.32 118.73 22.88 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.64 1.176 . . . . 0.0 109.732 167.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.13 117.28 33.64 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.5 tp -115.18 128.89 56.47 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.79 0.836 . . . . 0.0 110.205 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -114.96 120.51 40.15 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.061 0.545 . . . . 0.0 109.962 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -110.18 133.58 53.08 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.764 0.825 . . . . 0.0 110.66 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -116.21 141.61 47.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.59 118.07 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.664 0.786 . . . . 0.0 110.615 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 55.2 44.15 28.15 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.33 3.05 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 120.477 2.951 . . . . 0.0 120.477 -164.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.98 122.81 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 120.256 2.028 . . . . 0.0 110.21 -167.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.8 m -94.73 125.73 39.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.334 0.654 . . . . 0.0 111.488 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.422 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 14.4 t -97.78 127.45 43.74 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.076 0.55 . . . . 0.0 110.762 158.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -107.58 129.31 55.0 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.385 0.612 . . . . 0.0 111.403 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -127.76 137.9 52.58 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.667 0.787 . . . . 0.0 111.031 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.74 131.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -131.21 130.37 42.86 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.453 0.701 . . . . 0.0 110.823 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -101.33 131.31 47.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.166 -1.584 . . . . 0.0 112.475 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.35 121.71 15.46 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.37 -38.23 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.8 t60 . . . . . 0 N--CA 1.488 1.435 0 CA-C-N 120.056 1.298 . . . . 0.0 107.796 169.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.532 H182 HD21 ' A' ' 29' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -72.48 140.24 32.83 Favored 'Trans proline' 0 CA--C 1.561 1.871 0 C-N-CA 122.622 2.215 . . . . 0.0 115.815 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.42 131.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.271 0.558 . . . . 0.0 111.237 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -83.24 100.89 10.89 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 120.651 -1.281 . . . . 0.0 112.422 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -71.76 1.85 6.27 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -54.62 108.36 0.38 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.45 177.94 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 CA-C-O 122.652 1.14 . . . . 0.0 115.157 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -111.01 116.61 31.47 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.426 1.09 . . . . 0.0 109.16 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -118.27 112.36 19.98 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.197 0.599 . . . . 0.0 109.539 -166.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -83.44 140.57 32.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.928 . . . . 0.0 113.41 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.463 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.7 ttm -69.7 125.1 25.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.235 1.38 . . . . 0.0 113.732 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.18 -57.75 2.9 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.657 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.0 m -127.89 149.95 50.08 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.29 1.043 . . . . 0.0 112.485 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.67 89.66 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.37 120.61 40.78 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.382 0.673 . . . . 0.0 110.62 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 33.6 t30 67.55 35.75 4.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -79.04 -41.02 29.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.327 -1.483 . . . . 0.0 114.84 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -50.51 -44.69 56.19 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 165.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.05 -36.36 69.58 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.877 1.671 . . . . 0.0 115.148 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -56.49 -49.01 75.92 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 164.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.21 -33.78 72.1 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -61.07 -41.35 96.45 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 164.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -18.22 56.7 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 165.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.65 -4.9 59.24 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 162.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 63.8 46.81 3.81 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 120.528 1.513 . . . . 0.0 114.707 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -93.01 140.95 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.812 0.815 . . . . 0.0 109.693 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.0 149.32 37.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.2 -45.0 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.75 62.92 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.85 -36.47 83.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -59.37 -49.94 75.88 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.588 1.995 . . . . 0.0 115.667 167.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -61.78 -42.42 98.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.65 -56.84 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.83 0.741 . . . . 0.0 111.308 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.51 87.54 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.93 -33.49 75.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.59 -30.31 65.68 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 167.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.71 137.64 47.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.972 1.26 . . . . 0.0 113.536 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -108.26 85.88 3.0 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.17 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.4 Cg_endo -68.6 154.16 72.09 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.601 2.2 . . . . 0.0 114.926 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.71 118.23 36.06 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -85.89 112.3 21.03 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.748 -0.595 . . . . 0.0 110.531 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.85 109.67 22.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.714 -0.616 . . . . 0.0 109.637 167.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.44 126.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.01 108.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.14 113.78 27.54 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.179 0.992 . . . . 0.0 110.532 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -106.57 80.53 1.48 Allowed 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 123.845 0.858 . . . . 0.0 109.446 168.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.0 2.68 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 121.316 -0.865 . . . . 0.0 114.47 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.1 -25.63 22.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 164.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -74.43 118.03 16.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.909 1.686 . . . . 0.0 111.323 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.9 ttp -138.2 131.86 30.96 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.098 0.952 . . . . 0.0 111.902 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.53 103.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -93.04 112.12 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.18 98.79 8.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.7 m -86.07 98.91 11.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.694 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.5 mt -102.34 115.18 30.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.498 0.666 . . . . 0.0 110.884 -165.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.0 t -128.98 146.78 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.475 0.71 . . . . 0.0 109.922 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 t -64.05 -15.36 59.31 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.23 -48.69 13.74 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -159.77 132.76 6.8 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.393 0.997 . . . . 0.0 111.041 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.78 124.4 46.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.564 -0.71 . . . . 0.0 110.413 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -112.44 117.1 31.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mm -113.53 119.12 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -171.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 83.0 mtp -105.7 109.1 20.94 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.292 0.637 . . . . 0.0 109.33 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -109.8 108.94 19.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -153.58 160.06 42.34 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -99.34 129.23 45.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 111.322 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.41 124.56 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.17 5.57 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -163.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -96.64 144.86 26.29 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.743 1.271 . . . . 0.0 112.876 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.26 113.0 21.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 0.0 110.673 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -121.42 149.48 42.95 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.664 0.786 . . . . 0.0 112.671 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.48 97.23 2.53 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 112.974 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.15 103.3 16.0 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.414 -0.804 . . . . 0.0 110.373 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -85.22 104.09 14.77 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.007 0.432 . . . . 0.0 110.48 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mp -83.96 53.32 2.54 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.863 0.839 . . . . 0.0 112.848 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -86.99 138.54 31.42 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.77 -31.93 6.19 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -153.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mt -92.81 -71.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.525 1.13 . . . . 0.0 108.324 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -126.58 -17.3 5.09 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.279 11.1 t70 62.35 73.09 0.48 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 120.246 1.385 . . . . 0.0 112.57 -158.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -133.42 131.76 40.35 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.15 0.58 . . . . 0.0 110.224 172.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -102.66 102.05 12.22 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.768 0.827 . . . . 0.0 109.771 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.53 124.52 51.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.044 0.538 . . . . 0.0 111.576 -172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.69 99.2 2.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.001 0.905 . . . . 0.0 109.667 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -113.2 120.39 41.08 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.06 -158.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.8 m -98.28 121.16 39.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -106.66 128.23 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -145.79 156.8 43.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.646 -1.284 . . . . 0.0 112.899 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -85.23 118.28 24.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.976 -1.078 . . . . 0.0 112.352 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -91.88 77.82 5.43 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 161.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -107.28 1.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -73.34 -30.44 63.34 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 169.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -90.25 132.58 35.44 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 120.527 1.512 . . . . 0.0 111.97 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.1 tp -89.79 106.39 18.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.709 -0.619 . . . . 0.0 110.03 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -112.76 130.95 55.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.6 0.714 . . . . 0.0 111.089 -168.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.6 t -126.93 134.16 50.48 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.706 0.802 . . . . 0.0 113.058 -170.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.92 121.05 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.441 0.696 . . . . 0.0 109.704 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -100.35 97.07 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.526 0.73 . . . . 0.0 109.883 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.02 114.64 27.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 111.362 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.29 -112.16 0.36 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 120.919 -1.113 . . . . 0.0 114.027 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -80.09 -11.37 59.77 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -123.0 148.46 45.48 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 119.537 1.062 . . . . 0.0 111.869 -170.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.57 133.86 37.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.69 43.68 59.87 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 119.588 2.595 . . . . 0.0 119.588 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -94.89 135.05 36.86 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 117.79 0.795 . . . . 0.0 111.783 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.96 -167.56 36.18 Favored Glycine 0 N--CA 1.481 1.65 0 CA-C-O 122.126 0.848 . . . . 0.0 114.706 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -156.0 153.27 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -126.7 124.74 40.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -123.64 135.68 54.06 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.536 0.734 . . . . 0.0 111.74 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -150.15 169.14 21.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.68 128.2 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.63 93.83 4.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 162.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.99 -114.6 4.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 121.221 -0.925 . . . . 0.0 114.986 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -96.03 23.56 6.33 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 163.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.4 128.63 53.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.936 1.243 . . . . 0.0 111.118 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.83 126.39 35.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.227 1.011 . . . . 0.0 109.812 168.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.68 122.77 43.31 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.09 120.26 28.49 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.574 0.749 . . . . 0.0 110.267 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -100.03 125.5 46.1 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.114 0.566 . . . . 0.0 109.727 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 11.5 mtp -119.66 120.78 37.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.435 0.694 . . . . 0.0 110.308 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -109.09 135.89 49.5 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.46 117.71 10.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.605 0.762 . . . . 0.0 109.05 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.292 11.5 mt-10 54.63 47.84 21.7 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.15 -31.02 1.83 Allowed Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.799 2.68 . . . . 0.0 119.799 -166.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 50.9 t -79.68 122.23 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 119.239 1.519 . . . . 0.0 111.296 -164.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.2 m -94.36 126.98 39.96 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.363 0.665 . . . . 0.0 111.483 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.8 t -100.18 129.8 46.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.405 0.682 . . . . 0.0 110.83 162.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -103.63 110.57 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.194 0.598 . . . . 0.0 110.562 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -108.88 120.67 43.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.514 0.725 . . . . 0.0 109.511 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.82 130.42 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -133.27 150.11 51.93 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.441 0.696 . . . . 0.0 111.3 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -115.49 133.79 55.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.345 -1.472 . . . . 0.0 112.153 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -69.74 123.02 20.34 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.65 -37.45 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.565 1.529 0 CA-C-N 120.051 1.296 . . . . 0.0 108.264 169.53 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.423 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 CA--C 1.573 1.838 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.92 165.38 32.48 Favored 'Trans proline' 0 CA--C 1.568 2.21 0 C-N-CA 122.529 2.153 . . . . 0.0 115.132 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.8 m -54.45 138.84 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -160.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.45 93.26 4.72 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -75.96 -2.06 28.61 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 169.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -60.71 109.18 0.97 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.009 1.731 . . . . 0.0 113.956 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.42 179.67 34.4 Favored Glycine 0 N--CA 1.486 1.967 0 CA-C-O 122.907 1.282 . . . . 0.0 115.801 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -109.51 109.53 20.36 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.422 1.089 . . . . 0.0 109.118 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -110.88 111.79 23.18 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 137.62 32.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 0.0 112.728 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 ttp -68.5 118.67 11.85 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -172.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.6 mt -79.58 -45.05 19.92 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -153.68 160.26 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.618 -1.301 . . . . 0.0 113.13 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -141.64 117.61 10.55 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.014 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.67 122.97 39.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.469 0.708 . . . . 0.0 110.213 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.8 t30 66.72 36.85 4.48 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -80.3 -42.43 23.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.607 -1.308 . . . . 0.0 114.505 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.34 -39.96 80.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.74 -42.09 78.08 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 121.039 1.745 . . . . 0.0 114.809 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -55.88 -46.9 78.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 168.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -68.45 -37.23 80.02 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -57.72 -44.36 85.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.315 -1.491 . . . . 0.0 114.903 162.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -16.9 47.72 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 118.205 2.669 . . . . 0.0 118.205 166.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.82 2.19 56.89 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 38.7 t70 64.92 58.57 0.93 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.232 1.413 . . . . 0.0 114.022 -170.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -111.12 140.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-O 121.48 0.657 . . . . 0.0 109.84 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -65.54 150.45 48.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.15 -45.38 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.65 72.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.18 -41.59 97.07 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -56.99 -47.85 79.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.99 -56.04 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.915 0.78 . . . . 0.0 111.741 171.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.56 77.07 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -68.71 -33.68 74.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 167.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.72 -26.2 60.58 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.23 146.84 48.76 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.128 1.331 . . . . 0.0 114.147 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -104.44 89.87 2.92 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 118.211 -0.899 . . . . 0.0 109.899 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.29 150.4 47.07 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 122.404 2.069 . . . . 0.0 114.731 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -114.75 117.08 29.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -85.3 107.28 17.24 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.591 -0.693 . . . . 0.0 110.866 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.69 108.29 19.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.516 -0.74 . . . . 0.0 109.219 167.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.77 136.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.58 110.98 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -95.37 108.16 20.34 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.337 0.655 . . . . 0.0 109.929 170.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.31 76.14 1.68 Allowed 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 121.558 0.694 . . . . 0.0 109.661 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 -103.79 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.34 -0.85 . . . . 0.0 114.766 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.97 -22.6 21.86 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 162.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -75.67 114.2 13.99 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 120.642 1.564 . . . . 0.0 111.557 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 tpp -120.0 132.49 55.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.843 0.457 . . . . 0.0 111.468 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.99 101.39 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.0 mt -96.8 110.37 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -105.07 97.58 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.8 m -83.02 99.48 9.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.7 mt -98.87 116.42 31.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.824 -0.547 . . . . 0.0 110.69 -166.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.5 t -137.86 152.55 49.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.602 0.761 . . . . 0.0 110.637 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -74.44 -49.31 22.9 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -153.53 135.75 14.87 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.569 1.077 . . . . 0.0 111.657 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -89.79 120.36 30.97 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -113.5 106.02 14.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.645 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.24 127.39 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.479 0.712 . . . . 0.0 109.317 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.9 mtp -109.15 110.69 21.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.838 0.855 . . . . 0.0 109.352 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -112.99 117.34 31.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.451 0.7 . . . . 0.0 109.84 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -156.95 155.92 32.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -96.27 125.23 40.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 111.148 165.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.53 124.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.547 0.739 . . . . 0.0 109.532 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.05 -41.78 2.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -157.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -92.97 142.39 27.35 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.878 0.871 . . . . 0.0 113.169 -170.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -87.66 124.13 33.22 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.862 -0.524 . . . . 0.0 110.976 166.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -132.76 152.42 51.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.826 0.85 . . . . 0.0 111.554 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.75 105.28 5.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.425 -1.422 . . . . 0.0 112.317 169.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -92.24 114.06 26.5 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -77.39 121.3 23.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 159.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.532 HD22 HH21 ' A' ' 104' ' ' ARG . 4.4 mp -87.86 63.32 7.36 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.197 0.998 . . . . 0.0 111.653 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -79.45 118.77 21.63 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.723 0.809 . . . . 0.0 111.166 -168.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.24 -48.43 0.94 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 -159.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -80.37 -85.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -171.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.08 8.26 13.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 55.94 46.27 22.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.41 140.99 52.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.784 . . . . 0.0 111.268 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.95 111.33 20.73 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.266 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.83 135.41 45.43 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.291 0.637 . . . . 0.0 111.285 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mmt -77.58 99.46 5.75 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.225 1.012 . . . . 0.0 109.614 165.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.6 m -104.28 122.55 45.64 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.657 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.6 m -103.78 126.57 51.0 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 166.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.6 t -111.34 128.75 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -134.14 149.93 51.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.063 0.945 . . . . 0.0 111.925 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -85.11 128.9 34.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.647 -1.283 . . . . 0.0 114.294 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -122.09 68.98 0.94 Allowed 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 123.964 0.905 . . . . 0.0 109.953 164.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.18 -103.48 1.01 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.25 -30.18 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -90.35 116.45 28.32 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 119.255 0.934 . . . . 0.0 110.907 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -89.26 109.68 20.54 Favored 'General case' 0 CA--C 1.562 1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.201 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -95.31 140.35 30.33 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.219 1.008 . . . . 0.0 111.595 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 51.8 t -137.73 133.88 34.66 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.12 128.83 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.636 0.774 . . . . 0.0 109.526 168.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -107.12 103.47 12.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.812 0.845 . . . . 0.0 110.102 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -86.71 113.07 22.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 111.48 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.11 -129.79 1.21 Allowed Glycine 0 N--CA 1.487 2.058 0 O-C-N 121.652 -0.655 . . . . 0.0 113.789 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.0 -22.18 45.9 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -170.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -105.66 142.08 36.0 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.481 1.491 . . . . 0.0 111.593 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -86.82 141.71 28.62 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.2 50.71 60.72 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -170.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.532 HH21 HD22 ' A' ' 74' ' ' LEU . 18.5 ttt180 -109.38 125.08 52.01 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.544 0.738 . . . . 0.0 110.344 -170.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.61 35.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.4 159.35 37.3 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.377 1.085 . . . . 0.0 113.348 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.5 m -133.33 125.13 28.54 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -121.12 136.1 55.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.906 -0.496 . . . . 0.0 111.677 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -146.65 156.37 43.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.912 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.35 126.69 47.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -111.64 94.22 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 158.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.83 -110.44 3.16 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.163 -0.961 . . . . 0.0 115.236 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -95.74 7.61 45.81 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 164.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -110.96 127.15 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.23 1.377 . . . . 0.0 111.834 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 tp -85.29 115.87 23.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.168 0.987 . . . . 0.0 109.39 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.19 120.02 39.62 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 tp -117.32 120.75 39.17 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.835 0.854 . . . . 0.0 110.425 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -97.09 123.5 40.86 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 162.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.432 ' SD ' H202 ' A' ' 175' ' ' RTL . 73.7 mtm -112.88 126.65 55.68 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.519 0.6 . . . . 0.0 109.763 170.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -121.82 137.19 54.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.542 -0.724 . . . . 0.0 112.364 -167.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.4 126.8 5.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.12 0.568 . . . . 0.0 110.922 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 57.25 40.93 27.53 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.28 -13.34 2.79 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 120.261 2.864 . . . . 0.0 120.261 -163.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.75 122.08 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 119.701 1.75 . . . . 0.0 109.174 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -102.9 126.47 50.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 122.949 0.5 . . . . 0.0 111.074 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.6 t -95.77 131.57 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.269 0.628 . . . . 0.0 111.131 162.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -112.69 112.35 23.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.062 0.545 . . . . 0.0 110.092 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -115.32 144.81 43.19 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.44 0.696 . . . . 0.0 111.847 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.0 t -123.62 127.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.61 131.63 46.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.59 0.756 . . . . 0.0 110.43 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -104.32 131.66 51.42 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.546 -1.346 . . . . 0.0 112.031 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -68.99 113.52 6.45 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.71 -31.17 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 170.871 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.432 H202 ' SD ' ' A' ' 119' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 51.8 mtm . . . . . 0 CA--C 1.569 1.688 0 CA-C-O 115.597 -2.144 . . . . 0.0 112.616 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.29 113.66 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 125.397 2.963 . . . . 0.0 115.33 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.59 144.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.062 0.934 . . . . 0.0 111.877 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -76.92 106.95 8.92 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.492 -0.755 . . . . 0.0 111.793 170.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.9 3.25 42.7 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -59.73 120.54 9.72 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.076 1.762 . . . . 0.0 114.793 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 174.12 28.2 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 122.847 1.248 . . . . 0.0 115.446 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -107.71 111.52 23.76 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.108 0.963 . . . . 0.0 108.573 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -114.28 111.85 22.17 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -90.66 139.8 30.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.057 -1.027 . . . . 0.0 113.189 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 36.7 ttp -72.94 125.6 27.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.441 -1.412 . . . . 0.0 114.17 -171.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.06 -50.3 7.14 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 169.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.3 p -136.79 149.28 47.69 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 119.369 0.986 . . . . 0.0 113.459 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -128.21 103.73 7.35 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.42 -60.8 1.87 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.24 43.31 3.15 Favored 'General case' 0 CA--C 1.572 1.826 0 C-N-CA 123.868 0.867 . . . . 0.0 110.575 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -76.65 -45.66 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.79 -47.95 70.3 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 166.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.59 -37.22 86.82 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.38 -43.75 83.88 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 120.85 1.659 . . . . 0.0 115.149 162.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.83 -38.14 85.85 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 172.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -55.93 -43.23 77.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 162.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.22 62.28 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.56 12.48 29.43 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 164.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.264 28.0 t70 56.92 47.9 16.88 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 120.602 1.546 . . . . 0.0 115.036 -174.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -93.35 155.57 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.448 -0.783 . . . . 0.0 110.722 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 151.13 47.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.45 -43.87 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.73 62.75 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 33.8 tp -61.35 -39.34 90.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -54.1 -39.01 65.99 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -71.57 -50.56 29.84 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.68 -54.56 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 123.906 0.883 . . . . 0.0 112.468 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.71 75.61 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.91 -39.89 91.0 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 165.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.78 -24.01 62.51 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.04 148.04 51.54 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.45 1.477 . . . . 0.0 113.72 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -107.67 86.54 2.95 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.03 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 53.5 Cg_endo -72.69 154.82 54.51 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 115.934 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -118.81 111.42 18.42 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -83.53 107.19 15.84 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.59 -0.694 . . . . 0.0 110.708 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.54 107.95 19.91 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.84 125.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -110.89 105.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.0 105.96 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.269 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.2 77.85 5.22 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.68 0.792 . . . . 0.0 109.922 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.29 -97.12 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 O-C-N 121.416 -0.803 . . . . 0.0 114.793 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.47 -17.51 20.49 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 164.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.99 114.11 21.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.789 1.631 . . . . 0.0 111.264 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.7 ttm -121.04 124.13 44.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.568 0.747 . . . . 0.0 111.225 -167.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.6 mt -114.08 96.79 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.6 mt -90.17 112.29 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -106.48 97.79 7.55 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 m -82.77 94.44 7.63 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.0 109.338 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -90.81 131.75 36.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.121 0.568 . . . . 0.0 111.687 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -150.88 155.9 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.097 0.951 . . . . 0.0 111.909 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.8 p -61.13 -32.57 72.26 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -78.1 -55.11 5.54 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -155.57 139.95 16.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.959 0.799 . . . . 0.0 110.238 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -88.82 125.11 34.76 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.051 0.54 . . . . 0.0 110.826 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -104.21 118.03 35.65 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.109 0.868 . . . . 0.0 110.584 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.11 120.7 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.8 mtp -108.84 111.54 23.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.258 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.09 108.44 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.408 0.683 . . . . 0.0 109.272 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -152.48 155.02 36.67 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -167.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.35 134.73 40.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.817 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.44 123.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.78 5.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -154.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -95.18 135.39 36.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.389 1.095 . . . . 0.0 112.772 -161.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -85.66 107.08 17.39 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 122.033 -0.417 . . . . 0.0 110.15 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -116.85 157.83 24.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.81 0.844 . . . . 0.0 112.33 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.63 104.46 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.672 -1.268 . . . . 0.0 112.167 169.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -90.75 107.09 18.95 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 121.39 -0.818 . . . . 0.0 108.959 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -82.7 120.29 25.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 164.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.401 HD22 HH21 ' A' ' 104' ' ' ARG . 4.7 mp -90.9 49.97 1.73 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -74.17 132.96 42.7 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.218 1.007 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 -50.17 1.03 Allowed Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.571 -0.705 . . . . 0.0 114.576 -158.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 mt -79.35 -66.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 125.002 1.321 . . . . 0.0 111.067 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -143.99 -6.54 0.76 Allowed 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.877 1.671 . . . . 0.0 114.175 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.287 3.3 t70 52.03 45.56 28.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -127.01 141.08 51.88 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.574 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -84.23 127.36 33.9 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.707 0.765 . . . . 0.0 112.564 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.6 m -113.51 141.29 47.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.578 0.751 . . . . 0.0 111.076 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.29 98.35 4.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 159.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.41 HG23 ' SG ' ' A' ' 95' ' ' CYS . 89.9 m -99.66 121.53 41.36 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.0 m -109.33 120.42 42.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 t -110.64 124.99 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.0 m -134.63 158.52 43.83 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 112.565 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -88.06 113.67 23.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 112.093 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.35 77.15 3.4 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.933 0.873 . . . . 0.0 109.256 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.07 -105.67 1.27 Allowed Glycine 0 CA--C 1.547 2.048 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.959 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -86.36 -26.35 24.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -83.18 134.24 34.99 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.611 1.55 . . . . 0.0 112.268 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.66 100.71 13.51 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.734 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -108.24 140.34 41.62 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.677 0.791 . . . . 0.0 111.482 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' A' ' 84' ' ' THR . 50.2 t -134.19 141.44 47.05 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -170.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -114.17 128.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.783 0.833 . . . . 0.0 109.84 166.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -101.88 103.86 14.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.499 0.72 . . . . 0.0 109.264 173.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -89.14 99.75 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.187 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.16 94.4 0.09 OUTLIER Glycine 0 N--CA 1.488 2.114 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 -169.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.296 40.0 mt-10 73.19 -51.07 0.71 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 161.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -99.27 144.77 28.01 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.622 0.769 . . . . 0.0 111.306 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.77 162.48 21.7 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.69 51.97 48.93 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.401 HH21 HD22 ' A' ' 74' ' ' LEU . 27.7 ttt180 -121.19 122.27 39.6 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.533 0.682 . . . . 0.0 111.926 -159.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.93 -162.83 34.44 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 121.447 -0.783 . . . . 0.0 114.064 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.268 67.3 p-90 -156.79 168.32 27.8 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 123.215 1.484 . . . . 0.0 113.115 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -146.86 130.57 16.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.975 -1.703 . . . . 0.0 108.599 168.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -127.53 142.48 51.37 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.282 1.039 . . . . 0.0 112.255 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -146.59 167.48 23.63 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.9 mt -114.62 126.7 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.284 -0.885 . . . . 0.0 109.176 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.35 89.85 3.24 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 163.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.67 -110.47 3.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -99.32 17.12 20.88 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -110.55 126.21 54.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.496 1.044 . . . . 0.0 111.593 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.4 tp -86.43 122.39 30.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.801 0.84 . . . . 0.0 109.683 166.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -111.15 119.49 39.15 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.0 tp -118.17 128.63 54.9 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.717 0.807 . . . . 0.0 110.54 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -108.53 119.34 39.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.619 0.767 . . . . 0.0 109.547 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.461 ' SD ' H202 ' A' ' 175' ' ' RTL . 70.2 mtm -112.92 129.87 56.32 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.487 0.715 . . . . 0.0 111.312 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -123.61 132.78 53.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 111.901 -167.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.27 129.79 14.91 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.779 0.831 . . . . 0.0 109.305 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 55.57 36.08 26.45 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.07 -3.83 27.43 Favored Glycine 0 CA--C 1.557 2.684 0 N-CA-C 119.878 2.711 . . . . 0.0 119.878 -164.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.92 113.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 120.071 1.935 . . . . 0.0 109.091 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.0 m -93.37 119.39 32.44 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -173.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.8 t -90.81 125.96 35.87 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.385 0.674 . . . . 0.0 112.067 164.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -98.4 122.84 42.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.791 0.436 . . . . 0.0 110.33 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -117.82 139.85 50.51 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.315 0.646 . . . . 0.0 110.664 168.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.0 130.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -128.82 136.42 50.46 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 123.299 0.64 . . . . 0.0 111.411 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -96.09 127.32 42.0 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.649 1.179 . . . . 0.0 111.501 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -68.55 119.82 13.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.185 0.902 . . . . 0.0 112.777 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.22 -38.5 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 CA--C 1.561 1.389 0 CA-C-N 119.78 1.173 . . . . 0.0 107.909 169.542 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 175' ' ' RTL . . . . . 0.464 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.572 1.802 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.53 -82.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 125.077 2.849 . . . . 0.0 113.114 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.15 -27.69 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 121.395 -0.816 . . . . 0.0 112.37 157.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.343 15.3 t70 68.46 90.06 0.1 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.366 1.466 . . . . 0.0 112.66 -167.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.41 15.62 1.22 Allowed 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -59.19 117.32 4.61 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.48 176.08 30.12 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-O 122.6 1.111 . . . . 0.0 115.865 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -106.94 113.86 27.6 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.442 1.097 . . . . 0.0 109.034 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -117.56 112.99 21.32 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -92.67 140.64 29.32 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.843 -1.161 . . . . 0.0 113.397 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.5 ttp -70.4 117.37 11.85 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-N 119.726 1.148 . . . . 0.0 114.0 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.14 -46.88 21.98 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 167.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.2 m -153.75 160.49 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.811 1.291 . . . . 0.0 112.704 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -150.33 112.75 4.68 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.773 -174.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.3 -69.74 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -117.19 42.22 2.59 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -73.44 -36.01 65.86 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -59.85 -39.56 85.6 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.79 -40.28 83.95 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 167.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.35 -47.81 82.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.25 -39.37 75.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -54.4 -43.43 71.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 162.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.85 51.7 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 165.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.16 2.2 47.74 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.297 20.2 t70 63.64 49.34 3.04 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -167.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.83 146.41 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.162 0.982 . . . . 0.0 110.13 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -65.89 153.63 41.47 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.3 t -59.72 -44.74 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.45 -49.55 74.26 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.76 -43.25 98.23 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -52.46 -50.84 61.84 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 165.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.98 -45.14 93.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.27 -54.43 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 118.945 0.793 . . . . 0.0 111.6 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.51 -29.92 65.35 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.29 -26.8 56.26 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.6 144.37 57.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.367 1.439 . . . . 0.0 113.563 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -107.73 84.62 2.05 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.847 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.02 156.5 47.46 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.579 2.186 . . . . 0.0 115.171 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.42 118.83 33.78 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HZ1' HD22 ' A' ' 117' ' ' LEU . 60.3 mttt -84.81 108.14 17.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.36 -0.837 . . . . 0.0 110.661 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -96.22 107.66 20.03 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.1 128.13 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.51 107.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -100.04 118.7 36.98 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.356 0.663 . . . . 0.0 110.708 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.41 81.83 1.58 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 -104.19 1.16 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -82.3 -27.36 32.35 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -79.12 116.13 19.21 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.196 1.362 . . . . 0.0 111.943 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -124.28 127.13 47.2 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 121.506 0.67 . . . . 0.0 110.971 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.05 99.26 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.3 mt -91.24 107.03 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -100.95 99.91 10.45 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -88.0 99.41 12.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.08 129.07 48.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.066 0.546 . . . . 0.0 111.848 -162.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -148.18 145.92 28.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.58 0.705 . . . . 0.0 110.379 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.5 p -60.78 -26.03 66.96 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -73.31 -50.63 21.1 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 165.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -159.74 133.44 7.21 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.624 1.102 . . . . 0.0 111.268 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -97.91 139.73 33.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.64 . . . . 0.0 111.395 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -123.77 119.99 31.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -0.779 . . . . 0.0 110.251 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -113.35 122.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.3 mtp -109.48 106.17 15.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.717 -0.614 . . . . 0.0 109.793 175.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -107.76 112.28 24.87 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.516 0.726 . . . . 0.0 109.738 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.24 155.84 31.51 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -95.67 130.84 42.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 111.054 164.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 t -69.14 123.53 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 109.933 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.14 -34.41 4.84 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 -161.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -94.56 147.55 23.16 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.815 1.307 . . . . 0.0 113.065 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.59 124.69 35.94 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.787 -0.57 . . . . 0.0 110.865 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -133.53 151.95 51.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.568 0.747 . . . . 0.0 112.568 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.4 110.39 7.65 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.436 1.113 . . . . 0.0 112.324 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -94.04 100.12 12.3 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.224 1.01 . . . . 0.0 109.554 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.26 104.58 8.94 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.447 0.641 . . . . 0.0 110.003 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mt -90.45 45.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -81.86 131.5 35.26 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.198 0.999 . . . . 0.0 110.546 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.2 -34.99 4.48 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.924 1.529 . . . . 0.0 116.924 -159.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 mt -86.36 -67.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 124.439 1.096 . . . . 0.0 109.553 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -136.59 -7.35 1.94 Allowed 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.257 26.8 t0 57.4 64.69 1.53 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 120.304 1.411 . . . . 0.0 114.666 -166.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -136.82 144.12 43.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.6 -0.688 . . . . 0.0 111.057 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -97.6 112.02 24.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 111.066 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -110.31 146.55 35.53 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.41 0.684 . . . . 0.0 111.701 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.8 mmt -82.09 97.6 8.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.161 -1.587 . . . . 0.0 110.229 171.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.436 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 36.1 m -91.91 126.29 36.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 111.634 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 m -107.39 125.96 51.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 162.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.82 127.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -129.29 159.08 37.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.029 0.931 . . . . 0.0 111.829 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -88.74 126.15 35.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.603 -1.311 . . . . 0.0 112.278 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -102.05 74.19 1.43 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 158.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.44 -98.72 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 -173.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.31 -35.33 61.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -87.63 129.89 34.97 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.111 0.869 . . . . 0.0 111.776 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.6 tp -88.58 107.56 18.97 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 123.286 0.634 . . . . 0.0 109.761 173.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -114.08 132.4 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.583 0.753 . . . . 0.0 111.527 -167.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.436 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 40.6 t -131.65 138.42 48.75 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.38 124.77 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.444 167.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -101.06 97.26 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 0.0 109.544 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -85.2 115.82 23.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 112.01 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.59 0.3 Allowed Glycine 0 N--CA 1.483 1.833 0 O-C-N 121.396 -0.815 . . . . 0.0 113.663 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -87.67 -7.89 56.85 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -166.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -126.38 143.7 51.08 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.458 1.481 . . . . 0.0 112.081 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -85.67 113.63 22.02 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.424 0.63 . . . . 0.0 112.523 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.93 56.68 6.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -101.54 130.68 47.88 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.413 0.625 . . . . 0.0 111.243 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.15 -170.21 40.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -155.62 153.45 30.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.2 m -127.83 121.05 29.13 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -119.65 123.42 43.79 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.599 0.759 . . . . 0.0 110.67 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -142.86 153.29 43.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 113.194 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -100.64 126.12 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.0 109.227 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.57 92.83 3.99 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.99 -115.13 4.82 Favored Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.637 -0.664 . . . . 0.0 114.473 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 p30 -94.58 8.05 43.57 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 164.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.18 126.71 53.55 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.598 1.545 . . . . 0.0 111.141 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.41 113.57 25.51 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.32 1.048 . . . . 0.0 109.226 169.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -99.46 125.48 45.21 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 109.531 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.433 HD22 ' HZ1' ' A' ' 40' ' ' LYS . 31.6 tp -122.47 120.5 34.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.696 0.798 . . . . 0.0 110.267 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.05 130.33 47.05 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.936 165.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -125.02 129.26 49.94 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.68 1.127 . . . . 0.0 111.111 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.21 144.36 45.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.483 -0.76 . . . . 0.0 112.715 -171.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.73 127.89 4.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.539 0.736 . . . . 0.0 110.162 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 52.57 50.28 18.55 Favored 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.89 -20.29 1.88 Allowed Glycine 0 CA--C 1.557 2.671 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.7 t -67.84 172.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 CA-C-N 120.146 1.973 . . . . 0.0 112.993 -169.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.5 m -144.28 115.3 7.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 119.31 -2.119 . . . . 0.0 109.83 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -93.84 121.92 35.79 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.752 0.821 . . . . 0.0 111.381 166.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -98.11 123.99 42.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.822 0.449 . . . . 0.0 111.433 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -122.0 139.19 53.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.937 0.895 . . . . 0.0 110.499 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 36.2 t -120.26 126.77 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -127.58 122.33 32.93 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.56 0.744 . . . . 0.0 110.575 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -98.19 135.24 40.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.471 -1.393 . . . . 0.0 112.872 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -69.11 121.79 17.44 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.33 -35.78 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 120.057 1.299 . . . . 0.0 108.232 169.885 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.6 t0 . . . . . 0 CA--C 1.565 1.529 0 CA-C-O 121.397 0.618 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.76 -0.45 23.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -58.25 104.94 0.24 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 121.293 1.86 . . . . 0.0 114.767 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.39 -179.03 36.17 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-O 123.117 1.398 . . . . 0.0 115.938 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -113.38 116.19 29.28 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 113.651 -1.274 . . . . 0.0 109.399 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -117.19 113.36 22.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -167.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -90.37 140.19 29.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.104 -0.997 . . . . 0.0 113.337 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.6 ttm -67.2 122.03 16.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.17 -45.72 13.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 166.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.7 m -152.71 159.6 43.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.418 -1.426 . . . . 0.0 113.871 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -134.43 113.13 11.53 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.594 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -122.01 123.68 42.2 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.331 0.653 . . . . 0.0 110.492 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.276 37.7 t30 68.06 30.47 5.89 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -79.25 -40.57 30.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.159 -1.588 . . . . 0.0 115.179 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -55.03 -42.2 72.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.11 -42.08 89.71 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -55.94 -48.06 76.41 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.75 -39.88 80.09 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -54.9 -44.05 73.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.69 -23.76 60.08 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.3 3.65 38.67 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.288 17.5 t0 61.27 48.33 6.26 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -169.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.29 147.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.001 0.905 . . . . 0.0 110.329 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -63.06 152.76 36.13 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.3 t -60.63 -43.75 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.84 -52.71 61.91 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -62.82 -36.96 84.91 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -54.04 -50.27 67.07 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 163.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -66.58 -44.92 80.95 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.07 -57.5 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.204 0.911 . . . . 0.0 111.928 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.23 70.98 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -71.15 -35.08 71.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.68 -32.55 73.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.5 mt -73.92 128.15 34.75 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 119.373 0.988 . . . . 0.0 112.331 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -102.64 94.36 5.05 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.942 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.64 161.14 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.294 1.996 . . . . 0.0 115.683 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -104.16 124.41 49.05 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.629 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -88.24 109.34 19.85 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.234 -0.916 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.67 112.18 23.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.91 163.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.97 128.8 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.29 112.72 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.44 1.096 . . . . 0.0 110.52 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -127.34 76.03 1.63 Allowed 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.483 -0.76 . . . . 0.0 110.143 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -102.32 1.21 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.436 -0.79 . . . . 0.0 114.214 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.83 -26.35 20.57 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 162.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -70.56 134.31 47.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.333 1.879 . . . . 0.0 112.768 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 ttm -145.5 130.73 18.51 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.43 0.633 . . . . 0.0 112.074 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.15 108.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.16 110.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -100.98 106.31 17.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.65 -0.656 . . . . 0.0 109.822 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.1 m -88.97 99.45 12.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.49 125.86 41.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.107 0.563 . . . . 0.0 111.525 -163.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -147.31 155.39 41.98 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.097 0.951 . . . . 0.0 111.739 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -62.83 -32.86 74.15 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -75.46 -54.02 7.73 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -152.12 134.01 14.88 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.839 0.745 . . . . 0.0 110.383 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -92.77 122.42 35.14 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.13 0.572 . . . . 0.0 109.821 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -109.55 106.61 16.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.305 0.642 . . . . 0.0 110.499 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.1 mp -105.08 124.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.2 mtp -108.42 110.28 21.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.768 0.827 . . . . 0.0 109.498 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -107.52 118.17 36.01 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.338 0.655 . . . . 0.0 109.775 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.34 155.2 33.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -96.38 129.27 43.76 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.809 0.814 . . . . 0.0 110.713 159.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.96 128.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 C-N-CA 123.995 0.918 . . . . 0.0 109.686 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.13 -47.41 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 115.779 1.071 . . . . 0.0 115.779 -156.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -83.92 135.85 34.32 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.35 105.87 16.32 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.709 0.403 . . . . 0.0 110.36 169.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -113.49 157.14 22.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.864 0.84 . . . . 0.0 113.06 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.21 101.58 5.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 112.349 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -102.41 104.69 15.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.496 -0.752 . . . . 0.0 110.332 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -81.8 113.98 20.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.34 66.3 5.79 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.553 1.168 . . . . 0.0 112.101 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -75.71 117.64 17.68 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.387 1.075 . . . . 0.0 111.25 -168.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.56 -52.62 0.62 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -162.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.02 -68.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 124.733 1.213 . . . . 0.0 110.178 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -130.89 -6.09 3.99 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.285 17.3 t0 51.57 45.31 28.26 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -166.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -108.38 139.11 43.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 110.582 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -81.6 116.12 21.2 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 112.01 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.5 m -108.5 142.0 39.55 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.683 0.793 . . . . 0.0 111.293 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.01 94.73 7.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.132 168.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -99.82 123.55 44.19 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.576 -0.702 . . . . 0.0 110.621 -164.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 m -112.59 122.01 46.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.65 132.72 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -126.76 146.78 50.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.921 0.888 . . . . 0.0 111.685 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.3 m95 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 111.961 175.52 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.888 0.851 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.0 111.23 22.6 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -115.47 123.79 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.125 0.57 . . . . 0.0 110.614 -162.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.72 136.69 54.95 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.43 128.23 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.401 0.68 . . . . 0.0 109.543 165.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -104.34 101.68 11.38 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.549 0.74 . . . . 0.0 109.169 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -85.48 115.57 23.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.863 -1.148 . . . . 0.0 111.596 -170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.57 -120.37 0.63 Allowed Glycine 0 N--CA 1.485 1.915 0 O-C-N 121.905 -0.497 . . . . 0.0 113.516 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.4 -21.52 33.0 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -108.85 144.78 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.654 1.57 . . . . 0.0 113.033 -166.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.55 115.6 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.34 0.59 . . . . 0.0 112.179 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.46 45.47 78.11 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -85.05 124.35 31.63 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.388 0.613 . . . . 0.0 111.329 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.19 -169.14 41.3 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.248 0.916 . . . . 0.0 114.817 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -157.77 153.25 26.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.983 0.897 . . . . 0.0 113.211 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -129.26 125.33 36.62 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.263 3.3 pt20 -126.58 138.64 53.48 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -148.59 159.73 43.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.454 -0.779 . . . . 0.0 113.0 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.8 mt -98.4 125.33 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.32 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -111.53 97.09 6.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 161.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.84 -109.74 2.89 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.46 -0.775 . . . . 0.0 114.15 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -100.46 15.41 28.0 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -113.0 121.22 43.99 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.912 1.687 . . . . 0.0 111.842 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.97 117.02 20.44 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.218 1.007 . . . . 0.0 110.138 167.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -105.68 117.66 34.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.2 tp -113.96 126.83 55.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.027 0.931 . . . . 0.0 110.801 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -106.61 123.53 48.25 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.345 0.658 . . . . 0.0 109.489 164.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -113.21 128.13 56.38 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -115.07 137.0 52.51 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.84 119.98 7.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.548 0.739 . . . . 0.0 110.208 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 55.2 46.92 22.81 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.02 -33.0 0.91 Allowed Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.361 2.504 . . . . 0.0 119.361 -164.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.51 119.93 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.828 1.251 . . . . 0.0 111.209 -166.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.0 m -102.85 115.96 31.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.126 0.571 . . . . 0.0 111.022 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 t -88.8 131.27 35.15 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.056 0.542 . . . . 0.0 111.427 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -113.1 119.66 38.61 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.027 0.531 . . . . 0.0 110.294 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -124.95 133.73 52.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.43 0.692 . . . . 0.0 111.0 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.25 130.39 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.58 128.1 38.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.399 0.68 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -98.94 133.76 42.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.343 -1.473 . . . . 0.0 112.39 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -69.26 122.52 19.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.55 -38.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 N--CA 1.488 1.436 0 CA-C-N 119.927 1.239 . . . . 0.0 107.962 168.516 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.287 6.0 t70 . . . . . 0 CA--C 1.563 1.468 0 CA-C-O 121.524 0.678 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -81.32 13.92 2.69 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -63.38 116.76 5.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.36 173.18 26.44 Favored Glycine 0 N--CA 1.488 2.157 0 CA-C-O 122.697 1.165 . . . . 0.0 115.859 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -101.87 116.83 33.55 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.189 0.995 . . . . 0.0 109.497 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -117.82 110.8 18.23 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -93.34 139.88 30.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.111 -0.993 . . . . 0.0 112.851 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.4 ttp -69.46 125.71 27.54 Favored 'General case' 0 CA--C 1.571 1.772 0 O-C-N 120.419 -1.426 . . . . 0.0 114.68 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.84 -50.92 6.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.5 p -136.36 155.17 50.42 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -143.55 117.65 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.032 0.933 . . . . 0.0 108.947 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.05 -71.38 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -166.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -121.97 41.88 3.27 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.956 0.884 . . . . 0.0 112.108 -171.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.455 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 8.1 t80 -73.57 -39.94 64.29 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -57.22 -43.84 83.22 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.78 -39.05 84.1 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -56.54 -45.93 80.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 167.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 mt -71.38 -37.48 71.6 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -55.09 -46.0 75.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 161.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.0 -20.81 41.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.06 5.68 50.63 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.286 23.8 t70 61.03 50.13 5.25 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.52 1.509 . . . . 0.0 114.87 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -93.38 150.38 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.892 0.854 . . . . 0.0 109.891 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -63.81 152.42 39.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.79 -44.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.28 64.13 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.37 -38.52 89.9 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -53.99 -53.1 57.63 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -62.15 -43.72 98.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.4 mt -64.1 -53.81 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.898 0.879 . . . . 0.0 111.919 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.65 85.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -61.91 -36.67 82.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.58 -20.68 53.62 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.23 156.88 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -96.15 103.17 12.72 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.182 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.49 146.9 19.63 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.696 2.264 . . . . 0.0 112.947 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -134.28 107.7 7.8 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -83.77 107.45 16.19 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.516 -0.74 . . . . 0.0 111.094 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -94.31 106.43 18.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.63 129.24 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.2 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -99.71 109.84 22.28 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.082 0.553 . . . . 0.0 110.209 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -100.39 81.14 2.32 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.439 0.696 . . . . 0.0 109.304 167.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.63 -102.97 1.03 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 115.02 0.768 . . . . 0.0 115.02 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -86.32 -26.83 24.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 164.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -75.2 119.27 19.1 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.417 1.462 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 ttm -122.29 123.44 41.44 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.586 0.707 . . . . 0.0 110.538 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.9 mt -110.69 95.59 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.7 mt -93.1 104.25 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -100.82 99.29 9.78 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -87.09 100.49 12.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.311 -0.868 . . . . 0.0 109.364 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.3 mt -104.49 112.54 25.64 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.674 0.75 . . . . 0.0 110.531 -164.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -131.99 155.08 48.61 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.976 0.893 . . . . 0.0 111.309 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -65.58 -19.23 65.83 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -83.97 -50.76 7.72 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 119.057 0.844 . . . . 0.0 113.065 168.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -153.2 148.22 26.64 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.882 0.848 . . . . 0.0 110.505 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.52 130.44 50.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.885 . . . . 0.0 110.125 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.74 104.59 11.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.79 -0.569 . . . . 0.0 110.765 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.48 128.23 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.603 0.761 . . . . 0.0 109.122 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -113.41 108.1 16.75 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.722 0.809 . . . . 0.0 109.513 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.27 98.13 7.28 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.641 0.776 . . . . 0.0 110.446 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -144.8 155.92 43.76 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -93.11 131.34 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.863 -1.148 . . . . 0.0 111.007 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.1 t -68.37 126.64 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.65 -0.656 . . . . 0.0 110.689 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.14 -30.61 8.14 Favored Glycine 0 CA--C 1.552 2.384 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -91.86 144.8 25.11 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.168 1.484 . . . . 0.0 112.746 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.6 128.08 36.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 111.507 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.01 149.27 51.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.655 0.782 . . . . 0.0 112.36 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -74.15 101.08 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.035 -1.04 . . . . 0.0 111.913 172.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -94.03 116.01 28.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.546 0.738 . . . . 0.0 110.206 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -80.94 127.43 32.56 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.586 0.707 . . . . 0.0 109.72 163.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mt -99.37 60.98 1.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.135 0.969 . . . . 0.0 111.128 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 119.15 23.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.318 1.047 . . . . 0.0 111.712 -166.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.65 -42.4 1.92 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -162.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.21 -69.57 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.107 0.963 . . . . 0.0 110.125 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -141.3 -1.02 1.37 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 166.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 28.2 m-20 63.93 65.26 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 120.22 1.373 . . . . 0.0 113.575 -173.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HE ' ' HZ2' ' A' ' 101' ' ' LYS . 82.9 mmt-85 -122.2 142.34 50.53 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.612 0.765 . . . . 0.0 110.643 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.38 111.12 22.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.529 165.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m -117.7 145.02 44.72 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.45 0.7 . . . . 0.0 112.098 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.0 mtp -83.4 98.99 9.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -98.86 122.56 42.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.076 0.55 . . . . 0.0 110.182 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.0 m -102.68 131.87 49.19 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 95' ' ' CYS . 38.2 t -117.91 122.59 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.1 m -131.01 158.05 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.78 0.832 . . . . 0.0 112.007 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.9 m95 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.69 -1.256 . . . . 0.0 112.214 175.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.664 0.745 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.95 103.34 16.01 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.24 0.616 . . . . 0.0 109.511 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -110.74 131.79 54.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.572 0.749 . . . . 0.0 111.269 -167.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 86' ' ' VAL . 50.2 t -130.93 141.86 50.31 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.43 128.1 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.913 0.885 . . . . 0.0 109.302 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -106.22 95.99 6.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.711 0.804 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.76 120.46 27.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 112.128 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.49 -115.55 0.47 Allowed Glycine 0 N--CA 1.486 1.989 0 O-C-N 121.25 -0.906 . . . . 0.0 113.531 171.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.7 -13.5 57.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.428 ' HZ2' ' HE ' ' A' ' 80' ' ' ARG . 21.1 mmtp -114.71 146.4 40.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.294 1.406 . . . . 0.0 112.359 -170.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -90.24 103.27 15.97 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.462 -162.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.42 50.44 21.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -170.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -89.76 137.21 32.53 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.945 0.879 . . . . 0.0 111.933 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.42 -161.17 27.67 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 121.936 0.742 . . . . 0.0 114.257 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -157.42 157.93 34.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.866 . . . . 0.0 112.638 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -132.77 124.74 28.66 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.286 1.3 pt20 -129.43 141.82 50.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.48 161.2 43.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 0.0 112.53 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -103.83 123.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.934 . . . . 0.0 109.15 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.33 85.19 2.21 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 162.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.05 -111.77 4.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.96 -5.95 58.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 165.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.66 127.28 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 120.396 1.453 . . . . 0.0 111.92 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.1 tp -88.41 117.86 27.63 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.847 0.859 . . . . 0.0 109.724 166.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -100.77 121.52 41.82 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.756 0.823 . . . . 0.0 109.277 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -117.53 130.69 56.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.993 0.917 . . . . 0.0 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.77 118.93 34.97 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.733 0.813 . . . . 0.0 109.554 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.4 mtm -110.63 132.04 54.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.497 -0.752 . . . . 0.0 111.265 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -124.35 133.73 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.86 . . . . 0.0 112.169 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.57 126.88 8.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.272 0.629 . . . . 0.0 110.966 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 57.3 36.51 27.38 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.04 -19.94 2.65 Favored Glycine 0 CA--C 1.558 2.753 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 -162.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.79 119.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 119.568 1.684 . . . . 0.0 109.562 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -101.59 121.84 42.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.446 0.641 . . . . 0.0 110.743 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.455 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 7.1 t -97.6 124.82 42.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 169.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -102.31 127.29 49.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.957 -0.465 . . . . 0.0 111.666 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -127.16 142.82 51.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.941 0.896 . . . . 0.0 111.274 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.54 132.52 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.4 132.13 48.51 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.516 0.726 . . . . 0.0 111.235 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -97.2 127.98 43.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.702 -1.249 . . . . 0.0 112.18 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -67.19 122.94 18.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.1 -39.71 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.103 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.257 0.551 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -81.27 4.49 20.29 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -57.83 108.57 0.59 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.725 1.602 . . . . 0.0 115.144 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.89 179.12 33.5 Favored Glycine 0 N--CA 1.486 2.01 0 CA-C-O 122.756 1.198 . . . . 0.0 115.753 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -110.48 118.84 37.34 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.704 1.201 . . . . 0.0 109.151 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -119.15 118.86 32.5 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -88.76 144.89 25.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.943 -1.098 . . . . 0.0 112.905 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.415 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 7.3 ttp -71.83 124.68 25.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.498 -1.376 . . . . 0.0 113.495 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.07 -48.4 7.77 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.9 m -157.27 160.08 38.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.4 . . . . 0.0 112.993 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -142.69 124.5 15.1 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.342 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -126.41 125.08 41.59 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.062 0.945 . . . . 0.0 109.877 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.1 t30 66.1 37.17 5.3 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.557 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 5.7 t80 -79.04 -43.45 24.2 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.27 -34.76 77.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -70.37 -41.43 73.1 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -53.34 -47.31 69.47 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 120.458 1.481 . . . . 0.0 114.842 166.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.89 -38.35 70.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.83 -45.38 78.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.085 -1.635 . . . . 0.0 115.061 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -18.75 43.31 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 166.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.34 -4.54 59.05 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 25.8 t70 67.38 52.97 0.78 Allowed 'General case' 0 CA--C 1.572 1.805 0 CA-C-N 120.154 1.343 . . . . 0.0 113.996 -166.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -102.86 146.43 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.977 0.894 . . . . 0.0 109.685 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.76 152.38 44.45 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -60.28 -44.12 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.88 65.88 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 116.004 1.854 . . . . 0.0 116.004 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.82 -41.7 96.22 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -52.33 -53.21 47.45 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 166.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -63.23 -43.91 96.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.88 -53.65 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.631 0.772 . . . . 0.0 111.869 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.68 81.77 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -68.6 -30.91 69.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.31 -29.52 62.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 166.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.15 131.55 42.94 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.041 1.291 . . . . 0.0 112.723 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -105.63 89.51 3.48 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.482 173.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.4 Cg_endo -72.6 165.38 32.88 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.371 2.047 . . . . 0.0 115.601 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -111.6 120.24 41.42 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -89.92 110.58 21.53 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.438 -0.789 . . . . 0.0 111.004 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -98.53 110.13 22.78 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.713 -0.617 . . . . 0.0 109.802 169.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.44 125.83 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.43 107.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 165.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -102.42 102.09 12.38 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.643 0.777 . . . . 0.0 109.998 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -92.75 79.32 4.75 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 109.963 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.55 -101.79 0.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 114.508 0.563 . . . . 0.0 114.508 -173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.34 -26.62 24.76 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -79.1 106.27 11.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.772 1.624 . . . . 0.0 111.635 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -112.45 124.03 51.6 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.968 0.907 . . . . 0.0 110.722 -172.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.95 96.84 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.93 108.36 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -102.6 98.94 8.92 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.226 0.61 . . . . 0.0 109.38 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -84.14 101.41 11.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.14 127.5 43.16 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.074 0.55 . . . . 0.0 111.692 -166.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 t -150.79 153.48 35.53 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.981 0.896 . . . . 0.0 111.646 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.6 -31.83 72.73 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -73.02 -51.26 18.88 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -155.55 138.36 15.29 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.032 0.833 . . . . 0.0 110.792 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -99.18 116.92 32.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -107.5 107.71 18.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.854 -0.529 . . . . 0.0 111.035 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.51 127.24 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.1 105.55 15.61 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.596 0.758 . . . . 0.0 109.421 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.02 113.48 26.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.611 0.764 . . . . 0.0 109.753 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.83 157.23 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -168.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -97.35 132.15 43.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 111.473 165.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -69.78 122.09 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 123.38 0.672 . . . . 0.0 110.154 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.93 -37.96 3.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 -158.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.87 136.75 32.87 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 118.25 1.025 . . . . 0.0 113.547 -165.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -87.6 117.38 26.37 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.878 0.471 . . . . 0.0 110.93 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -134.24 145.77 49.46 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.378 0.671 . . . . 0.0 112.287 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.04 101.88 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.463 -1.398 . . . . 0.0 112.958 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.4 112.19 24.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.242 0.617 . . . . 0.0 110.444 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.81 114.99 19.15 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.581 0.705 . . . . 0.0 110.775 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.93 55.26 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 112.857 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 t -74.07 133.57 42.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.55 -54.18 1.48 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.707 -0.62 . . . . 0.0 114.116 -158.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.2 mt -71.27 -63.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.667 0.787 . . . . 0.0 111.221 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -139.21 -3.99 1.53 Allowed 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 166.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.416 4.4 p30 50.14 64.1 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.789 1.632 . . . . 0.0 115.088 -159.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -124.6 130.4 52.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.359 0.664 . . . . 0.0 109.747 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -90.81 112.91 24.92 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.854 -0.529 . . . . 0.0 110.246 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.8 m -123.54 132.44 53.9 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.361 0.665 . . . . 0.0 111.264 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtp -70.04 99.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.423 1.106 . . . . 0.0 110.395 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -108.19 122.35 46.74 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.844 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.6 m -107.68 120.51 42.44 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.9 t -109.62 124.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.7 m -138.44 155.28 48.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 112.473 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 70.6 m95 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.842 -1.162 . . . . 0.0 112.385 177.129 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.561 0.695 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.34 114.61 26.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.707 -0.62 . . . . 0.0 109.809 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.586 0.755 . . . . 0.0 111.26 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.6 t -128.0 138.37 52.57 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p -117.37 131.17 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.916 0.887 . . . . 0.0 109.654 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.18 97.8 7.2 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.0 0.92 . . . . 0.0 109.17 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -91.67 119.68 31.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.481 -0.762 . . . . 0.0 112.025 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.11 -107.15 0.28 Allowed Glycine 0 N--CA 1.487 2.036 0 O-C-N 121.211 -0.931 . . . . 0.0 113.48 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.6 -12.05 59.95 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -126.44 145.08 50.62 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.093 1.315 . . . . 0.0 112.053 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.13 110.57 18.13 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.779 0.832 . . . . 0.0 111.418 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.39 46.13 73.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -85.01 139.97 31.38 Favored 'General case' 0 CA--C 1.569 1.682 0 CA-C-N 118.001 0.901 . . . . 0.0 111.668 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.15 -164.49 33.87 Favored Glycine 0 N--CA 1.484 1.854 0 O-C-N 121.391 -0.818 . . . . 0.0 114.736 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.65 157.08 32.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -128.78 130.11 46.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -131.85 144.14 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.712 0.768 . . . . 0.0 112.882 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.4 p90 -153.52 163.63 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.452 0.701 . . . . 0.0 112.723 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.9 129.62 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.396 -0.815 . . . . 0.0 108.888 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.64 98.27 6.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 162.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.84 -115.06 4.58 Favored Glycine 0 N--CA 1.49 2.27 0 O-C-N 121.559 -0.713 . . . . 0.0 114.353 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -95.73 12.96 28.08 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 163.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -112.55 132.83 54.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.554 1.524 . . . . 0.0 112.553 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.65 120.24 31.55 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.254 1.022 . . . . 0.0 108.961 170.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -109.74 124.14 50.74 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 108.895 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.8 tp -130.81 132.51 45.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.644 0.777 . . . . 0.0 110.251 -167.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.17 120.11 34.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.735 -0.603 . . . . 0.0 110.02 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 64.1 mtm -112.1 132.21 54.98 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.622 0.769 . . . . 0.0 111.322 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -124.2 137.25 54.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 112.287 -167.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.61 124.59 8.62 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.096 0.559 . . . . 0.0 110.882 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 54.75 43.58 29.85 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.72 -28.56 1.3 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 119.587 2.595 . . . . 0.0 119.587 -164.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.89 120.91 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 118.909 1.354 . . . . 0.0 110.564 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 m -101.9 125.39 48.57 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 121.375 0.607 . . . . 0.0 111.032 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.557 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 13.1 t -92.82 133.57 35.93 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.352 0.661 . . . . 0.0 111.291 163.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -102.14 126.68 49.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.272 0.629 . . . . 0.0 110.536 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -128.6 138.98 52.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.058 0.943 . . . . 0.0 111.131 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.12 127.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -126.92 152.57 46.94 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.501 1.12 . . . . 0.0 110.65 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -124.45 135.91 53.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.214 -1.554 . . . . 0.0 112.714 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -70.23 125.4 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.18 -37.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 120.209 1.368 . . . . 0.0 108.346 169.119 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 CA--C 1.565 1.541 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -74.85 0.96 13.82 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 170.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -57.88 112.92 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 121.333 1.879 . . . . 0.0 114.57 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.0 32.32 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-O 123.108 1.393 . . . . 0.0 116.081 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -112.4 113.57 25.83 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.75 -1.225 . . . . 0.0 108.862 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -115.42 115.54 26.72 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -166.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -89.91 143.44 26.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 113.258 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.44 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 12.8 ttp -75.54 127.33 32.86 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 113.77 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -93.1 -45.88 7.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -157.2 158.22 35.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.4 -1.438 . . . . 0.0 113.1 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -137.18 132.26 33.68 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.762 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.33 120.44 19.91 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.351 0.661 . . . . 0.0 109.956 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.278 45.0 t30 65.36 32.14 9.94 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 117.506 2.409 . . . . 0.0 117.506 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -78.12 -37.25 46.6 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -56.31 -41.97 76.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.77 -39.33 84.11 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -58.63 -47.88 82.9 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 167.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.29 -40.39 90.0 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -54.66 -46.0 73.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 162.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.86 -13.74 27.17 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.81 -50.09 5.53 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.43 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.94 5.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.938 1.695 . . . . 0.0 115.126 163.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.69 147.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 118.626 -2.546 . . . . 0.0 113.118 -146.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -67.1 154.42 41.26 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.96 -47.11 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.83 64.08 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.33 -36.88 85.39 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -54.58 -50.23 68.49 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -60.43 -44.3 95.93 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.6 -56.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 123.895 0.878 . . . . 0.0 111.821 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.99 77.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -69.07 -32.29 71.65 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.04 -27.47 60.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.79 141.6 49.69 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.216 1.371 . . . . 0.0 113.706 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -100.68 92.93 2.53 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.467 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 72.4 Cg_endo -71.8 155.33 58.38 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 122.629 2.219 . . . . 0.0 114.946 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.96 117.77 35.07 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.114 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.06 108.02 18.69 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.609 -0.682 . . . . 0.0 110.382 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -93.35 109.64 21.19 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.196 168.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mt -107.25 128.42 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.55 108.31 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -102.48 112.62 25.42 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.993 0.917 . . . . 0.0 110.483 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -105.48 75.97 1.18 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.597 -0.689 . . . . 0.0 109.669 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.48 -99.3 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -78.24 -37.93 44.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -77.02 116.07 17.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 120.333 1.424 . . . . 0.0 112.31 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.9 ttm -126.59 124.81 40.79 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.655 0.782 . . . . 0.0 110.866 -170.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.7 99.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.19 110.9 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -106.93 97.27 7.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.6 m -83.49 102.82 12.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.11 116.85 32.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.587 0.708 . . . . 0.0 111.094 -166.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -135.66 150.76 49.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.53 0.732 . . . . 0.0 110.099 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -63.42 -27.05 69.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.03 -41.48 64.17 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 164.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -158.19 129.89 6.75 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.847 1.203 . . . . 0.0 112.931 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -105.03 120.65 42.01 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.641 0.777 . . . . 0.0 109.765 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -121.85 109.98 15.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.758 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.84 125.75 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -103.55 107.32 18.12 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.49 0.716 . . . . 0.0 109.348 166.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -107.66 112.13 24.69 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.473 0.709 . . . . 0.0 109.583 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -154.51 164.27 38.93 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.32 134.23 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.969 167.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.23 134.92 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 O-C-N 121.149 -0.97 . . . . 0.0 110.55 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.22 46.18 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -163.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.36 145.0 35.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.926 1.363 . . . . 0.0 110.236 -162.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -90.72 128.9 36.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -139.21 158.99 43.19 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.143 0.973 . . . . 0.0 112.882 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.37 92.17 3.34 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 111.763 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -88.43 100.2 12.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.06 101.04 13.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 122.955 0.502 . . . . 0.0 110.552 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 mp -83.41 52.11 2.15 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.9 m -70.68 124.38 24.14 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.357 1.063 . . . . 0.0 110.302 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.28 -16.3 49.42 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 -162.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.21 -82.01 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.792 1.796 . . . . 0.0 106.948 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -122.3 17.55 10.64 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 52.88 46.97 25.7 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -129.27 140.56 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.64 0.733 . . . . 0.0 112.466 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -87.72 109.25 19.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.622 0.769 . . . . 0.0 111.149 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.4 m -101.37 140.31 35.84 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.438 0.695 . . . . 0.0 111.603 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.8 80.41 7.27 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.459 1.123 . . . . 0.0 110.193 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.7 m -85.51 128.08 34.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.173 -0.954 . . . . 0.0 110.672 -166.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -116.5 118.51 32.86 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 t -112.66 125.05 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.8 m -135.78 156.78 48.28 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.961 0.886 . . . . 0.0 112.928 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.4 m95 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.356 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttp . . . . . 0 CA--C 1.557 1.228 0 CA-C-O 121.945 0.878 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.2 tp -85.85 106.02 16.76 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -94.67 129.99 41.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.955 0.902 . . . . 0.0 111.459 -172.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -125.06 127.35 46.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.651 0.78 . . . . 0.0 112.068 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.59 119.64 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -95.41 97.1 9.57 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -81.38 115.87 20.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 111.692 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.37 -126.13 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 O-C-N 122.11 -0.369 . . . . 0.0 113.292 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.36 -31.69 37.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.59 144.79 26.91 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.041 1.292 . . . . 0.0 113.084 -164.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -81.63 106.31 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.351 0.661 . . . . 0.0 112.081 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.92 53.6 14.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -89.96 124.7 34.96 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.303 0.641 . . . . 0.0 110.857 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.9 -166.95 38.02 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -160.17 157.28 28.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.255 1.026 . . . . 0.0 113.004 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -128.94 129.83 45.96 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.0 139.42 52.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -148.61 166.33 28.62 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 52.1 mt -106.44 122.91 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.501 -0.749 . . . . 0.0 109.349 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -110.87 86.87 2.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.534 -0.729 . . . . 0.0 109.907 164.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.24 -109.69 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.527 -0.733 . . . . 0.0 113.557 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.92 43.69 1.4 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 156.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.25 124.67 43.51 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.624 0.77 . . . . 0.0 109.634 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.71 113.37 25.44 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 121.737 0.78 . . . . 0.0 108.975 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.92 124.04 48.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.4 tp -125.02 125.97 44.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.725 0.81 . . . . 0.0 110.716 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -108.46 123.29 48.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.41 135.76 52.71 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.695 -0.628 . . . . 0.0 111.582 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -123.76 133.77 53.78 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 112.735 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.78 5.88 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.794 0.838 . . . . 0.0 110.214 173.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 56.29 41.49 29.09 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.91 -12.05 2.3 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 120.11 2.804 . . . . 0.0 120.11 -163.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.11 123.53 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 119.692 1.746 . . . . 0.0 109.69 -166.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 m -99.6 118.01 35.21 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.662 0.385 . . . . 0.0 110.341 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -99.51 122.78 43.08 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.144 0.578 . . . . 0.0 110.856 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -101.77 129.46 47.96 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.683 0.754 . . . . 0.0 111.441 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -137.85 131.71 31.48 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.989 0.916 . . . . 0.0 110.276 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.88 132.47 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 109.017 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -132.42 149.75 52.28 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.842 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -124.14 128.27 49.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.431 -1.418 . . . . 0.0 111.127 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -71.49 120.16 16.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.465 -0.772 . . . . 0.0 112.838 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.3 -38.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 CA--C 1.566 1.568 0 CA-C-N 119.702 1.137 . . . . 0.0 108.219 169.591 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 . . . . . 0 CA--C 1.565 1.528 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -80.64 6.32 13.04 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -59.34 112.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 121.422 1.919 . . . . 0.0 114.799 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.6 178.82 33.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -109.67 109.73 20.55 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.595 1.158 . . . . 0.0 109.043 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -112.48 110.04 19.99 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -168.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -86.57 137.72 32.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.103 -0.998 . . . . 0.0 113.193 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ttp -74.1 122.39 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.02 1.282 . . . . 0.0 114.043 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 mt -82.16 -53.76 5.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.424 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -130.91 154.72 47.8 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -172.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -136.94 109.45 7.42 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.761 0.824 . . . . 0.0 108.839 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -93.07 -64.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -124.91 44.94 2.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.68 0.752 . . . . 0.0 111.916 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 4.3 t80 -72.5 -38.56 68.09 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.8 -41.74 96.23 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -71.16 -40.01 71.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -53.17 -47.27 68.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.24 -37.76 71.98 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -55.84 -44.16 77.73 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 163.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.47 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.95 1.06 53.94 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.289 4.2 t70 64.2 49.83 2.54 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -168.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.59 145.89 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.94 0.876 . . . . 0.0 109.903 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -61.93 153.97 27.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.01 -47.5 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.5 62.68 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.0 tp -66.33 -25.67 66.93 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -64.95 -47.23 78.37 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.767 1.621 . . . . 0.0 113.86 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -50.98 67.32 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -53.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 124.097 0.959 . . . . 0.0 112.212 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.2 -35.88 78.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -69.08 -32.61 72.19 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.63 -28.65 62.88 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.22 135.04 48.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.061 1.3 . . . . 0.0 112.826 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.57 89.59 2.28 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.648 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.29 151.96 60.81 Favored 'Trans proline' 0 CA--C 1.561 1.858 0 CA-C-N 123.056 2.127 . . . . 0.0 115.371 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.66 115.49 30.34 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -84.26 107.54 16.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.456 -0.778 . . . . 0.0 110.495 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -94.54 110.25 22.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -105.71 126.25 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.7 t -112.02 108.95 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -106.13 111.34 23.92 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 121.931 0.872 . . . . 0.0 110.702 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -99.78 76.24 1.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.659 1.184 . . . . 0.0 109.459 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.96 -106.46 1.93 Allowed Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.067 -1.021 . . . . 0.0 114.682 -175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.85 -22.12 24.63 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 162.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -70.09 120.99 16.62 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 120.132 1.333 . . . . 0.0 111.712 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -136.54 122.73 20.44 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 121.498 0.666 . . . . 0.0 111.043 -163.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.4 mt -116.21 99.98 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -95.66 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -99.68 98.86 9.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -84.1 95.67 8.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 109.019 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -93.26 124.52 37.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.057 0.543 . . . . 0.0 111.149 -166.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 t -146.34 154.16 41.34 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.107 0.956 . . . . 0.0 111.83 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -61.86 -30.82 71.11 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -77.82 -52.38 9.0 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -153.67 138.43 17.04 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.175 0.898 . . . . 0.0 110.877 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -93.08 117.79 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.736 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -106.21 104.22 13.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.521 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.29 125.47 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.2 mtp -103.98 110.13 22.16 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.309 165.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.56 111.1 20.83 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.238 1.015 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.34 168.82 26.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -164.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -106.8 135.21 48.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.975 -1.078 . . . . 0.0 110.238 161.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.0 125.55 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 O-C-N 121.42 -0.8 . . . . 0.0 108.94 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.58 -35.08 4.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -155.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 138.48 34.1 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 118.383 1.092 . . . . 0.0 113.165 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -87.62 114.77 24.53 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 122.024 -0.423 . . . . 0.0 110.336 167.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.95 148.6 50.51 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.497 0.719 . . . . 0.0 112.567 -173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.77 99.7 4.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 112.083 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.54 109.01 20.3 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.485 -0.759 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -79.38 106.07 11.15 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.215 0.531 . . . . 0.0 110.284 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.93 49.59 1.76 Allowed 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -79.95 130.39 35.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 113.275 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.89 -50.51 0.96 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.4 -0.813 . . . . 0.0 114.744 -154.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.8 mt -78.43 -65.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 124.398 1.079 . . . . 0.0 110.838 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -147.06 7.66 0.92 Allowed 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.274 2.3 m-20 57.46 30.55 18.83 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -104.57 141.1 37.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 111.298 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.86 98.28 11.28 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.155 0.582 . . . . 0.0 109.591 173.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.24 146.01 28.61 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.428 0.632 . . . . 0.0 112.104 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -79.26 95.66 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.914 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.8 m -93.99 126.72 39.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.058 0.543 . . . . 0.0 110.149 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -116.63 130.4 56.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.4 t -116.69 130.3 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -125.58 139.82 53.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.076 0.951 . . . . 0.0 111.087 -175.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.5 m95 . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 112.611 177.09 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.391 0.615 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -98.51 114.71 27.22 Favored 'General case' 0 CA--C 1.561 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.171 169.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -117.15 129.24 55.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.147 0.579 . . . . 0.0 111.064 -163.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.43 ' SG ' HG22 ' A' ' 86' ' ' VAL . 53.5 t -130.37 145.56 51.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -121.74 135.34 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 124.175 0.99 . . . . 0.0 110.42 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.0 95.55 5.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.834 0.853 . . . . 0.0 109.734 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.25 124.37 33.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.642 -1.286 . . . . 0.0 112.843 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 -112.3 0.27 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 121.661 -0.649 . . . . 0.0 112.283 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -83.2 -10.05 58.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -113.16 143.97 43.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.549 1.522 . . . . 0.0 113.186 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -80.55 124.15 28.71 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.31 42.37 99.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 118.494 2.158 . . . . 0.0 118.494 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -91.36 134.08 34.91 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.843 0.83 . . . . 0.0 111.595 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.66 -163.83 32.49 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 121.882 0.712 . . . . 0.0 114.298 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -156.88 153.53 28.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -129.52 126.04 37.69 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.44 137.95 54.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -148.58 163.2 37.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 112.913 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.29 125.04 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.97 96.58 6.03 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.4 -109.0 2.67 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.374 -0.829 . . . . 0.0 113.882 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -109.75 25.71 11.48 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 158.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -108.81 123.63 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.917 1.235 . . . . 0.0 110.974 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -82.21 115.52 21.33 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.069 0.947 . . . . 0.0 109.151 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -102.16 115.45 30.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.4 123.15 49.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.809 0.843 . . . . 0.0 111.163 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.11 124.25 47.38 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 165.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.3 mtm -116.35 128.99 56.01 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.104 0.865 . . . . 0.0 110.904 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -116.18 136.78 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.55 120.42 8.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.594 0.757 . . . . 0.0 110.022 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 59.07 39.91 22.7 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.94 -34.87 1.25 Allowed Glycine 0 CA--C 1.558 2.749 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -161.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.08 118.36 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.008 1.323 . . . . 0.0 111.238 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.4 m -107.39 119.71 40.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.588 -168.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.461 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 11.8 t -94.36 126.13 39.42 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.531 0.732 . . . . 0.0 111.984 170.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -100.18 127.93 46.35 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.338 0.59 . . . . 0.0 111.751 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -127.64 137.12 52.44 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.899 0.88 . . . . 0.0 110.964 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.23 131.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.51 127.27 43.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.523 0.729 . . . . 0.0 110.319 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.79 123.38 41.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.762 -1.211 . . . . 0.0 111.559 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.55 115.85 8.41 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.237 0.926 . . . . 0.0 112.469 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.7 -36.96 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.588 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 171.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.548 0.213 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -76.56 -1.8 29.26 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -55.44 113.72 1.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 121.189 1.813 . . . . 0.0 114.7 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.69 -179.85 29.66 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-O 122.72 1.178 . . . . 0.0 115.53 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -113.2 118.91 36.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.311 1.044 . . . . 0.0 109.188 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -121.39 114.76 21.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -165.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -88.76 140.89 28.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.255 -0.903 . . . . 0.0 113.254 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.461 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 4.8 ttm -70.34 120.55 16.18 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.46 -45.24 16.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -153.58 159.09 42.07 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.236 1.38 . . . . 0.0 113.549 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -134.07 101.94 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.955 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.0 123.55 50.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.197 0.599 . . . . 0.0 111.001 -171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 29.6 t30 66.31 36.26 5.44 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 5.1 t80 -79.14 -39.16 34.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.54 -40.59 79.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -66.18 -41.53 90.13 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -55.99 -48.11 76.47 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.88 -40.62 75.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -55.31 -45.87 76.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.69 -20.99 24.53 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 164.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.8 mt -96.17 13.19 28.19 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.304 22.8 t70 60.74 56.48 2.96 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-N 120.709 1.595 . . . . 0.0 113.464 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -106.62 146.82 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 122.093 0.949 . . . . 0.0 110.165 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -64.04 153.01 38.71 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -61.25 -44.03 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.98 -52.12 64.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.81 -38.72 91.84 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -53.2 -53.03 56.68 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -62.46 -46.49 88.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.58 -57.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 123.729 0.812 . . . . 0.0 111.774 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.13 72.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -69.91 -36.83 75.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 165.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.1 mt -73.01 -24.52 60.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.78 143.22 49.61 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.152 1.342 . . . . 0.0 113.805 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -102.82 90.27 2.23 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.757 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 59.6 Cg_endo -69.31 155.74 66.53 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 123.054 2.127 . . . . 0.0 114.987 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.3 118.83 34.37 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -86.03 115.4 23.61 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.525 -0.735 . . . . 0.0 110.849 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -102.2 106.44 17.27 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mp -101.18 131.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.313 -0.867 . . . . 0.0 109.237 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.63 109.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.47 106.62 17.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.883 0.873 . . . . 0.0 110.082 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -99.37 80.4 2.41 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 123.57 0.748 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.89 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.513 -0.742 . . . . 0.0 114.189 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -93.07 -20.14 20.83 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 163.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -74.16 105.89 5.57 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.667 2.03 . . . . 0.0 111.211 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.5 ttm -116.73 124.85 50.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.59 0.756 . . . . 0.0 110.557 -170.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.03 98.39 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.2 mt -94.32 110.83 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.29 96.09 6.12 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.1 m -85.78 99.11 11.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 108.79 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.18 115.93 28.46 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.832 -0.542 . . . . 0.0 111.343 -164.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 t -134.3 151.82 51.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.766 0.793 . . . . 0.0 110.521 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -64.05 -29.33 70.48 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.73 -51.31 28.16 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 167.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.88 134.93 13.92 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.38 0.991 . . . . 0.0 111.213 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.44 118.76 30.83 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 123.781 0.832 . . . . 0.0 109.555 170.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -102.81 116.84 33.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 110.4 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.27 117.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.9 mtp -105.6 105.31 15.28 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -108.36 108.82 19.95 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.575 0.75 . . . . 0.0 109.555 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.85 155.93 33.8 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -90.48 126.74 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.7 165.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.89 121.77 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 168.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.54 -35.13 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 -156.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.44 140.99 32.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.491 1.145 . . . . 0.0 113.3 -165.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -86.3 108.37 18.38 Favored 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 122.818 0.447 . . . . 0.0 110.387 166.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -119.92 143.4 48.0 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.673 0.789 . . . . 0.0 112.504 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.35 97.7 2.55 Favored 'General case' 0 CA--C 1.567 1.609 0 O-C-N 120.935 -1.103 . . . . 0.0 112.609 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -93.51 113.47 25.61 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.452 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.28 105.07 12.18 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.734 0.414 . . . . 0.0 110.752 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.55 52.32 2.31 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -83.58 132.43 34.91 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.089 0.947 . . . . 0.0 111.647 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.58 -62.17 0.38 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.273 -151.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mt -72.11 -70.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.559 1.144 . . . . 0.0 110.202 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -136.08 9.79 3.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 169.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 58.84 45.19 15.73 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -135.17 143.77 46.66 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.725 0.774 . . . . 0.0 111.282 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -88.0 126.24 34.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.624 -0.672 . . . . 0.0 111.341 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -122.66 140.64 52.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.156 0.582 . . . . 0.0 111.142 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.11 97.18 5.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 168.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.6 m -95.55 123.25 39.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.42 0.688 . . . . 0.0 110.218 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 m -107.43 126.8 52.96 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 168.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.19 135.86 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -149.95 152.43 34.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.443 -1.411 . . . . 0.0 112.729 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.5 m95 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 120.861 -1.149 . . . . 0.0 112.653 178.278 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.426 0.632 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.73 105.09 16.71 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -109.76 136.1 49.63 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.606 0.762 . . . . 0.0 111.377 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -134.93 138.17 43.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.36 133.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 123.715 0.806 . . . . 0.0 110.242 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -112.56 98.52 7.3 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.626 0.771 . . . . 0.0 109.575 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.31 117.02 27.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.424 -0.798 . . . . 0.0 111.749 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.27 -131.12 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 O-C-N 121.233 -0.917 . . . . 0.0 113.619 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.05 -34.81 69.05 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -96.34 140.0 31.64 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.226 1.012 . . . . 0.0 112.315 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.45 122.56 26.58 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -165.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.06 52.27 53.83 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -93.41 138.87 31.31 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.723 0.773 . . . . 0.0 111.707 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.96 -168.54 35.72 Favored Glycine 0 N--CA 1.485 1.911 0 CA-C-O 121.918 0.732 . . . . 0.0 114.722 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -156.49 153.64 29.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.6 m -128.52 123.12 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -123.57 131.75 53.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.699 0.8 . . . . 0.0 111.397 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -148.89 175.43 11.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.239 -0.913 . . . . 0.0 112.76 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.78 135.8 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.916 -1.115 . . . . 0.0 109.262 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.57 93.12 3.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 165.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.74 -120.04 5.26 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.873 -0.517 . . . . 0.0 113.351 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.43 41.27 1.25 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 161.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -131.1 118.67 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.348 0.659 . . . . 0.0 109.399 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.31 122.31 26.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.891 0.876 . . . . 0.0 110.437 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -112.91 119.79 39.17 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.2 tp -124.61 124.86 43.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.643 0.777 . . . . 0.0 110.53 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.95 121.31 42.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 165.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.7 mtm -110.62 127.46 55.26 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.905 0.775 . . . . 0.0 110.318 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -119.2 145.41 46.06 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.98 122.53 2.59 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.067 0.547 . . . . 0.0 110.75 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.299 7.1 mt-10 50.88 50.82 18.28 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.88 -28.77 2.78 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 120.162 2.825 . . . . 0.0 120.162 -169.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -76.05 156.0 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.817 1.309 . . . . 0.0 112.075 -171.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -123.54 127.51 48.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.0 110.688 168.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 17.5 t -94.24 136.86 34.07 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.999 0.52 . . . . 0.0 111.199 156.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -114.64 123.94 50.58 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.072 0.549 . . . . 0.0 110.272 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -121.12 135.13 55.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.72 -0.612 . . . . 0.0 111.17 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.12 129.3 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -133.27 136.78 45.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.525 -0.734 . . . . 0.0 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -103.62 133.24 48.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.308 -1.495 . . . . 0.0 112.676 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -69.14 122.89 19.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.6 m -117.53 -37.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 119.761 1.164 . . . . 0.0 107.93 170.413 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.258 46.7 t0 . . . . . 0 CA--C 1.569 1.687 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.97 6.07 14.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.32 108.85 0.99 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.481 1.492 . . . . 0.0 114.652 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.87 -179.64 33.44 Favored Glycine 0 N--CA 1.485 1.958 0 CA-C-O 122.807 1.226 . . . . 0.0 115.58 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -107.5 118.22 36.15 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.45 1.1 . . . . 0.0 109.274 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -117.12 111.75 19.93 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -168.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -85.3 139.03 31.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 112.765 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 30.6 ttm -65.92 124.99 24.0 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 120.092 1.315 . . . . 0.0 114.355 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -86.08 -43.99 12.63 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -153.0 156.9 39.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.366 -1.459 . . . . 0.0 113.408 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -131.35 109.23 10.2 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.922 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.06 121.09 38.11 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.272 0.629 . . . . 0.0 110.499 -168.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 30.3 t30 68.01 31.83 5.34 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 9.1 t80 -78.43 -38.46 41.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.93 -41.45 74.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.0 -37.85 78.94 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -55.1 -47.38 75.04 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 120.26 1.391 . . . . 0.0 114.658 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.96 -40.59 71.87 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -54.68 -42.86 71.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 165.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 -29.15 60.78 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.4 -0.71 53.75 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 17.2 t0 66.71 48.12 1.45 Allowed 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 144.47 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.985 172.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -64.53 155.0 34.34 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 171.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.94 -43.84 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.67 50.27 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.33 -37.42 85.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -56.78 -51.7 67.89 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 165.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -62.94 -46.74 86.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.45 -56.9 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.042 0.837 . . . . 0.0 111.719 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.39 -27.98 67.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -75.19 -33.67 61.45 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.63 -34.16 76.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 166.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.36 130.28 40.95 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.176 0.988 . . . . 0.0 112.278 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.39 100.01 9.63 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.838 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 38.1 Cg_endo -66.8 154.89 72.98 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 CA-C-N 123.466 2.274 . . . . 0.0 114.967 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -108.24 119.63 40.03 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -89.46 113.85 25.27 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.358 -0.839 . . . . 0.0 110.863 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.78 106.97 19.3 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.807 -0.558 . . . . 0.0 109.545 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -102.24 130.6 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.58 108.79 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 167.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -94.59 102.63 14.56 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.393 0.677 . . . . 0.0 110.064 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 74.05 3.02 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 121.492 0.663 . . . . 0.0 110.4 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 -103.48 0.98 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.592 -0.692 . . . . 0.0 114.591 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.62 -32.49 23.69 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 165.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -80.17 104.2 10.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.623 1.556 . . . . 0.0 110.998 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp -114.33 132.14 56.29 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 122.295 1.045 . . . . 0.0 111.47 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.31 99.73 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.78 110.26 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -103.6 101.61 11.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.726 -0.608 . . . . 0.0 109.476 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -86.13 102.76 14.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.48 130.24 49.23 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.931 0.492 . . . . 0.0 111.494 -166.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.6 t -149.17 155.15 40.22 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.117 0.96 . . . . 0.0 111.675 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.2 p -62.02 -32.56 73.07 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.81 -50.55 13.19 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -151.82 136.85 17.33 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 119.388 0.994 . . . . 0.0 112.273 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -94.08 136.82 33.96 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 121.738 -0.601 . . . . 0.0 110.98 166.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -128.26 113.44 15.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 110.807 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.98 129.57 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 123.478 0.711 . . . . 0.0 109.467 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtp -108.59 108.04 18.77 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.639 0.776 . . . . 0.0 110.005 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.03 118.12 35.18 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.137 0.975 . . . . 0.0 111.825 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.2 149.55 22.97 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -165.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -94.46 127.23 40.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 0.0 111.095 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.87 130.62 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 123.332 0.653 . . . . 0.0 111.209 -174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.14 -36.19 4.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -162.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.18 140.46 29.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.579 1.189 . . . . 0.0 112.813 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -87.14 114.82 24.08 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.804 -0.56 . . . . 0.0 110.877 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -121.71 139.23 53.83 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 111.92 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.45 90.58 2.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.11 . . . . 0.0 113.431 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -92.15 113.24 25.45 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.406 -0.808 . . . . 0.0 110.72 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.54 127.77 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.35 1.072 . . . . 0.0 111.209 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.15 49.38 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.616 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.3 t -71.76 137.19 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.418 1.087 . . . . 0.0 113.314 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.66 -57.0 0.98 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 120.862 -0.685 . . . . 0.0 114.083 -154.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -79.56 -67.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.649 1.18 . . . . 0.0 110.169 -171.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.84 25.35 0.84 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 160.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.301 0.9 OUTLIER 61.41 8.01 2.0 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -82.3 139.58 34.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.806 -1.184 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -92.87 108.57 20.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.3 m -112.77 124.0 51.59 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.654 0.74 . . . . 0.0 110.751 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtp -72.55 92.56 1.5 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.585 1.184 . . . . 0.0 111.043 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -100.98 123.98 46.0 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.268 -157.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.6 m -104.66 119.49 39.11 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.41 HG22 ' SG ' ' A' ' 95' ' ' CYS . 30.0 t -104.93 127.76 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.8 m -129.44 155.32 45.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 112.422 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 74.4 m95 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.0 111.71 172.199 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.667 0.746 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -92.87 98.08 11.15 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.169 0.588 . . . . 0.0 109.585 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -102.02 131.05 48.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.511 0.724 . . . . 0.0 110.963 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 86' ' ' VAL . 51.9 t -128.81 142.17 51.06 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.93 126.12 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.768 0.827 . . . . 0.0 109.445 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.69 96.47 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.139 0.976 . . . . 0.0 109.069 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -96.27 116.32 28.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.177 -0.952 . . . . 0.0 111.985 -166.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.97 -105.93 0.19 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.297 -0.877 . . . . 0.0 112.792 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -79.09 -30.43 43.88 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.53 141.3 40.62 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.864 1.211 . . . . 0.0 113.018 -162.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.43 111.93 16.18 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.78 46.03 92.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 117.727 1.851 . . . . 0.0 117.727 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -83.44 137.98 33.67 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 118.282 1.041 . . . . 0.0 111.064 172.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.98 -163.49 34.48 Favored Glycine 0 N--CA 1.483 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 114.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.275 63.4 p-90 -158.06 169.06 25.41 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.547 1.165 . . . . 0.0 113.69 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.7 m -146.87 119.55 8.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.054 -1.654 . . . . 0.0 109.032 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -116.25 135.04 54.25 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -147.8 171.9 14.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.556 -0.715 . . . . 0.0 112.776 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.91 128.53 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.345 -0.847 . . . . 0.0 109.37 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.14 87.51 2.73 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.936 0.874 . . . . 0.0 110.281 166.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.12 -116.49 4.27 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.724 -0.61 . . . . 0.0 113.246 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -94.17 24.61 4.25 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 160.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.51 125.64 50.3 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.725 1.148 . . . . 0.0 111.349 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.03 120.31 25.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.36 0.664 . . . . 0.0 109.852 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.78 118.76 37.02 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.1 tp -125.94 122.21 35.34 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.593 0.757 . . . . 0.0 110.448 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.99 126.7 47.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.201 0.6 . . . . 0.0 109.535 167.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.1 mtp -122.68 123.87 42.12 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.983 0.913 . . . . 0.0 110.448 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -121.98 135.17 54.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 111.814 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.32 124.38 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.186 0.594 . . . . 0.0 110.737 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 56.29 41.36 29.26 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.07 -20.48 1.52 Allowed Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.702 2.641 . . . . 0.0 119.702 -164.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 51.0 t -80.43 118.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.723 1.761 . . . . 0.0 109.82 -169.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.5 m -99.53 124.33 44.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.797 0.808 . . . . 0.0 111.264 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.429 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 10.4 t -99.08 130.28 45.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.28 1.032 . . . . 0.0 110.894 168.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -105.31 117.86 35.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 110.568 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -117.47 125.33 50.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.554 0.742 . . . . 0.0 109.771 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.81 129.83 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.9 149.63 52.23 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 123.435 0.694 . . . . 0.0 111.453 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -115.54 132.53 56.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.106 -1.621 . . . . 0.0 112.252 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -69.3 124.8 24.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.38 -40.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 . . . . . 0 CA--C 1.562 1.435 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.663 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 t0 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.159 0.504 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -83.39 0.83 44.29 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -58.87 106.29 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 121.27 1.85 . . . . 0.0 114.791 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.89 176.87 32.45 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-O 122.825 1.236 . . . . 0.0 115.83 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -105.45 120.54 41.88 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.439 1.096 . . . . 0.0 109.9 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -119.53 113.23 20.42 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -92.07 140.32 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.741 -1.224 . . . . 0.0 113.197 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.7 ttp -73.52 123.58 24.21 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.654 1.57 . . . . 0.0 114.388 -171.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.01 -52.69 6.11 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.158 0.983 . . . . 0.0 113.465 169.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -136.96 154.47 50.42 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -138.72 106.88 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.213 0.605 . . . . 0.0 109.819 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.99 121.92 41.88 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.622 0.769 . . . . 0.0 110.186 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 27.7 t30 63.44 32.98 14.06 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -79.39 -46.61 17.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.491 -1.381 . . . . 0.0 114.411 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -58.45 -39.13 79.04 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.73 -40.81 84.15 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -56.66 -49.15 75.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 164.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.9 -37.81 88.89 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -52.29 -47.37 65.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 162.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.24 -18.52 61.42 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.18 4.16 52.95 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.263 5.8 t70 66.24 46.63 2.0 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -171.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.07 142.57 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.748 0.785 . . . . 0.0 109.46 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -64.43 154.61 35.17 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.44 -46.05 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.82 -50.23 69.09 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 tp -64.2 -35.49 80.98 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -57.13 -42.1 80.3 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 163.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.56 -43.86 75.71 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -64.04 -56.56 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 123.927 0.891 . . . . 0.0 111.821 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.95 77.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -71.26 -30.16 65.96 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.76 -30.74 64.38 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 167.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.98 140.27 50.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.666 1.121 . . . . 0.0 113.569 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -94.05 100.45 4.87 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.443 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.75 157.27 60.97 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 123.248 2.196 . . . . 0.0 114.152 167.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -128.11 118.12 22.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.315 -1.491 . . . . 0.0 108.793 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -86.07 109.26 18.71 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.714 -0.616 . . . . 0.0 111.005 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.68 107.44 19.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 168.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.1 mt -104.08 127.35 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.5 t -112.36 107.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -102.39 97.42 7.67 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.912 0.885 . . . . 0.0 109.888 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.46 78.44 4.99 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.379 -0.825 . . . . 0.0 110.129 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 -103.7 1.1 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.881 -0.512 . . . . 0.0 114.374 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.5 -26.21 32.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 164.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -81.22 105.78 12.69 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.374 1.443 . . . . 0.0 111.552 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -109.86 122.13 46.81 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.155 0.978 . . . . 0.0 111.203 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -114.48 97.29 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.3 mt -91.54 109.44 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -102.72 99.01 8.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -86.05 98.04 10.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 108.756 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -95.93 115.44 27.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.7 -0.625 . . . . 0.0 110.203 -165.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 t -133.41 152.61 51.93 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.735 0.778 . . . . 0.0 110.72 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.9 p -63.1 -29.38 70.76 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -75.94 -49.52 17.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -154.61 135.06 13.37 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 119.414 1.006 . . . . 0.0 111.604 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -85.99 117.32 24.76 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.432 0.693 . . . . 0.0 110.222 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -106.14 103.95 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.363 -0.835 . . . . 0.0 110.374 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.72 124.17 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -102.93 107.4 18.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.646 0.778 . . . . 0.0 109.375 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -108.09 110.29 21.93 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.721 0.808 . . . . 0.0 109.83 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.36 160.27 41.61 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -101.94 138.22 39.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 110.969 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.33 133.56 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.31 -25.33 27.4 Favored Glycine 0 CA--C 1.552 2.387 0 N-CA-C 117.73 1.852 . . . . 0.0 117.73 -164.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -101.98 134.26 45.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.178 1.489 . . . . 0.0 111.04 -158.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -83.06 103.15 12.28 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.999 0.52 . . . . 0.0 111.231 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.96 138.73 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.442 0.697 . . . . 0.0 112.286 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.98 96.49 1.04 Allowed 'General case' 0 CA--C 1.57 1.719 0 O-C-N 120.955 -1.091 . . . . 0.0 112.953 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -89.88 113.12 24.67 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.25 108.69 15.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.872 -0.518 . . . . 0.0 109.644 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mp -85.2 56.22 3.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.161 0.981 . . . . 0.0 113.474 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.0 t -78.32 129.16 34.69 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.508 1.147 . . . . 0.0 112.846 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.31 -42.2 2.01 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.3 -88.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -113.49 7.59 17.54 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 57.11 44.63 22.18 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -137.17 142.98 42.17 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.53 131.27 34.99 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.273 0.629 . . . . 0.0 112.5 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.2 125.92 27.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.102 0.561 . . . . 0.0 111.343 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 mmt -68.38 100.97 1.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.672 1.225 . . . . 0.0 110.555 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 m -100.46 122.22 42.84 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.755 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -110.93 118.58 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 t -109.91 121.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.4 m -127.83 147.4 50.44 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.843 0.857 . . . . 0.0 112.359 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.8 m95 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 120.985 -1.072 . . . . 0.0 112.234 174.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.604 0.716 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -87.68 113.32 23.25 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 121.387 -0.82 . . . . 0.0 109.955 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -100.41 137.62 38.58 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.958 0.903 . . . . 0.0 111.735 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.4 t -131.64 136.87 48.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.364 0.666 . . . . 0.0 112.636 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.3 123.69 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.413 0.685 . . . . 0.0 109.776 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -99.8 98.38 9.19 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.513 1.125 . . . . 0.0 109.472 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -89.74 115.21 26.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 111.445 -171.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.35 -112.59 0.27 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 121.767 -0.583 . . . . 0.0 112.457 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.18 -31.21 23.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -96.99 142.55 28.81 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.387 1.089 . . . . 0.0 113.797 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.53 106.77 11.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.044 -172.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.34 66.33 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -172.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -82.14 133.31 35.26 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.194 0.598 . . . . 0.0 110.823 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.43 -159.48 31.2 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -160.38 160.13 31.92 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.315 1.055 . . . . 0.0 112.92 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.3 m -133.04 128.45 36.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.113 -0.992 . . . . 0.0 108.396 170.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.77 138.48 53.37 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.7 163.85 37.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.3 mt -102.63 126.73 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.328 -0.857 . . . . 0.0 109.878 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.71 90.21 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.805 0.812 . . . . 0.0 110.175 164.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.14 -116.02 4.18 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 121.639 -0.663 . . . . 0.0 113.445 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -90.84 18.91 5.99 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 161.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -118.45 122.33 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.451 1.478 . . . . 0.0 111.113 -166.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.3 tp -82.85 111.89 19.16 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -98.04 119.39 36.59 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.63 117.8 26.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.601 0.76 . . . . 0.0 110.234 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.93 131.65 39.16 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.088 0.555 . . . . 0.0 109.781 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.0 mtp -127.07 121.44 31.54 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.444 0.698 . . . . 0.0 109.571 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -117.25 137.76 52.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 112.87 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.32 115.12 5.28 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 0.0 111.009 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.26 3.1 mt-10 58.14 44.65 18.77 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.24 -28.99 0.98 Allowed Glycine 0 CA--C 1.559 2.789 0 N-CA-C 119.172 2.429 . . . . 0.0 119.172 -162.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.5 t -71.69 115.26 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.752 1.221 . . . . 0.0 110.198 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.8 m -106.1 117.52 34.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.261 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 t -89.91 134.82 34.0 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.314 0.646 . . . . 0.0 111.448 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -109.68 118.61 37.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.756 -0.59 . . . . 0.0 110.809 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -116.66 137.06 52.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.65 0.78 . . . . 0.0 110.183 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.03 130.01 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -126.61 131.15 51.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.654 -0.654 . . . . 0.0 110.994 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -94.72 130.33 41.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.731 -1.231 . . . . 0.0 112.217 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -64.91 123.86 20.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.69 -36.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 120.228 1.377 . . . . 0.0 108.04 171.564 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 CA--C 1.561 1.387 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -76.47 -0.9 24.66 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -58.96 114.34 2.52 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 122.029 2.195 . . . . 0.0 114.407 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.03 177.7 28.58 Favored Glycine 0 N--CA 1.486 2.002 0 CA-C-O 122.925 1.292 . . . . 0.0 115.811 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -110.75 111.16 22.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.478 1.111 . . . . 0.0 108.904 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -114.16 111.82 22.19 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -166.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.56 142.43 27.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 112.815 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.5 ttp -72.18 121.61 19.62 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.834 1.197 . . . . 0.0 113.53 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.8 mt -81.88 -44.43 16.86 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 169.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.2 m -154.11 160.65 42.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.458 -1.401 . . . . 0.0 113.343 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.65 120.47 17.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.137 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.94 120.74 31.17 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 110.185 -170.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 32.6 t30 65.86 36.57 5.99 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.594 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 6.3 t80 -81.62 -42.34 20.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.14 -34.82 74.07 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.47 -44.78 70.48 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.018 1.736 . . . . 0.0 114.651 165.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -55.05 -45.45 75.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.73 -37.45 73.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.23 -43.73 87.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.2 -1.562 . . . . 0.0 114.848 163.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.27 24.84 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 163.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.0 mt -96.7 9.41 41.73 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 22.9 t70 62.61 59.93 1.4 Allowed 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 120.438 1.472 . . . . 0.0 113.145 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.98 139.08 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.616 0.722 . . . . 0.0 110.106 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.56 150.84 47.74 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.58 -47.01 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -49.98 70.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.23 -42.53 99.4 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 171.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -56.83 -48.57 77.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 121.304 1.866 . . . . 0.0 115.741 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.32 -43.32 99.06 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.56 -54.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 118.842 0.746 . . . . 0.0 111.691 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.52 78.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -66.77 -33.84 76.5 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 167.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.1 -25.08 58.23 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -70.68 147.74 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.365 1.439 . . . . 0.0 114.517 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -100.24 95.83 4.5 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.091 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.61 141.49 46.0 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.479 2.119 . . . . 0.0 113.786 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.39 114.53 23.67 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -87.02 109.42 19.38 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.726 -0.609 . . . . 0.0 110.924 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.52 105.31 17.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 167.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mt -104.26 129.69 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.9 t -112.37 106.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -101.54 103.5 14.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.247 0.619 . . . . 0.0 109.781 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.65 72.0 5.85 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.39 -94.3 0.47 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.83 -25.11 17.5 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 166.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -83.63 116.42 22.61 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.416 1.462 . . . . 0.0 111.077 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.3 ttm -126.51 124.5 40.19 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.558 0.694 . . . . 0.0 110.945 -165.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.76 101.67 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.73 111.32 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -104.86 96.17 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 m -82.8 99.17 9.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 0.0 108.871 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.21 121.27 37.8 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.322 0.582 . . . . 0.0 110.401 -168.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -139.52 153.45 47.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.632 0.729 . . . . 0.0 110.67 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -63.6 -28.9 70.24 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.29 -52.55 10.58 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 170.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -156.04 136.75 13.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 119.461 1.028 . . . . 0.0 111.277 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.8 121.0 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.572 0.749 . . . . 0.0 110.111 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -109.72 116.74 32.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 110.366 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mm -110.64 119.66 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.2 mtp -107.33 104.17 13.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.825 -0.547 . . . . 0.0 110.082 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -110.14 115.75 30.29 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.074 0.95 . . . . 0.0 111.615 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -158.39 153.34 25.17 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -93.04 134.09 35.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.09 -1.007 . . . . 0.0 110.455 161.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.11 124.69 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.385 -0.822 . . . . 0.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.14 -38.32 3.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -155.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.94 133.76 35.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 117.959 0.88 . . . . 0.0 113.279 -161.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.46 102.58 12.18 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 121.953 -0.467 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -116.29 144.34 44.36 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.623 0.769 . . . . 0.0 112.173 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.59 92.21 3.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.597 -1.314 . . . . 0.0 113.197 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.17 118.9 24.42 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.388 -0.82 . . . . 0.0 110.767 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -76.8 127.81 33.45 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.759 -0.588 . . . . 0.0 110.518 161.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.3 55.29 0.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.553 0.692 . . . . 0.0 112.571 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.8 t -82.87 131.01 35.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 112.521 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -49.8 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.297 -0.877 . . . . 0.0 114.642 -155.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -78.34 -72.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.443 1.097 . . . . 0.0 109.902 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -135.34 -2.54 2.48 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.288 1.7 m-20 58.71 45.0 16.44 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -116.07 139.99 49.73 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.779 0.831 . . . . 0.0 110.993 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -83.54 124.24 30.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.108 0.48 . . . . 0.0 110.464 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 83.7 m -124.42 122.24 37.12 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.262 0.625 . . . . 0.0 110.851 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.73 99.05 2.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.292 1.044 . . . . 0.0 109.996 173.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.9 m -111.56 121.04 44.09 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.87 -158.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -104.76 120.66 41.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.74 128.04 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.9 m -132.75 145.72 51.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.595 0.758 . . . . 0.0 111.631 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m95 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.343 173.287 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.664 0.745 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.9 tp -89.44 105.76 18.0 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.815 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.26 147.82 24.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.058 0.943 . . . . 0.0 111.964 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.8 t -141.57 135.83 30.46 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.89 126.54 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.541 0.736 . . . . 0.0 109.046 163.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -102.53 108.13 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.518 0.727 . . . . 0.0 109.527 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -86.39 101.96 13.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.801 -1.187 . . . . 0.0 110.453 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.28 92.81 0.09 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.311 79.9 mt-10 70.11 -46.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -106.74 151.47 25.09 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.506 1.146 . . . . 0.0 113.191 -153.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -86.72 107.64 18.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.586 -0.697 . . . . 0.0 111.89 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.64 55.61 8.31 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -95.57 129.1 42.87 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 122.967 0.507 . . . . 0.0 111.719 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.22 -147.78 13.4 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -160.98 161.44 31.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.959 0.885 . . . . 0.0 112.958 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.2 m -134.97 123.38 23.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -123.29 131.96 53.85 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.508 0.723 . . . . 0.0 111.287 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.97 169.24 20.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.877 -1.139 . . . . 0.0 113.209 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -113.48 128.01 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -113.28 90.03 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.87 -113.13 4.06 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.46 -0.775 . . . . 0.0 114.819 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -88.25 4.4 45.97 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.46 131.65 54.06 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 120.037 1.289 . . . . 0.0 112.365 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.43 122.0 35.4 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -111.52 123.05 49.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.9 tp -123.4 121.14 35.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.351 0.661 . . . . 0.0 111.07 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.46 129.71 42.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.404 0.681 . . . . 0.0 110.235 163.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.6 mtm -119.69 130.85 55.23 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.736 0.698 . . . . 0.0 110.722 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -125.47 133.31 52.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 112.609 -164.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.28 131.88 7.69 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 55.02 38.78 31.08 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.36 3.72 Favored Glycine 0 CA--C 1.559 2.786 0 N-CA-C 120.182 2.833 . . . . 0.0 120.182 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.66 121.8 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 119.87 1.835 . . . . 0.0 108.6 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.2 m -98.59 124.37 43.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 121.671 0.748 . . . . 0.0 110.691 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.594 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 11.2 t -92.74 143.79 25.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.686 . . . . 0.0 111.345 160.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.8 122.87 44.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.937 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -115.34 130.8 57.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.73 132.11 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -128.97 159.29 36.34 Favored 'General case' 0 CA--C 1.574 1.887 0 C-N-CA 124.437 1.095 . . . . 0.0 111.206 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -130.94 132.11 44.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.534 -1.354 . . . . 0.0 111.846 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.51 116.17 10.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.18 -33.96 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t60 . . . . . 0 CA--C 1.562 1.414 0 CA-C-N 119.951 1.25 . . . . 0.0 107.993 170.017 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 t0 . . . . . 0 CA--C 1.564 1.506 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.8 -4.0 44.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -54.84 108.86 0.44 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 121.285 1.857 . . . . 0.0 115.136 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.56 -175.99 35.55 Favored Glycine 0 CA--C 1.546 2.017 0 CA-C-O 122.829 1.238 . . . . 0.0 115.828 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -117.51 118.06 31.14 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.311 1.045 . . . . 0.0 109.356 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -121.54 117.13 26.02 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.69 -0.631 . . . . 0.0 109.582 -164.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -84.99 147.07 26.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 0.0 113.537 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 31.9 ttm -70.61 128.93 37.78 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 120.372 1.442 . . . . 0.0 113.459 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.38 -45.71 9.76 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -157.3 156.13 31.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.255 1.843 . . . . 0.0 114.458 173.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -104.75 123.29 47.39 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.761 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.97 -66.74 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -126.44 39.16 3.99 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.206 0.602 . . . . 0.0 112.114 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -70.58 -36.84 73.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.77 -47.32 70.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.56 -37.72 77.12 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -52.94 -48.11 67.56 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 120.838 1.654 . . . . 0.0 114.049 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.0 -35.83 69.57 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -54.0 -46.03 71.64 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.605 1.548 . . . . 0.0 114.899 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.63 -23.4 58.92 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.75 -9.54 59.3 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 166.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.329 16.9 t70 71.93 48.71 0.27 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.489 1.516 . . . . 0.0 114.763 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.5 t -89.94 149.79 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 122.289 1.042 . . . . 0.0 110.561 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -62.95 149.09 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -60.64 -40.8 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.18 -55.31 34.71 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.64 -41.99 91.76 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -53.22 -51.96 60.46 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 168.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -65.61 -41.76 92.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.76 -58.13 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.332 0.969 . . . . 0.0 111.519 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.08 74.23 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.09 -28.82 63.56 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 166.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.85 -23.6 39.0 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 mt -69.93 149.51 47.71 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.673 1.578 . . . . 0.0 114.681 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -101.84 91.04 2.14 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.212 171.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 92.7 Cg_endo -75.18 152.35 39.85 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.532 2.154 . . . . 0.0 114.224 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -109.4 117.74 34.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.351 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -84.84 111.94 20.09 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.328 -0.857 . . . . 0.0 110.746 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 107.95 19.75 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.759 -0.588 . . . . 0.0 109.632 165.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -102.92 127.35 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.46 106.32 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 170.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.48 105.58 17.57 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.157 0.583 . . . . 0.0 110.159 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -95.3 79.9 3.51 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.53 0.681 . . . . 0.0 109.751 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.93 -105.06 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.21 -26.67 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 165.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -82.11 107.06 14.51 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.515 1.507 . . . . 0.0 111.49 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.4 ttm -108.44 124.64 50.72 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.999 0.92 . . . . 0.0 111.04 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.48 102.22 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.68 107.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -100.13 101.49 12.55 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -85.1 101.18 12.23 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 mt -99.03 121.33 40.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.899 0.48 . . . . 0.0 111.506 -164.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.8 t -144.41 150.61 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.908 0.861 . . . . 0.0 111.304 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.9 p -63.21 -31.19 72.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -71.04 -52.47 19.34 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -155.39 135.94 13.36 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.94 0.791 . . . . 0.0 110.857 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -88.53 127.77 35.55 Favored 'General case' 0 CA--C 1.568 1.636 0 O-C-N 121.876 -0.515 . . . . 0.0 110.582 167.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -110.14 123.42 49.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.585 -0.697 . . . . 0.0 110.857 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.69 121.09 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -112.46 104.51 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -108.78 110.43 21.81 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.63 0.772 . . . . 0.0 108.926 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -153.67 154.84 34.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -167.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -100.13 125.86 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.728 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.49 125.87 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.639 -0.663 . . . . 0.0 110.811 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.52 -38.86 3.12 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 116.723 1.449 . . . . 0.0 116.723 -161.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -85.47 146.97 26.69 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 118.405 1.102 . . . . 0.0 113.919 -172.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -93.58 112.97 24.97 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.979 0.512 . . . . 0.0 110.003 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -120.82 148.52 43.9 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.985 0.914 . . . . 0.0 112.473 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -70.46 103.04 2.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.662 -1.274 . . . . 0.0 111.757 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -89.99 113.99 25.76 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.17 0.588 . . . . 0.0 109.892 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.94 122.49 24.24 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 121.082 0.468 . . . . 0.0 110.237 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -105.15 44.18 1.05 Allowed 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -81.0 132.67 35.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.952 -1.093 . . . . 0.0 111.366 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.33 -57.65 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.811 -151.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.8 mt -74.42 -63.41 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.76 17.56 1.27 Allowed 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 159.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.05 42.2 31.12 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -111.24 145.1 39.33 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.662 0.785 . . . . 0.0 111.342 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -90.38 117.6 29.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.04 . . . . 0.0 110.013 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.0 m -111.07 144.1 40.72 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.11 90.3 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.55 168.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.0 m -90.69 129.93 36.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 -172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 m -116.63 125.37 51.68 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.438 HG22 ' SG ' ' A' ' 95' ' ' CYS . 40.6 t -115.39 128.76 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.6 m -132.63 148.92 52.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.196 -0.94 . . . . 0.0 112.377 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.824 -1.172 . . . . 0.0 113.344 177.592 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 121.93 0.872 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.6 111.65 23.05 Favored 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -114.83 128.43 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.507 0.723 . . . . 0.0 110.532 -161.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 86' ' ' VAL . 54.1 t -130.67 142.86 50.44 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.2 129.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.493 164.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -103.93 95.9 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -88.72 115.91 26.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.941 -1.099 . . . . 0.0 112.015 -167.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.18 -126.64 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 O-C-N 121.248 -0.907 . . . . 0.0 114.164 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.63 -32.1 65.64 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -103.99 138.65 40.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.823 1.192 . . . . 0.0 111.784 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.41 142.6 30.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.55 45.93 94.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 117.551 1.78 . . . . 0.0 117.551 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -99.95 130.92 46.17 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 121.698 0.761 . . . . 0.0 111.032 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.68 -166.4 34.75 Favored Glycine 0 N--CA 1.482 1.748 0 CA-C-O 121.806 0.67 . . . . 0.0 114.415 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -157.96 156.45 31.25 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.0 m -133.37 124.66 27.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.54 128.78 48.5 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.646 0.778 . . . . 0.0 111.336 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -146.32 169.26 19.18 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.113 -0.992 . . . . 0.0 113.191 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.2 mt -109.1 124.44 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.34 86.78 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.388 163.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.87 -110.54 3.25 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 121.231 -0.918 . . . . 0.0 115.045 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.66 -6.03 59.34 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 162.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.0 137.26 39.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.697 1.589 . . . . 0.0 112.826 -172.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.06 120.17 36.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.612 0.765 . . . . 0.0 109.04 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -110.11 117.58 34.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.2 tp -121.0 117.08 26.36 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.471 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.99 129.7 40.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.955 0.502 . . . . 0.0 109.867 166.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.8 mtp -124.45 123.43 40.14 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.742 0.817 . . . . 0.0 110.089 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -114.29 140.23 48.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.615 -0.678 . . . . 0.0 112.461 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.11 120.13 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.585 0.754 . . . . 0.0 109.506 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 58.56 41.34 22.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.75 -32.76 1.44 Allowed Glycine 0 CA--C 1.558 2.731 0 N-CA-C 118.852 2.301 . . . . 0.0 118.852 -163.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.28 116.19 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 124.757 1.223 . . . . 0.0 110.78 -168.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -106.37 115.31 29.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.099 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.0 t -97.49 127.21 43.26 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.784 0.834 . . . . 0.0 112.082 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -93.53 116.38 28.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -103.36 119.12 38.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 132.86 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -131.09 160.56 34.33 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 124.116 0.966 . . . . 0.0 111.703 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.12 129.7 40.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 110.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -68.47 124.87 24.75 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.56 -40.19 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.563 1.47 0 CA-C-N 119.781 1.173 . . . . 0.0 108.258 169.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.261 52.3 t0 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -78.54 5.26 11.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 117.975 2.583 . . . . 0.0 117.975 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -61.42 107.66 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.806 1.639 . . . . 0.0 114.481 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.17 178.79 32.53 Favored Glycine 0 N--CA 1.484 1.89 0 CA-C-O 122.621 1.123 . . . . 0.0 114.888 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -107.76 118.76 37.58 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.33 1.052 . . . . 0.0 109.27 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -118.81 112.48 19.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -168.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -89.53 139.55 30.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 112.831 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.434 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.2 ttp -69.31 121.52 17.05 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 119.889 1.222 . . . . 0.0 114.042 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.93 -44.41 18.29 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -152.95 159.13 42.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.398 -1.439 . . . . 0.0 113.724 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -140.39 118.76 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.692 -174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.96 118.3 19.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.745 -0.597 . . . . 0.0 110.439 -167.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.283 23.1 t30 66.6 33.76 6.33 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -80.25 -42.34 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.78 -42.85 80.16 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.28 -39.87 89.71 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -54.79 -47.58 73.81 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.64 -40.44 73.07 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -57.88 -41.9 83.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 165.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.43 58.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 164.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 mt -86.75 -49.67 7.29 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.22 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 125.835 1.654 . . . . 0.0 114.986 165.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.01 148.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 119.306 -2.121 . . . . 0.0 112.886 -136.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.66 153.21 40.2 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -60.0 -41.81 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.49 -54.73 42.3 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 172.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.16 -38.17 85.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -57.18 -51.22 70.21 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.38 -41.71 93.44 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.17 -58.21 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 119.446 1.021 . . . . 0.0 111.373 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.64 76.48 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -68.45 -36.22 78.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.83 -28.75 63.78 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.0 mt -72.5 135.24 45.63 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.541 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 101.99 7.97 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.565 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 34.1 Cg_endo -65.76 142.99 72.26 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 CA-C-N 123.315 2.22 . . . . 0.0 113.94 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.54 113.39 25.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -88.57 110.78 21.18 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.767 -0.583 . . . . 0.0 111.287 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -97.84 106.91 19.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.61 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.18 109.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 164.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -102.22 109.88 21.68 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.537 0.735 . . . . 0.0 109.99 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -100.19 74.97 1.79 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.05 -104.02 0.89 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.12 -31.3 39.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.06 127.58 33.55 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.893 1.678 . . . . 0.0 111.701 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.11 123.67 22.24 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-O 121.348 0.594 . . . . 0.0 111.274 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.4 mt -109.61 105.8 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.16 115.71 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -107.39 96.16 6.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -86.75 95.52 9.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 mt -95.15 130.74 41.76 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -162.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -149.52 152.72 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.926 0.87 . . . . 0.0 110.97 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.6 p -62.33 -31.65 72.3 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -75.27 -52.46 10.81 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -151.0 129.27 11.97 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 119.042 0.837 . . . . 0.0 110.498 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.3 123.16 33.84 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.307 0.643 . . . . 0.0 109.568 167.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -103.56 110.85 23.05 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 119.087 0.858 . . . . 0.0 109.658 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.9 mm -104.1 116.9 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.1 mtp -103.81 133.91 48.0 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.37 109.43 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.97 160.44 41.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -167.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -103.37 131.09 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.836 0.827 . . . . 0.0 110.519 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.89 131.63 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 CA-C-O 121.966 0.889 . . . . 0.0 110.166 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.9 22.76 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 -161.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -101.33 143.22 31.64 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.241 1.521 . . . . 0.0 111.608 -166.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.39 108.8 20.14 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.003 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.13 146.97 44.69 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.54 108.02 4.72 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.96 0.886 . . . . 0.0 112.524 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.41 106.78 15.36 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.663 0.785 . . . . 0.0 109.939 -168.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.54 119.44 24.71 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.817 0.818 . . . . 0.0 110.707 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.04 52.49 1.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 m -73.66 128.22 34.91 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.468 1.107 . . . . 0.0 112.46 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.52 -60.98 0.41 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.987 -0.446 . . . . 0.0 113.648 -157.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.61 -61.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 124.245 1.018 . . . . 0.0 110.95 -174.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -143.63 3.57 1.29 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 165.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 7.8 t70 44.62 55.28 5.95 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -163.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.521 ' HE ' ' HZ1' ' A' ' 101' ' ' LYS . 76.2 mmt-85 -110.89 138.18 47.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.661 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -97.88 104.45 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.2 m -109.27 145.62 35.62 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.363 0.601 . . . . 0.0 111.862 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.8 mmm -85.17 91.72 8.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.147 169.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.9 m -96.6 122.66 39.76 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.653 -166.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 m -100.21 117.14 33.82 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -105.76 128.92 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -141.6 153.9 45.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.965 -1.085 . . . . 0.0 112.585 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.4 m95 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.979 -1.076 . . . . 0.0 111.868 175.756 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.334 0.588 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.74 106.69 18.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.097 -1.002 . . . . 0.0 110.098 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -95.37 150.42 20.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.967 0.907 . . . . 0.0 112.395 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -146.44 135.17 22.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.013 0.525 . . . . 0.0 112.315 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.93 126.6 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.65 0.78 . . . . 0.0 109.173 167.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -103.3 92.28 4.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -86.18 134.25 33.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.855 . . . . 0.0 112.961 -167.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 141.23 -90.68 0.18 Allowed Glycine 0 N--CA 1.486 2.031 0 O-C-N 121.441 -0.787 . . . . 0.0 113.713 167.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.29 -12.4 59.07 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -169.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HZ1' ' HE ' ' A' ' 80' ' ' ARG . 24.0 mmtm -129.21 148.98 51.19 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.672 1.578 . . . . 0.0 112.757 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -82.11 114.18 20.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.787 0.835 . . . . 0.0 111.258 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.54 43.04 99.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 118.11 2.004 . . . . 0.0 118.11 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -86.17 135.93 33.39 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.304 1.052 . . . . 0.0 111.635 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -170.79 38.6 Favored Glycine 0 N--CA 1.482 1.721 0 CA-C-O 122.12 0.845 . . . . 0.0 114.262 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 61.7 p-90 -153.56 165.06 37.07 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.406 1.098 . . . . 0.0 113.183 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 m -138.47 125.77 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.43 129.0 42.46 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.725 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -151.62 165.49 34.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.002 -1.061 . . . . 0.0 113.242 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -107.41 131.0 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -0.936 . . . . 0.0 109.298 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -119.2 95.45 4.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 162.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.77 -117.4 4.72 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.677 -0.64 . . . . 0.0 114.151 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -94.59 15.9 16.85 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.994 1.849 . . . . 0.0 115.994 162.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -113.74 125.21 53.86 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.583 1.083 . . . . 0.0 111.055 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.3 120.64 26.1 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.375 1.07 . . . . 0.0 109.712 166.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -107.11 119.14 38.57 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.579 0.751 . . . . 0.0 108.979 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 tp -115.66 128.55 56.0 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.756 0.822 . . . . 0.0 110.013 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.88 123.8 50.66 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.638 0.775 . . . . 0.0 110.042 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.7 mtm -115.41 137.17 52.34 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.857 0.863 . . . . 0.0 111.483 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -127.11 135.05 50.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.539 -0.726 . . . . 0.0 111.578 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.77 125.4 6.38 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.118 0.567 . . . . 0.0 111.438 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 54.56 42.6 31.2 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.38 -6.95 6.92 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 120.377 2.911 . . . . 0.0 120.377 -165.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.21 126.15 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.281 2.04 . . . . 0.0 109.93 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -108.47 128.99 55.27 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.934 0.894 . . . . 0.0 111.085 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.4 t -125.12 126.5 45.41 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 0.0 112.75 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.95 135.54 35.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.552 -0.718 . . . . 0.0 112.127 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -129.04 134.5 48.15 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.351 0.661 . . . . 0.0 110.656 162.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.6 t -116.68 130.32 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.84 132.73 43.95 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.905 0.775 . . . . 0.0 111.252 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -103.61 133.75 48.1 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.227 -1.545 . . . . 0.0 112.631 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.96 120.88 16.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.0 -38.57 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 . . . . . 0 CA--C 1.563 1.464 0 CA-C-N 119.933 1.242 . . . . 0.0 108.318 169.274 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 . . . . . 0 CA--C 1.565 1.557 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -78.8 2.1 21.01 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -57.82 105.68 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 121.348 1.886 . . . . 0.0 115.114 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.53 179.83 35.55 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -109.64 113.0 25.41 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.592 1.157 . . . . 0.0 109.218 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -115.15 111.61 21.28 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -168.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.31 141.35 28.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.6 ttp -71.76 121.69 19.36 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.615 -1.303 . . . . 0.0 113.987 -173.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.2 mt -83.13 -45.09 14.36 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -153.52 160.45 42.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.505 -1.372 . . . . 0.0 113.333 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.34 117.98 10.4 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.002 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.76 121.0 35.26 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.749 0.82 . . . . 0.0 109.834 -172.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.285 31.1 t30 68.36 34.2 3.87 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -78.68 -40.53 33.66 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -56.4 -35.86 68.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 168.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.76 -41.92 67.83 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.946 1.703 . . . . 0.0 114.675 166.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.25 -51.12 65.54 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 120.079 1.308 . . . . 0.0 113.802 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.04 -38.18 82.21 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -59.92 -39.21 84.69 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -34.3 62.77 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 165.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.96 -9.79 58.86 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.318 15.9 t0 67.95 49.8 0.87 Allowed 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 125.592 1.557 . . . . 0.0 114.581 -161.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.5 t -93.51 137.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.93 0.872 . . . . 0.0 109.758 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -61.82 150.52 36.96 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 176.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -52.51 -44.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.51 68.96 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 172.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -36.29 80.79 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -61.97 -51.21 69.01 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.307 1.867 . . . . 0.0 115.447 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -60.22 -44.58 95.05 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.08 -55.96 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.724 0.693 . . . . 0.0 111.391 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.41 77.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -70.67 -32.05 69.18 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.61 -24.12 53.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -72.22 154.28 41.1 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -99.0 95.96 3.68 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.364 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.72 143.65 30.32 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.507 2.138 . . . . 0.0 113.477 166.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.14 117.22 32.67 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -85.92 107.18 17.6 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.371 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.22 108.7 20.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 170.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -106.6 127.84 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -116.15 109.15 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -106.79 105.48 15.53 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 123.881 0.873 . . . . 0.0 110.578 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.78 75.68 6.47 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 110.054 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.39 -100.36 0.47 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 115.231 0.853 . . . . 0.0 115.231 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.54 -29.04 28.19 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.17 110.49 17.42 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.353 1.433 . . . . 0.0 111.016 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -126.98 130.67 50.51 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.439 1.114 . . . . 0.0 111.949 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.86 101.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.2 mt -93.12 110.59 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -103.1 100.13 10.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -83.25 97.9 9.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.84 112.38 25.47 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.667 0.746 . . . . 0.0 110.627 -165.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 t -127.98 149.87 50.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.486 0.66 . . . . 0.0 109.789 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -61.33 -28.26 69.09 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -76.11 -42.47 46.99 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 166.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -156.47 131.39 9.06 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 120.214 1.37 . . . . 0.0 112.864 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -109.29 122.2 46.83 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.532 0.733 . . . . 0.0 110.297 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.42 108.88 15.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.325 -0.86 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.09 127.59 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-O 121.65 0.738 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -108.64 105.81 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.814 0.846 . . . . 0.0 109.505 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -104.99 116.65 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.429 0.692 . . . . 0.0 109.775 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -153.66 155.79 36.69 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.28 128.45 46.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.442 -0.786 . . . . 0.0 110.522 165.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.7 t -68.27 121.93 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 123.453 0.701 . . . . 0.0 110.255 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.36 -35.17 4.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -162.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.1 140.31 29.58 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.732 1.266 . . . . 0.0 112.06 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.13 107.12 18.99 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 122.041 -0.412 . . . . 0.0 111.079 171.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -112.46 133.77 54.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.577 0.751 . . . . 0.0 112.026 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.97 94.2 2.32 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 112.18 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -96.63 130.28 43.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.641 -0.662 . . . . 0.0 111.616 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.51 124.29 28.82 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD21 HE22 ' A' ' 97' ' ' GLN . 0.9 OUTLIER -78.19 67.73 4.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.115 1.436 . . . . 0.0 111.665 171.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -75.52 126.14 30.43 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.483 -166.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.22 64.75 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -170.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.75 -75.26 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.35 7.48 4.22 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.5 t0 43.84 59.98 2.9 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -115.2 141.51 47.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.59 -0.694 . . . . 0.0 111.375 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.47 115.52 28.1 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.335 0.654 . . . . 0.0 110.607 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.8 m -120.42 135.24 55.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.284 0.633 . . . . 0.0 111.751 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.0 mmm -76.63 99.77 5.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.787 . . . . 0.0 110.463 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.4 m -101.49 118.74 37.58 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.696 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.6 m -97.6 124.17 41.78 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.46 132.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.9 m -151.07 153.58 35.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.321 -1.487 . . . . 0.0 113.234 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.336 . . . . 0.0 113.27 -179.327 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.236 0.541 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.8 tp -89.4 107.36 19.03 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.586 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -90.1 141.35 28.77 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.898 0.879 . . . . 0.0 111.563 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -133.14 125.52 29.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.516 0.726 . . . . 0.0 110.923 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -113.19 121.63 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 123.225 0.61 . . . . 0.0 109.731 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.524 HE22 HD21 ' A' ' 74' ' ' LEU . 13.4 mt-30 -103.65 102.11 11.97 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.392 0.677 . . . . 0.0 111.024 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.34 125.0 39.66 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.68 -118.01 0.62 Allowed Glycine 0 N--CA 1.49 2.241 0 O-C-N 121.102 -0.999 . . . . 0.0 112.976 170.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.55 -36.12 81.89 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -89.55 130.86 35.8 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -163.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.4 117.82 22.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.566 . . . . 0.0 111.889 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.11 46.94 93.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 117.737 1.855 . . . . 0.0 117.737 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -93.01 136.92 32.83 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.19 0.995 . . . . 0.0 111.762 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 -171.12 43.03 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 122.842 1.245 . . . . 0.0 114.244 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -154.08 152.78 30.86 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.101 0.953 . . . . 0.0 112.47 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 79.3 m -125.59 125.14 42.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.64 139.24 53.32 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -151.78 164.14 37.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 113.072 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.51 140.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 122.847 1.308 . . . . 0.0 110.689 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -137.16 84.05 2.03 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.08 -111.16 3.4 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.846 -0.533 . . . . 0.0 113.816 -171.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -93.03 6.96 46.07 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -106.62 127.59 53.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.96 1.709 . . . . 0.0 112.741 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.7 tp -85.61 119.16 25.64 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.119 0.968 . . . . 0.0 109.381 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.52 122.57 46.28 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.9 126.32 48.4 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.599 0.76 . . . . 0.0 111.473 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -106.0 123.1 47.45 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.394 0.678 . . . . 0.0 109.639 164.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 63.7 mtm -110.09 129.75 55.64 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 118.948 0.795 . . . . 0.0 110.64 172.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -125.68 144.55 50.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.41 127.7 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.606 0.763 . . . . 0.0 110.978 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 51.1 49.7 20.61 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.7 -32.54 1.43 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.67 157.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 125.14 1.376 . . . . 0.0 112.866 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.6 m -129.94 121.95 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.712 -1.243 . . . . 0.0 110.218 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.5 t -97.14 131.68 43.66 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.3 0.64 . . . . 0.0 110.508 161.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -113.8 120.01 39.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.859 -0.526 . . . . 0.0 110.511 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -120.18 139.24 52.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.565 0.746 . . . . 0.0 111.48 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.05 129.79 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.16 142.3 51.22 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.924 0.89 . . . . 0.0 110.663 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -112.59 133.38 54.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.377 -1.452 . . . . 0.0 111.94 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -67.92 122.64 18.61 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.4 m -117.27 -34.49 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t60 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 169.118 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 CA--C 1.565 1.546 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -81.27 2.51 27.71 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -59.56 116.12 3.78 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.219 1.827 . . . . 0.0 114.59 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.94 177.95 31.52 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-O 123.246 1.47 . . . . 0.0 115.758 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -110.44 112.37 24.25 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 113.727 -1.236 . . . . 0.0 108.677 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -112.47 122.68 48.4 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -167.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -91.87 143.94 25.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.802 -1.186 . . . . 0.0 113.092 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.402 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.5 ttm -73.49 122.41 22.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.721 -1.237 . . . . 0.0 112.988 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.31 -44.74 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -154.0 158.31 40.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.459 -1.4 . . . . 0.0 112.645 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -135.8 100.62 4.51 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.08 -64.42 1.15 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -154.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -120.54 43.55 2.71 Favored 'General case' 0 CA--C 1.571 1.773 0 C-N-CA 123.717 0.807 . . . . 0.0 111.273 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 17.0 t80 -73.62 -39.85 64.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.54 -46.05 70.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.44 -39.82 85.43 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -55.73 -45.98 77.87 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 165.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.97 -41.42 86.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -53.83 -44.71 70.47 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.89 52.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 166.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.68 -5.71 56.8 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 164.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 7.5 t70 69.6 62.78 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 120.38 1.445 . . . . 0.0 112.996 -164.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 83.5 t -104.03 148.23 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.19 0.995 . . . . 0.0 110.034 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -62.25 151.88 35.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.77 -42.91 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.95 -54.37 45.52 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.63 -38.5 84.98 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -53.53 -52.13 60.65 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -65.29 -45.28 85.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.17 -56.49 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.538 0.735 . . . . 0.0 111.819 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -27.01 66.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.11 -43.22 83.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 162.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.67 -28.14 65.62 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 mt -68.46 135.59 51.91 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 120.034 1.288 . . . . 0.0 112.893 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -113.06 84.57 7.16 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.19 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 70.7 Cg_endo -71.95 168.6 23.46 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 122.624 2.216 . . . . 0.0 116.054 -176.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.77 121.86 45.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.145 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -89.88 110.23 21.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.613 -0.679 . . . . 0.0 110.009 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.3 108.78 20.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 167.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -106.19 123.96 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.53 107.94 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -103.04 119.02 38.1 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.928 0.891 . . . . 0.0 109.36 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.7 -60.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 112.546 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.81 101.49 0.15 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.455 1.0 OUTLIER 60.46 -45.16 0.1 Allowed 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -150.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -70.34 126.66 30.28 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-N 119.874 1.215 . . . . 0.0 112.361 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 ttp -143.39 131.89 22.3 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.105 0.955 . . . . 0.0 111.674 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.9 mt -115.4 109.78 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -97.44 115.72 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -111.54 96.01 5.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.702 -0.624 . . . . 0.0 109.347 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.3 m -87.13 103.06 15.04 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.9 mt -101.04 114.86 29.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -130.28 149.29 52.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.7 0.8 . . . . 0.0 110.209 168.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -65.77 -16.36 63.72 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 167.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -76.56 -53.31 8.24 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.459 1.027 . . . . 0.0 112.739 163.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -155.0 135.16 13.1 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 121.784 0.802 . . . . 0.0 111.023 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.19 121.42 34.53 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.765 0.826 . . . . 0.0 110.084 173.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -112.34 104.94 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.833 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.82 125.28 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 121.818 0.818 . . . . 0.0 109.106 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.9 mtp -103.67 109.99 21.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.64 0.776 . . . . 0.0 109.015 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -108.31 110.6 22.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.554 0.742 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.69 42.25 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -166.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.24 129.9 55.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 168.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.07 123.51 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 123.519 0.728 . . . . 0.0 110.287 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.31 -32.32 7.66 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 117.333 1.693 . . . . 0.0 117.333 -164.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -87.87 145.15 26.2 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.991 1.395 . . . . 0.0 112.578 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.97 120.09 32.3 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.79 -0.569 . . . . 0.0 111.068 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -126.55 151.32 48.05 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.917 0.887 . . . . 0.0 112.263 -171.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.64 97.73 3.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.655 -1.278 . . . . 0.0 112.253 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -84.57 105.23 15.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.37 101.96 9.31 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.157 0.503 . . . . 0.0 110.362 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.48 52.44 2.37 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -83.08 130.73 35.15 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.034 0.934 . . . . 0.0 111.382 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.6 -51.62 0.73 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 -151.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.13 -73.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -164.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.88 28.91 2.11 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 159.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.28 16.7 m-20 55.83 31.26 17.32 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.154 2.649 . . . . 0.0 118.154 174.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -108.01 141.18 40.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 113.147 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -90.92 109.73 20.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.226 0.611 . . . . 0.0 110.667 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.1 m -107.14 128.46 54.42 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.045 0.538 . . . . 0.0 111.343 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 95.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.267 1.032 . . . . 0.0 110.483 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.9 m -105.47 125.92 51.54 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.607 -0.683 . . . . 0.0 109.941 -161.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 m -116.62 115.94 26.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.415 HG22 ' SG ' ' A' ' 95' ' ' CYS . 60.8 t -107.53 121.65 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -138.25 150.41 46.66 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.144 0.883 . . . . 0.0 111.874 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 85.5 m95 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 120.427 -1.421 . . . . 0.0 112.593 175.23 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.105 0.479 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.23 104.34 15.69 Favored 'General case' 0 CA--C 1.564 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -110.45 131.59 54.92 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.689 0.757 . . . . 0.0 111.152 -167.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 86' ' ' VAL . 52.9 t -125.66 138.07 53.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.6 0.76 . . . . 0.0 112.88 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -113.58 126.93 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 123.673 0.789 . . . . 0.0 109.178 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -102.49 95.37 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.485 0.714 . . . . 0.0 109.144 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.78 123.38 29.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.918 -1.114 . . . . 0.0 112.276 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.45 -90.66 0.11 Allowed Glycine 0 N--CA 1.484 1.886 0 O-C-N 121.598 -0.689 . . . . 0.0 114.49 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -88.74 -12.81 41.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -161.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -131.58 149.56 52.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.44 1.473 . . . . 0.0 111.612 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.39 115.01 21.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.459 1.104 . . . . 0.0 111.601 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.36 53.39 6.8 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -105.55 128.19 53.45 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.908 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.0 40.77 Favored Glycine 0 N--CA 1.486 1.997 0 O-C-N 121.601 -0.687 . . . . 0.0 114.395 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.255 40.1 p-90 -155.44 157.39 36.92 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.4 m -131.63 124.03 29.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.405 -0.81 . . . . 0.0 109.003 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.94 133.97 53.6 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.759 0.824 . . . . 0.0 111.722 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -149.78 171.52 16.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 0.0 112.746 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.23 126.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.45 90.71 3.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.438 163.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.98 -110.66 3.17 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.326 -0.858 . . . . 0.0 114.91 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.84 5.25 44.58 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 163.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -110.37 126.71 54.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.596 1.544 . . . . 0.0 112.432 -170.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.299 0.64 . . . . 0.0 109.791 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -113.55 120.14 39.94 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.0 tp -121.53 123.95 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.094 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -99.8 121.88 41.94 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.501 0.721 . . . . 0.0 110.025 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 50.1 mtm -115.44 132.97 56.46 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.536 1.062 . . . . 0.0 111.854 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.65 134.66 55.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 112.911 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.43 124.68 12.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 0.0 109.97 172.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 53.79 40.28 31.32 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 -8.35 9.54 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 120.263 2.865 . . . . 0.0 120.263 -164.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.58 117.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 120.399 2.1 . . . . 0.0 109.298 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.9 m -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.341 0.656 . . . . 0.0 111.234 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.45 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 8.6 t -97.22 129.79 44.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 111.753 166.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -98.18 125.41 43.2 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.696 0.68 . . . . 0.0 110.644 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -113.36 123.71 50.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.312 0.645 . . . . 0.0 109.323 169.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.81 133.65 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -135.4 156.61 48.63 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.522 1.129 . . . . 0.0 111.259 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.83 126.71 42.16 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.561 -1.337 . . . . 0.0 110.449 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -69.29 122.16 18.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.133 -0.979 . . . . 0.0 113.087 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.99 -38.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.5 t60 . . . . . 0 N--CA 1.487 1.404 0 CA-C-N 119.851 1.205 . . . . 0.0 108.112 170.071 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 t0 . . . . . 0 CA--C 1.564 1.502 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -82.53 4.49 24.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -60.6 114.28 2.9 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 121.419 1.918 . . . . 0.0 114.443 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.27 178.06 30.97 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-O 122.79 1.217 . . . . 0.0 115.738 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -108.88 115.26 29.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.399 1.079 . . . . 0.0 109.184 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -116.8 112.93 21.82 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.426 0.691 . . . . 0.0 109.189 -167.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -85.33 142.7 29.14 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.185 -0.947 . . . . 0.0 112.61 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.3 ttp -73.64 121.61 20.99 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-N 120.459 1.481 . . . . 0.0 113.042 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt -81.7 -44.12 17.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -154.5 160.22 41.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.413 -1.43 . . . . 0.0 113.322 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -136.0 118.86 16.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.808 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -124.26 122.68 38.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.597 0.759 . . . . 0.0 110.145 -170.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.2 t30 65.91 38.23 5.11 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.67 -40.89 16.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.77 -37.54 68.69 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.48 -41.12 69.75 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 120.922 1.692 . . . . 0.0 114.9 167.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -54.93 -46.67 74.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.55 -37.44 68.26 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -57.91 -41.38 82.51 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 164.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.15 -18.05 32.53 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 165.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -95.42 9.92 38.25 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 165.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.271 20.1 t70 57.99 50.16 10.66 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.5 t -98.72 141.01 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.836 0.827 . . . . 0.0 110.024 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.8 149.86 45.95 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.74 -45.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -50.58 70.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.36 -43.6 98.59 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -58.21 -47.88 82.08 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -60.04 -43.58 95.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.51 -56.98 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 118.717 0.69 . . . . 0.0 111.374 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.54 81.6 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -67.51 -32.59 73.5 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.34 -24.24 46.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 170.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.0 mt -68.92 147.05 52.23 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.513 1.506 . . . . 0.0 114.302 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.95 90.89 4.8 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.262 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.2 147.01 47.13 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.617 2.211 . . . . 0.0 114.415 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.99 117.84 29.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -88.44 110.75 21.08 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.654 -0.654 . . . . 0.0 111.084 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -96.08 107.7 20.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.514 -0.742 . . . . 0.0 109.355 167.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -105.84 127.33 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.18 110.08 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -106.78 110.86 23.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.312 0.645 . . . . 0.0 110.603 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -101.99 81.27 2.09 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.664 0.785 . . . . 0.0 109.52 168.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.91 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 121.559 -0.713 . . . . 0.0 114.341 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.76 -20.02 22.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 163.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -77.91 112.62 14.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.019 1.736 . . . . 0.0 111.923 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.3 ttm -123.27 125.01 44.27 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.677 0.751 . . . . 0.0 111.037 -165.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.1 mm -111.39 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -92.69 108.02 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.67 94.62 6.19 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.7 m -85.41 98.6 10.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.133 -0.979 . . . . 0.0 108.887 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.5 mt -97.18 115.13 27.01 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.848 -0.533 . . . . 0.0 110.7 -165.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 t -132.86 152.71 51.8 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.756 0.788 . . . . 0.0 110.476 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.6 p -64.34 -28.59 69.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -73.79 -48.19 33.34 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -154.89 135.57 13.54 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.498 1.044 . . . . 0.0 111.831 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.23 116.18 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.552 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -105.8 108.38 19.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 110.316 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mm -106.64 119.2 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.48 112.32 24.15 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.589 0.756 . . . . 0.0 109.641 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -112.27 112.36 23.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.599 0.76 . . . . 0.0 109.272 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -155.99 145.58 21.02 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -91.53 124.76 35.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.806 165.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.37 124.34 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.64 -0.663 . . . . 0.0 109.516 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.93 -39.27 2.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -157.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -95.6 152.83 18.09 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.561 1.181 . . . . 0.0 112.752 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -93.12 125.89 37.94 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.405 168.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.74 144.23 48.96 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.496 0.718 . . . . 0.0 112.32 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.27 100.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.493 -1.38 . . . . 0.0 112.978 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.94 104.91 16.72 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 121.829 -0.545 . . . . 0.0 109.707 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -74.0 99.18 3.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.793 0.437 . . . . 0.0 111.359 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.54 52.08 2.0 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -88.07 127.44 35.4 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.337 1.055 . . . . 0.0 111.411 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.97 -44.83 1.4 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 -148.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -93.66 -74.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.471 1.108 . . . . 0.0 108.647 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -122.46 -6.02 8.73 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 168.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 21.6 m-20 63.53 49.03 3.21 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 mtm-85 -141.94 143.26 33.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.116 -0.99 . . . . 0.0 111.475 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.86 94.97 6.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 -173.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -83.24 136.72 34.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.593 -0.692 . . . . 0.0 112.794 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.9 mtp -82.91 91.72 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.588 1.185 . . . . 0.0 110.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.429 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 40.4 m -102.75 122.13 43.84 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.414 -0.803 . . . . 0.0 110.898 -156.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -103.49 122.42 44.88 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.9 t -109.29 127.11 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -124.31 152.95 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.763 0.825 . . . . 0.0 111.924 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.4 m95 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 120.933 -1.104 . . . . 0.0 113.193 178.143 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 122.162 0.982 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 tp -88.79 109.32 20.07 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -111.76 126.97 55.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 -162.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.429 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 44.8 t -127.62 135.41 50.23 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -168.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -112.83 122.28 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.607 0.763 . . . . 0.0 109.367 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -98.25 93.58 6.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.612 0.765 . . . . 0.0 109.111 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -85.77 122.51 29.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.8 -1.188 . . . . 0.0 112.309 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.8 -111.23 0.36 Allowed Glycine 0 N--CA 1.484 1.896 0 O-C-N 121.623 -0.673 . . . . 0.0 113.405 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.39 -3.61 56.53 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -121.06 143.42 49.08 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.196 1.362 . . . . 0.0 113.067 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -81.48 97.63 7.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -170.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.93 49.81 6.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.57 138.05 31.88 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.735 0.779 . . . . 0.0 112.436 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 -166.3 35.24 Favored Glycine 0 N--CA 1.486 1.974 0 CA-C-O 121.934 0.741 . . . . 0.0 114.807 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -159.09 153.35 23.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.8 m -130.23 125.98 36.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -126.3 129.15 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.765 0.826 . . . . 0.0 110.849 -172.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -145.72 167.56 22.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.978 -1.076 . . . . 0.0 113.449 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.8 mt -110.34 126.46 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.95 89.37 3.04 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 164.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.79 -112.05 3.57 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.299 -0.876 . . . . 0.0 114.679 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -89.99 2.96 54.55 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 161.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -102.63 134.43 46.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.557 1.526 . . . . 0.0 112.518 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -97.19 122.8 40.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.082 0.953 . . . . 0.0 109.19 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -114.52 122.38 46.39 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.464 0.706 . . . . 0.0 109.279 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp -123.95 122.15 37.18 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.456 0.702 . . . . 0.0 110.832 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.1 128.56 44.68 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.217 0.607 . . . . 0.0 109.865 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.4 mtm -117.95 130.43 56.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 118.894 0.77 . . . . 0.0 110.597 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -113.92 138.19 50.66 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.575 0.75 . . . . 0.0 112.818 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.87 116.51 4.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 110.2 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.305 6.0 mt-10 54.07 50.18 17.18 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.11 -14.48 3.84 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 120.577 2.991 . . . . 0.0 120.577 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.77 124.51 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.447 2.123 . . . . 0.0 110.017 -166.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -93.54 123.2 36.69 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.134 0.574 . . . . 0.0 110.697 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.67 135.92 37.91 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.066 0.547 . . . . 0.0 111.061 159.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -113.43 118.83 35.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.807 -0.558 . . . . 0.0 110.58 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -114.75 133.75 55.66 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.465 0.65 . . . . 0.0 110.903 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.36 131.0 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -127.66 160.42 31.68 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 124.475 1.11 . . . . 0.0 111.196 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -133.22 133.28 42.51 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.488 -1.383 . . . . 0.0 112.263 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -70.25 123.63 22.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.71 -37.56 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 . . . . . 0 CA--C 1.567 1.61 0 CA-C-N 119.739 1.154 . . . . 0.0 108.344 171.233 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.7 t0 . . . . . 0 CA--C 1.566 1.564 0 CA-C-O 121.24 0.543 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -81.83 -2.46 51.05 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 173.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -58.01 108.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 121.092 1.769 . . . . 0.0 114.499 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.71 33.94 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-O 122.609 1.116 . . . . 0.0 114.98 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -118.74 118.33 31.31 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.17 0.988 . . . . 0.0 109.441 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.19 114.72 20.66 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -164.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.04 141.15 29.15 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.978 -1.076 . . . . 0.0 113.769 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.1 ttp -76.24 119.21 19.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.26 -44.5 17.65 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -154.26 158.52 40.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.535 -1.353 . . . . 0.0 113.372 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -130.68 100.03 5.16 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.093 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -103.02 115.19 30.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.53 -0.731 . . . . 0.0 110.145 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 42.2 t30 58.56 31.31 20.91 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.14 -34.15 76.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 167.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 -49.54 77.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -37.11 80.11 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -57.73 -45.79 85.32 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.01 -40.33 78.74 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -55.48 -45.33 76.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.96 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 166.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.24 2.25 54.53 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.275 26.9 t0 64.49 56.61 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 120.259 1.39 . . . . 0.0 113.296 -169.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -103.1 139.45 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -66.77 157.17 33.53 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.9 t -60.7 -45.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -47.55 83.81 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.47 -44.77 92.94 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -52.09 -56.3 15.33 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -57.04 -33.07 66.84 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.18 -59.28 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 CA-C-N 118.757 0.708 . . . . 0.0 111.192 164.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.79 91.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -60.53 -36.7 79.03 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 170.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.58 -20.01 37.37 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.37 138.2 51.16 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 120.292 1.406 . . . . 0.0 113.091 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -111.23 85.4 5.44 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.22 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.8 158.83 54.52 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.608 2.205 . . . . 0.0 116.18 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.13 116.87 33.33 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.291 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -86.44 111.74 20.83 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.376 -0.828 . . . . 0.0 110.483 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.32 110.67 23.18 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.3 129.05 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.73 109.54 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -101.4 102.51 13.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.821 0.849 . . . . 0.0 110.126 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.8 71.93 5.72 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.72 0.808 . . . . 0.0 110.249 167.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.53 0.45 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -80.48 -33.38 36.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.74 114.83 19.9 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 120.186 1.357 . . . . 0.0 111.493 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.3 ttm -125.37 123.33 39.12 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.514 0.673 . . . . 0.0 110.984 -167.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.59 100.95 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.54 112.58 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -104.95 102.19 11.72 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 m -86.16 99.19 11.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.2 mt -99.6 116.05 30.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.088 0.555 . . . . 0.0 110.317 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -131.11 154.66 48.07 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.946 0.879 . . . . 0.0 110.741 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.3 p -62.97 -31.61 72.76 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -79.0 -45.06 21.0 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -158.01 132.69 8.4 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.973 1.261 . . . . 0.0 112.555 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -96.56 121.11 38.03 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.435 0.694 . . . . 0.0 110.388 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -110.67 104.63 13.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.375 -0.828 . . . . 0.0 110.631 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.54 125.54 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 122.087 0.946 . . . . 0.0 108.586 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.9 mtp -112.57 128.18 56.29 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.515 1.126 . . . . 0.0 108.603 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.04 95.15 3.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.686 . . . . 0.0 109.244 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -129.85 151.18 50.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -97.05 119.31 35.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.584 -0.698 . . . . 0.0 109.831 166.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.37 118.1 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 C-N-CA 123.458 0.703 . . . . 0.0 110.119 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.89 -43.45 1.49 Allowed Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -158.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.64 147.3 25.33 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.65 134.99 35.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.766 -0.584 . . . . 0.0 111.578 165.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -144.11 156.54 44.39 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.833 0.825 . . . . 0.0 112.903 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.98 98.16 3.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.46 0.704 . . . . 0.0 111.88 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -100.33 101.47 12.47 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.574 -0.704 . . . . 0.0 111.262 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -81.35 109.63 16.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.807 -0.558 . . . . 0.0 110.544 167.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.33 57.36 3.6 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-O 121.988 0.899 . . . . 0.0 112.854 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.0 t -76.31 140.48 41.52 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.15 0.98 . . . . 0.0 113.126 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.55 -46.43 1.96 Allowed Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -159.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mt -78.66 -74.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.513 1.125 . . . . 0.0 110.044 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -134.36 -3.47 2.71 Favored 'General case' 0 CA--C 1.574 1.886 0 C-N-CA 125.482 1.513 . . . . 0.0 114.457 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 1.6 m-20 54.1 57.18 6.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.68 134.58 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.19 0.519 . . . . 0.0 111.096 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -85.65 125.51 33.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.646 0.778 . . . . 0.0 111.61 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.92 148.7 48.21 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.493 0.717 . . . . 0.0 112.121 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.04 97.77 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.597 168.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.2 m -100.64 122.18 42.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 122.04 -0.412 . . . . 0.0 111.337 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -111.77 122.82 48.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.43 131.61 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.4 m -133.22 148.6 52.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 111.788 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 62.8 m95 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 111.121 172.089 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.58 0.705 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.52 108.64 21.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.537 -0.727 . . . . 0.0 110.218 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -112.46 132.39 55.08 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.463 0.705 . . . . 0.0 111.256 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -126.19 136.1 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.95 130.02 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -120.88 95.65 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.674 . . . . 0.0 110.405 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -77.91 120.83 23.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 112.925 -173.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.64 -115.71 0.35 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.989 -0.444 . . . . 0.0 112.255 172.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -78.53 -25.72 45.61 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -108.44 148.66 29.85 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.307 1.412 . . . . 0.0 112.957 -157.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.32 110.1 17.17 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.175 0.99 . . . . 0.0 111.85 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.49 51.52 9.59 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -92.76 116.59 29.16 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 117.316 0.558 . . . . 0.0 111.836 -171.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.55 -168.65 39.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -154.03 157.99 39.89 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.943 0.877 . . . . 0.0 112.958 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.5 m -132.93 127.49 34.41 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.036 -1.04 . . . . 0.0 108.682 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -127.58 131.44 49.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.778 . . . . 0.0 111.088 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.48 174.15 12.8 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.96 132.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.963 . . . . 0.0 109.436 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.09 92.17 3.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.743 0.817 . . . . 0.0 109.048 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.19 -114.85 4.44 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.346 -0.847 . . . . 0.0 114.746 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -88.7 4.98 45.38 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 163.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -106.56 129.92 54.41 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.101 1.319 . . . . 0.0 111.93 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.07 122.18 30.55 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.251 1.02 . . . . 0.0 109.733 166.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -113.44 124.33 52.17 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.733 0.813 . . . . 0.0 109.578 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.7 tp -127.83 119.5 25.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.253 0.621 . . . . 0.0 110.629 -173.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -90.26 135.23 33.8 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.892 0.477 . . . . 0.0 110.316 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.0 mtp -130.22 124.13 31.8 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.6 0.76 . . . . 0.0 109.856 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -122.88 132.32 54.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -0.753 . . . . 0.0 111.872 -164.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.03 131.66 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.233 0.613 . . . . 0.0 111.451 174.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 56.24 39.34 30.26 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.03 0.95 16.83 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 120.193 2.837 . . . . 0.0 120.193 -163.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.59 118.98 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 120.065 1.933 . . . . 0.0 108.942 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.4 m -95.04 116.88 29.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.658 0.742 . . . . 0.0 110.337 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.6 t -91.71 141.62 28.49 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.496 0.718 . . . . 0.0 111.116 161.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -115.58 123.28 48.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.399 -0.813 . . . . 0.0 110.952 166.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.43 129.14 56.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.187 0.595 . . . . 0.0 109.928 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.82 128.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -127.84 147.1 50.43 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.699 0.799 . . . . 0.0 111.002 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -116.37 135.81 53.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.378 -1.451 . . . . 0.0 112.29 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -70.06 122.95 20.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.29 -37.56 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 CA--C 1.567 1.603 0 CA-C-N 120.069 1.304 . . . . 0.0 108.595 170.467 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t70 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 121.783 0.801 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -75.17 3.18 9.16 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.716 2.488 . . . . 0.0 117.716 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -54.91 111.12 0.76 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.287 1.858 . . . . 0.0 114.959 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.44 175.86 28.85 Favored Glycine 0 N--CA 1.488 2.132 0 CA-C-O 122.217 0.898 . . . . 0.0 115.167 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -109.6 116.39 31.67 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.389 1.075 . . . . 0.0 109.515 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -118.33 112.73 20.42 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.688 -0.632 . . . . 0.0 109.412 -166.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.53 141.77 28.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.064 -1.023 . . . . 0.0 113.558 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttp -70.87 124.34 24.1 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -172.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.3 mt -85.67 -53.59 5.06 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.8 p -138.62 150.88 46.74 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 119.435 1.016 . . . . 0.0 113.477 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -129.13 113.78 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.867 0.867 . . . . 0.0 109.229 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -115.98 117.3 29.75 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 0.0 109.76 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.6 t30 63.74 36.45 10.61 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.422 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 4.3 t80 -74.57 -39.78 62.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.604 -1.31 . . . . 0.0 114.439 175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.46 -41.84 97.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 174.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.13 -39.43 78.89 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.17 -49.42 71.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 165.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.75 -40.88 88.47 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -55.03 -46.39 75.27 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 164.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.32 -18.36 49.16 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 166.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.6 mt -91.03 3.53 54.5 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.279 40.3 m-20 66.12 52.17 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.116 1.366 . . . . 0.0 114.406 -171.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.95 144.57 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 122.123 0.964 . . . . 0.0 110.139 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -63.86 154.32 34.03 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.73 -44.42 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.74 -50.85 67.37 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.32 -40.12 95.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 170.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -55.05 -40.5 70.37 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -69.75 -48.45 59.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.916 -1.115 . . . . 0.0 113.761 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.63 -57.86 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.012 0.925 . . . . 0.0 112.136 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -30.35 71.42 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -69.09 -36.54 77.68 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.97 -23.63 59.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.53 152.42 41.88 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 120.404 1.456 . . . . 0.0 114.644 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -101.35 90.26 1.65 Allowed Pre-proline 0 CA--C 1.574 1.892 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.314 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.7 146.48 54.46 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 122.848 2.053 . . . . 0.0 114.808 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.23 113.16 24.93 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -89.67 107.39 19.06 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.375 -0.828 . . . . 0.0 110.538 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.71 107.22 19.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.717 -0.615 . . . . 0.0 109.908 172.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.65 131.42 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.3 t -113.21 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -93.65 104.86 16.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.221 0.609 . . . . 0.0 109.954 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.31 75.55 2.95 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 121.527 0.679 . . . . 0.0 109.931 167.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.23 -104.43 1.04 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -81.65 -32.0 32.06 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -81.24 107.39 13.99 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.935 1.243 . . . . 0.0 110.952 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.3 ttp -116.16 124.0 49.24 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.962 0.887 . . . . 0.0 111.047 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.41 101.57 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.9 mt -98.18 105.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -97.48 99.43 10.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -88.08 97.14 10.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.21 -0.931 . . . . 0.0 109.135 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.8 mt -100.39 121.73 42.0 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.261 0.624 . . . . 0.0 110.976 -164.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -139.49 157.24 46.18 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.122 0.963 . . . . 0.0 111.356 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.9 p -65.09 -30.81 71.79 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -74.98 -48.89 21.95 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 165.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -153.75 138.83 17.33 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 119.651 1.114 . . . . 0.0 113.431 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -94.03 128.16 40.23 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.724 0.81 . . . . 0.0 109.982 168.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -118.95 103.93 10.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.016 -1.052 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.29 128.25 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.9 mtp -115.41 104.86 12.19 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.636 0.775 . . . . 0.0 110.256 173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -111.12 113.64 26.31 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.031 0.933 . . . . 0.0 111.583 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.64 149.36 27.48 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -169.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -92.32 129.26 38.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 111.075 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.75 129.45 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 123.218 0.607 . . . . 0.0 111.048 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.64 -31.92 7.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -161.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -84.83 133.42 34.33 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.96 1.38 . . . . 0.0 112.993 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -86.55 98.39 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.786 0.435 . . . . 0.0 110.223 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -105.41 147.24 28.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.52 106.38 3.97 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.916 0.865 . . . . 0.0 112.131 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.73 103.03 10.8 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.616 0.766 . . . . 0.0 109.748 -166.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.81 116.68 20.11 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 121.84 0.829 . . . . 0.0 110.58 172.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.73 45.49 1.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.1 t -76.58 137.64 39.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.086 0.954 . . . . 0.0 112.593 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.83 -59.41 0.54 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.601 -152.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.03 -75.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 123.748 0.819 . . . . 0.0 109.595 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -140.33 21.14 2.4 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 174.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.268 11.9 t70 50.18 48.99 21.31 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 176.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -127.71 142.47 51.32 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.981 0.896 . . . . 0.0 112.378 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -97.35 101.86 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.797 0.839 . . . . 0.0 110.652 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.3 m -102.11 147.67 26.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.518 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.97 95.22 10.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 109.009 167.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 124.19 47.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 111.243 -166.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -107.55 123.74 48.89 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -108.8 128.87 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t -123.57 149.66 45.01 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.98 0.912 . . . . 0.0 111.833 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 7.1 m95 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 120.89 -1.131 . . . . 0.0 112.228 170.543 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.649 0.737 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.66 110.18 21.08 Favored 'General case' 0 CA--C 1.564 1.51 0 O-C-N 121.518 -0.739 . . . . 0.0 109.123 172.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.7 122.4 45.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.099 0.56 . . . . 0.0 110.433 -161.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 52.5 t -122.07 138.88 54.28 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.05 123.85 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.601 0.76 . . . . 0.0 109.25 168.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -102.35 93.85 5.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -91.45 117.45 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 111.824 -166.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.8 -90.21 0.1 OUTLIER Glycine 0 N--CA 1.481 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 113.262 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -91.51 -16.98 26.4 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -164.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -125.33 148.35 48.76 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.22 1.373 . . . . 0.0 112.093 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.45 112.35 17.7 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 123.762 0.825 . . . . 0.0 112.231 -172.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.56 90.15 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -86.47 135.6 33.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.776 0.798 . . . . 0.0 111.431 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.9 -170.93 40.76 Favored Glycine 0 N--CA 1.482 1.757 0 CA-C-O 121.994 0.774 . . . . 0.0 114.602 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -156.42 150.42 25.11 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.2 m -124.87 125.99 44.85 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.48 129.16 48.12 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.513 0.725 . . . . 0.0 111.02 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.81 170.86 16.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.146 -0.971 . . . . 0.0 113.16 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.15 127.6 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.293 -0.88 . . . . 0.0 109.054 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.39 91.6 3.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 161.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.86 -111.7 3.54 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.172 -0.955 . . . . 0.0 115.03 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -94.06 8.82 40.11 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 162.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -107.84 123.8 49.13 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.399 1.454 . . . . 0.0 111.489 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.1 tp -81.32 118.73 22.88 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.64 1.176 . . . . 0.0 109.732 167.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.13 117.28 33.64 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.5 tp -115.18 128.89 56.47 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.79 0.836 . . . . 0.0 110.205 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -114.96 120.51 40.15 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.061 0.545 . . . . 0.0 109.962 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -110.18 133.58 53.08 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.764 0.825 . . . . 0.0 110.66 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -116.21 141.61 47.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.59 118.07 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.664 0.786 . . . . 0.0 110.615 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 55.2 44.15 28.15 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.33 3.05 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 120.477 2.951 . . . . 0.0 120.477 -164.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.98 122.81 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 120.256 2.028 . . . . 0.0 110.21 -167.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.8 m -94.73 125.73 39.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.334 0.654 . . . . 0.0 111.488 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.422 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 14.4 t -97.78 127.45 43.74 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.076 0.55 . . . . 0.0 110.762 158.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -107.58 129.31 55.0 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.385 0.612 . . . . 0.0 111.403 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -127.76 137.9 52.58 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.667 0.787 . . . . 0.0 111.031 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.74 131.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -131.21 130.37 42.86 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.453 0.701 . . . . 0.0 110.823 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -101.33 131.31 47.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.166 -1.584 . . . . 0.0 112.475 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.35 121.71 15.46 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.37 -38.23 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.8 t60 . . . . . 0 N--CA 1.488 1.435 0 CA-C-N 120.056 1.298 . . . . 0.0 107.796 169.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 121.879 0.847 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -71.76 1.85 6.27 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -54.62 108.36 0.38 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.45 177.94 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 CA-C-O 122.652 1.14 . . . . 0.0 115.157 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -111.01 116.61 31.47 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.426 1.09 . . . . 0.0 109.16 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -118.27 112.36 19.98 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.197 0.599 . . . . 0.0 109.539 -166.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -83.44 140.57 32.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.928 . . . . 0.0 113.41 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.463 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.7 ttm -69.7 125.1 25.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.235 1.38 . . . . 0.0 113.732 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.18 -57.75 2.9 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.657 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.0 m -127.89 149.95 50.08 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.29 1.043 . . . . 0.0 112.485 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.67 89.66 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.37 120.61 40.78 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.382 0.673 . . . . 0.0 110.62 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 33.6 t30 67.55 35.75 4.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -79.04 -41.02 29.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.327 -1.483 . . . . 0.0 114.84 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -50.51 -44.69 56.19 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 165.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.05 -36.36 69.58 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.877 1.671 . . . . 0.0 115.148 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -56.49 -49.01 75.92 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 164.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.21 -33.78 72.1 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -61.07 -41.35 96.45 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 164.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -18.22 56.7 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 165.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.65 -4.9 59.24 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 162.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 63.8 46.81 3.81 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 120.528 1.513 . . . . 0.0 114.707 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -93.01 140.95 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.812 0.815 . . . . 0.0 109.693 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.0 149.32 37.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.2 -45.0 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.75 62.92 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.85 -36.47 83.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -59.37 -49.94 75.88 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.588 1.995 . . . . 0.0 115.667 167.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -61.78 -42.42 98.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.65 -56.84 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.83 0.741 . . . . 0.0 111.308 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.51 87.54 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.93 -33.49 75.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.59 -30.31 65.68 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 167.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.71 137.64 47.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.972 1.26 . . . . 0.0 113.536 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -108.26 85.88 3.0 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.17 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.4 Cg_endo -68.6 154.16 72.09 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.601 2.2 . . . . 0.0 114.926 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.71 118.23 36.06 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -85.89 112.3 21.03 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.748 -0.595 . . . . 0.0 110.531 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.85 109.67 22.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.714 -0.616 . . . . 0.0 109.637 167.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.44 126.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.01 108.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.14 113.78 27.54 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.179 0.992 . . . . 0.0 110.532 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -106.57 80.53 1.48 Allowed 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 123.845 0.858 . . . . 0.0 109.446 168.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.0 2.68 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 121.316 -0.865 . . . . 0.0 114.47 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.1 -25.63 22.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 164.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -74.43 118.03 16.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.909 1.686 . . . . 0.0 111.323 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.9 ttp -138.2 131.86 30.96 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.098 0.952 . . . . 0.0 111.902 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.53 103.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -93.04 112.12 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.18 98.79 8.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.7 m -86.07 98.91 11.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.694 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.5 mt -102.34 115.18 30.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.498 0.666 . . . . 0.0 110.884 -165.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.0 t -128.98 146.78 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.475 0.71 . . . . 0.0 109.922 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 t -64.05 -15.36 59.31 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.23 -48.69 13.74 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -159.77 132.76 6.8 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.393 0.997 . . . . 0.0 111.041 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.78 124.4 46.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.564 -0.71 . . . . 0.0 110.413 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -112.44 117.1 31.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mm -113.53 119.12 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -171.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 83.0 mtp -105.7 109.1 20.94 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.292 0.637 . . . . 0.0 109.33 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -109.8 108.94 19.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -153.58 160.06 42.34 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -99.34 129.23 45.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 111.322 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.41 124.56 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.17 5.57 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -163.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -96.64 144.86 26.29 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.743 1.271 . . . . 0.0 112.876 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.26 113.0 21.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 0.0 110.673 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -121.42 149.48 42.95 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.664 0.786 . . . . 0.0 112.671 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.48 97.23 2.53 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 112.974 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.15 103.3 16.0 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.414 -0.804 . . . . 0.0 110.373 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -85.22 104.09 14.77 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.007 0.432 . . . . 0.0 110.48 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mp -83.96 53.32 2.54 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.863 0.839 . . . . 0.0 112.848 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -86.99 138.54 31.42 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.77 -31.93 6.19 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -153.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mt -92.81 -71.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.525 1.13 . . . . 0.0 108.324 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -126.58 -17.3 5.09 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.279 11.1 t70 62.35 73.09 0.48 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 120.246 1.385 . . . . 0.0 112.57 -158.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -133.42 131.76 40.35 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.15 0.58 . . . . 0.0 110.224 172.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -102.66 102.05 12.22 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.768 0.827 . . . . 0.0 109.771 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.53 124.52 51.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.044 0.538 . . . . 0.0 111.576 -172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.69 99.2 2.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.001 0.905 . . . . 0.0 109.667 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -113.2 120.39 41.08 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.06 -158.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.8 m -98.28 121.16 39.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -106.66 128.23 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -145.79 156.8 43.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.646 -1.284 . . . . 0.0 112.899 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.5 m95 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 120.976 -1.078 . . . . 0.0 112.352 -179.406 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.436 0.636 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.1 tp -89.79 106.39 18.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.709 -0.619 . . . . 0.0 110.03 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -112.76 130.95 55.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.6 0.714 . . . . 0.0 111.089 -168.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.6 t -126.93 134.16 50.48 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.706 0.802 . . . . 0.0 113.058 -170.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.92 121.05 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.441 0.696 . . . . 0.0 109.704 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -100.35 97.07 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.526 0.73 . . . . 0.0 109.883 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.02 114.64 27.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 111.362 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.29 -112.16 0.36 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 120.919 -1.113 . . . . 0.0 114.027 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -80.09 -11.37 59.77 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -123.0 148.46 45.48 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 119.537 1.062 . . . . 0.0 111.869 -170.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.57 133.86 37.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.69 43.68 59.87 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 119.588 2.595 . . . . 0.0 119.588 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -94.89 135.05 36.86 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 117.79 0.795 . . . . 0.0 111.783 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.96 -167.56 36.18 Favored Glycine 0 N--CA 1.481 1.65 0 CA-C-O 122.126 0.848 . . . . 0.0 114.706 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -156.0 153.27 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -126.7 124.74 40.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -123.64 135.68 54.06 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.536 0.734 . . . . 0.0 111.74 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -150.15 169.14 21.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.68 128.2 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.63 93.83 4.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 162.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.99 -114.6 4.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 121.221 -0.925 . . . . 0.0 114.986 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -96.03 23.56 6.33 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 163.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.4 128.63 53.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.936 1.243 . . . . 0.0 111.118 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.83 126.39 35.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.227 1.011 . . . . 0.0 109.812 168.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.68 122.77 43.31 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.09 120.26 28.49 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.574 0.749 . . . . 0.0 110.267 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -100.03 125.5 46.1 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.114 0.566 . . . . 0.0 109.727 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 11.5 mtp -119.66 120.78 37.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.435 0.694 . . . . 0.0 110.308 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -109.09 135.89 49.5 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.46 117.71 10.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.605 0.762 . . . . 0.0 109.05 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.292 11.5 mt-10 54.63 47.84 21.7 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.15 -31.02 1.83 Allowed Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.799 2.68 . . . . 0.0 119.799 -166.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 50.9 t -79.68 122.23 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 119.239 1.519 . . . . 0.0 111.296 -164.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.2 m -94.36 126.98 39.96 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.363 0.665 . . . . 0.0 111.483 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.8 t -100.18 129.8 46.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.405 0.682 . . . . 0.0 110.83 162.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -103.63 110.57 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.194 0.598 . . . . 0.0 110.562 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -108.88 120.67 43.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.514 0.725 . . . . 0.0 109.511 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.82 130.42 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -133.27 150.11 51.93 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.441 0.696 . . . . 0.0 111.3 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -115.49 133.79 55.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.345 -1.472 . . . . 0.0 112.153 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -69.74 123.02 20.34 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.65 -37.45 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.565 1.529 0 CA-C-N 120.051 1.296 . . . . 0.0 108.264 169.53 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 CA--C 1.562 1.429 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -75.96 -2.06 28.61 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 169.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -60.71 109.18 0.97 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.009 1.731 . . . . 0.0 113.956 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.42 179.67 34.4 Favored Glycine 0 N--CA 1.486 1.967 0 CA-C-O 122.907 1.282 . . . . 0.0 115.801 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -109.51 109.53 20.36 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.422 1.089 . . . . 0.0 109.118 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -110.88 111.79 23.18 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 137.62 32.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 0.0 112.728 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 ttp -68.5 118.67 11.85 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -172.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.6 mt -79.58 -45.05 19.92 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -153.68 160.26 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.618 -1.301 . . . . 0.0 113.13 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -141.64 117.61 10.55 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.014 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.67 122.97 39.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.469 0.708 . . . . 0.0 110.213 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.8 t30 66.72 36.85 4.48 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -80.3 -42.43 23.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.607 -1.308 . . . . 0.0 114.505 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.34 -39.96 80.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.74 -42.09 78.08 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 121.039 1.745 . . . . 0.0 114.809 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -55.88 -46.9 78.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 168.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -68.45 -37.23 80.02 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -57.72 -44.36 85.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.315 -1.491 . . . . 0.0 114.903 162.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -16.9 47.72 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 118.205 2.669 . . . . 0.0 118.205 166.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.82 2.19 56.89 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 38.7 t70 64.92 58.57 0.93 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.232 1.413 . . . . 0.0 114.022 -170.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -111.12 140.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-O 121.48 0.657 . . . . 0.0 109.84 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -65.54 150.45 48.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.15 -45.38 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.65 72.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.18 -41.59 97.07 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -56.99 -47.85 79.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.99 -56.04 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.915 0.78 . . . . 0.0 111.741 171.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.56 77.07 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -68.71 -33.68 74.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 167.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.72 -26.2 60.58 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.23 146.84 48.76 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.128 1.331 . . . . 0.0 114.147 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -104.44 89.87 2.92 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 118.211 -0.899 . . . . 0.0 109.899 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.29 150.4 47.07 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 122.404 2.069 . . . . 0.0 114.731 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -114.75 117.08 29.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -85.3 107.28 17.24 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.591 -0.693 . . . . 0.0 110.866 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.69 108.29 19.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.516 -0.74 . . . . 0.0 109.219 167.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.77 136.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.58 110.98 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -95.37 108.16 20.34 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.337 0.655 . . . . 0.0 109.929 170.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.31 76.14 1.68 Allowed 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 121.558 0.694 . . . . 0.0 109.661 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 -103.79 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.34 -0.85 . . . . 0.0 114.766 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.97 -22.6 21.86 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 162.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -75.67 114.2 13.99 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 120.642 1.564 . . . . 0.0 111.557 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 tpp -120.0 132.49 55.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.843 0.457 . . . . 0.0 111.468 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.99 101.39 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.0 mt -96.8 110.37 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -105.07 97.58 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.8 m -83.02 99.48 9.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.7 mt -98.87 116.42 31.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.824 -0.547 . . . . 0.0 110.69 -166.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.5 t -137.86 152.55 49.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.602 0.761 . . . . 0.0 110.637 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -74.44 -49.31 22.9 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -153.53 135.75 14.87 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.569 1.077 . . . . 0.0 111.657 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -89.79 120.36 30.97 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -113.5 106.02 14.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.645 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.24 127.39 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.479 0.712 . . . . 0.0 109.317 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.9 mtp -109.15 110.69 21.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.838 0.855 . . . . 0.0 109.352 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -112.99 117.34 31.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.451 0.7 . . . . 0.0 109.84 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -156.95 155.92 32.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -96.27 125.23 40.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 111.148 165.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.53 124.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.547 0.739 . . . . 0.0 109.532 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.05 -41.78 2.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -157.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -92.97 142.39 27.35 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.878 0.871 . . . . 0.0 113.169 -170.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -87.66 124.13 33.22 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.862 -0.524 . . . . 0.0 110.976 166.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -132.76 152.42 51.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.826 0.85 . . . . 0.0 111.554 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.75 105.28 5.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.425 -1.422 . . . . 0.0 112.317 169.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -92.24 114.06 26.5 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -77.39 121.3 23.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 159.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.532 HD22 HH21 ' A' ' 104' ' ' ARG . 4.4 mp -87.86 63.32 7.36 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.197 0.998 . . . . 0.0 111.653 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -79.45 118.77 21.63 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.723 0.809 . . . . 0.0 111.166 -168.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.24 -48.43 0.94 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 -159.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -80.37 -85.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -171.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.08 8.26 13.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 55.94 46.27 22.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.41 140.99 52.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.784 . . . . 0.0 111.268 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.95 111.33 20.73 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.266 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.83 135.41 45.43 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.291 0.637 . . . . 0.0 111.285 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mmt -77.58 99.46 5.75 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.225 1.012 . . . . 0.0 109.614 165.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.6 m -104.28 122.55 45.64 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.657 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.6 m -103.78 126.57 51.0 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 166.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.6 t -111.34 128.75 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -134.14 149.93 51.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.063 0.945 . . . . 0.0 111.925 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.0 m95 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.647 -1.283 . . . . 0.0 114.294 -179.062 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.533 0.683 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -89.26 109.68 20.54 Favored 'General case' 0 CA--C 1.562 1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.201 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -95.31 140.35 30.33 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.219 1.008 . . . . 0.0 111.595 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 51.8 t -137.73 133.88 34.66 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.12 128.83 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.636 0.774 . . . . 0.0 109.526 168.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -107.12 103.47 12.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.812 0.845 . . . . 0.0 110.102 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -86.71 113.07 22.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 111.48 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.11 -129.79 1.21 Allowed Glycine 0 N--CA 1.487 2.058 0 O-C-N 121.652 -0.655 . . . . 0.0 113.789 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.0 -22.18 45.9 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -170.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -105.66 142.08 36.0 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.481 1.491 . . . . 0.0 111.593 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -86.82 141.71 28.62 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.2 50.71 60.72 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -170.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.532 HH21 HD22 ' A' ' 74' ' ' LEU . 18.5 ttt180 -109.38 125.08 52.01 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.544 0.738 . . . . 0.0 110.344 -170.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.61 35.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.4 159.35 37.3 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.377 1.085 . . . . 0.0 113.348 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.5 m -133.33 125.13 28.54 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -121.12 136.1 55.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.906 -0.496 . . . . 0.0 111.677 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -146.65 156.37 43.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.912 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.35 126.69 47.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -111.64 94.22 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 158.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.83 -110.44 3.16 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.163 -0.961 . . . . 0.0 115.236 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -95.74 7.61 45.81 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 164.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -110.96 127.15 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.23 1.377 . . . . 0.0 111.834 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 tp -85.29 115.87 23.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.168 0.987 . . . . 0.0 109.39 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.19 120.02 39.62 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 tp -117.32 120.75 39.17 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.835 0.854 . . . . 0.0 110.425 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -97.09 123.5 40.86 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 162.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.7 mtm -112.88 126.65 55.68 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.519 0.6 . . . . 0.0 109.763 170.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -121.82 137.19 54.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.542 -0.724 . . . . 0.0 112.364 -167.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.4 126.8 5.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.12 0.568 . . . . 0.0 110.922 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 57.25 40.93 27.53 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.28 -13.34 2.79 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 120.261 2.864 . . . . 0.0 120.261 -163.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.75 122.08 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 119.701 1.75 . . . . 0.0 109.174 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -102.9 126.47 50.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 122.949 0.5 . . . . 0.0 111.074 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.6 t -95.77 131.57 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.269 0.628 . . . . 0.0 111.131 162.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -112.69 112.35 23.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.062 0.545 . . . . 0.0 110.092 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -115.32 144.81 43.19 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.44 0.696 . . . . 0.0 111.847 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.0 t -123.62 127.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.61 131.63 46.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.59 0.756 . . . . 0.0 110.43 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -104.32 131.66 51.42 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.546 -1.346 . . . . 0.0 112.031 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -68.99 113.52 6.45 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.71 -31.17 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 170.871 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 . . . . . 0 CA--C 1.567 1.634 0 CA-C-O 121.232 0.539 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.9 3.25 42.7 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -59.73 120.54 9.72 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.076 1.762 . . . . 0.0 114.793 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 174.12 28.2 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 122.847 1.248 . . . . 0.0 115.446 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -107.71 111.52 23.76 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.108 0.963 . . . . 0.0 108.573 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -114.28 111.85 22.17 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -90.66 139.8 30.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.057 -1.027 . . . . 0.0 113.189 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 36.7 ttp -72.94 125.6 27.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.441 -1.412 . . . . 0.0 114.17 -171.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.06 -50.3 7.14 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 169.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.3 p -136.79 149.28 47.69 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 119.369 0.986 . . . . 0.0 113.459 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -128.21 103.73 7.35 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.42 -60.8 1.87 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.24 43.31 3.15 Favored 'General case' 0 CA--C 1.572 1.826 0 C-N-CA 123.868 0.867 . . . . 0.0 110.575 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -76.65 -45.66 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.79 -47.95 70.3 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 166.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.59 -37.22 86.82 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.38 -43.75 83.88 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 120.85 1.659 . . . . 0.0 115.149 162.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.83 -38.14 85.85 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 172.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -55.93 -43.23 77.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 162.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.22 62.28 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.56 12.48 29.43 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 164.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.264 28.0 t70 56.92 47.9 16.88 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 120.602 1.546 . . . . 0.0 115.036 -174.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -93.35 155.57 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.448 -0.783 . . . . 0.0 110.722 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 151.13 47.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.45 -43.87 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.73 62.75 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 33.8 tp -61.35 -39.34 90.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -54.1 -39.01 65.99 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -71.57 -50.56 29.84 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.68 -54.56 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 123.906 0.883 . . . . 0.0 112.468 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.71 75.61 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.91 -39.89 91.0 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 165.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.78 -24.01 62.51 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.04 148.04 51.54 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.45 1.477 . . . . 0.0 113.72 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -107.67 86.54 2.95 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.03 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 53.5 Cg_endo -72.69 154.82 54.51 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 115.934 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -118.81 111.42 18.42 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -83.53 107.19 15.84 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.59 -0.694 . . . . 0.0 110.708 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.54 107.95 19.91 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.84 125.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -110.89 105.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.0 105.96 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.269 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.2 77.85 5.22 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.68 0.792 . . . . 0.0 109.922 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.29 -97.12 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 O-C-N 121.416 -0.803 . . . . 0.0 114.793 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.47 -17.51 20.49 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 164.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.99 114.11 21.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.789 1.631 . . . . 0.0 111.264 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.7 ttm -121.04 124.13 44.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.568 0.747 . . . . 0.0 111.225 -167.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.6 mt -114.08 96.79 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.6 mt -90.17 112.29 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -106.48 97.79 7.55 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 m -82.77 94.44 7.63 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.0 109.338 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -90.81 131.75 36.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.121 0.568 . . . . 0.0 111.687 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -150.88 155.9 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.097 0.951 . . . . 0.0 111.909 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.8 p -61.13 -32.57 72.26 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -78.1 -55.11 5.54 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -155.57 139.95 16.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.959 0.799 . . . . 0.0 110.238 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -88.82 125.11 34.76 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.051 0.54 . . . . 0.0 110.826 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -104.21 118.03 35.65 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.109 0.868 . . . . 0.0 110.584 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.11 120.7 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.8 mtp -108.84 111.54 23.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.258 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.09 108.44 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.408 0.683 . . . . 0.0 109.272 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -152.48 155.02 36.67 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -167.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.35 134.73 40.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.817 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.44 123.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.78 5.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -154.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -95.18 135.39 36.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.389 1.095 . . . . 0.0 112.772 -161.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -85.66 107.08 17.39 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 122.033 -0.417 . . . . 0.0 110.15 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -116.85 157.83 24.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.81 0.844 . . . . 0.0 112.33 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.63 104.46 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.672 -1.268 . . . . 0.0 112.167 169.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -90.75 107.09 18.95 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 121.39 -0.818 . . . . 0.0 108.959 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -82.7 120.29 25.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 164.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.401 HD22 HH21 ' A' ' 104' ' ' ARG . 4.7 mp -90.9 49.97 1.73 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -74.17 132.96 42.7 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.218 1.007 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 -50.17 1.03 Allowed Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.571 -0.705 . . . . 0.0 114.576 -158.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 mt -79.35 -66.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 125.002 1.321 . . . . 0.0 111.067 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -143.99 -6.54 0.76 Allowed 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.877 1.671 . . . . 0.0 114.175 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.287 3.3 t70 52.03 45.56 28.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -127.01 141.08 51.88 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.574 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -84.23 127.36 33.9 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.707 0.765 . . . . 0.0 112.564 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.6 m -113.51 141.29 47.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.578 0.751 . . . . 0.0 111.076 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.29 98.35 4.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 159.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.41 HG23 ' SG ' ' A' ' 95' ' ' CYS . 89.9 m -99.66 121.53 41.36 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.0 m -109.33 120.42 42.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 t -110.64 124.99 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.0 m -134.63 158.52 43.83 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 112.565 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 79.2 m95 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 112.093 177.384 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.671 0.748 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.66 100.71 13.51 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.734 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -108.24 140.34 41.62 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.677 0.791 . . . . 0.0 111.482 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' A' ' 84' ' ' THR . 50.2 t -134.19 141.44 47.05 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -170.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -114.17 128.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.783 0.833 . . . . 0.0 109.84 166.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -101.88 103.86 14.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.499 0.72 . . . . 0.0 109.264 173.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -89.14 99.75 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.187 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.16 94.4 0.09 OUTLIER Glycine 0 N--CA 1.488 2.114 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 -169.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.296 40.0 mt-10 73.19 -51.07 0.71 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 161.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -99.27 144.77 28.01 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.622 0.769 . . . . 0.0 111.306 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.77 162.48 21.7 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.69 51.97 48.93 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.401 HH21 HD22 ' A' ' 74' ' ' LEU . 27.7 ttt180 -121.19 122.27 39.6 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.533 0.682 . . . . 0.0 111.926 -159.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.93 -162.83 34.44 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 121.447 -0.783 . . . . 0.0 114.064 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.268 67.3 p-90 -156.79 168.32 27.8 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 123.215 1.484 . . . . 0.0 113.115 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -146.86 130.57 16.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.975 -1.703 . . . . 0.0 108.599 168.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -127.53 142.48 51.37 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.282 1.039 . . . . 0.0 112.255 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -146.59 167.48 23.63 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.9 mt -114.62 126.7 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.284 -0.885 . . . . 0.0 109.176 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.35 89.85 3.24 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 163.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.67 -110.47 3.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -99.32 17.12 20.88 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -110.55 126.21 54.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.496 1.044 . . . . 0.0 111.593 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.4 tp -86.43 122.39 30.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.801 0.84 . . . . 0.0 109.683 166.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -111.15 119.49 39.15 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.0 tp -118.17 128.63 54.9 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.717 0.807 . . . . 0.0 110.54 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -108.53 119.34 39.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.619 0.767 . . . . 0.0 109.547 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.2 mtm -112.92 129.87 56.32 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.487 0.715 . . . . 0.0 111.312 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -123.61 132.78 53.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 111.901 -167.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.27 129.79 14.91 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.779 0.831 . . . . 0.0 109.305 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 55.57 36.08 26.45 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.07 -3.83 27.43 Favored Glycine 0 CA--C 1.557 2.684 0 N-CA-C 119.878 2.711 . . . . 0.0 119.878 -164.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.92 113.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 120.071 1.935 . . . . 0.0 109.091 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.0 m -93.37 119.39 32.44 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -173.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.8 t -90.81 125.96 35.87 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.385 0.674 . . . . 0.0 112.067 164.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -98.4 122.84 42.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.791 0.436 . . . . 0.0 110.33 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -117.82 139.85 50.51 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.315 0.646 . . . . 0.0 110.664 168.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.0 130.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -128.82 136.42 50.46 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 123.299 0.64 . . . . 0.0 111.411 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -96.09 127.32 42.0 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.649 1.179 . . . . 0.0 111.501 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -68.55 119.82 13.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.185 0.902 . . . . 0.0 112.777 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.22 -38.5 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 CA--C 1.561 1.389 0 CA-C-N 119.78 1.173 . . . . 0.0 107.909 169.542 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.343 15.3 t70 . . . . . 0 CA--C 1.56 1.343 0 CA-C-O 121.705 0.764 . . . . 0.0 112.66 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.41 15.62 1.22 Allowed 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -59.19 117.32 4.61 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.48 176.08 30.12 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-O 122.6 1.111 . . . . 0.0 115.865 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -106.94 113.86 27.6 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.442 1.097 . . . . 0.0 109.034 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -117.56 112.99 21.32 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -92.67 140.64 29.32 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.843 -1.161 . . . . 0.0 113.397 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.5 ttp -70.4 117.37 11.85 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-N 119.726 1.148 . . . . 0.0 114.0 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.14 -46.88 21.98 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 167.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.2 m -153.75 160.49 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.811 1.291 . . . . 0.0 112.704 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -150.33 112.75 4.68 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.773 -174.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.3 -69.74 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -117.19 42.22 2.59 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -73.44 -36.01 65.86 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -59.85 -39.56 85.6 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.79 -40.28 83.95 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 167.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.35 -47.81 82.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.25 -39.37 75.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -54.4 -43.43 71.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 162.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.85 51.7 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 165.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.16 2.2 47.74 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.297 20.2 t70 63.64 49.34 3.04 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -167.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.83 146.41 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.162 0.982 . . . . 0.0 110.13 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -65.89 153.63 41.47 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.3 t -59.72 -44.74 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.45 -49.55 74.26 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.76 -43.25 98.23 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -52.46 -50.84 61.84 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 165.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.98 -45.14 93.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.27 -54.43 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 118.945 0.793 . . . . 0.0 111.6 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.51 -29.92 65.35 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.29 -26.8 56.26 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.6 144.37 57.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.367 1.439 . . . . 0.0 113.563 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -107.73 84.62 2.05 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.847 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.02 156.5 47.46 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.579 2.186 . . . . 0.0 115.171 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.42 118.83 33.78 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HZ1' HD22 ' A' ' 117' ' ' LEU . 60.3 mttt -84.81 108.14 17.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.36 -0.837 . . . . 0.0 110.661 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -96.22 107.66 20.03 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.1 128.13 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.51 107.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -100.04 118.7 36.98 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.356 0.663 . . . . 0.0 110.708 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.41 81.83 1.58 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 -104.19 1.16 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -82.3 -27.36 32.35 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -79.12 116.13 19.21 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.196 1.362 . . . . 0.0 111.943 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -124.28 127.13 47.2 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 121.506 0.67 . . . . 0.0 110.971 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.05 99.26 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.3 mt -91.24 107.03 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -100.95 99.91 10.45 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -88.0 99.41 12.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.08 129.07 48.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.066 0.546 . . . . 0.0 111.848 -162.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -148.18 145.92 28.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.58 0.705 . . . . 0.0 110.379 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.5 p -60.78 -26.03 66.96 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -73.31 -50.63 21.1 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 165.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -159.74 133.44 7.21 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.624 1.102 . . . . 0.0 111.268 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -97.91 139.73 33.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.64 . . . . 0.0 111.395 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -123.77 119.99 31.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -0.779 . . . . 0.0 110.251 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -113.35 122.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.3 mtp -109.48 106.17 15.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.717 -0.614 . . . . 0.0 109.793 175.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -107.76 112.28 24.87 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.516 0.726 . . . . 0.0 109.738 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.24 155.84 31.51 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -95.67 130.84 42.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 111.054 164.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 t -69.14 123.53 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 109.933 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.14 -34.41 4.84 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 -161.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -94.56 147.55 23.16 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.815 1.307 . . . . 0.0 113.065 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.59 124.69 35.94 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.787 -0.57 . . . . 0.0 110.865 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -133.53 151.95 51.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.568 0.747 . . . . 0.0 112.568 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.4 110.39 7.65 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.436 1.113 . . . . 0.0 112.324 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -94.04 100.12 12.3 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.224 1.01 . . . . 0.0 109.554 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.26 104.58 8.94 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.447 0.641 . . . . 0.0 110.003 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mt -90.45 45.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -81.86 131.5 35.26 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.198 0.999 . . . . 0.0 110.546 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.2 -34.99 4.48 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.924 1.529 . . . . 0.0 116.924 -159.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 mt -86.36 -67.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 124.439 1.096 . . . . 0.0 109.553 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -136.59 -7.35 1.94 Allowed 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.257 26.8 t0 57.4 64.69 1.53 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 120.304 1.411 . . . . 0.0 114.666 -166.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -136.82 144.12 43.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.6 -0.688 . . . . 0.0 111.057 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -97.6 112.02 24.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 111.066 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -110.31 146.55 35.53 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.41 0.684 . . . . 0.0 111.701 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.8 mmt -82.09 97.6 8.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.161 -1.587 . . . . 0.0 110.229 171.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.436 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 36.1 m -91.91 126.29 36.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 111.634 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 m -107.39 125.96 51.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 162.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.82 127.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -129.29 159.08 37.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.029 0.931 . . . . 0.0 111.829 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.0 m95 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 120.603 -1.311 . . . . 0.0 112.278 173.427 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.55 0.691 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.6 tp -88.58 107.56 18.97 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 123.286 0.634 . . . . 0.0 109.761 173.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -114.08 132.4 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.583 0.753 . . . . 0.0 111.527 -167.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.436 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 40.6 t -131.65 138.42 48.75 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.38 124.77 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.444 167.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -101.06 97.26 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 0.0 109.544 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -85.2 115.82 23.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 112.01 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.59 0.3 Allowed Glycine 0 N--CA 1.483 1.833 0 O-C-N 121.396 -0.815 . . . . 0.0 113.663 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -87.67 -7.89 56.85 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -166.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -126.38 143.7 51.08 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.458 1.481 . . . . 0.0 112.081 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -85.67 113.63 22.02 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.424 0.63 . . . . 0.0 112.523 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.93 56.68 6.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -101.54 130.68 47.88 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.413 0.625 . . . . 0.0 111.243 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.15 -170.21 40.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -155.62 153.45 30.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.2 m -127.83 121.05 29.13 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -119.65 123.42 43.79 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.599 0.759 . . . . 0.0 110.67 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -142.86 153.29 43.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 113.194 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -100.64 126.12 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.0 109.227 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.57 92.83 3.99 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.99 -115.13 4.82 Favored Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.637 -0.664 . . . . 0.0 114.473 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 p30 -94.58 8.05 43.57 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 164.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.18 126.71 53.55 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.598 1.545 . . . . 0.0 111.141 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.41 113.57 25.51 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.32 1.048 . . . . 0.0 109.226 169.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -99.46 125.48 45.21 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 109.531 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.433 HD22 ' HZ1' ' A' ' 40' ' ' LYS . 31.6 tp -122.47 120.5 34.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.696 0.798 . . . . 0.0 110.267 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.05 130.33 47.05 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.936 165.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -125.02 129.26 49.94 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.68 1.127 . . . . 0.0 111.111 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.21 144.36 45.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.483 -0.76 . . . . 0.0 112.715 -171.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.73 127.89 4.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.539 0.736 . . . . 0.0 110.162 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 52.57 50.28 18.55 Favored 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.89 -20.29 1.88 Allowed Glycine 0 CA--C 1.557 2.671 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.7 t -67.84 172.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 CA-C-N 120.146 1.973 . . . . 0.0 112.993 -169.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.5 m -144.28 115.3 7.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 119.31 -2.119 . . . . 0.0 109.83 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -93.84 121.92 35.79 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.752 0.821 . . . . 0.0 111.381 166.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -98.11 123.99 42.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.822 0.449 . . . . 0.0 111.433 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -122.0 139.19 53.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.937 0.895 . . . . 0.0 110.499 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 36.2 t -120.26 126.77 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -127.58 122.33 32.93 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.56 0.744 . . . . 0.0 110.575 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -98.19 135.24 40.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.471 -1.393 . . . . 0.0 112.872 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -69.11 121.79 17.44 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.33 -35.78 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 120.057 1.299 . . . . 0.0 108.232 169.885 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.571 1.783 0 CA-C-O 117.549 -1.215 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.77 114.07 3.41 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 122.701 2.268 . . . . 0.0 114.709 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 m -69.35 143.85 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -172.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -78.97 95.85 5.58 Favored 'General case' 0 CA--C 1.565 1.529 0 O-C-N 121.616 -0.677 . . . . 0.0 112.408 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -76.76 -0.45 23.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -58.25 104.94 0.24 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 121.293 1.86 . . . . 0.0 114.767 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.39 -179.03 36.17 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-O 123.117 1.398 . . . . 0.0 115.938 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -113.38 116.19 29.28 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 113.651 -1.274 . . . . 0.0 109.399 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -117.19 113.36 22.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -167.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -90.37 140.19 29.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.104 -0.997 . . . . 0.0 113.337 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.6 ttm -67.2 122.03 16.94 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.17 -45.72 13.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 166.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.7 m -152.71 159.6 43.15 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.418 -1.426 . . . . 0.0 113.871 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -134.43 113.13 11.53 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.594 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -122.01 123.68 42.2 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.331 0.653 . . . . 0.0 110.492 -171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.276 37.7 t30 68.06 30.47 5.89 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -79.25 -40.57 30.26 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.159 -1.588 . . . . 0.0 115.179 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -55.03 -42.2 72.31 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -66.11 -42.08 89.71 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 170.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -55.94 -48.06 76.41 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.75 -39.88 80.09 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -54.9 -44.05 73.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.69 -23.76 60.08 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 165.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.3 3.65 38.67 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.288 17.5 t0 61.27 48.33 6.26 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -169.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.29 147.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.001 0.905 . . . . 0.0 110.329 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -63.06 152.76 36.13 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.3 t -60.63 -43.75 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.84 -52.71 61.91 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -62.82 -36.96 84.91 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -54.04 -50.27 67.07 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 163.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -66.58 -44.92 80.95 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.07 -57.5 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 119.204 0.911 . . . . 0.0 111.928 172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.49 -30.23 70.98 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 117.399 2.37 . . . . 0.0 117.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -71.15 -35.08 71.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 165.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.68 -32.55 73.29 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 167.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.5 mt -73.92 128.15 34.75 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 119.373 0.988 . . . . 0.0 112.331 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -102.64 94.36 5.05 Favored Pre-proline 0 CA--C 1.571 1.77 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.942 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.64 161.14 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 122.294 1.996 . . . . 0.0 115.683 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -104.16 124.41 49.05 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.629 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -88.24 109.34 19.85 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.234 -0.916 . . . . 0.0 110.653 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.67 112.18 23.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 108.91 163.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.0 mt -106.97 128.8 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.29 112.72 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.44 1.096 . . . . 0.0 110.52 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -127.34 76.03 1.63 Allowed 'General case' 0 CA--C 1.569 1.679 0 O-C-N 121.483 -0.76 . . . . 0.0 110.143 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -102.32 1.21 Allowed Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.436 -0.79 . . . . 0.0 114.214 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.83 -26.35 20.57 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 162.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -70.56 134.31 47.54 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 121.333 1.879 . . . . 0.0 112.768 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 ttm -145.5 130.73 18.51 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.43 0.633 . . . . 0.0 112.074 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.8 mt -115.15 108.35 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.16 110.02 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.3 mtt-85 -100.98 106.31 17.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.65 -0.656 . . . . 0.0 109.822 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.1 m -88.97 99.45 12.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.49 125.86 41.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.107 0.563 . . . . 0.0 111.525 -163.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -147.31 155.39 41.98 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.097 0.951 . . . . 0.0 111.739 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.6 p -62.83 -32.86 74.15 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -75.46 -54.02 7.73 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -152.12 134.01 14.88 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.839 0.745 . . . . 0.0 110.383 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -92.77 122.42 35.14 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 123.13 0.572 . . . . 0.0 109.821 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -109.55 106.61 16.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.305 0.642 . . . . 0.0 110.499 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.1 mp -105.08 124.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.2 mtp -108.42 110.28 21.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.768 0.827 . . . . 0.0 109.498 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -107.52 118.17 36.01 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.338 0.655 . . . . 0.0 109.775 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -155.34 155.2 33.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -96.38 129.27 43.76 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.809 0.814 . . . . 0.0 110.713 159.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.96 128.52 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 C-N-CA 123.995 0.918 . . . . 0.0 109.686 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.13 -47.41 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 115.779 1.071 . . . . 0.0 115.779 -156.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -83.92 135.85 34.32 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -167.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -85.35 105.87 16.32 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.709 0.403 . . . . 0.0 110.36 169.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -113.49 157.14 22.37 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.864 0.84 . . . . 0.0 113.06 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.21 101.58 5.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.161 -0.962 . . . . 0.0 112.349 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -102.41 104.69 15.18 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.496 -0.752 . . . . 0.0 110.332 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -81.8 113.98 20.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.34 66.3 5.79 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.553 1.168 . . . . 0.0 112.101 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.3 m -75.71 117.64 17.68 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.387 1.075 . . . . 0.0 111.25 -168.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.56 -52.62 0.62 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -162.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.0 mt -74.02 -68.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 124.733 1.213 . . . . 0.0 110.178 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.6 p-10 -130.89 -6.09 3.99 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.285 17.3 t0 51.57 45.31 28.26 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 -166.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -108.38 139.11 43.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 110.582 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -81.6 116.12 21.2 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 112.01 170.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.5 m -108.5 142.0 39.55 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.683 0.793 . . . . 0.0 111.293 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.01 94.73 7.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.132 168.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 84.8 m -99.82 123.55 44.19 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.576 -0.702 . . . . 0.0 110.621 -164.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.1 m -112.59 122.01 46.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.65 132.72 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.9 m -126.76 146.78 50.1 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.921 0.888 . . . . 0.0 111.685 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -87.43 116.9 25.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 111.961 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -105.06 62.88 0.7 Allowed 'General case' 0 CA--C 1.575 1.913 0 O-C-N 121.811 -0.556 . . . . 0.0 110.307 161.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.76 -95.12 0.12 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.096 1.599 . . . . 0.0 117.096 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.49 -32.85 60.7 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 167.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -94.88 121.69 36.74 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 119.302 0.956 . . . . 0.0 111.192 -177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.2 tp -91.0 111.23 22.6 Favored 'General case' 0 CA--C 1.561 1.367 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 169.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -115.47 123.79 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.125 0.57 . . . . 0.0 110.614 -162.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.7 t -122.72 136.69 54.95 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.43 128.23 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.401 0.68 . . . . 0.0 109.543 165.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -104.34 101.68 11.38 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.549 0.74 . . . . 0.0 109.169 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -85.48 115.57 23.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.863 -1.148 . . . . 0.0 111.596 -170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.57 -120.37 0.63 Allowed Glycine 0 N--CA 1.485 1.915 0 O-C-N 121.905 -0.497 . . . . 0.0 113.516 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.4 -21.52 33.0 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -172.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -108.85 144.78 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.654 1.57 . . . . 0.0 113.033 -166.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -80.55 115.6 20.15 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.34 0.59 . . . . 0.0 112.179 -171.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.46 45.47 78.11 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 117.112 1.605 . . . . 0.0 117.112 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -85.05 124.35 31.63 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.388 0.613 . . . . 0.0 111.329 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.19 -169.14 41.3 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.248 0.916 . . . . 0.0 114.817 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -157.77 153.25 26.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.983 0.897 . . . . 0.0 113.211 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -129.26 125.33 36.62 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.263 3.3 pt20 -126.58 138.64 53.48 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 175.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -148.59 159.73 43.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.454 -0.779 . . . . 0.0 113.0 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 45.8 mt -98.4 125.33 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.32 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -111.53 97.09 6.49 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 161.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.84 -109.74 2.89 Favored Glycine 0 N--CA 1.49 2.238 0 O-C-N 121.46 -0.775 . . . . 0.0 114.15 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -100.46 15.41 28.0 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 161.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -113.0 121.22 43.99 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.912 1.687 . . . . 0.0 111.842 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 tp -79.97 117.02 20.44 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.218 1.007 . . . . 0.0 110.138 167.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -105.68 117.66 34.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.2 tp -113.96 126.83 55.59 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.027 0.931 . . . . 0.0 110.801 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -106.61 123.53 48.25 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.345 0.658 . . . . 0.0 109.489 164.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 72.1 mtm -113.21 128.13 56.38 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.1 mtm180 -115.07 137.0 52.51 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.84 119.98 7.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.548 0.739 . . . . 0.0 110.208 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 55.2 46.92 22.81 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.02 -33.0 0.91 Allowed Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.361 2.504 . . . . 0.0 119.361 -164.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.51 119.93 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 124.828 1.251 . . . . 0.0 111.209 -166.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 47.0 m -102.85 115.96 31.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.126 0.571 . . . . 0.0 111.022 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 t -88.8 131.27 35.15 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.056 0.542 . . . . 0.0 111.427 166.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -113.1 119.66 38.61 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.027 0.531 . . . . 0.0 110.294 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -124.95 133.73 52.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.43 0.692 . . . . 0.0 111.0 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.25 130.39 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.58 128.1 38.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.399 0.68 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -98.94 133.76 42.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.343 -1.473 . . . . 0.0 112.39 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -69.26 122.52 19.02 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.55 -38.67 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 N--CA 1.488 1.436 0 CA-C-N 119.927 1.239 . . . . 0.0 107.962 168.516 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.42 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . 0.293 48.4 ttp . . . . . 0 CA--C 1.573 1.845 0 CA-C-O 115.583 -2.151 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.48 -78.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 125.39 2.961 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 t -93.67 -30.84 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 123.563 0.745 . . . . 0.0 112.932 166.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.287 6.0 t70 70.31 86.44 0.13 Allowed 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.757 1.623 . . . . 0.0 112.587 -172.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -81.32 13.92 2.69 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -63.38 116.76 5.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.36 173.18 26.44 Favored Glycine 0 N--CA 1.488 2.157 0 CA-C-O 122.697 1.165 . . . . 0.0 115.859 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -101.87 116.83 33.55 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.189 0.995 . . . . 0.0 109.497 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -117.82 110.8 18.23 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -93.34 139.88 30.17 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.111 -0.993 . . . . 0.0 112.851 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.4 ttp -69.46 125.71 27.54 Favored 'General case' 0 CA--C 1.571 1.772 0 O-C-N 120.419 -1.426 . . . . 0.0 114.68 -173.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.84 -50.92 6.14 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 169.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.5 p -136.36 155.17 50.42 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -143.55 117.65 9.49 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.032 0.933 . . . . 0.0 108.947 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.05 -71.38 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -166.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -121.97 41.88 3.27 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.956 0.884 . . . . 0.0 112.108 -171.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.455 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 8.1 t80 -73.57 -39.94 64.29 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -57.22 -43.84 83.22 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -67.78 -39.05 84.1 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -56.54 -45.93 80.91 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 167.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 mt -71.38 -37.48 71.6 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 ttp85 -55.09 -46.0 75.46 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 161.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.0 -20.81 41.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 165.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.06 5.68 50.63 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.286 23.8 t70 61.03 50.13 5.25 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.52 1.509 . . . . 0.0 114.87 -171.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -93.38 150.38 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.892 0.854 . . . . 0.0 109.891 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -63.81 152.42 39.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.79 -44.97 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.28 64.13 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.37 -38.52 89.9 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -53.99 -53.1 57.63 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -62.15 -43.72 98.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.4 mt -64.1 -53.81 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 123.898 0.879 . . . . 0.0 111.919 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.65 85.07 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -61.91 -36.67 82.02 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.58 -20.68 53.62 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.23 156.88 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -96.15 103.17 12.72 Favored Pre-proline 0 CA--C 1.573 1.86 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.182 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.49 146.9 19.63 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.696 2.264 . . . . 0.0 112.947 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -134.28 107.7 7.8 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttp -83.77 107.45 16.19 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.516 -0.74 . . . . 0.0 111.094 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -94.31 106.43 18.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 166.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.3 mt -104.63 129.24 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.6 t -115.2 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -99.71 109.84 22.28 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.082 0.553 . . . . 0.0 110.209 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -100.39 81.14 2.32 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.439 0.696 . . . . 0.0 109.304 167.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.63 -102.97 1.03 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 115.02 0.768 . . . . 0.0 115.02 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -86.32 -26.83 24.69 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 164.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -75.2 119.27 19.1 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 120.417 1.462 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.7 ttm -122.29 123.44 41.44 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 121.586 0.707 . . . . 0.0 110.538 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.9 mt -110.69 95.59 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.7 mt -93.1 104.25 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -100.82 99.29 9.78 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -87.09 100.49 12.68 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.311 -0.868 . . . . 0.0 109.364 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.3 mt -104.49 112.54 25.64 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.674 0.75 . . . . 0.0 110.531 -164.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -131.99 155.08 48.61 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.976 0.893 . . . . 0.0 111.309 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -65.58 -19.23 65.83 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -83.97 -50.76 7.72 Favored 'General case' 0 CA--C 1.569 1.681 0 CA-C-N 119.057 0.844 . . . . 0.0 113.065 168.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -153.2 148.22 26.64 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.882 0.848 . . . . 0.0 110.505 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -103.52 130.44 50.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.885 . . . . 0.0 110.125 172.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -117.74 104.59 11.13 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.79 -0.569 . . . . 0.0 110.765 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.48 128.23 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 123.603 0.761 . . . . 0.0 109.122 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -113.41 108.1 16.75 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.722 0.809 . . . . 0.0 109.513 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.27 98.13 7.28 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.641 0.776 . . . . 0.0 110.446 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -144.8 155.92 43.76 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -93.11 131.34 38.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.863 -1.148 . . . . 0.0 111.007 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.1 t -68.37 126.64 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.65 -0.656 . . . . 0.0 110.689 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.14 -30.61 8.14 Favored Glycine 0 CA--C 1.552 2.384 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -163.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -91.86 144.8 25.11 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.168 1.484 . . . . 0.0 112.746 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.6 128.08 36.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 111.507 168.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.01 149.27 51.19 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.655 0.782 . . . . 0.0 112.36 -173.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -74.15 101.08 3.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.035 -1.04 . . . . 0.0 111.913 172.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -94.03 116.01 28.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.546 0.738 . . . . 0.0 110.206 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -80.94 127.43 32.56 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.586 0.707 . . . . 0.0 109.72 163.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mt -99.37 60.98 1.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.135 0.969 . . . . 0.0 111.128 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -81.21 119.15 23.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.318 1.047 . . . . 0.0 111.712 -166.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.65 -42.4 1.92 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -162.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.1 mt -72.21 -69.57 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.107 0.963 . . . . 0.0 110.125 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -141.3 -1.02 1.37 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 166.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 28.2 m-20 63.93 65.26 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 120.22 1.373 . . . . 0.0 113.575 -173.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HE ' ' HZ2' ' A' ' 101' ' ' LYS . 82.9 mmt-85 -122.2 142.34 50.53 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.612 0.765 . . . . 0.0 110.643 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.38 111.12 22.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.529 165.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.8 m -117.7 145.02 44.72 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.45 0.7 . . . . 0.0 112.098 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.0 mtp -83.4 98.99 9.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -98.86 122.56 42.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.076 0.55 . . . . 0.0 110.182 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.0 m -102.68 131.87 49.19 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 95' ' ' CYS . 38.2 t -117.91 122.59 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 171.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.1 m -131.01 158.05 41.34 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.78 0.832 . . . . 0.0 112.007 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -85.8 121.42 28.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.69 -1.256 . . . . 0.0 112.214 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -94.66 73.61 3.68 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.533 0.682 . . . . 0.0 109.264 157.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.85 -100.35 0.32 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -169.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.44 -29.43 28.07 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -83.55 131.26 35.0 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.85 1.205 . . . . 0.0 111.823 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.3 tp -89.95 103.34 16.01 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 123.24 0.616 . . . . 0.0 109.511 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -110.74 131.79 54.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.572 0.749 . . . . 0.0 111.269 -167.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 86' ' ' VAL . 50.2 t -130.93 141.86 50.31 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -169.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.43 128.1 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.913 0.885 . . . . 0.0 109.302 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -106.22 95.99 6.16 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.711 0.804 . . . . 0.0 108.852 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.76 120.46 27.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 112.128 -170.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.49 -115.55 0.47 Allowed Glycine 0 N--CA 1.486 1.989 0 O-C-N 121.25 -0.906 . . . . 0.0 113.531 171.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.7 -13.5 57.77 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.428 ' HZ2' ' HE ' ' A' ' 80' ' ' ARG . 21.1 mmtp -114.71 146.4 40.96 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.294 1.406 . . . . 0.0 112.359 -170.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -90.24 103.27 15.97 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.462 -162.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.42 50.44 21.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -170.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -89.76 137.21 32.53 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.945 0.879 . . . . 0.0 111.933 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.42 -161.17 27.67 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 121.936 0.742 . . . . 0.0 114.257 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -157.42 157.93 34.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.729 -0.866 . . . . 0.0 112.638 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -132.77 124.74 28.66 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . 0.286 1.3 pt20 -129.43 141.82 50.94 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -151.48 161.2 43.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 0.0 112.53 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -103.83 123.88 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.934 . . . . 0.0 109.15 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.33 85.19 2.21 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 162.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.05 -111.77 4.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 115.777 1.071 . . . . 0.0 115.777 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.96 -5.95 58.13 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 165.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -107.66 127.28 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 120.396 1.453 . . . . 0.0 111.92 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.1 tp -88.41 117.86 27.63 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.847 0.859 . . . . 0.0 109.724 166.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -100.77 121.52 41.82 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.756 0.823 . . . . 0.0 109.277 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.4 tp -117.53 130.69 56.58 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.993 0.917 . . . . 0.0 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -114.77 118.93 34.97 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.733 0.813 . . . . 0.0 109.554 167.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 73.4 mtm -110.63 132.04 54.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.497 -0.752 . . . . 0.0 111.265 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -124.35 133.73 53.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.86 . . . . 0.0 112.169 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.57 126.88 8.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.272 0.629 . . . . 0.0 110.966 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 57.3 36.51 27.38 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -172.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.04 -19.94 2.65 Favored Glycine 0 CA--C 1.558 2.753 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 -162.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.79 119.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 119.568 1.684 . . . . 0.0 109.562 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.9 m -101.59 121.84 42.75 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.446 0.641 . . . . 0.0 110.743 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.455 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 7.1 t -97.6 124.82 42.02 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 169.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -102.31 127.29 49.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.957 -0.465 . . . . 0.0 111.666 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -127.16 142.82 51.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.941 0.896 . . . . 0.0 111.274 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.54 132.52 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -128.4 132.13 48.51 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.516 0.726 . . . . 0.0 111.235 -176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -97.2 127.98 43.66 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.702 -1.249 . . . . 0.0 112.18 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -67.19 122.94 18.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.1 -39.71 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 171.103 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.448 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.573 1.847 0 CA-C-O 117.861 -1.066 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.96 120.66 7.54 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.657 2.238 . . . . 0.0 114.77 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.61 148.5 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.766 0.793 . . . . 0.0 113.063 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -90.51 106.2 18.34 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.104 -0.998 . . . . 0.0 111.136 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -81.27 4.49 20.29 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 117.263 2.319 . . . . 0.0 117.263 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -57.83 108.57 0.59 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.725 1.602 . . . . 0.0 115.144 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.89 179.12 33.5 Favored Glycine 0 N--CA 1.486 2.01 0 CA-C-O 122.756 1.198 . . . . 0.0 115.753 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -110.48 118.84 37.34 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.704 1.201 . . . . 0.0 109.151 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -119.15 118.86 32.5 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -88.76 144.89 25.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.943 -1.098 . . . . 0.0 112.905 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.415 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 7.3 ttp -71.83 124.68 25.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.498 -1.376 . . . . 0.0 113.495 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.1 mt -88.07 -48.4 7.77 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 169.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.9 m -157.27 160.08 38.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.4 . . . . 0.0 112.993 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -142.69 124.5 15.1 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.342 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -126.41 125.08 41.59 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.062 0.945 . . . . 0.0 109.877 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 27.1 t30 66.1 37.17 5.3 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 116.96 2.208 . . . . 0.0 116.96 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.557 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 5.7 t80 -79.04 -43.45 24.2 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.27 -34.76 77.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -70.37 -41.43 73.1 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -53.34 -47.31 69.47 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 120.458 1.481 . . . . 0.0 114.842 166.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 mt -71.89 -38.35 70.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.83 -45.38 78.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.085 -1.635 . . . . 0.0 115.061 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.55 -18.75 43.31 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 166.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.34 -4.54 59.05 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 25.8 t70 67.38 52.97 0.78 Allowed 'General case' 0 CA--C 1.572 1.805 0 CA-C-N 120.154 1.343 . . . . 0.0 113.996 -166.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -102.86 146.43 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.977 0.894 . . . . 0.0 109.685 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -65.76 152.38 44.45 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.8 t -60.28 -44.12 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -51.88 65.88 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 116.004 1.854 . . . . 0.0 116.004 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.82 -41.7 96.22 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -52.33 -53.21 47.45 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 166.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -63.23 -43.91 96.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -61.88 -53.65 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 123.631 0.772 . . . . 0.0 111.869 171.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.68 81.77 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -68.6 -30.91 69.75 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.31 -29.52 62.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 166.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.2 mt -72.15 131.55 42.94 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.041 1.291 . . . . 0.0 112.723 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -105.63 89.51 3.48 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.482 173.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 74.4 Cg_endo -72.6 165.38 32.88 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.371 2.047 . . . . 0.0 115.601 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -111.6 120.24 41.42 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.509 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -89.92 110.58 21.53 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.438 -0.789 . . . . 0.0 111.004 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -98.53 110.13 22.78 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.713 -0.617 . . . . 0.0 109.802 169.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.44 125.83 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -108.43 107.56 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 165.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -102.42 102.09 12.38 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.643 0.777 . . . . 0.0 109.998 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -92.75 79.32 4.75 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 109.963 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.55 -101.79 0.81 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 114.508 0.563 . . . . 0.0 114.508 -173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -86.34 -26.62 24.76 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -79.1 106.27 11.02 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 120.772 1.624 . . . . 0.0 111.635 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.5 ttm -112.45 124.03 51.6 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.968 0.907 . . . . 0.0 110.722 -172.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -114.95 96.84 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.479 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.93 108.36 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -102.6 98.94 8.92 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.226 0.61 . . . . 0.0 109.38 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -84.14 101.41 11.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.14 127.5 43.16 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.074 0.55 . . . . 0.0 111.692 -166.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 t -150.79 153.48 35.53 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.981 0.896 . . . . 0.0 111.646 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.6 -31.83 72.73 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -73.02 -51.26 18.88 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 171.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -155.55 138.36 15.29 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.032 0.833 . . . . 0.0 110.792 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -99.18 116.92 32.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -107.5 107.71 18.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.854 -0.529 . . . . 0.0 111.035 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.51 127.24 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.1 105.55 15.61 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.596 0.758 . . . . 0.0 109.421 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -108.02 113.48 26.69 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.611 0.764 . . . . 0.0 109.753 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.83 157.23 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -168.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -97.35 132.15 43.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 0.0 111.473 165.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -69.78 122.09 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 C-N-CA 123.38 0.672 . . . . 0.0 110.154 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.93 -37.96 3.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 116.697 1.439 . . . . 0.0 116.697 -158.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -90.87 136.75 32.87 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 118.25 1.025 . . . . 0.0 113.547 -165.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -87.6 117.38 26.37 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.878 0.471 . . . . 0.0 110.93 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -134.24 145.77 49.46 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.378 0.671 . . . . 0.0 112.287 -171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -71.04 101.88 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.463 -1.398 . . . . 0.0 112.958 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.4 112.19 24.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.242 0.617 . . . . 0.0 110.444 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.81 114.99 19.15 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.581 0.705 . . . . 0.0 110.775 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 mt -88.93 55.26 3.28 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 112.857 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.8 t -74.07 133.57 42.89 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.55 -54.18 1.48 Allowed Glycine 0 N--CA 1.488 2.148 0 O-C-N 121.707 -0.62 . . . . 0.0 114.116 -158.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.2 mt -71.27 -63.47 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.667 0.787 . . . . 0.0 111.221 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -139.21 -3.99 1.53 Allowed 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 166.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.416 4.4 p30 50.14 64.1 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 120.789 1.632 . . . . 0.0 115.088 -159.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -124.6 130.4 52.38 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.359 0.664 . . . . 0.0 109.747 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -90.81 112.91 24.92 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.854 -0.529 . . . . 0.0 110.246 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 96.8 m -123.54 132.44 53.9 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.361 0.665 . . . . 0.0 111.264 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.0 mtp -70.04 99.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.423 1.106 . . . . 0.0 110.395 171.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.0 m -108.19 122.35 46.74 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.844 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 27.6 m -107.68 120.51 42.44 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.9 t -109.62 124.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.7 m -138.44 155.28 48.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 112.473 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -84.21 119.9 25.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.842 -1.162 . . . . 0.0 112.385 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.42 70.93 5.13 Favored 'General case' 0 CA--C 1.57 1.732 0 O-C-N 121.512 -0.742 . . . . 0.0 109.539 160.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.71 -108.96 2.47 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 -169.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -77.17 -22.37 52.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -97.47 135.7 38.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.234 1.379 . . . . 0.0 111.314 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.34 114.61 26.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.707 -0.62 . . . . 0.0 109.809 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.586 0.755 . . . . 0.0 111.26 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.6 t -128.0 138.37 52.57 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p -117.37 131.17 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 123.916 0.887 . . . . 0.0 109.654 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.18 97.8 7.2 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.0 0.92 . . . . 0.0 109.17 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -91.67 119.68 31.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.481 -0.762 . . . . 0.0 112.025 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.11 -107.15 0.28 Allowed Glycine 0 N--CA 1.487 2.036 0 O-C-N 121.211 -0.931 . . . . 0.0 113.48 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.6 -12.05 59.95 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 -170.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -126.44 145.08 50.62 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.093 1.315 . . . . 0.0 112.053 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -83.13 110.57 18.13 Favored 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 123.779 0.832 . . . . 0.0 111.418 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.39 46.13 73.09 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -174.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -85.01 139.97 31.38 Favored 'General case' 0 CA--C 1.569 1.682 0 CA-C-N 118.001 0.901 . . . . 0.0 111.668 175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.15 -164.49 33.87 Favored Glycine 0 N--CA 1.484 1.854 0 O-C-N 121.391 -0.818 . . . . 0.0 114.736 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.65 157.08 32.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -128.78 130.11 46.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -131.85 144.14 50.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.712 0.768 . . . . 0.0 112.882 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.4 p90 -153.52 163.63 39.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.452 0.701 . . . . 0.0 112.723 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.9 129.62 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.396 -0.815 . . . . 0.0 108.888 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.64 98.27 6.15 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 162.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.84 -115.06 4.58 Favored Glycine 0 N--CA 1.49 2.27 0 O-C-N 121.559 -0.713 . . . . 0.0 114.353 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -95.73 12.96 28.08 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 163.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -112.55 132.83 54.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.554 1.524 . . . . 0.0 112.553 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.65 120.24 31.55 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 124.254 1.022 . . . . 0.0 108.961 170.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -109.74 124.14 50.74 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.792 0.837 . . . . 0.0 108.895 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.8 tp -130.81 132.51 45.29 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.644 0.777 . . . . 0.0 110.251 -167.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.17 120.11 34.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.735 -0.603 . . . . 0.0 110.02 170.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.449 ' SD ' H202 ' A' ' 175' ' ' RTL . 64.1 mtm -112.1 132.21 54.98 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.622 0.769 . . . . 0.0 111.322 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -124.2 137.25 54.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 112.287 -167.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.61 124.59 8.62 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.096 0.559 . . . . 0.0 110.882 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 54.75 43.58 29.85 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.72 -28.56 1.3 Allowed Glycine 0 CA--C 1.555 2.593 0 N-CA-C 119.587 2.595 . . . . 0.0 119.587 -164.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.1 t -76.89 120.91 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 118.909 1.354 . . . . 0.0 110.564 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 m -101.9 125.39 48.57 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 121.375 0.607 . . . . 0.0 111.032 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.557 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 13.1 t -92.82 133.57 35.93 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.352 0.661 . . . . 0.0 111.291 163.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -102.14 126.68 49.16 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.272 0.629 . . . . 0.0 110.536 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -128.6 138.98 52.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.058 0.943 . . . . 0.0 111.131 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.6 t -127.12 127.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -126.92 152.57 46.94 Favored 'General case' 0 CA--C 1.573 1.86 0 C-N-CA 124.501 1.12 . . . . 0.0 110.65 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -124.45 135.91 53.61 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.214 -1.554 . . . . 0.0 112.714 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -70.23 125.4 26.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.18 -37.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 120.209 1.368 . . . . 0.0 108.346 169.119 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.449 H202 ' SD ' ' A' ' 119' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 CA--C 1.575 1.907 0 CA-C-O 118.884 -0.579 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -80.93 -173.65 1.92 Allowed 'Trans proline' 0 CA--C 1.568 2.209 0 C-N-CA 122.549 2.166 . . . . 0.0 115.293 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.46 126.71 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 120.765 -1.209 . . . . 0.0 111.613 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.14 102.14 8.31 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -74.85 0.96 13.82 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 170.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -57.88 112.92 1.64 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 121.333 1.879 . . . . 0.0 114.57 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.09 -179.0 32.32 Favored Glycine 0 N--CA 1.485 1.937 0 CA-C-O 123.108 1.393 . . . . 0.0 116.081 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -112.4 113.57 25.83 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.75 -1.225 . . . . 0.0 108.862 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -115.42 115.54 26.72 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -166.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -89.91 143.44 26.79 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 113.258 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.44 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 12.8 ttp -75.54 127.33 32.86 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 113.77 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 68.4 mt -93.1 -45.88 7.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -157.2 158.22 35.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.4 -1.438 . . . . 0.0 113.1 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -137.18 132.26 33.68 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.762 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.33 120.44 19.91 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.351 0.661 . . . . 0.0 109.956 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.278 45.0 t30 65.36 32.14 9.94 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 117.506 2.409 . . . . 0.0 117.506 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -78.12 -37.25 46.6 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -56.31 -41.97 76.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.77 -39.33 84.11 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -58.63 -47.88 82.9 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 167.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.29 -40.39 90.0 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 175.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -54.66 -46.0 73.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 162.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.86 -13.74 27.17 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 166.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.4 mt -93.81 -50.09 5.53 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.43 170.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.94 5.33 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 C-N-CA 125.938 1.695 . . . . 0.0 115.126 163.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.69 147.8 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 118.626 -2.546 . . . . 0.0 113.118 -146.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -67.1 154.42 41.26 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 171.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.96 -47.11 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.6 -51.83 64.08 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.33 -36.88 85.39 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -54.58 -50.23 68.49 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -60.43 -44.3 95.93 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.6 -56.76 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 C-N-CA 123.895 0.878 . . . . 0.0 111.821 170.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.99 77.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 117.749 2.499 . . . . 0.0 117.749 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -69.07 -32.29 71.65 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.04 -27.47 60.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.79 141.6 49.69 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.216 1.371 . . . . 0.0 113.706 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -100.68 92.93 2.53 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.467 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 72.4 Cg_endo -71.8 155.33 58.38 Favored 'Trans proline' 0 CA--C 1.563 1.972 0 C-N-CA 122.629 2.219 . . . . 0.0 114.946 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -108.96 117.77 35.07 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.114 172.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -87.06 108.02 18.69 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.609 -0.682 . . . . 0.0 110.382 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -93.35 109.64 21.19 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.444 -0.785 . . . . 0.0 109.196 168.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mt -107.25 128.42 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.55 108.31 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -102.48 112.62 25.42 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.993 0.917 . . . . 0.0 110.483 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -105.48 75.97 1.18 Allowed 'General case' 0 CA--C 1.569 1.696 0 O-C-N 121.597 -0.689 . . . . 0.0 109.669 165.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.48 -99.3 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 115.537 0.975 . . . . 0.0 115.537 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -78.24 -37.93 44.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -77.02 116.07 17.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-N 120.333 1.424 . . . . 0.0 112.31 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.9 ttm -126.59 124.81 40.79 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.655 0.782 . . . . 0.0 110.866 -170.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -115.7 99.42 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 74.5 mt -93.19 110.9 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -106.93 97.27 7.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.6 m -83.49 102.82 12.37 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.0 mt -106.11 116.85 32.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.587 0.708 . . . . 0.0 111.094 -166.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -135.66 150.76 49.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.53 0.732 . . . . 0.0 110.099 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 68.3 p -63.42 -27.05 69.03 Favored 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 174.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -73.03 -41.48 64.17 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 164.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -158.19 129.89 6.75 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 119.847 1.203 . . . . 0.0 112.931 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -105.03 120.65 42.01 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.641 0.777 . . . . 0.0 109.765 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -121.85 109.98 15.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.604 -0.685 . . . . 0.0 110.758 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.84 125.75 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -103.55 107.32 18.12 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.49 0.716 . . . . 0.0 109.348 166.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -107.66 112.13 24.69 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.473 0.709 . . . . 0.0 109.583 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -154.51 164.27 38.93 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -105.32 134.23 48.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.969 167.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.23 134.92 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 O-C-N 121.149 -0.97 . . . . 0.0 110.55 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.62 -21.22 46.18 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 117.486 1.754 . . . . 0.0 117.486 -163.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -108.36 145.0 35.16 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.926 1.363 . . . . 0.0 110.236 -162.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -90.72 128.9 36.82 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.089 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -139.21 158.99 43.19 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.143 0.973 . . . . 0.0 112.882 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -76.37 92.17 3.34 Favored 'General case' 0 CA--C 1.563 1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 111.763 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -88.43 100.2 12.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.097 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.06 101.04 13.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 122.955 0.502 . . . . 0.0 110.552 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 mp -83.41 52.11 2.15 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 93.9 m -70.68 124.38 24.14 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.357 1.063 . . . . 0.0 110.302 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.28 -16.3 49.42 Favored Glycine 0 CA--C 1.552 2.398 0 N-CA-C 118.121 2.008 . . . . 0.0 118.121 -162.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.21 -82.01 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-N 119.792 1.796 . . . . 0.0 106.948 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -122.3 17.55 10.64 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 52.88 46.97 25.7 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -129.27 140.56 51.4 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.64 0.733 . . . . 0.0 112.466 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -87.72 109.25 19.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.622 0.769 . . . . 0.0 111.149 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.4 m -101.37 140.31 35.84 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.438 0.695 . . . . 0.0 111.603 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.8 80.41 7.27 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.459 1.123 . . . . 0.0 110.193 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.7 m -85.51 128.08 34.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.173 -0.954 . . . . 0.0 110.672 -166.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 m -116.5 118.51 32.86 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 t -112.66 125.05 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.8 m -135.78 156.78 48.28 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.961 0.886 . . . . 0.0 112.928 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -88.11 122.9 32.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.69 66.25 0.66 Allowed 'General case' 0 CA--C 1.576 1.981 0 C-N-CA 123.59 0.756 . . . . 0.0 110.289 160.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.69 -96.39 0.25 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -79.35 -36.93 38.63 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -85.25 116.44 23.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.945 0.878 . . . . 0.0 112.287 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.2 tp -85.85 106.02 16.76 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -94.67 129.99 41.33 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.955 0.902 . . . . 0.0 111.459 -172.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 40.8 t -125.06 127.35 46.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.651 0.78 . . . . 0.0 112.068 -176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.59 119.64 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 167.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -95.41 97.1 9.57 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -81.38 115.87 20.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 111.692 -171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.37 -126.13 0.95 Allowed Glycine 0 N--CA 1.483 1.779 0 O-C-N 122.11 -0.369 . . . . 0.0 113.292 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.36 -31.69 37.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.59 144.79 26.91 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.041 1.292 . . . . 0.0 113.084 -164.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -81.63 106.31 13.47 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.351 0.661 . . . . 0.0 112.081 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.92 53.6 14.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -167.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -89.96 124.7 34.96 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.303 0.641 . . . . 0.0 110.857 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.9 -166.95 38.02 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 -175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -160.17 157.28 28.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.255 1.026 . . . . 0.0 113.004 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -128.94 129.83 45.96 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -129.0 139.42 52.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -148.61 166.33 28.62 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 52.1 mt -106.44 122.91 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.501 -0.749 . . . . 0.0 109.349 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -110.87 86.87 2.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.534 -0.729 . . . . 0.0 109.907 164.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.24 -109.69 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 O-C-N 121.527 -0.733 . . . . 0.0 113.557 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.92 43.69 1.4 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 156.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -123.25 124.67 43.51 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.624 0.77 . . . . 0.0 109.634 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.71 113.37 25.44 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-O 121.737 0.78 . . . . 0.0 108.975 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.92 124.04 48.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.4 tp -125.02 125.97 44.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.725 0.81 . . . . 0.0 110.716 -170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -108.46 123.29 48.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.509 ' SD ' H202 ' A' ' 175' ' ' RTL . 65.5 mtm -112.41 135.76 52.71 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.695 -0.628 . . . . 0.0 111.582 176.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -123.76 133.77 53.78 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.477 0.711 . . . . 0.0 112.735 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.78 5.88 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.794 0.838 . . . . 0.0 110.214 173.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 56.29 41.49 29.09 Favored 'General case' 0 N--CA 1.509 2.516 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.91 -12.05 2.3 Favored Glycine 0 CA--C 1.56 2.858 0 N-CA-C 120.11 2.804 . . . . 0.0 120.11 -163.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.11 123.53 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-N 119.692 1.746 . . . . 0.0 109.69 -166.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 m -99.6 118.01 35.21 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 122.662 0.385 . . . . 0.0 110.341 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -99.51 122.78 43.08 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.144 0.578 . . . . 0.0 110.856 169.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -101.77 129.46 47.96 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.683 0.754 . . . . 0.0 111.441 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -137.85 131.71 31.48 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.989 0.916 . . . . 0.0 110.276 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.88 132.47 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 109.017 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -132.42 149.75 52.28 Favored 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.842 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -124.14 128.27 49.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.431 -1.418 . . . . 0.0 111.127 -174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -71.49 120.16 16.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.465 -0.772 . . . . 0.0 112.838 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.3 -38.18 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 CA--C 1.566 1.568 0 CA-C-N 119.702 1.137 . . . . 0.0 108.219 169.591 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.509 H202 ' SD ' ' A' ' 119' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.7 mtm . . . . . 0 CA--C 1.574 1.901 0 CA-C-O 116.107 -1.902 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.09 133.57 13.67 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 124.994 2.819 . . . . 0.0 114.149 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -74.86 148.69 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.12 106.24 17.11 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 112.614 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -80.64 6.32 13.04 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -59.34 112.07 1.6 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 121.422 1.919 . . . . 0.0 114.799 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.6 178.82 33.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 116.471 1.349 . . . . 0.0 116.471 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -109.67 109.73 20.55 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.595 1.158 . . . . 0.0 109.043 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -112.48 110.04 19.99 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -168.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -86.57 137.72 32.28 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.103 -0.998 . . . . 0.0 113.193 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.3 ttp -74.1 122.39 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.02 1.282 . . . . 0.0 114.043 -173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.0 mt -82.16 -53.76 5.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.424 170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -130.91 154.72 47.8 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -172.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -136.94 109.45 7.42 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.761 0.824 . . . . 0.0 108.839 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -93.07 -64.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -166.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -124.91 44.94 2.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.68 0.752 . . . . 0.0 111.916 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 4.3 t80 -72.5 -38.56 68.09 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.8 -41.74 96.23 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -71.16 -40.01 71.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -53.17 -47.27 68.96 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 166.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.24 -37.76 71.98 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -55.84 -44.16 77.73 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 163.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.5 -21.47 62.47 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.95 1.06 53.94 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.289 4.2 t70 64.2 49.83 2.54 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -168.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.6 t -94.59 145.89 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.94 0.876 . . . . 0.0 109.903 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -61.93 153.97 27.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -59.01 -47.5 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -51.5 62.68 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.0 tp -66.33 -25.67 66.93 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -64.95 -47.23 78.37 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.767 1.621 . . . . 0.0 113.86 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -50.98 67.32 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -53.72 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 124.097 0.959 . . . . 0.0 112.212 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.2 -35.88 78.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -69.08 -32.61 72.19 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 168.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -72.63 -28.65 62.88 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.22 135.04 48.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.061 1.3 . . . . 0.0 112.826 176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -103.57 89.59 2.28 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.648 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.29 151.96 60.81 Favored 'Trans proline' 0 CA--C 1.561 1.858 0 CA-C-N 123.056 2.127 . . . . 0.0 115.371 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -105.66 115.49 30.34 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -84.26 107.54 16.62 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.456 -0.778 . . . . 0.0 110.495 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -94.54 110.25 22.07 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.597 -0.689 . . . . 0.0 109.195 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -105.71 126.25 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.7 t -112.02 108.95 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -106.13 111.34 23.92 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 121.931 0.872 . . . . 0.0 110.702 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -99.78 76.24 1.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 124.659 1.184 . . . . 0.0 109.459 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.96 -106.46 1.93 Allowed Glycine 0 N--CA 1.493 2.435 0 O-C-N 121.067 -1.021 . . . . 0.0 114.682 -175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.85 -22.12 24.63 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 162.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -70.09 120.99 16.62 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 120.132 1.333 . . . . 0.0 111.712 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.4 ttm -136.54 122.73 20.44 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-O 121.498 0.666 . . . . 0.0 111.043 -163.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.4 mt -116.21 99.98 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -95.66 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -99.68 98.86 9.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -84.1 95.67 8.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 109.019 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.1 mt -93.26 124.52 37.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.057 0.543 . . . . 0.0 111.149 -166.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.3 t -146.34 154.16 41.34 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.107 0.956 . . . . 0.0 111.83 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.9 p -61.86 -30.82 71.11 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -77.82 -52.38 9.0 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -153.67 138.43 17.04 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.175 0.898 . . . . 0.0 110.877 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -93.08 117.79 30.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.632 -0.667 . . . . 0.0 109.736 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -106.21 104.22 13.87 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.357 0.599 . . . . 0.0 110.521 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -95.29 125.47 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.2 mtp -103.98 110.13 22.16 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.309 165.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -114.56 111.1 20.83 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.238 1.015 . . . . 0.0 110.712 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -157.34 168.82 26.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -164.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -106.8 135.21 48.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.975 -1.078 . . . . 0.0 110.238 161.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.0 125.55 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 O-C-N 121.42 -0.8 . . . . 0.0 108.94 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.58 -35.08 4.59 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -155.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.58 138.48 34.1 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 118.383 1.092 . . . . 0.0 113.165 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -87.62 114.77 24.53 Favored 'General case' 0 CA--C 1.565 1.548 0 O-C-N 122.024 -0.423 . . . . 0.0 110.336 167.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.95 148.6 50.51 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.497 0.719 . . . . 0.0 112.567 -173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.77 99.7 4.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.154 -0.966 . . . . 0.0 112.083 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -91.54 109.01 20.3 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.485 -0.759 . . . . 0.0 110.21 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -79.38 106.07 11.15 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.215 0.531 . . . . 0.0 110.284 170.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.93 49.59 1.76 Allowed 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -79.95 130.39 35.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 113.275 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.89 -50.51 0.96 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.4 -0.813 . . . . 0.0 114.744 -154.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.8 mt -78.43 -65.9 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 124.398 1.079 . . . . 0.0 110.838 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -147.06 7.66 0.92 Allowed 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.274 2.3 m-20 57.46 30.55 18.83 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -104.57 141.1 37.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.977 -1.077 . . . . 0.0 111.298 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.86 98.28 11.28 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.155 0.582 . . . . 0.0 109.591 173.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.24 146.01 28.61 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.428 0.632 . . . . 0.0 112.104 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -79.26 95.66 5.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.914 171.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.8 m -93.99 126.72 39.37 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.058 0.543 . . . . 0.0 110.149 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.2 m -116.63 130.4 56.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.4 t -116.69 130.3 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -125.58 139.82 53.26 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.076 0.951 . . . . 0.0 111.087 -175.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -84.53 120.97 26.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.98 . . . . 0.0 112.611 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -111.59 61.16 0.62 Allowed 'General case' 0 CA--C 1.575 1.932 0 C-N-CA 123.871 0.869 . . . . 0.0 110.549 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.27 -93.28 0.19 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.14 -34.96 32.1 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -91.69 128.31 37.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.533 1.061 . . . . 0.0 111.252 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -98.51 114.71 27.22 Favored 'General case' 0 CA--C 1.561 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.171 169.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -117.15 129.24 55.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.147 0.579 . . . . 0.0 111.064 -163.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.43 ' SG ' HG22 ' A' ' 86' ' ' VAL . 53.5 t -130.37 145.56 51.82 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.1 p -121.74 135.34 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 124.175 0.99 . . . . 0.0 110.42 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -117.0 95.55 5.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.834 0.853 . . . . 0.0 109.734 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.25 124.37 33.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.642 -1.286 . . . . 0.0 112.843 -173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 -112.3 0.27 Allowed Glycine 0 N--CA 1.485 1.928 0 O-C-N 121.661 -0.649 . . . . 0.0 112.283 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -83.2 -10.05 58.82 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -113.16 143.97 43.46 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.549 1.522 . . . . 0.0 113.186 -170.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -80.55 124.15 28.71 Favored 'General case' 0 CA--C 1.564 1.507 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.31 42.37 99.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 118.494 2.158 . . . . 0.0 118.494 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -91.36 134.08 34.91 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 121.843 0.83 . . . . 0.0 111.595 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.66 -163.83 32.49 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 121.882 0.712 . . . . 0.0 114.298 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -156.88 153.53 28.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -129.52 126.04 37.69 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.44 137.95 54.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -148.58 163.2 37.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 112.913 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.29 125.04 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 109.327 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.97 96.58 6.03 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 161.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.4 -109.0 2.67 Favored Glycine 0 N--CA 1.491 2.312 0 O-C-N 121.374 -0.829 . . . . 0.0 113.882 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -109.75 25.71 11.48 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 158.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -108.81 123.63 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 119.917 1.235 . . . . 0.0 110.974 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -82.21 115.52 21.33 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.069 0.947 . . . . 0.0 109.151 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -102.16 115.45 30.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.4 123.15 49.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.809 0.843 . . . . 0.0 111.163 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.11 124.25 47.38 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 165.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 71.3 mtm -116.35 128.99 56.01 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.104 0.865 . . . . 0.0 110.904 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -116.18 136.78 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.55 120.42 8.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.594 0.757 . . . . 0.0 110.022 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 59.07 39.91 22.7 Favored 'General case' 0 N--CA 1.506 2.375 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.94 -34.87 1.25 Allowed Glycine 0 CA--C 1.558 2.749 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -161.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.08 118.36 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.008 1.323 . . . . 0.0 111.238 -170.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 91.4 m -107.39 119.71 40.16 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.588 -168.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.461 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 11.8 t -94.36 126.13 39.42 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.531 0.732 . . . . 0.0 111.984 170.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -100.18 127.93 46.35 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.338 0.59 . . . . 0.0 111.751 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -127.64 137.12 52.44 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.899 0.88 . . . . 0.0 110.964 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.23 131.07 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -127.51 127.27 43.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.523 0.729 . . . . 0.0 110.319 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -97.79 123.38 41.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.762 -1.211 . . . . 0.0 111.559 -174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.55 115.85 8.41 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 119.237 0.926 . . . . 0.0 112.469 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.7 -36.96 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.588 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 171.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.445 H151 H201 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 CA--C 1.571 1.788 0 CA-C-O 118.79 -0.624 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.11 120.7 7.79 Favored 'Trans proline' 0 CA--C 1.564 1.975 0 C-N-CA 122.741 2.294 . . . . 0.0 115.013 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -75.72 143.93 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.757 0.789 . . . . 0.0 112.945 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -83.2 103.26 12.47 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.095 -1.003 . . . . 0.0 111.567 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -76.56 -1.8 29.26 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -55.44 113.72 1.53 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 121.189 1.813 . . . . 0.0 114.7 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 153.69 -179.85 29.66 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-O 122.72 1.178 . . . . 0.0 115.53 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -113.2 118.91 36.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.311 1.044 . . . . 0.0 109.188 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -121.39 114.76 21.75 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -165.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -88.76 140.89 28.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.255 -0.903 . . . . 0.0 113.254 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.461 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 4.8 ttm -70.34 120.55 16.18 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.46 -45.24 16.3 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -153.58 159.09 42.07 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.236 1.38 . . . . 0.0 113.549 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -134.07 101.94 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.955 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.0 123.55 50.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.197 0.599 . . . . 0.0 111.001 -171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 29.6 t30 66.31 36.26 5.44 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 5.1 t80 -79.14 -39.16 34.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.54 -40.59 79.16 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 169.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -66.18 -41.53 90.13 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 169.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -55.99 -48.11 76.47 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 167.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.9 mt -69.88 -40.62 75.58 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -55.31 -45.87 76.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.69 -20.99 24.53 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 164.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.8 mt -96.17 13.19 28.19 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.304 22.8 t70 60.74 56.48 2.96 Favored 'General case' 0 CA--C 1.576 1.956 0 CA-C-N 120.709 1.595 . . . . 0.0 113.464 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -106.62 146.82 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 122.093 0.949 . . . . 0.0 110.165 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -64.04 153.01 38.71 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -61.25 -44.03 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.98 -52.12 64.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.81 -38.72 91.84 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -53.2 -53.03 56.68 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 165.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -62.46 -46.49 88.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.58 -57.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 123.729 0.812 . . . . 0.0 111.774 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.16 -31.13 72.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -69.91 -36.83 75.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 165.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.1 mt -73.01 -24.52 60.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 171.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.78 143.22 49.61 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.152 1.342 . . . . 0.0 113.805 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -102.82 90.27 2.23 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.757 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 59.6 Cg_endo -69.31 155.74 66.53 Favored 'Trans proline' 0 CA--C 1.564 1.977 0 CA-C-N 123.054 2.127 . . . . 0.0 114.987 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.3 118.83 34.37 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -86.03 115.4 23.61 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.525 -0.735 . . . . 0.0 110.849 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -102.2 106.44 17.27 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 169.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mp -101.18 131.12 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.313 -0.867 . . . . 0.0 109.237 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.2 t -113.63 109.25 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 167.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.47 106.62 17.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.883 0.873 . . . . 0.0 110.082 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -99.37 80.4 2.41 Favored 'General case' 0 CA--C 1.57 1.719 0 C-N-CA 123.57 0.748 . . . . 0.0 109.791 170.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.89 1.18 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.513 -0.742 . . . . 0.0 114.189 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -93.07 -20.14 20.83 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 163.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -74.16 105.89 5.57 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.667 2.03 . . . . 0.0 111.211 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.5 ttm -116.73 124.85 50.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.59 0.756 . . . . 0.0 110.557 -170.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.03 98.39 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.2 mt -94.32 110.83 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.29 96.09 6.12 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 51.1 m -85.78 99.11 11.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 108.79 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.18 115.93 28.46 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.832 -0.542 . . . . 0.0 111.343 -164.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.2 t -134.3 151.82 51.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.766 0.793 . . . . 0.0 110.521 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -64.05 -29.33 70.48 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -70.73 -51.31 28.16 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 167.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -153.88 134.93 13.92 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.38 0.991 . . . . 0.0 111.213 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.44 118.76 30.83 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 123.781 0.832 . . . . 0.0 109.555 170.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -102.81 116.84 33.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 110.4 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.5 mm -112.27 117.97 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -171.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.9 mtp -105.6 105.31 15.28 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -108.36 108.82 19.95 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.575 0.75 . . . . 0.0 109.555 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -155.85 155.93 33.8 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -90.48 126.74 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.7 165.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.89 121.77 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.14 -0.975 . . . . 0.0 108.69 168.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.54 -35.13 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 116.989 1.556 . . . . 0.0 116.989 -156.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -99.44 140.99 32.81 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.491 1.145 . . . . 0.0 113.3 -165.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -86.3 108.37 18.38 Favored 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 122.818 0.447 . . . . 0.0 110.387 166.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -119.92 143.4 48.0 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.673 0.789 . . . . 0.0 112.504 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.35 97.7 2.55 Favored 'General case' 0 CA--C 1.567 1.609 0 O-C-N 120.935 -1.103 . . . . 0.0 112.609 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -93.51 113.47 25.61 Favored 'General case' 0 CA--C 1.558 1.287 0 O-C-N 121.587 -0.696 . . . . 0.0 110.452 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.28 105.07 12.18 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.734 0.414 . . . . 0.0 110.752 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.55 52.32 2.31 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.2 m -83.58 132.43 34.91 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.089 0.947 . . . . 0.0 111.647 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.58 -62.17 0.38 Allowed Glycine 0 N--CA 1.486 2.003 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.273 -151.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mt -72.11 -70.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.559 1.144 . . . . 0.0 110.202 -170.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -136.08 9.79 3.27 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 169.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 58.84 45.19 15.73 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -135.17 143.77 46.66 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.725 0.774 . . . . 0.0 111.282 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -88.0 126.24 34.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.624 -0.672 . . . . 0.0 111.341 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.2 m -122.66 140.64 52.62 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.156 0.582 . . . . 0.0 111.142 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.11 97.18 5.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 168.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.6 m -95.55 123.25 39.01 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.42 0.688 . . . . 0.0 110.218 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.7 m -107.43 126.8 52.96 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 168.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.9 t -116.19 135.86 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -149.95 152.43 34.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.443 -1.411 . . . . 0.0 112.729 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -80.71 118.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.861 -1.149 . . . . 0.0 112.653 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.11 71.11 6.3 Favored 'General case' 0 CA--C 1.571 1.764 0 O-C-N 121.51 -0.744 . . . . 0.0 109.565 159.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.02 -109.67 2.94 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 114.675 0.63 . . . . 0.0 114.675 -170.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.76 -23.05 58.48 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -93.34 127.15 38.83 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.86 1.209 . . . . 0.0 111.367 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.73 105.09 16.71 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.551 -0.718 . . . . 0.0 109.552 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -109.76 136.1 49.63 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.606 0.762 . . . . 0.0 111.377 -168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -134.93 138.17 43.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.36 133.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 123.715 0.806 . . . . 0.0 110.242 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -112.56 98.52 7.3 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.626 0.771 . . . . 0.0 109.575 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.31 117.02 27.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.424 -0.798 . . . . 0.0 111.749 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.27 -131.12 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 O-C-N 121.233 -0.917 . . . . 0.0 113.619 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -72.05 -34.81 69.05 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -96.34 140.0 31.64 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.226 1.012 . . . . 0.0 112.315 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -79.45 122.56 26.58 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -165.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.06 52.27 53.83 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -93.41 138.87 31.31 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-O 121.723 0.773 . . . . 0.0 111.707 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -174.96 -168.54 35.72 Favored Glycine 0 N--CA 1.485 1.911 0 CA-C-O 121.918 0.732 . . . . 0.0 114.722 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -156.49 153.64 29.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.6 m -128.52 123.12 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -123.57 131.75 53.71 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.699 0.8 . . . . 0.0 111.397 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -148.89 175.43 11.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.239 -0.913 . . . . 0.0 112.76 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.2 mt -118.78 135.8 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.916 -1.115 . . . . 0.0 109.262 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.57 93.12 3.84 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 109.447 165.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.74 -120.04 5.26 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 121.873 -0.517 . . . . 0.0 113.351 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.43 41.27 1.25 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 161.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -131.1 118.67 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.348 0.659 . . . . 0.0 109.399 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.31 122.31 26.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.891 0.876 . . . . 0.0 110.437 171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -112.91 119.79 39.17 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.2 tp -124.61 124.86 43.13 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.643 0.777 . . . . 0.0 110.53 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.95 121.31 42.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 165.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 69.7 mtm -110.62 127.46 55.26 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.905 0.775 . . . . 0.0 110.318 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -119.2 145.41 46.06 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.98 122.53 2.59 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.067 0.547 . . . . 0.0 110.75 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.299 7.1 mt-10 50.88 50.82 18.28 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.88 -28.77 2.78 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 120.162 2.825 . . . . 0.0 120.162 -169.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -76.05 156.0 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 118.817 1.309 . . . . 0.0 112.075 -171.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -123.54 127.51 48.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.0 110.688 168.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 17.5 t -94.24 136.86 34.07 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.999 0.52 . . . . 0.0 111.199 156.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -114.64 123.94 50.58 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.072 0.549 . . . . 0.0 110.272 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -121.12 135.13 55.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.72 -0.612 . . . . 0.0 111.17 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.12 129.3 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -133.27 136.78 45.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.525 -0.734 . . . . 0.0 110.912 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -103.62 133.24 48.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.308 -1.495 . . . . 0.0 112.676 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -69.14 122.89 19.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.6 m -117.53 -37.42 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 119.761 1.164 . . . . 0.0 107.93 170.413 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.433 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 16.1 ttt . . . . . 0 CA--C 1.577 1.992 0 CA-C-O 117.918 -1.039 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 -121.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.573 2.441 0 C-N-CA 122.613 2.209 . . . . 0.0 114.56 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.42 -20.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.258 46.7 t0 65.44 83.06 0.17 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 125.082 1.353 . . . . 0.0 113.749 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.97 6.07 14.46 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.32 108.85 0.99 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.481 1.492 . . . . 0.0 114.652 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.87 -179.64 33.44 Favored Glycine 0 N--CA 1.485 1.958 0 CA-C-O 122.807 1.226 . . . . 0.0 115.58 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -107.5 118.22 36.15 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.45 1.1 . . . . 0.0 109.274 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -117.12 111.75 19.93 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -168.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -85.3 139.03 31.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 112.765 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 30.6 ttm -65.92 124.99 24.0 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 120.092 1.315 . . . . 0.0 114.355 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -86.08 -43.99 12.63 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -153.0 156.9 39.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.366 -1.459 . . . . 0.0 113.408 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -131.35 109.23 10.2 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.922 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.06 121.09 38.11 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.272 0.629 . . . . 0.0 110.499 -168.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.286 30.3 t30 68.01 31.83 5.34 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 9.1 t80 -78.43 -38.46 41.3 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.93 -41.45 74.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 168.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -69.0 -37.85 78.94 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -55.1 -47.38 75.04 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 120.26 1.391 . . . . 0.0 114.658 164.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.96 -40.59 71.87 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -54.68 -42.86 71.89 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 165.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.28 -29.15 60.78 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.4 -0.71 53.75 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.301 17.2 t0 66.71 48.12 1.45 Allowed 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.4 t -86.98 144.47 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.249 -0.907 . . . . 0.0 109.985 172.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -64.53 155.0 34.34 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 171.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -59.94 -43.84 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.67 50.27 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 172.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.33 -37.42 85.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -56.78 -51.7 67.89 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 165.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -62.94 -46.74 86.32 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.7 mt -60.45 -56.9 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.042 0.837 . . . . 0.0 111.719 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.39 -27.98 67.55 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -75.19 -33.67 61.45 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.63 -34.16 76.42 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 166.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.36 130.28 40.95 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.176 0.988 . . . . 0.0 112.278 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.39 100.01 9.63 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.838 174.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 38.1 Cg_endo -66.8 154.89 72.98 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 CA-C-N 123.466 2.274 . . . . 0.0 114.967 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -108.24 119.63 40.03 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -89.46 113.85 25.27 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.358 -0.839 . . . . 0.0 110.863 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.78 106.97 19.3 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.807 -0.558 . . . . 0.0 109.545 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -102.24 130.6 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.58 108.79 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 167.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -94.59 102.63 14.56 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.393 0.677 . . . . 0.0 110.064 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -96.0 74.05 3.02 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 121.492 0.663 . . . . 0.0 110.4 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.66 -103.48 0.98 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.592 -0.692 . . . . 0.0 114.591 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.62 -32.49 23.69 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 165.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -80.17 104.2 10.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.623 1.556 . . . . 0.0 110.998 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp -114.33 132.14 56.29 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 122.295 1.045 . . . . 0.0 111.47 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.31 99.73 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.2 mt -91.78 110.26 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -103.6 101.61 11.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.726 -0.608 . . . . 0.0 109.476 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -86.13 102.76 14.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.48 130.24 49.23 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.931 0.492 . . . . 0.0 111.494 -166.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.6 t -149.17 155.15 40.22 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.117 0.96 . . . . 0.0 111.675 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.2 p -62.02 -32.56 73.07 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -76.81 -50.55 13.19 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -151.82 136.85 17.33 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 119.388 0.994 . . . . 0.0 112.273 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -94.08 136.82 33.96 Favored 'General case' 0 CA--C 1.57 1.715 0 O-C-N 121.738 -0.601 . . . . 0.0 110.98 166.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -128.26 113.44 15.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 110.807 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.98 129.57 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 123.478 0.711 . . . . 0.0 109.467 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtp -108.59 108.04 18.77 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.639 0.776 . . . . 0.0 110.005 168.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.03 118.12 35.18 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 124.137 0.975 . . . . 0.0 111.825 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -157.2 149.55 22.97 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -165.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -94.46 127.23 40.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.472 -0.767 . . . . 0.0 111.095 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.87 130.62 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 123.332 0.653 . . . . 0.0 111.209 -174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.14 -36.19 4.55 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 116.829 1.492 . . . . 0.0 116.829 -162.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.18 140.46 29.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.579 1.189 . . . . 0.0 112.813 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -87.14 114.82 24.08 Favored 'General case' 0 CA--C 1.565 1.523 0 O-C-N 121.804 -0.56 . . . . 0.0 110.877 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -121.71 139.23 53.83 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.33 0.652 . . . . 0.0 111.92 -173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.45 90.58 2.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.11 . . . . 0.0 113.431 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -92.15 113.24 25.45 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.406 -0.808 . . . . 0.0 110.72 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.54 127.77 32.55 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.35 1.072 . . . . 0.0 111.209 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.15 49.38 0.95 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.616 -173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.3 t -71.76 137.19 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.418 1.087 . . . . 0.0 113.314 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.66 -57.0 0.98 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 120.862 -0.685 . . . . 0.0 114.083 -154.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.6 mt -79.56 -67.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 124.649 1.18 . . . . 0.0 110.169 -171.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.84 25.35 0.84 Allowed 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.67 1.729 . . . . 0.0 115.67 160.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.301 0.9 OUTLIER 61.41 8.01 2.0 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -82.3 139.58 34.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.806 -1.184 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -92.87 108.57 20.1 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.23 0.538 . . . . 0.0 110.628 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.3 m -112.77 124.0 51.59 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.654 0.74 . . . . 0.0 110.751 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtp -72.55 92.56 1.5 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.585 1.184 . . . . 0.0 111.043 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -100.98 123.98 46.0 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.268 -157.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.6 m -104.66 119.49 39.11 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.41 HG22 ' SG ' ' A' ' 95' ' ' CYS . 30.0 t -104.93 127.76 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.8 m -129.44 155.32 45.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 112.422 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -90.85 118.52 30.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.0 111.71 172.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.06 75.68 1.68 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 166.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.96 -106.04 1.45 Allowed Glycine 0 N--CA 1.488 2.109 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.183 -167.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.9 -19.51 25.74 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -83.89 133.45 34.72 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 121.085 1.766 . . . . 0.0 111.948 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.7 tp -92.87 98.08 11.15 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 123.169 0.588 . . . . 0.0 109.585 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -102.02 131.05 48.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.511 0.724 . . . . 0.0 110.963 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 86' ' ' VAL . 51.9 t -128.81 142.17 51.06 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -171.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.93 126.12 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.768 0.827 . . . . 0.0 109.445 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.69 96.47 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.139 0.976 . . . . 0.0 109.069 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -96.27 116.32 28.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.177 -0.952 . . . . 0.0 111.985 -166.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.97 -105.93 0.19 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.297 -0.877 . . . . 0.0 112.792 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -79.09 -30.43 43.88 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.53 141.3 40.62 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 119.864 1.211 . . . . 0.0 113.018 -162.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.43 111.93 16.18 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.78 46.03 92.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 117.727 1.851 . . . . 0.0 117.727 -172.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -83.44 137.98 33.67 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 118.282 1.041 . . . . 0.0 111.064 172.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.98 -163.49 34.48 Favored Glycine 0 N--CA 1.483 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 114.306 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.275 63.4 p-90 -158.06 169.06 25.41 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.547 1.165 . . . . 0.0 113.69 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.7 m -146.87 119.55 8.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.054 -1.654 . . . . 0.0 109.032 172.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -116.25 135.04 54.25 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.806 0.842 . . . . 0.0 111.576 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -147.8 171.9 14.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.556 -0.715 . . . . 0.0 112.776 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.91 128.53 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.345 -0.847 . . . . 0.0 109.37 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.14 87.51 2.73 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.936 0.874 . . . . 0.0 110.281 166.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.12 -116.49 4.27 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.724 -0.61 . . . . 0.0 113.246 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 59.4 p30 -94.17 24.61 4.25 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 160.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -118.51 125.64 50.3 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.725 1.148 . . . . 0.0 111.349 -169.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.03 120.31 25.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.36 0.664 . . . . 0.0 109.852 170.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -110.78 118.76 37.02 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.1 tp -125.94 122.21 35.34 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.593 0.757 . . . . 0.0 110.448 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.99 126.7 47.67 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.201 0.6 . . . . 0.0 109.535 167.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.1 mtp -122.68 123.87 42.12 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.983 0.913 . . . . 0.0 110.448 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -121.98 135.17 54.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.118 -0.989 . . . . 0.0 111.814 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.32 124.38 7.43 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.186 0.594 . . . . 0.0 110.737 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 56.29 41.36 29.26 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.07 -20.48 1.52 Allowed Glycine 0 CA--C 1.557 2.715 0 N-CA-C 119.702 2.641 . . . . 0.0 119.702 -164.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 51.0 t -80.43 118.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 119.723 1.761 . . . . 0.0 109.82 -169.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.5 m -99.53 124.33 44.61 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.797 0.808 . . . . 0.0 111.264 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.429 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 10.4 t -99.08 130.28 45.39 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.28 1.032 . . . . 0.0 110.894 168.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -105.31 117.86 35.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.642 -0.661 . . . . 0.0 110.568 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -117.47 125.33 50.73 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.554 0.742 . . . . 0.0 109.771 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.81 129.83 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.9 149.63 52.23 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 123.435 0.694 . . . . 0.0 111.453 -176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -115.54 132.53 56.6 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.106 -1.621 . . . . 0.0 112.252 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -69.3 124.8 24.8 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.38 -40.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 . . . . . 0 CA--C 1.562 1.435 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 170.663 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.434 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 57.1 mtt . . . . . 0 CA--C 1.574 1.878 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.33 130.55 14.13 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.725 2.283 . . . . 0.0 114.508 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.63 149.62 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.142 0.973 . . . . 0.0 113.429 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -87.52 106.22 17.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.37 -0.831 . . . . 0.0 111.833 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -83.39 0.83 44.29 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -58.87 106.29 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 121.27 1.85 . . . . 0.0 114.791 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.89 176.87 32.45 Favored Glycine 0 N--CA 1.486 2.011 0 CA-C-O 122.825 1.236 . . . . 0.0 115.83 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -105.45 120.54 41.88 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 124.439 1.096 . . . . 0.0 109.9 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -119.53 113.23 20.42 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -171.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -92.07 140.32 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.741 -1.224 . . . . 0.0 113.197 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.7 ttp -73.52 123.58 24.21 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 120.654 1.57 . . . . 0.0 114.388 -171.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.01 -52.69 6.11 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.158 0.983 . . . . 0.0 113.465 169.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -136.96 154.47 50.42 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -170.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -138.72 106.88 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.213 0.605 . . . . 0.0 109.819 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.99 121.92 41.88 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.622 0.769 . . . . 0.0 110.186 -171.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.265 27.7 t30 63.44 32.98 14.06 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -79.39 -46.61 17.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.491 -1.381 . . . . 0.0 114.411 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -58.45 -39.13 79.04 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.73 -40.81 84.15 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -56.66 -49.15 75.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 164.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.9 -37.81 88.89 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -52.29 -47.37 65.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 162.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.24 -18.52 61.42 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.18 4.16 52.95 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 167.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.263 5.8 t70 66.24 46.63 2.0 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -171.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.9 t -94.07 142.57 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.748 0.785 . . . . 0.0 109.46 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -64.43 154.61 35.17 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.44 -46.05 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.82 -50.23 69.09 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.2 tp -64.2 -35.49 80.98 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 171.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -57.13 -42.1 80.3 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 163.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -68.56 -43.86 75.71 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -64.04 -56.56 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 123.927 0.891 . . . . 0.0 111.821 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.95 77.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -71.26 -30.16 65.96 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 169.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.76 -30.74 64.38 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 167.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.98 140.27 50.82 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.666 1.121 . . . . 0.0 113.569 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -94.05 100.45 4.87 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.443 168.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.75 157.27 60.97 Favored 'Trans proline' 0 CA--C 1.565 2.073 0 CA-C-N 123.248 2.196 . . . . 0.0 114.152 167.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -128.11 118.12 22.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.315 -1.491 . . . . 0.0 108.793 174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -86.07 109.26 18.71 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.714 -0.616 . . . . 0.0 111.005 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.68 107.44 19.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 168.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.1 mt -104.08 127.35 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.5 t -112.36 107.82 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -102.39 97.42 7.67 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.912 0.885 . . . . 0.0 109.888 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.46 78.44 4.99 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.379 -0.825 . . . . 0.0 110.129 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 -103.7 1.1 Allowed Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.881 -0.512 . . . . 0.0 114.374 -174.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.5 -26.21 32.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 164.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -81.22 105.78 12.69 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.374 1.443 . . . . 0.0 111.552 -175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.1 ttm -109.86 122.13 46.81 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.155 0.978 . . . . 0.0 111.203 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -114.48 97.29 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 77.3 mt -91.54 109.44 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -102.72 99.01 8.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.5 m -86.05 98.04 10.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.272 -0.893 . . . . 0.0 108.756 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.0 mt -95.93 115.44 27.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.7 -0.625 . . . . 0.0 110.203 -165.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 t -133.41 152.61 51.93 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.735 0.778 . . . . 0.0 110.72 177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.9 p -63.1 -29.38 70.76 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -75.94 -49.52 17.55 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -154.61 135.06 13.37 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 119.414 1.006 . . . . 0.0 111.604 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -85.99 117.32 24.76 Favored 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 123.432 0.693 . . . . 0.0 110.222 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -106.14 103.95 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.363 -0.835 . . . . 0.0 110.374 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.72 124.17 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -102.93 107.4 18.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.646 0.778 . . . . 0.0 109.375 167.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -108.09 110.29 21.93 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.721 0.808 . . . . 0.0 109.83 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.36 160.27 41.61 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -169.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -101.94 138.22 39.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 110.969 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.33 133.56 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.31 -25.33 27.4 Favored Glycine 0 CA--C 1.552 2.387 0 N-CA-C 117.73 1.852 . . . . 0.0 117.73 -164.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -101.98 134.26 45.47 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.178 1.489 . . . . 0.0 111.04 -158.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -83.06 103.15 12.28 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.999 0.52 . . . . 0.0 111.231 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.96 138.73 49.96 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.442 0.697 . . . . 0.0 112.286 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.98 96.49 1.04 Allowed 'General case' 0 CA--C 1.57 1.719 0 O-C-N 120.955 -1.091 . . . . 0.0 112.953 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -89.88 113.12 24.67 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -82.25 108.69 15.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.872 -0.518 . . . . 0.0 109.644 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mp -85.2 56.22 3.85 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.161 0.981 . . . . 0.0 113.474 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.0 t -78.32 129.16 34.69 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.508 1.147 . . . . 0.0 112.846 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.31 -42.2 2.01 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.3 -88.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -113.49 7.59 17.54 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 167.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 57.11 44.63 22.18 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -137.17 142.98 42.17 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 -170.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -88.53 131.27 34.99 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.273 0.629 . . . . 0.0 112.5 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.2 125.92 27.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.102 0.561 . . . . 0.0 111.343 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 mmt -68.38 100.97 1.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.672 1.225 . . . . 0.0 110.555 170.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 m -100.46 122.22 42.84 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.755 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.2 m -110.93 118.58 36.49 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.0 t -109.91 121.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.4 m -127.83 147.4 50.44 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.843 0.857 . . . . 0.0 112.359 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -82.44 115.08 21.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.985 -1.072 . . . . 0.0 112.234 174.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -103.71 72.03 1.1 Allowed 'General case' 0 CA--C 1.568 1.647 0 CA-C-O 121.849 0.833 . . . . 0.0 109.74 166.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.37 -110.69 3.54 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.91 -26.05 59.36 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -101.29 126.54 48.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 119.901 1.228 . . . . 0.0 111.057 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -87.68 113.32 23.25 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 121.387 -0.82 . . . . 0.0 109.955 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -100.41 137.62 38.58 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.958 0.903 . . . . 0.0 111.735 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.4 t -131.64 136.87 48.07 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.364 0.666 . . . . 0.0 112.636 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.3 123.69 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 123.413 0.685 . . . . 0.0 109.776 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -99.8 98.38 9.19 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.513 1.125 . . . . 0.0 109.472 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -89.74 115.21 26.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 0.0 111.445 -171.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -165.35 -112.59 0.27 Allowed Glycine 0 N--CA 1.485 1.907 0 O-C-N 121.767 -0.583 . . . . 0.0 112.457 176.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.18 -31.21 23.34 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -96.99 142.55 28.81 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.387 1.089 . . . . 0.0 113.797 -166.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.53 106.77 11.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.044 -172.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.34 66.33 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 117.368 1.707 . . . . 0.0 117.368 -172.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -82.14 133.31 35.26 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.194 0.598 . . . . 0.0 110.823 174.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 171.43 -159.48 31.2 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 115.611 1.004 . . . . 0.0 115.611 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -160.38 160.13 31.92 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.315 1.055 . . . . 0.0 112.92 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.3 m -133.04 128.45 36.31 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.113 -0.992 . . . . 0.0 108.396 170.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.77 138.48 53.37 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.7 163.85 37.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.3 mt -102.63 126.73 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.328 -0.857 . . . . 0.0 109.878 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.71 90.21 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.805 0.812 . . . . 0.0 110.175 164.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.14 -116.02 4.18 Favored Glycine 0 N--CA 1.489 2.206 0 O-C-N 121.639 -0.663 . . . . 0.0 113.445 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -90.84 18.91 5.99 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 161.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -118.45 122.33 42.48 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.451 1.478 . . . . 0.0 111.113 -166.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.3 tp -82.85 111.89 19.16 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -98.04 119.39 36.59 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.5 tp -122.63 117.8 26.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.601 0.76 . . . . 0.0 110.234 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.93 131.65 39.16 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.088 0.555 . . . . 0.0 109.781 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.0 mtp -127.07 121.44 31.54 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.444 0.698 . . . . 0.0 109.571 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -117.25 137.76 52.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 112.87 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.32 115.12 5.28 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.158 0.583 . . . . 0.0 111.009 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.26 3.1 mt-10 58.14 44.65 18.77 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.24 -28.99 0.98 Allowed Glycine 0 CA--C 1.559 2.789 0 N-CA-C 119.172 2.429 . . . . 0.0 119.172 -162.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.5 t -71.69 115.26 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 124.752 1.221 . . . . 0.0 110.198 -169.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.8 m -106.1 117.52 34.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.261 -169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 t -89.91 134.82 34.0 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.314 0.646 . . . . 0.0 111.448 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -109.68 118.61 37.01 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.756 -0.59 . . . . 0.0 110.809 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -116.66 137.06 52.47 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.65 0.78 . . . . 0.0 110.183 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.03 130.01 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -126.61 131.15 51.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.654 -0.654 . . . . 0.0 110.994 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -94.72 130.33 41.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.731 -1.231 . . . . 0.0 112.217 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -64.91 123.86 20.53 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 173.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.69 -36.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 120.228 1.377 . . . . 0.0 108.04 171.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.542 ' H8 ' H161 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 CA--C 1.576 1.942 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.41 174.64 8.91 Favored 'Trans proline' 0 CA--C 1.57 2.285 0 C-N-CA 122.599 2.199 . . . . 0.0 115.141 172.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.23 127.11 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -83.4 102.4 12.01 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -159.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -76.47 -0.9 24.66 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -58.96 114.34 2.52 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 122.029 2.195 . . . . 0.0 114.407 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.03 177.7 28.58 Favored Glycine 0 N--CA 1.486 2.002 0 CA-C-O 122.925 1.292 . . . . 0.0 115.811 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -110.75 111.16 22.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.478 1.111 . . . . 0.0 108.904 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -114.16 111.82 22.19 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -166.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.56 142.43 27.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.203 -0.936 . . . . 0.0 112.815 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.5 ttp -72.18 121.61 19.62 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.834 1.197 . . . . 0.0 113.53 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.8 mt -81.88 -44.43 16.86 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 169.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.2 m -154.11 160.65 42.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.458 -1.401 . . . . 0.0 113.343 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -136.65 120.47 17.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.137 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.94 120.74 31.17 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.604 0.761 . . . . 0.0 110.185 -170.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 32.6 t30 65.86 36.57 5.99 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.594 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 6.3 t80 -81.62 -42.34 20.17 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.14 -34.82 74.07 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -69.47 -44.78 70.48 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.018 1.736 . . . . 0.0 114.651 165.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -55.05 -45.45 75.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.73 -37.45 73.48 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.23 -43.73 87.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.2 -1.562 . . . . 0.0 114.848 163.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.27 24.84 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 163.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.0 mt -96.7 9.41 41.73 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 22.9 t70 62.61 59.93 1.4 Allowed 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 120.438 1.472 . . . . 0.0 113.145 -173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.98 139.08 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 121.616 0.722 . . . . 0.0 110.106 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -65.56 150.84 47.74 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.58 -47.01 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -49.98 70.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.23 -42.53 99.4 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 171.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -56.83 -48.57 77.72 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 121.304 1.866 . . . . 0.0 115.741 169.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -61.32 -43.32 99.06 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -63.56 -54.7 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 118.842 0.746 . . . . 0.0 111.691 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.52 78.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -66.77 -33.84 76.5 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 167.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -75.1 -25.08 58.23 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 170.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -70.68 147.74 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 120.365 1.439 . . . . 0.0 114.517 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -100.24 95.83 4.5 Favored Pre-proline 0 CA--C 1.572 1.82 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.091 175.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.61 141.49 46.0 Favored 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.479 2.119 . . . . 0.0 113.786 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -117.39 114.53 23.67 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 169.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -87.02 109.42 19.38 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 121.726 -0.609 . . . . 0.0 110.924 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.52 105.31 17.38 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 167.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mt -104.26 129.69 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.9 t -112.37 106.66 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -101.54 103.5 14.36 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.247 0.619 . . . . 0.0 109.781 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -91.65 72.0 5.85 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 169.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.39 -94.3 0.47 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -93.83 -25.11 17.5 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 166.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -83.63 116.42 22.61 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 120.416 1.462 . . . . 0.0 111.077 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.3 ttm -126.51 124.5 40.19 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.558 0.694 . . . . 0.0 110.945 -165.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.76 101.67 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.73 111.32 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -104.86 96.17 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 m -82.8 99.17 9.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 0.0 108.871 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.21 121.27 37.8 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.322 0.582 . . . . 0.0 110.401 -168.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.5 t -139.52 153.45 47.47 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.632 0.729 . . . . 0.0 110.67 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -63.6 -28.9 70.24 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.29 -52.55 10.58 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 170.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -156.04 136.75 13.37 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 119.461 1.028 . . . . 0.0 111.277 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.8 121.0 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.572 0.749 . . . . 0.0 110.111 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -109.72 116.74 32.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 110.366 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mm -110.64 119.66 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.2 mtp -107.33 104.17 13.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.825 -0.547 . . . . 0.0 110.082 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -110.14 115.75 30.29 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 124.074 0.95 . . . . 0.0 111.615 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -158.39 153.34 25.17 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -93.04 134.09 35.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.09 -1.007 . . . . 0.0 110.455 161.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.11 124.69 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.385 -0.822 . . . . 0.0 110.049 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.14 -38.32 3.1 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.607 1.403 . . . . 0.0 116.607 -155.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.94 133.76 35.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 117.959 0.88 . . . . 0.0 113.279 -161.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.46 102.58 12.18 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 121.953 -0.467 . . . . 0.0 110.628 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -116.29 144.34 44.36 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.623 0.769 . . . . 0.0 112.173 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.59 92.21 3.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.597 -1.314 . . . . 0.0 113.197 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.17 118.9 24.42 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.388 -0.82 . . . . 0.0 110.767 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -76.8 127.81 33.45 Favored 'General case' 0 CA--C 1.566 1.569 0 O-C-N 121.759 -0.588 . . . . 0.0 110.518 161.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.3 55.29 0.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.553 0.692 . . . . 0.0 112.571 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.8 t -82.87 131.01 35.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 112.521 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.82 -49.8 0.95 Allowed Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.297 -0.877 . . . . 0.0 114.642 -155.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -78.34 -72.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.443 1.097 . . . . 0.0 109.902 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -135.34 -2.54 2.48 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.288 1.7 m-20 58.71 45.0 16.44 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -116.07 139.99 49.73 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.779 0.831 . . . . 0.0 110.993 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -83.54 124.24 30.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.108 0.48 . . . . 0.0 110.464 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 83.7 m -124.42 122.24 37.12 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.262 0.625 . . . . 0.0 110.851 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.73 99.05 2.06 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.292 1.044 . . . . 0.0 109.996 173.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.9 m -111.56 121.04 44.09 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.87 -158.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -104.76 120.66 41.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.74 128.04 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.9 m -132.75 145.72 51.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.595 0.758 . . . . 0.0 111.631 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -80.4 118.23 21.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.569 -1.332 . . . . 0.0 112.343 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.62 69.76 2.55 Favored 'General case' 0 CA--C 1.571 1.775 0 O-C-N 121.443 -0.786 . . . . 0.0 110.034 161.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.41 -96.94 0.19 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -83.3 -29.66 28.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -96.29 131.89 42.33 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 120.204 1.365 . . . . 0.0 111.466 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.9 tp -89.44 105.76 18.0 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.815 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -88.26 147.82 24.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.058 0.943 . . . . 0.0 111.964 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.8 t -141.57 135.83 30.46 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.89 126.54 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 123.541 0.736 . . . . 0.0 109.046 163.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -102.53 108.13 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.518 0.727 . . . . 0.0 109.527 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -86.39 101.96 13.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.801 -1.187 . . . . 0.0 110.453 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.28 92.81 0.09 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 114.166 0.426 . . . . 0.0 114.166 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.311 79.9 mt-10 70.11 -46.08 0.6 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -106.74 151.47 25.09 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.506 1.146 . . . . 0.0 113.191 -153.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -86.72 107.64 18.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.586 -0.697 . . . . 0.0 111.89 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.64 55.61 8.31 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 115.742 1.057 . . . . 0.0 115.742 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -95.57 129.1 42.87 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 122.967 0.507 . . . . 0.0 111.719 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.22 -147.78 13.4 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 114.848 0.699 . . . . 0.0 114.848 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -160.98 161.44 31.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.959 0.885 . . . . 0.0 112.958 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 84.2 m -134.97 123.38 23.25 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -123.29 131.96 53.85 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.508 0.723 . . . . 0.0 111.287 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -147.97 169.24 20.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.877 -1.139 . . . . 0.0 113.209 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -113.48 128.01 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -113.28 90.03 3.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 163.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.87 -113.13 4.06 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.46 -0.775 . . . . 0.0 114.819 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -88.25 4.4 45.97 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.46 131.65 54.06 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 120.037 1.289 . . . . 0.0 112.365 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.43 122.0 35.4 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.976 0.91 . . . . 0.0 109.352 171.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -111.52 123.05 49.42 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.9 tp -123.4 121.14 35.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.351 0.661 . . . . 0.0 111.07 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.46 129.71 42.54 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.404 0.681 . . . . 0.0 110.235 163.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 65.6 mtm -119.69 130.85 55.23 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 118.736 0.698 . . . . 0.0 110.722 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -125.47 133.31 52.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 112.609 -164.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.28 131.88 7.69 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 111.41 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 55.02 38.78 31.08 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.36 3.72 Favored Glycine 0 CA--C 1.559 2.786 0 N-CA-C 120.182 2.833 . . . . 0.0 120.182 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.66 121.8 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 119.87 1.835 . . . . 0.0 108.6 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.2 m -98.59 124.37 43.33 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-O 121.671 0.748 . . . . 0.0 110.691 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.594 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 11.2 t -92.74 143.79 25.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.686 . . . . 0.0 111.345 160.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -117.8 122.87 44.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.937 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -115.34 130.8 57.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.73 132.11 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -128.97 159.29 36.34 Favored 'General case' 0 CA--C 1.574 1.887 0 C-N-CA 124.437 1.095 . . . . 0.0 111.206 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -130.94 132.11 44.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.534 -1.354 . . . . 0.0 111.846 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.51 116.17 10.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.18 -33.96 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t60 . . . . . 0 CA--C 1.562 1.414 0 CA-C-N 119.951 1.25 . . . . 0.0 107.993 170.017 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.431 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 CA--C 1.571 1.764 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.6 119.58 6.01 Favored 'Trans proline' 0 CA--C 1.563 1.935 0 C-N-CA 122.649 2.232 . . . . 0.0 114.714 -175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.77 142.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 122.239 1.019 . . . . 0.0 113.426 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -80.96 100.43 8.92 Favored 'General case' 0 CA--C 1.564 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 112.855 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -77.8 -4.0 44.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -54.84 108.86 0.44 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 121.285 1.857 . . . . 0.0 115.136 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.56 -175.99 35.55 Favored Glycine 0 CA--C 1.546 2.017 0 CA-C-O 122.829 1.238 . . . . 0.0 115.828 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -117.51 118.06 31.14 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.311 1.045 . . . . 0.0 109.356 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -121.54 117.13 26.02 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.69 -0.631 . . . . 0.0 109.582 -164.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -84.99 147.07 26.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.94 -1.1 . . . . 0.0 113.537 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.493 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 31.9 ttm -70.61 128.93 37.78 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 120.372 1.442 . . . . 0.0 113.459 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.38 -45.71 9.76 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -157.3 156.13 31.88 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.255 1.843 . . . . 0.0 114.458 173.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -104.75 123.29 47.39 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.761 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -88.97 -66.74 0.89 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -126.44 39.16 3.99 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.206 0.602 . . . . 0.0 112.114 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -70.58 -36.84 73.8 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.77 -47.32 70.85 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.56 -37.72 77.12 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -52.94 -48.11 67.56 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 120.838 1.654 . . . . 0.0 114.049 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.0 -35.83 69.57 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -54.0 -46.03 71.64 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 120.605 1.548 . . . . 0.0 114.899 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.63 -23.4 58.92 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.4 mt -82.75 -9.54 59.3 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 166.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.329 16.9 t70 71.93 48.71 0.27 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.489 1.516 . . . . 0.0 114.763 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 78.5 t -89.94 149.79 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 122.289 1.042 . . . . 0.0 110.561 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -62.95 149.09 45.6 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -60.64 -40.8 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.18 -55.31 34.71 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.64 -41.99 91.76 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -53.22 -51.96 60.46 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 168.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -65.61 -41.76 92.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.76 -58.13 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.332 0.969 . . . . 0.0 111.519 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.08 74.23 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.09 -28.82 63.56 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 166.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.85 -23.6 39.0 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 mt -69.93 149.51 47.71 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 120.673 1.578 . . . . 0.0 114.681 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -101.84 91.04 2.14 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.212 171.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 92.7 Cg_endo -75.18 152.35 39.85 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.532 2.154 . . . . 0.0 114.224 169.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -109.4 117.74 34.82 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.351 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -84.84 111.94 20.09 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.328 -0.857 . . . . 0.0 110.746 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.67 107.95 19.75 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.759 -0.588 . . . . 0.0 109.632 165.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -102.92 127.35 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.46 106.32 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 170.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -95.48 105.58 17.57 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.157 0.583 . . . . 0.0 110.159 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -95.3 79.9 3.51 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.53 0.681 . . . . 0.0 109.751 168.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.93 -105.06 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.21 -26.67 33.1 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 165.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -82.11 107.06 14.51 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 120.515 1.507 . . . . 0.0 111.49 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 45.4 ttm -108.44 124.64 50.72 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 123.999 0.92 . . . . 0.0 111.04 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mp -115.48 102.22 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.68 107.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -100.13 101.49 12.55 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -85.1 101.18 12.23 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.5 mt -99.03 121.33 40.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.899 0.48 . . . . 0.0 111.506 -164.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.8 t -144.41 150.61 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.908 0.861 . . . . 0.0 111.304 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.9 p -63.21 -31.19 72.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -71.04 -52.47 19.34 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 168.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -155.39 135.94 13.36 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.94 0.791 . . . . 0.0 110.857 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -88.53 127.77 35.55 Favored 'General case' 0 CA--C 1.568 1.636 0 O-C-N 121.876 -0.515 . . . . 0.0 110.582 167.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -110.14 123.42 49.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.585 -0.697 . . . . 0.0 110.857 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.69 121.09 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 87.8 mtp -112.46 104.51 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -108.78 110.43 21.81 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.63 0.772 . . . . 0.0 108.926 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -153.67 154.84 34.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -167.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -100.13 125.86 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.728 169.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.49 125.87 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.639 -0.663 . . . . 0.0 110.811 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.52 -38.86 3.12 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 116.723 1.449 . . . . 0.0 116.723 -161.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -85.47 146.97 26.69 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 118.405 1.102 . . . . 0.0 113.919 -172.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -93.58 112.97 24.97 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 122.979 0.512 . . . . 0.0 110.003 170.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -120.82 148.52 43.9 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.985 0.914 . . . . 0.0 112.473 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -70.46 103.04 2.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.662 -1.274 . . . . 0.0 111.757 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -89.99 113.99 25.76 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.17 0.588 . . . . 0.0 109.892 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.94 122.49 24.24 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 121.082 0.468 . . . . 0.0 110.237 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mt -105.15 44.18 1.05 Allowed 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.5 m -81.0 132.67 35.39 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.952 -1.093 . . . . 0.0 111.366 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.33 -57.65 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.811 -151.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.8 mt -74.42 -63.41 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.376 1.07 . . . . 0.0 110.635 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -146.76 17.56 1.27 Allowed 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 159.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.05 42.2 31.12 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -173.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -111.24 145.1 39.33 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.662 0.785 . . . . 0.0 111.342 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -90.38 117.6 29.23 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.037 -1.04 . . . . 0.0 110.013 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 46.0 m -111.07 144.1 40.72 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.0 111.736 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -81.11 90.3 6.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.55 168.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.0 m -90.69 129.93 36.74 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.425 -0.797 . . . . 0.0 110.54 -172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.3 m -116.63 125.37 51.68 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.438 HG22 ' SG ' ' A' ' 95' ' ' CYS . 40.6 t -115.39 128.76 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.6 m -132.63 148.92 52.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.196 -0.94 . . . . 0.0 112.377 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -84.33 123.11 29.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.824 -1.172 . . . . 0.0 113.344 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -111.79 73.39 0.82 Allowed 'General case' 0 CA--C 1.572 1.806 0 C-N-CA 123.654 0.782 . . . . 0.0 109.666 162.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.01 -110.02 3.08 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -69.7 -24.11 63.53 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -99.13 120.62 39.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.206 0.912 . . . . 0.0 111.191 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.6 111.65 23.05 Favored 'General case' 0 CA--C 1.563 1.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -114.83 128.43 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.507 0.723 . . . . 0.0 110.532 -161.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 86' ' ' VAL . 54.1 t -130.67 142.86 50.44 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.2 129.37 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.493 164.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -103.93 95.9 6.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -88.72 115.91 26.6 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.941 -1.099 . . . . 0.0 112.015 -167.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.18 -126.64 0.9 Allowed Glycine 0 N--CA 1.487 2.079 0 O-C-N 121.248 -0.907 . . . . 0.0 114.164 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.63 -32.1 65.64 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -103.99 138.65 40.23 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 119.823 1.192 . . . . 0.0 111.784 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.41 142.6 30.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.55 45.93 94.8 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 117.551 1.78 . . . . 0.0 117.551 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -99.95 130.92 46.17 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 121.698 0.761 . . . . 0.0 111.032 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.68 -166.4 34.75 Favored Glycine 0 N--CA 1.482 1.748 0 CA-C-O 121.806 0.67 . . . . 0.0 114.415 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -157.96 156.45 31.25 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.0 m -133.37 124.66 27.59 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.54 128.78 48.5 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.646 0.778 . . . . 0.0 111.336 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -146.32 169.26 19.18 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.113 -0.992 . . . . 0.0 113.191 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.2 mt -109.1 124.44 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.34 86.78 2.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.648 -0.657 . . . . 0.0 109.388 163.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.87 -110.54 3.25 Favored Glycine 0 N--CA 1.491 2.343 0 O-C-N 121.231 -0.918 . . . . 0.0 115.045 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -83.66 -6.03 59.34 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 162.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -101.0 137.26 39.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 120.697 1.589 . . . . 0.0 112.826 -172.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.06 120.17 36.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.612 0.765 . . . . 0.0 109.04 171.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -110.11 117.58 34.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 63.2 tp -121.0 117.08 26.36 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.471 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.99 129.7 40.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.955 0.502 . . . . 0.0 109.867 166.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.8 mtp -124.45 123.43 40.14 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.742 0.817 . . . . 0.0 110.089 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -114.29 140.23 48.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.615 -0.678 . . . . 0.0 112.461 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.11 120.13 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.585 0.754 . . . . 0.0 109.506 171.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 58.56 41.34 22.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.75 -32.76 1.44 Allowed Glycine 0 CA--C 1.558 2.731 0 N-CA-C 118.852 2.301 . . . . 0.0 118.852 -163.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.28 116.19 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 124.757 1.223 . . . . 0.0 110.78 -168.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -106.37 115.31 29.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.566 0.698 . . . . 0.0 110.099 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.0 t -97.49 127.21 43.26 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.784 0.834 . . . . 0.0 112.082 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -93.53 116.38 28.9 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -103.36 119.12 38.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.3 t -107.37 132.86 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -131.09 160.56 34.33 Favored 'General case' 0 CA--C 1.573 1.858 0 C-N-CA 124.116 0.966 . . . . 0.0 111.703 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.12 129.7 40.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.796 -1.19 . . . . 0.0 110.511 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -68.47 124.87 24.75 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 35.6 m -117.56 -40.19 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 . . . . . 0 CA--C 1.563 1.47 0 CA-C-N 119.781 1.173 . . . . 0.0 108.258 169.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.434 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.575 1.923 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.47 -173.99 2.08 Favored 'Trans proline' 0 CA--C 1.57 2.298 0 C-N-CA 122.352 2.035 . . . . 0.0 115.623 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -60.4 -17.18 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 119.567 3.173 . . . . 0.0 119.567 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.261 52.3 t0 67.99 86.28 0.13 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.236 1.38 . . . . 0.0 113.802 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -78.54 5.26 11.25 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 117.975 2.583 . . . . 0.0 117.975 177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -61.42 107.66 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.806 1.639 . . . . 0.0 114.481 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.17 178.79 32.53 Favored Glycine 0 N--CA 1.484 1.89 0 CA-C-O 122.621 1.123 . . . . 0.0 114.888 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -107.76 118.76 37.58 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.33 1.052 . . . . 0.0 109.27 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -118.81 112.48 19.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -168.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -89.53 139.55 30.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.234 -0.916 . . . . 0.0 112.831 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.434 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 32.2 ttp -69.31 121.52 17.05 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 119.889 1.222 . . . . 0.0 114.042 -173.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.93 -44.41 18.29 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.6 m -152.95 159.13 42.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.398 -1.439 . . . . 0.0 113.724 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -140.39 118.76 12.14 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.692 -174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.96 118.3 19.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.745 -0.597 . . . . 0.0 110.439 -167.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.283 23.1 t30 66.6 33.76 6.33 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -80.25 -42.34 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.78 -42.85 80.16 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.28 -39.87 89.71 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 171.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -54.79 -47.58 73.81 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.64 -40.44 73.07 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -57.88 -41.9 83.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 165.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.43 58.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.698 2.481 . . . . 0.0 117.698 164.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 60.9 mt -86.75 -49.67 7.29 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.22 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 125.835 1.654 . . . . 0.0 114.986 165.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.2 t -82.01 148.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 119.306 -2.121 . . . . 0.0 112.886 -136.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -64.66 153.21 40.2 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 170.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -60.0 -41.81 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.49 -54.73 42.3 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 172.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.16 -38.17 85.5 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -57.18 -51.22 70.21 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 165.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -65.38 -41.71 93.44 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.8 mt -59.17 -58.21 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 119.446 1.021 . . . . 0.0 111.373 168.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.64 76.48 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -68.45 -36.22 78.71 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 167.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.83 -28.75 63.78 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.0 mt -72.5 135.24 45.63 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.541 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.64 101.99 7.97 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.565 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 34.1 Cg_endo -65.76 142.99 72.26 Favored 'Trans proline' 0 CA--C 1.562 1.887 0 CA-C-N 123.315 2.22 . . . . 0.0 113.94 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.54 113.39 25.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -88.57 110.78 21.18 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.767 -0.583 . . . . 0.0 111.287 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -97.84 106.91 19.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.61 129.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.18 109.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 164.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -102.22 109.88 21.68 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.537 0.735 . . . . 0.0 109.99 174.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -100.19 74.97 1.79 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 121.536 0.684 . . . . 0.0 109.791 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.05 -104.02 0.89 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.12 -31.3 39.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 165.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.06 127.58 33.55 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.893 1.678 . . . . 0.0 111.701 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.6 ttm -136.11 123.67 22.24 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-O 121.348 0.594 . . . . 0.0 111.274 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.4 mt -109.61 105.8 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.16 115.71 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -107.39 96.16 6.21 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.7 m -86.75 95.52 9.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.6 mt -95.15 130.74 41.76 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -162.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -149.52 152.72 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.926 0.87 . . . . 0.0 110.97 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.6 p -62.33 -31.65 72.3 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 174.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -75.27 -52.46 10.81 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -151.0 129.27 11.97 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 119.042 0.837 . . . . 0.0 110.498 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -90.3 123.16 33.84 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.307 0.643 . . . . 0.0 109.568 167.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -103.56 110.85 23.05 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 119.087 0.858 . . . . 0.0 109.658 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.9 mm -104.1 116.9 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.1 mtp -103.81 133.91 48.0 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.37 109.43 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.97 160.44 41.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -167.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -103.37 131.09 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.836 0.827 . . . . 0.0 110.519 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.89 131.63 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.862 0 CA-C-O 121.966 0.889 . . . . 0.0 110.166 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.9 22.76 Favored Glycine 0 CA--C 1.554 2.514 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 -161.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -101.33 143.22 31.64 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.241 1.521 . . . . 0.0 111.608 -166.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -91.39 108.8 20.14 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.003 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -119.13 146.97 44.69 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.54 108.02 4.72 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.96 0.886 . . . . 0.0 112.524 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -112.41 106.78 15.36 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.663 0.785 . . . . 0.0 109.939 -168.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -83.54 119.44 24.71 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.817 0.818 . . . . 0.0 110.707 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.04 52.49 1.06 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 m -73.66 128.22 34.91 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.468 1.107 . . . . 0.0 112.46 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.52 -60.98 0.41 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.987 -0.446 . . . . 0.0 113.648 -157.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.6 mt -70.61 -61.73 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 124.245 1.018 . . . . 0.0 110.95 -174.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -143.63 3.57 1.29 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 165.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 7.8 t70 44.62 55.28 5.95 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 -163.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.521 ' HE ' ' HZ1' ' A' ' 101' ' ' LYS . 76.2 mmt-85 -110.89 138.18 47.6 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.661 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -97.88 104.45 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 87.2 m -109.27 145.62 35.62 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.363 0.601 . . . . 0.0 111.862 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.8 mmm -85.17 91.72 8.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.147 169.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.9 m -96.6 122.66 39.76 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.643 -0.661 . . . . 0.0 110.653 -166.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 35.2 m -100.21 117.14 33.82 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -105.76 128.92 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -141.6 153.9 45.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.965 -1.085 . . . . 0.0 112.585 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -81.27 114.32 19.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.979 -1.076 . . . . 0.0 111.868 175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -85.42 70.24 10.78 Favored 'General case' 0 CA--C 1.572 1.806 0 CA-C-O 121.597 0.713 . . . . 0.0 110.121 162.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.33 -98.84 0.21 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -169.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.47 -26.03 26.54 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -94.11 138.99 31.55 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.667 1.576 . . . . 0.0 111.513 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.74 106.69 18.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.097 -1.002 . . . . 0.0 110.098 175.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -95.37 150.42 20.29 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.967 0.907 . . . . 0.0 112.395 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.3 t -146.44 135.17 22.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.013 0.525 . . . . 0.0 112.315 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -120.93 126.6 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.65 0.78 . . . . 0.0 109.173 167.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -103.3 92.28 4.43 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -86.18 134.25 33.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.855 . . . . 0.0 112.961 -167.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 141.23 -90.68 0.18 Allowed Glycine 0 N--CA 1.486 2.031 0 O-C-N 121.441 -0.787 . . . . 0.0 113.713 167.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -81.29 -12.4 59.07 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -169.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HZ1' ' HE ' ' A' ' 80' ' ' ARG . 24.0 mmtm -129.21 148.98 51.19 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 120.672 1.578 . . . . 0.0 112.757 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -82.11 114.18 20.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.787 0.835 . . . . 0.0 111.258 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.54 43.04 99.59 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 118.11 2.004 . . . . 0.0 118.11 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -86.17 135.93 33.39 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.304 1.052 . . . . 0.0 111.635 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -170.79 38.6 Favored Glycine 0 N--CA 1.482 1.721 0 CA-C-O 122.12 0.845 . . . . 0.0 114.262 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 61.7 p-90 -153.56 165.06 37.07 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.406 1.098 . . . . 0.0 113.183 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 m -138.47 125.77 21.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.43 129.0 42.46 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.725 -172.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 p90 -151.62 165.49 34.14 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.002 -1.061 . . . . 0.0 113.242 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -107.41 131.0 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -0.936 . . . . 0.0 109.298 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -119.2 95.45 4.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 162.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.77 -117.4 4.72 Favored Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.677 -0.64 . . . . 0.0 114.151 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -94.59 15.9 16.85 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.994 1.849 . . . . 0.0 115.994 162.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -113.74 125.21 53.86 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 119.583 1.083 . . . . 0.0 111.055 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -83.3 120.64 26.1 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.375 1.07 . . . . 0.0 109.712 166.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -107.11 119.14 38.57 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.579 0.751 . . . . 0.0 108.979 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 tp -115.66 128.55 56.0 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.756 0.822 . . . . 0.0 110.013 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -113.88 123.8 50.66 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.638 0.775 . . . . 0.0 110.042 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 66.7 mtm -115.41 137.17 52.34 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.857 0.863 . . . . 0.0 111.483 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -127.11 135.05 50.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.539 -0.726 . . . . 0.0 111.578 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.77 125.4 6.38 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.118 0.567 . . . . 0.0 111.438 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 54.56 42.6 31.2 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.38 -6.95 6.92 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 120.377 2.911 . . . . 0.0 120.377 -165.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.21 126.15 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.281 2.04 . . . . 0.0 109.93 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 55.4 m -108.47 128.99 55.27 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 123.934 0.894 . . . . 0.0 111.085 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.4 t -125.12 126.5 45.41 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.297 1.039 . . . . 0.0 112.75 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.95 135.54 35.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.552 -0.718 . . . . 0.0 112.127 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -129.04 134.5 48.15 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.351 0.661 . . . . 0.0 110.656 162.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 35.6 t -116.68 130.32 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.84 132.73 43.95 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.905 0.775 . . . . 0.0 111.252 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -103.61 133.75 48.1 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.227 -1.545 . . . . 0.0 112.631 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.96 120.88 16.35 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.0 -38.57 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 . . . . . 0 CA--C 1.563 1.464 0 CA-C-N 119.933 1.242 . . . . 0.0 108.318 169.274 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.409 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 78.2 mtp . . . . . 0 CA--C 1.572 1.802 0 CA-C-O 115.91 -1.995 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.27 92.74 0.74 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 CA-C-N 125.482 2.994 . . . . 0.0 114.683 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.0 147.9 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -80.9 105.76 12.38 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.452 -0.78 . . . . 0.0 112.554 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -78.8 2.1 21.01 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -57.82 105.68 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 121.348 1.886 . . . . 0.0 115.114 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.53 179.83 35.55 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -109.64 113.0 25.41 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.592 1.157 . . . . 0.0 109.218 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -115.15 111.61 21.28 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -168.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.31 141.35 28.87 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.6 ttp -71.76 121.69 19.36 Favored 'General case' 0 CA--C 1.568 1.667 0 O-C-N 120.615 -1.303 . . . . 0.0 113.987 -173.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.2 mt -83.13 -45.09 14.36 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 168.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -153.52 160.45 42.51 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.505 -1.372 . . . . 0.0 113.333 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -142.34 117.98 10.4 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.002 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.76 121.0 35.26 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.749 0.82 . . . . 0.0 109.834 -172.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.285 31.1 t30 68.36 34.2 3.87 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -78.68 -40.53 33.66 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -56.4 -35.86 68.25 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 168.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.76 -41.92 67.83 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.946 1.703 . . . . 0.0 114.675 166.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.25 -51.12 65.54 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 120.079 1.308 . . . . 0.0 113.802 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.04 -38.18 82.21 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -59.92 -39.21 84.69 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.86 -34.3 62.77 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 165.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -71.96 -9.79 58.86 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.318 15.9 t0 67.95 49.8 0.87 Allowed 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 125.592 1.557 . . . . 0.0 114.581 -161.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.5 t -93.51 137.01 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.93 0.872 . . . . 0.0 109.758 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -61.82 150.52 36.96 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 176.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -52.51 -44.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.51 68.96 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 172.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -36.29 80.79 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -61.97 -51.21 69.01 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 121.307 1.867 . . . . 0.0 115.447 167.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -60.22 -44.58 95.05 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.08 -55.96 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-N 118.724 0.693 . . . . 0.0 111.391 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.17 -35.41 77.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -70.67 -32.05 69.18 Favored 'General case' 0 CA--C 1.571 1.75 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.61 -24.12 53.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.6 mt -72.22 154.28 41.1 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -99.0 95.96 3.68 Favored Pre-proline 0 CA--C 1.574 1.883 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.364 168.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.72 143.65 30.32 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 C-N-CA 122.507 2.138 . . . . 0.0 113.477 166.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.14 117.22 32.67 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -85.92 107.18 17.6 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.371 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.22 108.7 20.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 170.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -106.6 127.84 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -116.15 109.15 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -106.79 105.48 15.53 Favored 'General case' 0 CA--C 1.564 1.499 0 C-N-CA 123.881 0.873 . . . . 0.0 110.578 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.78 75.68 6.47 Favored 'General case' 0 CA--C 1.57 1.745 0 O-C-N 121.453 -0.779 . . . . 0.0 110.054 166.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.39 -100.36 0.47 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 115.231 0.853 . . . . 0.0 115.231 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.54 -29.04 28.19 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.17 110.49 17.42 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.353 1.433 . . . . 0.0 111.016 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 ttp -126.98 130.67 50.51 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.439 1.114 . . . . 0.0 111.949 -169.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.86 101.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.2 mt -93.12 110.59 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -103.1 100.13 10.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.5 m -83.25 97.9 9.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.84 112.38 25.47 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.667 0.746 . . . . 0.0 110.627 -165.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 t -127.98 149.87 50.16 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.486 0.66 . . . . 0.0 109.789 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.1 p -61.33 -28.26 69.09 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -76.11 -42.47 46.99 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 166.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -156.47 131.39 9.06 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 120.214 1.37 . . . . 0.0 112.864 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -109.29 122.2 46.83 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.532 0.733 . . . . 0.0 110.297 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.42 108.88 15.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.325 -0.86 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.09 127.59 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-O 121.65 0.738 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mtp -108.64 105.81 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.814 0.846 . . . . 0.0 109.505 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -104.99 116.65 32.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.429 0.692 . . . . 0.0 109.775 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -153.66 155.79 36.69 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -100.28 128.45 46.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.442 -0.786 . . . . 0.0 110.522 165.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 49.7 t -68.27 121.93 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 123.453 0.701 . . . . 0.0 110.255 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.36 -35.17 4.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 -162.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.1 140.31 29.58 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 118.732 1.266 . . . . 0.0 112.06 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -91.13 107.12 18.99 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 122.041 -0.412 . . . . 0.0 111.079 171.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -112.46 133.77 54.35 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 123.577 0.751 . . . . 0.0 112.026 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.97 94.2 2.32 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 112.18 173.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -96.63 130.28 43.87 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.641 -0.662 . . . . 0.0 111.616 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.51 124.29 28.82 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD21 HE22 ' A' ' 97' ' ' GLN . 0.9 OUTLIER -78.19 67.73 4.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 123.115 1.436 . . . . 0.0 111.665 171.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 m -75.52 126.14 30.43 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.483 -166.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.22 64.75 Favored Glycine 0 CA--C 1.555 2.551 0 N-CA-C 118.826 2.29 . . . . 0.0 118.826 -170.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.75 -75.26 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.35 7.48 4.22 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 42.5 t0 43.84 59.98 2.9 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -115.2 141.51 47.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.59 -0.694 . . . . 0.0 111.375 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.47 115.52 28.1 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.335 0.654 . . . . 0.0 110.607 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 90.8 m -120.42 135.24 55.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.284 0.633 . . . . 0.0 111.751 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.0 mmm -76.63 99.77 5.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.787 . . . . 0.0 110.463 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.4 m -101.49 118.74 37.58 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.696 -169.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.6 m -97.6 124.17 41.78 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 162.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.46 132.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.9 m -151.07 153.58 35.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.321 -1.487 . . . . 0.0 113.234 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -84.97 117.58 24.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.336 . . . . 0.0 113.27 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -99.12 78.97 2.29 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 123.427 0.691 . . . . 0.0 109.258 164.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.24 -121.69 21.61 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 114.592 0.597 . . . . 0.0 114.592 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -76.36 -8.33 56.88 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 168.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -98.23 128.76 44.85 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 120.067 1.303 . . . . 0.0 110.662 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 20.8 tp -89.4 107.36 19.03 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.586 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -90.1 141.35 28.77 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.898 0.879 . . . . 0.0 111.563 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 41.9 t -133.14 125.52 29.68 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.516 0.726 . . . . 0.0 110.923 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -113.19 121.63 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 123.225 0.61 . . . . 0.0 109.731 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.524 HE22 HD21 ' A' ' 74' ' ' LEU . 13.4 mt-30 -103.65 102.11 11.97 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.392 0.677 . . . . 0.0 111.024 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.34 125.0 39.66 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.68 -118.01 0.62 Allowed Glycine 0 N--CA 1.49 2.241 0 O-C-N 121.102 -0.999 . . . . 0.0 112.976 170.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.55 -36.12 81.89 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 170.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -89.55 130.86 35.8 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -163.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.4 117.82 22.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.795 -0.566 . . . . 0.0 111.889 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.11 46.94 93.01 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 117.737 1.855 . . . . 0.0 117.737 -176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -93.01 136.92 32.83 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.19 0.995 . . . . 0.0 111.762 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.18 -171.12 43.03 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-O 122.842 1.245 . . . . 0.0 114.244 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -154.08 152.78 30.86 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.101 0.953 . . . . 0.0 112.47 171.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 79.3 m -125.59 125.14 42.69 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.64 139.24 53.32 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 p90 -151.78 164.14 37.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 113.072 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.51 140.44 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 CA-C-O 122.847 1.308 . . . . 0.0 110.689 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -137.16 84.05 2.03 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.08 -111.16 3.4 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 121.846 -0.533 . . . . 0.0 113.816 -171.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -93.03 6.96 46.07 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -106.62 127.59 53.47 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.96 1.709 . . . . 0.0 112.741 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.7 tp -85.61 119.16 25.64 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.119 0.968 . . . . 0.0 109.381 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.52 122.57 46.28 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.61 0.764 . . . . 0.0 109.197 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.8 tp -121.9 126.32 48.4 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.599 0.76 . . . . 0.0 111.473 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -106.0 123.1 47.45 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.394 0.678 . . . . 0.0 109.639 164.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 63.7 mtm -110.09 129.75 55.64 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 118.948 0.795 . . . . 0.0 110.64 172.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -125.68 144.55 50.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.41 127.7 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.606 0.763 . . . . 0.0 110.978 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 51.1 49.7 20.61 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.7 -32.54 1.43 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.67 157.64 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 C-N-CA 125.14 1.376 . . . . 0.0 112.866 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.6 m -129.94 121.95 27.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.712 -1.243 . . . . 0.0 110.218 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 13.5 t -97.14 131.68 43.66 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.3 0.64 . . . . 0.0 110.508 161.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -113.8 120.01 39.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.859 -0.526 . . . . 0.0 110.511 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -120.18 139.24 52.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.565 0.746 . . . . 0.0 111.48 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.05 129.79 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.16 142.3 51.22 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.924 0.89 . . . . 0.0 110.663 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -112.59 133.38 54.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.377 -1.452 . . . . 0.0 111.94 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -67.92 122.64 18.61 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.4 m -117.27 -34.49 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 t60 . . . . . 0 C--O 1.254 1.312 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 169.118 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.442 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 CA--C 1.571 1.752 0 CA-C-O 115.994 -1.955 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.28 115.76 3.5 Favored 'Trans proline' 0 C--N 1.374 1.917 0 CA-C-N 124.946 2.802 . . . . 0.0 115.012 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.96 139.94 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 CA-C-O 122.003 0.906 . . . . 0.0 110.314 -174.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.72 104.04 8.02 Favored 'General case' 0 CA--C 1.565 1.546 0 O-C-N 121.328 -0.857 . . . . 0.0 113.282 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -81.27 2.51 27.71 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -59.56 116.12 3.78 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.219 1.827 . . . . 0.0 114.59 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.94 177.95 31.52 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-O 123.246 1.47 . . . . 0.0 115.758 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -110.44 112.37 24.25 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 113.727 -1.236 . . . . 0.0 108.677 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -112.47 122.68 48.4 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -167.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -91.87 143.94 25.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.802 -1.186 . . . . 0.0 113.092 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.402 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.5 ttm -73.49 122.41 22.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.721 -1.237 . . . . 0.0 112.988 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.31 -44.74 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -154.0 158.31 40.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.459 -1.4 . . . . 0.0 112.645 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -135.8 100.62 4.51 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.08 -64.42 1.15 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -154.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -120.54 43.55 2.71 Favored 'General case' 0 CA--C 1.571 1.773 0 C-N-CA 123.717 0.807 . . . . 0.0 111.273 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 17.0 t80 -73.62 -39.85 64.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.54 -46.05 70.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 168.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -67.44 -39.82 85.43 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -55.73 -45.98 77.87 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 165.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.97 -41.42 86.87 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -53.83 -44.71 70.47 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.47 -15.89 52.38 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 166.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.68 -5.71 56.8 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 164.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 7.5 t70 69.6 62.78 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 120.38 1.445 . . . . 0.0 112.996 -164.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 83.5 t -104.03 148.23 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.19 0.995 . . . . 0.0 110.034 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -62.25 151.88 35.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.77 -42.91 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.95 -54.37 45.52 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.63 -38.5 84.98 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 170.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -53.53 -52.13 60.65 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -65.29 -45.28 85.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.17 -56.49 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.538 0.735 . . . . 0.0 111.819 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.51 -27.01 66.63 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -67.11 -43.22 83.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 162.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.67 -28.14 65.62 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.8 mt -68.46 135.59 51.91 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 120.034 1.288 . . . . 0.0 112.893 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -113.06 84.57 7.16 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.201 -0.904 . . . . 0.0 109.19 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 70.7 Cg_endo -71.95 168.6 23.46 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 122.624 2.216 . . . . 0.0 116.054 -176.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -106.77 121.86 45.22 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.145 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -89.88 110.23 21.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.613 -0.679 . . . . 0.0 110.009 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -93.3 108.78 20.36 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 167.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -106.19 123.96 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.53 107.94 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 172.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -103.04 119.02 38.1 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.928 0.891 . . . . 0.0 109.36 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.7 -60.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.422 -0.799 . . . . 0.0 112.546 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.81 101.49 0.15 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.455 1.0 OUTLIER 60.46 -45.16 0.1 Allowed 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -150.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -70.34 126.66 30.28 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-N 119.874 1.215 . . . . 0.0 112.361 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 ttp -143.39 131.89 22.3 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.105 0.955 . . . . 0.0 111.674 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.9 mt -115.4 109.78 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.4 mt -97.44 115.72 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -111.54 96.01 5.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.702 -0.624 . . . . 0.0 109.347 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.3 m -87.13 103.06 15.04 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.9 mt -101.04 114.86 29.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 111.606 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -130.28 149.29 52.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.7 0.8 . . . . 0.0 110.209 168.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -65.77 -16.36 63.72 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.639 2.459 . . . . 0.0 117.639 167.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -76.56 -53.31 8.24 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-N 119.459 1.027 . . . . 0.0 112.739 163.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttm-85 -155.0 135.16 13.1 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 121.784 0.802 . . . . 0.0 111.023 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.19 121.42 34.53 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 123.765 0.826 . . . . 0.0 110.084 173.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -112.34 104.94 13.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.184 -0.948 . . . . 0.0 110.833 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.82 125.28 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-O 121.818 0.818 . . . . 0.0 109.106 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.9 mtp -103.67 109.99 21.89 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.64 0.776 . . . . 0.0 109.015 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -108.31 110.6 22.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.554 0.742 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.69 42.25 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -166.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -108.24 129.9 55.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 168.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.07 123.51 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 123.519 0.728 . . . . 0.0 110.287 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.31 -32.32 7.66 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 117.333 1.693 . . . . 0.0 117.333 -164.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -87.87 145.15 26.2 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.991 1.395 . . . . 0.0 112.578 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.97 120.09 32.3 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 121.79 -0.569 . . . . 0.0 111.068 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -126.55 151.32 48.05 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.917 0.887 . . . . 0.0 112.263 -171.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.64 97.73 3.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.655 -1.278 . . . . 0.0 112.253 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -84.57 105.23 15.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.37 101.96 9.31 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.157 0.503 . . . . 0.0 110.362 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mt -84.48 52.44 2.37 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -83.08 130.73 35.15 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.034 0.934 . . . . 0.0 111.382 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.6 -51.62 0.73 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.143 0.817 . . . . 0.0 115.143 -151.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 mt -87.13 -73.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -164.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.88 28.91 2.11 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 159.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.28 16.7 m-20 55.83 31.26 17.32 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 118.154 2.649 . . . . 0.0 118.154 174.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -108.01 141.18 40.06 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.257 -0.902 . . . . 0.0 113.147 -176.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -90.92 109.73 20.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.226 0.611 . . . . 0.0 110.667 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.1 m -107.14 128.46 54.42 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.045 0.538 . . . . 0.0 111.343 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.53 95.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.267 1.032 . . . . 0.0 110.483 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.9 m -105.47 125.92 51.54 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.607 -0.683 . . . . 0.0 109.941 -161.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.9 m -116.62 115.94 26.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.415 HG22 ' SG ' ' A' ' 95' ' ' CYS . 60.8 t -107.53 121.65 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.0 m -138.25 150.41 46.66 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 119.144 0.883 . . . . 0.0 111.874 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -78.94 115.82 18.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.427 -1.421 . . . . 0.0 112.593 175.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -93.56 83.01 4.42 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 162.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.86 -107.29 1.8 Allowed Glycine 0 CA--C 1.547 2.083 0 N-CA-C 114.47 0.548 . . . . 0.0 114.47 -171.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.35 -0.26 52.87 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 171.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -103.18 127.36 50.5 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 121.06 1.754 . . . . 0.0 110.385 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.23 104.34 15.69 Favored 'General case' 0 CA--C 1.564 1.482 0 O-C-N 121.395 -0.816 . . . . 0.0 109.63 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -110.45 131.59 54.92 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.689 0.757 . . . . 0.0 111.152 -167.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 86' ' ' VAL . 52.9 t -125.66 138.07 53.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.6 0.76 . . . . 0.0 112.88 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.1 p -113.58 126.93 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 123.673 0.789 . . . . 0.0 109.178 166.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -102.49 95.37 6.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.485 0.714 . . . . 0.0 109.144 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -83.78 123.38 29.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.918 -1.114 . . . . 0.0 112.276 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.45 -90.66 0.11 Allowed Glycine 0 N--CA 1.484 1.886 0 O-C-N 121.598 -0.689 . . . . 0.0 114.49 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -88.74 -12.81 41.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -161.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -131.58 149.56 52.46 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 120.44 1.473 . . . . 0.0 111.612 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.39 115.01 21.23 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.459 1.104 . . . . 0.0 111.601 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.36 53.39 6.8 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -105.55 128.19 53.45 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.908 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.86 -169.0 40.77 Favored Glycine 0 N--CA 1.486 1.997 0 O-C-N 121.601 -0.687 . . . . 0.0 114.395 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.255 40.1 p-90 -155.44 157.39 36.92 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.4 m -131.63 124.03 29.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.405 -0.81 . . . . 0.0 109.003 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.94 133.97 53.6 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.759 0.824 . . . . 0.0 111.722 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -149.78 171.52 16.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 0.0 112.746 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.23 126.42 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.45 90.71 3.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.438 163.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.98 -110.66 3.17 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.326 -0.858 . . . . 0.0 114.91 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.84 5.25 44.58 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 163.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -110.37 126.71 54.56 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.596 1.544 . . . . 0.0 112.432 -170.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.1 tp -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.299 0.64 . . . . 0.0 109.791 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -113.55 120.14 39.94 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.0 tp -121.53 123.95 43.22 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.094 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -99.8 121.88 41.94 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.501 0.721 . . . . 0.0 110.025 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 50.1 mtm -115.44 132.97 56.46 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.536 1.062 . . . . 0.0 111.854 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -119.65 134.66 55.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 112.911 -172.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.43 124.68 12.97 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.635 0.774 . . . . 0.0 109.97 172.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 53.79 40.28 31.32 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 -8.35 9.54 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 120.263 2.865 . . . . 0.0 120.263 -164.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.58 117.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 120.399 2.1 . . . . 0.0 109.298 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.9 m -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.341 0.656 . . . . 0.0 111.234 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.45 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 8.6 t -97.22 129.79 44.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 111.753 166.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -98.18 125.41 43.2 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.696 0.68 . . . . 0.0 110.644 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -113.36 123.71 50.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.312 0.645 . . . . 0.0 109.323 169.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.81 133.65 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -135.4 156.61 48.63 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.522 1.129 . . . . 0.0 111.259 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.83 126.71 42.16 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.561 -1.337 . . . . 0.0 110.449 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -69.29 122.16 18.31 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.133 -0.979 . . . . 0.0 113.087 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.99 -38.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.5 t60 . . . . . 0 N--CA 1.487 1.404 0 CA-C-N 119.851 1.205 . . . . 0.0 108.112 170.071 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.459 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 CA--C 1.57 1.73 0 CA-C-O 117.602 -1.189 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.63 120.97 7.02 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 C-N-CA 122.637 2.225 . . . . 0.0 114.773 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.4 m -72.81 151.72 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -87.59 104.77 16.81 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.53 -0.731 . . . . 0.0 112.046 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -82.53 4.49 24.28 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -60.6 114.28 2.9 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 121.419 1.918 . . . . 0.0 114.443 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.27 178.06 30.97 Favored Glycine 0 N--CA 1.488 2.115 0 CA-C-O 122.79 1.217 . . . . 0.0 115.738 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -108.88 115.26 29.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.399 1.079 . . . . 0.0 109.184 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -116.8 112.93 21.82 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.426 0.691 . . . . 0.0 109.189 -167.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -85.33 142.7 29.14 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.185 -0.947 . . . . 0.0 112.61 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 38.3 ttp -73.64 121.61 20.99 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-N 120.459 1.481 . . . . 0.0 113.042 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt -81.7 -44.12 17.53 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -154.5 160.22 41.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.413 -1.43 . . . . 0.0 113.322 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -136.0 118.86 16.22 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.808 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -124.26 122.68 38.42 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.597 0.759 . . . . 0.0 110.145 -170.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.2 t30 65.91 38.23 5.11 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.67 -40.89 16.86 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.77 -37.54 68.69 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.48 -41.12 69.75 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 120.922 1.692 . . . . 0.0 114.9 167.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -54.93 -46.67 74.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.55 -37.44 68.26 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -57.91 -41.38 82.51 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 164.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.15 -18.05 32.53 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 165.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -95.42 9.92 38.25 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 165.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.271 20.1 t70 57.99 50.16 10.66 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -171.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.5 t -98.72 141.01 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.836 0.827 . . . . 0.0 110.024 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.8 149.86 45.95 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.74 -45.73 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -50.58 70.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 tt -61.36 -43.6 98.59 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -58.21 -47.88 82.08 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 170.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -60.04 -43.58 95.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.51 -56.98 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 118.717 0.69 . . . . 0.0 111.374 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.54 81.6 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -67.51 -32.59 73.5 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.34 -24.24 46.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 170.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.0 mt -68.92 147.05 52.23 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.513 1.506 . . . . 0.0 114.302 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.95 90.89 4.8 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.262 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.2 147.01 47.13 Favored 'Trans proline' 0 CA--C 1.564 2.005 0 C-N-CA 122.617 2.211 . . . . 0.0 114.415 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.99 117.84 29.89 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -88.44 110.75 21.08 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.654 -0.654 . . . . 0.0 111.084 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -96.08 107.7 20.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.514 -0.742 . . . . 0.0 109.355 167.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -105.84 127.33 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.18 110.08 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -106.78 110.86 23.15 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.312 0.645 . . . . 0.0 110.603 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -101.99 81.27 2.09 Favored 'General case' 0 CA--C 1.568 1.655 0 C-N-CA 123.664 0.785 . . . . 0.0 109.52 168.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.96 -102.91 1.05 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 121.559 -0.713 . . . . 0.0 114.341 -174.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.76 -20.02 22.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 163.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -77.91 112.62 14.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.019 1.736 . . . . 0.0 111.923 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.3 ttm -123.27 125.01 44.27 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 121.677 0.751 . . . . 0.0 111.037 -165.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.1 mm -111.39 96.8 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -92.69 108.02 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -100.67 94.62 6.19 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.7 m -85.41 98.6 10.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.133 -0.979 . . . . 0.0 108.887 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.5 mt -97.18 115.13 27.01 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.848 -0.533 . . . . 0.0 110.7 -165.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 t -132.86 152.71 51.8 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.756 0.788 . . . . 0.0 110.476 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.6 p -64.34 -28.59 69.81 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -73.79 -48.19 33.34 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -154.89 135.57 13.54 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.498 1.044 . . . . 0.0 111.831 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -94.23 116.18 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.661 -0.649 . . . . 0.0 109.552 173.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -105.8 108.38 19.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 110.316 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mm -106.64 119.2 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 86.9 mtp -110.48 112.32 24.15 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.589 0.756 . . . . 0.0 109.641 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -112.27 112.36 23.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.599 0.76 . . . . 0.0 109.272 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -155.99 145.58 21.02 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -169.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -91.53 124.76 35.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 110.806 165.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.37 124.34 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.64 -0.663 . . . . 0.0 109.516 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.93 -39.27 2.72 Favored Glycine 0 CA--C 1.552 2.374 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -157.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -95.6 152.83 18.09 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.561 1.181 . . . . 0.0 112.752 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -93.12 125.89 37.94 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.405 168.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -133.74 144.23 48.96 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.496 0.718 . . . . 0.0 112.32 -174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.27 100.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.493 -1.38 . . . . 0.0 112.978 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.94 104.91 16.72 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 121.829 -0.545 . . . . 0.0 109.707 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -74.0 99.18 3.23 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.793 0.437 . . . . 0.0 111.359 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.54 52.08 2.0 Allowed 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -88.07 127.44 35.4 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.337 1.055 . . . . 0.0 111.411 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.97 -44.83 1.4 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 -148.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.5 mt -93.66 -74.33 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 124.471 1.108 . . . . 0.0 108.647 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -122.46 -6.02 8.73 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 168.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.258 21.6 m-20 63.53 49.03 3.21 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 mtm-85 -141.94 143.26 33.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.116 -0.99 . . . . 0.0 111.475 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.86 94.97 6.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 -173.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.8 m -83.24 136.72 34.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.593 -0.692 . . . . 0.0 112.794 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 37.9 mtp -82.91 91.72 7.17 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.588 1.185 . . . . 0.0 110.552 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.429 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 40.4 m -102.75 122.13 43.84 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.414 -0.803 . . . . 0.0 110.898 -156.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -103.49 122.42 44.88 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG22 ' SG ' ' A' ' 95' ' ' CYS . 22.9 t -109.29 127.11 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -124.31 152.95 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.763 0.825 . . . . 0.0 111.924 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -88.98 120.94 30.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.933 -1.104 . . . . 0.0 113.193 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -112.18 67.35 0.65 Allowed 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 123.536 0.734 . . . . 0.0 110.412 164.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.05 -102.76 0.68 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.38 -31.37 65.52 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 164.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -94.83 117.14 29.65 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 122.162 0.982 . . . . 0.0 110.845 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.8 tp -88.79 109.32 20.07 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -111.76 126.97 55.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 -162.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.429 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 44.8 t -127.62 135.41 50.23 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -168.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -112.83 122.28 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.607 0.763 . . . . 0.0 109.367 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -98.25 93.58 6.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.612 0.765 . . . . 0.0 109.111 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -85.77 122.51 29.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.8 -1.188 . . . . 0.0 112.309 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.8 -111.23 0.36 Allowed Glycine 0 N--CA 1.484 1.896 0 O-C-N 121.623 -0.673 . . . . 0.0 113.405 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.39 -3.61 56.53 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -121.06 143.42 49.08 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 120.196 1.362 . . . . 0.0 113.067 -171.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -81.48 97.63 7.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -170.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.93 49.81 6.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -174.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.57 138.05 31.88 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 121.735 0.779 . . . . 0.0 112.436 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.94 -166.3 35.24 Favored Glycine 0 N--CA 1.486 1.974 0 CA-C-O 121.934 0.741 . . . . 0.0 114.807 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -159.09 153.35 23.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.8 m -130.23 125.98 36.2 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -126.3 129.15 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.765 0.826 . . . . 0.0 110.849 -172.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -145.72 167.56 22.84 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.978 -1.076 . . . . 0.0 113.449 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.8 mt -110.34 126.46 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.95 89.37 3.04 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 164.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.79 -112.05 3.57 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.299 -0.876 . . . . 0.0 114.679 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -89.99 2.96 54.55 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 161.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -102.63 134.43 46.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.557 1.526 . . . . 0.0 112.518 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -97.19 122.8 40.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.082 0.953 . . . . 0.0 109.19 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -114.52 122.38 46.39 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.464 0.706 . . . . 0.0 109.279 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.9 tp -123.95 122.15 37.18 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.456 0.702 . . . . 0.0 110.832 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.1 128.56 44.68 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.217 0.607 . . . . 0.0 109.865 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 70.4 mtm -117.95 130.43 56.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 118.894 0.77 . . . . 0.0 110.597 174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -113.92 138.19 50.66 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.575 0.75 . . . . 0.0 112.818 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.87 116.51 4.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.446 0.698 . . . . 0.0 110.2 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.305 6.0 mt-10 54.07 50.18 17.18 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -175.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.11 -14.48 3.84 Favored Glycine 0 CA--C 1.555 2.541 0 N-CA-C 120.577 2.991 . . . . 0.0 120.577 -167.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.77 124.51 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-N 120.447 2.123 . . . . 0.0 110.017 -166.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -93.54 123.2 36.69 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.134 0.574 . . . . 0.0 110.697 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.67 135.92 37.91 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.066 0.547 . . . . 0.0 111.061 159.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -113.43 118.83 35.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.807 -0.558 . . . . 0.0 110.58 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -114.75 133.75 55.66 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.465 0.65 . . . . 0.0 110.903 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.36 131.0 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -127.66 160.42 31.68 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 124.475 1.11 . . . . 0.0 111.196 -177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -133.22 133.28 42.51 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.488 -1.383 . . . . 0.0 112.263 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -70.25 123.63 22.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.71 -37.56 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 . . . . . 0 CA--C 1.567 1.61 0 CA-C-N 119.739 1.154 . . . . 0.0 108.344 171.233 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . 0.289 55.6 ttm . . . . . 0 CA--C 1.571 1.767 0 CA-C-O 115.602 -2.142 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.63 164.63 35.08 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 CA-C-N 125.22 2.9 . . . . 0.0 114.946 167.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.14 136.09 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 120.973 -1.079 . . . . 0.0 112.429 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -82.99 102.82 11.99 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 121.24 0.543 . . . . 0.0 112.072 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -81.83 -2.46 51.05 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 173.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -58.01 108.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 121.092 1.769 . . . . 0.0 114.499 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.06 -174.71 33.94 Favored Glycine 0 CA--C 1.546 1.977 0 CA-C-O 122.609 1.116 . . . . 0.0 114.98 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -118.74 118.33 31.31 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.17 0.988 . . . . 0.0 109.441 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -123.19 114.72 20.66 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -164.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -91.04 141.15 29.15 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.978 -1.076 . . . . 0.0 113.769 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 6.1 ttp -76.24 119.21 19.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -171.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.26 -44.5 17.65 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -154.26 158.52 40.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.535 -1.353 . . . . 0.0 113.372 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -130.68 100.03 5.16 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.093 -173.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -103.02 115.19 30.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.53 -0.731 . . . . 0.0 110.145 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 42.2 t30 58.56 31.31 20.91 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -67.14 -34.15 76.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 167.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -59.38 -49.54 77.4 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.38 -37.11 80.11 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -57.73 -45.79 85.32 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.01 -40.33 78.74 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -55.48 -45.33 76.97 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.03 -20.96 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.067 2.618 . . . . 0.0 118.067 166.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.24 2.25 54.53 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.275 26.9 t0 64.49 56.61 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 120.259 1.39 . . . . 0.0 113.296 -169.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -103.1 139.45 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -66.77 157.17 33.53 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.9 t -60.7 -45.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.53 -47.55 83.81 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.47 -44.77 92.94 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 168.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -52.09 -56.3 15.33 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 165.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -57.04 -33.07 66.84 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.18 -59.28 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 CA-C-N 118.757 0.708 . . . . 0.0 111.192 164.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.79 91.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -60.53 -36.7 79.03 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 170.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.58 -20.01 37.37 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.37 138.2 51.16 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 120.292 1.406 . . . . 0.0 113.091 177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -111.23 85.4 5.44 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.22 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.8 158.83 54.52 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.608 2.205 . . . . 0.0 116.18 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.13 116.87 33.33 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.291 170.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -86.44 111.74 20.83 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.376 -0.828 . . . . 0.0 110.483 172.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.32 110.67 23.18 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.3 129.05 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.73 109.54 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -101.4 102.51 13.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.821 0.849 . . . . 0.0 110.126 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.8 71.93 5.72 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.72 0.808 . . . . 0.0 110.249 167.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.53 0.45 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -80.48 -33.38 36.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.74 114.83 19.9 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 120.186 1.357 . . . . 0.0 111.493 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.3 ttm -125.37 123.33 39.12 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.514 0.673 . . . . 0.0 110.984 -167.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.59 100.95 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.9 mt -97.54 112.58 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.0 mtt85 -104.95 102.19 11.72 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 m -86.16 99.19 11.35 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.2 mt -99.6 116.05 30.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.088 0.555 . . . . 0.0 110.317 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -131.11 154.66 48.07 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.946 0.879 . . . . 0.0 110.741 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.3 p -62.97 -31.61 72.76 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -79.0 -45.06 21.0 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -158.01 132.69 8.4 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.973 1.261 . . . . 0.0 112.555 -177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -96.56 121.11 38.03 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 123.435 0.694 . . . . 0.0 110.388 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -110.67 104.63 13.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.375 -0.828 . . . . 0.0 110.631 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mp -100.54 125.54 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 122.087 0.946 . . . . 0.0 108.586 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 81.9 mtp -112.57 128.18 56.29 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.515 1.126 . . . . 0.0 108.603 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -130.04 95.15 3.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.602 -0.686 . . . . 0.0 109.244 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -129.85 151.18 50.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -97.05 119.31 35.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.584 -0.698 . . . . 0.0 109.831 166.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.37 118.1 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 C-N-CA 123.458 0.703 . . . . 0.0 110.119 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.89 -43.45 1.49 Allowed Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 -158.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -87.64 147.3 25.33 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -93.65 134.99 35.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.766 -0.584 . . . . 0.0 111.578 165.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -144.11 156.54 44.39 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.833 0.825 . . . . 0.0 112.903 -169.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.98 98.16 3.53 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.46 0.704 . . . . 0.0 111.88 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -100.33 101.47 12.47 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.574 -0.704 . . . . 0.0 111.262 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -81.35 109.63 16.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.807 -0.558 . . . . 0.0 110.544 167.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.33 57.36 3.6 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-O 121.988 0.899 . . . . 0.0 112.854 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.0 t -76.31 140.48 41.52 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.15 0.98 . . . . 0.0 113.126 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.55 -46.43 1.96 Allowed Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 -159.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HA ' H183 ' A' ' 175' ' ' RTL . 30.6 mt -78.66 -74.19 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 124.513 1.125 . . . . 0.0 110.044 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -134.36 -3.47 2.71 Favored 'General case' 0 CA--C 1.574 1.886 0 C-N-CA 125.482 1.513 . . . . 0.0 114.457 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.271 1.6 m-20 54.1 57.18 6.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -133.68 134.58 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.19 0.519 . . . . 0.0 111.096 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -85.65 125.51 33.21 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.646 0.778 . . . . 0.0 111.61 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 89.8 m -124.92 148.7 48.21 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.493 0.717 . . . . 0.0 112.121 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.04 97.77 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.597 168.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.2 m -100.64 122.18 42.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 122.04 -0.412 . . . . 0.0 111.337 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -111.77 122.82 48.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.43 131.61 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.4 m -133.22 148.6 52.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.165 -0.96 . . . . 0.0 111.788 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -82.95 115.13 21.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 111.121 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.82 71.75 10.83 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.419 -0.801 . . . . 0.0 109.957 163.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.0 -89.72 0.08 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -165.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -106.88 -16.71 14.39 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -87.59 139.37 30.61 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.905 1.684 . . . . 0.0 111.472 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.52 108.64 21.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.537 -0.727 . . . . 0.0 110.218 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -112.46 132.39 55.08 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.463 0.705 . . . . 0.0 111.256 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -126.19 136.1 52.43 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.95 130.02 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -120.88 95.65 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.384 0.674 . . . . 0.0 110.405 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -77.91 120.83 23.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 112.925 -173.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.64 -115.71 0.35 Allowed Glycine 0 N--CA 1.486 2.007 0 O-C-N 121.989 -0.444 . . . . 0.0 112.255 172.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -78.53 -25.72 45.61 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -108.44 148.66 29.85 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.307 1.412 . . . . 0.0 112.957 -157.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.32 110.1 17.17 Favored 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.175 0.99 . . . . 0.0 111.85 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.49 51.52 9.59 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -92.76 116.59 29.16 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 117.316 0.558 . . . . 0.0 111.836 -171.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 178.55 -168.65 39.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 115.762 1.065 . . . . 0.0 115.762 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -154.03 157.99 39.89 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.943 0.877 . . . . 0.0 112.958 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.5 m -132.93 127.49 34.41 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.036 -1.04 . . . . 0.0 108.682 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -127.58 131.44 49.98 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.778 . . . . 0.0 111.088 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.48 174.15 12.8 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.96 132.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.16 -0.963 . . . . 0.0 109.436 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.09 92.17 3.85 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.743 0.817 . . . . 0.0 109.048 164.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.19 -114.85 4.44 Favored Glycine 0 N--CA 1.49 2.295 0 O-C-N 121.346 -0.847 . . . . 0.0 114.746 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -88.7 4.98 45.38 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 163.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -106.56 129.92 54.41 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.101 1.319 . . . . 0.0 111.93 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.07 122.18 30.55 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.251 1.02 . . . . 0.0 109.733 166.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -113.44 124.33 52.17 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.733 0.813 . . . . 0.0 109.578 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.7 tp -127.83 119.5 25.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.253 0.621 . . . . 0.0 110.629 -173.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -90.26 135.23 33.8 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.892 0.477 . . . . 0.0 110.316 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.0 mtp -130.22 124.13 31.8 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.6 0.76 . . . . 0.0 109.856 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -122.88 132.32 54.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.495 -0.753 . . . . 0.0 111.872 -164.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.03 131.66 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.233 0.613 . . . . 0.0 111.451 174.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 56.24 39.34 30.26 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.03 0.95 16.83 Favored Glycine 0 CA--C 1.558 2.754 0 N-CA-C 120.193 2.837 . . . . 0.0 120.193 -163.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.59 118.98 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-N 120.065 1.933 . . . . 0.0 108.942 -170.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 90.4 m -95.04 116.88 29.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.658 0.742 . . . . 0.0 110.337 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 8.6 t -91.71 141.62 28.49 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.496 0.718 . . . . 0.0 111.116 161.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -115.58 123.28 48.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.399 -0.813 . . . . 0.0 110.952 166.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.43 129.14 56.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.187 0.595 . . . . 0.0 109.928 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.82 128.48 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -127.84 147.1 50.43 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.699 0.799 . . . . 0.0 111.002 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -116.37 135.81 53.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.378 -1.451 . . . . 0.0 112.29 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -70.06 122.95 20.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.29 -37.56 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 CA--C 1.567 1.603 0 CA-C-N 120.069 1.304 . . . . 0.0 108.595 170.467 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.472 H183 ' HA ' ' A' ' 77' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.572 1.822 0 CA-C-O 115.984 -1.96 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.5 172.25 16.08 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 CA-C-N 125.16 2.878 . . . . 0.0 115.533 173.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.13 125.43 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 120.982 -1.074 . . . . 0.0 112.002 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.04 106.8 17.46 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.783 0.801 . . . . 0.0 112.185 -170.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -75.17 3.18 9.16 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.716 2.488 . . . . 0.0 117.716 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -54.91 111.12 0.76 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 121.287 1.858 . . . . 0.0 114.959 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.44 175.86 28.85 Favored Glycine 0 N--CA 1.488 2.132 0 CA-C-O 122.217 0.898 . . . . 0.0 115.167 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -109.6 116.39 31.67 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.389 1.075 . . . . 0.0 109.515 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -118.33 112.73 20.42 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 121.688 -0.632 . . . . 0.0 109.412 -166.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.53 141.77 28.36 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.064 -1.023 . . . . 0.0 113.558 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 37.4 ttp -70.87 124.34 24.1 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -172.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.3 mt -85.67 -53.59 5.06 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.8 p -138.62 150.88 46.74 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 119.435 1.016 . . . . 0.0 113.477 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -129.13 113.78 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.867 0.867 . . . . 0.0 109.229 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -115.98 117.3 29.75 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 0.0 109.76 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.6 t30 63.74 36.45 10.61 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.422 ' HD1' ' HG ' ' A' ' 126' ' ' CYS . 4.3 t80 -74.57 -39.78 62.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.604 -1.31 . . . . 0.0 114.439 175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.46 -41.84 97.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 174.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.13 -39.43 78.89 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 169.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.17 -49.42 71.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 165.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.75 -40.88 88.47 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -55.03 -46.39 75.27 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 164.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.32 -18.36 49.16 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 166.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.6 mt -91.03 3.53 54.5 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 167.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.279 40.3 m-20 66.12 52.17 1.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.116 1.366 . . . . 0.0 114.406 -171.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.95 144.57 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 122.123 0.964 . . . . 0.0 110.139 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -63.86 154.32 34.03 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -60.73 -44.42 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.74 -50.85 67.37 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.447 2.018 . . . . 0.0 116.447 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.532 HD21 H182 ' A' ' 175' ' ' RTL . 4.9 tt -62.32 -40.12 95.28 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 170.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -55.05 -40.5 70.37 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 165.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -69.75 -48.45 59.32 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.916 -1.115 . . . . 0.0 113.761 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.63 -57.86 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.012 0.925 . . . . 0.0 112.136 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -30.35 71.42 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 117.747 2.499 . . . . 0.0 117.747 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -69.09 -36.54 77.68 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.97 -23.63 59.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.8 mt -72.53 152.42 41.88 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 120.404 1.456 . . . . 0.0 114.644 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -101.35 90.26 1.65 Allowed Pre-proline 0 CA--C 1.574 1.892 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.314 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.7 146.48 54.46 Favored 'Trans proline' 0 CA--C 1.565 2.042 0 CA-C-N 122.848 2.053 . . . . 0.0 114.808 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.23 113.16 24.93 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -89.67 107.39 19.06 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.375 -0.828 . . . . 0.0 110.538 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -98.71 107.22 19.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.717 -0.615 . . . . 0.0 109.908 172.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.65 131.42 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.3 t -113.21 107.17 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -93.65 104.86 16.94 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.221 0.609 . . . . 0.0 109.954 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.31 75.55 2.95 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 121.527 0.679 . . . . 0.0 109.931 167.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.23 -104.43 1.04 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -81.65 -32.0 32.06 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 166.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -81.24 107.39 13.99 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.935 1.243 . . . . 0.0 110.952 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.3 ttp -116.16 124.0 49.24 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 121.962 0.887 . . . . 0.0 111.047 -174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mp -110.41 101.57 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.9 mt -98.18 105.57 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -175.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -97.48 99.43 10.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -88.08 97.14 10.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.21 -0.931 . . . . 0.0 109.135 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.8 mt -100.39 121.73 42.0 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.261 0.624 . . . . 0.0 110.976 -164.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.5 t -139.49 157.24 46.18 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.122 0.963 . . . . 0.0 111.356 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.9 p -65.09 -30.81 71.79 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.138 1.903 . . . . 0.0 116.138 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -74.98 -48.89 21.95 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 165.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -153.75 138.83 17.33 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 119.651 1.114 . . . . 0.0 113.431 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -94.03 128.16 40.23 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 123.724 0.81 . . . . 0.0 109.982 168.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -118.95 103.93 10.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.016 -1.052 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -93.29 128.25 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 73.9 mtp -115.41 104.86 12.19 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.636 0.775 . . . . 0.0 110.256 173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -111.12 113.64 26.31 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.031 0.933 . . . . 0.0 111.583 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.64 149.36 27.48 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -169.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -92.32 129.26 38.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.577 -0.702 . . . . 0.0 111.075 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.75 129.45 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 123.218 0.607 . . . . 0.0 111.048 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.64 -31.92 7.38 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -161.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -84.83 133.42 34.33 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.96 1.38 . . . . 0.0 112.993 -170.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -86.55 98.39 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.786 0.435 . . . . 0.0 110.223 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -105.41 147.24 28.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.52 106.38 3.97 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.916 0.865 . . . . 0.0 112.131 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -113.73 103.03 10.8 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.616 0.766 . . . . 0.0 109.748 -166.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.81 116.68 20.11 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-O 121.84 0.829 . . . . 0.0 110.58 172.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mt -96.73 45.49 1.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.1 t -76.58 137.64 39.66 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.086 0.954 . . . . 0.0 112.593 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.83 -59.41 0.54 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.601 -152.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.03 -75.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 123.748 0.819 . . . . 0.0 109.595 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -140.33 21.14 2.4 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 174.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.268 11.9 t70 50.18 48.99 21.31 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 176.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -127.71 142.47 51.32 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.981 0.896 . . . . 0.0 112.378 -174.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -97.35 101.86 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.797 0.839 . . . . 0.0 110.652 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 88.3 m -102.11 147.67 26.32 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.518 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mmm -87.97 95.22 10.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.026 . . . . 0.0 109.009 167.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 99.7 m -101.9 124.19 47.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 111.243 -166.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -107.55 123.74 48.89 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -108.8 128.87 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t -123.57 149.66 45.01 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.98 0.912 . . . . 0.0 111.833 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -90.44 115.81 27.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.89 -1.131 . . . . 0.0 112.228 170.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -98.43 66.19 1.7 Allowed 'General case' 0 CA--C 1.574 1.892 0 O-C-N 121.687 -0.633 . . . . 0.0 110.26 157.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.14 0.02 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.76 -27.41 23.64 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -100.28 122.89 43.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 120.223 1.374 . . . . 0.0 111.076 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.66 110.18 21.08 Favored 'General case' 0 CA--C 1.564 1.51 0 O-C-N 121.518 -0.739 . . . . 0.0 109.123 172.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -115.7 122.4 45.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.099 0.56 . . . . 0.0 110.433 -161.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 52.5 t -122.07 138.88 54.28 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.05 123.85 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.601 0.76 . . . . 0.0 109.25 168.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -102.35 93.85 5.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -91.45 117.45 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 111.824 -166.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.8 -90.21 0.1 OUTLIER Glycine 0 N--CA 1.481 1.694 0 O-C-N 121.466 -0.771 . . . . 0.0 113.262 171.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -91.51 -16.98 26.4 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -164.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -125.33 148.35 48.76 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.22 1.373 . . . . 0.0 112.093 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -80.45 112.35 17.7 Favored 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 123.762 0.825 . . . . 0.0 112.231 -172.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.4 44.56 90.15 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 117.44 1.736 . . . . 0.0 117.44 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -86.47 135.6 33.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.776 0.798 . . . . 0.0 111.431 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.9 -170.93 40.76 Favored Glycine 0 N--CA 1.482 1.757 0 CA-C-O 121.994 0.774 . . . . 0.0 114.602 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -156.42 150.42 25.11 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.2 m -124.87 125.99 44.85 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.48 129.16 48.12 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.513 0.725 . . . . 0.0 111.02 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.81 170.86 16.14 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.146 -0.971 . . . . 0.0 113.16 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.15 127.6 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.293 -0.88 . . . . 0.0 109.054 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -111.39 91.6 3.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 161.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.86 -111.7 3.54 Favored Glycine 0 N--CA 1.491 2.354 0 O-C-N 121.172 -0.955 . . . . 0.0 115.03 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -94.06 8.82 40.11 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 162.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -107.84 123.8 49.13 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 120.399 1.454 . . . . 0.0 111.489 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.1 tp -81.32 118.73 22.88 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.64 1.176 . . . . 0.0 109.732 167.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -107.13 117.28 33.64 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.5 tp -115.18 128.89 56.47 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.79 0.836 . . . . 0.0 110.205 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -114.96 120.51 40.15 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.061 0.545 . . . . 0.0 109.962 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 68.5 mtm -110.18 133.58 53.08 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.764 0.825 . . . . 0.0 110.66 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -116.21 141.61 47.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.59 118.07 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.664 0.786 . . . . 0.0 110.615 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 55.2 44.15 28.15 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.41 -16.33 3.05 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 120.477 2.951 . . . . 0.0 120.477 -164.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.8 t -89.98 122.81 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 120.256 2.028 . . . . 0.0 110.21 -167.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.8 m -94.73 125.73 39.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.334 0.654 . . . . 0.0 111.488 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.422 ' HG ' ' HD1' ' A' ' 16' ' ' PHE . 14.4 t -97.78 127.45 43.74 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.076 0.55 . . . . 0.0 110.762 158.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -107.58 129.31 55.0 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.385 0.612 . . . . 0.0 111.403 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -127.76 137.9 52.58 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.667 0.787 . . . . 0.0 111.031 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.74 131.44 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -131.21 130.37 42.86 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.453 0.701 . . . . 0.0 110.823 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -101.33 131.31 47.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.166 -1.584 . . . . 0.0 112.475 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.35 121.71 15.46 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.37 -38.23 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.8 t60 . . . . . 0 N--CA 1.488 1.435 0 CA-C-N 120.056 1.298 . . . . 0.0 107.796 169.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.532 H182 HD21 ' A' ' 29' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.578 2.028 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -72.48 140.24 32.83 Favored 'Trans proline' 0 CA--C 1.561 1.871 0 C-N-CA 122.622 2.215 . . . . 0.0 115.815 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.42 131.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.271 0.558 . . . . 0.0 111.237 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -83.24 100.89 10.89 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 120.651 -1.281 . . . . 0.0 112.422 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -71.76 1.85 6.27 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 118.095 2.628 . . . . 0.0 118.095 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -54.62 108.36 0.38 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.45 177.94 31.04 Favored Glycine 0 N--CA 1.486 1.998 0 CA-C-O 122.652 1.14 . . . . 0.0 115.157 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -111.01 116.61 31.47 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.426 1.09 . . . . 0.0 109.16 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -118.27 112.36 19.98 Favored 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 123.197 0.599 . . . . 0.0 109.539 -166.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -83.44 140.57 32.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.928 . . . . 0.0 113.41 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.463 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 11.7 ttm -69.7 125.1 25.71 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.235 1.38 . . . . 0.0 113.732 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.18 -57.75 2.9 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.657 164.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.0 m -127.89 149.95 50.08 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.29 1.043 . . . . 0.0 112.485 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.67 89.66 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.37 120.61 40.78 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.382 0.673 . . . . 0.0 110.62 -167.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.27 33.6 t30 67.55 35.75 4.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -79.04 -41.02 29.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.327 -1.483 . . . . 0.0 114.84 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -50.51 -44.69 56.19 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 165.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -72.05 -36.36 69.58 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.877 1.671 . . . . 0.0 115.148 171.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -56.49 -49.01 75.92 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 164.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.21 -33.78 72.1 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -61.07 -41.35 96.45 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 164.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -18.22 56.7 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 165.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.65 -4.9 59.24 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 162.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 63.8 46.81 3.81 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 120.528 1.513 . . . . 0.0 114.707 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -93.01 140.95 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.812 0.815 . . . . 0.0 109.693 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -61.0 149.32 37.14 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.2 -45.0 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.75 62.92 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.85 -36.47 83.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.6 mtm105 -59.37 -49.94 75.88 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.588 1.995 . . . . 0.0 115.667 167.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -61.78 -42.42 98.97 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -62.65 -56.84 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 118.83 0.741 . . . . 0.0 111.308 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.51 87.54 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.93 -33.49 75.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.59 -30.31 65.68 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 167.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.1 mt -71.71 137.64 47.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 119.972 1.26 . . . . 0.0 113.536 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -108.26 85.88 3.0 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.17 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 60.4 Cg_endo -68.6 154.16 72.09 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 C-N-CA 122.601 2.2 . . . . 0.0 114.926 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.71 118.23 36.06 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -85.89 112.3 21.03 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.748 -0.595 . . . . 0.0 110.531 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.85 109.67 22.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.714 -0.616 . . . . 0.0 109.637 167.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mp -101.44 126.13 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.1 t -110.01 108.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.14 113.78 27.54 Favored 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 124.179 0.992 . . . . 0.0 110.532 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -106.57 80.53 1.48 Allowed 'General case' 0 CA--C 1.57 1.728 0 C-N-CA 123.845 0.858 . . . . 0.0 109.446 168.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.0 2.68 Favored Glycine 0 N--CA 1.492 2.375 0 O-C-N 121.316 -0.865 . . . . 0.0 114.47 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.1 -25.63 22.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 164.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -74.43 118.03 16.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.909 1.686 . . . . 0.0 111.323 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.9 ttp -138.2 131.86 30.96 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.098 0.952 . . . . 0.0 111.902 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.53 103.56 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.9 mt -93.04 112.12 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -107.18 98.79 8.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.7 m -86.07 98.91 11.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.155 -0.965 . . . . 0.0 108.694 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.5 mt -102.34 115.18 30.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.498 0.666 . . . . 0.0 110.884 -165.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.0 t -128.98 146.78 50.88 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.475 0.71 . . . . 0.0 109.922 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 t -64.05 -15.36 59.31 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 171.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.23 -48.69 13.74 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -159.77 132.76 6.8 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.393 0.997 . . . . 0.0 111.041 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.78 124.4 46.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.564 -0.71 . . . . 0.0 110.413 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -112.44 117.1 31.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mm -113.53 119.12 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -171.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 83.0 mtp -105.7 109.1 20.94 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.292 0.637 . . . . 0.0 109.33 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -109.8 108.94 19.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -153.58 160.06 42.34 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -99.34 129.23 45.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 111.322 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.0 t -70.41 124.56 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 172.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.13 -33.17 5.57 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -163.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -96.64 144.86 26.29 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.743 1.271 . . . . 0.0 112.876 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.26 113.0 21.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 0.0 110.673 168.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -121.42 149.48 42.95 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.664 0.786 . . . . 0.0 112.671 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.48 97.23 2.53 Favored 'General case' 0 CA--C 1.569 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 112.974 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.15 103.3 16.0 Favored 'General case' 0 CA--C 1.556 1.209 0 O-C-N 121.414 -0.804 . . . . 0.0 110.373 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -85.22 104.09 14.77 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.007 0.432 . . . . 0.0 110.48 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mp -83.96 53.32 2.54 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.863 0.839 . . . . 0.0 112.848 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -86.99 138.54 31.42 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.517 1.127 . . . . 0.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.77 -31.93 6.19 Favored Glycine 0 CA--C 1.552 2.395 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -153.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 mt -92.81 -71.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.525 1.13 . . . . 0.0 108.324 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -126.58 -17.3 5.09 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.279 11.1 t70 62.35 73.09 0.48 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 120.246 1.385 . . . . 0.0 112.57 -158.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.7 mmt-85 -133.42 131.76 40.35 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.15 0.58 . . . . 0.0 110.224 172.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -102.66 102.05 12.22 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.768 0.827 . . . . 0.0 109.771 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -110.53 124.52 51.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.044 0.538 . . . . 0.0 111.576 -172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.69 99.2 2.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.001 0.905 . . . . 0.0 109.667 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.4 m -113.2 120.39 41.08 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.06 -158.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.8 m -98.28 121.16 39.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -106.66 128.23 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 m -145.79 156.8 43.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.646 -1.284 . . . . 0.0 112.899 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -85.23 118.28 24.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.976 -1.078 . . . . 0.0 112.352 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -91.88 77.82 5.43 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 161.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.61 -107.28 1.32 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -73.34 -30.44 63.34 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 169.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -90.25 132.58 35.44 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 120.527 1.512 . . . . 0.0 111.97 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.1 tp -89.79 106.39 18.44 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.709 -0.619 . . . . 0.0 110.03 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -112.76 130.95 55.89 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.6 0.714 . . . . 0.0 111.089 -168.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 39.6 t -126.93 134.16 50.48 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.706 0.802 . . . . 0.0 113.058 -170.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.2 p -114.92 121.05 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.441 0.696 . . . . 0.0 109.704 170.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -100.35 97.07 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.526 0.73 . . . . 0.0 109.883 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -91.02 114.64 27.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 111.362 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.29 -112.16 0.36 Allowed Glycine 0 N--CA 1.486 2.008 0 O-C-N 120.919 -1.113 . . . . 0.0 114.027 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -80.09 -11.37 59.77 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -171.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -123.0 148.46 45.48 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 119.537 1.062 . . . . 0.0 111.869 -170.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.57 133.86 37.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.69 43.68 59.87 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 119.588 2.595 . . . . 0.0 119.588 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -94.89 135.05 36.86 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 117.79 0.795 . . . . 0.0 111.783 -173.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.96 -167.56 36.18 Favored Glycine 0 N--CA 1.481 1.65 0 CA-C-O 122.126 0.848 . . . . 0.0 114.706 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -156.0 153.27 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -126.7 124.74 40.5 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -123.64 135.68 54.06 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.536 0.734 . . . . 0.0 111.74 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -150.15 169.14 21.99 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.5 mt -113.68 128.2 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -111.63 93.83 4.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 162.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.99 -114.6 4.85 Favored Glycine 0 N--CA 1.49 2.258 0 O-C-N 121.221 -0.925 . . . . 0.0 114.986 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -96.03 23.56 6.33 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 163.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.4 128.63 53.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.936 1.243 . . . . 0.0 111.118 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.83 126.39 35.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.227 1.011 . . . . 0.0 109.812 168.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.68 122.77 43.31 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.09 120.26 28.49 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.574 0.749 . . . . 0.0 110.267 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -100.03 125.5 46.1 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.114 0.566 . . . . 0.0 109.727 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 11.5 mtp -119.66 120.78 37.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.435 0.694 . . . . 0.0 110.308 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 -109.09 135.89 49.5 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.46 117.71 10.72 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.605 0.762 . . . . 0.0 109.05 171.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . 0.292 11.5 mt-10 54.63 47.84 21.7 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 -172.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.15 -31.02 1.83 Allowed Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.799 2.68 . . . . 0.0 119.799 -166.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 50.9 t -79.68 122.23 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 119.239 1.519 . . . . 0.0 111.296 -164.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.2 m -94.36 126.98 39.96 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.363 0.665 . . . . 0.0 111.483 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 17.8 t -100.18 129.8 46.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.405 0.682 . . . . 0.0 110.83 162.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -103.63 110.57 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.194 0.598 . . . . 0.0 110.562 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -108.88 120.67 43.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.514 0.725 . . . . 0.0 109.511 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.9 t -117.82 130.42 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -173.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -133.27 150.11 51.93 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.441 0.696 . . . . 0.0 111.3 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -115.49 133.79 55.7 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.345 -1.472 . . . . 0.0 112.153 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -69.74 123.02 20.34 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.65 -37.45 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.565 1.529 0 CA-C-N 120.051 1.296 . . . . 0.0 108.264 169.53 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.423 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 CA--C 1.573 1.838 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.92 165.38 32.48 Favored 'Trans proline' 0 CA--C 1.568 2.21 0 C-N-CA 122.529 2.153 . . . . 0.0 115.132 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.8 m -54.45 138.84 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -160.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.45 93.26 4.72 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -75.96 -2.06 28.61 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 169.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -60.71 109.18 0.97 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.009 1.731 . . . . 0.0 113.956 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.42 179.67 34.4 Favored Glycine 0 N--CA 1.486 1.967 0 CA-C-O 122.907 1.282 . . . . 0.0 115.801 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -109.51 109.53 20.36 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.422 1.089 . . . . 0.0 109.118 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -110.88 111.79 23.18 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -168.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.33 137.62 32.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 0.0 112.728 -176.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 ttp -68.5 118.67 11.85 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -172.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.6 mt -79.58 -45.05 19.92 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 168.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -153.68 160.26 42.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.618 -1.301 . . . . 0.0 113.13 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -141.64 117.61 10.55 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.014 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.67 122.97 39.48 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.469 0.708 . . . . 0.0 110.213 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.267 31.8 t30 66.72 36.85 4.48 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 176.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -80.3 -42.43 23.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.607 -1.308 . . . . 0.0 114.505 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -58.34 -39.96 80.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.74 -42.09 78.08 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 121.039 1.745 . . . . 0.0 114.809 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -55.88 -46.9 78.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 168.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -68.45 -37.23 80.02 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -57.72 -44.36 85.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.315 -1.491 . . . . 0.0 114.903 162.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.94 -16.9 47.72 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 118.205 2.669 . . . . 0.0 118.205 166.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.82 2.19 56.89 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.303 38.7 t70 64.92 58.57 0.93 Allowed 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 125.232 1.413 . . . . 0.0 114.022 -170.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.4 t -111.12 140.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-O 121.48 0.657 . . . . 0.0 109.84 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -65.54 150.45 48.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.15 -45.38 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.65 72.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.18 -41.59 97.07 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 172.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -56.99 -47.85 79.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.0 mt -61.99 -56.04 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 118.915 0.78 . . . . 0.0 111.741 171.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.56 77.07 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -68.71 -33.68 74.35 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 167.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.72 -26.2 60.58 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.23 146.84 48.76 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.128 1.331 . . . . 0.0 114.147 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -104.44 89.87 2.92 Favored Pre-proline 0 CA--C 1.572 1.823 0 CA-C-O 118.211 -0.899 . . . . 0.0 109.899 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.29 150.4 47.07 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 122.404 2.069 . . . . 0.0 114.731 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -114.75 117.08 29.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 172.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -85.3 107.28 17.24 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.591 -0.693 . . . . 0.0 110.866 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.69 108.29 19.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.516 -0.74 . . . . 0.0 109.219 167.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.77 136.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.58 110.98 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -95.37 108.16 20.34 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.337 0.655 . . . . 0.0 109.929 170.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.31 76.14 1.68 Allowed 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 121.558 0.694 . . . . 0.0 109.661 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 -103.79 1.12 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.34 -0.85 . . . . 0.0 114.766 -174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.97 -22.6 21.86 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 162.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -75.67 114.2 13.99 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 120.642 1.564 . . . . 0.0 111.557 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.5 tpp -120.0 132.49 55.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.843 0.457 . . . . 0.0 111.468 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.99 101.39 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.0 mt -96.8 110.37 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -105.07 97.58 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.8 m -83.02 99.48 9.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.7 mt -98.87 116.42 31.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.824 -0.547 . . . . 0.0 110.69 -166.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.5 t -137.86 152.55 49.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.602 0.761 . . . . 0.0 110.637 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.8 p -62.56 -31.59 72.42 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -74.44 -49.31 22.9 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -153.53 135.75 14.87 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.569 1.077 . . . . 0.0 111.657 175.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -89.79 120.36 30.97 Favored 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 123.847 0.859 . . . . 0.0 109.836 169.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -113.5 106.02 14.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.442 -0.786 . . . . 0.0 110.645 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.24 127.39 52.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.479 0.712 . . . . 0.0 109.317 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 88.9 mtp -109.15 110.69 21.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.838 0.855 . . . . 0.0 109.352 169.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -112.99 117.34 31.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.451 0.7 . . . . 0.0 109.84 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -156.95 155.92 32.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -96.27 125.23 40.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 111.148 165.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.53 124.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.547 0.739 . . . . 0.0 109.532 176.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.05 -41.78 2.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -157.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -92.97 142.39 27.35 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.878 0.871 . . . . 0.0 113.169 -170.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -87.66 124.13 33.22 Favored 'General case' 0 CA--C 1.566 1.583 0 O-C-N 121.862 -0.524 . . . . 0.0 110.976 166.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -132.76 152.42 51.77 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.826 0.85 . . . . 0.0 111.554 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.75 105.28 5.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.425 -1.422 . . . . 0.0 112.317 169.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -92.24 114.06 26.5 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.295 -0.878 . . . . 0.0 109.193 166.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -77.39 121.3 23.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 159.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.532 HD22 HH21 ' A' ' 104' ' ' ARG . 4.4 mp -87.86 63.32 7.36 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.197 0.998 . . . . 0.0 111.653 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.9 m -79.45 118.77 21.63 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.723 0.809 . . . . 0.0 111.166 -168.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.24 -48.43 0.94 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 115.87 1.108 . . . . 0.0 115.87 -159.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.7 mt -80.37 -85.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -171.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.08 8.26 13.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 55.94 46.27 22.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 mtt-85 -123.41 140.99 52.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.446 -0.784 . . . . 0.0 111.268 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.95 111.33 20.73 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.211 0.529 . . . . 0.0 111.266 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.7 m -103.83 135.41 45.43 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.291 0.637 . . . . 0.0 111.285 171.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mmt -77.58 99.46 5.75 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.225 1.012 . . . . 0.0 109.614 165.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.6 m -104.28 122.55 45.64 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.657 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.6 m -103.78 126.57 51.0 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 166.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.6 t -111.34 128.75 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.2 m -134.14 149.93 51.09 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.063 0.945 . . . . 0.0 111.925 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -85.11 128.9 34.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.647 -1.283 . . . . 0.0 114.294 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -122.09 68.98 0.94 Allowed 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 123.964 0.905 . . . . 0.0 109.953 164.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.18 -103.48 1.01 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 116.265 1.266 . . . . 0.0 116.265 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -77.25 -30.18 54.35 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -90.35 116.45 28.32 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 119.255 0.934 . . . . 0.0 110.907 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -89.26 109.68 20.54 Favored 'General case' 0 CA--C 1.562 1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.201 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -95.31 140.35 30.33 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.219 1.008 . . . . 0.0 111.595 -171.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 51.8 t -137.73 133.88 34.66 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -116.12 128.83 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.636 0.774 . . . . 0.0 109.526 168.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -107.12 103.47 12.88 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.812 0.845 . . . . 0.0 110.102 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -86.71 113.07 22.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.074 -1.016 . . . . 0.0 111.48 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.11 -129.79 1.21 Allowed Glycine 0 N--CA 1.487 2.058 0 O-C-N 121.652 -0.655 . . . . 0.0 113.789 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -79.0 -22.18 45.9 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -170.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -105.66 142.08 36.0 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.481 1.491 . . . . 0.0 111.593 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -86.82 141.71 28.62 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.2 50.71 60.72 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 -170.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.532 HH21 HD22 ' A' ' 74' ' ' LEU . 18.5 ttt180 -109.38 125.08 52.01 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.544 0.738 . . . . 0.0 110.344 -170.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.61 -164.61 35.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -157.4 159.35 37.3 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.377 1.085 . . . . 0.0 113.348 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.5 m -133.33 125.13 28.54 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -121.12 136.1 55.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.906 -0.496 . . . . 0.0 111.677 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.3 p90 -146.65 156.37 43.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.912 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.1 mt -95.35 126.69 47.78 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -111.64 94.22 4.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 158.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.83 -110.44 3.16 Favored Glycine 0 N--CA 1.491 2.34 0 O-C-N 121.163 -0.961 . . . . 0.0 115.236 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.2 p30 -95.74 7.61 45.81 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 164.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -110.96 127.15 55.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.23 1.377 . . . . 0.0 111.834 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 tp -85.29 115.87 23.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.168 0.987 . . . . 0.0 109.39 166.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.19 120.02 39.62 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 tp -117.32 120.75 39.17 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.835 0.854 . . . . 0.0 110.425 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -97.09 123.5 40.86 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 162.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.432 ' SD ' H202 ' A' ' 175' ' ' RTL . 73.7 mtm -112.88 126.65 55.68 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.519 0.6 . . . . 0.0 109.763 170.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -121.82 137.19 54.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.542 -0.724 . . . . 0.0 112.364 -167.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.4 126.8 5.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.12 0.568 . . . . 0.0 110.922 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 57.25 40.93 27.53 Favored 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.28 -13.34 2.79 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 120.261 2.864 . . . . 0.0 120.261 -163.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.75 122.08 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 119.701 1.75 . . . . 0.0 109.174 -169.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.0 m -102.9 126.47 50.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 122.949 0.5 . . . . 0.0 111.074 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 16.6 t -95.77 131.57 41.91 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.269 0.628 . . . . 0.0 111.131 162.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -112.69 112.35 23.8 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.062 0.545 . . . . 0.0 110.092 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -115.32 144.81 43.19 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.44 0.696 . . . . 0.0 111.847 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.0 t -123.62 127.99 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.61 131.63 46.53 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 123.59 0.756 . . . . 0.0 110.43 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -104.32 131.66 51.42 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.546 -1.346 . . . . 0.0 112.031 -175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -68.99 113.52 6.45 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.71 -31.17 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 . . . . . 0 CA--C 1.566 1.592 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 170.871 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.432 H202 ' SD ' ' A' ' 119' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 51.8 mtm . . . . . 0 CA--C 1.569 1.688 0 CA-C-O 115.597 -2.144 . . . . 0.0 112.616 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.29 113.66 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 125.397 2.963 . . . . 0.0 115.33 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.59 144.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.062 0.934 . . . . 0.0 111.877 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -76.92 106.95 8.92 Favored 'General case' 0 CA--C 1.567 1.634 0 O-C-N 121.492 -0.755 . . . . 0.0 111.793 170.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.9 3.25 42.7 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -59.73 120.54 9.72 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.076 1.762 . . . . 0.0 114.793 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.91 174.12 28.2 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 122.847 1.248 . . . . 0.0 115.446 177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -107.71 111.52 23.76 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.108 0.963 . . . . 0.0 108.573 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -114.28 111.85 22.17 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -167.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -90.66 139.8 30.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.057 -1.027 . . . . 0.0 113.189 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' A' ' 38' ' ' PRO . 36.7 ttp -72.94 125.6 27.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.441 -1.412 . . . . 0.0 114.17 -171.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.2 mt -86.06 -50.3 7.14 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 169.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.3 p -136.79 149.28 47.69 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 119.369 0.986 . . . . 0.0 113.459 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -128.21 103.73 7.35 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.42 -60.8 1.87 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -127.24 43.31 3.15 Favored 'General case' 0 CA--C 1.572 1.826 0 C-N-CA 123.868 0.867 . . . . 0.0 110.575 -178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -76.65 -45.66 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.79 -47.95 70.3 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 166.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -64.59 -37.22 86.82 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -57.38 -43.75 83.88 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 120.85 1.659 . . . . 0.0 115.149 162.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.83 -38.14 85.85 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 172.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 ttp85 -55.93 -43.23 77.18 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 162.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.22 62.28 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.56 12.48 29.43 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 164.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.264 28.0 t70 56.92 47.9 16.88 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 120.602 1.546 . . . . 0.0 115.036 -174.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -93.35 155.57 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.448 -0.783 . . . . 0.0 110.722 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 151.13 47.06 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.45 -43.87 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.73 62.75 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 33.8 tp -61.35 -39.34 90.22 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 169.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -54.1 -39.01 65.99 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -71.57 -50.56 29.84 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 61.6 mt -64.68 -54.56 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 C-N-CA 123.906 0.883 . . . . 0.0 112.468 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.71 75.61 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -65.91 -39.89 91.0 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 165.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.78 -24.01 62.51 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 mt -68.04 148.04 51.54 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.45 1.477 . . . . 0.0 113.72 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -107.67 86.54 2.95 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.03 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 53.5 Cg_endo -72.69 154.82 54.51 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 115.934 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -118.81 111.42 18.42 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -83.53 107.19 15.84 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.59 -0.694 . . . . 0.0 110.708 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -94.54 107.95 19.91 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.8 mt -105.84 125.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -110.89 105.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.0 105.96 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.269 172.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -92.2 77.85 5.22 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.68 0.792 . . . . 0.0 109.922 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.29 -97.12 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 O-C-N 121.416 -0.803 . . . . 0.0 114.793 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.47 -17.51 20.49 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 164.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -82.99 114.11 21.04 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 120.789 1.631 . . . . 0.0 111.264 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.7 ttm -121.04 124.13 44.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.568 0.747 . . . . 0.0 111.225 -167.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.6 mt -114.08 96.79 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.6 mt -90.17 112.29 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -106.48 97.79 7.55 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.5 m -82.77 94.44 7.63 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.0 109.338 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.8 mt -90.81 131.75 36.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.121 0.568 . . . . 0.0 111.687 -168.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.1 t -150.88 155.9 40.12 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.097 0.951 . . . . 0.0 111.909 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.8 p -61.13 -32.57 72.26 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 172.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -78.1 -55.11 5.54 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -155.57 139.95 16.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.959 0.799 . . . . 0.0 110.238 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -88.82 125.11 34.76 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 123.051 0.54 . . . . 0.0 110.826 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -104.21 118.03 35.65 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.109 0.868 . . . . 0.0 110.584 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mm -112.11 120.7 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 95.8 mtp -108.84 111.54 23.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.377 0.671 . . . . 0.0 109.258 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.09 108.44 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.408 0.683 . . . . 0.0 109.272 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -152.48 155.02 36.67 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -167.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.35 134.73 40.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.817 166.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.44 123.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.78 5.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -154.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -95.18 135.39 36.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.389 1.095 . . . . 0.0 112.772 -161.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -85.66 107.08 17.39 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 122.033 -0.417 . . . . 0.0 110.15 167.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -116.85 157.83 24.97 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.81 0.844 . . . . 0.0 112.33 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.63 104.46 6.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.672 -1.268 . . . . 0.0 112.167 169.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -90.75 107.09 18.95 Favored 'General case' 0 CA--C 1.559 1.321 0 O-C-N 121.39 -0.818 . . . . 0.0 108.959 168.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -82.7 120.29 25.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 164.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.401 HD22 HH21 ' A' ' 104' ' ' ARG . 4.7 mp -90.9 49.97 1.73 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.9 t -74.17 132.96 42.7 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.218 1.007 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.03 -50.17 1.03 Allowed Glycine 0 N--CA 1.488 2.155 0 O-C-N 121.571 -0.705 . . . . 0.0 114.576 -158.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 mt -79.35 -66.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 125.002 1.321 . . . . 0.0 111.067 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -143.99 -6.54 0.76 Allowed 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.877 1.671 . . . . 0.0 114.175 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.287 3.3 t70 52.03 45.56 28.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -127.01 141.08 51.88 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.526 0.679 . . . . 0.0 110.574 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -84.23 127.36 33.9 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.707 0.765 . . . . 0.0 112.564 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 94.6 m -113.51 141.29 47.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.578 0.751 . . . . 0.0 111.076 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.29 98.35 4.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 159.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.41 HG23 ' SG ' ' A' ' 95' ' ' CYS . 89.9 m -99.66 121.53 41.36 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 42.0 m -109.33 120.42 42.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 t -110.64 124.99 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.0 m -134.63 158.52 43.83 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 112.565 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -88.06 113.67 23.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 112.093 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.35 77.15 3.4 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.933 0.873 . . . . 0.0 109.256 164.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.07 -105.67 1.27 Allowed Glycine 0 CA--C 1.547 2.048 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.959 -168.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -86.36 -26.35 24.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -83.18 134.24 34.99 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.611 1.55 . . . . 0.0 112.268 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -90.66 100.71 13.51 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.734 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -108.24 140.34 41.62 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.677 0.791 . . . . 0.0 111.482 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' A' ' 84' ' ' THR . 50.2 t -134.19 141.44 47.05 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -170.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.8 p -114.17 128.58 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 123.783 0.833 . . . . 0.0 109.84 166.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -101.88 103.86 14.56 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.499 0.72 . . . . 0.0 109.264 173.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -89.14 99.75 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 110.187 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.16 94.4 0.09 OUTLIER Glycine 0 N--CA 1.488 2.114 0 N-CA-C 116.344 1.298 . . . . 0.0 116.344 -169.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.296 40.0 mt-10 73.19 -51.07 0.71 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 161.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -99.27 144.77 28.01 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.622 0.769 . . . . 0.0 111.306 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.77 162.48 21.7 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.69 51.97 48.93 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 117.74 1.856 . . . . 0.0 117.74 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.401 HH21 HD22 ' A' ' 74' ' ' LEU . 27.7 ttt180 -121.19 122.27 39.6 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.533 0.682 . . . . 0.0 111.926 -159.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 172.93 -162.83 34.44 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 121.447 -0.783 . . . . 0.0 114.064 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.268 67.3 p-90 -156.79 168.32 27.8 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 123.215 1.484 . . . . 0.0 113.115 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -146.86 130.57 16.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.975 -1.703 . . . . 0.0 108.599 168.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -127.53 142.48 51.37 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.282 1.039 . . . . 0.0 112.255 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -146.59 167.48 23.63 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 65.9 mt -114.62 126.7 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.284 -0.885 . . . . 0.0 109.176 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.35 89.85 3.24 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 163.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.67 -110.47 3.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 115.195 0.838 . . . . 0.0 115.195 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -99.32 17.12 20.88 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 164.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -110.55 126.21 54.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.496 1.044 . . . . 0.0 111.593 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.4 tp -86.43 122.39 30.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.801 0.84 . . . . 0.0 109.683 166.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -111.15 119.49 39.15 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 51.0 tp -118.17 128.63 54.9 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.717 0.807 . . . . 0.0 110.54 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -108.53 119.34 39.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.619 0.767 . . . . 0.0 109.547 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.461 ' SD ' H202 ' A' ' 175' ' ' RTL . 70.2 mtm -112.92 129.87 56.32 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.487 0.715 . . . . 0.0 111.312 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -123.61 132.78 53.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 111.901 -167.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.27 129.79 14.91 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.779 0.831 . . . . 0.0 109.305 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 55.57 36.08 26.45 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.07 -3.83 27.43 Favored Glycine 0 CA--C 1.557 2.684 0 N-CA-C 119.878 2.711 . . . . 0.0 119.878 -164.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.92 113.64 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-N 120.071 1.935 . . . . 0.0 109.091 -169.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 87.0 m -93.37 119.39 32.44 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.772 0.829 . . . . 0.0 111.007 -173.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.8 t -90.81 125.96 35.87 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.385 0.674 . . . . 0.0 112.067 164.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -98.4 122.84 42.09 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.791 0.436 . . . . 0.0 110.33 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -117.82 139.85 50.51 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.315 0.646 . . . . 0.0 110.664 168.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -120.0 130.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -128.82 136.42 50.46 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 123.299 0.64 . . . . 0.0 111.411 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 tpmt? -96.09 127.32 42.0 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.649 1.179 . . . . 0.0 111.501 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -68.55 119.82 13.61 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.185 0.902 . . . . 0.0 112.777 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.22 -38.5 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 CA--C 1.561 1.389 0 CA-C-N 119.78 1.173 . . . . 0.0 107.909 169.542 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . 0.464 ' H11' H191 ' A' ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.572 1.802 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.53 -82.95 0.01 OUTLIER 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 125.077 2.849 . . . . 0.0 113.114 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.15 -27.69 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 121.395 -0.816 . . . . 0.0 112.37 157.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.343 15.3 t70 68.46 90.06 0.1 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.366 1.466 . . . . 0.0 112.66 -167.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -79.41 15.62 1.22 Allowed 'General case' 0 CA--C 1.581 2.161 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -59.19 117.32 4.61 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.48 176.08 30.12 Favored Glycine 0 N--CA 1.489 2.185 0 CA-C-O 122.6 1.111 . . . . 0.0 115.865 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -106.94 113.86 27.6 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.442 1.097 . . . . 0.0 109.034 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -117.56 112.99 21.32 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -92.67 140.64 29.32 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.843 -1.161 . . . . 0.0 113.397 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.5 ttp -70.4 117.37 11.85 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-N 119.726 1.148 . . . . 0.0 114.0 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.14 -46.88 21.98 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 167.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.2 m -153.75 160.49 42.3 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.811 1.291 . . . . 0.0 112.704 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -150.33 112.75 4.68 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.773 -174.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.3 -69.74 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -117.19 42.22 2.59 Favored 'General case' 0 CA--C 1.569 1.696 0 C-N-CA 123.882 0.873 . . . . 0.0 112.217 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -73.44 -36.01 65.86 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -59.85 -39.56 85.6 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.79 -40.28 83.95 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 167.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.35 -47.81 82.57 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 169.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.25 -39.37 75.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.7 ttp85 -54.4 -43.43 71.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 162.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.85 51.7 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 165.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.16 2.2 47.74 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 166.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.297 20.2 t70 63.64 49.34 3.04 Favored 'General case' 0 CA--C 1.574 1.865 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -167.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -95.83 146.41 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.162 0.982 . . . . 0.0 110.13 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -65.89 153.63 41.47 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.3 t -59.72 -44.74 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.45 -49.55 74.26 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.7 tt -60.76 -43.25 98.23 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -52.46 -50.84 61.84 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 165.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -62.98 -45.14 93.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.8 mt -61.27 -54.43 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 118.945 0.793 . . . . 0.0 111.6 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.5 -38.1 80.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 117.79 2.515 . . . . 0.0 117.79 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -71.51 -29.92 65.35 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 168.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -76.29 -26.8 56.26 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.6 144.37 57.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.367 1.439 . . . . 0.0 113.563 177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -107.73 84.62 2.05 Favored Pre-proline 0 CA--C 1.573 1.837 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.847 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.02 156.5 47.46 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.579 2.186 . . . . 0.0 115.171 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -116.42 118.83 33.78 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HZ1' HD22 ' A' ' 117' ' ' LEU . 60.3 mttt -84.81 108.14 17.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.36 -0.837 . . . . 0.0 110.661 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -96.22 107.66 20.03 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 168.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.5 mt -104.1 128.13 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -114.51 107.32 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -100.04 118.7 36.98 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.356 0.663 . . . . 0.0 110.708 172.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -107.41 81.83 1.58 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 -104.19 1.16 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -82.3 -27.36 32.35 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -79.12 116.13 19.21 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 120.196 1.362 . . . . 0.0 111.943 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.9 ttm -124.28 127.13 47.2 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 121.506 0.67 . . . . 0.0 110.971 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.05 99.26 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.3 mt -91.24 107.03 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -100.95 99.91 10.45 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -88.0 99.41 12.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.4 mt -102.08 129.07 48.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.066 0.546 . . . . 0.0 111.848 -162.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -148.18 145.92 28.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.58 0.705 . . . . 0.0 110.379 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.5 p -60.78 -26.03 66.96 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -73.31 -50.63 21.1 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 165.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -159.74 133.44 7.21 Favored 'General case' 0 CA--C 1.564 1.482 0 CA-C-N 119.624 1.102 . . . . 0.0 111.268 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -97.91 139.73 33.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.675 -0.64 . . . . 0.0 111.395 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -123.77 119.99 31.36 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -0.779 . . . . 0.0 110.251 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mm -113.35 122.21 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -171.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.3 mtp -109.48 106.17 15.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.717 -0.614 . . . . 0.0 109.793 175.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -107.76 112.28 24.87 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.516 0.726 . . . . 0.0 109.738 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.24 155.84 31.51 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -167.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -95.67 130.84 42.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 111.054 164.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.0 t -69.14 123.53 22.9 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.86 0 O-C-N 121.637 -0.664 . . . . 0.0 109.933 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.14 -34.41 4.84 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 116.895 1.518 . . . . 0.0 116.895 -161.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -94.56 147.55 23.16 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.815 1.307 . . . . 0.0 113.065 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.59 124.69 35.94 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.787 -0.57 . . . . 0.0 110.865 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -133.53 151.95 51.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.568 0.747 . . . . 0.0 112.568 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.4 110.39 7.65 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.436 1.113 . . . . 0.0 112.324 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -94.04 100.12 12.3 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.224 1.01 . . . . 0.0 109.554 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.26 104.58 8.94 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.447 0.641 . . . . 0.0 110.003 175.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mt -90.45 45.83 1.29 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 m -81.86 131.5 35.26 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.198 0.999 . . . . 0.0 110.546 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.2 -34.99 4.48 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.924 1.529 . . . . 0.0 116.924 -159.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 mt -86.36 -67.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 124.439 1.096 . . . . 0.0 109.553 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -136.59 -7.35 1.94 Allowed 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.257 26.8 t0 57.4 64.69 1.53 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 120.304 1.411 . . . . 0.0 114.666 -166.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -136.82 144.12 43.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.6 -0.688 . . . . 0.0 111.057 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -97.6 112.02 24.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.349 -0.844 . . . . 0.0 111.066 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -110.31 146.55 35.53 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.41 0.684 . . . . 0.0 111.701 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.8 mmt -82.09 97.6 8.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.161 -1.587 . . . . 0.0 110.229 171.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.436 ' CG2' ' SG ' ' A' ' 95' ' ' CYS . 36.1 m -91.91 126.29 36.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.716 -0.615 . . . . 0.0 111.634 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 m -107.39 125.96 51.88 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 162.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.5 t -111.82 127.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -129.29 159.08 37.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.029 0.931 . . . . 0.0 111.829 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -88.74 126.15 35.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.603 -1.311 . . . . 0.0 112.278 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -102.05 74.19 1.43 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 158.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.44 -98.72 0.15 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 -173.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.31 -35.33 61.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 169.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -87.63 129.89 34.97 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.111 0.869 . . . . 0.0 111.776 -170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.6 tp -88.58 107.56 18.97 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 123.286 0.634 . . . . 0.0 109.761 173.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -114.08 132.4 56.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.583 0.753 . . . . 0.0 111.527 -167.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.436 ' SG ' ' CG2' ' A' ' 84' ' ' THR . 40.6 t -131.65 138.42 48.75 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.38 124.77 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.444 167.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -101.06 97.26 7.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.581 -0.699 . . . . 0.0 109.544 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -85.2 115.82 23.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 0.0 112.01 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.58 -110.59 0.3 Allowed Glycine 0 N--CA 1.483 1.833 0 O-C-N 121.396 -0.815 . . . . 0.0 113.663 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -87.67 -7.89 56.85 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -166.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -126.38 143.7 51.08 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.458 1.481 . . . . 0.0 112.081 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -85.67 113.63 22.02 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.424 0.63 . . . . 0.0 112.523 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.93 56.68 6.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -101.54 130.68 47.88 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 121.413 0.625 . . . . 0.0 111.243 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.15 -170.21 40.01 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -155.62 153.45 30.08 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.2 m -127.83 121.05 29.13 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -119.65 123.42 43.79 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 123.599 0.759 . . . . 0.0 110.67 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -142.86 153.29 43.03 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 113.194 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -100.64 126.12 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.0 109.227 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.57 92.83 3.99 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.99 -115.13 4.82 Favored Glycine 0 N--CA 1.488 2.146 0 O-C-N 121.637 -0.664 . . . . 0.0 114.473 -176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 58.2 p30 -94.58 8.05 43.57 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 164.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.18 126.71 53.55 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 120.598 1.545 . . . . 0.0 111.141 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 tp -90.41 113.57 25.51 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.32 1.048 . . . . 0.0 109.226 169.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -99.46 125.48 45.21 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 109.531 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.433 HD22 ' HZ1' ' A' ' 40' ' ' LYS . 31.6 tp -122.47 120.5 34.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.696 0.798 . . . . 0.0 110.267 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.05 130.33 47.05 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.936 165.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -125.02 129.26 49.94 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.68 1.127 . . . . 0.0 111.111 176.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -118.21 144.36 45.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.483 -0.76 . . . . 0.0 112.715 -171.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.73 127.89 4.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.539 0.736 . . . . 0.0 110.162 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 52.57 50.28 18.55 Favored 'General case' 0 N--CA 1.508 2.429 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -170.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.89 -20.29 1.88 Allowed Glycine 0 CA--C 1.557 2.671 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 -169.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.7 t -67.84 172.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 CA-C-N 120.146 1.973 . . . . 0.0 112.993 -169.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.5 m -144.28 115.3 7.87 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 119.31 -2.119 . . . . 0.0 109.83 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 7.8 t -93.84 121.92 35.79 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.752 0.821 . . . . 0.0 111.381 166.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -98.11 123.99 42.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.822 0.449 . . . . 0.0 111.433 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -122.0 139.19 53.98 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.937 0.895 . . . . 0.0 110.499 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 36.2 t -120.26 126.77 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -127.58 122.33 32.93 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.56 0.744 . . . . 0.0 110.575 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -98.19 135.24 40.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.471 -1.393 . . . . 0.0 112.872 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -69.11 121.79 17.44 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.33 -35.78 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 120.057 1.299 . . . . 0.0 108.232 169.885 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' RTL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_